data_4b2s_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4b2s _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 30.5 p -137.83 142.11 40.79 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -94.6 -134.16 7.38 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.769 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 78.2 Cg_exo -53.56 146.54 42.64 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.818 3.012 . . . . 0.0 113.162 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 645' ' ' THR . 31.3 Cg_endo -65.71 158.07 55.44 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.537 2.158 . . . . 0.0 111.421 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 681' ' ' LEU . 25.0 Cg_endo -71.79 -169.24 0.42 Allowed 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.96 2.44 . . . . 0.0 112.054 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.86 146.73 33.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.735 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.9 tt -81.97 141.49 33.24 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -33.28 -69.83 0.08 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.859 1.663 . . . . 0.0 111.142 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 3.1 t30 -108.81 -38.32 5.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.011 -1.075 . . . . 0.0 109.924 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -76.42 -151.28 3.71 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.166 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -169.28 179.51 3.91 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.681 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.9 p -98.92 142.6 14.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 123.312 0.645 . . . . 0.0 110.006 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -97.01 -27.46 14.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.071 0.463 . . . . 0.0 110.777 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.29 142.62 35.97 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.637 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -83.56 159.47 21.65 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.398 0.618 . . . . 0.0 111.003 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.47 HG23 ' HD2' ' A' ' 633' ' ' PRO . 21.3 p -73.42 122.81 22.7 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.759 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 648' ' ' GLU . 43.3 mtmt -96.76 -29.27 13.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.769 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 40.8 mt-10 71.47 -26.2 0.17 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 125.984 1.714 . . . . 0.0 113.041 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 646' ' ' LYS . 8.3 pt-20 -95.17 42.21 1.09 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.041 0.536 . . . . 0.0 110.987 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.615 ' HD2' ' CD1' ' A' ' 649' ' ' TYR . 80.0 m-85 -69.85 -73.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 92.74 -68.09 1.81 Allowed Glycine 0 C--N 1.293 -1.809 0 C-N-CA 120.387 -0.911 . . . . 0.0 114.499 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -161.51 138.57 8.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 117.196 0.498 . . . . 0.0 112.168 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 26.1 m 63.9 13.86 7.92 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.904 1.681 . . . . 0.0 113.282 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 8.6 mm-40 -78.54 136.29 37.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.426 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 t -110.46 143.28 20.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 56.7 t -132.26 135.76 57.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.259 0.624 . . . . 0.0 109.866 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.92 132.48 49.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 122.174 0.987 . . . . 0.0 111.783 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' A' ' 657' ' ' TYR . 41.7 m-85 -108.52 166.74 10.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.596 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' A' ' 659' ' ' CYS . 45.6 p90 -137.13 160.09 39.98 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 69.6 m -98.31 169.36 9.62 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.653 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.477 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.53 165.27 3.14 Favored Pre-proline 0 C--O 1.2 -1.539 0 C-N-CA 124.329 1.052 . . . . 0.0 109.367 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 72.6 Cg_endo -75.59 12.88 1.26 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.749 2.299 . . . . 0.0 112.577 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.461 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 25.4 ptt180 -144.21 10.6 1.5 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.896 0.855 . . . . 0.0 110.041 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 45.5 m-85 -134.81 138.22 44.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.202 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 711' ' ' TYR . 11.3 mt -104.28 154.75 19.42 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.332 0.586 . . . . 0.0 110.048 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.522 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 55.0 tpp -73.52 124.61 26.2 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.022 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -110.82 -25.76 9.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.969 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.05 -172.92 46.35 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.45 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 57.9 Cg_endo -72.43 -9.76 24.58 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.377 2.718 . . . . 0.0 112.345 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.2 p-10 55.96 -0.25 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 127.6 2.36 . . . . 0.0 115.947 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 31.8 mtmt -130.24 144.36 51.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.0 pt -136.11 167.64 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 123.425 0.453 . . . . 0.0 109.897 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.8 tt0 -135.87 140.56 44.23 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 123.751 0.821 . . . . 0.0 110.461 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.8 t -85.14 99.2 10.91 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.756 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.64 165.35 2.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.307 2.2 p30 -75.5 80.51 2.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 118.426 -1.31 . . . . 0.0 113.763 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.84 -40.26 0.5 Allowed Glycine 0 N--CA 1.419 -2.451 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.249 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -165.12 175.76 9.09 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -81.55 171.2 14.95 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.691 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 23.0 p -82.89 -165.62 1.11 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.59 0.234 . . . . 0.0 111.493 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 94.8 m -66.69 111.98 3.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.523 HD22 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -69.52 154.4 94.87 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.487 175.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.735 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 56.0 Cg_endo -69.62 -178.76 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.502 2.134 . . . . 0.0 114.444 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.7 145.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 86.7 m -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.55 140.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 662' ' ' ARG . 7.3 p . . . . . 0 C--N 1.295 -1.763 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 18.7 p . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 120.978 0.418 . . . . 0.0 111.9 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 8.7 m -93.27 -2.75 54.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 99.2 -87.3 0.76 Allowed Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.747 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.6 t70 -158.45 -167.56 2.2 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.611 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -73.63 133.17 80.12 Favored Pre-proline 0 N--CA 1.407 -2.615 0 C-N-CA 123.899 0.879 . . . . 0.0 109.998 175.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.578 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 66.9 Cg_endo -73.68 -164.89 0.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.248 2.632 . . . . 0.0 111.301 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -117.7 142.08 47.65 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.55 HD11 ' HA3' ' A' ' 700' ' ' GLY . 3.5 tt -117.09 137.46 52.26 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.403 ' HG2' HD21 ' A' ' 697' ' ' LEU . 14.4 pt-20 -41.69 -40.01 1.84 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 113.113 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.628 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 97.1 m-70 -145.32 29.38 1.16 Allowed 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.55 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -133.3 170.38 22.28 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.567 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -158.54 -155.41 0.48 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -136.79 152.16 49.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -167.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.451 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -92.44 -48.95 6.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.859 178.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.7 pp -124.83 152.92 43.33 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.4 p -147.88 124.17 10.89 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.319 1.048 . . . . 0.0 109.096 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.4 t -131.78 92.0 31.8 Favored Pre-proline 0 C--N 1.289 -2.052 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.601 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -87.16 149.47 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 122.634 2.223 . . . . 0.0 111.454 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.82 132.94 29.17 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.133 -1.611 . . . . 0.0 112.493 0.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.627 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 46.6 m-85 -76.48 92.38 3.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.035 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.68 166.72 21.54 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 123.548 0.53 . . . . 0.0 111.656 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 3.6 t80 -66.91 135.28 53.59 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.31 60.34 Favored Glycine 0 N--CA 1.402 -3.617 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.95 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.66 166.22 19.34 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.502 0.651 . . . . 0.0 110.885 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 0.9 OUTLIER -127.62 158.24 38.06 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.414 0.626 . . . . 0.0 111.157 -172.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 694' ' ' ILE . 26.2 t -142.04 142.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.606 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -102.33 126.12 49.25 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 120.802 0.334 . . . . 0.0 110.102 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.6 m-85 -97.7 154.98 17.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.929 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.493 HD21 ' N ' ' A' ' 719' ' ' CYS . 0.2 OUTLIER -137.23 135.74 37.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -177.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.493 ' N ' HD21 ' A' ' 718' ' ' ASN . 95.6 m -93.48 144.24 25.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 63.1 m -56.68 161.77 2.62 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.91 140.37 55.49 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.762 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.7 m 79.12 -2.19 2.25 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 125.962 1.705 . . . . 0.0 111.712 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 723' ' ' PHE . 59.1 m-85 -116.56 140.17 49.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.947 -0.471 . . . . 0.0 110.419 173.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 9.2 t -108.24 141.73 39.57 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.663 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -91.03 137.98 31.95 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.23 0.538 . . . . 0.0 110.7 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.49 115.0 44.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.06 -154.38 20.24 Favored Glycine 0 CA--C 1.472 -2.623 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -94.63 130.2 41.19 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -63.19 -29.95 71.2 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.121 0.888 . . . . 0.0 111.624 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 6.0 p -113.95 152.9 30.18 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 121.602 0.715 . . . . 0.0 112.073 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.495 HG22 HD21 ' A' ' 741' ' ' LEU . 7.7 pt -127.73 167.27 23.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.481 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 82.9 m -133.49 135.92 44.76 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.7 t -67.29 109.04 2.96 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.768 0.827 . . . . 0.0 110.471 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.6 mm -126.83 99.01 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.46 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 66.56 30.07 8.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.525 1.13 . . . . 0.0 112.172 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 97.02 0.37 60.1 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.559 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.39 143.61 38.54 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.578 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -78.3 166.05 23.14 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 38.0 p -48.67 -69.46 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.19 -30.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.495 HD21 HG22 ' A' ' 731' ' ' ILE . 20.2 mt 67.73 148.91 0.12 Allowed Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 124.856 1.347 . . . . 0.0 111.564 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.663 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 77.7 Cg_endo -80.77 175.28 10.17 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.016 1.811 . . . . 0.0 109.693 174.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.88 134.93 54.87 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.628 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 4.4 m -102.47 122.72 44.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.72 149.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.55 112.62 4.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 124.161 0.913 . . . . 0.0 111.239 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.41 HD12 ' HB ' ' A' ' 724' ' ' THR . 56.6 mt . . . . . 0 C--O 1.249 1.038 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.6 p -168.61 152.38 5.63 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.16 -138.41 9.66 Favored Glycine 1 N--CA 1.392 -4.253 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.422 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 51.0 Cg_exo -54.6 144.38 64.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.6 2.866 . . . . 0.0 112.891 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.75 ' HD2' HG23 ' A' ' 645' ' ' THR . 30.7 Cg_endo -61.51 162.68 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.269 2.646 . . . . 0.0 112.895 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.489 ' HG2' HD22 ' A' ' 681' ' ' LEU . 32.2 Cg_endo -75.5 -165.42 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.548 2.165 . . . . 0.0 111.194 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.44 174.69 5.75 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 682' ' ' PRO . 17.2 tp -109.36 144.55 37.39 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.75 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -32.66 -59.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.547 1.939 . . . . 0.0 111.784 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.3 t30 -120.2 -44.75 2.48 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.316 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -76.83 -152.79 4.89 Favored Glycine 0 CA--C 1.495 -1.19 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.393 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 658' ' ' TYR . 2.5 t-20 -156.86 -178.25 7.22 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.364 -1.334 . . . . 0.0 110.152 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.26 146.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -111.0 -13.38 14.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.836 0.827 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.476 ' HB2' HG11 ' A' ' 655' ' ' VAL . 15.6 mm-40 -79.89 134.94 36.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.635 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 644' ' ' LYS . 9.3 mmpt? -67.5 158.47 31.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.842 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.75 HG23 ' HD2' ' A' ' 633' ' ' PRO . 65.4 p -107.11 151.09 25.84 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.318 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -99.5 -87.93 0.35 Allowed 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.933 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.523 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 12.1 pt-20 156.88 -36.21 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.434 0 C-N-CA 125.713 1.605 . . . . 0.0 107.956 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -126.07 107.87 10.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.846 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 7.7 m-85 -101.73 -72.19 0.69 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.753 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 114.85 -105.49 1.5 Allowed Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.545 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -138.58 140.98 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.644 0.222 . . . . 0.0 110.494 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 41.3 m 72.82 15.8 4.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.006 1.322 . . . . 0.0 112.987 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.846 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 14.5 mm-40 -75.11 133.92 41.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 671' ' ' ILE 0.263 0.5 OUTLIER -125.91 134.28 66.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.824 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 53.7 t -125.14 143.38 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.136 0.974 . . . . 0.0 111.239 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 669' ' ' ASN . 30.2 tt0 -104.62 133.49 49.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.865 0.841 . . . . 0.0 111.461 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 46.8 m-85 -105.48 166.58 10.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.415 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 640' ' ' ASN . 49.7 p90 -138.95 144.46 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 60.4 m -102.46 151.04 22.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.127 0.489 . . . . 0.0 110.183 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 15.0 m120 -52.48 159.96 1.48 Allowed Pre-proline 0 C--N 1.305 -1.358 0 C-N-CA 126.268 1.827 . . . . 0.0 114.739 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.24 6.89 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 124.008 3.139 . . . . 0.0 113.737 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -140.54 -2.15 1.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.642 0.734 . . . . 0.0 111.535 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 51.9 m-85 -116.62 122.8 45.65 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.405 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.533 HD23 ' CD1' ' A' ' 711' ' ' TYR . 11.0 mt -85.73 142.05 29.28 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.524 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.444 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 35.8 ttm -77.96 110.34 12.8 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.105 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.68 ' HD2' HD11 ' A' ' 685' ' ' ILE . 55.5 tttm -99.3 -39.04 8.62 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.018 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.34 -153.56 9.04 Favored Glycine 0 CA--C 1.503 -0.669 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.806 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.736 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 39.9 Cg_endo -70.07 -148.84 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.229 1.953 . . . . 0.0 110.252 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.444 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 2.0 p-10 -166.39 -28.31 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.888 -0.507 . . . . 0.0 110.096 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 97.3 mttt -112.75 124.15 51.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.166 176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.625 HG22 HD21 ' A' ' 681' ' ' LEU . 44.5 pt -109.24 166.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.656 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -137.78 141.57 40.89 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 123.052 0.541 . . . . 0.0 110.58 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.9 t -79.51 93.47 5.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.224 1.011 . . . . 0.0 108.429 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.19 163.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.232 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.33 86.62 0.6 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.901 1.334 . . . . 0.0 111.484 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 149.64 -47.92 0.61 Allowed Glycine 0 N--CA 1.407 -3.284 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.34 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -158.36 -179.79 8.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -78.4 166.77 22.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.5 p -76.98 -174.94 3.32 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 120.998 0.428 . . . . 0.0 111.555 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 29.6 m -69.94 120.02 15.03 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.919 0.866 . . . . 0.0 111.263 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.625 HD21 HG22 ' A' ' 671' ' ' ILE . 82.8 mt -66.87 146.56 99.11 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.153 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.736 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 34.8 Cg_endo -67.79 -173.87 0.53 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.051 2.501 . . . . 0.0 113.415 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.21 137.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 57.5 m -115.9 133.44 56.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.68 HD11 ' HD2' ' A' ' 666' ' ' LYS . 38.5 pt -130.27 136.57 58.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 122.917 0.487 . . . . 0.0 110.127 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.964 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.729 179.184 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.418 -2.055 0 CA-C-O 121.4 0.619 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.89 -16.32 18.06 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.446 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 109.55 -79.85 0.26 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.44 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 694' ' ' ILE . 15.9 t70 -173.61 -169.2 0.49 Allowed 'General case' 0 C--O 1.25 1.085 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.481 ' CG1' HG12 ' A' ' 715' ' ' VAL . 1.1 mp -67.75 138.35 93.15 Favored Pre-proline 0 C--N 1.285 -2.211 0 C-N-CA 124.141 0.976 . . . . 0.0 110.366 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.657 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -75.41 -165.74 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.659 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -123.73 122.05 37.07 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.739 -0.6 . . . . 0.0 110.046 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.698 HD21 ' HA3' ' A' ' 700' ' ' GLY . 31.6 tp -97.54 155.26 17.03 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.622 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 7.1 pt-20 -43.4 -40.9 3.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.551 1.14 . . . . 0.0 112.188 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.622 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 20.9 m80 -136.25 -40.78 0.65 Allowed 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.878 -173.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.698 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -75.65 168.27 54.79 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.479 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -150.71 -148.3 0.26 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.85 154.33 50.54 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.774 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.422 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -90.9 -43.92 9.7 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 121.736 0.779 . . . . 0.0 109.437 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.26 149.15 45.45 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.44 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.461 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 2.4 p -117.13 146.35 43.23 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.7 t -130.81 86.63 51.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-O 121.669 0.747 . . . . 0.0 111.896 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -92.89 147.42 2.57 Favored 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.855 2.37 . . . . 0.0 111.984 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.9 131.26 23.7 Favored 'Cis proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.604 -1.832 . . . . 0.0 111.161 0.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 27.0 m-85 -73.79 94.88 2.32 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 3.1 m-85 -98.91 172.43 7.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.533 ' CD1' HD23 ' A' ' 664' ' ' LEU . 1.1 t80 -65.92 138.11 57.62 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.47 68.74 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.266 -1.445 . . . . 0.0 112.416 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 732' ' ' THR . 23.8 t70 -76.17 165.71 24.51 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.4 m -134.24 146.08 49.74 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.199 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.481 HG12 ' CG1' ' A' ' 694' ' ' ILE . 40.8 t -135.58 147.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.448 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.536 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 29.5 mt-10 -111.1 127.29 55.51 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.738 176.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 1.7 m-85 -95.58 146.65 24.3 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.422 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -124.64 133.6 53.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.759 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 50.5 t -82.69 164.79 20.48 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.4 m -69.93 152.91 43.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.51 146.19 46.98 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.7 t 83.44 -2.16 1.17 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.886 1.674 . . . . 0.0 109.7 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -121.36 148.81 43.86 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.44 ' HB ' HD12 ' A' ' 747' ' ' ILE . 8.8 t -114.39 137.15 52.18 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.759 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.1 ptm -92.33 141.83 28.11 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.223 0.535 . . . . 0.0 109.944 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.28 120.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 130.34 -147.6 18.27 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -98.53 129.37 45.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.411 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -65.92 -27.88 68.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.293 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.536 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -115.18 157.48 23.59 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.065 0.459 . . . . 0.0 111.071 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.511 HD13 ' CG ' ' A' ' 738' ' ' TRP . 6.6 pt -130.32 166.87 26.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.118 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 85.1 m -136.31 137.06 40.27 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -75.34 119.67 19.75 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.869 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.8 mm -127.58 110.15 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 70.75 26.99 3.71 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.415 1.086 . . . . 0.0 112.697 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.21 77.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.298 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.98 152.8 38.17 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.657 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 83.3 m95 -85.89 154.31 21.61 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 118.97 0.805 . . . . 0.0 109.721 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 732' ' ' THR . 31.9 p -33.56 -69.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.14 -32.18 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.472 HD21 HG22 ' A' ' 731' ' ' ILE . 29.9 mt 69.49 154.88 0.15 Allowed Pre-proline 0 C--N 1.322 -0.614 0 O-C-N 124.517 1.136 . . . . 0.0 111.47 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.538 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 68.7 Cg_endo -84.5 -163.71 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.407 2.071 . . . . 0.0 111.55 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 725' ' ' MET . 3.1 pt20 -139.94 155.27 47.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.45 141.59 44.81 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.931 0.396 . . . . 0.0 111.317 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.85 140.89 46.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.34 119.03 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.587 0.554 . . . . 0.0 111.446 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.44 HD12 ' HB ' ' A' ' 724' ' ' THR . 65.7 mt . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 31.5 p -164.36 135.83 4.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.12 -125.28 5.58 Favored Glycine 1 N--CA 1.386 -4.633 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.509 ' HB3' HG22 ' A' ' 645' ' ' THR . 32.4 Cg_exo -54.91 142.4 75.63 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.657 2.904 . . . . 0.0 114.232 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.686 ' HD2' HG23 ' A' ' 645' ' ' THR . 38.1 Cg_endo -64.79 161.65 35.2 Favored 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.598 2.866 . . . . 0.0 112.239 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 681' ' ' LEU . 32.6 Cg_endo -72.18 -164.15 0.17 Allowed 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 111.493 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.6 178.53 4.6 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 657' ' ' TYR . 27.6 tp -121.15 145.32 47.94 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 636' ' ' LEU . 14.0 tp -34.01 -68.66 0.11 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 126.056 1.743 . . . . 0.0 113.868 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.44 42.05 2.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 124.416 2.055 . . . . 0.0 107.848 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.22 -168.17 17.97 Favored Glycine 1 C--N 1.237 -4.932 0 CA-C-N 111.064 -2.789 . . . . 0.0 109.377 176.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -155.97 178.45 10.26 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.142 0.471 . . . . 0.0 110.483 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 90.9 t -83.41 134.23 27.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.936 0.894 . . . . 0.0 108.66 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.616 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 15.0 ptpt -92.98 -20.75 20.28 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.297 0.57 . . . . 0.0 110.651 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.27 169.31 10.69 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.243 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 27.4 mmtp -109.11 147.59 32.19 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.908 0.385 . . . . 0.0 110.398 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.686 HG23 ' HD2' ' A' ' 633' ' ' PRO . 82.8 p -76.04 140.04 41.73 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -170.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -96.76 -8.54 31.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.94 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.42 ' OE2' ' HG3' ' A' ' 632' ' ' PRO . 27.6 mm-40 68.06 -24.73 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.787 1.635 . . . . 0.0 113.437 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.3 mt-10 -124.89 102.93 7.78 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 31.5 m-85 -113.27 -73.61 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 102.45 -68.61 0.35 Allowed Glycine 0 C--N 1.309 -0.954 0 C-N-CA 121.016 -0.612 . . . . 0.0 114.033 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -167.28 150.3 6.27 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 79.2 p 65.56 13.3 8.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.219 1.807 . . . . 0.0 112.893 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.5 mm-40 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.829 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.0 m -116.74 145.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 20.9 t -129.39 133.21 65.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.352 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 30.3 tt0 -101.14 126.52 47.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.963 0.887 . . . . 0.0 111.597 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 657' ' ' TYR . 60.6 m-85 -97.54 158.53 15.43 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.005 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.604 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 44.3 p90 -137.14 146.98 45.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.3 m -92.1 160.76 15.05 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 660' ' ' ASN . 1.4 m120 -55.15 163.19 1.69 Allowed Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.03 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.35 8.43 1.82 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.759 2.972 . . . . 0.0 113.221 -173.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.527 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 15.5 ptt180 -128.07 -5.64 5.55 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.673 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.541 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 47.6 m-85 -117.81 144.17 45.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.431 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.572 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 4.8 mp -100.66 140.08 35.44 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.283 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.536 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 50.6 tpp -72.78 114.59 11.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -99.57 -34.17 10.34 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.51 -177.95 49.31 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.915 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 59.3 Cg_endo -70.71 -6.54 19.29 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 123.847 3.032 . . . . 0.0 113.734 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.295 3.0 p-10 57.06 -35.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.916 2.486 . . . . 0.0 116.537 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 54.7 mtmt -103.4 135.87 44.22 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 111.477 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.785 HG22 HD13 ' A' ' 681' ' ' LEU . 51.2 pt -121.35 166.37 15.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.812 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 31.2 tt0 -137.31 137.97 39.51 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 123.95 0.9 . . . . 0.0 109.676 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 45.3 t -83.0 113.99 20.96 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.63 -171.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.215 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.98 48.75 1.27 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -173.38 -42.03 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.934 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 678' ' ' TRP . 0.0 OUTLIER -166.9 -174.45 2.72 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.7 m95 -79.76 169.08 18.46 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 679' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 672' ' ' GLN . 27.7 p -82.33 -176.0 5.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 21.0 m -60.13 114.2 2.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.197 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.785 HD13 HG22 ' A' ' 671' ' ' ILE . 0.8 OUTLIER -63.08 153.82 79.73 Favored Pre-proline 0 N--CA 1.413 -2.315 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.372 177.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.622 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 36.4 Cg_endo -77.53 -176.14 3.06 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.558 2.172 . . . . 0.0 113.347 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.28 144.72 29.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 83.3 m -119.62 136.86 54.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.69 143.31 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.541 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.4 p . . . . . 0 C--N 1.286 -2.188 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.852 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 61.3 p . . . . . 0 N--CA 1.413 -2.32 0 CA-C-O 121.59 0.71 . . . . 0.0 111.878 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 5.4 m -90.5 6.44 43.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.155 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 85.08 -82.1 1.71 Allowed Glycine 0 CA--C 1.489 -1.581 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.498 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.711 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.3 t0 -158.34 -173.42 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.654 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.7 mt -72.97 131.33 83.92 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 123.91 0.884 . . . . 0.0 111.875 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.591 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -73.97 -168.94 0.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.627 2.884 . . . . 0.0 112.371 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.41 122.19 46.5 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.384 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.565 HD11 ' HA3' ' A' ' 700' ' ' GLY . 5.0 tt -93.84 136.62 33.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.574 ' OE2' ' HB2' ' A' ' 743' ' ' GLN . 13.2 pt-20 -48.12 -38.43 17.79 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 39.7 m80 -142.48 34.07 1.46 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -140.14 -170.59 12.06 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.534 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -163.32 -152.26 0.2 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.022 1.729 . . . . 0.0 107.389 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.22 156.96 45.84 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.441 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -94.92 -70.63 0.7 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.45 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.1 pp -98.65 139.53 34.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.672 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.5 m -132.48 122.3 24.69 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.9 t -128.77 94.88 33.52 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 0.0 110.551 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.78 152.64 5.06 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 122.351 2.034 . . . . 0.0 111.885 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.95 134.22 32.48 Favored 'Cis proline' 0 C--O 1.24 0.618 0 C-N-CA 123.151 -1.604 . . . . 0.0 111.15 -2.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.711 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.6 m-85 -79.38 88.87 4.98 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 4.8 m-30 -82.6 168.33 17.43 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.105 0.479 . . . . 0.0 111.391 179.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.572 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.6 t80 -60.84 133.97 56.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.88 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.7 -21.8 44.14 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.025 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.38 163.99 26.44 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-N 117.67 0.735 . . . . 0.0 110.014 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 4.8 m -125.46 161.95 25.96 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.21 0.528 . . . . 0.0 110.385 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.535 HG12 HG12 ' A' ' 694' ' ' ILE . 25.0 t -142.88 139.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.564 175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.439 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 43.0 mt-10 -101.88 123.57 46.03 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' A' ' 717' ' ' PHE . 2.2 m-85 -92.42 158.59 15.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.441 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 18.5 t-20 -134.39 147.81 50.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 34.5 t -102.76 141.79 34.99 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 37.6 m -58.47 143.76 44.54 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.7 -33.27 68.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.6 m -82.2 4.96 21.41 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.693 -0.629 . . . . 0.0 111.339 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 97.6 m-85 -125.35 158.99 32.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 5.4 t -116.87 131.79 56.86 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.686 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.5 ptm -87.96 136.75 32.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.587 0.708 . . . . 0.0 110.283 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 55.4 mt -107.74 116.21 50.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.362 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.29 -151.19 18.54 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -108.44 156.04 19.9 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 32.0 ptt180 -86.08 -28.33 24.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.439 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 6.7 m -91.42 145.25 24.79 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.557 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.471 HG22 HD21 ' A' ' 741' ' ' LEU . 6.0 pt -125.61 174.07 10.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.342 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 86.7 m -141.37 136.28 31.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.29 108.79 3.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.418 0.687 . . . . 0.0 111.011 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.4 mm -123.3 104.04 13.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 121.257 0.551 . . . . 0.0 111.093 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 66.76 19.9 10.69 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.644 1.178 . . . . 0.0 112.368 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 104.14 -3.6 44.39 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.917 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.11 133.19 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.591 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -68.33 153.91 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 35.8 p -37.05 -69.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.56 -32.05 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 731' ' ' ILE . 15.2 mt 68.34 153.25 0.13 Allowed Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 124.753 1.283 . . . . 0.0 111.392 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.534 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 60.6 Cg_endo -83.28 -173.4 1.64 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.767 1.644 . . . . 0.0 109.657 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.574 ' HB2' ' OE2' ' A' ' 698' ' ' GLU . 2.8 pt20 -134.39 153.58 51.83 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 86.7 m -117.08 134.81 54.3 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 123.309 0.38 . . . . 0.0 110.963 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.18 143.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.12 116.41 5.36 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 124.225 0.953 . . . . 0.0 110.893 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.045 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.484 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 34.8 p . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 14.0 p -171.66 142.62 1.61 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -88.52 -144.15 9.76 Favored Glycine 0 N--CA 1.396 -3.975 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.898 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.696 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 41.1 Cg_exo -54.11 148.02 41.59 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 123.788 2.992 . . . . 0.0 112.117 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.615 ' HD2' HG23 ' A' ' 645' ' ' THR . 30.3 Cg_endo -62.76 156.05 55.79 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.578 2.186 . . . . 0.0 111.784 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.47 ' HG2' HD12 ' A' ' 681' ' ' LEU . 23.1 Cg_endo -67.76 -172.61 0.41 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 122.482 2.121 . . . . 0.0 111.038 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.16 152.96 22.78 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.641 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 2.7 tt -89.07 134.09 34.13 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 56.7 tp -22.16 -56.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.554 2.342 . . . . 0.0 113.757 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.4 t30 -125.94 -39.64 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.541 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -71.27 -155.17 1.82 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.405 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -168.84 177.76 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.04 -0.683 . . . . 0.0 111.033 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.66 147.17 5.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 124.823 1.249 . . . . 0.0 109.05 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -109.27 -12.17 14.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.052 0.453 . . . . 0.0 111.12 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.75 165.79 13.96 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.364 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -77.7 150.8 34.44 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.308 0.575 . . . . 0.0 110.874 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.615 HG23 ' HD2' ' A' ' 633' ' ' PRO . 28.7 p -84.52 114.36 21.9 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.785 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.8 -15.17 40.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.382 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.696 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.0 mt-10 65.88 -6.53 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.68 86.29 1.39 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.441 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 17.5 m-85 -83.88 -74.13 0.39 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.045 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 117.52 -104.79 1.2 Allowed Glycine 0 C--O 1.211 -1.334 0 C-N-CA 119.84 -1.172 . . . . 0.0 113.252 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -137.68 138.1 39.05 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.864 0.332 . . . . 0.0 110.337 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.5 m 69.32 16.34 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.205 . . . . 0.0 112.467 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.441 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 16.2 mm-40 -82.73 126.07 31.96 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.1 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.9 m -107.4 149.82 10.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.135 0.493 . . . . 0.0 111.881 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 45.3 t -130.65 132.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.449 ' HG3' ' ND2' ' A' ' 669' ' ' ASN . 34.4 tt0 -98.95 130.38 45.31 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 122.096 0.951 . . . . 0.0 112.236 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 657' ' ' TYR . 59.4 m-85 -107.81 169.25 8.72 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.688 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -140.94 155.65 46.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 68.2 m -99.05 159.47 14.94 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.298 0.571 . . . . 0.0 110.061 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.86 157.76 28.05 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.832 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.43 -2.22 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 123.281 2.654 . . . . 0.0 115.117 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.29 -0.51 5.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.356 1.074 . . . . 0.0 110.972 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.404 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 31.1 m-85 -112.68 137.78 50.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.592 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 711' ' ' TYR . 9.8 mt -104.77 146.41 29.01 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 43.0 ttm -79.91 123.65 27.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.967 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -112.53 -34.79 5.74 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.02 -149.01 8.13 Favored Glycine 0 CA--C 1.504 -0.617 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.031 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 55.5 Cg_endo -72.93 -147.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.277 1.985 . . . . 0.0 109.361 171.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.486 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 2.2 p-10 -161.45 -28.4 0.05 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 122.104 -0.373 . . . . 0.0 110.505 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.9 mtmt -115.64 134.52 54.96 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.242 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.5 pt -117.43 169.12 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.3 tt0 -137.15 139.06 40.91 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 123.338 0.398 . . . . 0.0 110.222 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.07 103.55 14.85 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.87 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.291 3.0 p-10 -77.71 80.15 4.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.004 1.383 . . . . 0.0 113.492 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 153.87 -54.33 0.44 Allowed Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.391 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.11 -171.15 3.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.53 -176.85 6.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.103 0.478 . . . . 0.0 112.009 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.7 p -97.94 -166.77 1.42 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.11 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 23.1 m -69.78 117.36 11.27 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.195 0.521 . . . . 0.0 111.362 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 671' ' ' ILE . 4.6 mm? -68.66 151.08 97.44 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.414 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.592 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 71.3 Cg_endo -80.73 176.94 8.55 Favored 'Trans proline' 0 CA--C 1.474 -2.516 0 C-N-CA 123.456 2.77 . . . . 0.0 111.787 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.81 151.89 35.19 Favored 'Isoleucine or valine' 1 N--CA 1.352 -5.361 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.638 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 71.3 m -123.58 136.01 54.29 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.26 140.19 49.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.286 -2.164 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.534 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 37.6 p . . . . . 0 N--CA 1.428 -1.537 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.36 -1.47 44.41 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.366 0.667 . . . . 0.0 111.079 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 91.32 -82.15 1.26 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.656 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 27.9 t70 -159.98 178.09 10.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.588 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 3.5 mt -68.73 131.43 91.25 Favored Pre-proline 0 N--CA 1.42 -1.943 0 C-N-CA 124.454 1.101 . . . . 0.0 111.556 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.4 Cg_endo -74.14 -176.43 2.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.296 2.664 . . . . 0.0 111.24 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.57 136.75 52.47 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 121.255 0.55 . . . . 0.0 109.683 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.633 HD11 ' HA3' ' A' ' 700' ' ' GLY . 2.9 tt -109.97 142.54 41.21 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.8 pt-20 -46.19 -36.65 6.21 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 34.7 m80 -146.48 21.55 1.33 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.239 0.542 . . . . 0.0 109.889 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.633 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -127.33 175.4 18.18 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.549 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -163.26 -159.38 0.53 Allowed 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.58 145.92 41.18 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.613 -169.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -51.87 5.45 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.632 0.729 . . . . 0.0 109.388 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.43 150.69 32.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.074 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.1 p -137.85 127.46 25.13 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 124.391 1.076 . . . . 0.0 108.936 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.9 m -123.78 81.32 55.5 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.514 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.411 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.3 Cg_endo -91.87 144.15 2.9 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 123.111 2.541 . . . . 0.0 112.024 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.5 Cg_endo -71.89 129.01 15.65 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.006 -1.664 . . . . 0.0 111.239 -0.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.625 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 23.6 m-85 -74.43 94.07 2.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.223 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.625 ' HE1' ' CE2' ' A' ' 710' ' ' TYR . 6.3 m-85 -85.08 161.15 19.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 117.923 0.328 . . . . 0.0 111.403 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.614 ' HD2' ' CD1' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -61.16 135.07 57.64 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.77 -12.36 59.37 Favored Glycine 0 N--CA 1.403 -3.521 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.821 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -92.81 179.81 5.36 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -140.62 161.94 36.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.618 0.723 . . . . 0.0 111.783 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 694' ' ' ILE . 20.4 t -139.21 145.15 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.146 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 35.8 mt-10 -105.82 129.2 54.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.308 0.575 . . . . 0.0 110.526 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.588 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.2 m-85 -109.12 153.08 24.21 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.957 1.703 . . . . 0.0 108.69 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -150.4 160.41 43.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 92.2 m -96.56 156.51 16.31 Favored 'General case' 0 C--N 1.27 -2.877 0 O-C-N 123.68 0.612 . . . . 0.0 110.484 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 25.8 m -67.25 162.56 22.4 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.868 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.83 147.24 53.51 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 35.2 t 87.35 -10.97 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.57 1.948 . . . . 0.0 108.413 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' A' ' 723' ' ' PHE . 71.7 m-85 -120.97 147.01 46.06 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-O 121.399 0.619 . . . . 0.0 110.73 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.9 t -115.5 147.14 41.0 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.481 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 8.0 ptm -96.57 146.85 24.45 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.067 0.46 . . . . 0.0 111.001 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 29.2 mt -126.22 116.61 46.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.4 -139.65 11.12 Favored Glycine 0 CA--C 1.479 -2.181 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.987 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -111.69 131.94 54.95 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.987 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -62.69 -32.78 73.92 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 124.303 1.002 . . . . 0.0 111.699 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 32.4 p -108.54 149.35 28.97 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.886 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 741' ' ' LEU . 12.7 pt -125.25 166.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.393 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 45.1 m -131.85 136.87 47.79 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 48.4 t -71.21 107.2 4.11 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.909 0.756 . . . . 0.0 109.306 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 737' ' ' VAL . 51.4 mm -127.74 108.8 18.71 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 68.98 20.2 7.91 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.46 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.06 60.82 Favored Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.462 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 734' ' ' ILE . 3.5 m -122.57 150.27 26.26 Favored 'Isoleucine or valine' 1 N--CA 1.37 -4.432 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.4 m95 -83.9 153.79 23.77 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 37.8 p -35.71 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -160.29 -29.27 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 731' ' ' ILE . 17.8 mt 70.2 149.61 0.12 Allowed Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 124.65 1.219 . . . . 0.0 111.863 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.481 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 61.5 Cg_endo -77.38 -178.67 4.76 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.282 1.988 . . . . 0.0 110.479 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.53 140.26 51.89 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 20.3 m -100.78 142.57 32.06 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.823 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.99 141.92 43.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.02 118.4 10.42 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 123.721 0.638 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--O 1.261 1.679 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.206 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 18.0 t . . . . . 0 N--CA 1.438 -1.043 0 CA-C-O 122.133 0.968 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.6 p -110.59 171.79 7.25 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.025 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -106.38 -132.71 7.2 Favored Glycine 0 N--CA 1.4 -3.722 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 23.5 Cg_exo -63.94 145.04 89.58 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 123.281 2.654 . . . . 0.0 112.603 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.75 157.08 49.49 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 123.158 2.572 . . . . 0.0 112.29 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD12 ' A' ' 681' ' ' LEU . 34.3 Cg_endo -68.8 -164.58 0.11 Allowed 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 123.192 2.595 . . . . 0.0 111.627 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.57 164.83 11.75 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.795 -0.566 . . . . 0.0 110.516 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.558 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 31.9 tp -104.13 147.74 27.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.429 ' H ' HD13 ' A' ' 636' ' ' LEU . 6.0 tt -35.54 -65.8 0.22 Allowed 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 127.503 2.321 . . . . 0.0 111.286 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -115.7 -43.44 3.02 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.38 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -88.54 -146.01 11.9 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -165.37 -170.51 1.89 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.204 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.5 p -101.23 143.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 123.691 0.796 . . . . 0.0 110.575 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -101.34 -16.67 16.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.344 0.592 . . . . 0.0 110.515 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -81.75 128.71 34.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.351 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 150.85 48.67 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.559 0.695 . . . . 0.0 111.997 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 31.8 p -76.5 124.96 28.38 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.832 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 648' ' ' GLU . 47.5 mtmt -99.82 -12.28 20.03 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.105 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.531 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 43.4 mt-10 67.92 -12.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.11 1.364 . . . . 0.0 113.841 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.1 tt0 -148.91 108.49 3.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.827 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 4.5 m-85 -105.75 -65.85 1.03 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 127.81 -117.55 2.65 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -138.38 157.32 46.46 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.6 p 62.59 12.16 5.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.408 1.483 . . . . 0.0 113.104 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.827 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 9.0 mm-40 -76.5 136.64 39.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.297 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 t -112.27 139.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 9.7 t -126.3 137.7 56.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 123.679 0.792 . . . . 0.0 109.585 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 32.8 tt0 -109.15 127.49 54.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.818 0.818 . . . . 0.0 111.342 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 64.8 m-85 -97.45 164.32 12.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.288 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 31.6 p90 -135.4 149.48 49.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.506 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.3 m -95.52 160.03 14.71 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 662' ' ' ARG . 3.4 m-20 -55.21 155.33 9.31 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.888 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.05 11.01 0.34 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 123.388 2.725 . . . . 0.0 113.3 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.697 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 22.0 ptt180 -126.51 -6.48 6.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.858 0.837 . . . . 0.0 111.37 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 40.4 m-85 -122.36 146.45 47.31 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.514 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 711' ' ' TYR . 6.4 mp -105.14 146.45 29.17 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.983 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.44 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.4 tpp -75.07 116.89 16.31 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.489 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.497 ' HD2' HD11 ' A' ' 685' ' ' ILE . 63.8 tttm -102.45 -37.51 7.98 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.339 0.59 . . . . 0.0 110.62 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.73 -172.25 42.43 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.374 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.6 108.87 2.65 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.312 2.008 . . . . 0.0 110.49 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 24.5 p-10 -71.96 -10.24 59.5 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.309 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 656' ' ' GLU . 35.7 mtmt -114.92 129.45 56.71 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.351 0.596 . . . . 0.0 110.69 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 681' ' ' LEU . 48.5 pt -124.72 165.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.878 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.5 tt0 -137.53 139.83 40.72 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.092 0.557 . . . . 0.0 110.381 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.43 105.88 14.73 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.81 -171.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.42 77.97 1.9 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.084 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.4 -39.3 1.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.359 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.92 -179.53 7.08 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 122.634 -0.333 . . . . 0.0 110.281 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.81 161.62 15.2 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.1 p -71.74 -170.36 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.339 0.59 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 18.9 m -69.21 112.75 6.0 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.939 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.682 HD13 HG22 ' A' ' 671' ' ' ILE . 1.8 mp -61.19 149.86 81.13 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.508 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.56 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 37.2 Cg_endo -75.65 -173.49 1.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.249 2.632 . . . . 0.0 114.414 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.2 t -140.18 138.79 37.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 81.0 m -111.55 136.72 50.35 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.497 HD11 ' HD2' ' A' ' 666' ' ' LYS . 30.1 pt -132.83 139.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 123.536 0.523 . . . . 0.0 110.047 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.285 -2.205 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.638 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.414 -2.274 0 CA-C-O 121.83 0.824 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.3 m -91.21 -8.66 47.87 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.734 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.86 -73.41 1.17 Allowed Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.802 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.501 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.8 t70 -176.38 -171.45 0.41 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.622 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -66.35 132.08 94.33 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 123.926 0.89 . . . . 0.0 110.509 175.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.626 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.8 Cg_endo -73.72 -176.82 2.75 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 123.725 2.95 . . . . 0.0 112.066 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.65 126.71 49.84 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.831 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.587 HD21 ' HG2' ' A' ' 698' ' ' GLU . 3.8 tt -108.05 136.87 47.02 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.587 ' HG2' HD21 ' A' ' 697' ' ' LEU . 13.8 pt-20 -39.72 -42.82 1.3 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.712 1.605 . . . . 0.0 112.901 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.922 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 43.9 m80 -145.36 29.29 1.16 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -176.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -140.9 168.65 25.22 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.779 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -154.53 -153.93 0.48 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 125.636 1.574 . . . . 0.0 106.835 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.68 158.66 43.84 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.631 -167.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.532 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -99.22 -55.34 2.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.988 -178.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.68 143.1 48.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.9 m -130.21 137.33 50.0 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 29.6 t -127.44 92.4 43.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 121.666 -0.646 . . . . 0.0 112.47 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -93.15 144.58 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 C-N-CA 122.865 2.377 . . . . 0.0 112.054 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.22 132.24 26.45 Favored 'Cis proline' 0 C--O 1.248 1.012 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.001 0.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 709' ' ' TYR . 21.8 m-85 -75.12 98.08 3.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.697 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 26.7 m-85 -100.99 -177.31 3.42 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.46 0.648 . . . . 0.0 111.277 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.717 ' HB3' HD12 ' A' ' 664' ' ' LEU . 11.4 t80 -70.61 135.14 48.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.209 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.4 0.86 81.92 Favored Glycine 0 C--N 1.291 -1.965 0 CA-C-N 115.535 -0.757 . . . . 0.0 113.788 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.88 173.16 12.5 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -136.76 143.83 43.47 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.872 0.368 . . . . 0.0 110.207 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 731' ' ' ILE . 39.9 t -136.93 140.28 43.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.224 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 50.6 mt-10 -103.48 122.92 45.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.622 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 3.9 m-85 -97.79 152.16 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 124.199 1.0 . . . . 0.0 111.512 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.532 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.2 t30 -138.23 147.79 44.1 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 725' ' ' MET . 90.1 m -98.24 160.84 14.03 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 60.1 m -56.62 147.15 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.12 -28.05 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.368 0.667 . . . . 0.0 111.858 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 6.9 m -80.81 -2.38 46.97 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.201 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 723' ' ' PHE . 83.7 m-85 -124.8 151.63 44.93 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 10.4 t -112.86 140.14 47.91 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.72 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 0.8 OUTLIER -87.05 128.88 35.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.459 0.647 . . . . 0.0 112.154 -176.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.41 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 38.1 mt -106.2 99.59 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 135.79 -155.99 22.59 Favored Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -112.23 168.15 9.85 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 123.79 0.347 . . . . 0.0 110.489 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' A' ' 716' ' ' GLU . 18.2 ptt180 -82.1 -37.78 25.8 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.544 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.8 p -99.34 132.24 44.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -170.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.507 HG22 HD21 ' A' ' 741' ' ' LEU . 8.3 pt -112.28 169.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.768 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 27.6 m -136.01 139.82 43.41 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 44.4 t -82.03 118.63 23.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.626 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 737' ' ' VAL . 45.4 mm -125.8 104.45 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.145 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 71.58 33.59 1.8 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.925 0.89 . . . . 0.0 112.41 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.16 -8.77 79.08 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.922 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 734' ' ' ILE . 2.3 m -118.25 148.39 21.12 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.626 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 87.4 m95 -86.81 152.46 22.46 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.4 p -33.02 -71.39 0.06 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.42 -30.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.507 HD21 HG22 ' A' ' 731' ' ' ILE . 17.5 mt 67.91 147.23 0.11 Allowed Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 124.92 1.388 . . . . 0.0 111.816 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.72 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 60.2 Cg_endo -76.73 -179.65 5.58 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.217 1.945 . . . . 0.0 110.683 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.41 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 20.2 pt20 -123.12 129.73 51.84 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.922 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.7 m -100.76 120.52 40.22 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.5 151.18 17.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 123.509 0.506 . . . . 0.0 109.926 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.78 114.36 4.98 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 124.311 1.007 . . . . 0.0 110.71 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.608 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 121.156 0.503 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 10.2 p -142.05 -170.96 3.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -122.6 -136.24 4.82 Favored Glycine 0 N--CA 1.402 -3.588 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.557 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 25.1 Cg_exo -61.26 142.19 95.48 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 122.45 2.1 . . . . 0.0 111.411 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 645' ' ' THR . 18.6 Cg_endo -58.72 154.49 42.95 Favored 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.929 2.419 . . . . 0.0 111.849 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD22 ' A' ' 681' ' ' LEU . 18.5 Cg_endo -65.08 -167.23 0.1 OUTLIER 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.042 2.494 . . . . 0.0 111.546 176.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.43 159.79 17.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.104 -1.039 . . . . 0.0 109.709 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.7 tp -95.96 140.89 30.05 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.651 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.402 ' H ' HD13 ' A' ' 636' ' ' LEU . 5.9 tt -32.74 -62.16 0.25 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.258 2.223 . . . . 0.0 111.556 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.604 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.7 t30 -123.2 -33.97 3.21 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.831 -178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -90.14 -142.94 10.0 Favored Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.727 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.63 -173.34 2.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 117.563 0.681 . . . . 0.0 109.577 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.4 p -101.82 131.05 50.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 123.746 0.818 . . . . 0.0 109.815 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 7.7 ptpt -91.75 -13.03 32.26 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.54 0.686 . . . . 0.0 109.563 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.579 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 10.5 mm-40 -76.67 144.2 39.57 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.991 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -66.77 152.2 45.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.548 HG23 ' HD2' ' A' ' 633' ' ' PRO . 37.1 p -95.01 120.05 34.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.241 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.99 -20.73 32.31 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.058 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.557 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 35.5 mt-10 70.22 -13.77 0.42 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.265 1.426 . . . . 0.0 113.105 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -132.49 103.49 6.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' A' ' 649' ' ' TYR . 7.8 m-85 -116.36 -173.51 2.38 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -156.18 -155.91 7.6 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -78.02 135.79 37.83 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 120.528 0.204 . . . . 0.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 23.5 m 75.23 18.11 2.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.579 1.152 . . . . 0.0 112.903 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 11.1 mm-40 -84.98 130.87 34.55 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 672' ' ' GLN . 12.9 m -111.89 147.65 15.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.819 0.819 . . . . 0.0 112.995 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.5 t -128.12 135.11 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.775 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.579 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 40.2 tt0 -107.26 132.32 53.22 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.07 0.938 . . . . 0.0 111.393 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.632 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 68.3 m-85 -106.44 166.37 10.59 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.069 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.454 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 46.0 p90 -140.0 151.47 45.51 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.757 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 91.4 m -96.46 162.1 13.63 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.604 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.5 OUTLIER -54.78 152.99 11.87 Favored Pre-proline 0 C--O 1.216 -0.668 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.517 ' HB2' ' OD2' ' A' ' 713' ' ' ASP . 64.5 Cg_endo -66.14 1.91 2.14 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.676 2.917 . . . . 0.0 114.995 -171.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -119.97 -4.73 10.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.837 0.827 . . . . 0.0 111.044 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.667 ' HD2' ' CD1' ' A' ' 663' ' ' PHE . 32.4 m-85 -115.11 142.42 46.68 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.241 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.98 140.27 33.38 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.644 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.563 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.1 tpp -70.64 109.76 5.09 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.697 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.55 ' HD2' HD11 ' A' ' 685' ' ' ILE . 61.7 tttm -96.14 -34.47 11.67 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.581 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -77.64 -172.98 39.37 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.917 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.75 -4.91 15.85 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.359 2.706 . . . . 0.0 113.419 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.63 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 2.6 p-10 52.11 3.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 127.339 2.255 . . . . 0.0 115.864 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 85.9 mttt -137.81 137.26 38.0 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.561 HG22 ' HG ' ' A' ' 681' ' ' LEU . 42.3 pt -129.09 166.26 27.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 654' ' ' VAL . 29.1 tt0 -137.41 139.89 40.98 Favored 'General case' 0 C--N 1.28 -2.44 0 O-C-N 123.717 0.635 . . . . 0.0 109.334 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.6 t -85.01 108.16 17.48 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.83 -166.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.29 58.76 2.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.976 0.893 . . . . 0.0 112.188 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 166.12 -38.39 0.26 Allowed Glycine 0 N--CA 1.415 -2.73 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.415 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -160.69 -178.53 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -85.46 158.29 20.23 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 40.6 p -76.87 -174.72 3.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 41.7 m -60.06 114.79 3.03 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.341 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.561 ' HG ' HG22 ' A' ' 671' ' ' ILE . 5.6 mp -73.12 151.13 90.27 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 91.2 Cg_endo -74.1 178.32 7.07 Favored 'Trans proline' 0 CA--C 1.468 -2.803 0 C-N-CA 123.626 2.884 . . . . 0.0 113.032 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 666' ' ' LYS . 34.9 m -139.11 163.25 26.94 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.293 -175.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 82.4 m -129.11 142.35 50.91 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 666' ' ' LYS . 25.9 pt -134.77 148.59 29.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.292 -1.912 0 CA-C-O 122.673 1.225 . . . . 0.0 111.573 -178.469 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p . . . . . 0 N--CA 1.439 -0.996 0 CA-C-O 120.578 0.228 . . . . 0.0 111.569 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.59 -21.38 28.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 110.63 -78.95 0.25 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.624 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.8 t0 -162.6 -168.01 1.71 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.594 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 2.9 mt -77.81 132.31 68.38 Favored Pre-proline 0 C--N 1.282 -2.339 0 C-N-CA 125.11 1.364 . . . . 0.0 111.079 176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 69.7 Cg_endo -72.94 -169.04 0.45 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.39 2.727 . . . . 0.0 111.584 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.11 136.04 53.55 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.685 HD21 ' HA3' ' A' ' 700' ' ' GLY . 26.4 tp -116.2 145.21 43.29 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.5 pt-20 -45.33 -45.35 12.3 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.839 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.4 m80 -142.97 27.38 1.63 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.743 0.782 . . . . 0.0 109.055 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.685 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -136.27 168.28 24.13 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.799 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -156.14 -151.49 0.34 Allowed 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.46 144.7 46.57 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.095 -168.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.549 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -83.58 -59.78 2.33 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.604 0.716 . . . . 0.0 109.301 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.0 pp -115.97 139.87 49.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.456 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.52 ' O ' ' HD3' ' A' ' 707' ' ' PRO . 12.9 m -118.16 122.85 44.09 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 6.0 m -115.44 87.03 15.91 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.511 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 705' ' ' SER . 12.8 Cg_endo -95.86 150.75 1.4 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 123.07 2.513 . . . . 0.0 112.805 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.9 130.61 18.34 Favored 'Cis proline' 0 C--O 1.237 0.472 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.047 -1.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.624 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 18.5 m-85 -75.43 91.44 2.75 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.641 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 9.3 m-85 -85.26 170.22 13.02 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 122.542 0.337 . . . . 0.0 111.427 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 2.0 t80 -62.41 132.5 52.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.19 69.74 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.041 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 661' ' ' PRO . 3.8 t70 -75.97 173.27 11.44 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.0 OUTLIER -139.72 147.44 40.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.51 0.671 . . . . 0.0 110.912 -173.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 694' ' ' ILE . 38.8 t -138.32 142.95 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.219 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 43.6 mt-10 -110.36 121.43 45.28 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.501 0.667 . . . . 0.0 110.464 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' A' ' 717' ' ' PHE . 2.5 m-85 -92.9 147.54 22.76 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 125.163 1.385 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.549 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -129.33 130.86 46.65 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.421 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.1 m -88.28 143.37 27.06 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 28.9 m -50.95 139.8 16.65 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 123.647 0.592 . . . . 0.0 109.504 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -49.97 -35.7 25.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.8 m -76.61 0.19 21.06 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.787 0.803 . . . . 0.0 111.655 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -117.99 147.94 42.7 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.452 ' HB ' HG12 ' A' ' 747' ' ' ILE . 9.3 t -109.38 138.29 45.96 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.675 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 2.6 ptm -90.04 135.47 33.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.259 0.552 . . . . 0.0 110.672 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.433 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 43.7 mt -115.37 113.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.67 -156.27 16.09 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -109.89 139.64 44.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.684 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -61.27 -35.11 76.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.887 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 12.9 p -94.56 148.53 22.16 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.937 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.493 HG22 HD21 ' A' ' 741' ' ' LEU . 9.0 pt -131.19 165.45 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.546 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 36.2 m -132.64 134.26 44.64 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 710' ' ' TYR . 42.9 t -70.48 111.73 6.23 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.815 0.446 . . . . 0.0 111.375 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.5 110.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 68.73 13.31 8.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.667 1.187 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.79 2.79 46.27 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.316 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.73 130.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 84.8 m95 -63.32 156.86 24.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 25.2 p -37.87 -71.69 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.54 -26.89 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 731' ' ' ILE . 20.8 mt 69.42 153.33 0.14 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 111.908 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.675 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 67.3 Cg_endo -81.61 -168.65 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.642 2.228 . . . . 0.0 111.589 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.433 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 27.9 pt20 -131.93 137.31 47.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.839 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.3 m -110.15 121.15 44.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.32 146.31 25.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.31 117.73 7.03 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.407 0.442 . . . . 0.0 110.566 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.452 HG12 ' HB ' ' A' ' 724' ' ' THR . 68.7 mt . . . . . 0 C--O 1.252 1.213 0 O-C-N 124.398 1.061 . . . . 0.0 110.782 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.996 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.1 m . . . . . 0 C--O 1.238 0.492 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 27.4 p -120.55 154.8 34.86 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.32 -136.84 9.05 Favored Glycine 0 N--CA 1.413 -2.872 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.602 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.944 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 35.1 Cg_exo -56.35 148.74 59.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.077 3.185 . . . . 0.0 114.135 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 655' ' ' VAL . 29.6 Cg_endo -64.8 153.14 79.37 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 122.877 2.385 . . . . 0.0 112.468 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.504 ' HG2' HD22 ' A' ' 681' ' ' LEU . 20.9 Cg_endo -67.95 -170.76 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 123.288 2.659 . . . . 0.0 112.249 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -109.65 144.47 37.96 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 682' ' ' PRO . 19.0 tp -84.01 147.17 27.58 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -34.37 -66.17 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.809 1.644 . . . . 0.0 111.152 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -110.63 -51.77 2.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.109 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -81.48 -147.56 5.86 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.535 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.423 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.6 t-20 -166.4 -167.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.928 0.864 . . . . 0.0 110.592 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 655' ' ' VAL . 83.7 t -90.32 133.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 125.53 1.532 . . . . 0.0 109.425 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.529 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.0 ptpt -94.05 -12.08 29.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.683 0.754 . . . . 0.0 109.971 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 158.07 18.88 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.676 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -88.18 165.43 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 38.0 p -82.49 118.02 22.93 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-O 121.319 0.581 . . . . 0.0 110.628 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 648' ' ' GLU . 45.5 mtmt -86.83 -29.31 22.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.944 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.8 mt-10 67.13 -3.68 0.95 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.678 1.591 . . . . 0.0 113.441 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 646' ' ' LYS . 42.6 mt-10 -133.85 82.78 2.0 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.617 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 16.2 m-85 -95.08 -72.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.104 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.996 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.77 -71.82 0.27 Allowed Glycine 0 C--N 1.295 -1.73 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.844 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.9 145.3 6.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 78.4 p 62.48 14.63 7.14 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.313 1.845 . . . . 0.0 113.019 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 16.1 mm-40 -83.71 142.07 30.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.173 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 14.7 m -120.81 153.7 24.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.274 0.559 . . . . 0.0 111.744 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 633' ' ' PRO . 39.6 t -135.03 134.44 53.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.154 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -100.76 128.68 46.71 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 121.942 0.877 . . . . 0.0 110.8 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 56.8 m-85 -100.94 157.44 16.74 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.942 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.529 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.1 p90 -133.21 151.0 51.95 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.556 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 98.9 m -94.19 154.31 17.63 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 171.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -49.97 156.43 1.31 Allowed Pre-proline 0 C--O 1.193 -1.881 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.54 -30.53 12.22 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 123.883 3.055 . . . . 0.0 114.052 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.584 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 41.1 ptt180 -97.6 -9.96 25.99 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.633 ' HD1' ' CD2' ' A' ' 663' ' ' PHE . 55.6 m-85 -111.8 150.31 30.51 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.933 0.873 . . . . 0.0 112.531 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.945 HD12 ' HB3' ' A' ' 711' ' ' TYR . 11.0 mp -112.61 151.09 30.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.412 0.625 . . . . 0.0 110.99 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.568 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.1 tpp -76.93 127.99 33.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.048 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.457 ' HB3' HG11 ' A' ' 683' ' ' VAL . 61.5 tttp -112.35 -45.14 3.29 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.088 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.05 -171.57 47.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.353 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.49 104.04 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.847 2.364 . . . . 0.0 111.374 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -72.47 6.18 2.53 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.663 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 91.6 mttt -132.97 136.19 45.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 45.4 pt -122.75 167.37 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -135.06 139.2 44.58 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.671 0.607 . . . . 0.0 110.971 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 48.5 t -82.03 104.13 12.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.381 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 675' ' ' ASP . 79.1 t -83.22 171.24 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 674' ' ' VAL . 11.3 p-10 -75.64 72.35 2.58 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.6 1.19 . . . . 0.0 110.592 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 160.58 -41.73 0.43 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.742 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.5 179.48 7.74 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -90.44 169.95 10.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.6 p -84.19 -168.32 2.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 123.14 0.576 . . . . 0.0 112.238 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 48.1 m -69.85 113.34 6.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.053 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.504 HD22 ' HG2' ' A' ' 634' ' ' PRO . 7.2 mp -69.88 153.59 95.36 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.913 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.51 ' HG2' HD11 ' A' ' 636' ' ' LEU . 43.2 Cg_endo -70.88 -167.09 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.997 2.465 . . . . 0.0 113.523 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 666' ' ' LYS . 14.4 p -150.59 149.55 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.406 ' SG ' HD22 ' A' ' 636' ' ' LEU . 73.3 m -116.27 143.66 45.23 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.461 0.475 . . . . 0.0 110.503 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' A' ' 666' ' ' LYS . 28.4 pt -136.39 147.89 27.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.736 0.814 . . . . 0.0 108.918 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.284 -2.271 0 CA-C-O 122.837 1.303 . . . . 0.0 110.294 179.041 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 120.354 0.121 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.46 -13.35 30.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.061 0.458 . . . . 0.0 111.356 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.63 -63.56 1.33 Allowed Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.403 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.7 t70 -173.95 -168.93 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.603 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -68.63 137.55 90.66 Favored Pre-proline 0 C--N 1.276 -2.602 0 C-N-CA 123.469 0.708 . . . . 0.0 109.745 172.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.685 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -73.85 -168.64 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.296 2.664 . . . . 0.0 110.903 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.33 119.14 33.74 Favored 'General case' 0 N--CA 1.408 -2.541 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.223 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 1.005 HD21 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -94.23 144.49 25.47 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.2 pt-20 -44.89 -46.33 10.82 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.154 0.982 . . . . 0.0 112.872 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.601 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 45.5 m80 -143.29 15.67 1.86 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.521 0.677 . . . . 0.0 109.854 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 1.005 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -122.65 -179.14 15.77 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -162.47 -153.77 0.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 125.405 1.482 . . . . 0.0 107.138 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.5 161.95 36.66 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.242 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.591 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -98.04 -54.85 2.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.61 147.07 36.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.048 -175.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.747 ' HB2' ' HH ' ' A' ' 709' ' ' TYR . 5.4 p -128.52 117.97 22.22 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.243 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.6 p -116.71 94.7 44.48 Favored Pre-proline 0 C--N 1.288 -2.091 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -93.02 152.61 2.63 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 123.149 2.566 . . . . 0.0 111.806 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 710' ' ' TYR . 73.3 Cg_endo -72.92 134.12 33.54 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.963 -1.682 . . . . 0.0 111.047 -1.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.632 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 18.6 m-85 -76.78 78.76 3.39 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.64 ' HE2' ' CE1' ' A' ' 710' ' ' TYR . 14.4 m-85 -92.48 174.01 7.5 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 711' ' ' TYR . 9.6 t80 -60.47 128.94 39.16 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.765 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.34 58.3 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.566 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.37 175.86 8.01 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -141.36 150.64 42.69 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.538 0.685 . . . . 0.0 111.147 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.469 HG12 ' CG1' ' A' ' 694' ' ' ILE . 42.4 t -134.49 143.51 37.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.388 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 25.3 mt-10 -105.7 127.64 53.19 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.161 0.505 . . . . 0.0 109.966 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.622 ' HE1' ' CE2' ' A' ' 717' ' ' PHE . 2.5 m-85 -101.6 153.83 19.4 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 124.933 1.293 . . . . 0.0 110.312 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.591 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 29.2 t-20 -143.25 169.51 17.49 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 48.2 t -117.36 160.56 20.94 Favored 'General case' 0 C--N 1.253 -3.614 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 56.6 m -61.37 145.12 52.64 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.39 -21.32 64.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.5 m -78.48 -2.0 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.244 1.021 . . . . 0.0 110.392 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.48 159.49 34.38 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.6 t -120.2 138.74 53.46 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.482 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.2 ptm -91.41 145.78 24.35 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.561 0.696 . . . . 0.0 110.174 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.71 112.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 131.37 -153.51 20.44 Favored Glycine 0 C--N 1.287 -2.16 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -113.08 159.61 19.02 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 122.673 1.225 . . . . 0.0 111.418 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -74.87 -51.03 14.95 Favored 'General case' 1 N--CA 1.376 -4.162 0 CA-C-N 111.253 -2.703 . . . . 0.0 110.535 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 28.7 p -89.43 139.74 30.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -167.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.509 HG22 HD21 ' A' ' 741' ' ' LEU . 12.2 pt -124.06 162.9 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.246 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 28.5 m -128.05 135.7 50.21 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 54.0 t -71.67 105.6 3.76 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.551 0.532 . . . . 0.0 110.795 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.2 96.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-O 122.154 0.978 . . . . 0.0 111.405 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.58 18.06 9.95 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.042 1.737 . . . . 0.0 112.496 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 114.62 -2.17 23.33 Favored Glycine 0 C--N 1.291 -1.929 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.423 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 27.3 t -129.27 135.6 61.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.685 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.4 m95 -72.64 161.15 31.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 21.3 p -43.12 -74.17 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.585 HE21 ' N ' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -162.28 -28.23 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.585 ' N ' HE21 ' A' ' 740' ' ' GLN . 20.1 mt 69.71 157.99 0.15 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.531 1.144 . . . . 0.0 111.477 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.29 -162.9 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.875 1.717 . . . . 0.0 110.737 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -146.39 140.98 26.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 80.2 m -100.19 156.92 16.94 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.214 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.33 147.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.31 126.9 31.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.729 0.3 . . . . 0.0 111.6 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.308 -1.211 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.253 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.705 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 51.9 m . . . . . 0 C--O 1.239 0.517 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.0 164.77 12.05 Favored 'General case' 0 C--O 1.265 1.895 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.387 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.02 -134.95 8.52 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.583 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 50.1 Cg_exo -53.75 144.05 55.88 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.679 2.919 . . . . 0.0 113.28 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.514 ' HB3' HG22 ' A' ' 655' ' ' VAL . 28.7 Cg_endo -63.92 158.71 45.77 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 123.296 2.664 . . . . 0.0 112.459 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.507 ' HG2' HD22 ' A' ' 681' ' ' LEU . 12.4 Cg_endo -72.49 -169.91 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.425 2.083 . . . . 0.0 112.062 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.85 165.69 11.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.403 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.599 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.6 tp -112.9 140.6 47.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 5.7 tt -28.16 -64.78 0.09 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.597 2.359 . . . . 0.0 112.105 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.48 -33.53 3.01 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.406 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.46 -146.05 8.4 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.418 175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -170.31 -169.91 0.89 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 118.02 0.91 . . . . 0.0 111.412 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.66 133.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.677 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.6 ptpt -94.83 -16.57 22.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.405 0.621 . . . . 0.0 110.07 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.82 160.07 15.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.11 168.41 14.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.928 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 73.0 p -83.93 125.61 32.19 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.82 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 648' ' ' GLU . 50.1 mtmt -86.08 -25.6 25.76 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.752 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.0 mt-10 73.49 -17.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.698 1.199 . . . . 0.0 112.574 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 646' ' ' LYS . 45.2 tt0 -129.66 99.91 5.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 9.9 m-85 -104.57 -67.32 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.705 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 107.1 -95.32 0.99 Allowed Glycine 0 C--N 1.289 -2.046 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.09 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -148.26 149.06 31.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.28 23.3 p 64.52 14.12 8.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.07 1.748 . . . . 0.0 113.706 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 37.9 mm-40 -85.55 138.82 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.656 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.9 m -118.42 146.54 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.568 0.699 . . . . 0.0 112.244 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 60.9 t -126.02 135.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.61 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.29 123.05 42.17 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.936 0.874 . . . . 0.0 110.262 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 59.2 m-85 -97.92 160.65 14.17 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.796 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.631 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 39.0 p90 -136.12 143.99 44.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.743 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 60.4 m -84.54 161.45 20.2 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.555 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -55.66 154.05 14.05 Favored Pre-proline 0 C--O 1.207 -1.163 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.555 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 27.4 Cg_endo -58.81 -13.75 19.45 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.727 2.952 . . . . 0.0 115.136 -170.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.514 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 12.9 ptt180 -108.67 -4.09 17.35 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.888 0.852 . . . . 0.0 111.76 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.619 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 43.2 m-85 -110.3 148.74 31.33 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.277 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.945 HD12 ' HB3' ' A' ' 711' ' ' TYR . 10.8 mp -106.25 145.48 31.53 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 48.9 tpp -77.03 113.85 15.19 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.625 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.49 ' HB3' HG21 ' A' ' 683' ' ' VAL . 21.6 tptm -101.9 -25.16 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -82.35 -174.61 50.04 Favored Glycine 0 C--N 1.307 -1.036 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.36 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.07 8.81 3.31 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 123.05 2.5 . . . . 0.0 113.812 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.555 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.31 10.1 p-10 49.92 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 128.72 2.808 . . . . 0.0 116.925 -177.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.6 mttt -94.93 142.24 27.71 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 123.796 0.839 . . . . 0.0 110.278 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.681 HG22 ' HG ' ' A' ' 681' ' ' LEU . 41.2 pt -129.88 164.56 32.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.897 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.3 tt0 -129.44 135.97 49.33 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.957 0.903 . . . . 0.0 110.254 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.8 t -82.8 98.74 9.29 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 3.3 p -91.5 -178.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.079 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.41 74.65 3.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.506 1.146 . . . . 0.0 113.161 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 159.23 -39.67 0.49 Allowed Glycine 0 N--CA 1.417 -2.6 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.249 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -167.01 -174.01 2.54 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.438 ' CE3' HG13 ' A' ' 671' ' ' ILE . 85.5 m95 -84.16 164.98 18.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.4 p -76.9 -174.76 3.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 122.707 0.403 . . . . 0.0 111.292 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.2 m -64.58 111.19 2.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.388 0.613 . . . . 0.0 110.83 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.681 ' HG ' HG22 ' A' ' 671' ' ' ILE . 4.0 mp -68.15 151.17 97.4 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -72.23 176.63 8.29 Favored 'Trans proline' 0 CA--C 1.468 -2.795 0 C-N-CA 123.425 2.75 . . . . 0.0 113.754 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 666' ' ' LYS . 34.8 m -136.81 159.0 37.34 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.937 0 CA-C-N 112.156 -2.293 . . . . 0.0 107.71 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 92.1 m -121.54 150.14 42.08 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.319 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.93 147.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.9 p . . . . . 0 C--N 1.286 -2.166 0 CA-C-O 122.511 1.148 . . . . 0.0 110.026 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.425 -1.694 0 CA-C-O 120.779 0.323 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . 0.421 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 19.5 m -100.26 -16.15 17.82 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.824 0.821 . . . . 0.0 110.607 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 107.68 -89.99 0.61 Allowed Glycine 0 CA--C 1.484 -1.845 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.898 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.698 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t0 -152.46 -172.23 4.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.605 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.4 mt -72.83 132.7 82.82 Favored Pre-proline 0 N--CA 1.406 -2.648 0 C-N-CA 125.129 1.372 . . . . 0.0 109.308 173.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.687 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 38.8 Cg_endo -68.35 177.01 4.96 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.271 2.647 . . . . 0.0 112.857 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.84 98.61 8.17 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.769 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.912 HD21 ' HA3' ' A' ' 700' ' ' GLY . 33.5 tp -81.4 135.66 35.67 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.7 pt-20 -43.51 -42.67 5.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.568 1.147 . . . . 0.0 112.758 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.52 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 41.2 m80 -141.77 24.18 2.05 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.571 0.701 . . . . 0.0 109.966 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.912 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -132.26 170.54 21.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.835 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -157.95 -152.14 0.33 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 126.158 1.783 . . . . 0.0 106.489 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -142.1 156.13 45.38 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 119.254 0.934 . . . . 0.0 111.366 -168.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.538 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.2 OUTLIER -90.07 -48.79 6.97 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.31 148.81 38.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.059 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 22.8 p -126.92 136.87 52.88 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 1.9 p -130.8 78.31 73.92 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-O 121.532 0.682 . . . . 0.0 112.628 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -91.71 147.8 3.32 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.949 2.432 . . . . 0.0 112.653 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.88 130.86 22.32 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.669 -1.805 . . . . 0.0 110.898 -0.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.698 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 25.5 m-85 -73.06 106.84 5.09 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.514 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 17.2 m-85 -100.59 173.56 6.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.909 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.637 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 3.7 t80 -62.95 134.62 56.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.477 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.44 -14.74 64.73 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.039 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.6 167.09 22.44 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.2 m -131.2 155.32 47.27 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 694' ' ' ILE . 25.4 t -144.65 134.69 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 730' ' ' SER . 17.2 mt-10 -100.06 122.79 43.48 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.733 0.778 . . . . 0.0 110.711 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.2 m-85 -94.85 154.73 17.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.52 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.538 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 64.9 t30 -134.93 152.22 51.55 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 45.1 t -99.07 162.9 12.81 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 42.9 t -60.65 142.57 55.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.95 -20.05 65.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.131 0.491 . . . . 0.0 111.76 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 0.26 55.8 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.94 0.876 . . . . 0.0 110.341 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -125.82 162.12 25.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.4 t -118.57 137.75 53.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.619 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.4 ptm -95.45 138.49 33.06 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.329 0.585 . . . . 0.0 109.718 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.37 112.25 39.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 122.07 -160.67 16.44 Favored Glycine 0 CA--C 1.478 -2.28 0 O-C-N 123.418 0.449 . . . . 0.0 112.61 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -91.53 129.09 37.57 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 13.4 ptt180 -68.96 -28.94 67.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.825 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.555 ' HB2' ' HG2' ' A' ' 716' ' ' GLU . 32.2 t -102.3 150.41 23.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.31 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 715' ' ' VAL . 2.9 pt -128.46 175.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.451 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 70.3 m -143.76 135.13 25.92 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.56 114.59 13.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.5 mm -117.46 103.45 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.39 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 61.5 41.8 12.15 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.309 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 91.68 -11.67 71.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.965 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.68 123.34 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.289 -0.536 . . . . 0.0 109.62 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.687 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.5 m95 -63.83 142.4 58.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.0 p -28.72 -70.3 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.96 -28.99 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.469 HD21 HG22 ' A' ' 731' ' ' ILE . 23.8 mt 69.01 156.25 0.15 Allowed Pre-proline 0 C--O 1.237 0.429 0 O-C-N 124.612 1.195 . . . . 0.0 110.988 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.524 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 72.5 Cg_endo -80.29 -166.16 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.718 1.612 . . . . 0.0 109.842 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -137.58 135.53 36.73 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.0 m -94.5 138.56 32.27 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.359 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.66 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.23 119.83 12.77 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.501 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.257 1.48 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.733 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 67.7 m . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.55 155.95 20.27 Favored 'General case' 0 C--O 1.268 2.047 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.55 -134.53 6.98 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.771 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 39.2 Cg_exo -58.19 143.76 96.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.847 2.364 . . . . 0.0 112.322 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.713 ' HD2' HG23 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.71 150.75 87.68 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.602 2.202 . . . . 0.0 112.691 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.502 ' HG2' HD22 ' A' ' 681' ' ' LEU . 18.3 Cg_endo -69.69 -173.05 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.762 2.974 . . . . 0.0 112.857 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.07 146.73 27.07 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.628 HD21 ' N ' ' A' ' 637' ' ' LEU . 4.5 tt -87.35 142.23 28.04 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.628 ' N ' HD21 ' A' ' 636' ' ' LEU . 0.7 OUTLIER -33.26 -71.92 0.05 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.847 1.659 . . . . 0.0 110.16 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.73 41.09 3.06 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.569 1.652 . . . . 0.0 110.13 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -133.2 -148.79 5.99 Favored Glycine 1 C--N 1.234 -5.139 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.862 177.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.4 t-20 -172.22 178.33 2.89 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.793 HG23 ' CE2' ' A' ' 657' ' ' TYR . 9.9 t -102.39 137.97 28.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 124.168 0.987 . . . . 0.0 108.655 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -100.37 -10.54 21.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.014 0.911 . . . . 0.0 109.339 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.85 135.32 34.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.534 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -75.75 150.71 37.73 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.713 HG23 ' HD2' ' A' ' 633' ' ' PRO . 58.5 p -71.6 127.85 33.9 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.617 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 648' ' ' GLU . 45.5 mtmt -90.76 -20.96 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.771 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 69.43 -20.53 0.17 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.276 1.431 . . . . 0.0 113.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.1 tp10 -127.64 94.83 4.06 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.588 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 14.7 m-85 -102.89 -62.98 1.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.233 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 109.6 -102.17 1.56 Allowed Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -149.14 154.54 39.35 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 53.6 p 65.93 16.57 10.52 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.254 1.422 . . . . 0.0 112.648 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.588 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 7.4 mm-40 -88.45 139.33 30.59 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.897 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 672' ' ' GLN . 6.9 m -118.36 145.9 23.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.607 0.717 . . . . 0.0 112.513 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 633' ' ' PRO . 77.5 t -128.74 135.43 62.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.645 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -101.01 133.54 45.35 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.552 0.692 . . . . 0.0 110.508 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 657' ' ' TYR . 53.3 m-85 -111.16 164.19 13.12 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.313 1.045 . . . . 0.0 110.632 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.62 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 51.4 p90 -137.68 158.07 45.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 96.2 m -95.01 165.56 12.38 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 118.189 0.45 . . . . 0.0 110.041 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.518 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -59.61 156.53 32.24 Favored Pre-proline 0 C--O 1.216 -0.705 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.518 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 73.2 Cg_endo -72.91 14.59 0.51 Allowed 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 123.878 3.052 . . . . 0.0 113.348 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.598 ' O ' HG21 ' A' ' 686' ' ' VAL . 14.4 ptt180 -129.58 -6.29 4.67 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.68 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -122.91 150.31 43.1 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.635 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.359 0.0 OUTLIER -114.9 137.65 51.72 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.069 -179.948 . . . . . . . . 4 4 . 1 . 009 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.544 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 57.3 tpp -60.98 114.0 2.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.492 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -102.84 -33.56 9.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.226 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.1 -172.57 37.18 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.621 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 83.2 Cg_endo -76.37 -5.64 16.36 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.107 2.538 . . . . 0.0 112.786 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.496 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 1.4 p-10 56.45 -5.94 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 128.025 2.53 . . . . 0.0 115.662 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -133.06 133.87 43.6 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.272 0.629 . . . . 0.0 109.616 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.612 HG22 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -121.32 166.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.546 ' HB2' HG13 ' A' ' 654' ' ' VAL . 54.3 tt0 -142.0 140.29 32.63 Favored 'General case' 0 N--CA 1.414 -2.268 0 O-C-N 123.753 0.658 . . . . 0.0 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 8.9 t -80.04 108.67 13.81 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.783 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.61 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -89.12 73.19 8.2 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.439 1.114 . . . . 0.0 111.251 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.13 -55.95 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.18 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.03 -168.96 2.92 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -86.17 167.56 14.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 28.7 p -78.18 -176.0 4.4 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 122.876 0.471 . . . . 0.0 110.864 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 78.1 m -68.45 113.25 5.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.408 0.623 . . . . 0.0 110.794 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.612 ' HG ' HG22 ' A' ' 671' ' ' ILE . 6.9 mp -63.28 151.94 85.91 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.522 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.551 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 40.6 Cg_endo -66.31 172.23 9.24 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 122.531 2.154 . . . . 0.0 113.627 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.62 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.159 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 74.5 m -118.87 135.37 54.59 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.49 HG13 HD23 ' A' ' 664' ' ' LEU . 27.0 pt -128.61 143.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 662' ' ' ARG . 8.4 p . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 9.1 m -88.62 -9.14 53.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.581 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 100.27 -81.73 0.51 Allowed Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.646 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.5 t70 -161.89 -173.0 3.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 715' ' ' VAL . 2.4 mt -70.72 135.59 85.79 Favored Pre-proline 0 N--CA 1.4 -2.959 0 C-N-CA 125.522 1.529 . . . . 0.0 110.917 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.664 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 61.4 Cg_endo -74.29 -177.3 3.18 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 123.181 2.587 . . . . 0.0 110.371 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.09 123.29 45.24 Favored 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.698 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.819 HD21 ' HA3' ' A' ' 700' ' ' GLY . 40.5 tp -86.21 138.51 31.82 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 11.2 pt-20 -41.61 -37.63 1.19 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.389 1.476 . . . . 0.0 113.163 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 54.4 m80 -145.26 27.52 1.26 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.819 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -139.26 173.43 22.72 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.193 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -155.2 -150.52 0.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 125.977 1.711 . . . . 0.0 106.828 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.63 152.14 43.72 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 119.256 0.935 . . . . 0.0 112.04 -169.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -83.47 -56.66 3.62 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.3 144.97 35.09 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.626 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.5 p -142.71 116.49 9.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.926 -1.033 . . . . 0.0 108.67 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.2 m -128.34 91.75 43.19 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-O 121.182 0.515 . . . . 0.0 111.462 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.25 150.29 10.57 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.59 2.193 . . . . 0.0 111.351 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.96 134.79 37.53 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.233 -1.569 . . . . 0.0 112.41 1.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.646 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 34.0 m-85 -81.19 92.28 6.29 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.607 ' HE1' ' CE2' ' A' ' 710' ' ' TYR . 4.6 m-30 -85.48 163.54 18.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.378 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' A' ' 711' ' ' TYR . 2.0 t80 -62.14 139.53 58.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.96 -24.22 29.52 Favored Glycine 0 C--N 1.295 -1.721 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.282 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -76.44 167.33 22.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 118.073 0.936 . . . . 0.0 110.284 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 2.3 m -131.61 158.08 41.98 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.101 0.477 . . . . 0.0 110.41 -172.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.58 HG12 HG12 ' A' ' 694' ' ' ILE . 41.3 t -137.87 145.76 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.101 176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.531 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 39.2 mt-10 -111.73 121.94 46.45 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 121.57 0.7 . . . . 0.0 110.419 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.509 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.0 m-85 -93.32 146.86 23.41 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.307 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 7.5 t30 -127.67 134.59 49.61 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.3 t -92.92 142.63 27.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 52.4 m -52.94 138.57 29.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.482 0.489 . . . . 0.0 109.747 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.11 -29.17 65.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 41.5 m -79.68 -1.62 39.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.013 0.911 . . . . 0.0 111.03 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.43 159.25 24.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.4 t -118.79 139.35 51.72 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.635 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 8.1 ptm -93.04 141.21 28.66 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.355 0.598 . . . . 0.0 109.916 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 52.1 mt -111.18 100.91 11.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.91 -165.48 24.26 Favored Glycine 0 C--N 1.284 -2.347 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -101.31 171.54 7.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -93.81 -27.75 16.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.531 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.7 p -96.03 133.52 40.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.493 HG22 HD21 ' A' ' 741' ' ' LEU . 8.5 pt -120.03 166.31 14.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.289 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 60.9 m -133.17 135.34 45.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 40.5 t -68.25 108.23 3.1 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.004 0.815 . . . . 0.0 110.317 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 737' ' ' VAL . 48.6 mm -130.2 104.2 9.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 123.859 0.864 . . . . 0.0 109.904 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 69.93 23.94 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 96.65 -3.6 63.21 Favored Glycine 0 CA--C 1.481 -2.088 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.413 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 734' ' ' ILE . 4.1 m -126.03 153.26 34.05 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.664 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.4 m95 -87.91 169.08 12.32 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.5 p -47.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 731' ' ' ILE . 21.8 mt 68.58 156.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.493 0 O-C-N 124.691 1.244 . . . . 0.0 111.132 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.635 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 73.9 Cg_endo -79.2 -159.68 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.851 1.701 . . . . 0.0 109.431 173.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -143.67 142.1 30.85 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 88.7 m -101.13 144.13 30.39 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.194 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.9 148.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -74.33 125.75 29.17 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.411 0.444 . . . . 0.0 110.521 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.044 175.572 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 14.9 p -147.49 -173.32 4.24 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -115.94 -135.27 5.65 Favored Glycine 0 N--CA 1.405 -3.4 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.734 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 17.1 Cg_exo -65.43 144.29 79.21 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.658 2.238 . . . . 0.0 110.492 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.82 ' HD2' HG23 ' A' ' 645' ' ' THR . 23.9 Cg_endo -60.3 154.15 54.68 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.572 2.181 . . . . 0.0 112.307 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 681' ' ' LEU . 14.9 Cg_endo -64.2 -164.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.561 2.841 . . . . 0.0 113.265 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.19 165.61 12.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.299 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.54 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 52.2 tp -113.36 147.52 37.53 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.371 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 12.5 tp -40.59 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.988 1.715 . . . . 0.0 113.315 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -126.08 50.25 1.89 Allowed 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 123.534 1.635 . . . . 0.0 108.834 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -164.8 -154.43 7.94 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 111.358 -2.656 . . . . 0.0 108.962 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -166.93 -178.09 4.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.1 p -92.02 138.68 19.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 9.7 ptpt -98.08 -17.26 19.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.38 144.0 28.29 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.335 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 43.4 mmtm -85.45 134.32 34.06 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-O 121.915 0.864 . . . . 0.0 112.718 -173.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.82 HG23 ' HD2' ' A' ' 633' ' ' PRO . 11.0 p -64.99 122.1 16.23 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 113.193 -1.822 . . . . 0.0 113.658 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -89.53 -22.98 22.14 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.654 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.734 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 73.08 -7.71 1.45 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.164 1.386 . . . . 0.0 112.334 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.3 93.7 3.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 7.2 m-85 -121.54 132.97 55.0 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -101.52 -153.83 25.97 Favored Glycine 0 C--N 1.277 -2.745 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.272 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -75.91 149.62 37.71 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.283 76.2 p 71.13 11.19 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.653 1.581 . . . . 0.0 114.072 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 17.4 mm-40 -79.26 121.34 24.96 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.8 OUTLIER -109.15 139.69 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.14 0.495 . . . . 0.0 111.488 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.9 t -126.92 135.84 62.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.92 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.89 129.37 48.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.46 1.124 . . . . 0.0 112.614 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.54 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 45.9 m-85 -105.27 164.61 11.71 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.728 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 40.0 p90 -142.02 150.81 41.8 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.561 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 89.9 m -98.05 163.57 12.71 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.471 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.3 OUTLIER -59.25 159.04 16.66 Favored Pre-proline 0 N--CA 1.482 1.131 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 61.6 Cg_endo -68.12 -9.8 26.9 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.074 2.516 . . . . 0.0 113.441 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 21.6 ptt180 -101.68 -6.67 23.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.708 0.766 . . . . 0.0 111.16 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 48.2 m-85 -121.25 140.92 51.41 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.446 HD22 ' HB3' ' A' ' 711' ' ' TYR . 17.5 mt -99.66 139.68 34.96 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.831 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.568 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.2 tpp -72.3 109.03 5.75 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.238 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.618 ' HD2' HD11 ' A' ' 685' ' ' ILE . 81.3 tttt -94.97 -29.2 14.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -79.61 -173.05 44.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.618 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.74 -3.77 13.53 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.277 2.651 . . . . 0.0 113.13 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.263 2.8 p-10 58.65 -27.57 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 127.474 2.31 . . . . 0.0 116.167 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.2 mttt -108.5 139.6 43.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 121.937 -0.477 . . . . 0.0 110.346 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.622 HG22 ' HG ' ' A' ' 681' ' ' LEU . 45.6 pt -124.99 171.57 13.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.0 tt0 -142.39 140.6 32.08 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.85 100.0 8.61 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.316 1.055 . . . . 0.0 108.804 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.79 171.38 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.17 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.05 72.36 2.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.448 1.118 . . . . 0.0 111.029 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.23 -39.82 0.52 Allowed Glycine 0 N--CA 1.409 -3.145 0 CA-C-N 113.914 -1.493 . . . . 0.0 111.73 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.93 -178.94 6.41 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -84.04 164.77 19.07 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.9 p -74.67 -174.89 2.26 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.821 0.343 . . . . 0.0 111.749 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.5 m -71.1 111.15 6.23 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.184 0.516 . . . . 0.0 110.111 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 671' ' ' ILE . 6.2 mp -64.81 151.47 92.67 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.225 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.499 ' HG2' HD11 ' A' ' 636' ' ' LEU . 44.1 Cg_endo -67.71 -176.53 0.97 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.129 2.553 . . . . 0.0 114.115 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.09 142.92 27.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 85.0 m -114.12 133.09 55.8 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.618 HD11 ' HD2' ' A' ' 666' ' ' LYS . 26.1 pt -128.25 145.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.43 HG21 ' O ' ' A' ' 662' ' ' ARG . 12.0 p . . . . . 0 C--N 1.281 -2.371 0 CA-C-O 122.354 1.073 . . . . 0.0 108.578 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 120.999 0.428 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 31.5 m -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 67.88 53.66 22.11 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.257 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.2 t70 71.51 172.94 0.31 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.017 0.927 . . . . 0.0 113.25 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.544 ' CG1' HG12 ' A' ' 715' ' ' VAL . 1.3 mp -66.37 132.99 94.38 Favored Pre-proline 0 N--CA 1.434 -1.275 0 C-N-CA 124.18 0.992 . . . . 0.0 111.626 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.5 Cg_endo -75.58 -171.22 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.961 3.107 . . . . 0.0 111.683 176.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.17 139.28 49.48 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.373 0.606 . . . . 0.0 110.084 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.708 HD21 ' HA3' ' A' ' 700' ' ' GLY . 48.9 tp -107.61 148.27 29.53 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -43.14 -47.34 6.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.75 1.22 . . . . 0.0 112.758 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -142.86 30.73 1.45 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.042 0.925 . . . . 0.0 109.154 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.708 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -138.25 171.1 23.57 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.894 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -156.55 -150.88 0.3 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.847 1.659 . . . . 0.0 106.607 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.09 162.46 35.43 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.715 -169.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.515 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.03 -68.31 0.81 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.64 142.01 32.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.833 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.469 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 6.4 m -133.72 99.53 4.5 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 172.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.0 m -117.51 98.34 51.67 Favored Pre-proline 0 C--N 1.271 -2.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.002 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.04 159.45 15.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.241 2.628 . . . . 0.0 110.95 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 138.84 57.95 Favored 'Cis proline' 0 C--O 1.243 0.763 0 C-N-CA 123.89 -1.296 . . . . 0.0 112.261 0.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 21.8 m-85 -86.38 78.06 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.626 ' HD2' ' CD1' ' A' ' 710' ' ' TYR . 30.2 m-85 -79.59 161.6 25.83 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.738 0.304 . . . . 0.0 111.67 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 1.7 t80 -55.87 131.33 46.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -17.18 57.72 Favored Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.753 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.78 173.95 12.07 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -139.66 151.34 45.86 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.452 0.644 . . . . 0.0 111.045 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.544 HG12 ' CG1' ' A' ' 694' ' ' ILE . 32.6 t -135.02 142.07 41.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.809 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 33.0 mt-10 -104.17 128.89 51.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.606 0.717 . . . . 0.0 110.675 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 702' ' ' ALA . 1.4 m-85 -97.42 156.66 16.37 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.232 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.515 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -137.05 145.88 44.54 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 44.3 t -94.94 158.98 15.24 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 51.1 m -69.35 158.81 34.34 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.16 144.94 48.39 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 34.5 m 85.0 -5.75 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.325 1.85 . . . . 0.0 109.38 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -119.31 148.41 43.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.6 t -116.65 140.89 48.89 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.66 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.0 ptm -91.91 141.5 28.57 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.01 127.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 112.75 -133.75 11.54 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -115.4 163.08 16.24 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.8 -29.17 16.91 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.55 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 3.9 p -99.94 131.92 45.61 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 741' ' ' LEU . 7.3 pt -109.09 171.27 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.005 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 58.1 m -135.21 135.71 41.2 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.41 108.68 4.96 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.7 0.625 . . . . 0.0 110.163 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 737' ' ' VAL . 45.4 mm -128.39 111.7 24.59 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.702 0 C-N-CA 123.792 0.837 . . . . 0.0 110.579 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 67.01 17.08 10.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.97 49.93 Favored Glycine 0 CA--C 1.479 -2.186 0 C-N-CA 119.32 -1.419 . . . . 0.0 111.483 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 734' ' ' ILE . 9.9 m -125.12 152.89 31.97 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.201 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.563 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.3 m95 -83.26 159.17 22.0 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 11.3 p -38.82 -70.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.04 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 731' ' ' ILE . 20.3 mt 71.16 154.15 0.15 Allowed Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.441 1.096 . . . . 0.0 112.694 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.589 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 47.3 Cg_endo -74.36 -171.1 0.83 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.781 1.654 . . . . 0.0 109.02 172.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -147.57 142.24 26.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 89.2 m -92.17 153.97 18.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.546 0.529 . . . . 0.0 112.358 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.4 144.61 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -72.07 123.98 23.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.363 0.414 . . . . 0.0 111.318 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 67.3 m -131.81 136.07 47.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.82 -132.59 7.58 Favored Glycine 0 N--CA 1.41 -3.08 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.853 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -63.12 135.89 53.3 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.901 2.4 . . . . 0.0 111.874 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.843 ' HD2' HG23 ' A' ' 645' ' ' THR . 26.9 Cg_endo -60.22 157.23 36.04 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.348 2.698 . . . . 0.0 113.444 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.475 ' HG2' HD22 ' A' ' 681' ' ' LEU . 31.4 Cg_endo -71.52 -159.42 0.07 OUTLIER 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.509 2.806 . . . . 0.0 112.643 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . 0.4 ' O ' HD11 ' A' ' 681' ' ' LEU . 13.8 pt-20 -104.35 174.78 5.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.408 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.622 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.7 tt -117.86 142.03 47.77 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 169.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 54.0 tp -35.67 -68.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 127.437 2.295 . . . . 0.0 112.869 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.2 t30 -116.9 -31.0 5.56 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.31 1.052 . . . . 0.0 109.331 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -78.86 -157.04 10.39 Favored Glycine 0 C--N 1.298 -1.555 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.265 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -169.5 -177.01 2.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.3 p -101.08 140.53 19.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 123.398 0.679 . . . . 0.0 109.687 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.415 ' HB3' ' HD1' ' A' ' 658' ' ' TYR . 8.6 ptpt -95.77 -30.9 13.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.56 149.44 34.86 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.649 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 38.9 mmtm -86.94 161.7 18.09 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.789 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.843 HG23 ' HD2' ' A' ' 633' ' ' PRO . 14.5 p -84.0 122.68 29.1 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.767 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 648' ' ' GLU . 51.4 mtmt -82.31 -23.74 34.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.424 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.853 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.9 mt-10 67.62 -13.86 0.23 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.168 1.387 . . . . 0.0 113.648 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 646' ' ' LYS . 34.2 tt0 -133.28 87.38 2.39 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 11.9 m-85 -91.43 -65.53 1.0 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 112.02 -88.45 0.5 Allowed Glycine 0 C--N 1.296 -1.65 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.934 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -161.49 144.57 12.4 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 73.82 3.13 4.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.161 1.384 . . . . 0.0 111.391 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 65.4 mm-40 -74.88 140.79 44.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 3.4 m -115.71 151.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 123.993 0.808 . . . . 0.0 112.3 -176.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 52.2 t -133.24 134.59 57.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.441 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 125.28 48.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.091 0.948 . . . . 0.0 111.66 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.587 ' HB3' HD13 ' A' ' 636' ' ' LEU . 62.8 m-85 -100.68 168.84 9.43 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.832 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.604 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 41.0 p90 -138.94 153.15 48.19 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 63.6 m -94.41 163.31 13.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.409 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.6 OUTLIER -63.81 155.78 75.68 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 68.1 Cg_endo -69.41 9.81 0.5 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 123.672 2.915 . . . . 0.0 114.849 -172.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.488 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 32.2 ptt180 -131.83 5.72 4.27 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.864 0.84 . . . . 0.0 109.753 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 39.3 m-85 -123.95 143.07 50.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.698 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.56 HD23 ' CD1' ' A' ' 711' ' ' TYR . 12.2 mt -97.51 145.82 25.84 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.095 0.474 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.535 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.0 tpp -76.5 113.2 13.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.109 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.454 ' HE3' HD11 ' A' ' 685' ' ' ILE . 40.3 ttmt -93.31 -48.95 6.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.386 0.612 . . . . 0.0 109.775 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.53 -168.13 43.82 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.727 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.04 107.4 2.43 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.694 2.262 . . . . 0.0 111.182 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.0 p-10 -72.97 -5.01 35.83 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.056 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 48.7 mtmt -126.48 117.51 23.02 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.154 0.502 . . . . 0.0 110.28 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 681' ' ' LEU . 47.5 pt -108.78 168.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.427 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 21.3 tt0 -140.36 140.54 35.58 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 123.597 0.759 . . . . 0.0 110.845 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.0 106.98 7.9 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.756 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.18 -177.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.86 81.27 2.77 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.932 1.348 . . . . 0.0 111.691 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.87 -39.78 0.82 Allowed Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.393 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -165.69 -171.22 2.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.89 165.98 14.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 18.6 p -75.01 -179.78 4.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.271 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 47.2 m -62.7 115.7 4.54 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.671 0.748 . . . . 0.0 112.046 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.589 HD21 HG22 ' A' ' 671' ' ' ILE . 78.2 mt -64.37 146.24 97.99 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.17 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.622 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 60.0 Cg_endo -70.4 -174.39 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.916 2.411 . . . . 0.0 113.757 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 67.8 t -139.43 136.17 40.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.98 127.89 56.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.454 HD11 ' HE3' ' A' ' 666' ' ' LYS . 29.3 pt -125.41 147.71 30.06 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 662' ' ' ARG . 7.1 p . . . . . 0 C--N 1.288 -2.074 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.704 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 690' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 709' ' ' TYR . 17.0 p . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.0 m -83.43 -4.73 58.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.189 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 96.14 -87.37 0.97 Allowed Glycine 0 CA--C 1.486 -1.756 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.693 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 5.9 p-10 -154.25 -173.8 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.632 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.8 mt -71.27 133.04 85.62 Favored Pre-proline 0 N--CA 1.42 -1.933 0 C-N-CA 123.623 0.769 . . . . 0.0 112.115 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.685 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 63.0 Cg_endo -71.91 -177.77 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.417 2.745 . . . . 0.0 112.154 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.82 118.04 35.05 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.244 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.533 HD21 ' HG2' ' A' ' 698' ' ' GLU . 5.2 tt -93.6 140.97 29.01 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 175.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.533 ' HG2' HD21 ' A' ' 697' ' ' LEU . 9.4 pt-20 -45.67 -36.42 4.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.39 1.076 . . . . 0.0 113.042 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 95.3 m-70 -147.09 37.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.497 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -146.07 171.57 26.95 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.384 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -156.47 -152.23 0.36 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 126.247 1.819 . . . . 0.0 106.709 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -134.58 152.76 52.0 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.581 -1.248 . . . . 0.0 113.854 -167.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.425 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.57 -47.53 8.64 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.031 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.1 pp -119.69 129.89 54.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.29 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.536 ' HB3' ' HH ' ' A' ' 709' ' ' TYR . 3.5 m -126.97 126.19 42.77 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 12.3 t -135.24 92.72 17.59 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.737 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -87.03 153.24 8.36 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.63 2.22 . . . . 0.0 111.717 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.84 136.75 45.65 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.069 -1.638 . . . . 0.0 111.887 0.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.693 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 44.5 m-85 -81.9 93.92 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.01 166.08 23.26 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.594 0.558 . . . . 0.0 111.526 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 0.7 OUTLIER -67.15 137.74 56.52 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.99 -16.31 61.38 Favored Glycine 0 N--CA 1.422 -2.287 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.036 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 661' ' ' PRO . 22.1 t0 -77.79 164.79 24.9 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.8 m -128.12 156.02 43.5 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.22 0.533 . . . . 0.0 109.875 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.512 HG12 HG12 ' A' ' 694' ' ' ILE . 38.6 t -137.51 137.7 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.969 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -106.51 120.35 41.68 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' A' ' 717' ' ' PHE . 2.2 m-85 -92.35 147.51 22.85 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.541 1.136 . . . . 0.0 111.962 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.425 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.5 t30 -118.81 138.53 52.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 37.7 t -83.1 155.06 24.04 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.6 t -63.17 147.27 51.37 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.02 137.78 45.59 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 60.8 m 86.75 5.76 0.34 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 126.278 1.831 . . . . 0.0 110.665 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 69.1 m-85 -122.5 152.07 40.7 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.437 ' HB ' HD12 ' A' ' 747' ' ' ILE . 9.9 t -114.42 137.43 51.84 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.701 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.3 ptm -91.11 139.33 30.86 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.278 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.57 HD13 HE21 ' A' ' 743' ' ' GLN . 26.9 mt -121.66 119.29 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 124.38 -154.52 17.92 Favored Glycine 0 CA--C 1.475 -2.415 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -98.69 118.49 35.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.548 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -58.96 -24.65 62.79 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.72 -1.582 . . . . 0.0 113.049 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 6.7 m -117.29 149.36 40.59 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.305 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 741' ' ' LEU . 5.8 pt -128.64 173.77 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.656 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 90.3 m -140.7 136.91 33.09 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.8 t -69.06 109.04 3.8 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.511 0.724 . . . . 0.0 110.124 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.7 mm -127.46 104.25 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.996 0.427 . . . . 0.0 111.602 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 65.73 27.71 11.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.946 . . . . 0.0 111.894 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.42 5.11 62.06 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.648 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.7 t -135.2 140.83 44.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.685 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.6 m95 -79.91 148.45 31.27 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.1 p -33.38 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.78 -29.9 0.07 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -171.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.455 HD21 HG22 ' A' ' 731' ' ' ILE . 25.6 mt 65.72 156.83 0.13 Allowed Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 124.505 1.128 . . . . 0.0 111.725 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.606 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 72.1 Cg_endo -86.58 -179.28 2.97 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 121.782 1.654 . . . . 0.0 110.21 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.57 HE21 HD13 ' A' ' 726' ' ' ILE . 12.5 pt20 -126.32 142.49 51.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 92.2 m -105.37 139.76 39.52 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.317 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.15 144.86 36.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -70.46 115.85 10.12 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.499 0.499 . . . . 0.0 112.146 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' A' ' 724' ' ' THR . 64.6 mt . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.871 ' HB2' ' HB2' ' A' ' 649' ' ' TYR . 14.4 m -131.8 158.48 41.13 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.18 -150.57 16.89 Favored Glycine 1 N--CA 1.387 -4.628 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.935 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -60.28 149.17 87.06 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.588 ' HD2' HG23 ' A' ' 645' ' ' THR . 28.1 Cg_endo -63.77 149.55 90.5 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.754 1.636 . . . . 0.0 110.992 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.496 ' HG2' HD12 ' A' ' 681' ' ' LEU . 28.8 Cg_endo -68.28 -167.27 0.17 Allowed 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 122.823 2.349 . . . . 0.0 111.863 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.95 151.41 25.84 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.531 -0.731 . . . . 0.0 110.749 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.629 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 3.7 tt -92.69 136.82 32.9 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.529 ' N ' HD21 ' A' ' 636' ' ' LEU . 46.3 tp -32.01 -68.31 0.09 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.815 2.046 . . . . 0.0 113.958 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.33 33.66 3.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.939 1.828 . . . . 0.0 108.795 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.497 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -139.67 -156.28 6.88 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.814 174.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -174.8 -178.92 1.35 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.23 139.77 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 123.838 0.855 . . . . 0.0 111.202 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -96.0 -23.01 17.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.31 172.16 14.12 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -96.79 165.24 12.21 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.266 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.588 HG23 ' HD2' ' A' ' 633' ' ' PRO . 33.5 p -91.14 120.79 32.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.374 0.607 . . . . 0.0 111.586 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.33 -24.91 21.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.759 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.935 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 67.55 -12.91 0.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.496 1.518 . . . . 0.0 114.395 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -132.0 93.49 3.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.871 ' HB2' ' HB2' ' A' ' 630' ' ' CYS . 3.1 m-85 -110.33 -179.46 3.78 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.101 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -151.08 -150.31 5.28 Favored Glycine 0 N--CA 1.402 -3.578 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.251 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -80.1 134.02 36.14 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.0 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 75.66 17.87 2.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.877 1.271 . . . . 0.0 111.798 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 69.7 mm-40 -79.87 129.22 34.31 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.693 -0.629 . . . . 0.0 109.508 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 10.4 m -110.97 151.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 123.366 0.416 . . . . 0.0 111.461 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 633' ' ' PRO . 26.2 t -135.2 131.8 52.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.442 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -100.49 128.89 46.42 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.122 0.963 . . . . 0.0 112.089 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.8 m-85 -106.72 165.75 11.08 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.486 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 45.2 p90 -136.18 156.81 48.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 75.8 m -93.08 165.13 12.99 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.95 157.5 4.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.75 10.43 0.49 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.846 3.031 . . . . 0.0 114.009 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.55 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 11.2 ptt85 -133.25 -1.16 3.24 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.996 0.903 . . . . 0.0 111.61 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 46.0 m-85 -116.7 158.18 24.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.025 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.711 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.3 mp -115.33 140.72 48.87 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.386 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.583 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 56.6 tpp -75.45 118.43 18.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.516 ' HB3' HG21 ' A' ' 683' ' ' VAL . 38.0 ttmt -98.24 -47.09 5.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.077 0.465 . . . . 0.0 110.46 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.43 -170.95 46.03 Favored Glycine 0 C--O 1.242 0.629 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.405 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 104.52 1.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.494 2.129 . . . . 0.0 110.934 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.486 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.0 p-10 -69.32 -2.44 10.78 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.318 -177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 46.6 mtmt -121.91 128.79 51.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.139 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 43.7 pt -116.96 166.25 11.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.623 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.2 tt0 -138.46 139.57 38.88 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.75 0.656 . . . . 0.0 109.657 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 13.7 t -89.67 115.06 26.76 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 677' ' ' GLU . 20.0 m -89.58 -171.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.252 4.8 p-10 -78.75 76.97 5.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.477 1.132 . . . . 0.0 111.684 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.5 0.38 Allowed Glycine 0 N--CA 1.414 -2.804 0 CA-C-N 113.534 -1.666 . . . . 0.0 111.145 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 674' ' ' VAL . 10.9 pt-20 -149.79 -175.28 4.97 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 85.9 m95 -85.05 175.1 9.24 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.238 0.542 . . . . 0.0 111.469 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 30.5 p -88.81 -174.64 4.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.833 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 88.5 m -61.63 116.66 4.94 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 123.883 0.873 . . . . 0.0 111.927 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.521 HD11 HG22 ' A' ' 671' ' ' ILE . 4.4 mm? -68.4 143.48 95.56 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.581 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.597 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 84.4 Cg_endo -76.31 170.03 20.8 Favored 'Trans proline' 0 CA--C 1.461 -3.153 0 C-N-CA 123.585 2.857 . . . . 0.0 111.928 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 666' ' ' LYS . 18.6 m -131.75 156.52 42.65 Favored 'Isoleucine or valine' 1 N--CA 1.356 -5.167 0 CA-C-N 112.048 -2.342 . . . . 0.0 108.482 -174.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 95.8 m -128.33 138.0 52.19 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.22 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.39 152.35 36.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.4 p . . . . . 0 C--N 1.274 -2.678 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.402 -2.836 0 CA-C-O 121.49 0.662 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . 0.51 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 32.7 m -95.02 -12.17 27.1 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 103.64 -77.74 0.29 Allowed Glycine 0 CA--C 1.478 -2.251 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.415 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.484 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t70 -170.58 -165.24 0.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.3 mt -80.15 136.65 53.44 Favored Pre-proline 0 C--N 1.272 -2.793 0 C-N-CA 125.296 1.439 . . . . 0.0 111.315 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.583 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.5 Cg_endo -74.64 -177.22 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.252 2.635 . . . . 0.0 111.309 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.46 118.54 33.48 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.594 HD21 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -89.35 143.39 26.87 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 10.2 pt-20 -39.01 -47.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.03 1.332 . . . . 0.0 113.239 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 53.9 m80 -143.41 30.76 1.37 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.594 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -133.12 176.53 19.52 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.066 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -164.62 -156.03 0.3 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.306 1.842 . . . . 0.0 106.913 -174.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.41 150.69 47.84 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -167.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.438 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.5 -41.8 13.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.765 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.07 146.98 50.82 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.674 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.495 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 13.0 m -120.41 130.54 54.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.57 87.77 49.41 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -91.28 147.84 3.59 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.914 2.409 . . . . 0.0 112.152 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.84 128.33 16.1 Favored 'Cis proline' 0 C--O 1.241 0.671 0 C-N-CA 122.648 -1.814 . . . . 0.0 110.955 -0.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' A' ' 709' ' ' TYR . 12.7 m-85 -72.78 97.06 2.15 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.55 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 13.6 m-85 -97.11 176.83 5.79 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.326 0.584 . . . . 0.0 111.883 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.644 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 11.3 t80 -67.09 137.75 56.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.16 -1.53 88.65 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.369 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -84.78 174.17 10.09 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.3 m -143.04 153.31 42.82 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.144 0.497 . . . . 0.0 110.614 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.547 HG12 HG12 ' A' ' 694' ' ' ILE . 39.6 t -138.28 141.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.503 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 34.3 mt-10 -100.73 121.14 41.16 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.6 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.1 m-85 -98.38 161.52 13.64 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.611 1.164 . . . . 0.0 110.461 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 34.3 t-20 -149.45 163.21 38.42 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.469 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.6 m -108.23 154.72 21.36 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 19.3 m -61.22 154.14 24.29 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.255 0.347 . . . . 0.0 111.598 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.46 138.64 58.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.5 m 88.18 -0.83 0.45 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 126.929 2.092 . . . . 0.0 110.118 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.31 149.26 40.77 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -117.15 145.31 43.91 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.664 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -93.79 138.48 31.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.684 0.754 . . . . 0.0 111.729 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 51.9 mt -113.08 116.9 53.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 119.37 -139.67 14.35 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -128.19 167.54 16.69 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 120.895 0.379 . . . . 0.0 110.402 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -87.51 -33.83 18.84 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.542 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.0 p -93.57 133.78 36.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.493 HG22 HD21 ' A' ' 741' ' ' LEU . 7.8 pt -118.1 166.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.507 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 75.2 m -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.05 121.68 25.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.551 0.691 . . . . 0.0 112.206 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 737' ' ' VAL . 49.7 mm -128.43 108.38 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 70.63 27.07 3.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 95.17 -13.72 66.44 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.32 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 734' ' ' ILE . 2.6 m -113.73 158.51 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -173.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.583 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.8 m95 -96.12 158.61 15.36 Favored 'General case' 0 C--N 1.271 -2.835 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 42.5 p -39.59 -70.4 0.1 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.2 -28.38 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 731' ' ' ILE . 17.4 mt 68.98 157.78 0.15 Allowed Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.466 1.107 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.664 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 51.2 Cg_endo -77.51 -172.05 1.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.776 1.65 . . . . 0.0 111.577 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -125.1 130.38 52.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 9.6 m -107.39 126.07 52.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.64 147.07 28.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.66 114.87 8.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.903 0.752 . . . . 0.0 111.254 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.58 175.66 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.617 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 47.8 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.771 0.796 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 12.9 p -116.33 -172.08 2.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.076 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.67 -136.82 5.66 Favored Glycine 0 N--CA 1.398 -3.84 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 32.1 Cg_exo -58.04 147.54 82.08 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 123.685 2.923 . . . . 0.0 114.028 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.529 ' HB3' HG22 ' A' ' 655' ' ' VAL . 31.9 Cg_endo -64.66 157.34 56.22 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.137 2.558 . . . . 0.0 112.658 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD22 ' A' ' 681' ' ' LEU . 19.1 Cg_endo -66.73 -164.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.405 2.736 . . . . 0.0 111.421 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -114.75 159.23 20.81 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.461 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.54 HD12 ' HA3' ' A' ' 639' ' ' GLY . 1.0 OUTLIER -93.94 136.2 34.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -32.11 -65.55 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.563 1.945 . . . . 0.0 111.189 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 4.2 t30 -110.63 -33.53 6.55 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.448 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 636' ' ' LEU . . . -83.18 -147.12 6.99 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.691 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.04 -172.85 3.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.718 HG23 ' CE1' ' A' ' 657' ' ' TYR . 21.3 t -105.16 140.21 23.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 124.64 1.176 . . . . 0.0 109.215 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.0 ptpt -107.32 -11.68 15.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.666 0.746 . . . . 0.0 109.482 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 20.0 mm-40 -78.51 154.09 30.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.927 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.93 144.82 25.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.171 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.489 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 20.9 p -78.78 119.97 22.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.998 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -103.02 -13.82 16.71 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.045 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 52.4 mm-40 66.79 -29.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.148 1.379 . . . . 0.0 112.013 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.9 tt0 -112.66 102.49 10.55 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.489 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 6.7 m-85 -117.55 -160.04 0.76 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -176.03 -165.57 32.07 Favored Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.137 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . 0.474 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.1 t60 -69.8 137.12 51.59 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.4 m 75.85 4.33 3.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 124.694 1.246 . . . . 0.0 113.252 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 53.9 mm-40 -70.98 140.27 50.81 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.4 m -121.12 139.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 633' ' ' PRO . 39.3 t -121.71 132.59 70.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.743 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 38.5 tt0 -102.42 127.73 49.32 Favored 'General case' 0 N--CA 1.414 -2.231 0 O-C-N 124.109 0.881 . . . . 0.0 110.236 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.615 ' HD2' ' CD1' ' A' ' 657' ' ' TYR . 81.2 m-85 -101.96 161.27 13.8 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.604 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.59 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 51.6 p90 -136.89 142.23 42.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 79.9 m -85.24 163.33 18.72 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.596 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.6 OUTLIER -60.98 154.4 60.41 Favored Pre-proline 0 C--O 1.211 -0.923 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.596 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 58.6 Cg_endo -66.53 -4.04 10.16 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.975 3.117 . . . . 0.0 114.628 -172.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.563 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 13.3 ptt180 -110.6 -4.71 15.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.021 0.915 . . . . 0.0 111.111 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 38.9 m-85 -117.07 149.95 39.46 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.065 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.991 HD12 ' HB3' ' A' ' 711' ' ' TYR . 10.1 mp -108.71 146.54 33.32 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.617 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.498 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 51.7 tpp -71.04 123.22 21.59 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.647 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -99.57 -49.21 4.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -94.5 -162.42 35.14 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.497 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.64 106.2 2.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.538 2.159 . . . . 0.0 110.431 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 25.3 p-10 -68.96 -8.82 48.15 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.333 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.7 mttt -118.68 130.45 55.84 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.7 pt -120.22 165.46 15.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.903 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.1 tt0 -136.81 138.18 40.56 Favored 'General case' 0 C--N 1.283 -2.288 0 O-C-N 123.848 0.717 . . . . 0.0 110.196 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 47.5 t -84.29 107.92 16.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.78 -163.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -74.05 79.83 1.72 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.334 1.064 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.33 -51.2 0.73 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.681 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -155.6 -170.52 3.46 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -86.81 162.53 17.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.8 p -76.45 -178.21 4.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 86.6 m -58.87 113.93 2.3 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.798 0.839 . . . . 0.0 111.335 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.516 HD22 ' HG2' ' A' ' 634' ' ' PRO . 6.6 mp -71.46 156.21 91.76 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.534 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -73.64 -178.45 3.75 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 123.036 2.491 . . . . 0.0 113.539 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.54 149.55 31.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 83.9 m -119.67 128.83 54.19 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 35.8 pt -123.59 158.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.402 HG21 ' O ' ' A' ' 662' ' ' ARG . 12.5 p . . . . . 0 C--N 1.279 -2.493 0 CA-C-O 123.077 1.417 . . . . 0.0 110.421 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.425 -1.682 0 CA-C-O 121.246 0.546 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.0 m -90.11 -2.63 58.12 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.668 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 89.74 -75.93 1.77 Allowed Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.761 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 3.2 t70 -159.57 -166.78 1.85 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.641 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 2.3 mt -79.78 133.72 58.28 Favored Pre-proline 0 C--N 1.28 -2.438 0 C-N-CA 124.275 1.03 . . . . 0.0 111.043 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.514 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.9 Cg_endo -74.29 -176.58 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.075 2.516 . . . . 0.0 111.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.09 120.35 42.28 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.44 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.653 HD21 ' HA3' ' A' ' 700' ' ' GLY . 30.2 tp -90.46 138.63 31.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -41.61 -40.8 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.3 m-70 -142.19 27.44 1.76 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.653 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -131.52 -179.85 16.5 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.162 -0.927 . . . . 0.0 113.465 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -160.25 -152.53 0.29 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.982 2.113 . . . . 0.0 106.553 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.75 150.95 46.68 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 118.816 0.735 . . . . 0.0 112.506 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.468 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -84.43 -43.43 14.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.761 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.23 147.87 51.11 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.575 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 6.9 p -126.17 121.47 32.9 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.333 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.05 85.65 46.17 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -92.23 146.66 2.93 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 123.114 2.543 . . . . 0.0 111.827 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.73 130.11 18.98 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.037 -1.651 . . . . 0.0 111.456 -0.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.761 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 19.3 m-85 -78.05 83.6 4.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.611 ' HD2' ' CD1' ' A' ' 710' ' ' TYR . 20.9 m-85 -83.0 168.54 16.89 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 121.157 0.503 . . . . 0.0 111.536 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 1.9 t80 -59.89 127.2 30.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.084 176.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.33 -20.5 42.38 Favored Glycine 0 C--N 1.299 -1.515 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.537 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.31 170.18 16.6 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.5 m -138.87 148.98 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.451 0.643 . . . . 0.0 111.291 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 694' ' ' ILE . 42.5 t -131.83 143.07 41.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.995 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.1 mt-10 -109.97 122.29 47.21 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' A' ' 717' ' ' PHE . 2.3 m-85 -95.32 161.1 14.23 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 124.686 1.194 . . . . 0.0 111.399 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.468 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 55.6 t30 -150.1 147.86 28.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.528 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.4 m -91.37 165.06 13.61 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 720' ' ' SER . . . . . 0.409 ' HB3' ' CD1' ' A' ' 723' ' ' PHE . 47.3 t -50.69 147.01 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.64 -31.24 62.15 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 20.3 m -93.68 11.37 29.21 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 121.173 0.511 . . . . 0.0 111.89 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' A' ' 723' ' ' PHE . 75.9 m-85 -127.26 154.83 44.39 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -119.93 145.09 47.06 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.418 ' HB3' ' SG ' ' A' ' 719' ' ' CYS . 9.0 ptp -90.74 161.07 15.48 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-O 121.474 0.654 . . . . 0.0 109.954 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.18 122.94 66.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.65 -144.47 18.18 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -118.75 169.7 9.61 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 33.7 ptt180 -94.49 -28.67 15.33 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.539 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.4 p -86.19 146.43 26.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 741' ' ' LEU . 8.4 pt -130.34 168.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.262 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 99.2 m -137.49 136.26 37.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.15 109.15 4.46 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.507 0.504 . . . . 0.0 110.312 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.3 mm -123.89 107.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.361 0.6 . . . . 0.0 110.729 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 68.16 18.83 9.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.42 1.088 . . . . 0.0 113.211 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.3 55.57 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.665 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.03 142.47 40.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.514 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.2 m95 -75.53 163.09 27.73 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.0 p -46.33 -71.59 0.07 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -33.09 0.06 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 731' ' ' ILE . 15.2 mt 66.35 153.79 0.13 Allowed Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 124.497 1.123 . . . . 0.0 110.37 -176.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.3 -161.73 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.585 1.524 . . . . 0.0 111.022 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.56 132.26 30.83 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 10.1 m -94.56 146.49 24.08 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.35 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.82 155.1 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.87 124.57 24.35 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 123.685 0.615 . . . . 0.0 109.688 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.253 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 109.166 176.81 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.434 -1.228 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 25.8 p -145.61 177.87 8.56 Favored 'General case' 0 C--N 1.275 -2.631 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -116.7 -141.75 7.16 Favored Glycine 0 N--CA 1.402 -3.616 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.905 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.697 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 18.9 Cg_exo -60.58 146.07 97.67 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.075 2.517 . . . . 0.0 111.887 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.476 ' HD2' HG23 ' A' ' 645' ' ' THR . 11.5 Cg_endo -55.57 149.18 49.65 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 123.041 2.494 . . . . 0.0 112.233 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.484 ' HG2' HD22 ' A' ' 681' ' ' LEU . 17.9 Cg_endo -72.58 -168.26 0.39 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.312 2.675 . . . . 0.0 111.999 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -99.29 158.86 15.41 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.047 0.451 . . . . 0.0 110.823 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.726 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.8 tt -98.72 145.7 26.64 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.629 HD11 HG21 ' A' ' 683' ' ' VAL . 6.9 tt -33.52 -56.0 0.44 Allowed 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 127.325 2.25 . . . . 0.0 111.238 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.5 t30 -122.6 -47.55 2.09 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.556 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -68.88 -153.08 0.54 Allowed Glycine 0 N--CA 1.476 1.324 0 O-C-N 124.103 0.877 . . . . 0.0 114.681 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.5 t-20 -173.43 -172.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.922 0 O-C-N 122.275 -0.544 . . . . 0.0 111.045 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.407 ' H ' ' CG ' ' A' ' 640' ' ' ASN . 89.5 t -93.1 140.97 15.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 C-N-CA 125.921 1.688 . . . . 0.0 110.748 -173.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -104.55 -23.83 13.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.564 0.697 . . . . 0.0 109.604 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -69.88 156.26 39.34 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.629 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 59.5 mmtt -93.37 119.37 32.41 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.832 0.825 . . . . 0.0 110.468 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.476 HG23 ' HD2' ' A' ' 633' ' ' PRO . 77.3 p -67.6 121.68 16.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.428 -1.715 . . . . 0.0 112.034 -172.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.15 -26.77 25.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.314 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.697 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 43.4 mt-10 75.04 -18.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 112.663 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.33 98.21 6.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 172.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.556 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.7 m-85 -118.4 142.47 47.52 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -108.53 -71.07 0.71 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.787 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -160.48 143.25 13.2 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 54.8 m 70.14 13.52 7.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.877 0.871 . . . . 0.0 112.664 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 61.5 mm-40 -74.73 130.24 39.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.5 p -122.68 129.36 75.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.779 0.8 . . . . 0.0 112.46 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 78.8 t -118.84 136.63 55.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.197 -174.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.527 ' OE1' ' HE3' ' A' ' 670' ' ' LYS . 36.2 tt0 -100.62 133.63 44.78 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.631 0.729 . . . . 0.0 110.667 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.645 ' HE1' ' CE2' ' A' ' 657' ' ' TYR . 42.4 m-85 -104.81 166.11 10.61 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.445 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.641 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 35.4 p90 -130.21 151.07 51.14 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 67.2 m -100.1 154.93 18.02 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 11.2 m120 -51.89 162.33 0.8 Allowed Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 125.888 1.675 . . . . 0.0 113.707 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -18.48 40.28 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.369 2.712 . . . . 0.0 113.534 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.439 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 19.7 ptt180 -117.67 -3.71 11.26 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.728 0.775 . . . . 0.0 112.171 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 59.1 m-85 -112.87 137.91 50.51 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.119 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 711' ' ' TYR . 51.8 mt -106.64 143.39 34.8 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.19 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.6 tpp -70.67 110.95 5.79 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.257 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.517 ' HB3' HG11 ' A' ' 683' ' ' VAL . 83.3 tttt -101.66 -31.75 10.66 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -75.83 -175.06 37.76 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.661 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.642 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 40.5 Cg_endo -67.36 -11.24 31.47 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.581 2.854 . . . . 0.0 113.928 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 0.9 OUTLIER 62.2 -26.72 0.06 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 127.19 2.196 . . . . 0.0 115.15 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.527 ' HE3' ' OE1' ' A' ' 656' ' ' GLU . 88.1 mttt -117.74 134.77 54.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 123.102 0.561 . . . . 0.0 110.409 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.757 HG22 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -119.49 167.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.438 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -139.55 138.68 36.48 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 123.491 0.494 . . . . 0.0 110.243 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 43.4 t -84.67 107.03 16.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.78 -173.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -78.42 70.71 4.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.931 1.348 . . . . 0.0 112.719 -175.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.88 -54.57 0.22 Allowed Glycine 0 N--CA 1.416 -2.67 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.455 172.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -159.17 -166.97 1.95 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 90.6 m95 -80.81 161.64 24.39 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.812 0.339 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -75.46 -176.13 3.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.325 0.65 . . . . 0.0 112.017 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 32.9 m -63.19 115.22 4.31 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.159 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.757 ' HG ' HG22 ' A' ' 671' ' ' ILE . 5.7 mp -71.93 155.29 92.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.26 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.726 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 51.5 Cg_endo -68.55 179.73 2.89 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.142 2.561 . . . . 0.0 115.03 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 637' ' ' LEU . 2.2 p -136.54 137.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.319 -1.764 . . . . 0.0 106.66 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 95.3 m -111.16 133.96 53.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.75 146.39 33.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.273 -2.738 0 CA-C-O 121.291 0.567 . . . . 0.0 110.852 -178.155 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.413 -2.288 0 CA-C-O 122.272 1.034 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.6 m -89.52 -11.84 41.71 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.98 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.75 -89.68 0.57 Allowed Glycine 0 CA--C 1.472 -2.65 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.598 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 t70 -164.41 -167.61 1.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.512 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -68.72 130.79 91.58 Favored Pre-proline 0 N--CA 1.412 -2.33 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.588 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 41.9 Cg_endo -71.61 179.71 4.44 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.197 2.598 . . . . 0.0 111.607 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.76 124.32 49.43 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-O 121.667 0.746 . . . . 0.0 110.694 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.909 HD21 ' HA3' ' A' ' 700' ' ' GLY . 40.7 tp -100.06 133.56 44.28 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.8 -36.92 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -133.86 18.01 3.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.572 0.701 . . . . 0.0 111.512 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.909 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -128.02 176.51 18.04 Favored Glycine 0 N--CA 1.427 -1.96 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.841 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -157.3 -151.97 0.34 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.15 158.5 43.83 Favored 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.66 -168.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.438 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.47 -61.67 1.39 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.439 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 715' ' ' VAL . 4.0 pp -103.42 153.34 20.6 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.071 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.484 ' HB3' HD11 ' A' ' 694' ' ' ILE . 4.4 p -147.04 111.68 5.29 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.461 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 70.8 m -125.01 92.26 47.88 Favored Pre-proline 0 C--N 1.284 -2.239 0 CA-C-O 121.34 0.59 . . . . 0.0 111.747 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.3 154.97 12.54 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.697 2.265 . . . . 0.0 111.205 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.98 136.5 44.26 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.22 0.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 20.4 m-85 -82.14 101.48 10.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 3.3 m-85 -98.37 169.87 9.25 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.591 0.557 . . . . 0.0 109.76 176.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.629 ' HE2' ' CE1' ' A' ' 711' ' ' TYR . 4.5 t80 -54.6 138.5 41.01 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.296 175.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.94 42.74 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 118.894 -1.622 . . . . 0.0 113.905 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 714' ' ' SER . 25.3 t0 -80.46 172.6 13.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 119.006 -1.077 . . . . 0.0 109.839 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 713' ' ' ASP . 0.7 OUTLIER -128.01 158.71 37.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -173.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' A' ' 704' ' ' LEU . 16.1 t -142.51 138.52 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.831 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -95.66 122.42 38.41 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 123.406 0.441 . . . . 0.0 110.286 176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.609 ' HD2' ' CD1' ' A' ' 717' ' ' PHE . 2.0 m-85 -99.16 154.96 17.73 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 123.78 0.832 . . . . 0.0 110.024 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 56.2 t30 -144.8 150.26 36.87 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.0 t -104.57 160.21 15.12 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 27.4 m -67.24 142.66 56.85 Favored 'General case' 0 C--O 1.205 -1.264 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.54 -18.24 64.32 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -167.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 30.1 m -81.62 -3.24 52.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.43 1.11 . . . . 0.0 109.57 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 0.539 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 77.8 m-85 -126.37 151.27 47.86 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -114.96 131.97 56.72 Favored 'General case' 0 C--N 1.265 -3.084 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.65 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -85.29 138.04 32.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.39 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 132.72 -161.14 24.0 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -101.14 174.44 6.0 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.439 0.62 . . . . 0.0 111.101 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.24 -35.97 15.88 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.8 m -107.08 138.0 44.09 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.958 -169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.488 HG22 HD21 ' A' ' 741' ' ' LEU . 7.8 pt -113.44 173.75 2.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.062 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 732' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 739' ' ' THR . 95.7 m -138.98 137.3 36.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 46.7 t -79.5 121.78 25.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.962 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 733' ' ' CYS . 49.5 mm -126.88 104.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.5 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 63.11 49.11 3.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.116 1.367 . . . . 0.0 112.018 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 83.06 -4.71 79.64 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.637 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.588 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.9 m95 -67.6 165.48 16.92 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.764 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 732' ' ' THR . 20.4 p -44.24 -70.29 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.65 -27.24 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.488 HD21 HG22 ' A' ' 731' ' ' ILE . 17.9 mt 68.58 150.93 0.12 Allowed Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 124.598 1.159 . . . . 0.0 112.393 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.65 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 96.0 Cg_endo -78.68 -165.82 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.954 1.769 . . . . 0.0 110.361 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.9 143.64 32.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 71.5 m -93.62 151.82 19.42 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.535 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.74 145.04 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.95 127.33 32.46 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.041 0.448 . . . . 0.0 111.415 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.755 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 38.4 m -131.78 153.39 50.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.91 -135.22 8.83 Favored Glycine 0 N--CA 1.415 -2.753 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 52.3 Cg_exo -55.44 141.66 81.81 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.314 2.676 . . . . 0.0 112.622 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.15 153.75 74.58 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 123.05 2.5 . . . . 0.0 111.999 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.508 ' HG2' HD12 ' A' ' 681' ' ' LEU . 42.9 Cg_endo -70.31 -166.0 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.268 2.645 . . . . 0.0 111.941 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.99 158.96 15.93 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.28 0.562 . . . . 0.0 110.482 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 657' ' ' TYR . 20.5 tp -102.09 139.68 37.39 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -39.38 -67.57 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 O-C-N 124.816 1.323 . . . . 0.0 112.263 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.1 t30 -106.66 -37.44 6.43 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.679 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -95.04 -147.4 22.58 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -169.0 -166.42 0.63 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.372 1.086 . . . . 0.0 111.123 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.07 135.36 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.669 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.6 ptpt -102.53 -10.26 19.48 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.585 0.707 . . . . 0.0 109.597 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -93.79 173.73 7.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.11 146.59 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.954 -176.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.574 HG23 ' HD2' ' A' ' 633' ' ' PRO . 18.7 p -72.88 126.77 30.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 648' ' ' GLU . 41.5 mtmt -105.38 -12.2 16.13 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 632' ' ' PRO 0.283 10.4 pt-20 58.15 -30.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 127.169 2.188 . . . . 0.0 113.782 -171.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.2 tt0 -98.31 95.65 7.51 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 24.2 m-85 -114.5 -82.63 0.61 Allowed 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.895 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 98.05 -166.44 22.31 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -77.48 142.24 39.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.756 0.278 . . . . 0.0 111.21 -175.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 11.3 t 77.94 0.66 2.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.48 1.512 . . . . 0.0 113.38 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 29.7 mm-40 -70.51 133.68 47.01 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 18.0 t -109.63 150.29 12.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 123.557 0.535 . . . . 0.0 109.681 -176.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 633' ' ' PRO . 25.0 t -132.97 134.85 57.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 124.038 0.935 . . . . 0.0 109.302 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -101.73 124.9 48.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.172 0.987 . . . . 0.0 111.524 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 657' ' ' TYR . 57.3 m-85 -99.3 163.95 12.33 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.189 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 26.9 p90 -143.42 149.46 37.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.4 m -93.02 158.93 15.54 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.52 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -56.18 156.1 11.39 Favored Pre-proline 0 C--O 1.208 -1.08 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.775 176.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.53 -14.36 25.36 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 123.599 2.866 . . . . 0.0 115.404 -171.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.454 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 16.1 ptt180 -108.03 -7.1 16.23 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.409 0.623 . . . . 0.0 111.556 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.454 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 35.4 m-85 -109.6 139.33 44.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.178 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 711' ' ' TYR . 10.5 mp -99.7 142.08 31.66 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.791 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.558 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.7 tpp -71.71 117.19 12.98 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.441 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.536 ' HB3' HG21 ' A' ' 683' ' ' VAL . 13.2 tmtt? -107.01 -25.23 11.69 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.715 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -103.22 -169.54 25.93 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.197 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.55 105.6 2.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.482 2.122 . . . . 0.0 111.274 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.9 p-10 -69.74 -0.15 6.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.288 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 87.1 mttt -127.39 140.36 52.23 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.753 0.311 . . . . 0.0 110.52 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.823 HG22 HD13 ' A' ' 681' ' ' LEU . 46.0 pt -129.88 165.07 30.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 26.3 tt0 -143.15 140.43 30.8 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 123.266 0.626 . . . . 0.0 110.625 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 18.5 t -78.6 110.54 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.046 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.58 -171.1 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.533 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.31 75.29 8.27 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.812 1.291 . . . . 0.0 111.475 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.95 -43.48 0.47 Allowed Glycine 0 N--CA 1.411 -3.016 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.644 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.11 -171.58 2.7 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -82.69 167.67 17.99 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.6 p -77.77 -172.23 2.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.917 0.389 . . . . 0.0 111.803 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.6 m -68.7 113.54 6.27 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 123.319 0.647 . . . . 0.0 111.759 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.823 HD13 HG22 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -61.77 148.63 87.01 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.78 173.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 636' ' ' LEU . 89.4 Cg_endo -81.12 -177.22 3.56 Favored 'Trans proline' 0 CA--C 1.465 -2.929 0 C-N-CA 123.617 2.878 . . . . 0.0 112.517 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 666' ' ' LYS . 14.5 m -141.37 159.76 22.27 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.798 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.288 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 73.0 m -128.63 139.7 52.13 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.3 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 666' ' ' LYS . 32.1 pt -130.75 148.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--N 1.283 -2.283 0 CA-C-O 122.705 1.241 . . . . 0.0 110.509 179.394 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.412 -2.342 0 CA-C-O 121.368 0.604 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 38.7 m -108.49 -17.0 14.09 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.787 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.57 -80.45 0.27 Allowed Glycine 0 C--N 1.295 -1.745 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.959 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.447 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 10.5 t70 -173.43 -167.0 0.36 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -69.67 135.35 88.13 Favored Pre-proline 0 N--CA 1.407 -2.603 0 C-N-CA 123.327 0.651 . . . . 0.0 110.097 174.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.595 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 39.4 Cg_endo -70.67 -163.44 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.605 2.87 . . . . 0.0 111.991 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.99 126.18 51.82 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.141 0.496 . . . . 0.0 109.847 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.768 HD21 ' HA3' ' A' ' 700' ' ' GLY . 29.1 tp -112.58 135.47 53.26 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -39.82 -46.31 1.93 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.998 1.319 . . . . 0.0 113.906 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 94.6 m-70 -142.39 27.87 1.7 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.768 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -132.71 167.34 23.23 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.949 -177.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -157.15 -154.39 0.46 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.45 162.11 34.55 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.985 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.545 ' N ' HE21 ' A' ' 703' ' ' GLN . 0.0 OUTLIER -95.92 -57.23 2.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.518 0.675 . . . . 0.0 109.774 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 704' ' ' LEU . 3.9 pp -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.1 m -112.23 125.64 54.37 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 47.9 m -119.75 95.18 49.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-O 121.528 0.68 . . . . 0.0 112.353 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -91.09 154.43 3.85 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.809 2.339 . . . . 0.0 111.964 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.39 134.94 37.83 Favored 'Cis proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.753 -1.77 . . . . 0.0 111.043 -0.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' A' ' 709' ' ' TYR . 16.2 m-85 -76.17 97.82 4.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' A' ' 710' ' ' TYR . 23.4 m-85 -102.44 174.93 5.68 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.225 0.536 . . . . 0.0 110.315 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 2.9 t80 -65.78 129.33 39.41 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.2 -7.68 60.35 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.05 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.49 171.29 12.66 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 3.8 m -136.72 147.39 46.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.226 0.536 . . . . 0.0 110.99 -171.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.465 HG12 ' CG1' ' A' ' 694' ' ' ILE . 48.3 t -138.17 144.49 30.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.379 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.0 mt-10 -101.55 131.11 47.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.599 ' HD2' ' CD1' ' A' ' 717' ' ' PHE . 2.0 m-85 -105.63 157.93 17.06 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 123.784 0.834 . . . . 0.0 109.169 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -151.83 151.13 30.91 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.4 m -98.0 157.4 16.14 Favored 'General case' 0 C--N 1.26 -3.285 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 33.5 m -52.18 150.75 4.29 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 123.479 0.487 . . . . 0.0 110.273 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -32.11 62.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 42.7 m -91.09 12.97 18.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.78 0.8 . . . . 0.0 111.409 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.12 146.54 50.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.528 ' HB ' HD12 ' A' ' 747' ' ' ILE . 10.2 t -113.56 139.29 49.11 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.642 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 7.9 ptm -88.61 142.47 27.67 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.509 0.671 . . . . 0.0 110.97 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.419 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 53.8 mt -119.03 117.32 53.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.54 -143.64 14.77 Favored Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.61 135.13 42.53 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.813 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.62 -33.39 72.7 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.51 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.429 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.9 p -123.54 161.29 25.23 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.316 0.579 . . . . 0.0 111.676 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.549 HD13 ' CG ' ' A' ' 738' ' ' TRP . 7.0 pt -131.19 168.09 24.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.114 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 88.9 m -139.23 137.53 36.05 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.401 ' O ' HD11 ' A' ' 734' ' ' ILE . 42.0 t -78.66 120.66 23.66 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.575 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.401 HD11 ' O ' ' A' ' 733' ' ' CYS . 51.1 mm -126.37 105.97 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.304 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 70.29 30.54 3.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.561 1.145 . . . . 0.0 112.672 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.73 3.19 80.85 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.494 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.01 140.35 49.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.595 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -79.22 152.24 30.75 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 30.6 p -31.95 -66.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.85 -34.89 0.05 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.494 HD21 HG23 ' A' ' 731' ' ' ILE . 32.5 mt 67.98 150.69 0.12 Allowed Pre-proline 0 C--N 1.318 -0.771 0 O-C-N 125.08 1.487 . . . . 0.0 111.282 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.642 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 90.2 Cg_endo -81.55 -172.37 1.46 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.251 1.967 . . . . 0.0 110.547 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.419 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 3.8 pt20 -134.61 135.29 42.08 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.0 m -97.95 140.52 32.17 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.673 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.57 141.88 45.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.64 117.62 9.82 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.797 0.685 . . . . 0.0 111.788 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.528 HD12 ' HB ' ' A' ' 724' ' ' THR . 58.0 mt . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 49.0 m . . . . . 0 C--O 1.234 0.272 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.29 166.6 12.09 Favored 'General case' 0 C--O 1.263 1.781 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.054 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.3 -130.52 7.03 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.94 147.29 91.99 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.106 2.537 . . . . 0.0 112.857 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.468 ' HB3' HG22 ' A' ' 655' ' ' VAL . 38.7 Cg_endo -65.1 160.25 42.71 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.74 2.96 . . . . 0.0 112.727 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.456 ' HG2' HD22 ' A' ' 681' ' ' LEU . 51.7 Cg_endo -74.36 -163.47 0.18 Allowed 'Trans proline' 0 C--O 1.253 1.247 0 C-N-CA 122.986 2.457 . . . . 0.0 110.133 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.45 160.24 20.87 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.749 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 657' ' ' TYR . 19.4 tp -89.71 141.17 28.87 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.646 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.461 HD21 ' H ' ' A' ' 684' ' ' CYS . 32.7 tp -30.68 -59.59 0.2 Allowed 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.428 2.291 . . . . 0.0 113.321 172.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -119.56 -45.95 2.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.116 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -80.94 -154.74 11.1 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.63 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.1 -174.33 4.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.877 -0.778 . . . . 0.0 111.726 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.35 137.5 21.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 124.248 1.019 . . . . 0.0 109.108 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.635 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.3 ptpt -105.06 -7.73 18.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.66 0.743 . . . . 0.0 109.747 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.81 154.07 23.71 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.383 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -81.44 145.8 30.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.9 p -80.57 128.41 33.57 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.355 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.3 mtmt -102.76 -14.25 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 56.13 -16.14 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 C-N-CA 127.424 2.29 . . . . 0.0 115.404 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 646' ' ' LYS . 36.3 tt0 -122.6 85.56 2.44 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.661 ' HE2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 m-85 -93.61 -77.35 0.45 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.611 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 117.39 -97.36 0.73 Allowed Glycine 0 C--N 1.305 -1.15 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.391 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -155.17 143.03 19.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 12.2 t 72.71 9.97 5.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.357 1.463 . . . . 0.0 110.778 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 20.6 mm-40 -75.94 126.5 31.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.7 m -107.03 143.49 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.389 0.614 . . . . 0.0 112.078 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 43.0 t -125.65 133.47 69.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.784 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.77 125.89 48.52 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.086 0.946 . . . . 0.0 111.043 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.67 ' HD2' ' CD1' ' A' ' 657' ' ' TYR . 61.9 m-85 -99.89 157.0 16.83 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.687 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.635 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 49.5 p90 -134.61 152.36 51.72 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.588 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.7 t -108.73 169.83 8.41 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.784 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -61.57 152.89 72.9 Favored Pre-proline 0 C--O 1.194 -1.85 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.918 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.8 16.79 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.821 3.014 . . . . 0.0 113.997 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 19.0 ptt180 -137.38 3.81 2.6 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.918 0.866 . . . . 0.0 110.049 173.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 663' ' ' PHE . 59.7 m-85 -129.18 135.43 48.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.421 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.456 HD22 ' HB3' ' A' ' 711' ' ' TYR . 11.7 mt -95.44 144.64 25.79 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.957 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.567 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.1 tpp -73.39 113.71 10.79 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.175 174.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.551 ' HD2' HD11 ' A' ' 685' ' ' ILE . 62.1 tttm -100.59 -45.93 5.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.382 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.66 -173.77 50.01 Favored Glycine 0 C--O 1.236 0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.089 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.67 107.27 2.15 Favored 'Trans proline' 0 CA--C 1.503 -1.058 0 C-N-CA 122.812 2.341 . . . . 0.0 111.252 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.567 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -70.58 -7.77 46.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.561 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 55.9 mtmt -118.61 123.29 44.65 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 122.005 0.907 . . . . 0.0 110.388 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 50.0 pt -110.34 167.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.061 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 30.0 tt0 -138.05 137.12 37.49 Favored 'General case' 0 C--N 1.277 -2.57 0 O-C-N 123.545 0.528 . . . . 0.0 110.207 -175.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.85 104.98 12.61 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.8 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.85 -174.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.924 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.09 83.61 7.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.791 0.805 . . . . 0.0 110.085 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 154.22 -47.0 0.54 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.119 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.92 -172.26 2.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -88.26 168.04 13.05 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -77.95 -172.88 2.88 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.714 0.293 . . . . 0.0 111.451 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 61.9 m -73.25 114.96 12.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.874 0.845 . . . . 0.0 111.088 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.582 HD21 HG22 ' A' ' 671' ' ' ILE . 66.2 mt -57.98 145.93 70.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.527 ' HG2' HD11 ' A' ' 636' ' ' LEU . 18.0 Cg_endo -66.03 177.65 2.9 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.179 1.919 . . . . 0.0 113.273 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 146.83 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.461 ' H ' HD21 ' A' ' 637' ' ' LEU . 34.6 m -119.78 144.26 47.39 Favored 'General case' 0 C--N 1.276 -2.626 0 O-C-N 124.353 1.033 . . . . 0.0 108.34 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.551 HD11 ' HD2' ' A' ' 666' ' ' LYS . 27.8 pt -142.74 143.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.275 -2.665 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.27 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.41 -2.472 0 CA-C-O 121.678 0.751 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.36 -9.84 29.09 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.83 30.64 7.84 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.492 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.679 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.9 t0 68.78 179.6 0.24 Allowed 'General case' 0 C--O 1.241 0.611 0 O-C-N 124.306 0.65 . . . . 0.0 110.241 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.603 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 3.4 mt -69.03 129.76 91.94 Favored Pre-proline 0 N--CA 1.406 -2.644 0 C-N-CA 123.354 0.662 . . . . 0.0 110.58 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.594 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -70.0 -179.52 3.08 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 123.33 2.687 . . . . 0.0 111.795 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.11 115.16 27.86 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.356 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.573 HD11 ' HA3' ' A' ' 700' ' ' GLY . 2.5 tt -90.19 137.14 32.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.8 pt-20 -35.9 -43.65 0.32 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.7 1.6 . . . . 0.0 113.039 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 49.1 m80 -144.36 25.7 1.51 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.573 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -128.92 177.72 17.69 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.098 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -161.97 -158.44 0.54 Allowed 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.233 1.413 . . . . 0.0 107.625 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -140.26 156.04 46.63 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.257 -168.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.81 -68.0 0.82 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.865 0.728 . . . . 0.0 110.753 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.56 140.78 31.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.873 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.2 p -136.51 116.61 13.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.354 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 42.4 t -124.1 93.86 46.29 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-O 121.286 0.565 . . . . 0.0 110.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.7 153.04 10.18 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.806 2.337 . . . . 0.0 111.352 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.29 135.91 42.07 Favored 'Cis proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.13 0.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.679 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 28.4 m-85 -80.31 98.77 7.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.617 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 7.6 m-30 -93.65 173.35 7.73 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.951 0.782 . . . . 0.0 110.702 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.615 ' HD2' ' CD1' ' A' ' 711' ' ' TYR . 2.8 t80 -65.42 138.91 58.43 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.62 -14.15 65.86 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 118.001 -2.047 . . . . 0.0 112.693 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.64 167.2 21.97 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 117.479 0.639 . . . . 0.0 109.813 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 714' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.2 m -132.71 153.28 51.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.048 0.451 . . . . 0.0 110.172 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.541 HG12 HG12 ' A' ' 694' ' ' ILE . 37.9 t -142.62 143.17 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.804 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -98.36 124.08 42.83 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.603 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 1.6 m-85 -104.54 167.91 9.43 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.138 0.975 . . . . 0.0 109.263 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -163.92 167.88 20.08 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.8 m -110.06 162.05 14.94 Favored 'General case' 0 C--N 1.263 -3.192 0 O-C-N 123.147 0.279 . . . . 0.0 111.172 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 32.6 t -56.83 155.19 8.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.917 0.76 . . . . 0.0 110.303 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -55.39 -44.18 75.9 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.144 0.978 . . . . 0.0 112.117 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 9.2 t -77.67 5.72 8.71 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.419 0.688 . . . . 0.0 111.852 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -130.16 156.0 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.761 0.424 . . . . 0.0 109.936 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.2 t -117.15 142.45 46.99 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.482 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -90.39 146.65 24.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.433 0.635 . . . . 0.0 111.163 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.636 HD13 HE21 ' A' ' 743' ' ' GLN . 39.5 mt -119.64 118.36 56.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.13 -157.47 16.07 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -112.46 162.24 15.82 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 117.177 0.488 . . . . 0.0 110.56 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -81.59 -33.22 31.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 24.2 p -95.0 137.15 34.44 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.505 HG22 HD21 ' A' ' 741' ' ' LEU . 10.0 pt -121.25 166.21 16.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.883 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.6 m -136.58 139.13 41.93 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.3 t -78.11 120.47 22.98 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.125 0.488 . . . . 0.0 111.976 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.6 mm -128.26 110.87 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.893 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 65.81 30.25 10.15 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.602 1.161 . . . . 0.0 112.58 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.15 2.98 65.74 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.744 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.6 p -136.99 148.02 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.594 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.1 m95 -77.2 158.2 30.46 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.8 p -32.34 -72.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -28.24 0.03 OUTLIER 'General case' 0 C--O 1.243 0.713 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 731' ' ' ILE . 17.2 mt 69.1 152.02 0.13 Allowed Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.036 1.335 . . . . 0.0 111.578 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.482 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 57.4 Cg_endo -76.11 -169.56 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.964 1.776 . . . . 0.0 109.746 173.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.636 HE21 HD13 ' A' ' 726' ' ' ILE . 9.4 pt20 -135.85 150.58 49.44 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.8 m -110.8 134.93 52.09 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 145.66 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 123.335 0.397 . . . . 0.0 110.282 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.19 113.13 3.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 124.723 1.264 . . . . 0.0 111.684 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.311 -1.105 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.502 173.007 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.404 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.8 m . . . . . 0 C--O 1.24 0.575 0 CA-C-O 122.006 0.908 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.14 -169.97 1.55 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -115.46 -138.97 6.66 Favored Glycine 0 N--CA 1.41 -3.076 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.474 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.668 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 21.3 Cg_exo -62.55 150.85 86.24 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.854 2.369 . . . . 0.0 110.88 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.7 158.8 40.15 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.555 2.17 . . . . 0.0 112.083 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 671' ' ' ILE . 18.1 Cg_endo -75.53 -161.5 0.13 Allowed 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.881 2.387 . . . . 0.0 110.231 176.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.28 166.87 11.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.003 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.819 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.3 tt -103.55 140.58 37.33 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -36.98 -65.25 0.31 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.878 1.671 . . . . 0.0 111.676 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -108.49 -47.16 3.55 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.521 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -72.79 -155.71 3.02 Favored Glycine 0 C--O 1.242 0.639 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -171.0 0.53 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.73 132.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.416 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.503 ' HB3' ' CD2' ' A' ' 658' ' ' TYR . 18.3 pttp -102.51 -7.89 21.51 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.245 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -81.54 152.01 27.46 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.93 153.07 21.33 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 68.8 p -79.84 111.03 15.76 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.365 1.079 . . . . 0.0 112.081 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 13.2 mtpp -89.17 -26.7 21.14 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.96 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 53.0 mt-10 70.26 -30.21 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.604 1.562 . . . . 0.0 111.881 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 646' ' ' LYS . 33.6 mt-10 -91.94 82.91 5.13 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.264 0.554 . . . . 0.0 109.922 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 16.2 m-85 -118.31 106.02 12.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -83.14 -67.92 1.45 Allowed Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.973 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -161.12 142.04 11.43 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 122.752 -0.263 . . . . 0.0 110.315 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 2.6 t 70.34 12.29 7.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 111.303 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 13.6 mm-40 -77.73 125.27 29.08 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.219 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.627 HG13 ' HB2' ' A' ' 672' ' ' GLN . 15.6 m -110.01 144.96 17.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.196 0.522 . . . . 0.0 111.657 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.0 t -123.73 136.49 60.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -105.42 128.38 53.49 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-O 121.708 0.766 . . . . 0.0 109.415 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 657' ' ' TYR . 47.4 m-85 -99.0 163.29 12.64 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.583 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' A' ' 642' ' ' LYS . 45.5 p90 -133.82 155.04 50.53 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 5.8 t -101.78 163.61 12.16 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.109 -1.437 . . . . 0.0 108.863 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.28 155.51 26.2 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.789 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.26 14.53 0.22 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.601 2.867 . . . . 0.0 114.006 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.425 ' O ' HG21 ' A' ' 686' ' ' VAL . 11.8 ptt180 -137.99 -7.08 1.62 Allowed 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 32.8 m-85 -111.59 157.6 20.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.948 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.71 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.6 mp -111.11 135.59 51.41 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.163 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 54.0 tpp -71.23 119.34 15.22 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.71 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -105.26 -44.99 4.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.02 -171.98 48.36 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.506 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 36.3 Cg_endo -69.0 104.25 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.738 2.292 . . . . 0.0 111.429 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.2 p-10 -71.7 1.07 7.34 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.592 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.5 mttt -128.65 136.74 51.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.2 pt -126.48 162.1 31.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.627 ' HB2' HG13 ' A' ' 654' ' ' VAL . 28.4 tt0 -133.88 139.75 46.39 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 123.344 0.658 . . . . 0.0 110.738 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.86 102.63 12.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.93 -172.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.84 73.7 4.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.673 1.225 . . . . 0.0 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.28 -36.95 0.93 Allowed Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.992 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.51 -178.77 7.59 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -92.23 164.81 13.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 34.4 p -77.92 176.27 9.27 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.554 0.161 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.0 m -57.05 118.6 5.16 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.413 0.625 . . . . 0.0 112.38 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -62.1 149.32 86.85 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.745 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.819 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 55.7 Cg_endo -71.51 179.33 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.853 2.368 . . . . 0.0 113.581 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.03 141.89 45.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 5.2 m -120.24 137.47 54.2 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.264 0.352 . . . . 0.0 111.099 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.6 pt -135.73 143.82 35.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 662' ' ' ARG . 14.3 p . . . . . 0 C--N 1.289 -2.025 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.411 -2.378 0 CA-C-O 121.164 0.507 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.2 m -86.84 -7.08 58.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.424 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.58 -78.38 0.64 Allowed Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.756 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.535 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 6.8 p-10 -157.57 174.47 15.31 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.663 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 2.5 mt -67.79 126.58 92.79 Favored Pre-proline 0 N--CA 1.422 -1.845 0 C-N-CA 123.694 0.797 . . . . 0.0 111.217 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.586 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -68.21 173.15 9.95 Favored 'Trans proline' 0 N--CA 1.433 -2.077 0 C-N-CA 123.186 2.59 . . . . 0.0 112.556 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.12 120.28 37.17 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.37 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.785 HD21 ' HA3' ' A' ' 700' ' ' GLY . 24.3 tp -99.72 129.34 45.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -51.14 -36.39 40.5 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 89.2 m-70 -135.35 25.54 3.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.491 0.662 . . . . 0.0 109.875 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.785 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -135.79 179.08 18.16 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.919 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -161.1 -154.83 0.38 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.888 1.675 . . . . 0.0 106.499 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.29 150.73 49.04 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.787 -169.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.524 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -88.57 -45.88 9.53 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.39 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.44 154.06 42.55 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.281 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.5 p -136.39 128.18 29.15 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.382 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 30.2 t -124.36 85.85 55.3 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-O 121.442 0.639 . . . . 0.0 109.886 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.471 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 10.9 Cg_endo -93.39 154.64 2.49 Favored 'Trans proline' 0 N--CA 1.431 -2.195 0 C-N-CA 122.994 2.463 . . . . 0.0 112.055 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 37.8 Cg_endo -67.97 133.6 22.97 Favored 'Cis proline' 0 C--O 1.235 0.364 0 C-N-CA 122.795 -1.752 . . . . 0.0 109.963 -3.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.535 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 39.9 m-85 -73.28 82.37 1.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -174.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 8.1 m-85 -81.77 174.3 11.47 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 122.903 0.481 . . . . 0.0 111.188 179.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 39.3 t80 -62.98 140.55 58.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.943 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.38 70.21 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.389 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.39 166.97 22.02 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -132.86 144.4 50.17 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.163 0.506 . . . . 0.0 110.085 -171.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.54 HG12 HG12 ' A' ' 694' ' ' ILE . 45.5 t -130.13 138.22 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.913 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.64 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.6 mt-10 -106.17 120.92 43.07 Favored 'General case' 0 N--CA 1.409 -2.511 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.223 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.663 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 3.1 m-85 -96.28 160.72 14.28 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 125.082 1.353 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.524 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -148.12 143.53 27.19 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 78.4 m -88.13 158.86 18.43 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 123.59 0.556 . . . . 0.0 109.661 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.2 t -61.93 148.93 42.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.25 145.57 56.06 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 36.4 m 85.52 -5.41 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 110.144 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 1.66 ' HD2' ' CD1' ' A' ' 723' ' ' PHE . 49.7 m-85 -112.91 153.85 27.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 747' ' ' ILE . 6.8 t -116.83 143.6 45.49 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.629 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 4.3 ptm -94.53 138.74 32.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.75 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.1 mt -105.9 116.97 50.77 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.149 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 105.55 -141.43 15.37 Favored Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.593 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -102.39 129.54 48.89 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.316 0.579 . . . . 0.0 110.636 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.144 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.573 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 0.2 OUTLIER -103.97 148.51 26.11 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.451 HG22 HD21 ' A' ' 741' ' ' LEU . 8.4 pt -129.6 167.75 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.1 m -138.85 136.94 36.12 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.51 106.75 3.1 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 109.867 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . 0.457 ' HA ' ' CE2' ' A' ' 711' ' ' TYR . 52.1 mm -122.61 112.18 33.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.008 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 58.31 29.74 18.54 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.711 0.804 . . . . 0.0 112.724 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.92 6.59 61.84 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.857 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.33 139.05 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.586 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -70.01 150.96 46.1 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -39.14 -75.06 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -173.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.03 -29.06 0.07 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -171.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.451 HD21 HG22 ' A' ' 731' ' ' ILE . 23.6 mt 68.49 156.33 0.15 Allowed Pre-proline 0 C--O 1.239 0.546 0 O-C-N 124.619 1.2 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.629 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 46.5 Cg_endo -81.84 -167.9 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.113 1.875 . . . . 0.0 111.47 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -130.21 130.22 44.37 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 21.5 m -98.8 129.17 45.19 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.208 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.89 145.73 34.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -73.81 115.09 12.84 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.608 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.515 HD12 ' HB ' ' A' ' 724' ' ' THR . 60.6 mt . . . . . 0 C--O 1.255 1.348 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.644 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 45.9 t . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 21.0 p -168.25 149.18 4.96 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.97 -139.71 10.9 Favored Glycine 0 N--CA 1.403 -3.515 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.198 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.925 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 44.8 Cg_exo -53.16 142.07 56.61 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.65 2.9 . . . . 0.0 112.824 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.43 ' HB3' HG22 ' A' ' 655' ' ' VAL . 27.7 Cg_endo -61.01 151.34 78.97 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 123.073 2.516 . . . . 0.0 112.207 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.496 ' HG2' HD22 ' A' ' 681' ' ' LEU . 9.6 Cg_endo -63.3 179.54 0.84 Allowed 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.12 2.546 . . . . 0.0 112.722 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.1 145.73 24.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.618 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.4 tt -86.84 138.16 31.8 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.508 ' N ' HD21 ' A' ' 636' ' ' LEU . 54.0 tp -33.26 -65.63 0.17 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 126.196 1.798 . . . . 0.0 113.212 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 0.2 OUTLIER -135.77 30.98 3.08 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 123.976 1.846 . . . . 0.0 108.798 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.584 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -139.7 -156.87 7.07 Favored Glycine 1 C--N 1.241 -4.727 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.489 173.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -163.74 177.81 8.38 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.021 0.928 . . . . 0.0 109.965 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.49 140.16 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 123.241 0.616 . . . . 0.0 109.788 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 642' ' ' LYS . 9.4 ptpt -97.35 -11.98 23.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.077 0.465 . . . . 0.0 111.37 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.16 163.97 14.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.378 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -92.77 149.94 20.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.404 HG23 ' HD2' ' A' ' 633' ' ' PRO . 56.7 p -75.32 119.14 19.02 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.007 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -80.39 -20.71 43.4 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.925 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 65.51 -3.26 0.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.411 1.484 . . . . 0.0 114.993 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -148.93 95.06 2.35 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 16.6 m-85 -95.24 -68.84 0.78 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.212 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 111.7 -94.14 0.74 Allowed Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.408 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -148.17 142.96 26.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.897 0.349 . . . . 0.0 110.661 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 59.7 m 69.74 11.15 7.8 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.326 1.45 . . . . 0.0 113.262 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 9.6 mm-40 -77.04 127.75 33.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.6 t -104.45 141.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 123.758 0.661 . . . . 0.0 109.409 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 42.9 t -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 123.28 0.632 . . . . 0.0 109.543 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 32.2 tt0 -102.98 131.69 49.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 122.096 0.95 . . . . 0.0 112.354 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.537 ' HB3' HD11 ' A' ' 636' ' ' LEU . 63.4 m-85 -110.24 164.99 12.12 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.835 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.623 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 55.0 p90 -139.54 151.13 45.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 99.3 m -89.56 162.45 15.66 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.877 0.37 . . . . 0.0 111.311 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.92 158.72 12.03 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.265 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.29 1.11 0.73 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 124.302 3.334 . . . . 0.0 117.134 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.473 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 17.2 ptt-85 -131.98 -2.26 3.65 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.289 173.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -100.61 143.72 30.43 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.057 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.695 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.7 mp -100.8 140.14 35.5 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.561 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.589 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 50.9 tpp -69.63 113.74 7.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.416 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 683' ' ' VAL . 28.3 tptp -101.65 -12.2 18.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.993 0.901 . . . . 0.0 109.499 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -98.62 -171.35 31.73 Favored Glycine 0 C--N 1.293 -1.833 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.416 -177.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 88.6 Cg_endo -80.93 -5.91 13.11 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.068 2.512 . . . . 0.0 111.515 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.478 ' HA ' ' HG3' ' A' ' 682' ' ' PRO 0.259 2.3 p-10 57.82 -6.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.9 2.48 . . . . 0.0 115.764 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 656' ' ' GLU . 55.5 mtmt -130.92 141.84 50.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 118.283 0.492 . . . . 0.0 110.437 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.9 pt -131.76 169.87 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.897 -175.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.8 tt0 -137.08 140.7 42.16 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 122.843 0.457 . . . . 0.0 111.127 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 45.3 t -81.98 102.19 10.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.793 0.806 . . . . 0.0 109.689 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.99 170.16 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.73 70.95 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.841 1.256 . . . . 0.0 112.415 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 148.7 -30.81 1.25 Allowed Glycine 0 N--CA 1.405 -3.433 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.99 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.39 -177.53 3.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -86.13 174.95 8.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.579 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.3 p -89.38 -167.31 1.83 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.607 0.363 . . . . 0.0 111.419 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.4 m -65.54 112.21 3.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.044 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' A' ' 634' ' ' PRO . 5.3 mp -71.71 154.86 92.86 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.523 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.618 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 45.4 Cg_endo -68.09 175.95 6.0 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.433 2.089 . . . . 0.0 113.472 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 666' ' ' LYS . 50.5 t -129.06 151.08 35.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.4 m -132.11 123.71 27.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.66 141.64 45.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.408 -2.55 0 CA-C-O 121.421 0.629 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 42.5 m -81.62 -24.44 36.39 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.158 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.99 41.47 3.29 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 113.2 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.62 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 30.4 t70 66.26 176.87 0.22 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.504 0.722 . . . . 0.0 112.498 176.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.568 HG12 HG13 ' A' ' 715' ' ' VAL . 2.8 mt -73.87 131.0 82.23 Favored Pre-proline 0 N--CA 1.416 -2.173 0 C-N-CA 123.942 0.897 . . . . 0.0 111.005 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 717' ' ' PHE . 74.1 Cg_endo -73.82 -179.61 4.75 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.943 2.429 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -119.67 116.63 26.38 Favored 'General case' 0 C--N 1.262 -3.221 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.248 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.753 HD21 ' HA3' ' A' ' 700' ' ' GLY . 47.3 tp -82.37 139.81 33.86 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -46.33 -37.3 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -135.78 22.97 3.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.076 0.465 . . . . 0.0 111.259 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.753 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -132.72 167.4 23.21 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.075 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -156.58 -152.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.113 1.365 . . . . 0.0 107.33 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.22 148.46 48.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -167.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.528 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.69 -42.36 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.946 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.57 160.47 35.2 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.718 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 5.6 m -148.35 117.62 6.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 59.1 m -116.1 98.4 51.2 Favored Pre-proline 0 C--N 1.28 -2.446 0 CA-C-O 121.397 0.617 . . . . 0.0 110.795 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.401 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.5 Cg_endo -93.6 151.83 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.584 0 C-N-CA 122.349 2.033 . . . . 0.0 111.389 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 71.4 Cg_endo -72.97 133.2 29.33 Favored 'Cis proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.122 -1.616 . . . . 0.0 111.444 0.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 30.9 m-85 -72.74 96.8 2.09 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 3.4 m-85 -99.42 175.09 5.97 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.695 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 6.3 t80 -62.1 141.38 58.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.75 71.83 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.685 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.43 169.6 17.95 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -134.02 149.61 51.19 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 110.384 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.568 HG13 HG12 ' A' ' 694' ' ' ILE . 43.7 t -137.9 142.21 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.593 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.81 120.31 41.9 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 694' ' ' ILE . 1.9 m-85 -96.43 149.66 21.47 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 124.408 1.083 . . . . 0.0 110.36 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 53.1 t30 -136.4 152.3 50.47 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.741 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 46.6 t -91.86 166.31 12.8 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 48.5 t -58.42 157.59 8.6 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.254 0.549 . . . . 0.0 109.811 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.79 -35.87 82.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.506 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 15.1 m -90.82 5.42 48.48 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.204 0.525 . . . . 0.0 111.804 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -128.62 158.18 39.21 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.5 t -117.04 145.27 43.82 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.8 ptm -101.8 151.44 22.05 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.407 0.623 . . . . 0.0 110.797 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.0 mt -131.2 127.86 61.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.79 -153.46 16.63 Favored Glycine 0 CA--C 1.472 -2.614 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -98.75 119.01 36.78 Favored 'General case' 0 CA--C 1.465 -2.297 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.919 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -65.53 -27.38 68.41 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.178 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.6 p -107.91 147.73 30.59 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.344 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.511 HD13 ' CG ' ' A' ' 738' ' ' TRP . 8.4 pt -127.35 163.41 30.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.324 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 56.7 m -134.62 136.73 43.11 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.49 114.29 15.05 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.466 0.65 . . . . 0.0 111.432 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.04 97.53 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.914 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 68.05 34.14 4.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.735 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 101.19 -15.21 57.99 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.405 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.77 133.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.511 ' CG ' HD13 ' A' ' 731' ' ' ILE . 88.3 m95 -72.35 152.76 41.87 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.2 p -37.43 -66.54 0.24 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -31.01 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 731' ' ' ILE . 21.4 mt 66.09 148.75 0.11 Allowed Pre-proline 0 C--N 1.316 -0.855 0 O-C-N 124.796 1.31 . . . . 0.0 110.992 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.13 -172.13 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.812 1.675 . . . . 0.0 110.089 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -136.94 145.07 43.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 88.2 m -102.32 153.77 19.68 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.6 144.33 27.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.82 120.7 12.4 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 123.707 0.629 . . . . 0.0 111.199 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.252 1.235 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.165 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.506 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 8.0 p . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 28.6 p -175.91 146.36 0.71 Allowed 'General case' 0 C--O 1.253 1.238 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.62 -132.3 7.63 Favored Glycine 0 N--CA 1.414 -2.781 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.69 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.919 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 52.9 Cg_exo -53.77 140.34 67.37 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 124.002 3.135 . . . . 0.0 113.12 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 645' ' ' THR . 21.7 Cg_endo -61.97 154.24 63.14 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.575 2.183 . . . . 0.0 111.093 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 681' ' ' LEU . 14.6 Cg_endo -68.02 -168.81 0.21 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 122.517 2.145 . . . . 0.0 111.872 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.08 162.44 13.37 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.538 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.623 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 28.8 tp -101.19 138.18 38.56 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -27.75 -64.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.584 2.353 . . . . 0.0 111.731 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -117.36 -40.9 3.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.874 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.536 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -79.18 -128.77 0.6 Allowed Glycine 0 CA--C 1.504 -0.627 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.599 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -173.53 -175.6 1.15 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.0 p -99.5 144.64 11.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -99.7 -16.72 18.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.122 0.487 . . . . 0.0 111.123 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 145.11 24.94 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.38 152.08 27.65 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-O 121.833 0.825 . . . . 0.0 112.543 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.663 HG23 ' HD2' ' A' ' 633' ' ' PRO . 39.9 p -73.65 118.16 16.27 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.679 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -83.79 -22.78 31.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.001 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.919 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 32.0 mt-10 63.69 18.28 11.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.672 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -157.97 101.29 1.77 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.676 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 0.555 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 34.7 m-85 -117.45 -73.48 0.64 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.268 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.08 -88.57 0.65 Allowed Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.739 -1.22 . . . . 0.0 113.885 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -146.61 142.38 27.88 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.22 0.51 . . . . 0.0 110.793 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.3 p 68.18 11.5 8.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.884 1.674 . . . . 0.0 113.102 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.555 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 39.0 mm-40 -78.86 129.16 34.26 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.604 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.9 OUTLIER -120.11 131.14 73.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 112.111 -176.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 67.4 t -121.41 137.9 53.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.195 -171.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.37 134.03 48.27 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 122.508 1.147 . . . . 0.0 112.269 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.0 m-85 -109.9 164.06 12.95 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.158 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.97 145.72 42.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 96.3 m -91.5 153.4 19.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.536 ' OD1' ' HA2' ' A' ' 639' ' ' GLY . 4.2 m-20 -51.6 156.79 2.09 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.015 177.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.4 12.19 0.41 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 123.646 2.897 . . . . 0.0 112.801 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.557 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 40.4 ptt180 -133.35 0.34 3.35 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.793 0.806 . . . . 0.0 111.573 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 31.4 m-85 -125.03 150.6 46.59 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.57 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 5.9 mp -103.36 139.91 38.14 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.235 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.535 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.0 tpp -73.93 117.25 15.49 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.782 0.676 . . . . 0.0 109.206 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -101.27 -32.7 10.38 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.6 -174.98 48.84 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 114.981 -1.009 . . . . 0.0 114.1 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.36 -8.67 23.84 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 124.065 3.177 . . . . 0.0 112.854 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.0 p-10 58.48 -0.95 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.081 2.153 . . . . 0.0 115.358 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.8 mtmt -136.74 138.41 40.92 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.986 0.357 . . . . 0.0 110.495 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 681' ' ' LEU . 44.6 pt -126.13 171.59 14.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.54 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -143.77 141.14 30.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 122.701 0.4 . . . . 0.0 109.994 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 41.4 t -85.71 105.1 16.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.32 -171.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.24 84.96 3.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.861 1.315 . . . . 0.0 111.614 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.01 0.31 Allowed Glycine 0 N--CA 1.4 -3.744 0 CA-C-N 111.872 -2.422 . . . . 0.0 108.343 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.62 -172.97 4.37 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.6 m95 -78.42 159.68 28.16 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 41.1 p -75.82 -168.0 0.81 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.504 0.721 . . . . 0.0 112.236 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 91.8 m -77.26 116.85 18.23 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.446 0.641 . . . . 0.0 111.502 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 671' ' ' ILE . 4.3 mm? -58.09 145.38 73.33 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.689 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.503 ' HG2' HD11 ' A' ' 636' ' ' LEU . 30.1 Cg_endo -70.31 -172.95 0.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.44 2.093 . . . . 0.0 112.503 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.26 142.41 35.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.404 ' SG ' HD22 ' A' ' 636' ' ' LEU . 70.8 m -115.78 133.01 56.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.43 139.65 51.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 123.372 0.42 . . . . 0.0 109.939 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.7 p . . . . . 0 C--N 1.29 -1.987 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 120.937 0.399 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.5 m -90.86 -3.1 57.63 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.644 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 92.32 -68.94 1.84 Allowed Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.887 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.51 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.5 t70 -177.51 -167.29 0.15 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -70.1 130.86 89.29 Favored Pre-proline 0 N--CA 1.413 -2.309 0 O-C-N 123.483 0.489 . . . . 0.0 110.482 174.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.542 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.9 Cg_endo -75.22 -176.37 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.42 2.747 . . . . 0.0 111.879 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -104.87 125.6 51.06 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.874 HD21 ' HA3' ' A' ' 700' ' ' GLY . 21.2 tp -104.05 136.27 44.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -52.17 -34.96 47.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 84.8 m-70 -139.79 22.33 2.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.728 0.775 . . . . 0.0 110.552 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.874 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -131.24 173.38 20.4 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.205 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -157.54 -154.25 0.44 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.912 1.685 . . . . 0.0 106.845 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -141.13 158.16 44.29 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.983 -168.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -98.92 -56.75 2.34 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -118.96 151.64 37.81 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.0 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.0 p -123.43 160.83 26.02 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.6 t -150.41 86.82 5.02 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-O 121.496 0.665 . . . . 0.0 109.74 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . 0.468 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 12.5 Cg_endo -97.64 151.05 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.432 2.755 . . . . 0.0 113.374 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 58.2 Cg_endo -69.36 135.27 32.17 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.048 -1.647 . . . . 0.0 111.236 -0.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 0.51 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.0 m-85 -77.73 73.17 4.3 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.535 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 0.557 ' CD2' ' HB2' ' A' ' 662' ' ' ARG . 29.8 m-85 -84.36 176.97 8.34 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 0.735 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 20.3 t80 -62.69 139.0 58.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.971 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.37 54.88 Favored Glycine 0 C--N 1.296 -1.671 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.955 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.8 171.13 15.43 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.9 m -137.1 155.84 49.12 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.475 0.655 . . . . 0.0 110.626 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.448 HG12 ' CG1' ' A' ' 694' ' ' ILE . 36.2 t -141.33 144.86 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.068 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.531 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.1 mt-10 -109.9 128.17 55.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.376 0.607 . . . . 0.0 110.482 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 717' ' ' PHE . 3.3 m-85 -101.07 157.12 17.0 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.334 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.529 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 66.6 t30 -147.86 141.89 25.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.552 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.9 m -87.65 157.33 19.13 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.6 m -51.7 157.29 1.18 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.437 0.46 . . . . 0.0 110.858 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.83 -29.42 69.48 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -169.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 47.3 m -89.18 6.71 38.87 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 121.603 -0.686 . . . . 0.0 111.238 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -126.3 151.26 47.75 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 724' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 747' ' ' ILE . 11.1 t -119.79 145.92 46.16 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.598 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 6.5 ptm -93.3 147.28 23.06 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.337 0.589 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . 0.513 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 44.5 mt -119.75 127.57 75.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.37 -139.96 15.9 Favored Glycine 0 CA--C 1.479 -2.209 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -109.62 129.8 55.56 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.248 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -65.8 -29.49 69.99 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.277 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.531 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -107.98 149.18 28.7 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.698 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.498 HD13 ' CG ' ' A' ' 738' ' ' TRP . 7.2 pt -126.42 170.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.339 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 91.7 m -139.28 138.17 36.51 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.7 106.18 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.53 0.519 . . . . 0.0 109.649 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.52 115.82 47.13 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.619 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 60.96 19.49 9.89 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.813 1.245 . . . . 0.0 113.242 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.74 8.0 54.87 Favored Glycine 0 C--N 1.31 -0.908 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.06 139.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.542 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.6 m95 -66.14 147.63 53.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -34.91 -71.88 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -27.9 0.05 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.479 HD21 HG22 ' A' ' 731' ' ' ILE . 19.6 mt 68.22 151.26 0.12 Allowed Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 124.51 1.131 . . . . 0.0 111.799 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.598 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 62.5 Cg_endo -80.11 -173.29 1.8 Allowed 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 122.638 2.226 . . . . 0.0 111.74 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . 0.513 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 23.6 pt20 -128.88 128.23 43.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 13.8 m -90.68 141.01 29.23 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.783 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.25 147.78 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.11 121.04 21.45 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.232 0.333 . . . . 0.0 111.214 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' A' ' 724' ' ' THR . 58.1 mt . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 629' ' ' SER . . . . . 0.575 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.7 m . . . . . 0 N--CA 1.436 -1.154 0 CA-C-O 120.813 0.339 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 22.4 p -96.24 162.74 13.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.26 -136.11 8.95 Favored Glycine 0 N--CA 1.407 -3.266 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 632' ' ' PRO . . . . . 0.81 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 33.6 Cg_exo -58.63 147.03 89.37 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.485 2.79 . . . . 0.0 112.607 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 633' ' ' PRO . . . . . 0.632 ' HD2' HG23 ' A' ' 645' ' ' THR . 23.6 Cg_endo -62.07 158.8 37.25 Favored 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 123.408 2.738 . . . . 0.0 112.512 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 634' ' ' PRO . . . . . 0.586 ' HG2' ' HH ' ' A' ' 657' ' ' TYR . 22.0 Cg_endo -67.0 -156.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.608 2.872 . . . . 0.0 111.462 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -122.58 166.0 15.54 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.221 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 636' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 657' ' ' TYR . 33.9 tp -103.57 141.74 35.49 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 637' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 638' ' ' ASN . 2.2 tm? -40.83 -67.26 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.013 1.446 . . . . 0.0 110.991 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 638' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 1.3 t30 -129.13 52.5 1.96 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.16 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 639' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -176.16 -158.1 18.93 Favored Glycine 1 C--N 1.249 -4.256 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -167.86 -168.99 1.07 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.742 1.271 . . . . 0.0 112.027 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 68.0 t -92.61 132.77 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.299 1.44 . . . . 0.0 110.022 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 642' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.9 ptpt -104.05 -1.88 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.282 1.039 . . . . 0.0 109.222 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -90.61 173.9 7.8 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.247 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -104.03 147.12 27.76 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.151 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 645' ' ' THR . . . . . 0.632 HG23 ' HD2' ' A' ' 633' ' ' PRO . 40.1 p -80.83 117.06 21.16 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.634 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -83.27 -25.97 31.11 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.637 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 647' ' ' GLU . . . . . 0.81 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 44.3 mt-10 73.01 -7.18 1.54 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.843 1.257 . . . . 0.0 113.579 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -145.73 100.73 3.46 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 649' ' ' TYR . . . . . 1.635 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 m-85 -94.74 -70.0 0.73 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.763 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 650' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.7 -111.13 1.78 Allowed Glycine 0 C--N 1.312 -0.789 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.878 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -142.57 135.11 27.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.8 m 76.33 15.53 2.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.66 1.184 . . . . 0.0 111.88 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 653' ' ' GLU . . . . . 0.762 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 54.9 mm-40 -80.7 135.13 35.96 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.819 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 654' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -114.66 151.16 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 655' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 633' ' ' PRO . 48.0 t -131.92 135.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.177 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -103.13 130.15 50.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.519 0.676 . . . . 0.0 110.785 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 657' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 657' ' ' TYR . 71.0 m-85 -106.77 161.4 14.7 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.844 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 658' ' ' TYR . . . . . 1.592 ' HE2' ' CE1' ' A' ' 658' ' ' TYR . 53.8 p90 -136.63 152.17 50.13 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 659' ' ' CYS . . . . . 0.589 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.2 m -97.95 169.13 9.85 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 660' ' ' ASN . . . . . 0.443 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.2 OUTLIER -58.41 157.58 17.48 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 661' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 66.0 Cg_endo -72.04 7.6 1.66 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.778 2.985 . . . . 0.0 113.84 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 662' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 15.7 ptt180 -120.0 -9.58 9.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.766 0.793 . . . . 0.0 110.049 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 663' ' ' PHE . . . . . 0.467 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 41.9 m-85 -119.93 161.34 21.05 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 664' ' ' LEU . . . . . 0.733 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.318 0.0 OUTLIER -130.26 141.35 50.63 Favored 'General case' 0 C--N 1.256 -3.493 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.732 179.895 . . . . . . . . 4 4 . 1 . 020 nuclear orig core ' A' A ' 665' ' ' MET . . . . . 0.525 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.7 tpp -61.65 124.54 20.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.171 -177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 666' ' ' LYS . . . . . 0.449 ' HD2' HD11 ' A' ' 685' ' ' ILE . 63.5 tttm -106.35 -49.77 3.28 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.18 -163.52 39.02 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.951 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.87 105.27 2.05 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.601 2.2 . . . . 0.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 669' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.7 p-10 -72.49 4.99 3.28 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.199 -173.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 670' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 41.2 mtmt -132.27 128.98 38.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 671' ' ' ILE . . . . . 0.554 HG22 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -118.72 166.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 672' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 33.1 tt0 -134.52 137.61 44.0 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 123.657 0.598 . . . . 0.0 110.606 -175.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.47 110.18 17.97 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.955 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.96 -168.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.78 78.87 9.32 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.849 1.309 . . . . 0.0 111.66 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 146.45 -45.3 0.8 Allowed Glycine 0 N--CA 1.401 -3.668 0 CA-C-N 113.177 -1.829 . . . . 0.0 111.708 170.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.66 -168.78 3.0 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -102.0 168.4 9.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.7 p -78.67 -170.21 2.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.723 0.297 . . . . 0.0 111.194 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.1 m -71.14 112.56 7.38 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 121.267 0.556 . . . . 0.0 110.215 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 681' ' ' LEU . . . . . 0.554 ' HG ' HG22 ' A' ' 671' ' ' ILE . 5.5 mp -68.98 153.48 96.06 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.884 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 682' ' ' PRO . . . . . 0.519 ' HG2' HD11 ' A' ' 636' ' ' LEU . 75.7 Cg_endo -73.19 -176.35 2.4 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.031 2.487 . . . . 0.0 112.442 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 683' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 666' ' ' LYS . 11.2 p -145.27 146.65 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 684' ' ' CYS . . . . . 0.464 ' SG ' HD22 ' A' ' 636' ' ' LEU . 63.7 m -114.29 138.54 50.38 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 685' ' ' ILE . . . . . 0.449 HD11 ' HD2' ' A' ' 666' ' ' LYS . 21.9 pt -130.17 146.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 686' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 662' ' ' ARG . 9.1 p . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 26.2 m -93.21 -4.5 51.88 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.912 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 104.07 -90.21 0.72 Allowed Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 693' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 p-10 -168.65 -172.89 1.75 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.476 1.11 . . . . 0.0 108.107 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 694' ' ' ILE . . . . . 0.592 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -64.87 126.73 91.67 Favored Pre-proline 0 N--CA 1.434 -1.258 0 CA-C-O 121.555 0.693 . . . . 0.0 112.559 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 695' ' ' PRO . . . . . 0.534 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 50.6 Cg_endo -71.28 -174.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.511 2.807 . . . . 0.0 112.065 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -108.44 113.87 27.26 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.297 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 697' ' ' LEU . . . . . 0.89 HD21 ' HA3' ' A' ' 700' ' ' GLY . 20.3 tp -92.04 135.83 33.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.0 -34.37 69.94 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -137.0 18.41 3.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.856 0.836 . . . . 0.0 110.376 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 700' ' ' GLY . . . . . 0.89 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -127.32 176.33 17.88 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.746 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -158.33 -154.41 0.43 Allowed 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 702' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.79 156.09 47.64 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 118.819 0.736 . . . . 0.0 112.611 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 703' ' ' GLN . . . . . 0.516 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.37 -59.3 1.86 Allowed 'General case' 0 CA--C 1.496 -1.131 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.494 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 704' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.3 pp -114.6 127.71 55.93 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 705' ' ' SER . . . . . 0.43 ' HB3' HD11 ' A' ' 694' ' ' ILE . 1.8 p -106.38 124.06 49.02 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.569 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.4 p -125.67 90.78 49.86 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -90.74 150.35 4.11 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.644 2.229 . . . . 0.0 111.657 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 708' ' ' PRO . . . . . 0.426 ' HB2' ' CE1' ' A' ' 710' ' ' TYR . 73.1 Cg_endo -74.31 134.05 33.91 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.639 -1.817 . . . . 0.0 110.995 -1.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 709' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 709' ' ' TYR . 21.2 m-85 -77.7 82.51 4.1 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 710' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' A' ' 710' ' ' TYR . 5.9 m-30 -87.46 166.53 14.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.257 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 711' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 711' ' ' TYR . 3.3 t80 -61.13 135.99 57.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.06 -22.28 41.66 Favored Glycine 0 C--N 1.296 -1.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.504 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.69 163.62 27.5 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 117.817 0.808 . . . . 0.0 109.095 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.3 m -136.41 147.91 47.51 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.122 0.487 . . . . 0.0 110.144 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 715' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 730' ' ' SER . 33.6 t -130.59 140.46 48.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.911 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 716' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.2 mt-10 -102.33 128.27 48.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.164 0.506 . . . . 0.0 111.029 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 717' ' ' PHE . . . . . 1.629 ' HE2' ' CE1' ' A' ' 717' ' ' PHE . 3.1 m-85 -98.45 158.46 15.57 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 124.717 1.207 . . . . 0.0 109.707 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 718' ' ' ASN . . . . . 0.516 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 4.0 t-20 -144.61 145.16 31.64 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 719' ' ' CYS . . . . . 0.511 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 96.9 m -96.25 158.06 15.61 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -57.28 150.9 16.99 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.47 -39.46 61.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -172.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.8 t -78.39 1.83 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.668 0.747 . . . . 0.0 111.149 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 723' ' ' PHE . . . . . 1.597 ' HE1' ' CE2' ' A' ' 723' ' ' PHE . 80.3 m-85 -123.59 147.96 46.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -114.43 143.0 45.64 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 725' ' ' MET . . . . . 0.509 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 8.2 ptm -92.74 141.89 27.95 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.483 0.659 . . . . 0.0 110.489 -176.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 44.3 mt -114.81 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 123.53 -155.77 17.66 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.031 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -95.34 136.66 35.42 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 122.283 1.039 . . . . 0.0 108.407 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -70.32 -37.1 74.65 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.291 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 730' ' ' SER . . . . . 0.576 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.5 p -102.33 138.36 39.36 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-O 122.168 0.985 . . . . 0.0 113.368 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 731' ' ' ILE . . . . . 0.515 HG23 HD21 ' A' ' 741' ' ' LEU . 10.9 pt -115.97 167.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.3 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 44.0 m -134.02 137.33 44.65 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.32 103.94 1.38 Allowed 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.882 0.739 . . . . 0.0 109.778 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.9 mm -128.49 110.59 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.084 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 68.63 21.4 7.95 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.73 18.93 39.05 Favored Glycine 0 N--CA 1.434 -1.433 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.365 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.15 154.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 738' ' ' TRP . . . . . 0.534 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.6 m95 -76.21 169.72 17.67 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 739' ' ' THR . . . . . 0.613 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 9.2 p -49.98 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 740' ' ' GLN . . . . . 0.613 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -161.54 -30.67 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.066 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 741' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 731' ' ' ILE . 22.2 mt 70.79 153.58 0.15 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.685 1.24 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 742' ' ' PRO . . . . . 0.509 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 73.4 Cg_endo -81.8 -166.41 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.622 0 C-N-CA 121.927 1.751 . . . . 0.0 110.034 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.71 147.25 38.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 744' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 8.8 m -104.21 143.83 32.42 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.89 137.16 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.35 117.09 6.16 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 110.387 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.311 -1.091 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.523 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -95.29 82.28 3.71 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -45.03 86.86 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.613 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -150.47 18.53 0.83 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -68.38 98.12 0.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -90.8 -27.12 20.41 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 163.326 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.488 HG21 ' HB2' ' A' ' 651' ' ' HIS 0.305 13.8 p 43.89 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 127.231 2.213 . . . . 0.0 115.402 172.99 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.454 ' CD ' ' H ' ' A' ' 629' ' ' SER . 0.2 OUTLIER -66.54 -90.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.47 172.381 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.454 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 15.8 p 166.48 133.9 0.01 OUTLIER 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.963 1.705 . . . . 0.0 109.584 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 30.5 p -137.83 142.11 40.79 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.604 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -94.6 -134.16 7.38 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.769 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 78.2 Cg_exo -53.56 146.54 42.64 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.818 3.012 . . . . 0.0 113.162 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.47 ' HD2' HG23 ' A' ' 645' ' ' THR . 31.3 Cg_endo -65.71 158.07 55.44 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.537 2.158 . . . . 0.0 111.421 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 681' ' ' LEU . 25.0 Cg_endo -71.79 -169.24 0.42 Allowed 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.96 2.44 . . . . 0.0 112.054 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.86 146.73 33.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.735 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.9 tt -81.97 141.49 33.24 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -33.28 -69.83 0.08 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.859 1.663 . . . . 0.0 111.142 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.418 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 3.1 t30 -108.81 -38.32 5.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.011 -1.075 . . . . 0.0 109.924 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.546 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -76.42 -151.28 3.71 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.166 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -169.28 179.51 3.91 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.681 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.9 p -98.92 142.6 14.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 123.312 0.645 . . . . 0.0 110.006 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.4 ptpt -97.01 -27.46 14.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.071 0.463 . . . . 0.0 110.777 -178.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.29 142.62 35.97 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.637 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -83.56 159.47 21.65 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.398 0.618 . . . . 0.0 111.003 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.47 HG23 ' HD2' ' A' ' 633' ' ' PRO . 21.3 p -73.42 122.81 22.7 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.759 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.425 ' C ' ' H ' ' A' ' 648' ' ' GLU . 43.3 mtmt -96.76 -29.27 13.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.034 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.769 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 40.8 mt-10 71.47 -26.2 0.17 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 125.984 1.714 . . . . 0.0 113.041 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 646' ' ' LYS . 8.3 pt-20 -95.17 42.21 1.09 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.041 0.536 . . . . 0.0 110.987 -178.844 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.615 ' HD2' ' CD1' ' A' ' 649' ' ' TYR . 80.0 m-85 -69.85 -73.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 92.74 -68.09 1.81 Allowed Glycine 0 C--N 1.293 -1.809 0 C-N-CA 120.387 -0.911 . . . . 0.0 114.499 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.488 ' HB2' HG21 ' A' ' 627' ' ' VAL . 86.4 t60 -161.51 138.57 8.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 117.196 0.498 . . . . 0.0 112.168 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 26.1 m 63.9 13.86 7.92 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.904 1.681 . . . . 0.0 113.282 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.586 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 8.6 mm-40 -78.54 136.29 37.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.426 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 t -110.46 143.28 20.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.481 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 56.7 t -132.26 135.76 57.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.259 0.624 . . . . 0.0 109.866 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.92 132.48 49.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 122.174 0.987 . . . . 0.0 111.783 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.642 ' HD1' ' CD2' ' A' ' 657' ' ' TYR . 41.7 m-85 -108.52 166.74 10.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.596 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.408 ' HD1' ' O ' ' A' ' 659' ' ' CYS . 45.6 p90 -137.13 160.09 39.98 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.522 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 69.6 m -98.31 169.36 9.62 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.653 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.477 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.53 165.27 3.14 Favored Pre-proline 0 C--O 1.2 -1.539 0 C-N-CA 124.329 1.052 . . . . 0.0 109.367 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.477 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 72.6 Cg_endo -75.59 12.88 1.26 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.749 2.299 . . . . 0.0 112.577 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.461 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 25.4 ptt180 -144.21 10.6 1.5 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.896 0.855 . . . . 0.0 110.041 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.648 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 45.5 m-85 -134.81 138.22 44.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.202 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.56 HD22 ' HB3' ' A' ' 711' ' ' TYR . 11.3 mt -104.28 154.75 19.42 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.332 0.586 . . . . 0.0 110.048 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.522 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 55.0 tpp -73.52 124.61 26.2 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.022 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -110.82 -25.76 9.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.969 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.05 -172.92 46.35 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.45 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 57.9 Cg_endo -72.43 -9.76 24.58 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.377 2.718 . . . . 0.0 112.345 -179.304 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.447 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.2 p-10 55.96 -0.25 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 127.6 2.36 . . . . 0.0 115.947 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.481 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 31.8 mtmt -130.24 144.36 51.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.0 pt -136.11 167.64 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 123.425 0.453 . . . . 0.0 109.897 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.586 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.8 tt0 -135.87 140.56 44.23 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 123.751 0.821 . . . . 0.0 110.461 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.8 t -85.14 99.2 10.91 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.756 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.64 165.35 2.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.307 2.2 p30 -75.5 80.51 2.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 118.426 -1.31 . . . . 0.0 113.763 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.84 -40.26 0.5 Allowed Glycine 0 N--CA 1.419 -2.451 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.249 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -165.12 175.76 9.09 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -81.55 171.2 14.95 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.691 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 23.0 p -82.89 -165.62 1.11 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.59 0.234 . . . . 0.0 111.493 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 94.8 m -66.69 111.98 3.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.523 HD22 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -69.52 154.4 94.87 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.487 175.199 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.735 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 56.0 Cg_endo -69.62 -178.76 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.502 2.134 . . . . 0.0 114.444 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.7 145.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 86.7 m -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.55 140.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 662' ' ' ARG . 7.3 p -74.58 127.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.546 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -76.55 -24.6 53.59 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.745 0.783 . . . . 0.0 109.946 179.501 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 61.69 46.28 7.25 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.524 1.53 . . . . 0.0 108.256 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 689' ' ' SER . . . . . 0.481 ' HB2' ' HG2' ' A' ' 687' ' ' GLU . 20.2 m -131.65 155.5 47.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.054 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 18.7 p -127.05 154.9 44.08 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 120.978 0.418 . . . . 0.0 111.9 -178.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 8.7 m -93.27 -2.75 54.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 99.2 -87.3 0.76 Allowed Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.747 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.6 t70 -158.45 -167.56 2.2 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.611 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -73.63 133.17 80.12 Favored Pre-proline 0 N--CA 1.407 -2.615 0 C-N-CA 123.899 0.879 . . . . 0.0 109.998 175.427 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.578 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 66.9 Cg_endo -73.68 -164.89 0.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.248 2.632 . . . . 0.0 111.301 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -117.7 142.08 47.65 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.55 HD11 ' HA3' ' A' ' 700' ' ' GLY . 3.5 tt -117.09 137.46 52.26 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.403 ' HG2' HD21 ' A' ' 697' ' ' LEU . 14.4 pt-20 -41.69 -40.01 1.84 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 113.113 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.628 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 97.1 m-70 -145.32 29.38 1.16 Allowed 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.55 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -133.3 170.38 22.28 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.567 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -158.54 -155.41 0.48 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -136.79 152.16 49.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -167.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.451 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -92.44 -48.95 6.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.859 178.462 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.7 pp -124.83 152.92 43.33 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.4 p -147.88 124.17 10.89 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.319 1.048 . . . . 0.0 109.096 -178.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.4 t -131.78 92.0 31.8 Favored Pre-proline 0 C--N 1.289 -2.052 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.601 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -87.16 149.47 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 122.634 2.223 . . . . 0.0 111.454 175.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 67.6 Cg_endo -74.82 132.94 29.17 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.133 -1.611 . . . . 0.0 112.493 0.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.627 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 46.6 m-85 -76.48 92.38 3.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.035 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.455 ' HA ' ' O ' ' A' ' 689' ' ' SER . 3.3 m-85 -79.68 166.72 21.54 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 123.548 0.53 . . . . 0.0 111.656 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.638 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 3.6 t80 -66.91 135.28 53.59 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.31 60.34 Favored Glycine 0 N--CA 1.402 -3.617 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.95 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.66 166.22 19.34 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.502 0.651 . . . . 0.0 110.885 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 0.9 OUTLIER -127.62 158.24 38.06 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.414 0.626 . . . . 0.0 111.157 -172.82 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.552 HG12 HG12 ' A' ' 694' ' ' ILE . 26.2 t -142.04 142.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.606 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -102.33 126.12 49.25 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 120.802 0.334 . . . . 0.0 110.102 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.611 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.6 m-85 -97.7 154.98 17.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.929 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.493 HD21 ' N ' ' A' ' 719' ' ' CYS . 0.2 OUTLIER -137.23 135.74 37.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -177.502 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.493 ' N ' HD21 ' A' ' 718' ' ' ASN . 95.6 m -93.48 144.24 25.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 63.1 m -56.68 161.77 2.62 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.91 140.37 55.49 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.762 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.7 m 79.12 -2.19 2.25 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 125.962 1.705 . . . . 0.0 111.712 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 1.661 ' HD1' ' CD2' ' A' ' 723' ' ' PHE . 59.1 m-85 -116.56 140.17 49.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.947 -0.471 . . . . 0.0 110.419 173.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.439 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 9.2 t -108.24 141.73 39.57 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.663 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -91.03 137.98 31.95 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.23 0.538 . . . . 0.0 110.7 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.49 115.0 44.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.06 -154.38 20.24 Favored Glycine 0 CA--C 1.472 -2.623 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -94.63 130.2 41.19 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -63.19 -29.95 71.2 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.121 0.888 . . . . 0.0 111.624 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.416 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 6.0 p -113.95 152.9 30.18 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 121.602 0.715 . . . . 0.0 112.073 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.495 HG22 HD21 ' A' ' 741' ' ' LEU . 7.7 pt -127.73 167.27 23.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.481 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 82.9 m -133.49 135.92 44.76 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.7 t -67.29 109.04 2.96 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.768 0.827 . . . . 0.0 110.471 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.6 mm -126.83 99.01 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.46 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 66.56 30.07 8.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.525 1.13 . . . . 0.0 112.172 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 97.02 0.37 60.1 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.559 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.39 143.61 38.54 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.578 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -78.3 166.05 23.14 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 38.0 p -48.67 -69.46 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.19 -30.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.495 HD21 HG22 ' A' ' 731' ' ' ILE . 20.2 mt 67.73 148.91 0.12 Allowed Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 124.856 1.347 . . . . 0.0 111.564 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.663 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 77.7 Cg_endo -80.77 175.28 10.17 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.016 1.811 . . . . 0.0 109.693 174.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.88 134.93 54.87 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.628 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 4.4 m -102.47 122.72 44.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.72 149.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.55 112.62 4.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 124.161 0.913 . . . . 0.0 111.239 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.41 HD12 ' HB ' ' A' ' 724' ' ' THR . 56.6 mt . . . . . 0 C--O 1.249 1.038 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.41 ' H2 ' ' CD ' ' A' ' 623' ' ' GLU . 29.7 mm-40 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 120.641 0.258 . . . . 0.0 111.603 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -134.84 24.45 3.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.686 0.755 . . . . 0.0 108.993 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.41 ' CD ' ' H2 ' ' A' ' 621' ' ' GLU . 2.6 mp0 -76.55 -20.94 56.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.305 -174.722 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -95.89 -49.58 5.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -162.68 142.1 9.12 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -91.0 -123.82 2.88 Favored Glycine 0 N--CA 1.426 -2.004 0 O-C-N 123.649 0.593 . . . . 0.0 112.007 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.647 HG23 ' CD2' ' A' ' 651' ' ' HIS . 58.8 t 57.26 80.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 122.46 1.124 . . . . 0.0 108.566 -172.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.508 ' OE1' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -82.39 -94.4 0.05 Allowed 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.353 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.1 p 173.08 152.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.89 0.876 . . . . 0.0 109.104 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.6 p -168.61 152.38 5.63 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.16 -138.41 9.66 Favored Glycine 1 N--CA 1.392 -4.253 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.422 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.523 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 51.0 Cg_exo -54.6 144.38 64.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.6 2.866 . . . . 0.0 112.891 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.75 ' HD2' HG23 ' A' ' 645' ' ' THR . 30.7 Cg_endo -61.51 162.68 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.269 2.646 . . . . 0.0 112.895 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.489 ' HG2' HD22 ' A' ' 681' ' ' LEU . 32.2 Cg_endo -75.5 -165.42 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.548 2.165 . . . . 0.0 111.194 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.44 174.69 5.75 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.508 HD11 ' HG2' ' A' ' 682' ' ' PRO . 17.2 tp -109.36 144.55 37.39 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.75 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -32.66 -59.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.547 1.939 . . . . 0.0 111.784 179.064 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.3 t30 -120.2 -44.75 2.48 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.316 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.419 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -76.83 -152.79 4.89 Favored Glycine 0 CA--C 1.495 -1.19 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.393 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.435 ' HB3' ' CZ ' ' A' ' 658' ' ' TYR . 2.5 t-20 -156.86 -178.25 7.22 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.364 -1.334 . . . . 0.0 110.152 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.26 146.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -111.0 -13.38 14.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.836 0.827 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.476 ' HB2' HG11 ' A' ' 655' ' ' VAL . 15.6 mm-40 -79.89 134.94 36.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.635 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.587 ' HE2' ' HA ' ' A' ' 644' ' ' LYS . 9.3 mmpt? -67.5 158.47 31.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.842 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.75 HG23 ' HD2' ' A' ' 633' ' ' PRO . 65.4 p -107.11 151.09 25.84 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.318 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -99.5 -87.93 0.35 Allowed 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.933 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.523 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 12.1 pt-20 156.88 -36.21 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.434 0 C-N-CA 125.713 1.605 . . . . 0.0 107.956 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -126.07 107.87 10.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.846 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 7.7 m-85 -101.73 -72.19 0.69 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.753 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 114.85 -105.49 1.5 Allowed Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.545 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.647 ' CD2' HG23 ' A' ' 627' ' ' VAL . 81.1 t60 -138.58 140.98 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.644 0.222 . . . . 0.0 110.494 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 41.3 m 72.82 15.8 4.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.006 1.322 . . . . 0.0 112.987 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.846 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 14.5 mm-40 -75.11 133.92 41.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.465 ' HA ' ' O ' ' A' ' 671' ' ' ILE 0.263 0.5 OUTLIER -125.91 134.28 66.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.824 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.56 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 53.7 t -125.14 143.38 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.136 0.974 . . . . 0.0 111.239 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.428 ' HG3' ' ND2' ' A' ' 669' ' ' ASN . 30.2 tt0 -104.62 133.49 49.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.865 0.841 . . . . 0.0 111.461 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.408 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 46.8 m-85 -105.48 166.58 10.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.415 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.435 ' CZ ' ' HB3' ' A' ' 640' ' ' ASN . 49.7 p90 -138.95 144.46 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 60.4 m -102.46 151.04 22.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.127 0.489 . . . . 0.0 110.183 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.53 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 15.0 m120 -52.48 159.96 1.48 Allowed Pre-proline 0 C--N 1.305 -1.358 0 C-N-CA 126.268 1.827 . . . . 0.0 114.739 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -68.24 6.89 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 124.008 3.139 . . . . 0.0 113.737 -178.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 18.7 ptt180 -140.54 -2.15 1.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.642 0.734 . . . . 0.0 111.535 175.385 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.62 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 51.9 m-85 -116.62 122.8 45.65 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.405 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.533 HD23 ' CD1' ' A' ' 711' ' ' TYR . 11.0 mt -85.73 142.05 29.28 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.524 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.444 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 35.8 ttm -77.96 110.34 12.8 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.105 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.68 ' HD2' HD11 ' A' ' 685' ' ' ILE . 55.5 tttm -99.3 -39.04 8.62 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.018 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.34 -153.56 9.04 Favored Glycine 0 CA--C 1.503 -0.669 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.806 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.736 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 39.9 Cg_endo -70.07 -148.84 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.229 1.953 . . . . 0.0 110.252 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.444 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 2.0 p-10 -166.39 -28.31 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.888 -0.507 . . . . 0.0 110.096 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.56 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 97.3 mttt -112.75 124.15 51.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.166 176.086 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.625 HG22 HD21 ' A' ' 681' ' ' LEU . 44.5 pt -109.24 166.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.656 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.561 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -137.78 141.57 40.89 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 123.052 0.541 . . . . 0.0 110.58 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.9 t -79.51 93.47 5.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.224 1.011 . . . . 0.0 108.429 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.19 163.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.232 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.508 ' HA ' ' OE1' ' A' ' 628' ' ' GLN . 6.0 p-10 -70.33 86.62 0.6 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.901 1.334 . . . . 0.0 111.484 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 149.64 -47.92 0.61 Allowed Glycine 0 N--CA 1.407 -3.284 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.34 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -158.36 -179.79 8.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.375 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -78.4 166.77 22.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.5 p -76.98 -174.94 3.32 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 120.998 0.428 . . . . 0.0 111.555 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 29.6 m -69.94 120.02 15.03 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.919 0.866 . . . . 0.0 111.263 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.625 HD21 HG22 ' A' ' 671' ' ' ILE . 82.8 mt -66.87 146.56 99.11 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.153 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.736 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 34.8 Cg_endo -67.79 -173.87 0.53 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.051 2.501 . . . . 0.0 113.415 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.21 137.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.62 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 57.5 m -115.9 133.44 56.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.68 HD11 ' HD2' ' A' ' 666' ' ' LYS . 38.5 pt -130.27 136.57 58.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 122.917 0.487 . . . . 0.0 110.127 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.86 109.83 17.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.729 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 711' ' ' TYR . 0.0 OUTLIER -64.29 -26.02 68.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.452 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.562 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 21.3 tt0 71.81 25.7 3.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.094 1.358 . . . . 0.0 112.192 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 6.7 t -122.27 163.31 19.88 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.1 p -121.18 155.78 33.8 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.446 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.89 -16.32 18.06 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.446 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 109.55 -79.85 0.26 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.44 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.413 ' CG ' ' H ' ' A' ' 694' ' ' ILE . 15.9 t70 -173.61 -169.2 0.49 Allowed 'General case' 0 C--O 1.25 1.085 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.481 ' CG1' HG12 ' A' ' 715' ' ' VAL . 1.1 mp -67.75 138.35 93.15 Favored Pre-proline 0 C--N 1.285 -2.211 0 C-N-CA 124.141 0.976 . . . . 0.0 110.366 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.657 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -75.41 -165.74 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.659 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -123.73 122.05 37.07 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.739 -0.6 . . . . 0.0 110.046 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.698 HD21 ' HA3' ' A' ' 700' ' ' GLY . 31.6 tp -97.54 155.26 17.03 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.622 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 7.1 pt-20 -43.4 -40.9 3.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.551 1.14 . . . . 0.0 112.188 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.622 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 20.9 m80 -136.25 -40.78 0.65 Allowed 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.878 -173.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.698 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -75.65 168.27 54.79 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.479 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -150.71 -148.3 0.26 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.45 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.85 154.33 50.54 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.774 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.422 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -90.9 -43.92 9.7 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 121.736 0.779 . . . . 0.0 109.437 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.26 149.15 45.45 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.44 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.461 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 2.4 p -117.13 146.35 43.23 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.7 t -130.81 86.63 51.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-O 121.669 0.747 . . . . 0.0 111.896 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -92.89 147.42 2.57 Favored 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.855 2.37 . . . . 0.0 111.984 175.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 98.6 Cg_endo -76.9 131.26 23.7 Favored 'Cis proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.604 -1.832 . . . . 0.0 111.161 0.825 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.461 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 27.0 m-85 -73.79 94.88 2.32 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 3.1 m-85 -98.91 172.43 7.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.6 ' HB3' ' HG2' ' A' ' 687' ' ' GLU . 1.1 t80 -65.92 138.11 57.62 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.47 68.74 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.266 -1.445 . . . . 0.0 112.416 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.435 ' O ' ' HA ' ' A' ' 732' ' ' THR . 23.8 t70 -76.17 165.71 24.51 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.471 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.4 m -134.24 146.08 49.74 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.199 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.481 HG12 ' CG1' ' A' ' 694' ' ' ILE . 40.8 t -135.58 147.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.448 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.536 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 29.5 mt-10 -111.1 127.29 55.51 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.738 176.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.451 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 1.7 m-85 -95.58 146.65 24.3 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.422 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -124.64 133.6 53.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.759 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 50.5 t -82.69 164.79 20.48 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.4 m -69.93 152.91 43.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.51 146.19 46.98 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.7 t 83.44 -2.16 1.17 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.886 1.674 . . . . 0.0 109.7 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -121.36 148.81 43.86 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.44 ' HB ' HD12 ' A' ' 747' ' ' ILE . 8.8 t -114.39 137.15 52.18 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.759 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.1 ptm -92.33 141.83 28.11 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.223 0.535 . . . . 0.0 109.944 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.28 120.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 130.34 -147.6 18.27 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -98.53 129.37 45.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.411 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -65.92 -27.88 68.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.293 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.536 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -115.18 157.48 23.59 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.065 0.459 . . . . 0.0 111.071 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.511 HD13 ' CG ' ' A' ' 738' ' ' TRP . 6.6 pt -130.32 166.87 26.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.118 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.435 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 85.1 m -136.31 137.06 40.27 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -75.34 119.67 19.75 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.869 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.8 mm -127.58 110.15 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 72.5 m-70 70.75 26.99 3.71 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.415 1.086 . . . . 0.0 112.697 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.21 77.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.298 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.98 152.8 38.17 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.657 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 83.3 m95 -85.89 154.31 21.61 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 118.97 0.805 . . . . 0.0 109.721 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 732' ' ' THR . 31.9 p -33.56 -69.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.14 -32.18 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.472 HD21 HG22 ' A' ' 731' ' ' ILE . 29.9 mt 69.49 154.88 0.15 Allowed Pre-proline 0 C--N 1.322 -0.614 0 O-C-N 124.517 1.136 . . . . 0.0 111.47 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.538 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 68.7 Cg_endo -84.5 -163.71 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.407 2.071 . . . . 0.0 111.55 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.49 ' O ' ' HA ' ' A' ' 725' ' ' MET . 3.1 pt20 -139.94 155.27 47.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.45 141.59 44.81 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.931 0.396 . . . . 0.0 111.317 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.85 140.89 46.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.34 119.03 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.587 0.554 . . . . 0.0 111.446 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.44 HD12 ' HB ' ' A' ' 724' ' ' THR . 65.7 mt . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--O 1.24 0.562 0 CA-C-O 121.088 0.47 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -100.0 -163.06 0.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.704 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.875 ' HB3' ' HA ' ' A' ' 628' ' ' GLN . 10.1 tp10 -147.75 155.35 41.61 Favored 'General case' 0 C--O 1.251 1.143 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 57.18 -95.64 0.06 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.048 1.339 . . . . 0.0 112.631 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -161.57 88.06 0.7 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.258 0.623 . . . . 0.0 109.477 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 62.53 40.28 98.91 Favored Glycine 0 CA--C 1.505 -0.538 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 5.9 p -170.3 80.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 122.541 1.162 . . . . 0.0 108.116 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.875 ' HA ' ' HB3' ' A' ' 623' ' ' GLU 0.255 1.9 pp0? -67.64 -88.89 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.691 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.469 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 54.8 m -179.25 136.57 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.833 1.253 . . . . 0.0 109.944 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 31.5 p -164.36 135.83 4.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.12 -125.28 5.58 Favored Glycine 1 N--CA 1.386 -4.633 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.509 ' HB3' HG22 ' A' ' 645' ' ' THR . 32.4 Cg_exo -54.91 142.4 75.63 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.657 2.904 . . . . 0.0 114.232 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.686 ' HD2' HG23 ' A' ' 645' ' ' THR . 38.1 Cg_endo -64.79 161.65 35.2 Favored 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.598 2.866 . . . . 0.0 112.239 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD12 ' A' ' 681' ' ' LEU . 32.6 Cg_endo -72.18 -164.15 0.17 Allowed 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 111.493 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.6 178.53 4.6 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.523 HD23 ' HB3' ' A' ' 657' ' ' TYR . 27.6 tp -121.15 145.32 47.94 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.41 ' H ' HD13 ' A' ' 636' ' ' LEU . 14.0 tp -34.01 -68.66 0.11 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 126.056 1.743 . . . . 0.0 113.868 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.44 42.05 2.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 124.416 2.055 . . . . 0.0 107.848 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.509 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.22 -168.17 17.97 Favored Glycine 1 C--N 1.237 -4.932 0 CA-C-N 111.064 -2.789 . . . . 0.0 109.377 176.454 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -155.97 178.45 10.26 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.142 0.471 . . . . 0.0 110.483 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 90.9 t -83.41 134.23 27.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.936 0.894 . . . . 0.0 108.66 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.616 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 15.0 ptpt -92.98 -20.75 20.28 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.297 0.57 . . . . 0.0 110.651 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.27 169.31 10.69 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.243 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.475 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 27.4 mmtp -109.11 147.59 32.19 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.908 0.385 . . . . 0.0 110.398 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.686 HG23 ' HD2' ' A' ' 633' ' ' PRO . 82.8 p -76.04 140.04 41.73 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -170.392 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.437 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -96.76 -8.54 31.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.94 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.42 ' OE2' ' HG3' ' A' ' 632' ' ' PRO . 27.6 mm-40 68.06 -24.73 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.787 1.635 . . . . 0.0 113.437 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.437 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.3 mt-10 -124.89 102.93 7.78 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.583 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 31.5 m-85 -113.27 -73.61 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 102.45 -68.61 0.35 Allowed Glycine 0 C--N 1.309 -0.954 0 C-N-CA 121.016 -0.612 . . . . 0.0 114.033 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -167.28 150.3 6.27 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 79.2 p 65.56 13.3 8.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.219 1.807 . . . . 0.0 112.893 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.5 mm-40 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.829 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.0 m -116.74 145.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.462 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 20.9 t -129.39 133.21 65.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.352 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.423 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 30.3 tt0 -101.14 126.52 47.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.963 0.887 . . . . 0.0 111.597 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.655 ' HD2' ' CD1' ' A' ' 657' ' ' TYR . 60.6 m-85 -97.54 158.53 15.43 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.005 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.604 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 44.3 p90 -137.14 146.98 45.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.509 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.3 m -92.1 160.76 15.05 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.408 HD21 ' HA ' ' A' ' 660' ' ' ASN . 1.4 m120 -55.15 163.19 1.69 Allowed Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.03 178.384 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.35 8.43 1.82 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.759 2.972 . . . . 0.0 113.221 -173.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.527 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 15.5 ptt180 -128.07 -5.64 5.55 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.673 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.541 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 47.6 m-85 -117.81 144.17 45.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.431 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.572 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 4.8 mp -100.66 140.08 35.44 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.283 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.536 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 50.6 tpp -72.78 114.59 11.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -99.57 -34.17 10.34 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.51 -177.95 49.31 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.915 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.622 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 59.3 Cg_endo -70.71 -6.54 19.29 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 123.847 3.032 . . . . 0.0 113.734 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.536 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.295 3.0 p-10 57.06 -35.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.916 2.486 . . . . 0.0 116.537 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.462 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 54.7 mtmt -103.4 135.87 44.22 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 111.477 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.785 HG22 HD13 ' A' ' 681' ' ' LEU . 51.2 pt -121.35 166.37 15.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.812 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 31.2 tt0 -137.31 137.97 39.51 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 123.95 0.9 . . . . 0.0 109.676 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.421 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 45.3 t -83.0 113.99 20.96 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.63 -171.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.215 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.98 48.75 1.27 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -173.38 -42.03 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.934 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 678' ' ' TRP . 0.0 OUTLIER -166.9 -174.45 2.72 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.421 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.7 m95 -79.76 169.08 18.46 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 679' ' ' THR . . . . . 0.407 HG21 ' O ' ' A' ' 672' ' ' GLN . 27.7 p -82.33 -176.0 5.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 21.0 m -60.13 114.2 2.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.197 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.785 HD13 HG22 ' A' ' 671' ' ' ILE . 0.8 OUTLIER -63.08 153.82 79.73 Favored Pre-proline 0 N--CA 1.413 -2.315 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.372 177.93 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.622 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 36.4 Cg_endo -77.53 -176.14 3.06 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.558 2.172 . . . . 0.0 113.347 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.28 144.72 29.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 83.3 m -119.62 136.86 54.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.148 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.69 143.31 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.541 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.4 p -87.3 136.28 23.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.852 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.489 ' HB2' HD12 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -68.48 -53.27 24.47 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.276 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.455 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 33.9 tt0 72.26 20.16 4.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.104 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 59.4 p -121.96 165.31 16.18 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 61.3 p -122.03 169.46 10.81 Favored 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.878 -176.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 5.4 m -90.5 6.44 43.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.155 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 85.08 -82.1 1.71 Allowed Glycine 0 CA--C 1.489 -1.581 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.498 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.711 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.3 t0 -158.34 -173.42 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.654 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.7 mt -72.97 131.33 83.92 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 123.91 0.884 . . . . 0.0 111.875 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.591 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -73.97 -168.94 0.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.627 2.884 . . . . 0.0 112.371 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.41 122.19 46.5 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.384 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.565 HD11 ' HA3' ' A' ' 700' ' ' GLY . 5.0 tt -93.84 136.62 33.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.574 ' OE2' ' HB2' ' A' ' 743' ' ' GLN . 13.2 pt-20 -48.12 -38.43 17.79 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 39.7 m80 -142.48 34.07 1.46 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.565 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -140.14 -170.59 12.06 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.534 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -163.32 -152.26 0.2 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.022 1.729 . . . . 0.0 107.389 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.487 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.22 156.96 45.84 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.441 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -94.92 -70.63 0.7 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.45 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.1 pp -98.65 139.53 34.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.672 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.5 m -132.48 122.3 24.69 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.9 t -128.77 94.88 33.52 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 0.0 110.551 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -89.78 152.64 5.06 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 122.351 2.034 . . . . 0.0 111.885 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.95 134.22 32.48 Favored 'Cis proline' 0 C--O 1.24 0.618 0 C-N-CA 123.151 -1.604 . . . . 0.0 111.15 -2.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.711 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.6 m-85 -79.38 88.87 4.98 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.455 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 4.8 m-30 -82.6 168.33 17.43 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.105 0.479 . . . . 0.0 111.391 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.572 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.6 t80 -60.84 133.97 56.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.88 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.7 -21.8 44.14 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.025 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.38 163.99 26.44 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-N 117.67 0.735 . . . . 0.0 110.014 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 4.8 m -125.46 161.95 25.96 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.21 0.528 . . . . 0.0 110.385 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.535 HG12 HG12 ' A' ' 694' ' ' ILE . 25.0 t -142.88 139.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.564 175.219 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.439 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 43.0 mt-10 -101.88 123.57 46.03 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.649 ' HE1' ' CE2' ' A' ' 717' ' ' PHE . 2.2 m-85 -92.42 158.59 15.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.441 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 18.5 t-20 -134.39 147.81 50.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.686 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 34.5 t -102.76 141.79 34.99 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 37.6 m -58.47 143.76 44.54 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.7 -33.27 68.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.6 m -82.2 4.96 21.41 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.693 -0.629 . . . . 0.0 111.339 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.55 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 97.6 m-85 -125.35 158.99 32.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 5.4 t -116.87 131.79 56.86 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.686 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.5 ptm -87.96 136.75 32.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.587 0.708 . . . . 0.0 110.283 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 55.4 mt -107.74 116.21 50.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.362 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.29 -151.19 18.54 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -108.44 156.04 19.9 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.411 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 32.0 ptt180 -86.08 -28.33 24.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.439 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 6.7 m -91.42 145.25 24.79 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.557 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.471 HG22 HD21 ' A' ' 741' ' ' LEU . 6.0 pt -125.61 174.07 10.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.342 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 86.7 m -141.37 136.28 31.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.29 108.79 3.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.418 0.687 . . . . 0.0 111.011 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.4 mm -123.3 104.04 13.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 121.257 0.551 . . . . 0.0 111.093 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 66.76 19.9 10.69 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.644 1.178 . . . . 0.0 112.368 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 104.14 -3.6 44.39 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.917 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.11 133.19 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.591 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -68.33 153.91 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 35.8 p -37.05 -69.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.56 -32.05 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.471 HD21 HG22 ' A' ' 731' ' ' ILE . 15.2 mt 68.34 153.25 0.13 Allowed Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 124.753 1.283 . . . . 0.0 111.392 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.534 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 60.6 Cg_endo -83.28 -173.4 1.64 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.767 1.644 . . . . 0.0 109.657 172.62 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.574 ' HB2' ' OE2' ' A' ' 698' ' ' GLU . 2.8 pt20 -134.39 153.58 51.83 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.744 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 86.7 m -117.08 134.81 54.3 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 123.309 0.38 . . . . 0.0 110.963 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.18 143.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.12 116.41 5.36 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 124.225 0.953 . . . . 0.0 110.893 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.045 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -119.03 -26.78 5.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.94 -38.2 61.81 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.289 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -86.57 98.63 11.19 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.596 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -82.01 120.71 25.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -73.28 -88.7 0.17 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.673 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 40.2 t 50.62 70.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 123.179 1.466 . . . . 0.0 108.802 -167.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.439 ' OE1' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -80.06 -97.1 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 112.332 -2.213 . . . . 0.0 112.149 -175.485 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.484 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 34.8 p 176.62 159.58 0.34 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.402 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 14.0 p -171.66 142.62 1.61 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -88.52 -144.15 9.76 Favored Glycine 0 N--CA 1.396 -3.975 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.898 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.696 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 41.1 Cg_exo -54.11 148.02 41.59 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 123.788 2.992 . . . . 0.0 112.117 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.615 ' HD2' HG23 ' A' ' 645' ' ' THR . 30.3 Cg_endo -62.76 156.05 55.79 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.578 2.186 . . . . 0.0 111.784 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.47 ' HG2' HD12 ' A' ' 681' ' ' LEU . 23.1 Cg_endo -67.76 -172.61 0.41 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 122.482 2.121 . . . . 0.0 111.038 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.16 152.96 22.78 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.641 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 2.7 tt -89.07 134.09 34.13 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 56.7 tp -22.16 -56.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.554 2.342 . . . . 0.0 113.757 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.411 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.4 t30 -125.94 -39.64 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.541 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -71.27 -155.17 1.82 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.405 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -168.84 177.76 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.04 -0.683 . . . . 0.0 111.033 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.66 147.17 5.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 124.823 1.249 . . . . 0.0 109.05 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -109.27 -12.17 14.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.052 0.453 . . . . 0.0 111.12 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.75 165.79 13.96 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.364 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -77.7 150.8 34.44 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.308 0.575 . . . . 0.0 110.874 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.615 HG23 ' HD2' ' A' ' 633' ' ' PRO . 28.7 p -84.52 114.36 21.9 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.785 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -86.8 -15.17 40.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.382 -177.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.696 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.0 mt-10 65.88 -6.53 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.68 86.29 1.39 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.441 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 17.5 m-85 -83.88 -74.13 0.39 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.045 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.484 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 117.52 -104.79 1.2 Allowed Glycine 0 C--O 1.211 -1.334 0 C-N-CA 119.84 -1.172 . . . . 0.0 113.252 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.673 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 83.0 t60 -137.68 138.1 39.05 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.864 0.332 . . . . 0.0 110.337 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.5 m 69.32 16.34 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.205 . . . . 0.0 112.467 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.441 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 16.2 mm-40 -82.73 126.07 31.96 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.1 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.536 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.9 m -107.4 149.82 10.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.135 0.493 . . . . 0.0 111.881 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.548 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 45.3 t -130.65 132.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.449 ' HG3' ' ND2' ' A' ' 669' ' ' ASN . 34.4 tt0 -98.95 130.38 45.31 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 122.096 0.951 . . . . 0.0 112.236 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.65 ' HE2' ' CE1' ' A' ' 657' ' ' TYR . 59.4 m-85 -107.81 169.25 8.72 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.688 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -140.94 155.65 46.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.43 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 68.2 m -99.05 159.47 14.94 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.298 0.571 . . . . 0.0 110.061 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.86 157.76 28.05 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.832 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.43 -2.22 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 123.281 2.654 . . . . 0.0 115.117 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.29 -0.51 5.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.356 1.074 . . . . 0.0 110.972 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.404 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 31.1 m-85 -112.68 137.78 50.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.592 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.692 HD23 ' CD1' ' A' ' 711' ' ' TYR . 9.8 mt -104.77 146.41 29.01 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.486 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 43.0 ttm -79.91 123.65 27.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.967 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -112.53 -34.79 5.74 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.02 -149.01 8.13 Favored Glycine 0 CA--C 1.504 -0.617 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.031 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.504 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 55.5 Cg_endo -72.93 -147.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.277 1.985 . . . . 0.0 109.361 171.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.486 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 2.2 p-10 -161.45 -28.4 0.05 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 122.104 -0.373 . . . . 0.0 110.505 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.548 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.9 mtmt -115.64 134.52 54.96 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.242 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.536 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.5 pt -117.43 169.12 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.415 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.3 tt0 -137.15 139.06 40.91 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 123.338 0.398 . . . . 0.0 110.222 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.07 103.55 14.85 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.87 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.439 ' HA ' ' OE1' ' A' ' 628' ' ' GLN 0.291 3.0 p-10 -77.71 80.15 4.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.004 1.383 . . . . 0.0 113.492 -177.729 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 153.87 -54.33 0.44 Allowed Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.391 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.11 -171.15 3.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.53 -176.85 6.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.103 0.478 . . . . 0.0 112.009 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.7 p -97.94 -166.77 1.42 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.11 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 23.1 m -69.78 117.36 11.27 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.195 0.521 . . . . 0.0 111.362 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.474 HD11 HG22 ' A' ' 671' ' ' ILE . 4.6 mm? -68.66 151.08 97.44 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.414 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.592 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 71.3 Cg_endo -80.73 176.94 8.55 Favored 'Trans proline' 0 CA--C 1.474 -2.516 0 C-N-CA 123.456 2.77 . . . . 0.0 111.787 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.81 151.89 35.19 Favored 'Isoleucine or valine' 1 N--CA 1.352 -5.361 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.638 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.411 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 71.3 m -123.58 136.01 54.29 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.26 140.19 49.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.5 p -76.64 127.47 37.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.48 ' HB3' ' CD1' ' A' ' 664' ' ' LEU . 7.9 pt-20 -73.93 -18.49 60.89 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 116.012 -2.275 . . . . 0.0 110.409 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 63.72 21.15 12.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.085 175.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 689' ' ' SER . . . . . 0.416 ' HB2' ' OE2' ' A' ' 687' ' ' GLU . 15.7 m -127.29 165.07 20.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 37.6 p -129.59 174.48 9.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.36 -1.47 44.41 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.366 0.667 . . . . 0.0 111.079 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 91.32 -82.15 1.26 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.656 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 27.9 t70 -159.98 178.09 10.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.588 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 3.5 mt -68.73 131.43 91.25 Favored Pre-proline 0 N--CA 1.42 -1.943 0 C-N-CA 124.454 1.101 . . . . 0.0 111.556 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.52 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.4 Cg_endo -74.14 -176.43 2.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.296 2.664 . . . . 0.0 111.24 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.57 136.75 52.47 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 121.255 0.55 . . . . 0.0 109.683 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.633 HD11 ' HA3' ' A' ' 700' ' ' GLY . 2.9 tt -109.97 142.54 41.21 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.8 pt-20 -46.19 -36.65 6.21 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.672 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 34.7 m80 -146.48 21.55 1.33 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.239 0.542 . . . . 0.0 109.889 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.633 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -127.33 175.4 18.18 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.549 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -163.26 -159.38 0.53 Allowed 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.401 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.58 145.92 41.18 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.613 -169.516 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -88.65 -51.87 5.45 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.632 0.729 . . . . 0.0 109.388 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.43 150.69 32.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.074 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.1 p -137.85 127.46 25.13 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 124.391 1.076 . . . . 0.0 108.936 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.9 m -123.78 81.32 55.5 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.514 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.411 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.3 Cg_endo -91.87 144.15 2.9 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 123.111 2.541 . . . . 0.0 112.024 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.411 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.5 Cg_endo -71.89 129.01 15.65 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.006 -1.664 . . . . 0.0 111.239 -0.241 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.625 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 23.6 m-85 -74.43 94.07 2.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.223 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.625 ' HE1' ' CE2' ' A' ' 710' ' ' TYR . 6.3 m-85 -85.08 161.15 19.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 117.923 0.328 . . . . 0.0 111.403 179.163 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.614 ' HD2' ' CD1' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -61.16 135.07 57.64 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.77 -12.36 59.37 Favored Glycine 0 N--CA 1.403 -3.521 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.821 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -92.81 179.81 5.36 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -140.62 161.94 36.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.618 0.723 . . . . 0.0 111.783 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.548 HG12 HG12 ' A' ' 694' ' ' ILE . 20.4 t -139.21 145.15 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.146 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.463 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 35.8 mt-10 -105.82 129.2 54.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.308 0.575 . . . . 0.0 110.526 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.588 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.2 m-85 -109.12 153.08 24.21 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.957 1.703 . . . . 0.0 108.69 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -150.4 160.41 43.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.443 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 92.2 m -96.56 156.51 16.31 Favored 'General case' 0 C--N 1.27 -2.877 0 O-C-N 123.68 0.612 . . . . 0.0 110.484 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 25.8 m -67.25 162.56 22.4 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.868 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.83 147.24 53.51 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 35.2 t 87.35 -10.97 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.57 1.948 . . . . 0.0 108.413 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 1.662 ' HE2' ' CE1' ' A' ' 723' ' ' PHE . 71.7 m-85 -120.97 147.01 46.06 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-O 121.399 0.619 . . . . 0.0 110.73 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.9 t -115.5 147.14 41.0 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.481 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 8.0 ptm -96.57 146.85 24.45 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.067 0.46 . . . . 0.0 111.001 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 29.2 mt -126.22 116.61 46.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.4 -139.65 11.12 Favored Glycine 0 CA--C 1.479 -2.181 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.987 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -111.69 131.94 54.95 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.987 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -62.69 -32.78 73.92 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 124.303 1.002 . . . . 0.0 111.699 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 32.4 p -108.54 149.35 28.97 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.886 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.505 HG23 HD21 ' A' ' 741' ' ' LEU . 12.7 pt -125.25 166.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.393 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 45.1 m -131.85 136.87 47.79 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 48.4 t -71.21 107.2 4.11 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.909 0.756 . . . . 0.0 109.306 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.527 ' O ' HG23 ' A' ' 737' ' ' VAL . 51.4 mm -127.74 108.8 18.71 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 68.98 20.2 7.91 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.46 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.06 60.82 Favored Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.462 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 734' ' ' ILE . 3.5 m -122.57 150.27 26.26 Favored 'Isoleucine or valine' 1 N--CA 1.37 -4.432 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.778 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.52 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.4 m95 -83.9 153.79 23.77 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 37.8 p -35.71 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -175.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -160.29 -29.27 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.505 HD21 HG23 ' A' ' 731' ' ' ILE . 17.8 mt 70.2 149.61 0.12 Allowed Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 124.65 1.219 . . . . 0.0 111.863 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.481 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 61.5 Cg_endo -77.38 -178.67 4.76 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.282 1.988 . . . . 0.0 110.479 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.53 140.26 51.89 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.507 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 20.3 m -100.78 142.57 32.06 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.823 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.99 141.92 43.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.02 118.4 10.42 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 123.721 0.638 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--O 1.261 1.679 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.206 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -79.8 -38.44 33.0 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.35 98.54 8.89 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -100.74 120.22 39.77 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.352 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -102.06 96.3 6.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -93.74 92.4 1.59 Allowed Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.752 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.554 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 85.8 t -156.05 68.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.457 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -69.9 -29.87 67.16 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.183 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.508 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 18.0 t 79.19 120.82 0.05 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 126.309 1.843 . . . . 0.0 110.449 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.6 p -110.59 171.79 7.25 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.025 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -106.38 -132.71 7.2 Favored Glycine 0 N--CA 1.4 -3.722 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.531 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 23.5 Cg_exo -63.94 145.04 89.58 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 123.281 2.654 . . . . 0.0 112.603 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.75 157.08 49.49 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 123.158 2.572 . . . . 0.0 112.29 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD12 ' A' ' 681' ' ' LEU . 34.3 Cg_endo -68.8 -164.58 0.11 Allowed 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 123.192 2.595 . . . . 0.0 111.627 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.57 164.83 11.75 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.795 -0.566 . . . . 0.0 110.516 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.558 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 31.9 tp -104.13 147.74 27.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.429 ' H ' HD13 ' A' ' 636' ' ' LEU . 6.0 tt -35.54 -65.8 0.22 Allowed 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 127.503 2.321 . . . . 0.0 111.286 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -115.7 -43.44 3.02 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.38 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.506 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -88.54 -146.01 11.9 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -165.37 -170.51 1.89 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.204 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.508 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.5 p -101.23 143.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 123.691 0.796 . . . . 0.0 110.575 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.1 ptpt -101.34 -16.67 16.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.344 0.592 . . . . 0.0 110.515 -178.137 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -81.75 128.71 34.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.351 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 150.85 48.67 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.559 0.695 . . . . 0.0 111.997 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 31.8 p -76.5 124.96 28.38 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.832 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 648' ' ' GLU . 47.5 mtmt -99.82 -12.28 20.03 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.105 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.531 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 43.4 mt-10 67.92 -12.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.11 1.364 . . . . 0.0 113.841 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.1 tt0 -148.91 108.49 3.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.827 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 4.5 m-85 -105.75 -65.85 1.03 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.508 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 127.81 -117.55 2.65 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.554 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 75.6 t60 -138.38 157.32 46.46 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.6 p 62.59 12.16 5.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.408 1.483 . . . . 0.0 113.104 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.827 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 9.0 mm-40 -76.5 136.64 39.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.297 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.597 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 t -112.27 139.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.468 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 9.7 t -126.3 137.7 56.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 123.679 0.792 . . . . 0.0 109.585 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.492 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 32.8 tt0 -109.15 127.49 54.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.818 0.818 . . . . 0.0 111.342 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.558 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 64.8 m-85 -97.45 164.32 12.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.288 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.642 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 31.6 p90 -135.4 149.48 49.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.506 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.3 m -95.52 160.03 14.71 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.428 ' C ' ' H ' ' A' ' 662' ' ' ARG . 3.4 m-20 -55.21 155.33 9.31 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.888 177.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.05 11.01 0.34 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 123.388 2.725 . . . . 0.0 113.3 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.697 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 22.0 ptt180 -126.51 -6.48 6.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.858 0.837 . . . . 0.0 111.37 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 40.4 m-85 -122.36 146.45 47.31 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.514 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.717 HD12 ' HB3' ' A' ' 711' ' ' TYR . 6.4 mp -105.14 146.45 29.17 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.983 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.44 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.4 tpp -75.07 116.89 16.31 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.489 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.497 ' HD2' HD11 ' A' ' 685' ' ' ILE . 63.8 tttm -102.45 -37.51 7.98 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.339 0.59 . . . . 0.0 110.62 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.73 -172.25 42.43 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.374 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.6 108.87 2.65 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.312 2.008 . . . . 0.0 110.49 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.56 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 24.5 p-10 -71.96 -10.24 59.5 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.309 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.492 ' HG3' ' HG3' ' A' ' 656' ' ' GLU . 35.7 mtmt -114.92 129.45 56.71 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.351 0.596 . . . . 0.0 110.69 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.682 HG22 HD13 ' A' ' 681' ' ' LEU . 48.5 pt -124.72 165.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.878 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.565 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.5 tt0 -137.53 139.83 40.72 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.092 0.557 . . . . 0.0 110.381 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.43 105.88 14.73 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.81 -171.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.42 77.97 1.9 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.084 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.457 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 140.4 -39.3 1.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.359 172.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.92 -179.53 7.08 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 122.634 -0.333 . . . . 0.0 110.281 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.81 161.62 15.2 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.1 p -71.74 -170.36 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.339 0.59 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 18.9 m -69.21 112.75 6.0 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.939 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.682 HD13 HG22 ' A' ' 671' ' ' ILE . 1.8 mp -61.19 149.86 81.13 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.508 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.56 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 37.2 Cg_endo -75.65 -173.49 1.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.249 2.632 . . . . 0.0 114.414 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.2 t -140.18 138.79 37.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 81.0 m -111.55 136.72 50.35 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.497 HD11 ' HD2' ' A' ' 666' ' ' LYS . 30.1 pt -132.83 139.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 123.536 0.523 . . . . 0.0 110.047 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.0 p -84.04 128.04 39.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.49 ' HG2' HD12 ' A' ' 664' ' ' LEU . 4.1 pt-20 -77.28 -18.94 57.15 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 118.9 -1.12 . . . . 0.0 109.333 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.715 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.261 11.4 pt-20 61.16 1.75 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 128.269 2.628 . . . . 0.0 115.149 176.75 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 23.2 m -97.15 144.79 26.64 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 59.2 p -113.34 165.89 12.01 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.364 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.3 m -91.21 -8.66 47.87 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.734 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.86 -73.41 1.17 Allowed Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.802 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.501 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.8 t70 -176.38 -171.45 0.41 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.622 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -66.35 132.08 94.33 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 123.926 0.89 . . . . 0.0 110.509 175.729 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.626 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.8 Cg_endo -73.72 -176.82 2.75 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 123.725 2.95 . . . . 0.0 112.066 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.65 126.71 49.84 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.831 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.587 HD21 ' HG2' ' A' ' 698' ' ' GLU . 3.8 tt -108.05 136.87 47.02 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.587 ' HG2' HD21 ' A' ' 697' ' ' LEU . 13.8 pt-20 -39.72 -42.82 1.3 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.712 1.605 . . . . 0.0 112.901 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.922 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 43.9 m80 -145.36 29.29 1.16 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -176.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.476 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -140.9 168.65 25.22 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.779 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -154.53 -153.93 0.48 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 125.636 1.574 . . . . 0.0 106.835 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.494 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.68 158.66 43.84 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.631 -167.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.532 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -99.22 -55.34 2.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.988 -178.953 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.68 143.1 48.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.9 m -130.21 137.33 50.0 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 29.6 t -127.44 92.4 43.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 121.666 -0.646 . . . . 0.0 112.47 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -93.15 144.58 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 C-N-CA 122.865 2.377 . . . . 0.0 112.054 174.013 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -74.22 132.24 26.45 Favored 'Cis proline' 0 C--O 1.248 1.012 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.001 0.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.651 ' HD2' ' CD1' ' A' ' 709' ' ' TYR . 21.8 m-85 -75.12 98.08 3.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.715 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 26.7 m-85 -100.99 -177.31 3.42 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.46 0.648 . . . . 0.0 111.277 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.717 ' HB3' HD12 ' A' ' 664' ' ' LEU . 11.4 t80 -70.61 135.14 48.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.209 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.4 0.86 81.92 Favored Glycine 0 C--N 1.291 -1.965 0 CA-C-N 115.535 -0.757 . . . . 0.0 113.788 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.88 173.16 12.5 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -136.76 143.83 43.47 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.872 0.368 . . . . 0.0 110.207 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.484 ' O ' HG12 ' A' ' 731' ' ' ILE . 39.9 t -136.93 140.28 43.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.224 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.544 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 50.6 mt-10 -103.48 122.92 45.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.622 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 3.9 m-85 -97.79 152.16 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 124.199 1.0 . . . . 0.0 111.512 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.532 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.2 t30 -138.23 147.79 44.1 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.471 ' SG ' ' HB2' ' A' ' 725' ' ' MET . 90.1 m -98.24 160.84 14.03 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 60.1 m -56.62 147.15 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.12 -28.05 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.368 0.667 . . . . 0.0 111.858 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 6.9 m -80.81 -2.38 46.97 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.201 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 1.661 ' HE1' ' CE2' ' A' ' 723' ' ' PHE . 83.7 m-85 -124.8 151.63 44.93 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.44 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 10.4 t -112.86 140.14 47.91 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.72 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 0.8 OUTLIER -87.05 128.88 35.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.459 0.647 . . . . 0.0 112.154 -176.109 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.41 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 38.1 mt -106.2 99.59 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 135.79 -155.99 22.59 Favored Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -112.23 168.15 9.85 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 123.79 0.347 . . . . 0.0 110.489 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.461 ' HD2' ' OE1' ' A' ' 716' ' ' GLU . 18.2 ptt180 -82.1 -37.78 25.8 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.544 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.8 p -99.34 132.24 44.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -170.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.507 HG22 HD21 ' A' ' 741' ' ' LEU . 8.3 pt -112.28 169.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.768 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 27.6 m -136.01 139.82 43.41 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 44.4 t -82.03 118.63 23.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.626 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.589 ' O ' HG23 ' A' ' 737' ' ' VAL . 45.4 mm -125.8 104.45 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.145 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.2 m-70 71.58 33.59 1.8 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.925 0.89 . . . . 0.0 112.41 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.16 -8.77 79.08 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.922 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.589 HG23 ' O ' ' A' ' 734' ' ' ILE . 2.3 m -118.25 148.39 21.12 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.707 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.626 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 87.4 m95 -86.81 152.46 22.46 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.4 p -33.02 -71.39 0.06 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.42 -30.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.507 HD21 HG22 ' A' ' 731' ' ' ILE . 17.5 mt 67.91 147.23 0.11 Allowed Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 124.92 1.388 . . . . 0.0 111.816 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.72 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 60.2 Cg_endo -76.73 -179.65 5.58 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.217 1.945 . . . . 0.0 110.683 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.41 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 20.2 pt20 -123.12 129.73 51.84 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.922 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.7 m -100.76 120.52 40.22 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.5 151.18 17.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 123.509 0.506 . . . . 0.0 109.926 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.78 114.36 4.98 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 124.311 1.007 . . . . 0.0 110.71 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.608 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.402 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -123.51 112.91 18.05 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -86.62 116.26 24.62 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.129 0.49 . . . . 0.0 110.733 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -78.35 136.94 37.8 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -65.03 112.25 3.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.126 0.489 . . . . 0.0 110.936 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -134.43 52.94 0.8 Allowed Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 5.8 m -155.71 66.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 124.521 1.129 . . . . 0.0 110.688 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.529 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 1.7 pp0? -80.31 -153.21 0.08 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.2 p -157.58 158.74 36.15 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.156 0.503 . . . . 0.0 111.314 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 10.2 p -142.05 -170.96 3.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -122.6 -136.24 4.82 Favored Glycine 0 N--CA 1.402 -3.588 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.557 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 25.1 Cg_exo -61.26 142.19 95.48 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 122.45 2.1 . . . . 0.0 111.411 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.548 ' HD2' HG23 ' A' ' 645' ' ' THR . 18.6 Cg_endo -58.72 154.49 42.95 Favored 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.929 2.419 . . . . 0.0 111.849 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD22 ' A' ' 681' ' ' LEU . 18.5 Cg_endo -65.08 -167.23 0.1 OUTLIER 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.042 2.494 . . . . 0.0 111.546 176.075 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.43 159.79 17.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.104 -1.039 . . . . 0.0 109.709 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.632 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.7 tp -95.96 140.89 30.05 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.651 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.402 ' H ' HD13 ' A' ' 636' ' ' LEU . 5.9 tt -32.74 -62.16 0.25 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.258 2.223 . . . . 0.0 111.556 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.604 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.7 t30 -123.2 -33.97 3.21 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.831 -178.157 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.757 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -90.14 -142.94 10.0 Favored Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.727 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.63 -173.34 2.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 117.563 0.681 . . . . 0.0 109.577 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.463 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.4 p -101.82 131.05 50.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 123.746 0.818 . . . . 0.0 109.815 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.454 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 7.7 ptpt -91.75 -13.03 32.26 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.54 0.686 . . . . 0.0 109.563 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.579 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 10.5 mm-40 -76.67 144.2 39.57 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.991 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -66.77 152.2 45.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.548 HG23 ' HD2' ' A' ' 633' ' ' PRO . 37.1 p -95.01 120.05 34.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.241 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.99 -20.73 32.31 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.058 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.557 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 35.5 mt-10 70.22 -13.77 0.42 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.265 1.426 . . . . 0.0 113.105 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -132.49 103.49 6.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.612 ' HD2' ' CD1' ' A' ' 649' ' ' TYR . 7.8 m-85 -116.36 -173.51 2.38 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -156.18 -155.91 7.6 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -177.785 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -78.02 135.79 37.83 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 120.528 0.204 . . . . 0.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 23.5 m 75.23 18.11 2.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.579 1.152 . . . . 0.0 112.903 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.424 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 11.1 mm-40 -84.98 130.87 34.55 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.466 HG13 ' HB2' ' A' ' 672' ' ' GLN . 12.9 m -111.89 147.65 15.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.819 0.819 . . . . 0.0 112.995 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.529 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.5 t -128.12 135.11 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.775 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.579 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 40.2 tt0 -107.26 132.32 53.22 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.07 0.938 . . . . 0.0 111.393 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.632 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 68.3 m-85 -106.44 166.37 10.59 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.069 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.454 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 46.0 p90 -140.0 151.47 45.51 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.757 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 91.4 m -96.46 162.1 13.63 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.604 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.5 OUTLIER -54.78 152.99 11.87 Favored Pre-proline 0 C--O 1.216 -0.668 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.346 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.517 ' HB2' ' OD2' ' A' ' 713' ' ' ASP . 64.5 Cg_endo -66.14 1.91 2.14 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.676 2.917 . . . . 0.0 114.995 -171.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -119.97 -4.73 10.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.837 0.827 . . . . 0.0 111.044 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.667 ' HD2' ' CD1' ' A' ' 663' ' ' PHE . 32.4 m-85 -115.11 142.42 46.68 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.241 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.58 ' HG ' ' HB2' ' A' ' 687' ' ' GLU . 16.3 mt -98.98 140.27 33.38 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.644 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.563 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.1 tpp -70.64 109.76 5.09 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.697 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.55 ' HD2' HD11 ' A' ' 685' ' ' ILE . 61.7 tttm -96.14 -34.47 11.67 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.581 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.41 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -77.64 -172.98 39.37 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.917 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.75 -4.91 15.85 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.359 2.706 . . . . 0.0 113.419 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.63 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 2.6 p-10 52.11 3.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 127.339 2.255 . . . . 0.0 115.864 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.529 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 85.9 mttt -137.81 137.26 38.0 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.561 HG22 ' HG ' ' A' ' 681' ' ' LEU . 42.3 pt -129.09 166.26 27.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.466 ' HB2' HG13 ' A' ' 654' ' ' VAL . 29.1 tt0 -137.41 139.89 40.98 Favored 'General case' 0 C--N 1.28 -2.44 0 O-C-N 123.717 0.635 . . . . 0.0 109.334 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.6 t -85.01 108.16 17.48 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.83 -166.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.529 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 6.0 p-10 -79.29 58.76 2.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.976 0.893 . . . . 0.0 112.188 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 166.12 -38.39 0.26 Allowed Glycine 0 N--CA 1.415 -2.73 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.415 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -160.69 -178.53 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -85.46 158.29 20.23 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 40.6 p -76.87 -174.72 3.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 41.7 m -60.06 114.79 3.03 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.341 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.561 ' HG ' HG22 ' A' ' 671' ' ' ILE . 5.6 mp -73.12 151.13 90.27 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.63 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 91.2 Cg_endo -74.1 178.32 7.07 Favored 'Trans proline' 0 CA--C 1.468 -2.803 0 C-N-CA 123.626 2.884 . . . . 0.0 113.032 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.483 HG21 ' HB3' ' A' ' 666' ' ' LYS . 34.9 m -139.11 163.25 26.94 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.293 -175.094 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.452 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 82.4 m -129.11 142.35 50.91 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.55 HD11 ' HD2' ' A' ' 666' ' ' LYS . 25.9 pt -134.77 148.59 29.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.54 117.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 122.673 1.225 . . . . 0.0 111.573 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.58 ' HB2' ' HG ' ' A' ' 664' ' ' LEU . 6.1 tp10 -60.09 -46.61 89.03 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.813 -1.994 . . . . 0.0 109.954 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.634 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 0.0 OUTLIER 63.56 61.53 1.01 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.237 -178.492 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 56.0 m -157.5 143.78 17.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 26.0 p -121.94 159.66 26.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 123.396 0.435 . . . . 0.0 111.569 -177.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.59 -21.38 28.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 110.63 -78.95 0.25 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.624 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.8 t0 -162.6 -168.01 1.71 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.594 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 2.9 mt -77.81 132.31 68.38 Favored Pre-proline 0 C--N 1.282 -2.339 0 C-N-CA 125.11 1.364 . . . . 0.0 111.079 176.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.521 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 69.7 Cg_endo -72.94 -169.04 0.45 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.39 2.727 . . . . 0.0 111.584 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.11 136.04 53.55 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.685 HD21 ' HA3' ' A' ' 700' ' ' GLY . 26.4 tp -116.2 145.21 43.29 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.5 pt-20 -45.33 -45.35 12.3 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.839 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.4 m80 -142.97 27.38 1.63 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.743 0.782 . . . . 0.0 109.055 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.685 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -136.27 168.28 24.13 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.799 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -156.14 -151.49 0.34 Allowed 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.465 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.46 144.7 46.57 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.095 -168.819 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.549 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -83.58 -59.78 2.33 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.604 0.716 . . . . 0.0 109.301 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.406 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.0 pp -115.97 139.87 49.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.456 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.52 ' O ' ' HD3' ' A' ' 707' ' ' PRO . 12.9 m -118.16 122.85 44.09 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 6.0 m -115.44 87.03 15.91 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.511 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.52 ' HD3' ' O ' ' A' ' 705' ' ' SER . 12.8 Cg_endo -95.86 150.75 1.4 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 123.07 2.513 . . . . 0.0 112.805 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -70.9 130.61 18.34 Favored 'Cis proline' 0 C--O 1.237 0.472 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.047 -1.582 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.624 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 18.5 m-85 -75.43 91.44 2.75 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.641 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 9.3 m-85 -85.26 170.22 13.02 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 122.542 0.337 . . . . 0.0 111.427 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.669 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 2.0 t80 -62.41 132.5 52.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.19 69.74 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.041 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.517 ' OD2' ' HB2' ' A' ' 661' ' ' PRO . 3.8 t70 -75.97 173.27 11.44 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.425 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.0 OUTLIER -139.72 147.44 40.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.51 0.671 . . . . 0.0 110.912 -173.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.569 HG12 HG12 ' A' ' 694' ' ' ILE . 38.8 t -138.32 142.95 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.219 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.577 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 43.6 mt-10 -110.36 121.43 45.28 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.501 0.667 . . . . 0.0 110.464 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.654 ' HE2' ' CE1' ' A' ' 717' ' ' PHE . 2.5 m-85 -92.9 147.54 22.76 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 125.163 1.385 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.549 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -129.33 130.86 46.65 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.421 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.1 m -88.28 143.37 27.06 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.352 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 28.9 m -50.95 139.8 16.65 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 123.647 0.592 . . . . 0.0 109.504 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -49.97 -35.7 25.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.8 m -76.61 0.19 21.06 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.787 0.803 . . . . 0.0 111.655 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -117.99 147.94 42.7 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.452 ' HB ' HG12 ' A' ' 747' ' ' ILE . 9.3 t -109.38 138.29 45.96 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.675 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 2.6 ptm -90.04 135.47 33.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.259 0.552 . . . . 0.0 110.672 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.433 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 43.7 mt -115.37 113.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.67 -156.27 16.09 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -109.89 139.64 44.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.684 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -61.27 -35.11 76.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.887 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.577 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 12.9 p -94.56 148.53 22.16 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.937 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.493 HG22 HD21 ' A' ' 741' ' ' LEU . 9.0 pt -131.19 165.45 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.546 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 36.2 m -132.64 134.26 44.64 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.699 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.403 ' HB3' ' O ' ' A' ' 710' ' ' TYR . 42.9 t -70.48 111.73 6.23 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.815 0.446 . . . . 0.0 111.375 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.5 110.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 68.73 13.31 8.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.667 1.187 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.79 2.79 46.27 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.316 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.73 130.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.521 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 84.8 m95 -63.32 156.86 24.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 25.2 p -37.87 -71.69 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -174.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.54 -26.89 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 731' ' ' ILE . 20.8 mt 69.42 153.33 0.14 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 111.908 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.675 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 67.3 Cg_endo -81.61 -168.65 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.642 2.228 . . . . 0.0 111.589 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.433 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 27.9 pt20 -131.93 137.31 47.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.839 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.3 m -110.15 121.15 44.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.32 146.31 25.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.31 117.73 7.03 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.407 0.442 . . . . 0.0 110.566 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.452 HG12 ' HB ' ' A' ' 724' ' ' THR . 68.7 mt . . . . . 0 C--O 1.252 1.213 0 O-C-N 124.398 1.061 . . . . 0.0 110.782 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.241 0.635 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 72.75 -75.48 0.08 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.321 1.448 . . . . 0.0 111.036 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . 0.4 ' CD ' ' H ' ' A' ' 624' ' ' ALA . 0.0 OUTLIER -145.83 -62.89 0.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . 0.4 ' H ' ' CD ' ' A' ' 623' ' ' GLU . . . -177.84 -34.55 0.01 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.822 0.449 . . . . 0.0 110.77 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . 55.79 69.19 0.76 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.615 1.166 . . . . 0.0 111.554 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -80.3 40.33 2.36 Favored Glycine 0 C--N 1.311 -0.855 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.517 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 8.4 p 179.64 52.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 123.16 1.457 . . . . 0.0 108.099 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -54.56 -26.0 29.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.854 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.996 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.1 m 85.66 121.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.828 1.651 . . . . 0.0 113.971 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 27.4 p -120.55 154.8 34.86 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.32 -136.84 9.05 Favored Glycine 0 N--CA 1.413 -2.872 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.602 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.944 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 35.1 Cg_exo -56.35 148.74 59.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.077 3.185 . . . . 0.0 114.135 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.541 ' HB3' HG22 ' A' ' 655' ' ' VAL . 29.6 Cg_endo -64.8 153.14 79.37 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 122.877 2.385 . . . . 0.0 112.468 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.504 ' HG2' HD22 ' A' ' 681' ' ' LEU . 20.9 Cg_endo -67.95 -170.76 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 123.288 2.659 . . . . 0.0 112.249 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -109.65 144.47 37.96 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.51 HD11 ' HG2' ' A' ' 682' ' ' PRO . 19.0 tp -84.01 147.17 27.58 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.6 tm? -34.37 -66.17 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.809 1.644 . . . . 0.0 111.152 174.835 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -110.63 -51.77 2.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.109 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.556 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -81.48 -147.56 5.86 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.535 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.423 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.6 t-20 -166.4 -167.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.928 0.864 . . . . 0.0 110.592 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.431 HG11 HG11 ' A' ' 655' ' ' VAL . 83.7 t -90.32 133.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 125.53 1.532 . . . . 0.0 109.425 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.529 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.0 ptpt -94.05 -12.08 29.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.683 0.754 . . . . 0.0 109.971 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 158.07 18.88 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.676 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -88.18 165.43 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 38.0 p -82.49 118.02 22.93 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-O 121.319 0.581 . . . . 0.0 110.628 -178.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.412 ' C ' ' H ' ' A' ' 648' ' ' GLU . 45.5 mtmt -86.83 -29.31 22.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.944 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.8 mt-10 67.13 -3.68 0.95 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.678 1.591 . . . . 0.0 113.441 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.412 ' H ' ' C ' ' A' ' 646' ' ' LYS . 42.6 mt-10 -133.85 82.78 2.0 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.617 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 16.2 m-85 -95.08 -72.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.104 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.996 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.77 -71.82 0.27 Allowed Glycine 0 C--N 1.295 -1.73 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.844 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.517 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 86.4 t60 -165.9 145.3 6.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 78.4 p 62.48 14.63 7.14 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.313 1.845 . . . . 0.0 113.019 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.455 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 16.1 mm-40 -83.71 142.07 30.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.173 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.461 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 14.7 m -120.81 153.7 24.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.274 0.559 . . . . 0.0 111.744 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.541 HG22 ' HB3' ' A' ' 633' ' ' PRO . 39.6 t -135.03 134.44 53.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.154 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -100.76 128.68 46.71 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 121.942 0.877 . . . . 0.0 110.8 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.481 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 56.8 m-85 -100.94 157.44 16.74 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.942 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.529 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.1 p90 -133.21 151.0 51.95 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.556 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 98.9 m -94.19 154.31 17.63 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 171.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -49.97 156.43 1.31 Allowed Pre-proline 0 C--O 1.193 -1.881 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.54 -30.53 12.22 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 123.883 3.055 . . . . 0.0 114.052 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.584 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 41.1 ptt180 -97.6 -9.96 25.99 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.633 ' HD1' ' CD2' ' A' ' 663' ' ' PHE . 55.6 m-85 -111.8 150.31 30.51 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.933 0.873 . . . . 0.0 112.531 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.945 HD12 ' HB3' ' A' ' 711' ' ' TYR . 11.0 mp -112.61 151.09 30.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.412 0.625 . . . . 0.0 110.99 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.568 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.1 tpp -76.93 127.99 33.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.048 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.457 ' HB3' HG11 ' A' ' 683' ' ' VAL . 61.5 tttp -112.35 -45.14 3.29 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.088 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.05 -171.57 47.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.353 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.49 104.04 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.847 2.364 . . . . 0.0 111.374 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -72.47 6.18 2.53 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.663 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.467 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 91.6 mttt -132.97 136.19 45.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.461 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 45.4 pt -122.75 167.37 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.455 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -135.06 139.2 44.58 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.671 0.607 . . . . 0.0 110.971 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 48.5 t -82.03 104.13 12.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.381 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.402 HG13 ' N ' ' A' ' 675' ' ' ASP . 79.1 t -83.22 171.24 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.69 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.402 ' N ' HG13 ' A' ' 674' ' ' VAL . 11.3 p-10 -75.64 72.35 2.58 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.6 1.19 . . . . 0.0 110.592 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 160.58 -41.73 0.43 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.742 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.5 179.48 7.74 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -90.44 169.95 10.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.6 p -84.19 -168.32 2.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 123.14 0.576 . . . . 0.0 112.238 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 48.1 m -69.85 113.34 6.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.053 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.504 HD22 ' HG2' ' A' ' 634' ' ' PRO . 7.2 mp -69.88 153.59 95.36 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.913 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.51 ' HG2' HD11 ' A' ' 636' ' ' LEU . 43.2 Cg_endo -70.88 -167.09 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.997 2.465 . . . . 0.0 113.523 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.457 HG11 ' HB3' ' A' ' 666' ' ' LYS . 14.4 p -150.59 149.55 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.406 ' SG ' HD22 ' A' ' 636' ' ' LEU . 73.3 m -116.27 143.66 45.23 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.461 0.475 . . . . 0.0 110.503 -175.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.418 HD11 ' HD2' ' A' ' 666' ' ' LYS . 28.4 pt -136.39 147.89 27.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.736 0.814 . . . . 0.0 108.918 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.479 HG11 ' HG3' ' A' ' 688' ' ' GLU . 9.1 p -87.43 130.38 37.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.837 1.303 . . . . 0.0 110.294 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -74.57 -37.75 62.86 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 112.836 -1.983 . . . . 0.0 108.959 177.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.847 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 27.1 mt-10 66.89 5.86 4.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 113.706 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 7.0 t -96.46 149.04 22.18 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 23.0 p -136.08 159.47 41.62 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.8 -174.163 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.46 -13.35 30.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.061 0.458 . . . . 0.0 111.356 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.63 -63.56 1.33 Allowed Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.403 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.7 t70 -173.95 -168.93 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.603 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -68.63 137.55 90.66 Favored Pre-proline 0 C--N 1.276 -2.602 0 C-N-CA 123.469 0.708 . . . . 0.0 109.745 172.272 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.685 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -73.85 -168.64 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.296 2.664 . . . . 0.0 110.903 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.33 119.14 33.74 Favored 'General case' 0 N--CA 1.408 -2.541 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.223 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 1.005 HD21 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -94.23 144.49 25.47 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.601 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.2 pt-20 -44.89 -46.33 10.82 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.154 0.982 . . . . 0.0 112.872 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.601 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 45.5 m80 -143.29 15.67 1.86 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.521 0.677 . . . . 0.0 109.854 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 1.005 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -122.65 -179.14 15.77 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -162.47 -153.77 0.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 125.405 1.482 . . . . 0.0 107.138 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.5 161.95 36.66 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.242 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.591 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -98.04 -54.85 2.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.61 147.07 36.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.048 -175.234 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.747 ' HB2' ' HH ' ' A' ' 709' ' ' TYR . 5.4 p -128.52 117.97 22.22 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.243 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.6 p -116.71 94.7 44.48 Favored Pre-proline 0 C--N 1.288 -2.091 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 6.6 Cg_endo -93.02 152.61 2.63 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 123.149 2.566 . . . . 0.0 111.806 175.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.434 ' HB2' ' CD1' ' A' ' 710' ' ' TYR . 73.3 Cg_endo -72.92 134.12 33.54 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.963 -1.682 . . . . 0.0 111.047 -1.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.632 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 18.6 m-85 -76.78 78.76 3.39 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.64 ' HE2' ' CE1' ' A' ' 710' ' ' TYR . 14.4 m-85 -92.48 174.01 7.5 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 711' ' ' TYR . 9.6 t80 -60.47 128.94 39.16 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.765 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.34 58.3 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.566 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.37 175.86 8.01 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -141.36 150.64 42.69 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.538 0.685 . . . . 0.0 111.147 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.469 HG12 ' CG1' ' A' ' 694' ' ' ILE . 42.4 t -134.49 143.51 37.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.388 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.5 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 25.3 mt-10 -105.7 127.64 53.19 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.161 0.505 . . . . 0.0 109.966 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.622 ' HE1' ' CE2' ' A' ' 717' ' ' PHE . 2.5 m-85 -101.6 153.83 19.4 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 124.933 1.293 . . . . 0.0 110.312 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.591 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 29.2 t-20 -143.25 169.51 17.49 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.482 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 48.2 t -117.36 160.56 20.94 Favored 'General case' 0 C--N 1.253 -3.614 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 56.6 m -61.37 145.12 52.64 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.39 -21.32 64.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.5 m -78.48 -2.0 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.244 1.021 . . . . 0.0 110.392 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.5 m-85 -127.48 159.49 34.38 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.6 t -120.2 138.74 53.46 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.482 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.2 ptm -91.41 145.78 24.35 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.561 0.696 . . . . 0.0 110.174 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.71 112.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 131.37 -153.51 20.44 Favored Glycine 0 C--N 1.287 -2.16 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -113.08 159.61 19.02 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 122.673 1.225 . . . . 0.0 111.418 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -74.87 -51.03 14.95 Favored 'General case' 1 N--CA 1.376 -4.162 0 CA-C-N 111.253 -2.703 . . . . 0.0 110.535 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.5 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 28.7 p -89.43 139.74 30.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -167.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.509 HG22 HD21 ' A' ' 741' ' ' LEU . 12.2 pt -124.06 162.9 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.246 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 28.5 m -128.05 135.7 50.21 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 54.0 t -71.67 105.6 3.76 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.551 0.532 . . . . 0.0 110.795 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.2 96.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-O 122.154 0.978 . . . . 0.0 111.405 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.4 m-70 67.58 18.06 9.95 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.042 1.737 . . . . 0.0 112.496 173.96 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 114.62 -2.17 23.33 Favored Glycine 0 C--N 1.291 -1.929 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.423 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 27.3 t -129.27 135.6 61.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.685 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.4 m95 -72.64 161.15 31.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.509 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 21.3 p -43.12 -74.17 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.585 HE21 ' N ' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -162.28 -28.23 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.068 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.585 ' N ' HE21 ' A' ' 740' ' ' GLN . 20.1 mt 69.71 157.99 0.15 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.531 1.144 . . . . 0.0 111.477 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 51.6 Cg_endo -77.29 -162.9 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.875 1.717 . . . . 0.0 110.737 174.642 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 3.0 pt20 -146.39 140.98 26.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.588 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 80.2 m -100.19 156.92 16.94 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.214 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.33 147.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.31 126.9 31.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.729 0.3 . . . . 0.0 111.6 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.308 -1.211 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.253 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.517 -0.317 0 N-CA-C 110.472 -0.195 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 58.45 83.84 0.11 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.318 1.047 . . . . 0.0 113.456 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.99 146.6 47.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 62.7 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.463 1.105 . . . . 0.0 111.513 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -83.55 90.46 7.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 111.97 113.48 3.31 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.432 HG21 ' CB ' ' A' ' 651' ' ' HIS 0.296 11.3 p 47.99 51.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 123.757 1.741 . . . . 0.0 113.184 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.456 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -58.52 -28.04 65.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.781 -2.008 . . . . 0.0 112.647 177.734 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.705 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 51.9 m 74.17 108.12 0.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 114.242 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.0 164.77 12.05 Favored 'General case' 0 C--O 1.265 1.895 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.387 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.02 -134.95 8.52 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.583 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 50.1 Cg_exo -53.75 144.05 55.88 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.679 2.919 . . . . 0.0 113.28 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.514 ' HB3' HG22 ' A' ' 655' ' ' VAL . 28.7 Cg_endo -63.92 158.71 45.77 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 123.296 2.664 . . . . 0.0 112.459 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.507 ' HG2' HD22 ' A' ' 681' ' ' LEU . 12.4 Cg_endo -72.49 -169.91 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.425 2.083 . . . . 0.0 112.062 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.85 165.69 11.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.403 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.599 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.6 tp -112.9 140.6 47.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 5.7 tt -28.16 -64.78 0.09 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.597 2.359 . . . . 0.0 112.105 179.131 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.48 -33.53 3.01 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.406 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.743 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.46 -146.05 8.4 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.418 175.48 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -170.31 -169.91 0.89 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 118.02 0.91 . . . . 0.0 111.412 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.66 133.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.677 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.6 ptpt -94.83 -16.57 22.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.405 0.621 . . . . 0.0 110.07 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.82 160.07 15.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.11 168.41 14.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.928 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 73.0 p -83.93 125.61 32.19 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.82 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.402 ' C ' ' H ' ' A' ' 648' ' ' GLU . 50.1 mtmt -86.08 -25.6 25.76 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.752 177.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.583 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.0 mt-10 73.49 -17.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.698 1.199 . . . . 0.0 112.574 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.402 ' H ' ' C ' ' A' ' 646' ' ' LYS . 45.2 tt0 -129.66 99.91 5.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 171.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 9.9 m-85 -104.57 -67.32 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.705 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 107.1 -95.32 0.99 Allowed Glycine 0 C--N 1.289 -2.046 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.09 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.432 ' CB ' HG21 ' A' ' 627' ' ' VAL . 83.9 t60 -148.26 149.06 31.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.28 23.3 p 64.52 14.12 8.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.07 1.748 . . . . 0.0 113.706 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.405 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 37.9 mm-40 -85.55 138.82 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.656 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.52 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.9 m -118.42 146.54 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.568 0.699 . . . . 0.0 112.244 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.549 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 60.9 t -126.02 135.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.61 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.29 123.05 42.17 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.936 0.874 . . . . 0.0 110.262 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.599 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 59.2 m-85 -97.92 160.65 14.17 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.796 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.631 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 39.0 p90 -136.12 143.99 44.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.743 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 60.4 m -84.54 161.45 20.2 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.555 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -55.66 154.05 14.05 Favored Pre-proline 0 C--O 1.207 -1.163 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.555 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 27.4 Cg_endo -58.81 -13.75 19.45 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.727 2.952 . . . . 0.0 115.136 -170.536 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.514 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 12.9 ptt180 -108.67 -4.09 17.35 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.888 0.852 . . . . 0.0 111.76 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.619 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 43.2 m-85 -110.3 148.74 31.33 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.277 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.945 HD12 ' HB3' ' A' ' 711' ' ' TYR . 10.8 mp -106.25 145.48 31.53 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.555 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 48.9 tpp -77.03 113.85 15.19 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.625 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.49 ' HB3' HG21 ' A' ' 683' ' ' VAL . 21.6 tptm -101.9 -25.16 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.421 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -82.35 -174.61 50.04 Favored Glycine 0 C--N 1.307 -1.036 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.36 -178.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.07 8.81 3.31 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 123.05 2.5 . . . . 0.0 113.812 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.555 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.31 10.1 p-10 49.92 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 128.72 2.808 . . . . 0.0 116.925 -177.946 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.549 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.6 mttt -94.93 142.24 27.71 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 123.796 0.839 . . . . 0.0 110.278 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.681 HG22 ' HG ' ' A' ' 681' ' ' LEU . 41.2 pt -129.88 164.56 32.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.897 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.405 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.3 tt0 -129.44 135.97 49.33 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.957 0.903 . . . . 0.0 110.254 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.8 t -82.8 98.74 9.29 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 3.3 p -91.5 -178.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.079 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.41 74.65 3.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.506 1.146 . . . . 0.0 113.161 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.456 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 159.23 -39.67 0.49 Allowed Glycine 0 N--CA 1.417 -2.6 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.249 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -167.01 -174.01 2.54 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.438 ' CE3' HG13 ' A' ' 671' ' ' ILE . 85.5 m95 -84.16 164.98 18.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.4 p -76.9 -174.76 3.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 122.707 0.403 . . . . 0.0 111.292 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.2 m -64.58 111.19 2.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.388 0.613 . . . . 0.0 110.83 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.681 ' HG ' HG22 ' A' ' 671' ' ' ILE . 4.0 mp -68.15 151.17 97.4 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -72.23 176.63 8.29 Favored 'Trans proline' 0 CA--C 1.468 -2.795 0 C-N-CA 123.425 2.75 . . . . 0.0 113.754 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.49 HG21 ' HB3' ' A' ' 666' ' ' LYS . 34.8 m -136.81 159.0 37.34 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.937 0 CA-C-N 112.156 -2.293 . . . . 0.0 107.71 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 92.1 m -121.54 150.14 42.08 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.319 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.93 147.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.9 p -91.27 123.56 43.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.511 1.148 . . . . 0.0 110.026 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.462 ' HG3' ' HB2' ' A' ' 689' ' ' SER . 9.5 tp10 -65.39 -38.5 90.16 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.154 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.423 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 30.5 tt0 66.26 21.51 11.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.417 1.103 . . . . 0.0 109.579 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 689' ' ' SER . . . . . 0.462 ' HB2' ' HG3' ' A' ' 687' ' ' GLU . 16.8 m -122.08 142.96 49.83 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 21.0 p -114.02 168.7 9.58 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.779 0.323 . . . . 0.0 110.806 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . 0.421 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 19.5 m -100.26 -16.15 17.82 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.824 0.821 . . . . 0.0 110.607 -177.964 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 107.68 -89.99 0.61 Allowed Glycine 0 CA--C 1.484 -1.845 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.898 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.698 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t0 -152.46 -172.23 4.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.605 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.4 mt -72.83 132.7 82.82 Favored Pre-proline 0 N--CA 1.406 -2.648 0 C-N-CA 125.129 1.372 . . . . 0.0 109.308 173.622 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.687 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 38.8 Cg_endo -68.35 177.01 4.96 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.271 2.647 . . . . 0.0 112.857 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.84 98.61 8.17 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.769 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.912 HD21 ' HA3' ' A' ' 700' ' ' GLY . 33.5 tp -81.4 135.66 35.67 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.52 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.7 pt-20 -43.51 -42.67 5.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.568 1.147 . . . . 0.0 112.758 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.52 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 41.2 m80 -141.77 24.18 2.05 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.571 0.701 . . . . 0.0 109.966 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.912 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -132.26 170.54 21.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.835 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -157.95 -152.14 0.33 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 126.158 1.783 . . . . 0.0 106.489 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.499 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -142.1 156.13 45.38 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 119.254 0.934 . . . . 0.0 111.366 -168.935 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.538 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.2 OUTLIER -90.07 -48.79 6.97 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.31 148.81 38.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.059 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 22.8 p -126.92 136.87 52.88 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 1.9 p -130.8 78.31 73.92 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-O 121.532 0.682 . . . . 0.0 112.628 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 8.7 Cg_endo -91.71 147.8 3.32 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.949 2.432 . . . . 0.0 112.653 179.091 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -74.88 130.86 22.32 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.669 -1.805 . . . . 0.0 110.898 -0.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.698 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 25.5 m-85 -73.06 106.84 5.09 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.514 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 17.2 m-85 -100.59 173.56 6.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.909 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.637 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 3.7 t80 -62.95 134.62 56.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.477 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.44 -14.74 64.73 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.039 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.6 167.09 22.44 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.2 m -131.2 155.32 47.27 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.572 HG12 HG12 ' A' ' 694' ' ' ILE . 25.4 t -144.65 134.69 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.555 ' HG2' ' HB2' ' A' ' 730' ' ' SER . 17.2 mt-10 -100.06 122.79 43.48 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.733 0.778 . . . . 0.0 110.711 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.605 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.2 m-85 -94.85 154.73 17.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.52 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.538 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 64.9 t30 -134.93 152.22 51.55 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.619 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 45.1 t -99.07 162.9 12.81 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 42.9 t -60.65 142.57 55.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.95 -20.05 65.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.131 0.491 . . . . 0.0 111.76 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 0.26 55.8 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.94 0.876 . . . . 0.0 110.341 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 51.1 m-85 -125.82 162.12 25.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.4 t -118.57 137.75 53.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.619 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.4 ptm -95.45 138.49 33.06 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.329 0.585 . . . . 0.0 109.718 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.37 112.25 39.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 122.07 -160.67 16.44 Favored Glycine 0 CA--C 1.478 -2.28 0 O-C-N 123.418 0.449 . . . . 0.0 112.61 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -91.53 129.09 37.57 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.42 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 13.4 ptt180 -68.96 -28.94 67.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.825 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.555 ' HB2' ' HG2' ' A' ' 716' ' ' GLU . 32.2 t -102.3 150.41 23.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.31 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.49 HG12 ' O ' ' A' ' 715' ' ' VAL . 2.9 pt -128.46 175.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.451 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 70.3 m -143.76 135.13 25.92 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 47.0 t -74.56 114.59 13.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -178.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.5 mm -117.46 103.45 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.39 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 61.5 41.8 12.15 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.309 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 91.68 -11.67 71.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.965 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.68 123.34 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.289 -0.536 . . . . 0.0 109.62 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.687 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.5 m95 -63.83 142.4 58.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.0 p -28.72 -70.3 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.96 -28.99 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.469 HD21 HG22 ' A' ' 731' ' ' ILE . 23.8 mt 69.01 156.25 0.15 Allowed Pre-proline 0 C--O 1.237 0.429 0 O-C-N 124.612 1.195 . . . . 0.0 110.988 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.524 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 72.5 Cg_endo -80.29 -166.16 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.718 1.612 . . . . 0.0 109.842 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -137.58 135.53 36.73 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.43 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.0 m -94.5 138.56 32.27 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.359 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.66 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.23 119.83 12.77 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.501 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.257 1.48 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.733 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -87.92 142.86 27.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.045 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -117.87 91.6 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -74.95 115.41 14.52 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.741 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -88.03 97.29 10.88 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -114.11 69.17 0.24 Allowed Glycine 0 N--CA 1.41 -3.096 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.7 p -177.3 85.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-O 123.163 1.458 . . . . 0.0 110.065 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.508 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -88.29 -21.85 24.22 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.675 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 67.7 m 81.7 106.52 0.06 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.764 1.625 . . . . 0.0 113.724 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.55 155.95 20.27 Favored 'General case' 0 C--O 1.268 2.047 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.55 -134.53 6.98 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.771 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 39.2 Cg_exo -58.19 143.76 96.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.847 2.364 . . . . 0.0 112.322 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.713 ' HD2' HG23 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.71 150.75 87.68 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.602 2.202 . . . . 0.0 112.691 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.502 ' HG2' HD22 ' A' ' 681' ' ' LEU . 18.3 Cg_endo -69.69 -173.05 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.762 2.974 . . . . 0.0 112.857 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.07 146.73 27.07 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.628 HD21 ' N ' ' A' ' 637' ' ' LEU . 4.5 tt -87.35 142.23 28.04 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.628 ' N ' HD21 ' A' ' 636' ' ' LEU . 0.7 OUTLIER -33.26 -71.92 0.05 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.847 1.659 . . . . 0.0 110.16 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.73 41.09 3.06 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.569 1.652 . . . . 0.0 110.13 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.494 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -133.2 -148.79 5.99 Favored Glycine 1 C--N 1.234 -5.139 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.862 177.579 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.413 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.4 t-20 -172.22 178.33 2.89 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.793 HG23 ' CE2' ' A' ' 657' ' ' TYR . 9.9 t -102.39 137.97 28.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 124.168 0.987 . . . . 0.0 108.655 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -100.37 -10.54 21.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.014 0.911 . . . . 0.0 109.339 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 7.8 mm-40 -92.85 135.32 34.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.534 -179.514 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -75.75 150.71 37.73 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.713 HG23 ' HD2' ' A' ' 633' ' ' PRO . 58.5 p -71.6 127.85 33.9 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.617 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.416 ' C ' ' H ' ' A' ' 648' ' ' GLU . 45.5 mtmt -90.76 -20.96 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.771 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 69.43 -20.53 0.17 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.276 1.431 . . . . 0.0 113.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.416 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.1 tp10 -127.64 94.83 4.06 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.506 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.588 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 14.7 m-85 -102.89 -62.98 1.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.233 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.52 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 109.6 -102.17 1.56 Allowed Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -149.14 154.54 39.35 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 53.6 p 65.93 16.57 10.52 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.254 1.422 . . . . 0.0 112.648 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.588 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 7.4 mm-40 -88.45 139.33 30.59 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.897 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.546 HG13 ' HB2' ' A' ' 672' ' ' GLN . 6.9 m -118.36 145.9 23.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.607 0.717 . . . . 0.0 112.513 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.518 HG22 ' HB3' ' A' ' 633' ' ' PRO . 77.5 t -128.74 135.43 62.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.645 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -101.01 133.54 45.35 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.552 0.692 . . . . 0.0 110.508 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.656 ' HE2' ' CE1' ' A' ' 657' ' ' TYR . 53.3 m-85 -111.16 164.19 13.12 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.313 1.045 . . . . 0.0 110.632 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.62 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 51.4 p90 -137.68 158.07 45.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.881 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.544 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 96.2 m -95.01 165.56 12.38 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 118.189 0.45 . . . . 0.0 110.041 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.518 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -59.61 156.53 32.24 Favored Pre-proline 0 C--O 1.216 -0.705 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.518 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 73.2 Cg_endo -72.91 14.59 0.51 Allowed 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 123.878 3.052 . . . . 0.0 113.348 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.598 ' O ' HG21 ' A' ' 686' ' ' VAL . 14.4 ptt180 -129.58 -6.29 4.67 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.68 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 38.2 m-85 -122.91 150.31 43.1 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.635 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.359 0.0 OUTLIER -114.9 137.65 51.72 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.069 -179.948 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.544 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 57.3 tpp -60.98 114.0 2.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.492 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -102.84 -33.56 9.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.226 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.1 -172.57 37.18 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.621 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.551 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 83.2 Cg_endo -76.37 -5.64 16.36 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.107 2.538 . . . . 0.0 112.786 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.496 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 1.4 p-10 56.45 -5.94 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 128.025 2.53 . . . . 0.0 115.662 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -133.06 133.87 43.6 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.272 0.629 . . . . 0.0 109.616 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.612 HG22 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -121.32 166.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.546 ' HB2' HG13 ' A' ' 654' ' ' VAL . 54.3 tt0 -142.0 140.29 32.63 Favored 'General case' 0 N--CA 1.414 -2.268 0 O-C-N 123.753 0.658 . . . . 0.0 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 8.9 t -80.04 108.67 13.81 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.783 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.61 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -89.12 73.19 8.2 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.439 1.114 . . . . 0.0 111.251 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.508 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 167.13 -55.95 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.18 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.03 -168.96 2.92 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -86.17 167.56 14.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 28.7 p -78.18 -176.0 4.4 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 122.876 0.471 . . . . 0.0 110.864 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 78.1 m -68.45 113.25 5.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.408 0.623 . . . . 0.0 110.794 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.612 ' HG ' HG22 ' A' ' 671' ' ' ILE . 6.9 mp -63.28 151.94 85.91 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.522 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.551 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 40.6 Cg_endo -66.31 172.23 9.24 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 122.531 2.154 . . . . 0.0 113.627 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.62 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.159 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 74.5 m -118.87 135.37 54.59 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.49 HG13 HD23 ' A' ' 664' ' ' LEU . 27.0 pt -128.61 143.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.598 HG21 ' O ' ' A' ' 662' ' ' ARG . 8.4 p -93.63 129.48 43.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.431 ' HB3' HD12 ' A' ' 664' ' ' LEU . 2.5 pt-20 -94.07 -11.34 30.86 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 117.219 -1.792 . . . . 0.0 109.91 176.413 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 55.55 55.91 6.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.079 177.398 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 8.7 t -154.94 167.05 31.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 19.3 p -126.54 159.87 32.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . 0.522 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 9.1 m -88.62 -9.14 53.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.581 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 100.27 -81.73 0.51 Allowed Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.646 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.5 t70 -161.89 -173.0 3.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.58 HG12 HG12 ' A' ' 715' ' ' VAL . 2.4 mt -70.72 135.59 85.79 Favored Pre-proline 0 N--CA 1.4 -2.959 0 C-N-CA 125.522 1.529 . . . . 0.0 110.917 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.664 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 61.4 Cg_endo -74.29 -177.3 3.18 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 123.181 2.587 . . . . 0.0 110.371 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.09 123.29 45.24 Favored 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.698 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.819 HD21 ' HA3' ' A' ' 700' ' ' GLY . 40.5 tp -86.21 138.51 31.82 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.418 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 11.2 pt-20 -41.61 -37.63 1.19 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.389 1.476 . . . . 0.0 113.163 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 54.4 m80 -145.26 27.52 1.26 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.819 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -139.26 173.43 22.72 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.193 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -155.2 -150.52 0.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 125.977 1.711 . . . . 0.0 106.828 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.63 152.14 43.72 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 119.256 0.935 . . . . 0.0 112.04 -169.684 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.459 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -83.47 -56.66 3.62 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.3 144.97 35.09 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.626 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.5 p -142.71 116.49 9.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.926 -1.033 . . . . 0.0 108.67 177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.2 m -128.34 91.75 43.19 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-O 121.182 0.515 . . . . 0.0 111.462 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.25 150.29 10.57 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.59 2.193 . . . . 0.0 111.351 176.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -74.96 134.79 37.53 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.233 -1.569 . . . . 0.0 112.41 1.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.646 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 34.0 m-85 -81.19 92.28 6.29 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.607 ' HE1' ' CE2' ' A' ' 710' ' ' TYR . 4.6 m-30 -85.48 163.54 18.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.378 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.611 ' HE2' ' CE1' ' A' ' 711' ' ' TYR . 2.0 t80 -62.14 139.53 58.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.96 -24.22 29.52 Favored Glycine 0 C--N 1.295 -1.721 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.282 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -76.44 167.33 22.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 118.073 0.936 . . . . 0.0 110.284 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.42 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 2.3 m -131.61 158.08 41.98 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.101 0.477 . . . . 0.0 110.41 -172.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.58 HG12 HG12 ' A' ' 694' ' ' ILE . 41.3 t -137.87 145.76 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.101 176.422 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.531 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 39.2 mt-10 -111.73 121.94 46.45 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 121.57 0.7 . . . . 0.0 110.419 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.509 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.0 m-85 -93.32 146.86 23.41 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.307 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.459 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 7.5 t30 -127.67 134.59 49.61 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.406 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.3 t -92.92 142.63 27.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 52.4 m -52.94 138.57 29.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.482 0.489 . . . . 0.0 109.747 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.11 -29.17 65.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.67 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 41.5 m -79.68 -1.62 39.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.013 0.911 . . . . 0.0 111.03 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.43 159.25 24.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.4 t -118.79 139.35 51.72 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.635 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 8.1 ptm -93.04 141.21 28.66 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.355 0.598 . . . . 0.0 109.916 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 52.1 mt -111.18 100.91 11.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.91 -165.48 24.26 Favored Glycine 0 C--N 1.284 -2.347 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -101.31 171.54 7.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -93.81 -27.75 16.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.531 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.7 p -96.03 133.52 40.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.493 HG22 HD21 ' A' ' 741' ' ' LEU . 8.5 pt -120.03 166.31 14.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.289 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 60.9 m -133.17 135.34 45.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.44 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 40.5 t -68.25 108.23 3.1 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.004 0.815 . . . . 0.0 110.317 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.608 ' O ' HG23 ' A' ' 737' ' ' VAL . 48.6 mm -130.2 104.2 9.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 123.859 0.864 . . . . 0.0 109.904 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 69.93 23.94 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.522 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 96.65 -3.6 63.21 Favored Glycine 0 CA--C 1.481 -2.088 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.413 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.608 HG23 ' O ' ' A' ' 734' ' ' ILE . 4.1 m -126.03 153.26 34.05 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.553 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.664 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.4 m95 -87.91 169.08 12.32 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.5 p -47.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 731' ' ' ILE . 21.8 mt 68.58 156.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.493 0 O-C-N 124.691 1.244 . . . . 0.0 111.132 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.635 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 73.9 Cg_endo -79.2 -159.68 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.851 1.701 . . . . 0.0 109.431 173.553 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -143.67 142.1 30.85 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.776 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 88.7 m -101.13 144.13 30.39 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.194 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.9 148.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -74.33 125.75 29.17 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.411 0.444 . . . . 0.0 110.521 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.044 175.572 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 77.83 11.78 1.97 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.079 1.352 . . . . 0.0 110.723 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -91.46 153.19 19.99 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 68.74 20.09 8.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.919 0.887 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -134.51 94.15 3.16 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 132.93 -77.82 0.37 Allowed Glycine 0 C--N 1.282 -2.446 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.512 ' HA ' ' HB3' ' A' ' 675' ' ' ASP 0.262 26.7 m 45.97 72.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 125.038 1.335 . . . . 0.0 112.669 175.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.542 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 0.9 OUTLIER -72.66 -153.07 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.933 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 17.2 t -157.5 163.8 38.06 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 14.9 p -147.49 -173.32 4.24 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -115.94 -135.27 5.65 Favored Glycine 0 N--CA 1.405 -3.4 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.734 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 17.1 Cg_exo -65.43 144.29 79.21 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.658 2.238 . . . . 0.0 110.492 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.82 ' HD2' HG23 ' A' ' 645' ' ' THR . 23.9 Cg_endo -60.3 154.15 54.68 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.572 2.181 . . . . 0.0 112.307 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.523 ' HG2' HD22 ' A' ' 681' ' ' LEU . 14.9 Cg_endo -64.2 -164.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.561 2.841 . . . . 0.0 113.265 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.19 165.61 12.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.299 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.54 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 52.2 tp -113.36 147.52 37.53 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.371 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 12.5 tp -40.59 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.988 1.715 . . . . 0.0 113.315 176.132 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -126.08 50.25 1.89 Allowed 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 123.534 1.635 . . . . 0.0 108.834 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.561 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -164.8 -154.43 7.94 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 111.358 -2.656 . . . . 0.0 108.962 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -166.93 -178.09 4.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.479 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.1 p -92.02 138.68 19.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.465 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 9.7 ptpt -98.08 -17.26 19.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.38 144.0 28.29 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.335 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.441 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 43.4 mmtm -85.45 134.32 34.06 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-O 121.915 0.864 . . . . 0.0 112.718 -173.736 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.82 HG23 ' HD2' ' A' ' 633' ' ' PRO . 11.0 p -64.99 122.1 16.23 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 113.193 -1.822 . . . . 0.0 113.658 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -89.53 -22.98 22.14 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.654 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.734 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 73.08 -7.71 1.45 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.164 1.386 . . . . 0.0 112.334 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.3 93.7 3.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.651 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 7.2 m-85 -121.54 132.97 55.0 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -101.52 -153.83 25.97 Favored Glycine 0 C--N 1.277 -2.745 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.272 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -75.91 149.62 37.71 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.283 76.2 p 71.13 11.19 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.653 1.581 . . . . 0.0 114.072 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.456 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 17.4 mm-40 -79.26 121.34 24.96 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.467 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.8 OUTLIER -109.15 139.69 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.14 0.495 . . . . 0.0 111.488 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.9 t -126.92 135.84 62.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.92 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.89 129.37 48.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.46 1.124 . . . . 0.0 112.614 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.54 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 45.9 m-85 -105.27 164.61 11.71 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.728 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.622 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 40.0 p90 -142.02 150.81 41.8 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.561 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 89.9 m -98.05 163.57 12.71 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.471 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.3 OUTLIER -59.25 159.04 16.66 Favored Pre-proline 0 N--CA 1.482 1.131 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.471 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 61.6 Cg_endo -68.12 -9.8 26.9 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.074 2.516 . . . . 0.0 113.441 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.502 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 21.6 ptt180 -101.68 -6.67 23.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.708 0.766 . . . . 0.0 111.16 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.483 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 48.2 m-85 -121.25 140.92 51.41 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.547 ' HG ' ' HB2' ' A' ' 687' ' ' GLU . 17.5 mt -99.66 139.68 34.96 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.831 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.568 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.2 tpp -72.3 109.03 5.75 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.238 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.618 ' HD2' HD11 ' A' ' 685' ' ' ILE . 81.3 tttt -94.97 -29.2 14.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -79.61 -173.05 44.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.618 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.74 -3.77 13.53 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.277 2.651 . . . . 0.0 113.13 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.568 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.263 2.8 p-10 58.65 -27.57 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 127.474 2.31 . . . . 0.0 116.167 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.494 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.2 mttt -108.5 139.6 43.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 121.937 -0.477 . . . . 0.0 110.346 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.622 HG22 ' HG ' ' A' ' 681' ' ' LEU . 45.6 pt -124.99 171.57 13.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.456 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.0 tt0 -142.39 140.6 32.08 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.85 100.0 8.61 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.316 1.055 . . . . 0.0 108.804 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.79 171.38 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.17 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.542 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 7.0 p-10 -76.05 72.36 2.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.448 1.118 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.23 -39.82 0.52 Allowed Glycine 0 N--CA 1.409 -3.145 0 CA-C-N 113.914 -1.493 . . . . 0.0 111.73 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.93 -178.94 6.41 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -84.04 164.77 19.07 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.9 p -74.67 -174.89 2.26 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.821 0.343 . . . . 0.0 111.749 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.5 m -71.1 111.15 6.23 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.184 0.516 . . . . 0.0 110.111 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.622 ' HG ' HG22 ' A' ' 671' ' ' ILE . 6.2 mp -64.81 151.47 92.67 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.225 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.499 ' HG2' HD11 ' A' ' 636' ' ' LEU . 44.1 Cg_endo -67.71 -176.53 0.97 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.129 2.553 . . . . 0.0 114.115 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.09 142.92 27.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.483 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 85.0 m -114.12 133.09 55.8 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.618 HD11 ' HD2' ' A' ' 666' ' ' LYS . 26.1 pt -128.25 145.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.476 HG11 ' HG3' ' A' ' 688' ' ' GLU . 12.0 p -81.59 126.55 39.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 122.354 1.073 . . . . 0.0 108.578 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.547 ' HB2' ' HG ' ' A' ' 664' ' ' LEU . 7.8 tp10 -60.05 -44.04 94.95 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 113.021 -1.899 . . . . 0.0 110.191 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.706 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 21.3 mt-10 65.22 14.87 9.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.413 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 13.4 m -119.08 133.1 56.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 27.4 p -121.08 164.13 17.3 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.965 -176.134 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 31.5 m -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 67.88 53.66 22.11 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.257 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.609 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.2 t70 71.51 172.94 0.31 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.017 0.927 . . . . 0.0 113.25 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.544 ' CG1' HG12 ' A' ' 715' ' ' VAL . 1.3 mp -66.37 132.99 94.38 Favored Pre-proline 0 N--CA 1.434 -1.275 0 C-N-CA 124.18 0.992 . . . . 0.0 111.626 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.563 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.5 Cg_endo -75.58 -171.22 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.961 3.107 . . . . 0.0 111.683 176.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.17 139.28 49.48 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.373 0.606 . . . . 0.0 110.084 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.708 HD21 ' HA3' ' A' ' 700' ' ' GLY . 48.9 tp -107.61 148.27 29.53 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -43.14 -47.34 6.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.75 1.22 . . . . 0.0 112.758 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -142.86 30.73 1.45 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.042 0.925 . . . . 0.0 109.154 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.708 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -138.25 171.1 23.57 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.894 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.0 p-90 -156.55 -150.88 0.3 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.847 1.659 . . . . 0.0 106.607 -176.283 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.09 162.46 35.43 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.715 -169.46 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.515 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.03 -68.31 0.81 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.64 142.01 32.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.833 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.469 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 6.4 m -133.72 99.53 4.5 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 172.604 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.0 m -117.51 98.34 51.67 Favored Pre-proline 0 C--N 1.271 -2.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.002 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.04 159.45 15.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.241 2.628 . . . . 0.0 110.95 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 138.84 57.95 Favored 'Cis proline' 0 C--O 1.243 0.763 0 C-N-CA 123.89 -1.296 . . . . 0.0 112.261 0.458 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 21.8 m-85 -86.38 78.06 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.626 ' HD2' ' CD1' ' A' ' 710' ' ' TYR . 30.2 m-85 -79.59 161.6 25.83 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.738 0.304 . . . . 0.0 111.67 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.655 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 1.7 t80 -55.87 131.33 46.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -17.18 57.72 Favored Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.753 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.78 173.95 12.07 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -139.66 151.34 45.86 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.452 0.644 . . . . 0.0 111.045 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.544 HG12 ' CG1' ' A' ' 694' ' ' ILE . 32.6 t -135.02 142.07 41.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.809 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.55 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 33.0 mt-10 -104.17 128.89 51.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.606 0.717 . . . . 0.0 110.675 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.446 ' HA ' ' HA ' ' A' ' 702' ' ' ALA . 1.4 m-85 -97.42 156.66 16.37 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.232 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.515 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -137.05 145.88 44.54 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.66 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 44.3 t -94.94 158.98 15.24 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 51.1 m -69.35 158.81 34.34 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.16 144.94 48.39 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 34.5 m 85.0 -5.75 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.325 1.85 . . . . 0.0 109.38 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -119.31 148.41 43.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.6 t -116.65 140.89 48.89 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.66 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.0 ptm -91.91 141.5 28.57 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.01 127.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 112.75 -133.75 11.54 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -115.4 163.08 16.24 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.8 -29.17 16.91 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.55 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 3.9 p -99.94 131.92 45.61 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 741' ' ' LEU . 7.3 pt -109.09 171.27 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.005 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 58.1 m -135.21 135.71 41.2 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.41 108.68 4.96 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.7 0.625 . . . . 0.0 110.163 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.559 ' O ' HG23 ' A' ' 737' ' ' VAL . 45.4 mm -128.39 111.7 24.59 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.702 0 C-N-CA 123.792 0.837 . . . . 0.0 110.579 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 67.01 17.08 10.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.97 49.93 Favored Glycine 0 CA--C 1.479 -2.186 0 C-N-CA 119.32 -1.419 . . . . 0.0 111.483 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.559 HG23 ' O ' ' A' ' 734' ' ' ILE . 9.9 m -125.12 152.89 31.97 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.201 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.563 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.3 m95 -83.26 159.17 22.0 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 11.3 p -38.82 -70.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.04 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 731' ' ' ILE . 20.3 mt 71.16 154.15 0.15 Allowed Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.441 1.096 . . . . 0.0 112.694 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.589 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 47.3 Cg_endo -74.36 -171.1 0.83 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.781 1.654 . . . . 0.0 109.02 172.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 17.5 pt20 -147.57 142.24 26.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 89.2 m -92.17 153.97 18.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.546 0.529 . . . . 0.0 112.358 -175.834 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.4 144.61 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -72.07 123.98 23.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.363 0.414 . . . . 0.0 111.318 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.983 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . 0.531 ' CD ' ' H ' ' A' ' 622' ' ' ALA . 1.6 tm-20 . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . 0.531 ' H ' ' CD ' ' A' ' 621' ' ' GLU . . . -70.99 -23.21 62.15 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.344 0.975 . . . . 0.0 109.357 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 73.1 89.09 0.09 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 126.009 1.724 . . . . 0.0 111.108 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -81.44 -24.67 36.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.409 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . 78.67 -53.96 0.47 Allowed 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 126.48 1.912 . . . . 0.0 110.328 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -140.22 159.99 26.26 Favored Glycine 2 C--N 1.251 -4.183 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.532 HG21 ' HB2' ' A' ' 651' ' ' HIS . 5.1 p -174.68 82.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 123.026 1.393 . . . . 0.0 110.493 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.439 ' CD ' ' H ' ' A' ' 629' ' ' SER . 0.0 OUTLIER -79.23 -88.01 0.06 Allowed 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.621 177.619 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.439 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 34.8 t 167.65 137.71 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.678 1.191 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 67.3 m -131.81 136.07 47.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.82 -132.59 7.58 Favored Glycine 0 N--CA 1.41 -3.08 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.853 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -63.12 135.89 53.3 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.901 2.4 . . . . 0.0 111.874 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.843 ' HD2' HG23 ' A' ' 645' ' ' THR . 26.9 Cg_endo -60.22 157.23 36.04 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.348 2.698 . . . . 0.0 113.444 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.475 ' HG2' HD22 ' A' ' 681' ' ' LEU . 31.4 Cg_endo -71.52 -159.42 0.07 OUTLIER 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.509 2.806 . . . . 0.0 112.643 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . 0.4 ' O ' HD11 ' A' ' 681' ' ' LEU . 13.8 pt-20 -104.35 174.78 5.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.408 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.622 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.7 tt -117.86 142.03 47.77 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 169.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 54.0 tp -35.67 -68.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 127.437 2.295 . . . . 0.0 112.869 176.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.409 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.2 t30 -116.9 -31.0 5.56 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.31 1.052 . . . . 0.0 109.331 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.524 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -78.86 -157.04 10.39 Favored Glycine 0 C--N 1.298 -1.555 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.265 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -169.5 -177.01 2.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.497 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.3 p -101.08 140.53 19.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 123.398 0.679 . . . . 0.0 109.687 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.415 ' HB3' ' HD1' ' A' ' 658' ' ' TYR . 8.6 ptpt -95.77 -30.9 13.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.56 149.44 34.86 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.649 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.448 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 38.9 mmtm -86.94 161.7 18.09 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.789 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.843 HG23 ' HD2' ' A' ' 633' ' ' PRO . 14.5 p -84.0 122.68 29.1 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.767 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.433 ' C ' ' H ' ' A' ' 648' ' ' GLU . 51.4 mtmt -82.31 -23.74 34.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.424 178.445 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.853 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.9 mt-10 67.62 -13.86 0.23 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.168 1.387 . . . . 0.0 113.648 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.433 ' H ' ' C ' ' A' ' 646' ' ' LYS . 34.2 tt0 -133.28 87.38 2.39 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.585 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.669 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 11.9 m-85 -91.43 -65.53 1.0 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 112.02 -88.45 0.5 Allowed Glycine 0 C--N 1.296 -1.65 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.934 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.532 ' HB2' HG21 ' A' ' 627' ' ' VAL . 80.9 t60 -161.49 144.57 12.4 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 73.82 3.13 4.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.161 1.384 . . . . 0.0 111.391 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.503 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 65.4 mm-40 -74.88 140.79 44.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.542 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 3.4 m -115.71 151.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 123.993 0.808 . . . . 0.0 112.3 -176.886 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 52.2 t -133.24 134.59 57.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.441 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 125.28 48.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.091 0.948 . . . . 0.0 111.66 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.587 ' HB3' HD13 ' A' ' 636' ' ' LEU . 62.8 m-85 -100.68 168.84 9.43 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.832 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.604 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 41.0 p90 -138.94 153.15 48.19 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.503 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 63.6 m -94.41 163.31 13.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.409 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.6 OUTLIER -63.81 155.78 75.68 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.321 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.437 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 68.1 Cg_endo -69.41 9.81 0.5 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 123.672 2.915 . . . . 0.0 114.849 -172.968 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.488 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 32.2 ptt180 -131.83 5.72 4.27 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.864 0.84 . . . . 0.0 109.753 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.488 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 39.3 m-85 -123.95 143.07 50.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.698 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.56 HD23 ' CD1' ' A' ' 711' ' ' TYR . 12.2 mt -97.51 145.82 25.84 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.095 0.474 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.535 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.0 tpp -76.5 113.2 13.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.109 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.454 ' HE3' HD11 ' A' ' 685' ' ' ILE . 40.3 ttmt -93.31 -48.95 6.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.386 0.612 . . . . 0.0 109.775 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.53 -168.13 43.82 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.727 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.04 107.4 2.43 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.694 2.262 . . . . 0.0 111.182 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.0 p-10 -72.97 -5.01 35.83 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.056 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.504 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 48.7 mtmt -126.48 117.51 23.02 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.154 0.502 . . . . 0.0 110.28 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.589 HG22 HD21 ' A' ' 681' ' ' LEU . 47.5 pt -108.78 168.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.427 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.503 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 21.3 tt0 -140.36 140.54 35.58 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 123.597 0.759 . . . . 0.0 110.845 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.0 106.98 7.9 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.756 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.18 -177.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.86 81.27 2.77 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.932 1.348 . . . . 0.0 111.691 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.87 -39.78 0.82 Allowed Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.393 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -165.69 -171.22 2.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.89 165.98 14.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 18.6 p -75.01 -179.78 4.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.271 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 47.2 m -62.7 115.7 4.54 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.671 0.748 . . . . 0.0 112.046 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.589 HD21 HG22 ' A' ' 671' ' ' ILE . 78.2 mt -64.37 146.24 97.99 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.17 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.622 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 60.0 Cg_endo -70.4 -174.39 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.916 2.411 . . . . 0.0 113.757 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 67.8 t -139.43 136.17 40.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 99.0 m -111.98 127.89 56.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.454 HD11 ' HE3' ' A' ' 666' ' ' LYS . 29.3 pt -125.41 147.71 30.06 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 662' ' ' ARG . 7.1 p -92.26 116.66 33.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.704 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.53 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.3 OUTLIER -78.16 -24.71 47.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.44 0.638 . . . . 0.0 109.509 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.541 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 8.4 tt0 58.34 47.75 13.46 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.834 1.653 . . . . 0.0 109.58 175.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 689' ' ' SER . . . . . 0.558 ' O ' ' HA ' ' A' ' 710' ' ' TYR . 33.0 m -128.88 149.56 50.72 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.821 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 690' ' ' THR . . . . . 0.402 ' HA ' ' O ' ' A' ' 709' ' ' TYR . 17.0 p -124.18 147.01 48.32 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.284 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.0 m -83.43 -4.73 58.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.189 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 96.14 -87.37 0.97 Allowed Glycine 0 CA--C 1.486 -1.756 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.693 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 5.9 p-10 -154.25 -173.8 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.632 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.8 mt -71.27 133.04 85.62 Favored Pre-proline 0 N--CA 1.42 -1.933 0 C-N-CA 123.623 0.769 . . . . 0.0 112.115 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.685 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 63.0 Cg_endo -71.91 -177.77 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.417 2.745 . . . . 0.0 112.154 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.82 118.04 35.05 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.244 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.533 HD21 ' HG2' ' A' ' 698' ' ' GLU . 5.2 tt -93.6 140.97 29.01 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 175.747 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.533 ' HG2' HD21 ' A' ' 697' ' ' LEU . 9.4 pt-20 -45.67 -36.42 4.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.39 1.076 . . . . 0.0 113.042 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 95.3 m-70 -147.09 37.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.497 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -146.07 171.57 26.95 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.384 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -156.47 -152.23 0.36 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 126.247 1.819 . . . . 0.0 106.709 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.541 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -134.58 152.76 52.0 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.581 -1.248 . . . . 0.0 113.854 -167.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.425 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.57 -47.53 8.64 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.031 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.471 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.1 pp -119.69 129.89 54.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.29 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.536 ' HB3' ' HH ' ' A' ' 709' ' ' TYR . 3.5 m -126.97 126.19 42.77 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.118 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 12.3 t -135.24 92.72 17.59 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.737 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_endo -87.03 153.24 8.36 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.63 2.22 . . . . 0.0 111.717 177.202 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -72.84 136.75 45.65 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.069 -1.638 . . . . 0.0 111.887 0.16 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.693 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 44.5 m-85 -81.9 93.92 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.558 ' HA ' ' O ' ' A' ' 689' ' ' SER . 3.2 m-85 -78.01 166.08 23.26 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.594 0.558 . . . . 0.0 111.526 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.653 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 0.7 OUTLIER -67.15 137.74 56.52 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.517 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.99 -16.31 61.38 Favored Glycine 0 N--CA 1.422 -2.287 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.036 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.437 ' HB2' ' O ' ' A' ' 661' ' ' PRO . 22.1 t0 -77.79 164.79 24.9 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.8 m -128.12 156.02 43.5 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.22 0.533 . . . . 0.0 109.875 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.512 HG12 HG12 ' A' ' 694' ' ' ILE . 38.6 t -137.51 137.7 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.969 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -106.51 120.35 41.68 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.663 ' HE2' ' CE1' ' A' ' 717' ' ' PHE . 2.2 m-85 -92.35 147.51 22.85 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.541 1.136 . . . . 0.0 111.962 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.425 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.5 t30 -118.81 138.53 52.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.701 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 37.7 t -83.1 155.06 24.04 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.6 t -63.17 147.27 51.37 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.02 137.78 45.59 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 60.8 m 86.75 5.76 0.34 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 126.278 1.831 . . . . 0.0 110.665 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.403 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 69.1 m-85 -122.5 152.07 40.7 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.437 ' HB ' HD12 ' A' ' 747' ' ' ILE . 9.9 t -114.42 137.43 51.84 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.701 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.3 ptm -91.11 139.33 30.86 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.278 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.57 HD13 HE21 ' A' ' 743' ' ' GLN . 26.9 mt -121.66 119.29 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 124.38 -154.52 17.92 Favored Glycine 0 CA--C 1.475 -2.415 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -98.69 118.49 35.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.548 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -58.96 -24.65 62.79 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.72 -1.582 . . . . 0.0 113.049 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 6.7 m -117.29 149.36 40.59 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.305 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 741' ' ' LEU . 5.8 pt -128.64 173.77 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.656 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 90.3 m -140.7 136.91 33.09 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.8 t -69.06 109.04 3.8 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.511 0.724 . . . . 0.0 110.124 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.7 mm -127.46 104.25 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.996 0.427 . . . . 0.0 111.602 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 65.73 27.71 11.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.946 . . . . 0.0 111.894 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.42 5.11 62.06 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.648 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.7 t -135.2 140.83 44.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.685 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.6 m95 -79.91 148.45 31.27 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.1 p -33.38 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.78 -29.9 0.07 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -171.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.455 HD21 HG22 ' A' ' 731' ' ' ILE . 25.6 mt 65.72 156.83 0.13 Allowed Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 124.505 1.128 . . . . 0.0 111.725 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.606 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 72.1 Cg_endo -86.58 -179.28 2.97 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 121.782 1.654 . . . . 0.0 110.21 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.57 HE21 HD13 ' A' ' 726' ' ' ILE . 12.5 pt20 -126.32 142.49 51.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.677 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 92.2 m -105.37 139.76 39.52 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.317 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.15 144.86 36.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -70.46 115.85 10.12 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.499 0.499 . . . . 0.0 112.146 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.437 HD12 ' HB ' ' A' ' 724' ' ' THR . 64.6 mt . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -174.1 149.11 1.41 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.06 -155.16 0.34 Allowed 'General case' 0 C--O 1.254 1.33 0 O-C-N 123.805 0.691 . . . . 0.0 109.882 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -129.25 148.43 51.18 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.43 19.39 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 109.74 -130.23 9.83 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . 0.314 14.4 p 46.3 81.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 123.405 1.574 . . . . 0.0 113.273 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -100.05 0.09 Allowed 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.363 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 47.7 t 178.8 140.53 0.1 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.871 ' HB2' ' HB2' ' A' ' 649' ' ' TYR . 14.4 m -131.8 158.48 41.13 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -107.18 -150.57 16.89 Favored Glycine 1 N--CA 1.387 -4.628 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 176.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.935 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -60.28 149.17 87.06 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.588 ' HD2' HG23 ' A' ' 645' ' ' THR . 28.1 Cg_endo -63.77 149.55 90.5 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.754 1.636 . . . . 0.0 110.992 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.496 ' HG2' HD12 ' A' ' 681' ' ' LEU . 28.8 Cg_endo -68.28 -167.27 0.17 Allowed 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 122.823 2.349 . . . . 0.0 111.863 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.95 151.41 25.84 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.531 -0.731 . . . . 0.0 110.749 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.629 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 3.7 tt -92.69 136.82 32.9 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.529 ' N ' HD21 ' A' ' 636' ' ' LEU . 46.3 tp -32.01 -68.31 0.09 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.815 2.046 . . . . 0.0 113.958 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.33 33.66 3.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.939 1.828 . . . . 0.0 108.795 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.497 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -139.67 -156.28 6.88 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.814 174.041 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -174.8 -178.92 1.35 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.471 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.23 139.77 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 123.838 0.855 . . . . 0.0 111.202 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -96.0 -23.01 17.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.31 172.16 14.12 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -96.79 165.24 12.21 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.266 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.588 HG23 ' HD2' ' A' ' 633' ' ' PRO . 33.5 p -91.14 120.79 32.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.374 0.607 . . . . 0.0 111.586 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.33 -24.91 21.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.759 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.935 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 67.55 -12.91 0.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.496 1.518 . . . . 0.0 114.395 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -132.0 93.49 3.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.871 ' HB2' ' HB2' ' A' ' 630' ' ' CYS . 3.1 m-85 -110.33 -179.46 3.78 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.101 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -151.08 -150.31 5.28 Favored Glycine 0 N--CA 1.402 -3.578 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.251 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -80.1 134.02 36.14 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.0 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 75.66 17.87 2.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.877 1.271 . . . . 0.0 111.798 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.514 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 69.7 mm-40 -79.87 129.22 34.31 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.693 -0.629 . . . . 0.0 109.508 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.521 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 10.4 m -110.97 151.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 123.366 0.416 . . . . 0.0 111.461 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.475 HG22 ' HB3' ' A' ' 633' ' ' PRO . 26.2 t -135.2 131.8 52.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.442 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -100.49 128.89 46.42 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.122 0.963 . . . . 0.0 112.089 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.629 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.8 m-85 -106.72 165.75 11.08 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.486 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.66 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 45.2 p90 -136.18 156.81 48.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.583 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 75.8 m -93.08 165.13 12.99 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.95 157.5 4.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.75 10.43 0.49 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.846 3.031 . . . . 0.0 114.009 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.55 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 11.2 ptt85 -133.25 -1.16 3.24 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.996 0.903 . . . . 0.0 111.61 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 46.0 m-85 -116.7 158.18 24.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.025 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.711 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.3 mp -115.33 140.72 48.87 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.386 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.583 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 56.6 tpp -75.45 118.43 18.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.516 ' HB3' HG21 ' A' ' 683' ' ' VAL . 38.0 ttmt -98.24 -47.09 5.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.077 0.465 . . . . 0.0 110.46 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.43 -170.95 46.03 Favored Glycine 0 C--O 1.242 0.629 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.405 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 104.52 1.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.494 2.129 . . . . 0.0 110.934 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.486 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.0 p-10 -69.32 -2.44 10.78 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.318 -177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.408 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 46.6 mtmt -121.91 128.79 51.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.139 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.521 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 43.7 pt -116.96 166.25 11.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.623 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.514 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.2 tt0 -138.46 139.57 38.88 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.75 0.656 . . . . 0.0 109.657 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.537 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 13.7 t -89.67 115.06 26.76 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . 0.445 HG23 ' O ' ' A' ' 677' ' ' GLU . 20.0 m -89.58 -171.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.252 4.8 p-10 -78.75 76.97 5.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.477 1.132 . . . . 0.0 111.684 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.5 0.38 Allowed Glycine 0 N--CA 1.414 -2.804 0 CA-C-N 113.534 -1.666 . . . . 0.0 111.145 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . 0.445 ' O ' HG23 ' A' ' 674' ' ' VAL . 10.9 pt-20 -149.79 -175.28 4.97 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.537 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 85.9 m95 -85.05 175.1 9.24 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.238 0.542 . . . . 0.0 111.469 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 30.5 p -88.81 -174.64 4.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.833 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 88.5 m -61.63 116.66 4.94 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 123.883 0.873 . . . . 0.0 111.927 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.521 HD11 HG22 ' A' ' 671' ' ' ILE . 4.4 mm? -68.4 143.48 95.56 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.581 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.597 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 84.4 Cg_endo -76.31 170.03 20.8 Favored 'Trans proline' 0 CA--C 1.461 -3.153 0 C-N-CA 123.585 2.857 . . . . 0.0 111.928 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.516 HG21 ' HB3' ' A' ' 666' ' ' LYS . 18.6 m -131.75 156.52 42.65 Favored 'Isoleucine or valine' 1 N--CA 1.356 -5.167 0 CA-C-N 112.048 -2.342 . . . . 0.0 108.482 -174.499 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 95.8 m -128.33 138.0 52.19 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.22 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.39 152.35 36.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.4 p -97.52 132.1 42.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.533 ' HG2' HD13 ' A' ' 664' ' ' LEU . 13.2 pt-20 -79.93 -20.72 45.04 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.454 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.971 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.502 15.2 pt-20 38.65 61.46 1.19 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 123.687 1.708 . . . . 0.0 114.859 -176.255 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 56.9 m -148.36 154.91 40.58 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 62.1 p -118.6 175.22 5.83 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.519 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . 0.51 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 32.7 m -95.02 -12.17 27.1 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 103.64 -77.74 0.29 Allowed Glycine 0 CA--C 1.478 -2.251 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.415 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.484 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t70 -170.58 -165.24 0.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.3 mt -80.15 136.65 53.44 Favored Pre-proline 0 C--N 1.272 -2.793 0 C-N-CA 125.296 1.439 . . . . 0.0 111.315 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.583 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.5 Cg_endo -74.64 -177.22 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.252 2.635 . . . . 0.0 111.309 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.46 118.54 33.48 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.594 HD21 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -89.35 143.39 26.87 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.489 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 10.2 pt-20 -39.01 -47.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.03 1.332 . . . . 0.0 113.239 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 53.9 m80 -143.41 30.76 1.37 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.594 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -133.12 176.53 19.52 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.066 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -164.62 -156.03 0.3 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.306 1.842 . . . . 0.0 106.913 -174.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.431 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.41 150.69 47.84 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -167.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.438 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.5 -41.8 13.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.765 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.07 146.98 50.82 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.674 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.495 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 13.0 m -120.41 130.54 54.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.313 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.57 87.77 49.41 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -91.28 147.84 3.59 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.914 2.409 . . . . 0.0 112.152 176.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -74.84 128.33 16.1 Favored 'Cis proline' 0 C--O 1.241 0.671 0 C-N-CA 122.648 -1.814 . . . . 0.0 110.955 -0.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' A' ' 709' ' ' TYR . 12.7 m-85 -72.78 97.06 2.15 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.971 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 13.6 m-85 -97.11 176.83 5.79 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.326 0.584 . . . . 0.0 111.883 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.644 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 11.3 t80 -67.09 137.75 56.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.16 -1.53 88.65 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.369 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -84.78 174.17 10.09 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.3 m -143.04 153.31 42.82 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.144 0.497 . . . . 0.0 110.614 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.547 HG12 HG12 ' A' ' 694' ' ' ILE . 39.6 t -138.28 141.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.503 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.542 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 34.3 mt-10 -100.73 121.14 41.16 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.6 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 2.1 m-85 -98.38 161.52 13.64 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.611 1.164 . . . . 0.0 110.461 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 34.3 t-20 -149.45 163.21 38.42 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.469 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.6 m -108.23 154.72 21.36 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 19.3 m -61.22 154.14 24.29 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.255 0.347 . . . . 0.0 111.598 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.46 138.64 58.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.5 m 88.18 -0.83 0.45 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 126.929 2.092 . . . . 0.0 110.118 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.31 149.26 40.77 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -117.15 145.31 43.91 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.664 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -93.79 138.48 31.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.684 0.754 . . . . 0.0 111.729 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 51.9 mt -113.08 116.9 53.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 119.37 -139.67 14.35 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -128.19 167.54 16.69 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 120.895 0.379 . . . . 0.0 110.402 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -87.51 -33.83 18.84 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.542 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.0 p -93.57 133.78 36.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.493 HG22 HD21 ' A' ' 741' ' ' LEU . 7.8 pt -118.1 166.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.507 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 75.2 m -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.34 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.05 121.68 25.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.551 0.691 . . . . 0.0 112.206 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.599 ' O ' HG23 ' A' ' 737' ' ' VAL . 49.7 mm -128.43 108.38 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 70.63 27.07 3.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . 0.51 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 95.17 -13.72 66.44 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.32 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . 0.599 HG23 ' O ' ' A' ' 734' ' ' ILE . 2.6 m -113.73 158.51 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -173.594 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.583 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.8 m95 -96.12 158.61 15.36 Favored 'General case' 0 C--N 1.271 -2.835 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 42.5 p -39.59 -70.4 0.1 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -174.322 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.2 -28.38 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.493 HD21 HG22 ' A' ' 731' ' ' ILE . 17.4 mt 68.98 157.78 0.15 Allowed Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.466 1.107 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.664 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 51.2 Cg_endo -77.51 -172.05 1.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.776 1.65 . . . . 0.0 111.577 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -125.1 130.38 52.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.903 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 9.6 m -107.39 126.07 52.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.64 147.07 28.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.66 114.87 8.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.903 0.752 . . . . 0.0 111.254 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.58 175.66 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 63.45 85.66 0.13 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.417 1.087 . . . . 0.0 112.201 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.78 -40.62 20.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.08 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -141.37 -48.57 0.4 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -81.12 172.88 13.13 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 675' ' ' ASP . . . 88.01 59.57 1.67 Allowed Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.567 ' HB ' ' HB2' ' A' ' 651' ' ' HIS . 33.7 m -128.7 -13.73 2.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 114.898 -0.651 . . . . 0.0 111.53 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . 0.254 2.9 pp0? 25.61 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 130.282 3.433 . . . . 0.0 118.868 -167.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.617 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 47.8 m 78.98 127.06 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 126.745 2.018 . . . . 0.0 112.057 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 12.9 p -116.33 -172.08 2.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.076 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.67 -136.82 5.66 Favored Glycine 0 N--CA 1.398 -3.84 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.407 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 32.1 Cg_exo -58.04 147.54 82.08 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 123.685 2.923 . . . . 0.0 114.028 -176.174 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.529 ' HB3' HG22 ' A' ' 655' ' ' VAL . 31.9 Cg_endo -64.66 157.34 56.22 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.137 2.558 . . . . 0.0 112.658 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD22 ' A' ' 681' ' ' LEU . 19.1 Cg_endo -66.73 -164.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.405 2.736 . . . . 0.0 111.421 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -114.75 159.23 20.81 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.461 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.54 HD12 ' HA3' ' A' ' 639' ' ' GLY . 1.0 OUTLIER -93.94 136.2 34.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.365 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -32.11 -65.55 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.563 1.945 . . . . 0.0 111.189 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.484 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 4.2 t30 -110.63 -33.53 6.55 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.448 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.54 ' HA3' HD12 ' A' ' 636' ' ' LEU . . . -83.18 -147.12 6.99 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.691 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.04 -172.85 3.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.718 HG23 ' CE1' ' A' ' 657' ' ' TYR . 21.3 t -105.16 140.21 23.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 124.64 1.176 . . . . 0.0 109.215 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.472 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.0 ptpt -107.32 -11.68 15.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.666 0.746 . . . . 0.0 109.482 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . 0.489 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 20.0 mm-40 -78.51 154.09 30.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.927 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.93 144.82 25.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.171 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.489 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 20.9 p -78.78 119.97 22.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.998 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.489 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -103.02 -13.82 16.71 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.045 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.407 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 52.4 mm-40 66.79 -29.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.148 1.379 . . . . 0.0 112.013 -175.24 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.489 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.9 tt0 -112.66 102.49 10.55 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.489 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 6.7 m-85 -117.55 -160.04 0.76 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.617 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -176.03 -165.57 32.07 Favored Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.137 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.567 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 69.1 t60 -69.8 137.12 51.59 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.4 m 75.85 4.33 3.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 124.694 1.246 . . . . 0.0 113.252 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.566 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 53.9 mm-40 -70.98 140.27 50.81 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.295 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.545 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.4 m -121.12 139.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.529 HG22 ' HB3' ' A' ' 633' ' ' PRO . 39.3 t -121.71 132.59 70.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.743 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.489 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 38.5 tt0 -102.42 127.73 49.32 Favored 'General case' 0 N--CA 1.414 -2.231 0 O-C-N 124.109 0.881 . . . . 0.0 110.236 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.615 ' HD2' ' CD1' ' A' ' 657' ' ' TYR . 81.2 m-85 -101.96 161.27 13.8 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.604 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.59 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 51.6 p90 -136.89 142.23 42.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.498 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 79.9 m -85.24 163.33 18.72 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.596 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.6 OUTLIER -60.98 154.4 60.41 Favored Pre-proline 0 C--O 1.211 -0.923 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.251 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.596 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 58.6 Cg_endo -66.53 -4.04 10.16 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.975 3.117 . . . . 0.0 114.628 -172.488 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.563 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 13.3 ptt180 -110.6 -4.71 15.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.021 0.915 . . . . 0.0 111.111 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.658 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 38.9 m-85 -117.07 149.95 39.46 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.065 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.991 HD12 ' HB3' ' A' ' 711' ' ' TYR . 10.1 mp -108.71 146.54 33.32 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.617 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.498 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 51.7 tpp -71.04 123.22 21.59 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.647 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -99.57 -49.21 4.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -94.5 -162.42 35.14 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.497 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.64 106.2 2.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.538 2.159 . . . . 0.0 110.431 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.477 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 25.3 p-10 -68.96 -8.82 48.15 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.333 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.474 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.7 mttt -118.68 130.45 55.84 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 46.7 pt -120.22 165.46 15.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.903 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.566 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.1 tt0 -136.81 138.18 40.56 Favored 'General case' 0 C--N 1.283 -2.288 0 O-C-N 123.848 0.717 . . . . 0.0 110.196 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.485 ' HB3' ' O ' ' A' ' 650' ' ' GLY . 47.5 t -84.29 107.92 16.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.78 -163.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.525 ' HB3' ' O ' ' A' ' 626' ' ' GLY . 13.7 p-10 -74.05 79.83 1.72 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.334 1.064 . . . . 0.0 110.419 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.33 -51.2 0.73 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.681 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -155.6 -170.52 3.46 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -86.81 162.53 17.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.8 p -76.45 -178.21 4.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 86.6 m -58.87 113.93 2.3 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.798 0.839 . . . . 0.0 111.335 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.516 HD22 ' HG2' ' A' ' 634' ' ' PRO . 6.6 mp -71.46 156.21 91.76 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.534 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.458 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -73.64 -178.45 3.75 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 123.036 2.491 . . . . 0.0 113.539 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.54 149.55 31.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.455 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 83.9 m -119.67 128.83 54.19 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 35.8 pt -123.59 158.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.41 HG23 ' HG3' ' A' ' 688' ' ' GLU . 12.5 p -103.38 118.77 50.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.493 0 CA-C-O 123.077 1.417 . . . . 0.0 110.421 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.413 ' HB2' HD11 ' A' ' 664' ' ' LEU . 7.8 tp10 -62.26 -36.93 83.57 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.388 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.904 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.251 24.1 mt-10 52.47 45.85 27.78 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.654 1.216 . . . . 0.0 113.609 -178.328 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 30.0 m -146.48 137.27 24.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 43.5 p -120.26 174.99 6.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.246 0.546 . . . . 0.0 111.095 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.0 m -90.11 -2.63 58.12 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.668 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 89.74 -75.93 1.77 Allowed Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.761 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 3.2 t70 -159.57 -166.78 1.85 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.641 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 2.3 mt -79.78 133.72 58.28 Favored Pre-proline 0 C--N 1.28 -2.438 0 C-N-CA 124.275 1.03 . . . . 0.0 111.043 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.514 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.9 Cg_endo -74.29 -176.58 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.075 2.516 . . . . 0.0 111.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.09 120.35 42.28 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.44 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.653 HD21 ' HA3' ' A' ' 700' ' ' GLY . 30.2 tp -90.46 138.63 31.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -41.61 -40.8 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.3 m-70 -142.19 27.44 1.76 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.653 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -131.52 -179.85 16.5 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.162 -0.927 . . . . 0.0 113.465 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -160.25 -152.53 0.29 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.982 2.113 . . . . 0.0 106.553 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.557 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.75 150.95 46.68 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 118.816 0.735 . . . . 0.0 112.506 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.468 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -84.43 -43.43 14.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.761 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.23 147.87 51.11 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.575 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 6.9 p -126.17 121.47 32.9 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.333 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.05 85.65 46.17 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 8.8 Cg_endo -92.23 146.66 2.93 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 123.114 2.543 . . . . 0.0 111.827 176.069 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.73 130.11 18.98 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.037 -1.651 . . . . 0.0 111.456 -0.01 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.761 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 19.3 m-85 -78.05 83.6 4.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.611 ' HD2' ' CD1' ' A' ' 710' ' ' TYR . 20.9 m-85 -83.0 168.54 16.89 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 121.157 0.503 . . . . 0.0 111.536 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 1.9 t80 -59.89 127.2 30.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.084 176.339 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.33 -20.5 42.38 Favored Glycine 0 C--N 1.299 -1.515 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.537 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.31 170.18 16.6 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.5 m -138.87 148.98 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.451 0.643 . . . . 0.0 111.291 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.537 HG12 HG12 ' A' ' 694' ' ' ILE . 42.5 t -131.83 143.07 41.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.995 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.539 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.1 mt-10 -109.97 122.29 47.21 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.643 ' HE1' ' CE2' ' A' ' 717' ' ' PHE . 2.3 m-85 -95.32 161.1 14.23 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 124.686 1.194 . . . . 0.0 111.399 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.468 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 55.6 t30 -150.1 147.86 28.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.528 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.4 m -91.37 165.06 13.61 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 720' ' ' SER . . . . . 0.409 ' HB3' ' CD1' ' A' ' 723' ' ' PHE . 47.3 t -50.69 147.01 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.64 -31.24 62.15 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 20.3 m -93.68 11.37 29.21 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 121.173 0.511 . . . . 0.0 111.89 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 1.649 ' HD1' ' CD2' ' A' ' 723' ' ' PHE . 75.9 m-85 -127.26 154.83 44.39 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -119.93 145.09 47.06 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.418 ' HB3' ' SG ' ' A' ' 719' ' ' CYS . 9.0 ptp -90.74 161.07 15.48 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-O 121.474 0.654 . . . . 0.0 109.954 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.18 122.94 66.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.65 -144.47 18.18 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -118.75 169.7 9.61 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . 0.559 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 33.7 ptt180 -94.49 -28.67 15.33 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.539 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.4 p -86.19 146.43 26.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.491 HG22 HD21 ' A' ' 741' ' ' LEU . 8.4 pt -130.34 168.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.262 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 99.2 m -137.49 136.26 37.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.15 109.15 4.46 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.507 0.504 . . . . 0.0 110.312 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.3 mm -123.89 107.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.361 0.6 . . . . 0.0 110.729 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 68.16 18.83 9.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.42 1.088 . . . . 0.0 113.211 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.3 55.57 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.665 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.03 142.47 40.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.514 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.2 m95 -75.53 163.09 27.73 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.0 p -46.33 -71.59 0.07 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -33.09 0.06 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.491 HD21 HG22 ' A' ' 731' ' ' ILE . 15.2 mt 66.35 153.79 0.13 Allowed Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 124.497 1.123 . . . . 0.0 110.37 -176.395 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.3 -161.73 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.585 1.524 . . . . 0.0 111.022 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.56 132.26 30.83 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.488 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 10.1 m -94.56 146.49 24.08 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.35 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.82 155.1 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.87 124.57 24.35 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 123.685 0.615 . . . . 0.0 109.688 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.253 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 109.166 176.81 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -78.14 127.76 32.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.683 0.278 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.66 15.87 26.77 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.165 0.507 . . . . 0.0 109.854 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . 0.487 ' HB3' ' HB3' ' A' ' 628' ' ' GLN . . . -154.55 143.17 20.74 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.36 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -88.38 -29.93 19.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 166.894 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 165.6 41.76 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.779 176.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.512 HG21 ' HB2' ' A' ' 651' ' ' HIS . 3.3 p 179.11 82.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.597 1.559 . . . . 0.0 107.721 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.487 ' HB3' ' HB3' ' A' ' 624' ' ' ALA . 0.0 OUTLIER -74.71 -96.4 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.919 178.817 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.7 t 166.92 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.431 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 25.8 p -145.61 177.87 8.56 Favored 'General case' 0 C--N 1.275 -2.631 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -116.7 -141.75 7.16 Favored Glycine 0 N--CA 1.402 -3.616 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.905 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.697 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 18.9 Cg_exo -60.58 146.07 97.67 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.075 2.517 . . . . 0.0 111.887 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.476 ' HD2' HG23 ' A' ' 645' ' ' THR . 11.5 Cg_endo -55.57 149.18 49.65 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 123.041 2.494 . . . . 0.0 112.233 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.484 ' HG2' HD22 ' A' ' 681' ' ' LEU . 17.9 Cg_endo -72.58 -168.26 0.39 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.312 2.675 . . . . 0.0 111.999 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -99.29 158.86 15.41 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.047 0.451 . . . . 0.0 110.823 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.726 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.8 tt -98.72 145.7 26.64 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.629 HD11 HG21 ' A' ' 683' ' ' VAL . 6.9 tt -33.52 -56.0 0.44 Allowed 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 127.325 2.25 . . . . 0.0 111.238 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.462 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.5 t30 -122.6 -47.55 2.09 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.556 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -68.88 -153.08 0.54 Allowed Glycine 0 N--CA 1.476 1.324 0 O-C-N 124.103 0.877 . . . . 0.0 114.681 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . 0.407 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.5 t-20 -173.43 -172.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.922 0 O-C-N 122.275 -0.544 . . . . 0.0 111.045 -178.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.407 ' H ' ' CG ' ' A' ' 640' ' ' ASN . 89.5 t -93.1 140.97 15.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 C-N-CA 125.921 1.688 . . . . 0.0 110.748 -173.567 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 14.6 ptpt -104.55 -23.83 13.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.564 0.697 . . . . 0.0 109.604 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -69.88 156.26 39.34 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.629 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . 0.486 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 59.5 mmtt -93.37 119.37 32.41 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.832 0.825 . . . . 0.0 110.468 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.476 HG23 ' HD2' ' A' ' 633' ' ' PRO . 77.3 p -67.6 121.68 16.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.428 -1.715 . . . . 0.0 112.034 -172.09 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.15 -26.77 25.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.314 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.697 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 43.4 mt-10 75.04 -18.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 112.663 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.33 98.21 6.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 172.673 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.556 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.7 m-85 -118.4 142.47 47.52 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -108.53 -71.07 0.71 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.787 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.512 ' HB2' HG21 ' A' ' 627' ' ' VAL . 80.6 t60 -160.48 143.25 13.2 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 54.8 m 70.14 13.52 7.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.877 0.871 . . . . 0.0 112.664 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.585 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 61.5 mm-40 -74.73 130.24 39.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.526 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.5 p -122.68 129.36 75.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.779 0.8 . . . . 0.0 112.46 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.494 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 78.8 t -118.84 136.63 55.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.197 -174.281 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.527 ' OE1' ' HE3' ' A' ' 670' ' ' LYS . 36.2 tt0 -100.62 133.63 44.78 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.631 0.729 . . . . 0.0 110.667 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.645 ' HE1' ' CE2' ' A' ' 657' ' ' TYR . 42.4 m-85 -104.81 166.11 10.61 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.445 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.641 ' HE1' ' CE2' ' A' ' 658' ' ' TYR . 35.4 p90 -130.21 151.07 51.14 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 67.2 m -100.1 154.93 18.02 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 11.2 m120 -51.89 162.33 0.8 Allowed Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 125.888 1.675 . . . . 0.0 113.707 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -18.48 40.28 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.369 2.712 . . . . 0.0 113.534 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.439 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 19.7 ptt180 -117.67 -3.71 11.26 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.728 0.775 . . . . 0.0 112.171 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.63 ' HE2' ' CE1' ' A' ' 663' ' ' PHE . 59.1 m-85 -112.87 137.91 50.51 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.119 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.528 HD22 ' HB3' ' A' ' 711' ' ' TYR . 51.8 mt -106.64 143.39 34.8 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.19 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.6 tpp -70.67 110.95 5.79 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.257 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.517 ' HB3' HG11 ' A' ' 683' ' ' VAL . 83.3 tttt -101.66 -31.75 10.66 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -75.83 -175.06 37.76 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.661 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.642 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 40.5 Cg_endo -67.36 -11.24 31.47 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.581 2.854 . . . . 0.0 113.928 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 0.9 OUTLIER 62.2 -26.72 0.06 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 127.19 2.196 . . . . 0.0 115.15 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.527 ' HE3' ' OE1' ' A' ' 656' ' ' GLU . 88.1 mttt -117.74 134.77 54.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 123.102 0.561 . . . . 0.0 110.409 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.757 HG22 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -119.49 167.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.438 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.585 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -139.55 138.68 36.48 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 123.491 0.494 . . . . 0.0 110.243 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.455 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 43.4 t -84.67 107.03 16.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.78 -173.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.414 ' HA ' ' OE1' ' A' ' 628' ' ' GLN . 16.3 p-10 -78.42 70.71 4.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.931 1.348 . . . . 0.0 112.719 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.88 -54.57 0.22 Allowed Glycine 0 N--CA 1.416 -2.67 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.455 172.641 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -159.17 -166.97 1.95 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.455 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 90.6 m95 -80.81 161.64 24.39 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.812 0.339 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -75.46 -176.13 3.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.325 0.65 . . . . 0.0 112.017 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 32.9 m -63.19 115.22 4.31 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.159 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.757 ' HG ' HG22 ' A' ' 671' ' ' ILE . 5.7 mp -71.93 155.29 92.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.26 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.726 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 51.5 Cg_endo -68.55 179.73 2.89 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.142 2.561 . . . . 0.0 115.03 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.629 HG21 HD11 ' A' ' 637' ' ' LEU . 2.2 p -136.54 137.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.319 -1.764 . . . . 0.0 106.66 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.583 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 95.3 m -111.16 133.96 53.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.75 146.39 33.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.477 HG11 ' HG2' ' A' ' 688' ' ' GLU . 10.9 p -77.91 130.86 35.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 121.291 0.567 . . . . 0.0 110.852 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.513 ' HG3' HD12 ' A' ' 664' ' ' LEU . 13.9 tt0 -57.38 -41.58 80.49 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.761 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.477 ' HG2' HG11 ' A' ' 686' ' ' VAL . 10.1 mm-40 61.77 32.85 18.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.022 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 67.1 m -150.81 165.93 32.05 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 12.9 p -125.89 162.14 25.85 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-O 122.272 1.034 . . . . 0.0 112.736 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.6 m -89.52 -11.84 41.71 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.98 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.75 -89.68 0.57 Allowed Glycine 0 CA--C 1.472 -2.65 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.598 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 t70 -164.41 -167.61 1.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.512 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -68.72 130.79 91.58 Favored Pre-proline 0 N--CA 1.412 -2.33 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.144 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.588 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 41.9 Cg_endo -71.61 179.71 4.44 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.197 2.598 . . . . 0.0 111.607 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.76 124.32 49.43 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-O 121.667 0.746 . . . . 0.0 110.694 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.909 HD21 ' HA3' ' A' ' 700' ' ' GLY . 40.7 tp -100.06 133.56 44.28 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.8 -36.92 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -133.86 18.01 3.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.572 0.701 . . . . 0.0 111.512 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.909 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -128.02 176.51 18.04 Favored Glycine 0 N--CA 1.427 -1.96 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.841 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -157.3 -151.97 0.34 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.438 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.15 158.5 43.83 Favored 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.66 -168.834 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.438 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.47 -61.67 1.39 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.439 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.592 HD12 ' HA ' ' A' ' 715' ' ' VAL . 4.0 pp -103.42 153.34 20.6 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.071 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.484 ' HB3' HD11 ' A' ' 694' ' ' ILE . 4.4 p -147.04 111.68 5.29 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.461 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 70.8 m -125.01 92.26 47.88 Favored Pre-proline 0 C--N 1.284 -2.239 0 CA-C-O 121.34 0.59 . . . . 0.0 111.747 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.3 154.97 12.54 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.697 2.265 . . . . 0.0 111.205 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.98 136.5 44.26 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.22 0.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.645 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 20.4 m-85 -82.14 101.48 10.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.639 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 3.3 m-85 -98.37 169.87 9.25 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.591 0.557 . . . . 0.0 109.76 176.782 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.629 ' HE2' ' CE1' ' A' ' 711' ' ' TYR . 4.5 t80 -54.6 138.5 41.01 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.296 175.004 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.94 42.74 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 118.894 -1.622 . . . . 0.0 113.905 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . 0.415 ' CG ' ' H ' ' A' ' 714' ' ' SER . 25.3 t0 -80.46 172.6 13.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 119.006 -1.077 . . . . 0.0 109.839 -178.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.415 ' H ' ' CG ' ' A' ' 713' ' ' ASP . 0.7 OUTLIER -128.01 158.71 37.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -173.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.592 ' HA ' HD12 ' A' ' 704' ' ' LEU . 16.1 t -142.51 138.52 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.831 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 50.7 mt-10 -95.66 122.42 38.41 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 123.406 0.441 . . . . 0.0 110.286 176.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.609 ' HD2' ' CD1' ' A' ' 717' ' ' PHE . 2.0 m-85 -99.16 154.96 17.73 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 123.78 0.832 . . . . 0.0 110.024 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.438 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 56.2 t30 -144.8 150.26 36.87 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.423 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.0 t -104.57 160.21 15.12 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 27.4 m -67.24 142.66 56.85 Favored 'General case' 0 C--O 1.205 -1.264 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.54 -18.24 64.32 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -167.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 30.1 m -81.62 -3.24 52.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.43 1.11 . . . . 0.0 109.57 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 0.539 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 77.8 m-85 -126.37 151.27 47.86 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -114.96 131.97 56.72 Favored 'General case' 0 C--N 1.265 -3.084 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.65 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -85.29 138.04 32.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.39 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 132.72 -161.14 24.0 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -101.14 174.44 6.0 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.439 0.62 . . . . 0.0 111.101 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.24 -35.97 15.88 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 5.8 m -107.08 138.0 44.09 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.958 -169.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.488 HG22 HD21 ' A' ' 741' ' ' LEU . 7.8 pt -113.44 173.75 2.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.062 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 732' ' ' THR . . . . . 0.403 ' O ' HG21 ' A' ' 739' ' ' THR . 95.7 m -138.98 137.3 36.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.522 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 46.7 t -79.5 121.78 25.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.962 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.412 HD11 ' O ' ' A' ' 733' ' ' CYS . 49.5 mm -126.88 104.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.5 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 63.11 49.11 3.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.116 1.367 . . . . 0.0 112.018 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 83.06 -4.71 79.64 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.637 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.588 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.9 m95 -67.6 165.48 16.92 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.764 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.403 HG21 ' O ' ' A' ' 732' ' ' THR . 20.4 p -44.24 -70.29 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.65 -27.24 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.488 HD21 HG22 ' A' ' 731' ' ' ILE . 17.9 mt 68.58 150.93 0.12 Allowed Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 124.598 1.159 . . . . 0.0 112.393 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.65 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 96.0 Cg_endo -78.68 -165.82 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.954 1.769 . . . . 0.0 110.361 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.9 143.64 32.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.539 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 71.5 m -93.62 151.82 19.42 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.535 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.74 145.04 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.95 127.33 32.46 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.041 0.448 . . . . 0.0 111.415 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.755 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--O 1.238 0.49 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 66.16 -168.53 0.21 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.764 0.826 . . . . 0.0 110.246 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -78.65 -71.32 0.44 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -121.8 -57.09 1.83 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -116.46 148.14 41.03 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.323 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -80.42 79.15 1.77 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.645 HG21 ' CB ' ' A' ' 651' ' ' HIS . 4.5 p -169.83 79.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.881 1.324 . . . . 0.0 110.831 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.55 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 1.9 pp0? -90.52 -151.56 0.25 Allowed 'General case' 0 C--N 1.268 -2.95 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 173.721 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 20.7 m -144.46 147.25 33.07 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 120.892 0.377 . . . . 0.0 111.172 -171.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 38.4 m -131.78 153.39 50.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.91 -135.22 8.83 Favored Glycine 0 N--CA 1.415 -2.753 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 175.652 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.428 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 52.3 Cg_exo -55.44 141.66 81.81 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.314 2.676 . . . . 0.0 112.622 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.574 ' HD2' HG23 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.15 153.75 74.58 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 123.05 2.5 . . . . 0.0 111.999 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.508 ' HG2' HD12 ' A' ' 681' ' ' LEU . 42.9 Cg_endo -70.31 -166.0 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.268 2.645 . . . . 0.0 111.941 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.99 158.96 15.93 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.28 0.562 . . . . 0.0 110.482 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.5 ' HB2' ' CD1' ' A' ' 657' ' ' TYR . 20.5 tp -102.09 139.68 37.39 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -39.38 -67.57 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 O-C-N 124.816 1.323 . . . . 0.0 112.263 178.415 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.52 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.1 t30 -106.66 -37.44 6.43 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.679 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.565 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -95.04 -147.4 22.58 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.7 t-20 -169.0 -166.42 0.63 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.372 1.086 . . . . 0.0 111.123 -178.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.07 135.36 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.669 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.6 ptpt -102.53 -10.26 19.48 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.585 0.707 . . . . 0.0 109.597 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -93.79 173.73 7.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.11 146.59 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.954 -176.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.574 HG23 ' HD2' ' A' ' 633' ' ' PRO . 18.7 p -72.88 126.77 30.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.522 ' C ' ' H ' ' A' ' 648' ' ' GLU . 41.5 mtmt -105.38 -12.2 16.13 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.057 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.428 ' HA ' ' HD3' ' A' ' 632' ' ' PRO 0.283 10.4 pt-20 58.15 -30.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 127.169 2.188 . . . . 0.0 113.782 -171.504 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.522 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.2 tt0 -98.31 95.65 7.51 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.668 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 24.2 m-85 -114.5 -82.63 0.61 Allowed 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.895 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 98.05 -166.44 22.31 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.645 ' CB ' HG21 ' A' ' 627' ' ' VAL . 77.2 t60 -77.48 142.24 39.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.756 0.278 . . . . 0.0 111.21 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 11.3 t 77.94 0.66 2.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.48 1.512 . . . . 0.0 113.38 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.576 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 29.7 mm-40 -70.51 133.68 47.01 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.596 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 18.0 t -109.63 150.29 12.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 123.557 0.535 . . . . 0.0 109.681 -176.696 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.52 HG22 ' HB3' ' A' ' 633' ' ' PRO . 25.0 t -132.97 134.85 57.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 124.038 0.935 . . . . 0.0 109.302 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -101.73 124.9 48.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.172 0.987 . . . . 0.0 111.524 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.66 ' HE2' ' CE1' ' A' ' 657' ' ' TYR . 57.3 m-85 -99.3 163.95 12.33 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.189 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.658 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 26.9 p90 -143.42 149.46 37.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.565 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.4 m -93.02 158.93 15.54 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.262 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.52 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -56.18 156.1 11.39 Favored Pre-proline 0 C--O 1.208 -1.08 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.775 176.432 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_endo -59.53 -14.36 25.36 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 123.599 2.866 . . . . 0.0 115.404 -171.53 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.454 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 16.1 ptt180 -108.03 -7.1 16.23 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.409 0.623 . . . . 0.0 111.556 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.454 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 35.4 m-85 -109.6 139.33 44.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.178 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.678 HD12 ' HB3' ' A' ' 711' ' ' TYR . 10.5 mp -99.7 142.08 31.66 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.791 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.558 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.7 tpp -71.71 117.19 12.98 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.441 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.536 ' HB3' HG21 ' A' ' 683' ' ' VAL . 13.2 tmtt? -107.01 -25.23 11.69 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.715 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -103.22 -169.54 25.93 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.197 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.55 105.6 2.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.482 2.122 . . . . 0.0 111.274 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.558 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.9 p-10 -69.74 -0.15 6.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.288 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 87.1 mttt -127.39 140.36 52.23 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.753 0.311 . . . . 0.0 110.52 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.823 HG22 HD13 ' A' ' 681' ' ' LEU . 46.0 pt -129.88 165.07 30.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.576 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 26.3 tt0 -143.15 140.43 30.8 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 123.266 0.626 . . . . 0.0 110.625 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 18.5 t -78.6 110.54 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.046 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.58 -171.1 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.533 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.55 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 8.5 p-10 -81.31 75.29 8.27 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.812 1.291 . . . . 0.0 111.475 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.481 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 158.95 -43.48 0.47 Allowed Glycine 0 N--CA 1.411 -3.016 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.644 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.11 -171.58 2.7 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -82.69 167.67 17.99 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.6 p -77.77 -172.23 2.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.917 0.389 . . . . 0.0 111.803 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.6 m -68.7 113.54 6.27 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 123.319 0.647 . . . . 0.0 111.759 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.823 HD13 HG22 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -61.77 148.63 87.01 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.78 173.535 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.49 ' HG2' HD11 ' A' ' 636' ' ' LEU . 89.4 Cg_endo -81.12 -177.22 3.56 Favored 'Trans proline' 0 CA--C 1.465 -2.929 0 C-N-CA 123.617 2.878 . . . . 0.0 112.517 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.536 HG21 ' HB3' ' A' ' 666' ' ' LYS . 14.5 m -141.37 159.76 22.27 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.798 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.288 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 73.0 m -128.63 139.7 52.13 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.3 -177.167 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.414 HG12 ' HB2' ' A' ' 666' ' ' LYS . 32.1 pt -130.75 148.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.3 p -92.26 118.13 37.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.705 1.241 . . . . 0.0 110.509 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -64.66 -43.07 94.79 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.947 174.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.906 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 30.2 tt0 67.59 8.84 6.63 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.076 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 23.9 m -98.36 139.18 34.51 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 36.8 p -113.26 168.9 9.34 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.368 0.604 . . . . 0.0 112.089 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 38.7 m -108.49 -17.0 14.09 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.787 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.57 -80.45 0.27 Allowed Glycine 0 C--N 1.295 -1.745 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.959 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.447 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 10.5 t70 -173.43 -167.0 0.36 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -69.67 135.35 88.13 Favored Pre-proline 0 N--CA 1.407 -2.603 0 C-N-CA 123.327 0.651 . . . . 0.0 110.097 174.493 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.595 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 39.4 Cg_endo -70.67 -163.44 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.605 2.87 . . . . 0.0 111.991 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.99 126.18 51.82 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.141 0.496 . . . . 0.0 109.847 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.768 HD21 ' HA3' ' A' ' 700' ' ' GLY . 29.1 tp -112.58 135.47 53.26 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -39.82 -46.31 1.93 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.998 1.319 . . . . 0.0 113.906 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 94.6 m-70 -142.39 27.87 1.7 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.768 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -132.71 167.34 23.23 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.949 -177.993 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.1 p-90 -157.15 -154.39 0.46 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.516 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.45 162.11 34.55 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.985 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.545 ' N ' HE21 ' A' ' 703' ' ' GLN . 0.0 OUTLIER -95.92 -57.23 2.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.518 0.675 . . . . 0.0 109.774 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.433 HD13 ' O ' ' A' ' 704' ' ' LEU . 3.9 pp -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.1 m -112.23 125.64 54.37 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 47.9 m -119.75 95.18 49.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-O 121.528 0.68 . . . . 0.0 112.353 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 7.0 Cg_endo -91.09 154.43 3.85 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.809 2.339 . . . . 0.0 111.964 176.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -76.39 134.94 37.83 Favored 'Cis proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.753 -1.77 . . . . 0.0 111.043 -0.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.655 ' HE2' ' CE1' ' A' ' 709' ' ' TYR . 16.2 m-85 -76.17 97.82 4.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.97 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.665 ' HE1' ' CE2' ' A' ' 710' ' ' TYR . 23.4 m-85 -102.44 174.93 5.68 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.225 0.536 . . . . 0.0 110.315 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.668 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 2.9 t80 -65.78 129.33 39.41 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.151 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.2 -7.68 60.35 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.05 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 9.5 t70 -84.49 171.29 12.66 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.533 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 3.8 m -136.72 147.39 46.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.226 0.536 . . . . 0.0 110.99 -171.785 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.465 HG12 ' CG1' ' A' ' 694' ' ' ILE . 48.3 t -138.17 144.49 30.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.379 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.429 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.0 mt-10 -101.55 131.11 47.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.599 ' HD2' ' CD1' ' A' ' 717' ' ' PHE . 2.0 m-85 -105.63 157.93 17.06 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 123.784 0.834 . . . . 0.0 109.169 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -151.83 151.13 30.91 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.531 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.4 m -98.0 157.4 16.14 Favored 'General case' 0 C--N 1.26 -3.285 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 33.5 m -52.18 150.75 4.29 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 123.479 0.487 . . . . 0.0 110.273 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -32.11 62.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 42.7 m -91.09 12.97 18.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.78 0.8 . . . . 0.0 111.409 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 81.8 m-85 -128.12 146.54 50.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 178.604 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.528 ' HB ' HD12 ' A' ' 747' ' ' ILE . 10.2 t -113.56 139.29 49.11 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.642 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 7.9 ptm -88.61 142.47 27.67 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.509 0.671 . . . . 0.0 110.97 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.419 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 53.8 mt -119.03 117.32 53.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.54 -143.64 14.77 Favored Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.61 135.13 42.53 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.813 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.62 -33.39 72.7 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.51 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.429 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.9 p -123.54 161.29 25.23 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.316 0.579 . . . . 0.0 111.676 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.549 HD13 ' CG ' ' A' ' 738' ' ' TRP . 7.0 pt -131.19 168.09 24.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.114 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 88.9 m -139.23 137.53 36.05 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.401 ' O ' HD11 ' A' ' 734' ' ' ILE . 42.0 t -78.66 120.66 23.66 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.575 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.401 HD11 ' O ' ' A' ' 733' ' ' CYS . 51.1 mm -126.37 105.97 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.304 -179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 70.29 30.54 3.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.561 1.145 . . . . 0.0 112.672 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.73 3.19 80.85 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.494 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.01 140.35 49.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.595 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -79.22 152.24 30.75 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 30.6 p -31.95 -66.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.85 -34.89 0.05 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.494 HD21 HG23 ' A' ' 731' ' ' ILE . 32.5 mt 67.98 150.69 0.12 Allowed Pre-proline 0 C--N 1.318 -0.771 0 O-C-N 125.08 1.487 . . . . 0.0 111.282 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.642 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 90.2 Cg_endo -81.55 -172.37 1.46 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.251 1.967 . . . . 0.0 110.547 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.419 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 3.8 pt20 -134.61 135.29 42.08 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.578 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.0 m -97.95 140.52 32.17 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.673 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.57 141.88 45.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.64 117.62 9.82 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.797 0.685 . . . . 0.0 111.788 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.528 HD12 ' HB ' ' A' ' 724' ' ' THR . 58.0 mt . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -129.95 9.14 5.31 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.669 -0.644 . . . . 0.0 112.189 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -9.64 40.48 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 67.83 -68.01 0.17 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.067 1.347 . . . . 0.0 111.72 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -85.51 131.77 34.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 105.82 155.56 21.75 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.603 HG21 ' CB ' ' A' ' 651' ' ' HIS . 10.0 p 44.97 50.18 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 CA-C-O 123.175 1.464 . . . . 0.0 111.108 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -47.68 -33.16 6.5 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.343 -1.753 . . . . 0.0 113.811 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.462 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 49.0 m 76.55 129.0 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.13 1.372 . . . . 0.0 114.582 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.29 166.6 12.09 Favored 'General case' 0 C--O 1.263 1.781 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.054 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.3 -130.52 7.03 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.94 147.29 91.99 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.106 2.537 . . . . 0.0 112.857 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.468 ' HB3' HG22 ' A' ' 655' ' ' VAL . 38.7 Cg_endo -65.1 160.25 42.71 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.74 2.96 . . . . 0.0 112.727 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.456 ' HG2' HD22 ' A' ' 681' ' ' LEU . 51.7 Cg_endo -74.36 -163.47 0.18 Allowed 'Trans proline' 0 C--O 1.253 1.247 0 C-N-CA 122.986 2.457 . . . . 0.0 110.133 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.45 160.24 20.87 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.749 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.55 ' HB2' ' CD1' ' A' ' 657' ' ' TYR . 19.4 tp -89.71 141.17 28.87 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.646 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.461 HD21 ' H ' ' A' ' 684' ' ' CYS . 32.7 tp -30.68 -59.59 0.2 Allowed 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.428 2.291 . . . . 0.0 113.321 172.979 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -119.56 -45.95 2.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.116 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.588 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -80.94 -154.74 11.1 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.63 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.1 -174.33 4.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.877 -0.778 . . . . 0.0 111.726 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.35 137.5 21.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 124.248 1.019 . . . . 0.0 109.108 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.635 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.3 ptpt -105.06 -7.73 18.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.66 0.743 . . . . 0.0 109.747 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.81 154.07 23.71 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.383 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 18.9 ptmt -81.44 145.8 30.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 173.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.9 p -80.57 128.41 33.57 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.355 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.469 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.3 mtmt -102.76 -14.25 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 56.13 -16.14 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 C-N-CA 127.424 2.29 . . . . 0.0 115.404 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.469 ' H ' ' C ' ' A' ' 646' ' ' LYS . 36.3 tt0 -122.6 85.56 2.44 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.661 ' HE2' ' CE1' ' A' ' 649' ' ' TYR . 6.3 m-85 -93.61 -77.35 0.45 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.611 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.462 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 117.39 -97.36 0.73 Allowed Glycine 0 C--N 1.305 -1.15 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.391 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.603 ' CB ' HG21 ' A' ' 627' ' ' VAL . 86.4 t60 -155.17 143.03 19.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 12.2 t 72.71 9.97 5.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.357 1.463 . . . . 0.0 110.778 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.525 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 20.6 mm-40 -75.94 126.5 31.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.604 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.7 m -107.03 143.49 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.389 0.614 . . . . 0.0 112.078 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 43.0 t -125.65 133.47 69.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.784 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.77 125.89 48.52 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.086 0.946 . . . . 0.0 111.043 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.67 ' HD2' ' CD1' ' A' ' 657' ' ' TYR . 61.9 m-85 -99.89 157.0 16.83 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.687 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.635 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 49.5 p90 -134.61 152.36 51.72 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.588 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.7 t -108.73 169.83 8.41 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.784 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -61.57 152.89 72.9 Favored Pre-proline 0 C--O 1.194 -1.85 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.918 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.8 16.79 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.821 3.014 . . . . 0.0 113.997 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.418 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 19.0 ptt180 -137.38 3.81 2.6 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.918 0.866 . . . . 0.0 110.049 173.201 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 1.649 ' HD2' ' CD1' ' A' ' 663' ' ' PHE . 59.7 m-85 -129.18 135.43 48.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.421 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.528 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 11.7 mt -95.44 144.64 25.79 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.957 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.567 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.1 tpp -73.39 113.71 10.79 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.175 174.046 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.551 ' HD2' HD11 ' A' ' 685' ' ' ILE . 62.1 tttm -100.59 -45.93 5.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.382 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.66 -173.77 50.01 Favored Glycine 0 C--O 1.236 0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.089 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.67 107.27 2.15 Favored 'Trans proline' 0 CA--C 1.503 -1.058 0 C-N-CA 122.812 2.341 . . . . 0.0 111.252 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.567 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -70.58 -7.77 46.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.561 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.473 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 55.9 mtmt -118.61 123.29 44.65 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 122.005 0.907 . . . . 0.0 110.388 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.604 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 50.0 pt -110.34 167.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.061 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.511 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 30.0 tt0 -138.05 137.12 37.49 Favored 'General case' 0 C--N 1.277 -2.57 0 O-C-N 123.545 0.528 . . . . 0.0 110.207 -175.561 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.85 104.98 12.61 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.8 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.85 -174.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.924 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.09 83.61 7.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.791 0.805 . . . . 0.0 110.085 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 154.22 -47.0 0.54 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.119 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.92 -172.26 2.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -88.26 168.04 13.05 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -77.95 -172.88 2.88 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.714 0.293 . . . . 0.0 111.451 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 61.9 m -73.25 114.96 12.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.874 0.845 . . . . 0.0 111.088 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.582 HD21 HG22 ' A' ' 671' ' ' ILE . 66.2 mt -57.98 145.93 70.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.527 ' HG2' HD11 ' A' ' 636' ' ' LEU . 18.0 Cg_endo -66.03 177.65 2.9 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.179 1.919 . . . . 0.0 113.273 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 146.83 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.461 ' H ' HD21 ' A' ' 637' ' ' LEU . 34.6 m -119.78 144.26 47.39 Favored 'General case' 0 C--N 1.276 -2.626 0 O-C-N 124.353 1.033 . . . . 0.0 108.34 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.551 HD11 ' HD2' ' A' ' 666' ' ' LYS . 27.8 pt -142.74 143.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.49 125.19 39.56 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.566 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -77.12 -22.42 52.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.107 -178.72 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 62.1 35.55 15.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.564 1.546 . . . . 0.0 108.755 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 689' ' ' SER . . . . . 0.46 ' HB2' ' HG2' ' A' ' 687' ' ' GLU . 16.2 m -121.19 130.55 53.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.502 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 3.7 p -102.7 149.5 24.39 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-O 121.678 0.751 . . . . 0.0 112.635 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.36 -9.84 29.09 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.83 30.64 7.84 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.492 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.679 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.9 t0 68.78 179.6 0.24 Allowed 'General case' 0 C--O 1.241 0.611 0 O-C-N 124.306 0.65 . . . . 0.0 110.241 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.603 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 3.4 mt -69.03 129.76 91.94 Favored Pre-proline 0 N--CA 1.406 -2.644 0 C-N-CA 123.354 0.662 . . . . 0.0 110.58 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.594 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -70.0 -179.52 3.08 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 123.33 2.687 . . . . 0.0 111.795 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.11 115.16 27.86 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.356 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.573 HD11 ' HA3' ' A' ' 700' ' ' GLY . 2.5 tt -90.19 137.14 32.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . 0.488 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.8 pt-20 -35.9 -43.65 0.32 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.7 1.6 . . . . 0.0 113.039 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 49.1 m80 -144.36 25.7 1.51 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.573 ' HA3' HD11 ' A' ' 697' ' ' LEU . . . -128.92 177.72 17.69 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.098 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 16.8 p-90 -161.97 -158.44 0.54 Allowed 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.233 1.413 . . . . 0.0 107.625 -176.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.524 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -140.26 156.04 46.63 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.257 -168.347 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.81 -68.0 0.82 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.865 0.728 . . . . 0.0 110.753 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.56 140.78 31.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.873 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.2 p -136.51 116.61 13.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.354 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 42.4 t -124.1 93.86 46.29 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-O 121.286 0.565 . . . . 0.0 110.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -85.7 153.04 10.18 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.806 2.337 . . . . 0.0 111.352 176.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -73.29 135.91 42.07 Favored 'Cis proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.13 0.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.679 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 28.4 m-85 -80.31 98.77 7.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.617 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 7.6 m-30 -93.65 173.35 7.73 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.951 0.782 . . . . 0.0 110.702 179.443 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.615 ' HD2' ' CD1' ' A' ' 711' ' ' TYR . 2.8 t80 -65.42 138.91 58.43 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.62 -14.15 65.86 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 118.001 -2.047 . . . . 0.0 112.693 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.64 167.2 21.97 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 117.479 0.639 . . . . 0.0 109.813 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 714' ' ' SER . . . . . 0.413 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.2 m -132.71 153.28 51.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.048 0.451 . . . . 0.0 110.172 -174.904 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.541 HG12 HG12 ' A' ' 694' ' ' ILE . 37.9 t -142.62 143.17 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.804 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -98.36 124.08 42.83 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.603 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 1.6 m-85 -104.54 167.91 9.43 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.138 0.975 . . . . 0.0 109.263 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -163.92 167.88 20.08 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.547 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.8 m -110.06 162.05 14.94 Favored 'General case' 0 C--N 1.263 -3.192 0 O-C-N 123.147 0.279 . . . . 0.0 111.172 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 32.6 t -56.83 155.19 8.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.917 0.76 . . . . 0.0 110.303 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -55.39 -44.18 75.9 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.144 0.978 . . . . 0.0 112.117 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 9.2 t -77.67 5.72 8.71 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.419 0.688 . . . . 0.0 111.852 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -130.16 156.0 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.761 0.424 . . . . 0.0 109.936 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.2 t -117.15 142.45 46.99 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.482 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -90.39 146.65 24.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.433 0.635 . . . . 0.0 111.163 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.636 HD13 HE21 ' A' ' 743' ' ' GLN . 39.5 mt -119.64 118.36 56.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.13 -157.47 16.07 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -112.46 162.24 15.82 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 117.177 0.488 . . . . 0.0 110.56 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -81.59 -33.22 31.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.41 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 24.2 p -95.0 137.15 34.44 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.505 HG22 HD21 ' A' ' 741' ' ' LEU . 10.0 pt -121.25 166.21 16.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.883 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.6 m -136.58 139.13 41.93 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.102 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . 0.436 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.3 t -78.11 120.47 22.98 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.125 0.488 . . . . 0.0 111.976 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.6 mm -128.26 110.87 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.893 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 65.81 30.25 10.15 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.602 1.161 . . . . 0.0 112.58 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.15 2.98 65.74 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.744 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.6 p -136.99 148.02 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.594 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.1 m95 -77.2 158.2 30.46 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.8 p -32.34 -72.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -176.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -28.24 0.03 OUTLIER 'General case' 0 C--O 1.243 0.713 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.505 HD21 HG22 ' A' ' 731' ' ' ILE . 17.2 mt 69.1 152.02 0.13 Allowed Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.036 1.335 . . . . 0.0 111.578 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.482 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 57.4 Cg_endo -76.11 -169.56 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.964 1.776 . . . . 0.0 109.746 173.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.636 HE21 HD13 ' A' ' 726' ' ' ILE . 9.4 pt20 -135.85 150.58 49.44 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.727 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.8 m -110.8 134.93 52.09 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 145.66 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 123.335 0.397 . . . . 0.0 110.282 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.19 113.13 3.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 124.723 1.264 . . . . 0.0 111.684 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.311 -1.105 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.502 173.007 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -129.37 144.71 51.35 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.44 -5.84 55.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.131 0.491 . . . . 0.0 111.164 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -154.3 135.29 13.84 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.074 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -131.79 91.96 3.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -72.5 72.57 0.99 Allowed Glycine 0 CA--C 1.486 -1.753 0 CA-C-N 115.067 -0.969 . . . . 0.0 115.248 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.2 p -179.95 93.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 123.052 1.406 . . . . 0.0 108.255 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.426 ' HG2' ' N ' ' A' ' 676' ' ' GLY . 2.6 pp0? -99.63 -25.29 14.46 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.856 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.404 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.8 m 72.44 123.87 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 O-C-N 124.961 1.413 . . . . 0.0 112.373 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.14 -169.97 1.55 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . 0.549 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -115.46 -138.97 6.66 Favored Glycine 0 N--CA 1.41 -3.076 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.474 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.668 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 21.3 Cg_exo -62.55 150.85 86.24 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.854 2.369 . . . . 0.0 110.88 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.7 158.8 40.15 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.555 2.17 . . . . 0.0 112.083 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.454 ' HD2' HD12 ' A' ' 671' ' ' ILE . 18.1 Cg_endo -75.53 -161.5 0.13 Allowed 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.881 2.387 . . . . 0.0 110.231 176.508 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.28 166.87 11.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.003 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.819 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.3 tt -103.55 140.58 37.33 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -36.98 -65.25 0.31 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.878 1.671 . . . . 0.0 111.676 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -108.49 -47.16 3.55 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.521 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.552 ' HA3' HD11 ' A' ' 636' ' ' LEU . . . -72.79 -155.71 3.02 Favored Glycine 0 C--O 1.242 0.639 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -171.0 0.53 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.73 132.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.416 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.503 ' HB3' ' CD2' ' A' ' 658' ' ' TYR . 18.3 pttp -102.51 -7.89 21.51 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.245 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -81.54 152.01 27.46 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.93 153.07 21.33 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 68.8 p -79.84 111.03 15.76 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.365 1.079 . . . . 0.0 112.081 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . 0.476 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 13.2 mtpp -89.17 -26.7 21.14 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.96 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.668 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 53.0 mt-10 70.26 -30.21 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.604 1.562 . . . . 0.0 111.881 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . 0.461 ' H ' ' C ' ' A' ' 646' ' ' LYS . 33.6 mt-10 -91.94 82.91 5.13 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.264 0.554 . . . . 0.0 109.922 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.637 ' HD1' ' CD2' ' A' ' 649' ' ' TYR . 16.2 m-85 -118.31 106.02 12.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.404 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -83.14 -67.92 1.45 Allowed Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.973 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -161.12 142.04 11.43 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 122.752 -0.263 . . . . 0.0 110.315 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 2.6 t 70.34 12.29 7.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 111.303 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.432 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 13.6 mm-40 -77.73 125.27 29.08 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.219 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.627 HG13 ' HB2' ' A' ' 672' ' ' GLN . 15.6 m -110.01 144.96 17.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.196 0.522 . . . . 0.0 111.657 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.429 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.0 t -123.73 136.49 60.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -105.42 128.38 53.49 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-O 121.708 0.766 . . . . 0.0 109.415 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.634 ' HD1' ' CD2' ' A' ' 657' ' ' TYR . 47.4 m-85 -99.0 163.29 12.64 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.583 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 0.503 ' CD2' ' HB3' ' A' ' 642' ' ' LYS . 45.5 p90 -133.82 155.04 50.53 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 5.8 t -101.78 163.61 12.16 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.109 -1.437 . . . . 0.0 108.863 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.28 155.51 26.2 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.789 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.26 14.53 0.22 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.601 2.867 . . . . 0.0 114.006 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.425 ' O ' HG21 ' A' ' 686' ' ' VAL . 11.8 ptt180 -137.99 -7.08 1.62 Allowed 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.403 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 32.8 m-85 -111.59 157.6 20.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.948 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.71 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.6 mp -111.11 135.59 51.41 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.163 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.527 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 54.0 tpp -71.23 119.34 15.22 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.71 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -105.26 -44.99 4.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.02 -171.98 48.36 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.506 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.419 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 36.3 Cg_endo -69.0 104.25 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.738 2.292 . . . . 0.0 111.429 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.527 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.2 p-10 -71.7 1.07 7.34 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.592 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.429 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.5 mttt -128.65 136.74 51.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.549 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.2 pt -126.48 162.1 31.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.627 ' HB2' HG13 ' A' ' 654' ' ' VAL . 28.4 tt0 -133.88 139.75 46.39 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 123.344 0.658 . . . . 0.0 110.738 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.86 102.63 12.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.93 -172.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.84 73.7 4.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.673 1.225 . . . . 0.0 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.426 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 150.28 -36.95 0.93 Allowed Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.992 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.51 -178.77 7.59 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -92.23 164.81 13.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.665 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 34.4 p -77.92 176.27 9.27 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.554 0.161 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.0 m -57.05 118.6 5.16 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.413 0.625 . . . . 0.0 112.38 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.45 HD12 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -62.1 149.32 86.85 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.745 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.819 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 55.7 Cg_endo -71.51 179.33 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.853 2.368 . . . . 0.0 113.581 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.03 141.89 45.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 5.2 m -120.24 137.47 54.2 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.264 0.352 . . . . 0.0 111.099 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.6 pt -135.73 143.82 35.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 662' ' ' ARG . 14.3 p -94.69 126.88 47.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.499 ' HG2' HD12 ' A' ' 664' ' ' LEU . 5.0 pt-20 -78.07 -17.5 56.92 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 118.844 -1.143 . . . . 0.0 109.182 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.558 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 63.8 tt0 51.22 63.25 2.32 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.102 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 50.6 m -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 7.4 p -108.05 160.51 15.74 Favored 'General case' 0 N--CA 1.411 -2.378 0 O-C-N 123.688 0.618 . . . . 0.0 111.711 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.2 m -86.84 -7.08 58.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.424 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.58 -78.38 0.64 Allowed Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.756 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.535 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 6.8 p-10 -157.57 174.47 15.31 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.663 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 2.5 mt -67.79 126.58 92.79 Favored Pre-proline 0 N--CA 1.422 -1.845 0 C-N-CA 123.694 0.797 . . . . 0.0 111.217 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.586 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -68.21 173.15 9.95 Favored 'Trans proline' 0 N--CA 1.433 -2.077 0 C-N-CA 123.186 2.59 . . . . 0.0 112.556 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.12 120.28 37.17 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.37 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.785 HD21 ' HA3' ' A' ' 700' ' ' GLY . 24.3 tp -99.72 129.34 45.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -51.14 -36.39 40.5 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 89.2 m-70 -135.35 25.54 3.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.491 0.662 . . . . 0.0 109.875 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.785 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -135.79 179.08 18.16 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.919 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -161.1 -154.83 0.38 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.888 1.675 . . . . 0.0 106.499 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.536 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.29 150.73 49.04 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.787 -169.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.524 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -88.57 -45.88 9.53 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.39 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.44 154.06 42.55 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.281 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.5 p -136.39 128.18 29.15 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.382 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 30.2 t -124.36 85.85 55.3 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-O 121.442 0.639 . . . . 0.0 109.886 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.471 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 10.9 Cg_endo -93.39 154.64 2.49 Favored 'Trans proline' 0 N--CA 1.431 -2.195 0 C-N-CA 122.994 2.463 . . . . 0.0 112.055 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 37.8 Cg_endo -67.97 133.6 22.97 Favored 'Cis proline' 0 C--O 1.235 0.364 0 C-N-CA 122.795 -1.752 . . . . 0.0 109.963 -3.362 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.535 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 39.9 m-85 -73.28 82.37 1.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -174.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.558 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 8.1 m-85 -81.77 174.3 11.47 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 122.903 0.481 . . . . 0.0 111.188 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.657 ' HE1' ' CE2' ' A' ' 711' ' ' TYR . 39.3 t80 -62.98 140.55 58.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.943 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.38 70.21 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.389 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.39 166.97 22.02 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -132.86 144.4 50.17 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.163 0.506 . . . . 0.0 110.085 -171.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.54 HG12 HG12 ' A' ' 694' ' ' ILE . 45.5 t -130.13 138.22 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.913 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.64 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.573 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.6 mt-10 -106.17 120.92 43.07 Favored 'General case' 0 N--CA 1.409 -2.511 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.223 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.663 ' CZ ' HG21 ' A' ' 694' ' ' ILE . 3.1 m-85 -96.28 160.72 14.28 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 125.082 1.353 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.524 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -148.12 143.53 27.19 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 78.4 m -88.13 158.86 18.43 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 123.59 0.556 . . . . 0.0 109.661 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.2 t -61.93 148.93 42.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.25 145.57 56.06 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 36.4 m 85.52 -5.41 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 110.144 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 1.66 ' HD2' ' CD1' ' A' ' 723' ' ' PHE . 49.7 m-85 -112.91 153.85 27.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.204 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.515 ' HB ' HD12 ' A' ' 747' ' ' ILE . 6.8 t -116.83 143.6 45.49 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.629 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 4.3 ptm -94.53 138.74 32.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.75 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.1 mt -105.9 116.97 50.77 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.149 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 105.55 -141.43 15.37 Favored Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.593 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -102.39 129.54 48.89 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.316 0.579 . . . . 0.0 110.636 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.144 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.573 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 0.2 OUTLIER -103.97 148.51 26.11 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.199 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.451 HG22 HD21 ' A' ' 741' ' ' LEU . 8.4 pt -129.6 167.75 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.1 m -138.85 136.94 36.12 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.51 106.75 3.1 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 109.867 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . 0.457 ' HA ' ' CE2' ' A' ' 711' ' ' TYR . 52.1 mm -122.61 112.18 33.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.008 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 58.31 29.74 18.54 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.711 0.804 . . . . 0.0 112.724 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.92 6.59 61.84 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.857 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.33 139.05 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.586 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -70.01 150.96 46.1 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -39.14 -75.06 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -173.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.03 -29.06 0.07 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -171.155 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.451 HD21 HG22 ' A' ' 731' ' ' ILE . 23.6 mt 68.49 156.33 0.15 Allowed Pre-proline 0 C--O 1.239 0.546 0 O-C-N 124.619 1.2 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.629 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 46.5 Cg_endo -81.84 -167.9 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.113 1.875 . . . . 0.0 111.47 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -130.21 130.22 44.37 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.7 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 21.5 m -98.8 129.17 45.19 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.208 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.89 145.73 34.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -73.81 115.09 12.84 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.608 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.515 HD12 ' HB ' ' A' ' 724' ' ' THR . 60.6 mt . . . . . 0 C--O 1.255 1.348 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -142.65 -171.78 3.5 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.11 31.0 20.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.269 0.628 . . . . 0.0 110.698 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 65.88 -78.65 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.774 1.23 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -126.61 -2.47 6.72 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.915 0.388 . . . . 0.0 110.524 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 81.16 102.75 0.34 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -172.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.591 HG23 ' CD2' ' A' ' 651' ' ' HIS . 87.4 t -153.23 90.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -90.56 0.09 Allowed 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.598 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.644 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 45.9 t 168.21 158.08 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . 0.401 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 21.0 p -168.25 149.18 4.96 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.97 -139.71 10.9 Favored Glycine 0 N--CA 1.403 -3.515 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.198 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.925 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 44.8 Cg_exo -53.16 142.07 56.61 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.65 2.9 . . . . 0.0 112.824 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.43 ' HB3' HG22 ' A' ' 655' ' ' VAL . 27.7 Cg_endo -61.01 151.34 78.97 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 123.073 2.516 . . . . 0.0 112.207 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.496 ' HG2' HD22 ' A' ' 681' ' ' LEU . 9.6 Cg_endo -63.3 179.54 0.84 Allowed 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.12 2.546 . . . . 0.0 112.722 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.1 145.73 24.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.618 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.4 tt -86.84 138.16 31.8 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.508 ' N ' HD21 ' A' ' 636' ' ' LEU . 54.0 tp -33.26 -65.63 0.17 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 126.196 1.798 . . . . 0.0 113.212 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.496 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 0.2 OUTLIER -135.77 30.98 3.08 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 123.976 1.846 . . . . 0.0 108.798 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.584 ' C ' ' HB3' ' A' ' 636' ' ' LEU . . . -139.7 -156.87 7.07 Favored Glycine 1 C--N 1.241 -4.727 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.489 173.99 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -163.74 177.81 8.38 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.021 0.928 . . . . 0.0 109.965 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.405 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.49 140.16 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 123.241 0.616 . . . . 0.0 109.788 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.403 ' HE2' ' HB3' ' A' ' 642' ' ' LYS . 9.4 ptpt -97.35 -11.98 23.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.077 0.465 . . . . 0.0 111.37 -175.058 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.16 163.97 14.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.378 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -92.77 149.94 20.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.404 HG23 ' HD2' ' A' ' 633' ' ' PRO . 56.7 p -75.32 119.14 19.02 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.007 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -80.39 -20.71 43.4 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.925 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 65.51 -3.26 0.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.411 1.484 . . . . 0.0 114.993 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -148.93 95.06 2.35 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.651 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 16.6 m-85 -95.24 -68.84 0.78 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.212 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.644 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 111.7 -94.14 0.74 Allowed Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.408 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.591 ' CD2' HG23 ' A' ' 627' ' ' VAL . 83.5 t60 -148.17 142.96 26.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.897 0.349 . . . . 0.0 110.661 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 59.7 m 69.74 11.15 7.8 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.326 1.45 . . . . 0.0 113.262 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.504 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 9.6 mm-40 -77.04 127.75 33.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.629 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.6 t -104.45 141.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 123.758 0.661 . . . . 0.0 109.409 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.449 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 42.9 t -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 123.28 0.632 . . . . 0.0 109.543 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . 0.482 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 32.2 tt0 -102.98 131.69 49.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 122.096 0.95 . . . . 0.0 112.354 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.537 ' HB3' HD11 ' A' ' 636' ' ' LEU . 63.4 m-85 -110.24 164.99 12.12 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.835 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.623 ' HD2' ' CD1' ' A' ' 658' ' ' TYR . 55.0 p90 -139.54 151.13 45.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.589 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 99.3 m -89.56 162.45 15.66 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.877 0.37 . . . . 0.0 111.311 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.92 158.72 12.03 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.265 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.29 1.11 0.73 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 124.302 3.334 . . . . 0.0 117.134 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.473 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 17.2 ptt-85 -131.98 -2.26 3.65 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.289 173.376 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -100.61 143.72 30.43 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.057 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.695 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.7 mp -100.8 140.14 35.5 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.561 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.589 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 50.9 tpp -69.63 113.74 7.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.416 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.613 ' HB3' ' HB ' ' A' ' 683' ' ' VAL . 28.3 tptp -101.65 -12.2 18.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.993 0.901 . . . . 0.0 109.499 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . 0.599 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -98.62 -171.35 31.73 Favored Glycine 0 C--N 1.293 -1.833 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.416 -177.007 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . 0.495 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 88.6 Cg_endo -80.93 -5.91 13.11 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.068 2.512 . . . . 0.0 111.515 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.478 ' HA ' ' HG3' ' A' ' 682' ' ' PRO 0.259 2.3 p-10 57.82 -6.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.9 2.48 . . . . 0.0 115.764 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.482 ' HG2' ' HA ' ' A' ' 656' ' ' GLU . 55.5 mtmt -130.92 141.84 50.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 118.283 0.492 . . . . 0.0 110.437 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.629 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.9 pt -131.76 169.87 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.897 -175.484 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.504 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.8 tt0 -137.08 140.7 42.16 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 122.843 0.457 . . . . 0.0 111.127 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 45.3 t -81.98 102.19 10.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.793 0.806 . . . . 0.0 109.689 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.99 170.16 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.73 70.95 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.841 1.256 . . . . 0.0 112.415 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 148.7 -30.81 1.25 Allowed Glycine 0 N--CA 1.405 -3.433 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.99 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.39 -177.53 3.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -86.13 174.95 8.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.579 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.3 p -89.38 -167.31 1.83 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.607 0.363 . . . . 0.0 111.419 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.4 m -65.54 112.21 3.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.044 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.496 HD22 ' HG2' ' A' ' 634' ' ' PRO . 5.3 mp -71.71 154.86 92.86 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.523 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.618 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 45.4 Cg_endo -68.09 175.95 6.0 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.433 2.089 . . . . 0.0 113.472 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.613 ' HB ' ' HB3' ' A' ' 666' ' ' LYS . 50.5 t -129.06 151.08 35.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.496 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.4 m -132.11 123.71 27.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.66 141.64 45.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.4 p -87.06 124.35 40.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.269 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.506 ' HG2' HD12 ' A' ' 664' ' ' LEU . 5.7 pt-20 -73.67 -20.77 60.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.417 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.594 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 27.3 tt0 62.21 40.21 11.85 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.056 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 17.3 m -122.68 156.78 33.66 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.2 p -115.66 145.44 42.72 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.421 0.629 . . . . 0.0 111.663 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 42.5 m -81.62 -24.44 36.39 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.158 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.99 41.47 3.29 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 113.2 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.62 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 30.4 t70 66.26 176.87 0.22 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.504 0.722 . . . . 0.0 112.498 176.366 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.568 HG12 HG13 ' A' ' 715' ' ' VAL . 2.8 mt -73.87 131.0 82.23 Favored Pre-proline 0 N--CA 1.416 -2.173 0 C-N-CA 123.942 0.897 . . . . 0.0 111.005 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.443 ' HG2' ' CZ ' ' A' ' 717' ' ' PHE . 74.1 Cg_endo -73.82 -179.61 4.75 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.943 2.429 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -119.67 116.63 26.38 Favored 'General case' 0 C--N 1.262 -3.221 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.248 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.753 HD21 ' HA3' ' A' ' 700' ' ' GLY . 47.3 tp -82.37 139.81 33.86 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -46.33 -37.3 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -135.78 22.97 3.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.076 0.465 . . . . 0.0 111.259 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.753 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -132.72 167.4 23.21 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.075 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -156.58 -152.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.113 1.365 . . . . 0.0 107.33 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.22 148.46 48.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -167.253 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.528 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.69 -42.36 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.946 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.57 160.47 35.2 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.718 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 5.6 m -148.35 117.62 6.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 59.1 m -116.1 98.4 51.2 Favored Pre-proline 0 C--N 1.28 -2.446 0 CA-C-O 121.397 0.617 . . . . 0.0 110.795 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.401 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.5 Cg_endo -93.6 151.83 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.584 0 C-N-CA 122.349 2.033 . . . . 0.0 111.389 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 71.4 Cg_endo -72.97 133.2 29.33 Favored 'Cis proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.122 -1.616 . . . . 0.0 111.444 0.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.655 ' HD1' ' CD2' ' A' ' 709' ' ' TYR . 30.9 m-85 -72.74 96.8 2.09 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.656 ' HD1' ' CD2' ' A' ' 710' ' ' TYR . 3.4 m-85 -99.42 175.09 5.97 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.695 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 6.3 t80 -62.1 141.38 58.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.75 71.83 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.685 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.43 169.6 17.95 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -134.02 149.61 51.19 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 110.384 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.568 HG13 HG12 ' A' ' 694' ' ' ILE . 43.7 t -137.9 142.21 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.593 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.81 120.31 41.9 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 0.484 ' CE1' HG21 ' A' ' 694' ' ' ILE . 1.9 m-85 -96.43 149.66 21.47 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 124.408 1.083 . . . . 0.0 110.36 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.528 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 53.1 t30 -136.4 152.3 50.47 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.741 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 46.6 t -91.86 166.31 12.8 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 48.5 t -58.42 157.59 8.6 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.254 0.549 . . . . 0.0 109.811 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.79 -35.87 82.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.506 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 15.1 m -90.82 5.42 48.48 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.204 0.525 . . . . 0.0 111.804 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -128.62 158.18 39.21 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.5 t -117.04 145.27 43.82 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.741 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.8 ptm -101.8 151.44 22.05 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.407 0.623 . . . . 0.0 110.797 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.0 mt -131.2 127.86 61.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.79 -153.46 16.63 Favored Glycine 0 CA--C 1.472 -2.614 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -98.75 119.01 36.78 Favored 'General case' 0 CA--C 1.465 -2.297 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.919 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -65.53 -27.38 68.41 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.178 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.6 p -107.91 147.73 30.59 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.344 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.511 HD13 ' CG ' ' A' ' 738' ' ' TRP . 8.4 pt -127.35 163.41 30.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.324 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 56.7 m -134.62 136.73 43.11 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.49 114.29 15.05 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.466 0.65 . . . . 0.0 111.432 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.04 97.53 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.914 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 68.05 34.14 4.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.735 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 101.19 -15.21 57.99 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.405 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.77 133.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.511 ' CG ' HD13 ' A' ' 731' ' ' ILE . 88.3 m95 -72.35 152.76 41.87 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.2 p -37.43 -66.54 0.24 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -31.01 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.484 HD21 HG22 ' A' ' 731' ' ' ILE . 21.4 mt 66.09 148.75 0.11 Allowed Pre-proline 0 C--N 1.316 -0.855 0 O-C-N 124.796 1.31 . . . . 0.0 110.992 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.13 -172.13 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.812 1.675 . . . . 0.0 110.089 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -136.94 145.07 43.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 88.2 m -102.32 153.77 19.68 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.6 144.33 27.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.82 120.7 12.4 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 123.707 0.629 . . . . 0.0 111.199 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.252 1.235 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.165 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 120.373 0.13 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -153.42 163.93 39.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -84.66 -17.55 38.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.301 0.572 . . . . 0.0 110.398 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -142.99 147.05 34.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -87.98 -10.28 50.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.661 0.743 . . . . 0.0 110.527 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 99.38 113.97 3.5 Favored Glycine 0 C--N 1.297 -1.584 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . 0.331 22.6 m 48.07 73.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 123.748 1.737 . . . . 0.0 111.492 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.458 ' CD ' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -73.68 -105.96 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 112.181 -2.281 . . . . 0.0 114.338 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.506 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 8.0 p 179.87 155.51 0.59 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.207 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 28.6 p -175.91 146.36 0.71 Allowed 'General case' 0 C--O 1.253 1.238 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.62 -132.3 7.63 Favored Glycine 0 N--CA 1.414 -2.781 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.69 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.919 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 52.9 Cg_exo -53.77 140.34 67.37 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 124.002 3.135 . . . . 0.0 113.12 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.663 ' HD2' HG23 ' A' ' 645' ' ' THR . 21.7 Cg_endo -61.97 154.24 63.14 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.575 2.183 . . . . 0.0 111.093 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.465 ' HG2' HD12 ' A' ' 681' ' ' LEU . 14.6 Cg_endo -68.02 -168.81 0.21 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 122.517 2.145 . . . . 0.0 111.872 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.08 162.44 13.37 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.538 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.623 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 28.8 tp -101.19 138.18 38.56 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.014 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.5 tm? -27.75 -64.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.584 2.353 . . . . 0.0 111.731 177.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -117.36 -40.9 3.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.874 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.536 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -79.18 -128.77 0.6 Allowed Glycine 0 CA--C 1.504 -0.627 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.599 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -173.53 -175.6 1.15 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . 0.448 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.0 p -99.5 144.64 11.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.5 ptpt -99.7 -16.72 18.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.122 0.487 . . . . 0.0 111.123 -176.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 145.11 24.94 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.38 152.08 27.65 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-O 121.833 0.825 . . . . 0.0 112.543 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.663 HG23 ' HD2' ' A' ' 633' ' ' PRO . 39.9 p -73.65 118.16 16.27 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.679 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -83.79 -22.78 31.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.001 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.919 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 32.0 mt-10 63.69 18.28 11.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.672 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -157.97 101.29 1.77 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.676 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 0.555 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 34.7 m-85 -117.45 -73.48 0.64 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.268 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.506 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.08 -88.57 0.65 Allowed Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.739 -1.22 . . . . 0.0 113.885 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -146.61 142.38 27.88 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.22 0.51 . . . . 0.0 110.793 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.3 p 68.18 11.5 8.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.884 1.674 . . . . 0.0 113.102 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.555 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 39.0 mm-40 -78.86 129.16 34.26 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.604 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.9 OUTLIER -120.11 131.14 73.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 112.111 -176.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.415 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 67.4 t -121.41 137.9 53.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.195 -171.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.37 134.03 48.27 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 122.508 1.147 . . . . 0.0 112.269 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 0.623 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.0 m-85 -109.9 164.06 12.95 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.158 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 48.9 p90 -137.97 145.72 42.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.319 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.489 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 96.3 m -91.5 153.4 19.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.536 ' OD1' ' HA2' ' A' ' 639' ' ' GLY . 4.2 m-20 -51.6 156.79 2.09 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.015 177.529 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.4 12.19 0.41 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 123.646 2.897 . . . . 0.0 112.801 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.557 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 40.4 ptt180 -133.35 0.34 3.35 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.793 0.806 . . . . 0.0 111.573 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.44 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 31.4 m-85 -125.03 150.6 46.59 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.57 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.735 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 5.9 mp -103.36 139.91 38.14 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.235 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.535 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.0 tpp -73.93 117.25 15.49 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.782 0.676 . . . . 0.0 109.206 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -101.27 -32.7 10.38 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.6 -174.98 48.84 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 114.981 -1.009 . . . . 0.0 114.1 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.36 -8.67 23.84 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 124.065 3.177 . . . . 0.0 112.854 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.535 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.0 p-10 58.48 -0.95 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.081 2.153 . . . . 0.0 115.358 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.415 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.8 mtmt -136.74 138.41 40.92 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.986 0.357 . . . . 0.0 110.495 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.475 HG22 HD11 ' A' ' 681' ' ' LEU . 44.6 pt -126.13 171.59 14.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.54 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.481 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -143.77 141.14 30.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 122.701 0.4 . . . . 0.0 109.994 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . 0.51 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 41.4 t -85.71 105.1 16.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.32 -171.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.458 ' HA ' ' CD ' ' A' ' 628' ' ' GLN . 6.0 p-10 -77.24 84.96 3.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.861 1.315 . . . . 0.0 111.614 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.01 0.31 Allowed Glycine 0 N--CA 1.4 -3.744 0 CA-C-N 111.872 -2.422 . . . . 0.0 108.343 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.62 -172.97 4.37 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . 0.51 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.6 m95 -78.42 159.68 28.16 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 41.1 p -75.82 -168.0 0.81 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.504 0.721 . . . . 0.0 112.236 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 91.8 m -77.26 116.85 18.23 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.446 0.641 . . . . 0.0 111.502 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.475 HD11 HG22 ' A' ' 671' ' ' ILE . 4.3 mm? -58.09 145.38 73.33 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.689 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.503 ' HG2' HD11 ' A' ' 636' ' ' LEU . 30.1 Cg_endo -70.31 -172.95 0.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.44 2.093 . . . . 0.0 112.503 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.26 142.41 35.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.404 ' SG ' HD22 ' A' ' 636' ' ' LEU . 70.8 m -115.78 133.01 56.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.43 139.65 51.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 123.372 0.42 . . . . 0.0 109.939 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.44 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.7 p -88.33 118.48 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.523 ' HG2' HD12 ' A' ' 664' ' ' LEU . 5.9 pt-20 -68.7 -19.3 64.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.664 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . 0.654 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 33.7 tt0 71.89 -2.28 2.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.431 1.892 . . . . 0.0 112.929 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 25.2 t -100.45 155.47 17.81 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 47.9 p -131.46 173.59 10.94 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 120.937 0.399 . . . . 0.0 111.093 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.5 m -90.86 -3.1 57.63 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.644 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 92.32 -68.94 1.84 Allowed Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.887 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.51 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.5 t70 -177.51 -167.29 0.15 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.6 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -70.1 130.86 89.29 Favored Pre-proline 0 N--CA 1.413 -2.309 0 O-C-N 123.483 0.489 . . . . 0.0 110.482 174.808 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.542 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.9 Cg_endo -75.22 -176.37 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.42 2.747 . . . . 0.0 111.879 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -104.87 125.6 51.06 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.874 HD21 ' HA3' ' A' ' 700' ' ' GLY . 21.2 tp -104.05 136.27 44.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -52.17 -34.96 47.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 84.8 m-70 -139.79 22.33 2.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.728 0.775 . . . . 0.0 110.552 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.874 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -131.24 173.38 20.4 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.205 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -157.54 -154.25 0.44 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.912 1.685 . . . . 0.0 106.845 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -141.13 158.16 44.29 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.983 -168.498 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.529 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -98.92 -56.75 2.34 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -118.96 151.64 37.81 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.0 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.0 p -123.43 160.83 26.02 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.6 t -150.41 86.82 5.02 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-O 121.496 0.665 . . . . 0.0 109.74 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . 0.468 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 12.5 Cg_endo -97.64 151.05 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.432 2.755 . . . . 0.0 113.374 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.468 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 58.2 Cg_endo -69.36 135.27 32.17 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.048 -1.647 . . . . 0.0 111.236 -0.145 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 0.51 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.0 m-85 -77.73 73.17 4.3 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.535 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 0.654 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 29.8 m-85 -84.36 176.97 8.34 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 0.735 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 20.3 t80 -62.69 139.0 58.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.971 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.37 54.88 Favored Glycine 0 C--N 1.296 -1.671 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.955 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.8 171.13 15.43 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.9 m -137.1 155.84 49.12 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.475 0.655 . . . . 0.0 110.626 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.448 HG12 ' CG1' ' A' ' 694' ' ' ILE . 36.2 t -141.33 144.86 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.068 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.531 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.1 mt-10 -109.9 128.17 55.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.376 0.607 . . . . 0.0 110.482 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.658 ' HD1' ' CD2' ' A' ' 717' ' ' PHE . 3.3 m-85 -101.07 157.12 17.0 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.334 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.529 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 66.6 t30 -147.86 141.89 25.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.552 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.9 m -87.65 157.33 19.13 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.6 m -51.7 157.29 1.18 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.437 0.46 . . . . 0.0 110.858 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.83 -29.42 69.48 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -169.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 47.3 m -89.18 6.71 38.87 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 121.603 -0.686 . . . . 0.0 111.238 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -126.3 151.26 47.75 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 724' ' ' THR . . . . . 0.43 ' HB ' HD12 ' A' ' 747' ' ' ILE . 11.1 t -119.79 145.92 46.16 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.598 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 6.5 ptm -93.3 147.28 23.06 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.337 0.589 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . 0.513 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 44.5 mt -119.75 127.57 75.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.37 -139.96 15.9 Favored Glycine 0 CA--C 1.479 -2.209 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -109.62 129.8 55.56 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.248 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -65.8 -29.49 69.99 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.277 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.531 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -107.98 149.18 28.7 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.698 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.498 HD13 ' CG ' ' A' ' 738' ' ' TRP . 7.2 pt -126.42 170.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.339 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 91.7 m -139.28 138.17 36.51 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.7 106.18 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.53 0.519 . . . . 0.0 109.649 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.52 115.82 47.13 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.619 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 42.2 m-70 60.96 19.49 9.89 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.813 1.245 . . . . 0.0 113.242 -179.713 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.74 8.0 54.87 Favored Glycine 0 C--N 1.31 -0.908 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.06 139.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.542 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.6 m95 -66.14 147.63 53.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -34.91 -71.88 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -27.9 0.05 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.479 HD21 HG22 ' A' ' 731' ' ' ILE . 19.6 mt 68.22 151.26 0.12 Allowed Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 124.51 1.131 . . . . 0.0 111.799 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.598 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 62.5 Cg_endo -80.11 -173.29 1.8 Allowed 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 122.638 2.226 . . . . 0.0 111.74 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . 0.513 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 23.6 pt20 -128.88 128.23 43.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.516 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 13.8 m -90.68 141.01 29.23 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.783 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.25 147.78 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.11 121.04 21.45 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.232 0.333 . . . . 0.0 111.214 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . 0.43 HD12 ' HB ' ' A' ' 724' ' ' THR . 58.1 mt . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -150.46 92.99 1.92 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.38 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.42 22.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.618 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -131.86 148.88 52.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.0 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -171.98 -70.12 0.04 OUTLIER Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.993 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 627' ' ' VAL . . . . . 0.661 HG23 ' CD2' ' A' ' 651' ' ' HIS . 93.5 t 58.5 82.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.336 1.065 . . . . 0.0 111.961 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 628' ' ' GLN . . . . . 0.551 ' CG ' ' HA ' ' A' ' 675' ' ' ASP . 1.3 pp0? -84.16 -147.47 0.09 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.884 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 629' ' ' SER . . . . . 0.575 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.7 m -157.56 111.76 2.62 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 122.115 -0.366 . . . . 0.0 110.794 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 22.4 p -96.24 162.74 13.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.26 -136.11 8.95 Favored Glycine 0 N--CA 1.407 -3.266 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 632' ' ' PRO . . . . . 0.81 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 33.6 Cg_exo -58.63 147.03 89.37 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.485 2.79 . . . . 0.0 112.607 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 633' ' ' PRO . . . . . 0.632 ' HD2' HG23 ' A' ' 645' ' ' THR . 23.6 Cg_endo -62.07 158.8 37.25 Favored 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 123.408 2.738 . . . . 0.0 112.512 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 634' ' ' PRO . . . . . 0.586 ' HG2' ' HH ' ' A' ' 657' ' ' TYR . 22.0 Cg_endo -67.0 -156.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.608 2.872 . . . . 0.0 111.462 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -122.58 166.0 15.54 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.221 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 636' ' ' LEU . . . . . 0.569 ' HB2' ' CD1' ' A' ' 657' ' ' TYR . 33.9 tp -103.57 141.74 35.49 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 637' ' ' LEU . . . . . 0.434 HD13 ' HB2' ' A' ' 638' ' ' ASN . 2.2 tm? -40.83 -67.26 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.013 1.446 . . . . 0.0 110.991 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 638' ' ' ASN . . . . . 0.443 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 1.3 t30 -129.13 52.5 1.96 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.16 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 639' ' ' GLY . . . . . 0.589 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -176.16 -158.1 18.93 Favored Glycine 1 C--N 1.249 -4.256 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -167.86 -168.99 1.07 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.742 1.271 . . . . 0.0 112.027 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 68.0 t -92.61 132.77 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.299 1.44 . . . . 0.0 110.022 -175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 642' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.9 ptpt -104.05 -1.88 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.282 1.039 . . . . 0.0 109.222 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.7 mm-40 -90.61 173.9 7.8 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.247 -179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -104.03 147.12 27.76 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.151 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 645' ' ' THR . . . . . 0.632 HG23 ' HD2' ' A' ' 633' ' ' PRO . 40.1 p -80.83 117.06 21.16 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.634 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -83.27 -25.97 31.11 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.637 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 647' ' ' GLU . . . . . 0.81 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 44.3 mt-10 73.01 -7.18 1.54 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.843 1.257 . . . . 0.0 113.579 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -145.73 100.73 3.46 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 649' ' ' TYR . . . . . 1.635 ' HE1' ' CE2' ' A' ' 649' ' ' TYR . 13.6 m-85 -94.74 -70.0 0.73 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.763 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 650' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.7 -111.13 1.78 Allowed Glycine 0 C--N 1.312 -0.789 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.878 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 651' ' ' HIS . . . . . 0.661 ' CD2' HG23 ' A' ' 627' ' ' VAL . 84.8 t60 -142.57 135.11 27.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.8 m 76.33 15.53 2.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.66 1.184 . . . . 0.0 111.88 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 653' ' ' GLU . . . . . 0.762 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 54.9 mm-40 -80.7 135.13 35.96 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.819 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 654' ' ' VAL . . . . . 0.519 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -114.66 151.16 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 655' ' ' VAL . . . . . 0.536 HG22 ' HB3' ' A' ' 633' ' ' PRO . 48.0 t -131.92 135.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.177 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -103.13 130.15 50.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.519 0.676 . . . . 0.0 110.785 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 657' ' ' TYR . . . . . 1.664 ' HD1' ' CD2' ' A' ' 657' ' ' TYR . 71.0 m-85 -106.77 161.4 14.7 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.844 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 658' ' ' TYR . . . . . 1.592 ' HE2' ' CE1' ' A' ' 658' ' ' TYR . 53.8 p90 -136.63 152.17 50.13 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 659' ' ' CYS . . . . . 0.589 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.2 m -97.95 169.13 9.85 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 660' ' ' ASN . . . . . 0.443 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.2 OUTLIER -58.41 157.58 17.48 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 661' ' ' PRO . . . . . 0.417 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 66.0 Cg_endo -72.04 7.6 1.66 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.778 2.985 . . . . 0.0 113.84 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 662' ' ' ARG . . . . . 0.523 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 15.7 ptt180 -120.0 -9.58 9.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.766 0.793 . . . . 0.0 110.049 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 663' ' ' PHE . . . . . 0.467 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 41.9 m-85 -119.93 161.34 21.05 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 664' ' ' LEU . . . . . 0.733 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.318 0.0 OUTLIER -130.26 141.35 50.63 Favored 'General case' 0 C--N 1.256 -3.493 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.732 179.895 . . . . . . . . 4 4 . 1 . 020 nuclear orig full ' A' A ' 665' ' ' MET . . . . . 0.525 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.7 tpp -61.65 124.54 20.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.171 -177.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 666' ' ' LYS . . . . . 0.449 ' HD2' HD11 ' A' ' 685' ' ' ILE . 63.5 tttm -106.35 -49.77 3.28 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.18 -163.52 39.02 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.951 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.87 105.27 2.05 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.601 2.2 . . . . 0.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 669' ' ' ASN . . . . . 0.525 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.7 p-10 -72.49 4.99 3.28 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.199 -173.051 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 670' ' ' LYS . . . . . 0.466 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 41.2 mtmt -132.27 128.98 38.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 671' ' ' ILE . . . . . 0.554 HG22 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -118.72 166.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 672' ' ' GLN . . . . . 0.512 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 33.1 tt0 -134.52 137.61 44.0 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 123.657 0.598 . . . . 0.0 110.606 -175.532 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.47 110.18 17.97 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.955 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.96 -168.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 675' ' ' ASP . . . . . 0.551 ' HA ' ' CG ' ' A' ' 628' ' ' GLN . 9.8 p-10 -82.78 78.87 9.32 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.849 1.309 . . . . 0.0 111.66 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 676' ' ' GLY . . . . . 0.508 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 146.45 -45.3 0.8 Allowed Glycine 0 N--CA 1.401 -3.668 0 CA-C-N 113.177 -1.829 . . . . 0.0 111.708 170.535 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.66 -168.78 3.0 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -102.0 168.4 9.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.7 p -78.67 -170.21 2.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.723 0.297 . . . . 0.0 111.194 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.1 m -71.14 112.56 7.38 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 121.267 0.556 . . . . 0.0 110.215 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 681' ' ' LEU . . . . . 0.554 ' HG ' HG22 ' A' ' 671' ' ' ILE . 5.5 mp -68.98 153.48 96.06 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.884 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 682' ' ' PRO . . . . . 0.519 ' HG2' HD11 ' A' ' 636' ' ' LEU . 75.7 Cg_endo -73.19 -176.35 2.4 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.031 2.487 . . . . 0.0 112.442 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 683' ' ' VAL . . . . . 0.448 HG11 ' HB3' ' A' ' 666' ' ' LYS . 11.2 p -145.27 146.65 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 684' ' ' CYS . . . . . 0.464 ' SG ' HD22 ' A' ' 636' ' ' LEU . 63.7 m -114.29 138.54 50.38 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 685' ' ' ILE . . . . . 0.449 HD11 ' HD2' ' A' ' 666' ' ' LYS . 21.9 pt -130.17 146.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 686' ' ' VAL . . . . . 0.512 HG21 ' O ' ' A' ' 662' ' ' ARG . 9.1 p -98.06 118.22 44.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 687' ' ' GLU . . . . . 0.475 ' HG2' HD12 ' A' ' 664' ' ' LEU . 5.3 pt-20 -85.6 -13.69 47.99 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.043 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . 0.27 12.3 pt-20 45.3 63.23 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.281 1.833 . . . . 0.0 113.922 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 8.8 t -147.38 156.84 43.26 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p -115.64 155.84 26.94 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.17 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 26.2 m -93.21 -4.5 51.88 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.912 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 104.07 -90.21 0.72 Allowed Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 693' ' ' ASP . . . . . 0.418 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 p-10 -168.65 -172.89 1.75 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.476 1.11 . . . . 0.0 108.107 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 694' ' ' ILE . . . . . 0.592 HG21 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -64.87 126.73 91.67 Favored Pre-proline 0 N--CA 1.434 -1.258 0 CA-C-O 121.555 0.693 . . . . 0.0 112.559 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 695' ' ' PRO . . . . . 0.534 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 50.6 Cg_endo -71.28 -174.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.511 2.807 . . . . 0.0 112.065 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -108.44 113.87 27.26 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.297 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 697' ' ' LEU . . . . . 0.89 HD21 ' HA3' ' A' ' 700' ' ' GLY . 20.3 tp -92.04 135.83 33.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.0 -34.37 69.94 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -137.0 18.41 3.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.856 0.836 . . . . 0.0 110.376 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 700' ' ' GLY . . . . . 0.89 ' HA3' HD21 ' A' ' 697' ' ' LEU . . . -127.32 176.33 17.88 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.746 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -158.33 -154.41 0.43 Allowed 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 702' ' ' ALA . . . . . 0.527 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.79 156.09 47.64 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 118.819 0.736 . . . . 0.0 112.611 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 703' ' ' GLN . . . . . 0.516 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.37 -59.3 1.86 Allowed 'General case' 0 CA--C 1.496 -1.131 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.494 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 704' ' ' LEU . . . . . 0.476 HD13 ' O ' ' A' ' 704' ' ' LEU . 4.3 pp -114.6 127.71 55.93 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 705' ' ' SER . . . . . 0.43 ' HB3' HD11 ' A' ' 694' ' ' ILE . 1.8 p -106.38 124.06 49.02 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.569 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.4 p -125.67 90.78 49.86 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.9 Cg_endo -90.74 150.35 4.11 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.644 2.229 . . . . 0.0 111.657 174.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 708' ' ' PRO . . . . . 0.426 ' HB2' ' CE1' ' A' ' 710' ' ' TYR . 73.1 Cg_endo -74.31 134.05 33.91 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.639 -1.817 . . . . 0.0 110.995 -1.222 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 709' ' ' TYR . . . . . 1.637 ' HE2' ' CE1' ' A' ' 709' ' ' TYR . 21.2 m-85 -77.7 82.51 4.1 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 710' ' ' TYR . . . . . 1.643 ' HE2' ' CE1' ' A' ' 710' ' ' TYR . 5.9 m-30 -87.46 166.53 14.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.257 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 711' ' ' TYR . . . . . 1.66 ' HD1' ' CD2' ' A' ' 711' ' ' TYR . 3.3 t80 -61.13 135.99 57.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.06 -22.28 41.66 Favored Glycine 0 C--N 1.296 -1.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.504 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.69 163.62 27.5 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 117.817 0.808 . . . . 0.0 109.095 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.3 m -136.41 147.91 47.51 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.122 0.487 . . . . 0.0 110.144 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 715' ' ' VAL . . . . . 0.479 ' O ' ' HA ' ' A' ' 730' ' ' SER . 33.6 t -130.59 140.46 48.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.911 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 716' ' ' GLU . . . . . 0.576 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.2 mt-10 -102.33 128.27 48.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.164 0.506 . . . . 0.0 111.029 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 717' ' ' PHE . . . . . 1.629 ' HE2' ' CE1' ' A' ' 717' ' ' PHE . 3.1 m-85 -98.45 158.46 15.57 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 124.717 1.207 . . . . 0.0 109.707 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 718' ' ' ASN . . . . . 0.516 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 4.0 t-20 -144.61 145.16 31.64 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 719' ' ' CYS . . . . . 0.511 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 96.9 m -96.25 158.06 15.61 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -57.28 150.9 16.99 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.47 -39.46 61.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -172.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.8 t -78.39 1.83 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.668 0.747 . . . . 0.0 111.149 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 723' ' ' PHE . . . . . 1.597 ' HE1' ' CE2' ' A' ' 723' ' ' PHE . 80.3 m-85 -123.59 147.96 46.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -114.43 143.0 45.64 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 725' ' ' MET . . . . . 0.509 ' HE3' ' HG3' ' A' ' 742' ' ' PRO . 8.2 ptm -92.74 141.89 27.95 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.483 0.659 . . . . 0.0 110.489 -176.367 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 44.3 mt -114.81 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 123.53 -155.77 17.66 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.031 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -95.34 136.66 35.42 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 122.283 1.039 . . . . 0.0 108.407 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -70.32 -37.1 74.65 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.291 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 730' ' ' SER . . . . . 0.576 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.5 p -102.33 138.36 39.36 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-O 122.168 0.985 . . . . 0.0 113.368 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 731' ' ' ILE . . . . . 0.515 HG23 HD21 ' A' ' 741' ' ' LEU . 10.9 pt -115.97 167.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.3 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 44.0 m -134.02 137.33 44.65 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.32 103.94 1.38 Allowed 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.882 0.739 . . . . 0.0 109.778 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.9 mm -128.49 110.59 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.084 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 68.63 21.4 7.95 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.73 18.93 39.05 Favored Glycine 0 N--CA 1.434 -1.433 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.365 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.15 154.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 738' ' ' TRP . . . . . 0.534 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.6 m95 -76.21 169.72 17.67 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 739' ' ' THR . . . . . 0.613 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 9.2 p -49.98 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 740' ' ' GLN . . . . . 0.613 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -161.54 -30.67 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.066 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 741' ' ' LEU . . . . . 0.515 HD21 HG23 ' A' ' 731' ' ' ILE . 22.2 mt 70.79 153.58 0.15 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.685 1.24 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 742' ' ' PRO . . . . . 0.509 ' HG3' ' HE3' ' A' ' 725' ' ' MET . 73.4 Cg_endo -81.8 -166.41 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.622 0 C-N-CA 121.927 1.751 . . . . 0.0 110.034 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.71 147.25 38.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 744' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 8.8 m -104.21 143.83 32.42 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.89 137.16 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.35 117.09 6.16 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 110.387 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.311 -1.091 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.523 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 30.5 p -137.83 142.11 40.79 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -94.6 -134.16 7.38 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.777 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 78.2 Cg_exo -53.56 146.54 42.64 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.818 3.012 . . . . 0.0 113.162 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 645' ' ' THR . 31.3 Cg_endo -65.71 158.07 55.44 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.537 2.158 . . . . 0.0 111.421 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.559 ' HG2' HD21 ' A' ' 681' ' ' LEU . 25.0 Cg_endo -71.79 -169.24 0.42 Allowed 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.96 2.44 . . . . 0.0 112.054 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.86 146.73 33.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 639' ' ' GLY . 2.9 tt -81.97 141.49 33.24 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -33.28 -69.83 0.08 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.859 1.663 . . . . 0.0 111.142 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 16.7 t-20 -108.81 -38.32 5.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.011 -1.075 . . . . 0.0 109.924 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -76.42 -151.28 3.71 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.166 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -169.28 179.51 3.91 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.681 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.9 p -98.92 142.6 14.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 123.312 0.645 . . . . 0.0 110.006 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.4 ptpt -97.01 -27.46 14.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.071 0.463 . . . . 0.0 110.777 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.29 142.62 35.97 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.637 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -83.56 159.47 21.65 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.398 0.618 . . . . 0.0 111.003 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 633' ' ' PRO . 21.3 p -73.42 122.81 22.7 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.759 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -96.76 -29.27 13.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.777 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 40.8 mt-10 71.47 -26.2 0.17 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 125.984 1.714 . . . . 0.0 113.041 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.17 42.21 1.09 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.041 0.536 . . . . 0.0 110.987 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.437 ' CA ' ' HG3' ' A' ' 653' ' ' GLU . 80.0 m-85 -69.85 -73.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 92.74 -68.09 1.81 Allowed Glycine 0 C--N 1.293 -1.809 0 C-N-CA 120.387 -0.911 . . . . 0.0 114.499 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -161.51 138.57 8.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 117.196 0.498 . . . . 0.0 112.168 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 26.1 m 63.9 13.86 7.92 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.904 1.681 . . . . 0.0 113.282 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 8.6 mm-40 -78.54 136.29 37.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.426 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 t -110.46 143.28 20.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 56.7 t -132.26 135.76 57.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.259 0.624 . . . . 0.0 109.866 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.92 132.48 49.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 122.174 0.987 . . . . 0.0 111.783 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.686 ' HB3' HD12 ' A' ' 636' ' ' LEU . 41.7 m-85 -108.52 166.74 10.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.596 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 45.6 p90 -137.13 160.09 39.98 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 69.6 m -98.31 169.36 9.62 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.653 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.49 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.53 165.27 3.14 Favored Pre-proline 0 C--O 1.2 -1.539 0 C-N-CA 124.329 1.052 . . . . 0.0 109.367 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 72.6 Cg_endo -75.59 12.88 1.26 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.749 2.299 . . . . 0.0 112.577 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.491 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 25.4 ptt180 -144.21 10.6 1.5 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.896 0.855 . . . . 0.0 110.041 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.491 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 45.5 m-85 -134.81 138.22 44.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.202 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 711' ' ' TYR . 11.3 mt -104.28 154.75 19.42 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.332 0.586 . . . . 0.0 110.048 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.52 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 55.0 tpp -73.52 124.61 26.2 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.022 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -110.82 -25.76 9.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.969 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.05 -172.92 46.35 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.45 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.43 -9.76 24.58 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.377 2.718 . . . . 0.0 112.345 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.503 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 8.4 p30 55.96 -0.25 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 127.6 2.36 . . . . 0.0 115.947 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 31.8 mtmt -130.24 144.36 51.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.0 pt -136.11 167.64 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 123.425 0.453 . . . . 0.0 109.897 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.8 tt0 -135.87 140.56 44.23 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 123.751 0.821 . . . . 0.0 110.461 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.8 t -85.14 99.2 10.91 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.756 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.64 165.35 2.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.307 2.2 p30 -75.5 80.51 2.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 118.426 -1.31 . . . . 0.0 113.763 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.84 -40.26 0.5 Allowed Glycine 0 N--CA 1.419 -2.451 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.249 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -165.12 175.76 9.09 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -81.55 171.2 14.95 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.691 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 23.0 p -82.89 -165.62 1.11 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.59 0.234 . . . . 0.0 111.493 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 94.8 m -66.69 111.98 3.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -69.52 154.4 94.87 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.487 175.199 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.676 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 56.0 Cg_endo -69.62 -178.76 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.502 2.134 . . . . 0.0 114.444 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.7 145.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 86.7 m -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.55 140.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.3 p . . . . . 0 C--N 1.295 -1.763 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 690' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 709' ' ' TYR . 18.7 p . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 120.978 0.418 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 8.7 m -93.27 -2.75 54.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 99.2 -87.3 0.76 Allowed Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.765 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.6 t70 -158.45 -167.56 2.2 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.618 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -73.63 133.17 80.12 Favored Pre-proline 0 N--CA 1.407 -2.615 0 C-N-CA 123.899 0.879 . . . . 0.0 109.998 175.427 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.591 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 66.9 Cg_endo -73.68 -164.89 0.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.248 2.632 . . . . 0.0 111.301 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -117.7 142.08 47.65 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 3.5 tt -117.09 137.46 52.26 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.41 ' HG2' HD23 ' A' ' 697' ' ' LEU . 14.4 pt-20 -41.69 -40.01 1.84 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 113.113 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 97.1 m-70 -145.32 29.38 1.16 Allowed 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.567 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -133.3 170.38 22.28 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.567 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -158.54 -155.41 0.48 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -136.79 152.16 49.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -167.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 9.4 mp0 -92.44 -48.95 6.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.859 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.7 pp -124.83 152.92 43.33 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 12.4 p -147.88 124.17 10.89 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.319 1.048 . . . . 0.0 109.096 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.4 t -131.78 92.0 31.8 Favored Pre-proline 0 C--N 1.289 -2.052 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.601 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.415 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.7 Cg_endo -87.16 149.47 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 122.634 2.223 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 67.6 Cg_endo -74.82 132.94 29.17 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.133 -1.611 . . . . 0.0 112.493 0.272 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.765 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 46.6 m-85 -76.48 92.38 3.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.035 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.68 166.72 21.54 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 123.548 0.53 . . . . 0.0 111.656 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.561 ' HB3' HD21 ' A' ' 664' ' ' LEU . 3.6 t80 -66.91 135.28 53.59 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.31 60.34 Favored Glycine 0 N--CA 1.402 -3.617 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.95 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.66 166.22 19.34 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.502 0.651 . . . . 0.0 110.885 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 0.9 OUTLIER -127.62 158.24 38.06 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.414 0.626 . . . . 0.0 111.157 -172.82 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.599 HG11 HG12 ' A' ' 694' ' ' ILE . 26.2 t -142.04 142.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.606 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -102.33 126.12 49.25 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 120.802 0.334 . . . . 0.0 110.102 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.6 m-85 -97.7 154.98 17.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.929 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.453 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 43.6 t-20 -137.23 135.74 37.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 95.6 m -93.48 144.24 25.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 63.1 m -56.68 161.77 2.62 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.91 140.37 55.49 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.762 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.7 m 79.12 -2.19 2.25 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 125.962 1.705 . . . . 0.0 111.712 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -116.56 140.17 49.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.947 -0.471 . . . . 0.0 110.419 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 9.2 t -108.24 141.73 39.57 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.59 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -91.03 137.98 31.95 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.23 0.538 . . . . 0.0 110.7 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.49 115.0 44.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.06 -154.38 20.24 Favored Glycine 0 CA--C 1.472 -2.623 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -94.63 130.2 41.19 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -63.19 -29.95 71.2 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.121 0.888 . . . . 0.0 111.624 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 6.0 p -113.95 152.9 30.18 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 121.602 0.715 . . . . 0.0 112.073 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 741' ' ' LEU . 7.7 pt -127.73 167.27 23.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.481 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 739' ' ' THR . 82.9 m -133.49 135.92 44.76 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.7 t -67.29 109.04 2.96 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.768 0.827 . . . . 0.0 110.471 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.6 mm -126.83 99.01 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.46 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 67.5 m80 66.56 30.07 8.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.525 1.13 . . . . 0.0 112.172 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 97.02 0.37 60.1 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.559 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.39 143.61 38.54 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.591 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -78.3 166.05 23.14 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 732' ' ' THR . 38.0 p -48.67 -69.46 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -30.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 731' ' ' ILE . 20.2 mt 67.73 148.91 0.12 Allowed Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 124.856 1.347 . . . . 0.0 111.564 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.59 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 77.7 Cg_endo -80.77 175.28 10.17 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.016 1.811 . . . . 0.0 109.693 174.893 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.88 134.93 54.87 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 4.4 m -102.47 122.72 44.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.72 149.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.55 112.62 4.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 124.161 0.913 . . . . 0.0 111.239 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 724' ' ' THR . 56.6 mt . . . . . 0 C--O 1.249 1.038 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.6 p -168.61 152.38 5.63 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.16 -138.41 9.66 Favored Glycine 1 N--CA 1.392 -4.253 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.422 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 51.0 Cg_exo -54.6 144.38 64.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.6 2.866 . . . . 0.0 112.891 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.7 Cg_endo -61.51 162.68 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.269 2.646 . . . . 0.0 112.895 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.528 ' HG2' HD21 ' A' ' 681' ' ' LEU . 32.2 Cg_endo -75.5 -165.42 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.548 2.165 . . . . 0.0 111.194 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.44 174.69 5.75 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.686 HD13 ' HG2' ' A' ' 682' ' ' PRO . 17.2 tp -109.36 144.55 37.39 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.75 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -32.66 -59.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.547 1.939 . . . . 0.0 111.784 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.3 t30 -120.2 -44.75 2.48 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.316 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -76.83 -152.79 4.89 Favored Glycine 0 CA--C 1.495 -1.19 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.393 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 658' ' ' TYR . 39.4 t30 -156.86 -178.25 7.22 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.364 -1.334 . . . . 0.0 110.152 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.26 146.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -111.0 -13.38 14.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.836 0.827 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 655' ' ' VAL . 15.6 mm-40 -79.89 134.94 36.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.635 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 644' ' ' LYS . 9.3 mmpt? -67.5 158.47 31.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.842 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 633' ' ' PRO . 65.4 p -107.11 151.09 25.84 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.318 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -99.5 -87.93 0.35 Allowed 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.933 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 12.1 pt-20 156.88 -36.21 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.434 0 C-N-CA 125.713 1.605 . . . . 0.0 107.956 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -126.07 107.87 10.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.854 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 7.7 m-85 -101.73 -72.19 0.69 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.753 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 114.85 -105.49 1.5 Allowed Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.545 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 27.2 t-80 -138.58 140.98 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.644 0.222 . . . . 0.0 110.494 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 41.3 m 72.82 15.8 4.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.006 1.322 . . . . 0.0 112.987 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.854 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 14.5 mm-40 -75.11 133.92 41.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 671' ' ' ILE 0.263 0.5 OUTLIER -125.91 134.28 66.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.824 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 53.7 t -125.14 143.38 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.136 0.974 . . . . 0.0 111.239 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 30.2 tt0 -104.62 133.49 49.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.865 0.841 . . . . 0.0 111.461 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 46.8 m-85 -105.48 166.58 10.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.415 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 640' ' ' ASN . 49.7 p90 -138.95 144.46 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 60.4 m -102.46 151.04 22.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.127 0.489 . . . . 0.0 110.183 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 15.0 m120 -52.48 159.96 1.48 Allowed Pre-proline 0 C--N 1.305 -1.358 0 C-N-CA 126.268 1.827 . . . . 0.0 114.739 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 56.6 Cg_endo -68.24 6.89 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 124.008 3.139 . . . . 0.0 113.737 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 18.7 ptt180 -140.54 -2.15 1.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.642 0.734 . . . . 0.0 111.535 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.708 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 51.9 m-85 -116.62 122.8 45.65 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.405 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 11.0 mt -85.73 142.05 29.28 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.524 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 35.8 ttm -77.96 110.34 12.8 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.105 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.682 ' HD2' HD13 ' A' ' 685' ' ' ILE . 55.5 tttm -99.3 -39.04 8.62 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.018 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.34 -153.56 9.04 Favored Glycine 0 CA--C 1.503 -0.669 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.806 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.689 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 39.9 Cg_endo -70.07 -148.84 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.229 1.953 . . . . 0.0 110.252 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.449 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 3.0 p30 -166.39 -28.31 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.888 -0.507 . . . . 0.0 110.096 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 97.3 mttt -112.75 124.15 51.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.166 176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 681' ' ' LEU . 44.5 pt -109.24 166.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.656 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -137.78 141.57 40.89 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 123.052 0.541 . . . . 0.0 110.58 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.9 t -79.51 93.47 5.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.224 1.011 . . . . 0.0 108.429 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.19 163.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.232 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.33 86.62 0.6 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.901 1.334 . . . . 0.0 111.484 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 149.64 -47.92 0.61 Allowed Glycine 0 N--CA 1.407 -3.284 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.34 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -158.36 -179.79 8.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -78.4 166.77 22.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.5 p -76.98 -174.94 3.32 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 120.998 0.428 . . . . 0.0 111.555 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 29.6 m -69.94 120.02 15.03 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.919 0.866 . . . . 0.0 111.263 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 671' ' ' ILE . 82.8 mt -66.87 146.56 99.11 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.153 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.689 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 34.8 Cg_endo -67.79 -173.87 0.53 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.051 2.501 . . . . 0.0 113.415 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.21 137.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 57.5 m -115.9 133.44 56.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.682 HD13 ' HD2' ' A' ' 666' ' ' LYS . 38.5 pt -130.27 136.57 58.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 122.917 0.487 . . . . 0.0 110.127 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.964 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.729 179.184 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.418 -2.055 0 CA-C-O 121.4 0.619 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.89 -16.32 18.06 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.446 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 109.55 -79.85 0.26 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.44 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.408 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 15.9 t70 -173.61 -169.2 0.49 Allowed 'General case' 0 C--O 1.25 1.085 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.518 HG13 HG11 ' A' ' 715' ' ' VAL . 1.1 mp -67.75 138.35 93.15 Favored Pre-proline 0 C--N 1.285 -2.211 0 C-N-CA 124.141 0.976 . . . . 0.0 110.366 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.667 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -75.41 -165.74 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.659 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -123.73 122.05 37.07 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.739 -0.6 . . . . 0.0 110.046 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.703 HD23 ' HA3' ' A' ' 700' ' ' GLY . 31.6 tp -97.54 155.26 17.03 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.619 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 7.1 pt-20 -43.4 -40.9 3.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.551 1.14 . . . . 0.0 112.188 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.619 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 20.9 m80 -136.25 -40.78 0.65 Allowed 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.878 -173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.703 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -75.65 168.27 54.79 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.479 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -150.71 -148.3 0.26 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.85 154.33 50.54 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.774 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.424 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 9.2 mp0 -90.9 -43.92 9.7 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 121.736 0.779 . . . . 0.0 109.437 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.26 149.15 45.45 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.44 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 2.4 p -117.13 146.35 43.23 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.7 t -130.81 86.63 51.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-O 121.669 0.747 . . . . 0.0 111.896 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.448 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.8 Cg_endo -92.89 147.42 2.57 Favored 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.855 2.37 . . . . 0.0 111.984 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 98.6 Cg_endo -76.9 131.26 23.7 Favored 'Cis proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.604 -1.832 . . . . 0.0 111.161 0.825 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 27.0 m-85 -73.79 94.88 2.32 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.91 172.43 7.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.492 ' CD1' HD22 ' A' ' 664' ' ' LEU . 1.1 t80 -65.92 138.11 57.62 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.47 68.74 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.266 -1.445 . . . . 0.0 112.416 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 732' ' ' THR . 23.8 t70 -76.17 165.71 24.51 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.4 m -134.24 146.08 49.74 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.199 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.518 HG11 HG13 ' A' ' 694' ' ' ILE . 40.8 t -135.58 147.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.448 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 29.5 mt-10 -111.1 127.29 55.51 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.738 176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.7 m-85 -95.58 146.65 24.3 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 65.3 t30 -124.64 133.6 53.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 50.5 t -82.69 164.79 20.48 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.4 m -69.93 152.91 43.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.51 146.19 46.98 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.7 t 83.44 -2.16 1.17 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.886 1.674 . . . . 0.0 109.7 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -121.36 148.81 43.86 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.449 ' HB ' HD11 ' A' ' 747' ' ' ILE . 8.8 t -114.39 137.15 52.18 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.796 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.1 ptm -92.33 141.83 28.11 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.223 0.535 . . . . 0.0 109.944 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.28 120.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 130.34 -147.6 18.27 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -98.53 129.37 45.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.411 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -65.92 -27.88 68.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.293 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.568 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -115.18 157.48 23.59 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.065 0.459 . . . . 0.0 111.071 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 741' ' ' LEU . 6.6 pt -130.32 166.87 26.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.118 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 85.1 m -136.31 137.06 40.27 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -75.34 119.67 19.75 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.869 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.8 mm -127.58 110.15 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 72.3 m80 70.75 26.99 3.71 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.415 1.086 . . . . 0.0 112.697 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.21 77.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.298 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.98 152.8 38.17 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.667 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 83.3 m95 -85.89 154.31 21.61 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 118.97 0.805 . . . . 0.0 109.721 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 732' ' ' THR . 31.9 p -33.56 -69.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.18 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 731' ' ' ILE . 29.9 mt 69.49 154.88 0.15 Allowed Pre-proline 0 C--N 1.322 -0.614 0 O-C-N 124.517 1.136 . . . . 0.0 111.47 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.568 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 68.7 Cg_endo -84.5 -163.71 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.407 2.071 . . . . 0.0 111.55 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 725' ' ' MET . 25.0 pt20 -139.94 155.27 47.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.45 141.59 44.81 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.931 0.396 . . . . 0.0 111.317 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.85 140.89 46.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.34 119.03 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.587 0.554 . . . . 0.0 111.446 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.449 HD11 ' HB ' ' A' ' 724' ' ' THR . 65.7 mt . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 31.5 p -164.36 135.83 4.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.12 -125.28 5.58 Favored Glycine 1 N--CA 1.386 -4.633 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.601 ' HB3' HG21 ' A' ' 645' ' ' THR . 32.4 Cg_exo -54.91 142.4 75.63 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.657 2.904 . . . . 0.0 114.232 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 645' ' ' THR . 38.1 Cg_endo -64.79 161.65 35.2 Favored 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.598 2.866 . . . . 0.0 112.239 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.514 ' HG2' HD11 ' A' ' 681' ' ' LEU . 32.6 Cg_endo -72.18 -164.15 0.17 Allowed 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 111.493 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.6 178.53 4.6 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 682' ' ' PRO . 27.6 tp -121.15 145.32 47.94 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 636' ' ' LEU . 14.0 tp -34.01 -68.66 0.11 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 126.056 1.743 . . . . 0.0 113.868 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -137.44 42.05 2.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 124.416 2.055 . . . . 0.0 107.848 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.22 -168.17 17.97 Favored Glycine 1 C--N 1.237 -4.932 0 CA-C-N 111.064 -2.789 . . . . 0.0 109.377 176.454 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -155.97 178.45 10.26 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.142 0.471 . . . . 0.0 110.483 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 90.9 t -83.41 134.23 27.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.936 0.894 . . . . 0.0 108.66 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.641 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 15.0 ptpt -92.98 -20.75 20.28 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.297 0.57 . . . . 0.0 110.651 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.27 169.31 10.69 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.243 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 27.4 mmtp -109.11 147.59 32.19 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.908 0.385 . . . . 0.0 110.398 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.674 HG22 ' HD2' ' A' ' 633' ' ' PRO . 82.8 p -76.04 140.04 41.73 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -170.392 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -96.76 -8.54 31.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.94 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.44 ' OE2' ' HG3' ' A' ' 632' ' ' PRO . 27.6 mm-40 68.06 -24.73 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.787 1.635 . . . . 0.0 113.437 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.3 mt-10 -124.89 102.93 7.78 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 31.5 m-85 -113.27 -73.61 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 102.45 -68.61 0.35 Allowed Glycine 0 C--N 1.309 -0.954 0 C-N-CA 121.016 -0.612 . . . . 0.0 114.033 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -167.28 150.3 6.27 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 79.2 p 65.56 13.3 8.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.219 1.807 . . . . 0.0 112.893 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.5 mm-40 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.829 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.0 m -116.74 145.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 20.9 t -129.39 133.21 65.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.352 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 30.3 tt0 -101.14 126.52 47.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.963 0.887 . . . . 0.0 111.597 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.556 ' HB3' HD22 ' A' ' 636' ' ' LEU . 60.6 m-85 -97.54 158.53 15.43 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.005 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.641 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.3 p90 -137.14 146.98 45.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.538 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.3 m -92.1 160.76 15.05 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -55.15 163.19 1.69 Allowed Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.03 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.35 8.43 1.82 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.759 2.972 . . . . 0.0 113.221 -173.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 15.5 ptt180 -128.07 -5.64 5.55 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.673 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 47.6 m-85 -117.81 144.17 45.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.431 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 4.8 mp -100.66 140.08 35.44 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.283 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.553 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 50.6 tpp -72.78 114.59 11.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -99.57 -34.17 10.34 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.51 -177.95 49.31 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.915 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.589 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 59.3 Cg_endo -70.71 -6.54 19.29 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 123.847 3.032 . . . . 0.0 113.734 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.295 6.8 p30 57.06 -35.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.916 2.486 . . . . 0.0 116.537 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 54.7 mtmt -103.4 135.87 44.22 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 111.477 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 681' ' ' LEU . 51.2 pt -121.35 166.37 15.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.812 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 31.2 tt0 -137.31 137.97 39.51 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 123.95 0.9 . . . . 0.0 109.676 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 45.3 t -83.0 113.99 20.96 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.63 -171.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.215 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.98 48.75 1.27 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -173.38 -42.03 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.934 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 678' ' ' TRP . 0.0 OUTLIER -166.9 -174.45 2.72 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 677' ' ' GLU . 89.7 m95 -79.76 169.08 18.46 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 679' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 672' ' ' GLN . 27.7 p -82.33 -176.0 5.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 21.0 m -60.13 114.2 2.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.197 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 671' ' ' ILE . 0.8 OUTLIER -63.08 153.82 79.73 Favored Pre-proline 0 N--CA 1.413 -2.315 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.372 177.93 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.715 ' HG2' HD13 ' A' ' 636' ' ' LEU . 36.4 Cg_endo -77.53 -176.14 3.06 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.558 2.172 . . . . 0.0 113.347 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.28 144.72 29.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.42 ' H ' HD23 ' A' ' 637' ' ' LEU . 83.3 m -119.62 136.86 54.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.69 143.31 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.4 p . . . . . 0 C--N 1.286 -2.188 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.852 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 690' ' ' THR . . . . . 0.411 HG22 ' HD1' ' A' ' 710' ' ' TYR . 61.3 p . . . . . 0 N--CA 1.413 -2.32 0 CA-C-O 121.59 0.71 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 5.4 m -90.5 6.44 43.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.155 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 85.08 -82.1 1.71 Allowed Glycine 0 CA--C 1.489 -1.581 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.498 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.721 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.3 t0 -158.34 -173.42 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.661 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.7 mt -72.97 131.33 83.92 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 123.91 0.884 . . . . 0.0 111.875 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.601 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -73.97 -168.94 0.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.627 2.884 . . . . 0.0 112.371 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.41 122.19 46.5 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.384 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.585 HD13 ' HA3' ' A' ' 700' ' ' GLY . 5.0 tt -93.84 136.62 33.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.592 ' OE2' ' HB2' ' A' ' 743' ' ' GLN . 13.2 pt-20 -48.12 -38.43 17.79 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 39.7 m80 -142.48 34.07 1.46 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.14 -170.59 12.06 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.534 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -163.32 -152.26 0.2 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.022 1.729 . . . . 0.0 107.389 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.22 156.96 45.84 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.442 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -94.92 -70.63 0.7 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.45 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -98.65 139.53 34.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.672 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.5 m -132.48 122.3 24.69 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.9 t -128.77 94.88 33.52 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 0.0 110.551 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.454 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.4 Cg_endo -89.78 152.64 5.06 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 122.351 2.034 . . . . 0.0 111.885 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 59.1 Cg_endo -71.95 134.22 32.48 Favored 'Cis proline' 0 C--O 1.24 0.618 0 C-N-CA 123.151 -1.604 . . . . 0.0 111.15 -2.016 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.721 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.6 m-85 -79.38 88.87 4.98 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.411 ' HD1' HG22 ' A' ' 690' ' ' THR . 4.8 m-30 -82.6 168.33 17.43 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.105 0.479 . . . . 0.0 111.391 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.6 t80 -60.84 133.97 56.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.88 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.7 -21.8 44.14 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.025 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.38 163.99 26.44 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-N 117.67 0.735 . . . . 0.0 110.014 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 4.8 m -125.46 161.95 25.96 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.21 0.528 . . . . 0.0 110.385 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.579 HG11 HG12 ' A' ' 694' ' ' ILE . 25.0 t -142.88 139.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.564 175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.437 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 43.0 mt-10 -101.88 123.57 46.03 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.661 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.42 158.59 15.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.442 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 18.5 t-20 -134.39 147.81 50.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 34.5 t -102.76 141.79 34.99 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 37.6 m -58.47 143.76 44.54 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.7 -33.27 68.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.6 m -82.2 4.96 21.41 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.693 -0.629 . . . . 0.0 111.339 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 97.6 m-85 -125.35 158.99 32.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 5.4 t -116.87 131.79 56.86 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.712 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.5 ptm -87.96 136.75 32.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.587 0.708 . . . . 0.0 110.283 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 55.4 mt -107.74 116.21 50.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.362 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.29 -151.19 18.54 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.44 156.04 19.9 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 32.0 ptt180 -86.08 -28.33 24.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 6.7 m -91.42 145.25 24.79 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.557 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.656 HG21 HD23 ' A' ' 741' ' ' LEU . 6.0 pt -125.61 174.07 10.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.342 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 86.7 m -141.37 136.28 31.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.29 108.79 3.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.418 0.687 . . . . 0.0 111.011 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.4 mm -123.3 104.04 13.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 121.257 0.551 . . . . 0.0 111.093 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 66.76 19.9 10.69 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.644 1.178 . . . . 0.0 112.368 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 104.14 -3.6 44.39 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.917 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.11 133.19 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.601 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -68.33 153.91 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 35.8 p -37.05 -69.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.56 -32.05 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.656 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 68.34 153.25 0.13 Allowed Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 124.753 1.283 . . . . 0.0 111.392 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.28 -173.4 1.64 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.767 1.644 . . . . 0.0 109.657 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.592 ' HB2' ' OE2' ' A' ' 698' ' ' GLU . 24.0 pt20 -134.39 153.58 51.83 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 86.7 m -117.08 134.81 54.3 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 123.309 0.38 . . . . 0.0 110.963 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.18 143.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.12 116.41 5.36 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 124.225 0.953 . . . . 0.0 110.893 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.045 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.492 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 34.8 p . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 14.0 p -171.66 142.62 1.61 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -88.52 -144.15 9.76 Favored Glycine 0 N--CA 1.396 -3.975 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.898 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.727 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 41.1 Cg_exo -54.11 148.02 41.59 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 123.788 2.992 . . . . 0.0 112.117 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.629 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.3 Cg_endo -62.76 156.05 55.79 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.578 2.186 . . . . 0.0 111.784 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.503 ' HG2' HD11 ' A' ' 681' ' ' LEU . 23.1 Cg_endo -67.76 -172.61 0.41 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 122.482 2.121 . . . . 0.0 111.038 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.16 152.96 22.78 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -89.07 134.09 34.13 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 56.7 tp -22.16 -56.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.554 2.342 . . . . 0.0 113.757 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.4 t30 -125.94 -39.64 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -71.27 -155.17 1.82 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.405 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -168.84 177.76 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.04 -0.683 . . . . 0.0 111.033 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.66 147.17 5.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 124.823 1.249 . . . . 0.0 109.05 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -109.27 -12.17 14.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.052 0.453 . . . . 0.0 111.12 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.75 165.79 13.96 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.364 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -77.7 150.8 34.44 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.308 0.575 . . . . 0.0 110.874 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.629 HG22 ' HD2' ' A' ' 633' ' ' PRO . 28.7 p -84.52 114.36 21.9 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.785 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 45.7 mtmt -86.8 -15.17 40.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.382 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.727 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.0 mt-10 65.88 -6.53 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.68 86.29 1.39 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.438 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 17.5 m-85 -83.88 -74.13 0.39 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.045 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 117.52 -104.79 1.2 Allowed Glycine 0 C--O 1.211 -1.334 0 C-N-CA 119.84 -1.172 . . . . 0.0 113.252 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -137.68 138.1 39.05 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.864 0.332 . . . . 0.0 110.337 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.5 m 69.32 16.34 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.205 . . . . 0.0 112.467 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 16.2 mm-40 -82.73 126.07 31.96 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.1 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.9 m -107.4 149.82 10.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.135 0.493 . . . . 0.0 111.881 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 45.3 t -130.65 132.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 34.4 tt0 -98.95 130.38 45.31 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 122.096 0.951 . . . . 0.0 112.236 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.72 ' HB3' HD12 ' A' ' 636' ' ' LEU . 59.4 m-85 -107.81 169.25 8.72 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.688 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -140.94 155.65 46.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 68.2 m -99.05 159.47 14.94 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.298 0.571 . . . . 0.0 110.061 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.86 157.76 28.05 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.832 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.43 -2.22 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 123.281 2.654 . . . . 0.0 115.117 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.29 -0.51 5.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.356 1.074 . . . . 0.0 110.972 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 31.1 m-85 -112.68 137.78 50.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.592 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 711' ' ' TYR . 9.8 mt -104.77 146.41 29.01 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 43.0 ttm -79.91 123.65 27.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.967 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -112.53 -34.79 5.74 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.02 -149.01 8.13 Favored Glycine 0 CA--C 1.504 -0.617 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.031 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.591 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 55.5 Cg_endo -72.93 -147.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.277 1.985 . . . . 0.0 109.361 171.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.48 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 4.9 p30 -161.45 -28.4 0.05 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 122.104 -0.373 . . . . 0.0 110.505 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.9 mtmt -115.64 134.52 54.96 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.242 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.5 pt -117.43 169.12 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.3 tt0 -137.15 139.06 40.91 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 123.338 0.398 . . . . 0.0 110.222 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.07 103.55 14.85 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.87 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.291 3.0 p-10 -77.71 80.15 4.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.004 1.383 . . . . 0.0 113.492 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 153.87 -54.33 0.44 Allowed Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.391 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.11 -171.15 3.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.53 -176.85 6.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.103 0.478 . . . . 0.0 112.009 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.7 p -97.94 -166.77 1.42 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.11 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 23.1 m -69.78 117.36 11.27 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.195 0.521 . . . . 0.0 111.362 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.503 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.6 mm? -68.66 151.08 97.44 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.414 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.591 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 71.3 Cg_endo -80.73 176.94 8.55 Favored 'Trans proline' 0 CA--C 1.474 -2.516 0 C-N-CA 123.456 2.77 . . . . 0.0 111.787 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.81 151.89 35.19 Favored 'Isoleucine or valine' 1 N--CA 1.352 -5.361 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.638 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 71.3 m -123.58 136.01 54.29 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.26 140.19 49.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.286 -2.164 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.534 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 37.6 p . . . . . 0 N--CA 1.428 -1.537 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.36 -1.47 44.41 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.366 0.667 . . . . 0.0 111.079 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 91.32 -82.15 1.26 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 27.9 t70 -159.98 178.09 10.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.602 HG12 HG11 ' A' ' 715' ' ' VAL . 3.5 mt -68.73 131.43 91.25 Favored Pre-proline 0 N--CA 1.42 -1.943 0 C-N-CA 124.454 1.101 . . . . 0.0 111.556 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.4 Cg_endo -74.14 -176.43 2.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.296 2.664 . . . . 0.0 111.24 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.57 136.75 52.47 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 121.255 0.55 . . . . 0.0 109.683 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.9 tt -109.97 142.54 41.21 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.8 pt-20 -46.19 -36.65 6.21 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 34.7 m80 -146.48 21.55 1.33 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.239 0.542 . . . . 0.0 109.889 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -127.33 175.4 18.18 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.549 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -163.26 -159.38 0.53 Allowed 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -138.58 145.92 41.18 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.613 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.65 -51.87 5.45 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.632 0.729 . . . . 0.0 109.388 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.43 150.69 32.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.074 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.1 p -137.85 127.46 25.13 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 124.391 1.076 . . . . 0.0 108.936 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.9 m -123.78 81.32 55.5 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.514 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.501 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.3 Cg_endo -91.87 144.15 2.9 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 123.111 2.541 . . . . 0.0 112.024 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.5 Cg_endo -71.89 129.01 15.65 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.006 -1.664 . . . . 0.0 111.239 -0.241 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 23.6 m-85 -74.43 94.07 2.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.223 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.08 161.15 19.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 117.923 0.328 . . . . 0.0 111.403 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.659 ' CD1' HD22 ' A' ' 664' ' ' LEU . 0.1 OUTLIER -61.16 135.07 57.64 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.77 -12.36 59.37 Favored Glycine 0 N--CA 1.403 -3.521 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.821 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -92.81 179.81 5.36 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -140.62 161.94 36.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.618 0.723 . . . . 0.0 111.783 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.602 HG11 HG12 ' A' ' 694' ' ' ILE . 20.4 t -139.21 145.15 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.146 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 35.8 mt-10 -105.82 129.2 54.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.308 0.575 . . . . 0.0 110.526 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.59 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -109.12 153.08 24.21 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.957 1.703 . . . . 0.0 108.69 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -150.4 160.41 43.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 92.2 m -96.56 156.51 16.31 Favored 'General case' 0 C--N 1.27 -2.877 0 O-C-N 123.68 0.612 . . . . 0.0 110.484 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 25.8 m -67.25 162.56 22.4 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.868 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.83 147.24 53.51 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 35.2 t 87.35 -10.97 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.57 1.948 . . . . 0.0 108.413 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 71.7 m-85 -120.97 147.01 46.06 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-O 121.399 0.619 . . . . 0.0 110.73 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.9 t -115.5 147.14 41.0 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.485 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.0 ptm -96.57 146.85 24.45 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.067 0.46 . . . . 0.0 111.001 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 29.2 mt -126.22 116.61 46.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.4 -139.65 11.12 Favored Glycine 0 CA--C 1.479 -2.181 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.987 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -111.69 131.94 54.95 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.987 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -62.69 -32.78 73.92 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 124.303 1.002 . . . . 0.0 111.699 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 32.4 p -108.54 149.35 28.97 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.886 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 12.7 pt -125.25 166.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.393 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 739' ' ' THR . 45.1 m -131.85 136.87 47.79 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 48.4 t -71.21 107.2 4.11 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.909 0.756 . . . . 0.0 109.306 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 737' ' ' VAL . 51.4 mm -127.74 108.8 18.71 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 36.8 m80 68.98 20.2 7.91 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.46 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.06 60.82 Favored Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.462 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 734' ' ' ILE . 3.5 m -122.57 150.27 26.26 Favored 'Isoleucine or valine' 1 N--CA 1.37 -4.432 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.778 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.4 m95 -83.9 153.79 23.77 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 732' ' ' THR . 37.8 p -35.71 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -175.26 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.29 -29.27 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 17.8 mt 70.2 149.61 0.12 Allowed Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 124.65 1.219 . . . . 0.0 111.863 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 61.5 Cg_endo -77.38 -178.67 4.76 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.282 1.988 . . . . 0.0 110.479 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.53 140.26 51.89 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 20.3 m -100.78 142.57 32.06 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.823 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.99 141.92 43.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.02 118.4 10.42 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 123.721 0.638 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--O 1.261 1.679 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.206 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 18.0 t . . . . . 0 N--CA 1.438 -1.043 0 CA-C-O 122.133 0.968 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.6 p -110.59 171.79 7.25 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.025 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -106.38 -132.71 7.2 Favored Glycine 0 N--CA 1.4 -3.722 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 23.5 Cg_exo -63.94 145.04 89.58 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 123.281 2.654 . . . . 0.0 112.603 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.75 157.08 49.49 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 123.158 2.572 . . . . 0.0 112.29 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.539 ' HG2' HD11 ' A' ' 681' ' ' LEU . 34.3 Cg_endo -68.8 -164.58 0.11 Allowed 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 123.192 2.595 . . . . 0.0 111.627 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.57 164.83 11.75 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.795 -0.566 . . . . 0.0 110.516 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.735 HD13 ' HG2' ' A' ' 682' ' ' PRO . 31.9 tp -104.13 147.74 27.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 636' ' ' LEU . 6.0 tt -35.54 -65.8 0.22 Allowed 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 127.503 2.321 . . . . 0.0 111.286 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -115.7 -43.44 3.02 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.38 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -88.54 -146.01 11.9 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -165.37 -170.51 1.89 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.204 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.5 p -101.23 143.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 123.691 0.796 . . . . 0.0 110.575 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.1 ptpt -101.34 -16.67 16.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.344 0.592 . . . . 0.0 110.515 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -81.75 128.71 34.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.351 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 150.85 48.67 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.559 0.695 . . . . 0.0 111.997 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 31.8 p -76.5 124.96 28.38 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.832 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 648' ' ' GLU . 47.5 mtmt -99.82 -12.28 20.03 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.105 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 43.4 mt-10 67.92 -12.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.11 1.364 . . . . 0.0 113.841 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.1 tt0 -148.91 108.49 3.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.834 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 4.5 m-85 -105.75 -65.85 1.03 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 127.81 -117.55 2.65 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -138.38 157.32 46.46 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.6 p 62.59 12.16 5.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.408 1.483 . . . . 0.0 113.104 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.834 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 9.0 mm-40 -76.5 136.64 39.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.297 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 t -112.27 139.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 9.7 t -126.3 137.7 56.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 123.679 0.792 . . . . 0.0 109.585 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.5 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 32.8 tt0 -109.15 127.49 54.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.818 0.818 . . . . 0.0 111.342 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 64.8 m-85 -97.45 164.32 12.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.288 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 31.6 p90 -135.4 149.48 49.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.501 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.3 m -95.52 160.03 14.71 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.21 155.33 9.31 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.888 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.05 11.01 0.34 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 123.388 2.725 . . . . 0.0 113.3 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.721 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 22.0 ptt180 -126.51 -6.48 6.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.858 0.837 . . . . 0.0 111.37 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.415 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 40.4 m-85 -122.36 146.45 47.31 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.514 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 711' ' ' TYR . 6.4 mp -105.14 146.45 29.17 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.983 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.4 tpp -75.07 116.89 16.31 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.489 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 685' ' ' ILE . 63.8 tttm -102.45 -37.51 7.98 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.339 0.59 . . . . 0.0 110.62 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.73 -172.25 42.43 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.374 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.6 108.87 2.65 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.312 2.008 . . . . 0.0 110.49 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 24.5 p-10 -71.96 -10.24 59.5 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.309 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 35.7 mtmt -114.92 129.45 56.71 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.351 0.596 . . . . 0.0 110.69 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.707 HG21 HD12 ' A' ' 681' ' ' LEU . 48.5 pt -124.72 165.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.878 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.5 tt0 -137.53 139.83 40.72 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.092 0.557 . . . . 0.0 110.381 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.43 105.88 14.73 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.81 -171.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.42 77.97 1.9 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.084 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.4 -39.3 1.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.359 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.92 -179.53 7.08 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 122.634 -0.333 . . . . 0.0 110.281 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.81 161.62 15.2 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.1 p -71.74 -170.36 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.339 0.59 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 18.9 m -69.21 112.75 6.0 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.939 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.707 HD12 HG21 ' A' ' 671' ' ' ILE . 1.8 mp -61.19 149.86 81.13 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.508 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 636' ' ' LEU . 37.2 Cg_endo -75.65 -173.49 1.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.249 2.632 . . . . 0.0 114.414 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.2 t -140.18 138.79 37.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 81.0 m -111.55 136.72 50.35 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.501 HG21 ' HD2' ' A' ' 666' ' ' LYS . 30.1 pt -132.83 139.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 123.536 0.523 . . . . 0.0 110.047 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.285 -2.205 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.638 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.414 -2.274 0 CA-C-O 121.83 0.824 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.3 m -91.21 -8.66 47.87 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.734 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.86 -73.41 1.17 Allowed Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.802 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.542 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.8 t70 -176.38 -171.45 0.41 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.637 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -66.35 132.08 94.33 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 123.926 0.89 . . . . 0.0 110.509 175.729 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.636 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.8 Cg_endo -73.72 -176.82 2.75 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 123.725 2.95 . . . . 0.0 112.066 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.65 126.71 49.84 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.831 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 698' ' ' GLU . 3.8 tt -108.05 136.87 47.02 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.599 ' HG2' HD23 ' A' ' 697' ' ' LEU . 13.8 pt-20 -39.72 -42.82 1.3 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.712 1.605 . . . . 0.0 112.901 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 43.9 m80 -145.36 29.29 1.16 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -176.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.9 168.65 25.22 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.779 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -154.53 -153.93 0.48 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 125.636 1.574 . . . . 0.0 106.835 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.68 158.66 43.84 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.631 -167.265 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.543 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -99.22 -55.34 2.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.988 -178.953 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.68 143.1 48.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.9 m -130.21 137.33 50.0 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 29.6 t -127.44 92.4 43.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 121.666 -0.646 . . . . 0.0 112.47 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.2 Cg_endo -93.15 144.58 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 C-N-CA 122.865 2.377 . . . . 0.0 112.054 174.013 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 97.3 Cg_endo -74.22 132.24 26.45 Favored 'Cis proline' 0 C--O 1.248 1.012 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.001 0.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -75.12 98.08 3.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.721 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 26.7 m-85 -100.99 -177.31 3.42 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.46 0.648 . . . . 0.0 111.277 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 664' ' ' LEU . 11.4 t80 -70.61 135.14 48.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.209 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.4 0.86 81.92 Favored Glycine 0 C--N 1.291 -1.965 0 CA-C-N 115.535 -0.757 . . . . 0.0 113.788 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.88 173.16 12.5 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -136.76 143.83 43.47 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.872 0.368 . . . . 0.0 110.207 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.494 HG11 HG13 ' A' ' 694' ' ' ILE . 39.9 t -136.93 140.28 43.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.224 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 50.6 mt-10 -103.48 122.92 45.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.637 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.9 m-85 -97.79 152.16 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 124.199 1.0 . . . . 0.0 111.512 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.543 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.2 t30 -138.23 147.79 44.1 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 725' ' ' MET . 90.1 m -98.24 160.84 14.03 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 720' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 723' ' ' PHE . 60.1 m -56.62 147.15 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.12 -28.05 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.368 0.667 . . . . 0.0 111.858 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 6.9 m -80.81 -2.38 46.97 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.201 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 720' ' ' SER . 83.7 m-85 -124.8 151.63 44.93 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 10.4 t -112.86 140.14 47.91 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.504 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 0.8 OUTLIER -87.05 128.88 35.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.459 0.647 . . . . 0.0 112.154 -176.109 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.423 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 38.1 mt -106.2 99.59 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 135.79 -155.99 22.59 Favored Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -112.23 168.15 9.85 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 123.79 0.347 . . . . 0.0 110.489 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 716' ' ' GLU . 18.2 ptt180 -82.1 -37.78 25.8 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.6 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.8 p -99.34 132.24 44.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -170.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.668 HG21 HD23 ' A' ' 741' ' ' LEU . 8.3 pt -112.28 169.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.768 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 27.6 m -136.01 139.82 43.41 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 44.4 t -82.03 118.63 23.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.626 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -125.8 104.45 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.145 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 73.9 m80 71.58 33.59 1.8 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.925 0.89 . . . . 0.0 112.41 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.16 -8.77 79.08 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.922 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.3 m -118.25 148.39 21.12 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.707 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.636 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 87.4 m95 -86.81 152.46 22.46 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.4 p -33.02 -71.39 0.06 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.42 -30.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.668 HD23 HG21 ' A' ' 731' ' ' ILE . 17.5 mt 67.91 147.23 0.11 Allowed Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 124.92 1.388 . . . . 0.0 111.816 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.431 ' HG2' HD11 ' A' ' 697' ' ' LEU . 60.2 Cg_endo -76.73 -179.65 5.58 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.217 1.945 . . . . 0.0 110.683 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 20.2 pt20 -123.12 129.73 51.84 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.7 m -100.76 120.52 40.22 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.5 151.18 17.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 123.509 0.506 . . . . 0.0 109.926 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.78 114.36 4.98 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 124.311 1.007 . . . . 0.0 110.71 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.608 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 121.156 0.503 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 10.2 p -142.05 -170.96 3.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -122.6 -136.24 4.82 Favored Glycine 0 N--CA 1.402 -3.588 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.598 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 25.1 Cg_exo -61.26 142.19 95.48 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 122.45 2.1 . . . . 0.0 111.411 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 645' ' ' THR . 18.6 Cg_endo -58.72 154.49 42.95 Favored 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.929 2.419 . . . . 0.0 111.849 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.5 Cg_endo -65.08 -167.23 0.1 OUTLIER 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.042 2.494 . . . . 0.0 111.546 176.075 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.43 159.79 17.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.104 -1.039 . . . . 0.0 109.709 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.651 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.7 tp -95.96 140.89 30.05 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.651 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.9 tt -32.74 -62.16 0.25 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.258 2.223 . . . . 0.0 111.556 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 660' ' ' ASN . 19.7 t-20 -123.2 -33.97 3.21 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.831 -178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -90.14 -142.94 10.0 Favored Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.727 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.63 -173.34 2.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 117.563 0.681 . . . . 0.0 109.577 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.4 p -101.82 131.05 50.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 123.746 0.818 . . . . 0.0 109.815 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.485 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 7.7 ptpt -91.75 -13.03 32.26 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.54 0.686 . . . . 0.0 109.563 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 10.5 mm-40 -76.67 144.2 39.57 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.991 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -66.77 152.2 45.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.558 HG22 ' HD2' ' A' ' 633' ' ' PRO . 37.1 p -95.01 120.05 34.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.241 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.99 -20.73 32.31 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.058 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 35.5 mt-10 70.22 -13.77 0.42 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.265 1.426 . . . . 0.0 113.105 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -132.49 103.49 6.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.449 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.8 m-85 -116.36 -173.51 2.38 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 653' ' ' GLU . . . -156.18 -155.91 7.6 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -78.02 135.79 37.83 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 120.528 0.204 . . . . 0.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 23.5 m 75.23 18.11 2.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.579 1.152 . . . . 0.0 112.903 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 650' ' ' GLY . 11.1 mm-40 -84.98 130.87 34.55 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 672' ' ' GLN . 12.9 m -111.89 147.65 15.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.819 0.819 . . . . 0.0 112.995 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.5 t -128.12 135.11 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.775 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.628 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 40.2 tt0 -107.26 132.32 53.22 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.07 0.938 . . . . 0.0 111.393 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 68.3 m-85 -106.44 166.37 10.59 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.069 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.485 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 46.0 p90 -140.0 151.47 45.51 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.773 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 91.4 m -96.46 162.1 13.63 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.5 OUTLIER -54.78 152.99 11.87 Favored Pre-proline 0 C--O 1.216 -0.668 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.346 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.534 ' HB2' ' OD2' ' A' ' 713' ' ' ASP . 64.5 Cg_endo -66.14 1.91 2.14 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.676 2.917 . . . . 0.0 114.995 -171.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -119.97 -4.73 10.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.837 0.827 . . . . 0.0 111.044 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 32.4 m-85 -115.11 142.42 46.68 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.241 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.98 140.27 33.38 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.644 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.1 tpp -70.64 109.76 5.09 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.697 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.561 ' HD2' HD13 ' A' ' 685' ' ' ILE . 61.7 tttm -96.14 -34.47 11.67 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.581 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.64 -172.98 39.37 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.917 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.75 -4.91 15.85 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.359 2.706 . . . . 0.0 113.419 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.653 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 7.1 p30 52.11 3.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 127.339 2.255 . . . . 0.0 115.864 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 85.9 mttt -137.81 137.26 38.0 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.586 HG21 ' HG ' ' A' ' 681' ' ' LEU . 42.3 pt -129.09 166.26 27.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.508 ' HB2' HG12 ' A' ' 654' ' ' VAL . 29.1 tt0 -137.41 139.89 40.98 Favored 'General case' 0 C--N 1.28 -2.44 0 O-C-N 123.717 0.635 . . . . 0.0 109.334 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.6 t -85.01 108.16 17.48 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.83 -166.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.29 58.76 2.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.976 0.893 . . . . 0.0 112.188 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 166.12 -38.39 0.26 Allowed Glycine 0 N--CA 1.415 -2.73 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.415 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -160.69 -178.53 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -85.46 158.29 20.23 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 40.6 p -76.87 -174.72 3.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 41.7 m -60.06 114.79 3.03 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.341 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -73.12 151.13 90.27 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.653 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 91.2 Cg_endo -74.1 178.32 7.07 Favored 'Trans proline' 0 CA--C 1.468 -2.803 0 C-N-CA 123.626 2.884 . . . . 0.0 113.032 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.9 m -139.11 163.25 26.94 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.293 -175.094 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 82.4 m -129.11 142.35 50.91 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.561 HD13 ' HD2' ' A' ' 666' ' ' LYS . 25.9 pt -134.77 148.59 29.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.292 -1.912 0 CA-C-O 122.673 1.225 . . . . 0.0 111.573 -178.469 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 690' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 710' ' ' TYR . 26.0 p . . . . . 0 N--CA 1.439 -0.996 0 CA-C-O 120.578 0.228 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.59 -21.38 28.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 110.63 -78.95 0.25 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.645 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.8 t0 -162.6 -168.01 1.71 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.632 HG12 HG11 ' A' ' 715' ' ' VAL . 2.9 mt -77.81 132.31 68.38 Favored Pre-proline 0 C--N 1.282 -2.339 0 C-N-CA 125.11 1.364 . . . . 0.0 111.079 176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 69.7 Cg_endo -72.94 -169.04 0.45 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.39 2.727 . . . . 0.0 111.584 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.11 136.04 53.55 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.7 HD23 ' HA3' ' A' ' 700' ' ' GLY . 26.4 tp -116.2 145.21 43.29 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.5 pt-20 -45.33 -45.35 12.3 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.4 m80 -142.97 27.38 1.63 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.743 0.782 . . . . 0.0 109.055 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.7 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.27 168.28 24.13 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.799 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -156.14 -151.49 0.34 Allowed 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.46 144.7 46.57 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.095 -168.819 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.556 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 9.6 mp0 -83.58 -59.78 2.33 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.604 0.716 . . . . 0.0 109.301 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.41 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.0 pp -115.97 139.87 49.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.456 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 707' ' ' PRO . 12.9 m -118.16 122.85 44.09 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 6.0 m -115.44 87.03 15.91 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.511 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 705' ' ' SER . 12.8 Cg_endo -95.86 150.75 1.4 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 123.07 2.513 . . . . 0.0 112.805 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 56.5 Cg_endo -70.9 130.61 18.34 Favored 'Cis proline' 0 C--O 1.237 0.472 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.047 -1.582 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.645 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 18.5 m-85 -75.43 91.44 2.75 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 690' ' ' THR . 9.3 m-85 -85.26 170.22 13.02 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 122.542 0.337 . . . . 0.0 111.427 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.41 132.5 52.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.19 69.74 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.041 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 661' ' ' PRO . 3.8 t70 -75.97 173.27 11.44 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 714' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.0 OUTLIER -139.72 147.44 40.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.51 0.671 . . . . 0.0 110.912 -173.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 694' ' ' ILE . 38.8 t -138.32 142.95 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.219 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 43.6 mt-10 -110.36 121.43 45.28 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.501 0.667 . . . . 0.0 110.464 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.6 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -92.9 147.54 22.76 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 125.163 1.385 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.556 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.8 t30 -129.33 130.86 46.65 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.1 m -88.28 143.37 27.06 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 28.9 m -50.95 139.8 16.65 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 123.647 0.592 . . . . 0.0 109.504 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -49.97 -35.7 25.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.8 m -76.61 0.19 21.06 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.787 0.803 . . . . 0.0 111.655 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -117.99 147.94 42.7 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.462 ' HB ' HG12 ' A' ' 747' ' ' ILE . 9.3 t -109.38 138.29 45.96 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.661 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 2.6 ptm -90.04 135.47 33.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.259 0.552 . . . . 0.0 110.672 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.446 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 43.7 mt -115.37 113.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.67 -156.27 16.09 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -109.89 139.64 44.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.684 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -61.27 -35.11 76.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.887 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 12.9 p -94.56 148.53 22.16 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.937 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.664 HG21 HD23 ' A' ' 741' ' ' LEU . 9.0 pt -131.19 165.45 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.546 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 739' ' ' THR . 36.2 m -132.64 134.26 44.64 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.48 111.73 6.23 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.815 0.446 . . . . 0.0 111.375 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.5 110.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 52.2 m80 68.73 13.31 8.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.667 1.187 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.79 2.79 46.27 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.316 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.73 130.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 84.8 m95 -63.32 156.86 24.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 732' ' ' THR . 25.2 p -37.87 -71.69 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -26.89 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.664 HD23 HG21 ' A' ' 731' ' ' ILE . 20.8 mt 69.42 153.33 0.14 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 111.908 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 67.3 Cg_endo -81.61 -168.65 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.642 2.228 . . . . 0.0 111.589 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.446 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 27.9 pt20 -131.93 137.31 47.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.3 m -110.15 121.15 44.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.32 146.31 25.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.31 117.73 7.03 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.407 0.442 . . . . 0.0 110.566 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.462 HG12 ' HB ' ' A' ' 724' ' ' THR . 68.7 mt . . . . . 0 C--O 1.252 1.213 0 O-C-N 124.398 1.061 . . . . 0.0 110.782 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 629' ' ' SER . . . . . 1.009 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.1 m . . . . . 0 C--O 1.238 0.492 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 27.4 p -120.55 154.8 34.86 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.32 -136.84 9.05 Favored Glycine 0 N--CA 1.413 -2.872 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.602 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.987 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 35.1 Cg_exo -56.35 148.74 59.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.077 3.185 . . . . 0.0 114.135 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 655' ' ' VAL . 29.6 Cg_endo -64.8 153.14 79.37 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 122.877 2.385 . . . . 0.0 112.468 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.538 ' HG2' HD21 ' A' ' 681' ' ' LEU . 20.9 Cg_endo -67.95 -170.76 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 123.288 2.659 . . . . 0.0 112.249 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -109.65 144.47 37.96 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.0 tp -84.01 147.17 27.58 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.6 tm? -34.37 -66.17 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.809 1.644 . . . . 0.0 111.152 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -110.63 -51.77 2.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.109 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -81.48 -147.56 5.86 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.535 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.6 t-20 -166.4 -167.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.928 0.864 . . . . 0.0 110.592 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 655' ' ' VAL . 83.7 t -90.32 133.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 125.53 1.532 . . . . 0.0 109.425 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.0 ptpt -94.05 -12.08 29.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.683 0.754 . . . . 0.0 109.971 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 158.07 18.88 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.676 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -88.18 165.43 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.432 ' HB ' ' HG3' ' A' ' 647' ' ' GLU . 38.0 p -82.49 118.02 22.93 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-O 121.319 0.581 . . . . 0.0 110.628 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -86.83 -29.31 22.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.987 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.8 mt-10 67.13 -3.68 0.95 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.678 1.591 . . . . 0.0 113.441 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.85 82.78 2.0 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.59 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 16.2 m-85 -95.08 -72.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.104 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 1.009 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.77 -71.82 0.27 Allowed Glycine 0 C--N 1.295 -1.73 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.844 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.9 145.3 6.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 78.4 p 62.48 14.63 7.14 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.313 1.845 . . . . 0.0 113.019 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 16.1 mm-40 -83.71 142.07 30.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.173 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 14.7 m -120.81 153.7 24.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.274 0.559 . . . . 0.0 111.744 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.6 t -135.03 134.44 53.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.154 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -100.76 128.68 46.71 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 121.942 0.877 . . . . 0.0 110.8 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 56.8 m-85 -100.94 157.44 16.74 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.942 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.55 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.1 p90 -133.21 151.0 51.95 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 98.9 m -94.19 154.31 17.63 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 171.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -49.97 156.43 1.31 Allowed Pre-proline 0 C--O 1.193 -1.881 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.54 -30.53 12.22 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 123.883 3.055 . . . . 0.0 114.052 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 41.1 ptt180 -97.6 -9.96 25.99 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 55.6 m-85 -111.8 150.31 30.51 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.933 0.873 . . . . 0.0 112.531 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 711' ' ' TYR . 11.0 mp -112.61 151.09 30.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.412 0.625 . . . . 0.0 110.99 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.626 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.1 tpp -76.93 127.99 33.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.048 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 61.5 tttp -112.35 -45.14 3.29 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.088 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.05 -171.57 47.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.353 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.49 104.04 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.847 2.364 . . . . 0.0 111.374 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 6.3 p30 -72.47 6.18 2.53 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.663 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 91.6 mttt -132.97 136.19 45.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.471 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.4 pt -122.75 167.37 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -135.06 139.2 44.58 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.671 0.607 . . . . 0.0 110.971 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 48.5 t -82.03 104.13 12.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.381 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.22 171.24 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -75.64 72.35 2.58 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.6 1.19 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 160.58 -41.73 0.43 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.742 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.5 179.48 7.74 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -90.44 169.95 10.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.6 p -84.19 -168.32 2.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 123.14 0.576 . . . . 0.0 112.238 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 48.1 m -69.85 113.34 6.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.053 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 634' ' ' PRO . 7.2 mp -69.88 153.59 95.36 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.913 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 43.2 Cg_endo -70.88 -167.09 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.997 2.465 . . . . 0.0 113.523 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 14.4 p -150.59 149.55 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 73.3 m -116.27 143.66 45.23 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.461 0.475 . . . . 0.0 110.503 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.42 HD13 ' HD2' ' A' ' 666' ' ' LYS . 28.4 pt -136.39 147.89 27.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.736 0.814 . . . . 0.0 108.918 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.284 -2.271 0 CA-C-O 122.837 1.303 . . . . 0.0 110.294 179.041 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 120.354 0.121 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.46 -13.35 30.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.061 0.458 . . . . 0.0 111.356 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.63 -63.56 1.33 Allowed Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.7 t70 -173.95 -168.93 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.615 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -68.63 137.55 90.66 Favored Pre-proline 0 C--N 1.276 -2.602 0 C-N-CA 123.469 0.708 . . . . 0.0 109.745 172.272 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.687 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -73.85 -168.64 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.296 2.664 . . . . 0.0 110.903 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.33 119.14 33.74 Favored 'General case' 0 N--CA 1.408 -2.541 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.223 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 1.004 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -94.23 144.49 25.47 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.593 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.2 pt-20 -44.89 -46.33 10.82 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.154 0.982 . . . . 0.0 112.872 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 45.5 m80 -143.29 15.67 1.86 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.521 0.677 . . . . 0.0 109.854 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 1.004 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -122.65 -179.14 15.77 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -162.47 -153.77 0.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 125.405 1.482 . . . . 0.0 107.138 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.5 161.95 36.66 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.242 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.46 ' OE1' ' HB2' ' A' ' 718' ' ' ASN . 1.0 OUTLIER -98.04 -54.85 2.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.61 147.07 36.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.048 -175.234 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.454 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 5.4 p -128.52 117.97 22.22 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.243 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.6 p -116.71 94.7 44.48 Favored Pre-proline 0 C--N 1.288 -2.091 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.463 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.6 Cg_endo -93.02 152.61 2.63 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 123.149 2.566 . . . . 0.0 111.806 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.3 Cg_endo -72.92 134.12 33.54 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.963 -1.682 . . . . 0.0 111.047 -1.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.454 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 18.6 m-85 -76.78 78.76 3.39 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.59 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 14.4 m-85 -92.48 174.01 7.5 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.963 ' HB3' HD11 ' A' ' 664' ' ' LEU . 9.6 t80 -60.47 128.94 39.16 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.765 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.34 58.3 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.566 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.37 175.86 8.01 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -141.36 150.64 42.69 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.538 0.685 . . . . 0.0 111.147 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 694' ' ' ILE . 42.4 t -134.49 143.51 37.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.388 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 25.3 mt-10 -105.7 127.64 53.19 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.161 0.505 . . . . 0.0 109.966 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.615 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -101.6 153.83 19.4 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 124.933 1.293 . . . . 0.0 110.312 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.46 ' HB2' ' OE1' ' A' ' 703' ' ' GLN . 29.2 t-20 -143.25 169.51 17.49 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 48.2 t -117.36 160.56 20.94 Favored 'General case' 0 C--N 1.253 -3.614 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 56.6 m -61.37 145.12 52.64 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.39 -21.32 64.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.5 m -78.48 -2.0 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.244 1.021 . . . . 0.0 110.392 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.416 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 97.5 m-85 -127.48 159.49 34.38 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.6 t -120.2 138.74 53.46 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.2 ptm -91.41 145.78 24.35 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.561 0.696 . . . . 0.0 110.174 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.71 112.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 131.37 -153.51 20.44 Favored Glycine 0 C--N 1.287 -2.16 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.08 159.61 19.02 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 122.673 1.225 . . . . 0.0 111.418 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -74.87 -51.03 14.95 Favored 'General case' 1 N--CA 1.376 -4.162 0 CA-C-N 111.253 -2.703 . . . . 0.0 110.535 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.495 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 28.7 p -89.43 139.74 30.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -167.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.672 HG21 HD23 ' A' ' 741' ' ' LEU . 12.2 pt -124.06 162.9 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.246 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 739' ' ' THR . 28.5 m -128.05 135.7 50.21 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 54.0 t -71.67 105.6 3.76 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.551 0.532 . . . . 0.0 110.795 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.2 96.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-O 122.154 0.978 . . . . 0.0 111.405 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 735' ' ' HIS . . . . . 0.499 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 95.4 m-70 67.58 18.06 9.95 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.042 1.737 . . . . 0.0 112.496 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 114.62 -2.17 23.33 Favored Glycine 0 C--N 1.291 -1.929 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.423 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 27.3 t -129.27 135.6 61.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.687 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.4 m95 -72.64 161.15 31.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 21.3 p -43.12 -74.17 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.522 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -162.28 -28.23 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.068 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 731' ' ' ILE . 20.1 mt 69.71 157.99 0.15 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.531 1.144 . . . . 0.0 111.477 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.412 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.6 Cg_endo -77.29 -162.9 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.875 1.717 . . . . 0.0 110.737 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.39 140.98 26.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 80.2 m -100.19 156.92 16.94 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.214 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.33 147.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.31 126.9 31.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.729 0.3 . . . . 0.0 111.6 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.308 -1.211 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.253 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.679 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 51.9 m . . . . . 0 C--O 1.239 0.517 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.0 164.77 12.05 Favored 'General case' 0 C--O 1.265 1.895 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.387 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.02 -134.95 8.52 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.62 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 50.1 Cg_exo -53.75 144.05 55.88 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.679 2.919 . . . . 0.0 113.28 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.577 ' HB3' HG21 ' A' ' 655' ' ' VAL . 28.7 Cg_endo -63.92 158.71 45.77 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 123.296 2.664 . . . . 0.0 112.459 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 681' ' ' LEU . 12.4 Cg_endo -72.49 -169.91 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.425 2.083 . . . . 0.0 112.062 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.85 165.69 11.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.403 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.6 tp -112.9 140.6 47.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.7 tt -28.16 -64.78 0.09 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.597 2.359 . . . . 0.0 112.105 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.48 -33.53 3.01 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.406 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.726 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.46 -146.05 8.4 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.418 175.48 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -170.31 -169.91 0.89 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 118.02 0.91 . . . . 0.0 111.412 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.66 133.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.695 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.6 ptpt -94.83 -16.57 22.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.405 0.621 . . . . 0.0 110.07 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.82 160.07 15.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.11 168.41 14.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.928 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 73.0 p -83.93 125.61 32.19 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.82 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -86.08 -25.6 25.76 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.752 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.62 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.0 mt-10 73.49 -17.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.698 1.199 . . . . 0.0 112.574 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -129.66 99.91 5.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.469 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.9 m-85 -104.57 -67.32 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 107.1 -95.32 0.99 Allowed Glycine 0 C--N 1.289 -2.046 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.09 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -148.26 149.06 31.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.28 23.3 p 64.52 14.12 8.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.07 1.748 . . . . 0.0 113.706 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 37.9 mm-40 -85.55 138.82 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.656 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.9 m -118.42 146.54 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.568 0.699 . . . . 0.0 112.244 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 633' ' ' PRO . 60.9 t -126.02 135.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.61 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.29 123.05 42.17 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.936 0.874 . . . . 0.0 110.262 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 59.2 m-85 -97.92 160.65 14.17 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.796 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.695 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 39.0 p90 -136.12 143.99 44.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.726 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 60.4 m -84.54 161.45 20.2 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.582 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -55.66 154.05 14.05 Favored Pre-proline 0 C--O 1.207 -1.163 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.582 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 27.4 Cg_endo -58.81 -13.75 19.45 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.727 2.952 . . . . 0.0 115.136 -170.536 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 12.9 ptt180 -108.67 -4.09 17.35 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.888 0.852 . . . . 0.0 111.76 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.461 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 43.2 m-85 -110.3 148.74 31.33 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.277 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.955 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.8 mp -106.25 145.48 31.53 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.589 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 48.9 tpp -77.03 113.85 15.19 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.625 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.552 ' HB3' HG23 ' A' ' 683' ' ' VAL . 21.6 tptm -101.9 -25.16 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.61 50.04 Favored Glycine 0 C--N 1.307 -1.036 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.36 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.07 8.81 3.31 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 123.05 2.5 . . . . 0.0 113.812 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.589 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.31 10.1 p-10 49.92 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 128.72 2.808 . . . . 0.0 116.925 -177.946 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.6 mttt -94.93 142.24 27.71 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 123.796 0.839 . . . . 0.0 110.278 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 681' ' ' LEU . 41.2 pt -129.88 164.56 32.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.897 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.3 tt0 -129.44 135.97 49.33 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.957 0.903 . . . . 0.0 110.254 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.8 t -82.8 98.74 9.29 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 3.3 p -91.5 -178.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.079 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.41 74.65 3.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.506 1.146 . . . . 0.0 113.161 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 159.23 -39.67 0.49 Allowed Glycine 0 N--CA 1.417 -2.6 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.249 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -167.01 -174.01 2.54 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.428 ' CE3' HG13 ' A' ' 671' ' ' ILE . 85.5 m95 -84.16 164.98 18.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.4 p -76.9 -174.76 3.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 122.707 0.403 . . . . 0.0 111.292 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.2 m -64.58 111.19 2.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.388 0.613 . . . . 0.0 110.83 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.694 ' HG ' HG21 ' A' ' 671' ' ' ILE . 4.0 mp -68.15 151.17 97.4 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.696 ' HG2' HD13 ' A' ' 636' ' ' LEU . 72.7 Cg_endo -72.23 176.63 8.29 Favored 'Trans proline' 0 CA--C 1.468 -2.795 0 C-N-CA 123.425 2.75 . . . . 0.0 113.754 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.8 m -136.81 159.0 37.34 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.937 0 CA-C-N 112.156 -2.293 . . . . 0.0 107.71 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 92.1 m -121.54 150.14 42.08 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.319 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.93 147.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.9 p . . . . . 0 C--N 1.286 -2.166 0 CA-C-O 122.511 1.148 . . . . 0.0 110.026 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.425 -1.694 0 CA-C-O 120.779 0.323 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.5 m -100.26 -16.15 17.82 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.824 0.821 . . . . 0.0 110.607 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 107.68 -89.99 0.61 Allowed Glycine 0 CA--C 1.484 -1.845 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.898 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.708 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t0 -152.46 -172.23 4.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.629 HG12 HG11 ' A' ' 715' ' ' VAL . 1.4 mt -72.83 132.7 82.82 Favored Pre-proline 0 N--CA 1.406 -2.648 0 C-N-CA 125.129 1.372 . . . . 0.0 109.308 173.622 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.701 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 38.8 Cg_endo -68.35 177.01 4.96 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.271 2.647 . . . . 0.0 112.857 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.84 98.61 8.17 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.769 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.939 HD23 ' HA3' ' A' ' 700' ' ' GLY . 33.5 tp -81.4 135.66 35.67 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.7 pt-20 -43.51 -42.67 5.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.568 1.147 . . . . 0.0 112.758 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.53 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 41.2 m80 -141.77 24.18 2.05 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.571 0.701 . . . . 0.0 109.966 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.939 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.26 170.54 21.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.835 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -157.95 -152.14 0.33 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 126.158 1.783 . . . . 0.0 106.489 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -142.1 156.13 45.38 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 119.254 0.934 . . . . 0.0 111.366 -168.935 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.405 ' OE1' ' HB2' ' A' ' 718' ' ' ASN . 1.0 OUTLIER -90.07 -48.79 6.97 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.31 148.81 38.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.059 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 22.8 p -126.92 136.87 52.88 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 1.9 p -130.8 78.31 73.92 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-O 121.532 0.682 . . . . 0.0 112.628 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.7 Cg_endo -91.71 147.8 3.32 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.949 2.432 . . . . 0.0 112.653 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 81.4 Cg_endo -74.88 130.86 22.32 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.669 -1.805 . . . . 0.0 110.898 -0.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.708 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 25.5 m-85 -73.06 106.84 5.09 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.53 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 17.2 m-85 -100.59 173.56 6.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.909 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.955 ' HB3' HD11 ' A' ' 664' ' ' LEU . 3.7 t80 -62.95 134.62 56.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.477 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.44 -14.74 64.73 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.039 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.6 167.09 22.44 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.2 m -131.2 155.32 47.27 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 694' ' ' ILE . 25.4 t -144.65 134.69 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 730' ' ' SER . 17.2 mt-10 -100.06 122.79 43.48 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.733 0.778 . . . . 0.0 110.711 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.612 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -94.85 154.73 17.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.52 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' OE1' ' A' ' 703' ' ' GLN . 64.9 t30 -134.93 152.22 51.55 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 45.1 t -99.07 162.9 12.81 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 42.9 t -60.65 142.57 55.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.95 -20.05 65.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.131 0.491 . . . . 0.0 111.76 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 0.26 55.8 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.94 0.876 . . . . 0.0 110.341 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 51.1 m-85 -125.82 162.12 25.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.4 t -118.57 137.75 53.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.4 ptm -95.45 138.49 33.06 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.329 0.585 . . . . 0.0 109.718 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.37 112.25 39.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 122.07 -160.67 16.44 Favored Glycine 0 CA--C 1.478 -2.28 0 O-C-N 123.418 0.449 . . . . 0.0 112.61 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -91.53 129.09 37.57 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 13.4 ptt180 -68.96 -28.94 67.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.825 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.2 t -102.3 150.41 23.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.31 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.639 HG21 HD23 ' A' ' 741' ' ' LEU . 2.9 pt -128.46 175.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.451 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 70.3 m -143.76 135.13 25.92 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.0 t -74.56 114.59 13.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.5 mm -117.46 103.45 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.39 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 61.5 41.8 12.15 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.309 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 91.68 -11.67 71.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.965 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.68 123.34 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.289 -0.536 . . . . 0.0 109.62 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.701 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.5 m95 -63.83 142.4 58.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.0 p -28.72 -70.3 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.96 -28.99 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 731' ' ' ILE . 23.8 mt 69.01 156.25 0.15 Allowed Pre-proline 0 C--O 1.237 0.429 0 O-C-N 124.612 1.195 . . . . 0.0 110.988 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.58 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 72.5 Cg_endo -80.29 -166.16 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.718 1.612 . . . . 0.0 109.842 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -137.58 135.53 36.73 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.0 m -94.5 138.56 32.27 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.359 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.66 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.23 119.83 12.77 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.501 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.257 1.48 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.733 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 67.7 m . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.55 155.95 20.27 Favored 'General case' 0 C--O 1.268 2.047 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.55 -134.53 6.98 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.797 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 39.2 Cg_exo -58.19 143.76 96.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.847 2.364 . . . . 0.0 112.322 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.718 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.71 150.75 87.68 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.602 2.202 . . . . 0.0 112.691 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.3 Cg_endo -69.69 -173.05 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.762 2.974 . . . . 0.0 112.857 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.07 146.73 27.07 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.849 HD12 ' HB3' ' A' ' 657' ' ' TYR . 4.5 tt -87.35 142.23 28.04 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.642 ' N ' HD23 ' A' ' 636' ' ' LEU . 0.7 OUTLIER -33.26 -71.92 0.05 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.847 1.659 . . . . 0.0 110.16 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -133.73 41.09 3.06 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.569 1.652 . . . . 0.0 110.13 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -133.2 -148.79 5.99 Favored Glycine 1 C--N 1.234 -5.139 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.862 177.579 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -172.22 178.33 2.89 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.83 HG22 ' CE2' ' A' ' 657' ' ' TYR . 9.9 t -102.39 137.97 28.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 124.168 0.987 . . . . 0.0 108.655 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -100.37 -10.54 21.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.014 0.911 . . . . 0.0 109.339 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 641' ' ' VAL . 7.8 mm-40 -92.85 135.32 34.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.534 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -75.75 150.71 37.73 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.718 HG22 ' HD2' ' A' ' 633' ' ' PRO . 58.5 p -71.6 127.85 33.9 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.617 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -90.76 -20.96 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.797 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 69.43 -20.53 0.17 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.276 1.431 . . . . 0.0 113.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.64 94.83 4.06 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.582 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 14.7 m-85 -102.89 -62.98 1.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.233 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 109.6 -102.17 1.56 Allowed Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -149.14 154.54 39.35 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 53.6 p 65.93 16.57 10.52 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.254 1.422 . . . . 0.0 112.648 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 7.4 mm-40 -88.45 139.33 30.59 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.897 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 672' ' ' GLN . 6.9 m -118.36 145.9 23.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.607 0.717 . . . . 0.0 112.513 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 633' ' ' PRO . 77.5 t -128.74 135.43 62.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.645 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -101.01 133.54 45.35 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.552 0.692 . . . . 0.0 110.508 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.849 ' HB3' HD12 ' A' ' 636' ' ' LEU . 53.3 m-85 -111.16 164.19 13.12 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.313 1.045 . . . . 0.0 110.632 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -137.68 158.07 45.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 96.2 m -95.01 165.56 12.38 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 118.189 0.45 . . . . 0.0 110.041 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.527 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -59.61 156.53 32.24 Favored Pre-proline 0 C--O 1.216 -0.705 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 73.2 Cg_endo -72.91 14.59 0.51 Allowed 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 123.878 3.052 . . . . 0.0 113.348 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 686' ' ' VAL . 14.4 ptt180 -129.58 -6.29 4.67 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.68 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.421 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 38.2 m-85 -122.91 150.31 43.1 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.644 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.359 0.0 OUTLIER -114.9 137.65 51.72 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.069 -179.948 . . . . . . . . 4 4 . 1 . 009 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.514 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 57.3 tpp -60.98 114.0 2.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.492 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -102.84 -33.56 9.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.226 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.1 -172.57 37.18 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.621 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 83.2 Cg_endo -76.37 -5.64 16.36 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.107 2.538 . . . . 0.0 112.786 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 4.7 p30 56.45 -5.94 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 128.025 2.53 . . . . 0.0 115.662 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 670' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -133.06 133.87 43.6 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.272 0.629 . . . . 0.0 109.616 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.63 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -121.32 166.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.563 ' HB2' HG12 ' A' ' 654' ' ' VAL . 9.1 tt0 -142.0 140.29 32.63 Favored 'General case' 0 N--CA 1.414 -2.268 0 O-C-N 123.753 0.658 . . . . 0.0 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 8.9 t -80.04 108.67 13.81 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.783 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.61 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -89.12 73.19 8.2 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.439 1.114 . . . . 0.0 111.251 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.13 -55.95 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.18 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.03 -168.96 2.92 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -86.17 167.56 14.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 28.7 p -78.18 -176.0 4.4 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 122.876 0.471 . . . . 0.0 110.864 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 78.1 m -68.45 113.25 5.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.408 0.623 . . . . 0.0 110.794 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.63 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.9 mp -63.28 151.94 85.91 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.522 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 669' ' ' ASN . 40.6 Cg_endo -66.31 172.23 9.24 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 122.531 2.154 . . . . 0.0 113.627 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.62 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.159 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 74.5 m -118.87 135.37 54.59 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.511 HG13 HD22 ' A' ' 664' ' ' LEU . 27.0 pt -128.61 143.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 662' ' ' ARG . 8.4 p . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 691' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 9.1 m -88.62 -9.14 53.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.581 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 100.27 -81.73 0.51 Allowed Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.678 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.5 t70 -161.89 -173.0 3.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 715' ' ' VAL . 2.4 mt -70.72 135.59 85.79 Favored Pre-proline 0 N--CA 1.4 -2.959 0 C-N-CA 125.522 1.529 . . . . 0.0 110.917 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.678 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 61.4 Cg_endo -74.29 -177.3 3.18 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 123.181 2.587 . . . . 0.0 110.371 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.09 123.29 45.24 Favored 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.698 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.5 tp -86.21 138.51 31.82 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 11.2 pt-20 -41.61 -37.63 1.19 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.389 1.476 . . . . 0.0 113.163 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 54.4 m80 -145.26 27.52 1.26 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -139.26 173.43 22.72 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.193 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -155.2 -150.52 0.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 125.977 1.711 . . . . 0.0 106.828 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.63 152.14 43.72 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 119.256 0.935 . . . . 0.0 112.04 -169.684 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -56.66 3.62 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.3 144.97 35.09 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.626 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.412 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 4.5 p -142.71 116.49 9.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.926 -1.033 . . . . 0.0 108.67 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.2 m -128.34 91.75 43.19 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-O 121.182 0.515 . . . . 0.0 111.462 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.414 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.25 150.29 10.57 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.59 2.193 . . . . 0.0 111.351 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 72.3 Cg_endo -74.96 134.79 37.53 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.233 -1.569 . . . . 0.0 112.41 1.132 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 34.0 m-85 -81.19 92.28 6.29 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.51 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 4.6 m-30 -85.48 163.54 18.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.378 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.644 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.0 t80 -62.14 139.53 58.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.96 -24.22 29.52 Favored Glycine 0 C--N 1.295 -1.721 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.282 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -76.44 167.33 22.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 118.073 0.936 . . . . 0.0 110.284 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.3 m -131.61 158.08 41.98 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.101 0.477 . . . . 0.0 110.41 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.638 HG11 HG12 ' A' ' 694' ' ' ILE . 41.3 t -137.87 145.76 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.101 176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.56 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 39.2 mt-10 -111.73 121.94 46.45 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 121.57 0.7 . . . . 0.0 110.419 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.517 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -93.32 146.86 23.41 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.307 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -127.67 134.59 49.61 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.3 t -92.92 142.63 27.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 52.4 m -52.94 138.57 29.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.482 0.489 . . . . 0.0 109.747 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.11 -29.17 65.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.67 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 41.5 m -79.68 -1.62 39.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.013 0.911 . . . . 0.0 111.03 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.43 159.25 24.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.4 t -118.79 139.35 51.72 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 8.1 ptm -93.04 141.21 28.66 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.355 0.598 . . . . 0.0 109.916 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 52.1 mt -111.18 100.91 11.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.91 -165.48 24.26 Favored Glycine 0 C--N 1.284 -2.347 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -101.31 171.54 7.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -93.81 -27.75 16.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.7 p -96.03 133.52 40.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 741' ' ' LEU . 8.5 pt -120.03 166.31 14.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.289 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 739' ' ' THR . 60.9 m -133.17 135.34 45.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 40.5 t -68.25 108.23 3.1 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.004 0.815 . . . . 0.0 110.317 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 737' ' ' VAL . 48.6 mm -130.2 104.2 9.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 123.859 0.864 . . . . 0.0 109.904 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.0 m80 69.93 23.94 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 96.65 -3.6 63.21 Favored Glycine 0 CA--C 1.481 -2.088 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.413 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 734' ' ' ILE . 4.1 m -126.03 153.26 34.05 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.553 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.678 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.4 m95 -87.91 169.08 12.32 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 732' ' ' THR . 41.5 p -47.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.33 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 731' ' ' ILE . 21.8 mt 68.58 156.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.493 0 O-C-N 124.691 1.244 . . . . 0.0 111.132 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.2 -159.68 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.851 1.701 . . . . 0.0 109.431 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -143.67 142.1 30.85 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 88.7 m -101.13 144.13 30.39 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.194 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.9 148.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -74.33 125.75 29.17 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.411 0.444 . . . . 0.0 110.521 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.044 175.572 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 14.9 p -147.49 -173.32 4.24 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -115.94 -135.27 5.65 Favored Glycine 0 N--CA 1.405 -3.4 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.758 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 17.1 Cg_exo -65.43 144.29 79.21 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.658 2.238 . . . . 0.0 110.492 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.9 Cg_endo -60.3 154.15 54.68 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.572 2.181 . . . . 0.0 112.307 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 681' ' ' LEU . 14.9 Cg_endo -64.2 -164.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.561 2.841 . . . . 0.0 113.265 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.19 165.61 12.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.299 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 682' ' ' PRO . 52.2 tp -113.36 147.52 37.53 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.371 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 636' ' ' LEU . 12.5 tp -40.59 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.988 1.715 . . . . 0.0 113.315 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -126.08 50.25 1.89 Allowed 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 123.534 1.635 . . . . 0.0 108.834 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -164.8 -154.43 7.94 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 111.358 -2.656 . . . . 0.0 108.962 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -166.93 -178.09 4.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.1 p -92.02 138.68 19.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 9.7 ptpt -98.08 -17.26 19.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.38 144.0 28.29 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.335 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 43.4 mmtm -85.45 134.32 34.06 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-O 121.915 0.864 . . . . 0.0 112.718 -173.736 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 633' ' ' PRO . 11.0 p -64.99 122.1 16.23 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 113.193 -1.822 . . . . 0.0 113.658 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -89.53 -22.98 22.14 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.654 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.758 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 73.08 -7.71 1.45 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.164 1.386 . . . . 0.0 112.334 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.3 93.7 3.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.511 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.2 m-85 -121.54 132.97 55.0 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -101.52 -153.83 25.97 Favored Glycine 0 C--N 1.277 -2.745 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.272 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -75.91 149.62 37.71 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.283 76.2 p 71.13 11.19 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.653 1.581 . . . . 0.0 114.072 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 17.4 mm-40 -79.26 121.34 24.96 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.8 OUTLIER -109.15 139.69 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.14 0.495 . . . . 0.0 111.488 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.9 t -126.92 135.84 62.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.92 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.89 129.37 48.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.46 1.124 . . . . 0.0 112.614 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 45.9 m-85 -105.27 164.61 11.71 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.728 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.493 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 40.0 p90 -142.02 150.81 41.8 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.587 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 89.9 m -98.05 163.57 12.71 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.3 OUTLIER -59.25 159.04 16.66 Favored Pre-proline 0 N--CA 1.482 1.131 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 61.6 Cg_endo -68.12 -9.8 26.9 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.074 2.516 . . . . 0.0 113.441 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 21.6 ptt180 -101.68 -6.67 23.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.708 0.766 . . . . 0.0 111.16 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 48.2 m-85 -121.25 140.92 51.41 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 711' ' ' TYR . 17.5 mt -99.66 139.68 34.96 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.831 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.607 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.2 tpp -72.3 109.03 5.75 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.238 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.629 ' HD2' HD13 ' A' ' 685' ' ' ILE . 81.3 tttt -94.97 -29.2 14.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -79.61 -173.05 44.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.618 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.74 -3.77 13.53 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.277 2.651 . . . . 0.0 113.13 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.607 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.263 6.3 p30 58.65 -27.57 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 127.474 2.31 . . . . 0.0 116.167 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.2 mttt -108.5 139.6 43.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 121.937 -0.477 . . . . 0.0 110.346 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.6 pt -124.99 171.57 13.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.0 tt0 -142.39 140.6 32.08 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.85 100.0 8.61 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.316 1.055 . . . . 0.0 108.804 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.79 171.38 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.17 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.05 72.36 2.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.448 1.118 . . . . 0.0 111.029 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.23 -39.82 0.52 Allowed Glycine 0 N--CA 1.409 -3.145 0 CA-C-N 113.914 -1.493 . . . . 0.0 111.73 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.93 -178.94 6.41 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -84.04 164.77 19.07 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.9 p -74.67 -174.89 2.26 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.821 0.343 . . . . 0.0 111.749 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.5 m -71.1 111.15 6.23 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.184 0.516 . . . . 0.0 110.111 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.646 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -64.81 151.47 92.67 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.225 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 636' ' ' LEU . 44.1 Cg_endo -67.71 -176.53 0.97 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.129 2.553 . . . . 0.0 114.115 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.09 142.92 27.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 85.0 m -114.12 133.09 55.8 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.629 HD13 ' HD2' ' A' ' 666' ' ' LYS . 26.1 pt -128.25 145.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 662' ' ' ARG . 12.0 p . . . . . 0 C--N 1.281 -2.371 0 CA-C-O 122.354 1.073 . . . . 0.0 108.578 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 120.999 0.428 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 31.5 m -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 67.88 53.66 22.11 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.257 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.2 t70 71.51 172.94 0.31 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.017 0.927 . . . . 0.0 113.25 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.558 ' CG1' HG11 ' A' ' 715' ' ' VAL . 1.3 mp -66.37 132.99 94.38 Favored Pre-proline 0 N--CA 1.434 -1.275 0 C-N-CA 124.18 0.992 . . . . 0.0 111.626 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.5 Cg_endo -75.58 -171.22 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.961 3.107 . . . . 0.0 111.683 176.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.17 139.28 49.48 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.373 0.606 . . . . 0.0 110.084 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.72 HD23 ' HA3' ' A' ' 700' ' ' GLY . 48.9 tp -107.61 148.27 29.53 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -43.14 -47.34 6.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.75 1.22 . . . . 0.0 112.758 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -142.86 30.73 1.45 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.042 0.925 . . . . 0.0 109.154 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.72 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -138.25 171.1 23.57 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.894 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.411 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 5.0 p-90 -156.55 -150.88 0.3 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.847 1.659 . . . . 0.0 106.607 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.09 162.46 35.43 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.715 -169.46 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.523 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.03 -68.31 0.81 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.64 142.01 32.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.833 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.51 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 6.4 m -133.72 99.53 4.5 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 172.604 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.0 m -117.51 98.34 51.67 Favored Pre-proline 0 C--N 1.271 -2.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.002 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.04 159.45 15.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.241 2.628 . . . . 0.0 110.95 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 138.84 57.95 Favored 'Cis proline' 0 C--O 1.243 0.763 0 C-N-CA 123.89 -1.296 . . . . 0.0 112.261 0.458 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -86.38 78.06 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.525 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 30.2 m-85 -79.59 161.6 25.83 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.738 0.304 . . . . 0.0 111.67 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.444 ' HB3' HD21 ' A' ' 664' ' ' LEU . 1.7 t80 -55.87 131.33 46.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -17.18 57.72 Favored Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.753 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.78 173.95 12.07 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -139.66 151.34 45.86 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.452 0.644 . . . . 0.0 111.045 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.558 HG11 ' CG1' ' A' ' 694' ' ' ILE . 32.6 t -135.02 142.07 41.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.809 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 33.0 mt-10 -104.17 128.89 51.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.606 0.717 . . . . 0.0 110.675 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.4 m-85 -97.42 156.66 16.37 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.232 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.523 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -137.05 145.88 44.54 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 44.3 t -94.94 158.98 15.24 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 51.1 m -69.35 158.81 34.34 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.16 144.94 48.39 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 34.5 m 85.0 -5.75 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.325 1.85 . . . . 0.0 109.38 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 52.4 m-85 -119.31 148.41 43.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.6 t -116.65 140.89 48.89 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.0 ptm -91.91 141.5 28.57 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.01 127.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 112.75 -133.75 11.54 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -115.4 163.08 16.24 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.8 -29.17 16.91 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 3.9 p -99.94 131.92 45.61 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.661 HG21 HD23 ' A' ' 741' ' ' LEU . 7.3 pt -109.09 171.27 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.005 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 58.1 m -135.21 135.71 41.2 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.41 108.68 4.96 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.7 0.625 . . . . 0.0 110.163 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -128.39 111.7 24.59 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.702 0 C-N-CA 123.792 0.837 . . . . 0.0 110.579 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 58.9 m80 67.01 17.08 10.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.97 49.93 Favored Glycine 0 CA--C 1.479 -2.186 0 C-N-CA 119.32 -1.419 . . . . 0.0 111.483 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 734' ' ' ILE . 9.9 m -125.12 152.89 31.97 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.201 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.579 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.3 m95 -83.26 159.17 22.0 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 11.3 p -38.82 -70.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.04 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 731' ' ' ILE . 20.3 mt 71.16 154.15 0.15 Allowed Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.441 1.096 . . . . 0.0 112.694 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 47.3 Cg_endo -74.36 -171.1 0.83 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.781 1.654 . . . . 0.0 109.02 172.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 697' ' ' LEU . 17.5 pt20 -147.57 142.24 26.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 89.2 m -92.17 153.97 18.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.546 0.529 . . . . 0.0 112.358 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.4 144.61 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -72.07 123.98 23.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.363 0.414 . . . . 0.0 111.318 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.983 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 67.3 m -131.81 136.07 47.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.82 -132.59 7.58 Favored Glycine 0 N--CA 1.41 -3.08 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.887 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -63.12 135.89 53.3 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.901 2.4 . . . . 0.0 111.874 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.866 ' HD2' HG22 ' A' ' 645' ' ' THR . 26.9 Cg_endo -60.22 157.23 36.04 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.348 2.698 . . . . 0.0 113.444 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 681' ' ' LEU . 31.4 Cg_endo -71.52 -159.42 0.07 OUTLIER 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.509 2.806 . . . . 0.0 112.643 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 635' ' ' GLU . . . . . 0.415 ' O ' HD13 ' A' ' 681' ' ' LEU . 13.8 pt-20 -104.35 174.78 5.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.408 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -117.86 142.03 47.77 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 169.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -35.67 -68.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 127.437 2.295 . . . . 0.0 112.869 176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 21.8 t-20 -116.9 -31.0 5.56 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.31 1.052 . . . . 0.0 109.331 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -78.86 -157.04 10.39 Favored Glycine 0 C--N 1.298 -1.555 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.265 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -169.5 -177.01 2.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.3 p -101.08 140.53 19.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 123.398 0.679 . . . . 0.0 109.687 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 8.6 ptpt -95.77 -30.9 13.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.56 149.44 34.86 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.649 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 38.9 mmtm -86.94 161.7 18.09 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.789 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.866 HG22 ' HD2' ' A' ' 633' ' ' PRO . 14.5 p -84.0 122.68 29.1 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.767 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -82.31 -23.74 34.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.424 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.887 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.9 mt-10 67.62 -13.86 0.23 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.168 1.387 . . . . 0.0 113.648 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -133.28 87.38 2.39 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.412 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 11.9 m-85 -91.43 -65.53 1.0 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 112.02 -88.45 0.5 Allowed Glycine 0 C--N 1.296 -1.65 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.934 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -161.49 144.57 12.4 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 73.82 3.13 4.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.161 1.384 . . . . 0.0 111.391 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 65.4 mm-40 -74.88 140.79 44.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 3.4 m -115.71 151.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 123.993 0.808 . . . . 0.0 112.3 -176.886 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 52.2 t -133.24 134.59 57.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.441 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 125.28 48.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.091 0.948 . . . . 0.0 111.66 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.766 ' HB3' HD12 ' A' ' 636' ' ' LEU . 62.8 m-85 -100.68 168.84 9.43 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.832 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 41.0 p90 -138.94 153.15 48.19 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 63.6 m -94.41 163.31 13.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.81 155.78 75.68 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 68.1 Cg_endo -69.41 9.81 0.5 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 123.672 2.915 . . . . 0.0 114.849 -172.968 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.514 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 32.2 ptt180 -131.83 5.72 4.27 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.864 0.84 . . . . 0.0 109.753 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 39.3 m-85 -123.95 143.07 50.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.698 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 711' ' ' TYR . 12.2 mt -97.51 145.82 25.84 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.095 0.474 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.0 tpp -76.5 113.2 13.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.109 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' A' ' 685' ' ' ILE . 40.3 ttmt -93.31 -48.95 6.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.386 0.612 . . . . 0.0 109.775 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.53 -168.13 43.82 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.727 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.04 107.4 2.43 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.694 2.262 . . . . 0.0 111.182 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.55 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.0 p30 -72.97 -5.01 35.83 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.056 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 48.7 mtmt -126.48 117.51 23.02 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.154 0.502 . . . . 0.0 110.28 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 681' ' ' LEU . 47.5 pt -108.78 168.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.427 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 21.3 tt0 -140.36 140.54 35.58 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 123.597 0.759 . . . . 0.0 110.845 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.0 106.98 7.9 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.756 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.18 -177.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.86 81.27 2.77 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.932 1.348 . . . . 0.0 111.691 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.87 -39.78 0.82 Allowed Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.393 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -165.69 -171.22 2.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.89 165.98 14.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 18.6 p -75.01 -179.78 4.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.271 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 47.2 m -62.7 115.7 4.54 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.671 0.748 . . . . 0.0 112.046 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 671' ' ' ILE . 78.2 mt -64.37 146.24 97.99 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.17 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.625 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 60.0 Cg_endo -70.4 -174.39 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.916 2.411 . . . . 0.0 113.757 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 67.8 t -139.43 136.17 40.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.0 m -111.98 127.89 56.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' A' ' 666' ' ' LYS . 29.3 pt -125.41 147.71 30.06 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.1 p . . . . . 0 C--N 1.288 -2.074 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.704 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.0 m -83.43 -4.73 58.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.189 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 96.14 -87.37 0.97 Allowed Glycine 0 CA--C 1.486 -1.756 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 5.9 p-10 -154.25 -173.8 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.636 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.8 mt -71.27 133.04 85.62 Favored Pre-proline 0 N--CA 1.42 -1.933 0 C-N-CA 123.623 0.769 . . . . 0.0 112.115 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 63.0 Cg_endo -71.91 -177.77 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.417 2.745 . . . . 0.0 112.154 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.82 118.04 35.05 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.244 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 698' ' ' GLU . 5.2 tt -93.6 140.97 29.01 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 175.747 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.556 ' HG2' HD23 ' A' ' 697' ' ' LEU . 9.4 pt-20 -45.67 -36.42 4.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.39 1.076 . . . . 0.0 113.042 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 95.3 m-70 -147.09 37.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -146.07 171.57 26.95 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.384 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -156.47 -152.23 0.36 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 126.247 1.819 . . . . 0.0 106.709 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -134.58 152.76 52.0 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.581 -1.248 . . . . 0.0 113.854 -167.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 12.6 mp0 -87.57 -47.53 8.64 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.031 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -119.69 129.89 54.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.29 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 3.5 m -126.97 126.19 42.77 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 12.3 t -135.24 92.72 17.59 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.737 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 3.5 Cg_endo -87.03 153.24 8.36 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.63 2.22 . . . . 0.0 111.717 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 60.6 Cg_endo -72.84 136.75 45.65 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.069 -1.638 . . . . 0.0 111.887 0.16 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 44.5 m-85 -81.9 93.92 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.01 166.08 23.26 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.594 0.558 . . . . 0.0 111.526 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.503 ' HB3' HD21 ' A' ' 664' ' ' LEU . 0.7 OUTLIER -67.15 137.74 56.52 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.517 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.99 -16.31 61.38 Favored Glycine 0 N--CA 1.422 -2.287 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.036 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 661' ' ' PRO . 22.1 t0 -77.79 164.79 24.9 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.8 m -128.12 156.02 43.5 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.22 0.533 . . . . 0.0 109.875 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.537 HG11 HG12 ' A' ' 694' ' ' ILE . 38.6 t -137.51 137.7 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.969 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -106.51 120.35 41.68 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.636 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.35 147.51 22.85 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.541 1.136 . . . . 0.0 111.962 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.427 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.5 t30 -118.81 138.53 52.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.716 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 37.7 t -83.1 155.06 24.04 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.6 t -63.17 147.27 51.37 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.02 137.78 45.59 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 60.8 m 86.75 5.76 0.34 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 126.278 1.831 . . . . 0.0 110.665 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 69.1 m-85 -122.5 152.07 40.7 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 747' ' ' ILE . 9.9 t -114.42 137.43 51.84 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.716 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.3 ptm -91.11 139.33 30.86 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.278 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.66 119.29 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 124.38 -154.52 17.92 Favored Glycine 0 CA--C 1.475 -2.415 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -98.69 118.49 35.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.548 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -58.96 -24.65 62.79 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.72 -1.582 . . . . 0.0 113.049 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 6.7 m -117.29 149.36 40.59 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.305 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.605 HG21 HD23 ' A' ' 741' ' ' LEU . 5.8 pt -128.64 173.77 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.656 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 90.3 m -140.7 136.91 33.09 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.8 t -69.06 109.04 3.8 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.511 0.724 . . . . 0.0 110.124 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.7 mm -127.46 104.25 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.996 0.427 . . . . 0.0 111.602 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.7 m80 65.73 27.71 11.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.946 . . . . 0.0 111.894 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.42 5.11 62.06 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.648 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.7 t -135.2 140.83 44.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.696 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.6 m95 -79.91 148.45 31.27 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.1 p -33.38 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.78 -29.9 0.07 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -171.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.605 HD23 HG21 ' A' ' 731' ' ' ILE . 25.6 mt 65.72 156.83 0.13 Allowed Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 124.505 1.128 . . . . 0.0 111.725 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.424 ' HG2' HD11 ' A' ' 697' ' ' LEU . 72.1 Cg_endo -86.58 -179.28 2.97 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 121.782 1.654 . . . . 0.0 110.21 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.32 142.49 51.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 92.2 m -105.37 139.76 39.52 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.317 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.15 144.86 36.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -70.46 115.85 10.12 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.499 0.499 . . . . 0.0 112.146 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' A' ' 724' ' ' THR . 64.6 mt . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.898 ' HB2' ' HB2' ' A' ' 649' ' ' TYR . 14.4 m -131.8 158.48 41.13 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -107.18 -150.57 16.89 Favored Glycine 1 N--CA 1.387 -4.628 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 176.466 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.98 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -60.28 149.17 87.06 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 645' ' ' THR . 28.1 Cg_endo -63.77 149.55 90.5 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.754 1.636 . . . . 0.0 110.992 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.537 ' HG2' HD11 ' A' ' 681' ' ' LEU . 28.8 Cg_endo -68.28 -167.27 0.17 Allowed 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 122.823 2.349 . . . . 0.0 111.863 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.95 151.41 25.84 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.531 -0.731 . . . . 0.0 110.749 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 657' ' ' TYR . 3.7 tt -92.69 136.82 32.9 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 636' ' ' LEU . 46.3 tp -32.01 -68.31 0.09 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.815 2.046 . . . . 0.0 113.958 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -134.33 33.66 3.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.939 1.828 . . . . 0.0 108.795 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.67 -156.28 6.88 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.814 174.041 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -174.8 -178.92 1.35 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.23 139.77 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 123.838 0.855 . . . . 0.0 111.202 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -96.0 -23.01 17.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.31 172.16 14.12 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -96.79 165.24 12.21 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.266 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.602 HG22 ' HD2' ' A' ' 633' ' ' PRO . 33.5 p -91.14 120.79 32.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.374 0.607 . . . . 0.0 111.586 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.33 -24.91 21.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.759 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.98 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 67.55 -12.91 0.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.496 1.518 . . . . 0.0 114.395 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -132.0 93.49 3.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 630' ' ' CYS . 3.1 m-85 -110.33 -179.46 3.78 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.101 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -151.08 -150.31 5.28 Favored Glycine 0 N--CA 1.402 -3.578 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.251 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -80.1 134.02 36.14 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.0 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 75.66 17.87 2.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.877 1.271 . . . . 0.0 111.798 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 69.7 mm-40 -79.87 129.22 34.31 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.693 -0.629 . . . . 0.0 109.508 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 10.4 m -110.97 151.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 123.366 0.416 . . . . 0.0 111.461 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 633' ' ' PRO . 26.2 t -135.2 131.8 52.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.442 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -100.49 128.89 46.42 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.122 0.963 . . . . 0.0 112.089 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.733 ' HB3' HD12 ' A' ' 636' ' ' LEU . 52.8 m-85 -106.72 165.75 11.08 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.486 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -136.18 156.81 48.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 75.8 m -93.08 165.13 12.99 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -53.95 157.5 4.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.75 10.43 0.49 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.846 3.031 . . . . 0.0 114.009 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.558 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 11.2 ptt85 -133.25 -1.16 3.24 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.996 0.903 . . . . 0.0 111.61 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 46.0 m-85 -116.7 158.18 24.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.025 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.708 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.3 mp -115.33 140.72 48.87 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.386 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.547 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 56.6 tpp -75.45 118.43 18.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 683' ' ' VAL . 38.0 ttmt -98.24 -47.09 5.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.077 0.465 . . . . 0.0 110.46 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.43 -170.95 46.03 Favored Glycine 0 C--O 1.242 0.629 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.405 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 104.52 1.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.494 2.129 . . . . 0.0 110.934 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 6.9 p30 -69.32 -2.44 10.78 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.318 -177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 46.6 mtmt -121.91 128.79 51.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.139 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 681' ' ' LEU . 43.7 pt -116.96 166.25 11.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.623 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 20.2 tt0 -138.46 139.57 38.88 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.75 0.656 . . . . 0.0 109.657 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 13.7 t -89.67 115.06 26.76 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 674' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 677' ' ' GLU . 20.0 m -89.58 -171.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.252 4.8 p-10 -78.75 76.97 5.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.477 1.132 . . . . 0.0 111.684 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.5 0.38 Allowed Glycine 0 N--CA 1.414 -2.804 0 CA-C-N 113.534 -1.666 . . . . 0.0 111.145 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 677' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 674' ' ' VAL . 10.9 pt-20 -149.79 -175.28 4.97 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 85.9 m95 -85.05 175.1 9.24 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.238 0.542 . . . . 0.0 111.469 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 30.5 p -88.81 -174.64 4.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.833 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 88.5 m -61.63 116.66 4.94 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 123.883 0.873 . . . . 0.0 111.927 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -68.4 143.48 95.56 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.581 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.524 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 84.4 Cg_endo -76.31 170.03 20.8 Favored 'Trans proline' 0 CA--C 1.461 -3.153 0 C-N-CA 123.585 2.857 . . . . 0.0 111.928 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 666' ' ' LYS . 18.6 m -131.75 156.52 42.65 Favored 'Isoleucine or valine' 1 N--CA 1.356 -5.167 0 CA-C-N 112.048 -2.342 . . . . 0.0 108.482 -174.499 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 95.8 m -128.33 138.0 52.19 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.22 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.39 152.35 36.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.4 p . . . . . 0 C--N 1.274 -2.678 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.402 -2.836 0 CA-C-O 121.49 0.662 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 691' ' ' CYS . . . . . 0.486 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 32.7 m -95.02 -12.17 27.1 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 103.64 -77.74 0.29 Allowed Glycine 0 CA--C 1.478 -2.251 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.415 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t70 -170.58 -165.24 0.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.3 mt -80.15 136.65 53.44 Favored Pre-proline 0 C--N 1.272 -2.793 0 C-N-CA 125.296 1.439 . . . . 0.0 111.315 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.597 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.5 Cg_endo -74.64 -177.22 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.252 2.635 . . . . 0.0 111.309 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.46 118.54 33.48 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.61 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -89.35 143.39 26.87 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 10.2 pt-20 -39.01 -47.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.03 1.332 . . . . 0.0 113.239 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 53.9 m80 -143.41 30.76 1.37 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.61 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -133.12 176.53 19.52 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.066 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -164.62 -156.03 0.3 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.306 1.842 . . . . 0.0 106.913 -174.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.41 150.69 47.84 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -167.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.445 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.5 -41.8 13.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.765 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.07 146.98 50.82 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.674 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.53 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 13.0 m -120.41 130.54 54.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.313 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.57 87.77 49.41 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.45 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.4 Cg_endo -91.28 147.84 3.59 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.914 2.409 . . . . 0.0 112.152 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.4 Cg_endo -74.84 128.33 16.1 Favored 'Cis proline' 0 C--O 1.241 0.671 0 C-N-CA 122.648 -1.814 . . . . 0.0 110.955 -0.585 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.53 ' OH ' ' HB3' ' A' ' 705' ' ' SER . 12.7 m-85 -72.78 97.06 2.15 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.558 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 13.6 m-85 -97.11 176.83 5.79 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.326 0.584 . . . . 0.0 111.883 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.708 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 11.3 t80 -67.09 137.75 56.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.16 -1.53 88.65 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.369 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -84.78 174.17 10.09 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.3 m -143.04 153.31 42.82 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.144 0.497 . . . . 0.0 110.614 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.578 HG11 HG12 ' A' ' 694' ' ' ILE . 39.6 t -138.28 141.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.503 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 34.3 mt-10 -100.73 121.14 41.16 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.605 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.1 m-85 -98.38 161.52 13.64 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.611 1.164 . . . . 0.0 110.461 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.445 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 34.3 t-20 -149.45 163.21 38.42 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.6 m -108.23 154.72 21.36 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 19.3 m -61.22 154.14 24.29 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.255 0.347 . . . . 0.0 111.598 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.46 138.64 58.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.5 m 88.18 -0.83 0.45 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 126.929 2.092 . . . . 0.0 110.118 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.31 149.26 40.77 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -117.15 145.31 43.91 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.67 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -93.79 138.48 31.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.684 0.754 . . . . 0.0 111.729 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 51.9 mt -113.08 116.9 53.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 119.37 -139.67 14.35 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -128.19 167.54 16.69 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 120.895 0.379 . . . . 0.0 110.402 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -87.51 -33.83 18.84 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.0 p -93.57 133.78 36.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -118.1 166.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.507 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 739' ' ' THR . 75.2 m -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.05 121.68 25.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.551 0.691 . . . . 0.0 112.206 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 737' ' ' VAL . 49.7 mm -128.43 108.38 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 30.6 m80 70.63 27.07 3.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 736' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 95.17 -13.72 66.44 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.32 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 737' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.6 m -113.73 158.51 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -173.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.597 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.8 m95 -96.12 158.61 15.36 Favored 'General case' 0 C--N 1.271 -2.835 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 732' ' ' THR . 42.5 p -39.59 -70.4 0.1 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.2 -28.38 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 731' ' ' ILE . 17.4 mt 68.98 157.78 0.15 Allowed Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.466 1.107 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.67 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.2 Cg_endo -77.51 -172.05 1.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.776 1.65 . . . . 0.0 111.577 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -125.1 130.38 52.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 9.6 m -107.39 126.07 52.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.64 147.07 28.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.66 114.87 8.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.903 0.752 . . . . 0.0 111.254 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.58 175.66 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.652 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 47.8 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.771 0.796 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 12.9 p -116.33 -172.08 2.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.076 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.67 -136.82 5.66 Favored Glycine 0 N--CA 1.398 -3.84 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.04 147.54 82.08 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 123.685 2.923 . . . . 0.0 114.028 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.9 Cg_endo -64.66 157.34 56.22 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.137 2.558 . . . . 0.0 112.658 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.57 ' HG2' HD21 ' A' ' 681' ' ' LEU . 19.1 Cg_endo -66.73 -164.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.405 2.736 . . . . 0.0 111.421 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -114.75 159.23 20.81 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.461 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 657' ' ' TYR . 1.0 OUTLIER -93.94 136.2 34.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.365 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -32.11 -65.55 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.563 1.945 . . . . 0.0 111.189 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 16.2 t-20 -110.63 -33.53 6.55 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.448 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.748 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -83.18 -147.12 6.99 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.691 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -162.04 -172.85 3.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.75 HG22 ' CE1' ' A' ' 657' ' ' TYR . 21.3 t -105.16 140.21 23.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 124.64 1.176 . . . . 0.0 109.215 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.0 ptpt -107.32 -11.68 15.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.666 0.746 . . . . 0.0 109.482 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.498 ' CG ' ' H ' ' A' ' 656' ' ' GLU . 20.0 mm-40 -78.51 154.09 30.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.927 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.93 144.82 25.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.171 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.496 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 20.9 p -78.78 119.97 22.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.998 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -103.02 -13.82 16.71 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.045 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 66.79 -29.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.148 1.379 . . . . 0.0 112.013 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.9 tt0 -112.66 102.49 10.55 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 6.7 m-85 -117.55 -160.04 0.76 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -176.03 -165.57 32.07 Favored Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.137 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 651' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.1 t60 -69.8 137.12 51.59 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.4 m 75.85 4.33 3.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 124.694 1.246 . . . . 0.0 113.252 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 53.9 mm-40 -70.98 140.27 50.81 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.295 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.4 m -121.12 139.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.3 t -121.71 132.59 70.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.743 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.498 ' H ' ' CG ' ' A' ' 643' ' ' GLU . 38.5 tt0 -102.42 127.73 49.32 Favored 'General case' 0 N--CA 1.414 -2.231 0 O-C-N 124.109 0.881 . . . . 0.0 110.236 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.774 ' HB3' HD12 ' A' ' 636' ' ' LEU . 81.2 m-85 -101.96 161.27 13.8 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.604 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.503 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 51.6 p90 -136.89 142.23 42.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 79.9 m -85.24 163.33 18.72 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.617 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.6 OUTLIER -60.98 154.4 60.41 Favored Pre-proline 0 C--O 1.211 -0.923 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.251 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.617 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 58.6 Cg_endo -66.53 -4.04 10.16 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.975 3.117 . . . . 0.0 114.628 -172.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.582 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 13.3 ptt180 -110.6 -4.71 15.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.021 0.915 . . . . 0.0 111.111 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.494 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 38.9 m-85 -117.07 149.95 39.46 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.065 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.1 mp -108.71 146.54 33.32 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.617 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.495 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 51.7 tpp -71.04 123.22 21.59 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.647 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -99.57 -49.21 4.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -94.5 -162.42 35.14 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.497 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.64 106.2 2.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.538 2.159 . . . . 0.0 110.431 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 25.3 p-10 -68.96 -8.82 48.15 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.333 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.7 mttt -118.68 130.45 55.84 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.54 HG21 ' HG ' ' A' ' 681' ' ' LEU . 46.7 pt -120.22 165.46 15.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.903 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.1 tt0 -136.81 138.18 40.56 Favored 'General case' 0 C--N 1.283 -2.288 0 O-C-N 123.848 0.717 . . . . 0.0 110.196 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 47.5 t -84.29 107.92 16.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.78 -163.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -74.05 79.83 1.72 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.334 1.064 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.33 -51.2 0.73 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.681 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -155.6 -170.52 3.46 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -86.81 162.53 17.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.8 p -76.45 -178.21 4.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 86.6 m -58.87 113.93 2.3 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.798 0.839 . . . . 0.0 111.335 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 634' ' ' PRO . 6.6 mp -71.46 156.21 91.76 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.534 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.438 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -73.64 -178.45 3.75 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 123.036 2.491 . . . . 0.0 113.539 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.54 149.55 31.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 83.9 m -119.67 128.83 54.19 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 35.8 pt -123.59 158.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 662' ' ' ARG . 12.5 p . . . . . 0 C--N 1.279 -2.493 0 CA-C-O 123.077 1.417 . . . . 0.0 110.421 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.425 -1.682 0 CA-C-O 121.246 0.546 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.0 m -90.11 -2.63 58.12 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.668 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 89.74 -75.93 1.77 Allowed Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.778 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 3.2 t70 -159.57 -166.78 1.85 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.649 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.3 mt -79.78 133.72 58.28 Favored Pre-proline 0 C--N 1.28 -2.438 0 C-N-CA 124.275 1.03 . . . . 0.0 111.043 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.9 Cg_endo -74.29 -176.58 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.075 2.516 . . . . 0.0 111.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.09 120.35 42.28 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.44 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.677 HD23 ' HA3' ' A' ' 700' ' ' GLY . 30.2 tp -90.46 138.63 31.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -41.61 -40.8 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.3 m-70 -142.19 27.44 1.76 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.677 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.52 -179.85 16.5 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.162 -0.927 . . . . 0.0 113.465 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -160.25 -152.53 0.29 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.982 2.113 . . . . 0.0 106.553 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.75 150.95 46.68 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 118.816 0.735 . . . . 0.0 112.506 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.486 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 12.3 mp0 -84.43 -43.43 14.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.761 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.23 147.87 51.11 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.575 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 6.9 p -126.17 121.47 32.9 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.333 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.05 85.65 46.17 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.471 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.8 Cg_endo -92.23 146.66 2.93 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 123.114 2.543 . . . . 0.0 111.827 176.069 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 64.6 Cg_endo -72.73 130.11 18.98 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.037 -1.651 . . . . 0.0 111.456 -0.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.778 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 19.3 m-85 -78.05 83.6 4.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.582 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 20.9 m-85 -83.0 168.54 16.89 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 121.157 0.503 . . . . 0.0 111.536 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 1.004 ' HB3' HD11 ' A' ' 664' ' ' LEU . 1.9 t80 -59.89 127.2 30.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.084 176.339 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.33 -20.5 42.38 Favored Glycine 0 C--N 1.299 -1.515 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.537 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.31 170.18 16.6 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.5 m -138.87 148.98 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.451 0.643 . . . . 0.0 111.291 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.563 HG11 HG12 ' A' ' 694' ' ' ILE . 42.5 t -131.83 143.07 41.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.995 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.1 mt-10 -109.97 122.29 47.21 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.649 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.3 m-85 -95.32 161.1 14.23 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 124.686 1.194 . . . . 0.0 111.399 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 55.6 t30 -150.1 147.86 28.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.4 m -91.37 165.06 13.61 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 720' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 723' ' ' PHE . 47.3 t -50.69 147.01 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.64 -31.24 62.15 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 20.3 m -93.68 11.37 29.21 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 121.173 0.511 . . . . 0.0 111.89 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 720' ' ' SER . 75.9 m-85 -127.26 154.83 44.39 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -119.93 145.09 47.06 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.451 ' HB3' ' SG ' ' A' ' 719' ' ' CYS . 9.0 ptp -90.74 161.07 15.48 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-O 121.474 0.654 . . . . 0.0 109.954 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.18 122.94 66.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.65 -144.47 18.18 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -118.75 169.7 9.61 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 729' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 33.7 ptt180 -94.49 -28.67 15.33 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.543 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.4 p -86.19 146.43 26.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -130.34 168.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.262 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 99.2 m -137.49 136.26 37.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.15 109.15 4.46 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.507 0.504 . . . . 0.0 110.312 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.3 mm -123.89 107.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.361 0.6 . . . . 0.0 110.729 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 57.6 m80 68.16 18.83 9.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.42 1.088 . . . . 0.0 113.211 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.3 55.57 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.665 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.03 142.47 40.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.53 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.2 m95 -75.53 163.09 27.73 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.0 p -46.33 -71.59 0.07 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.33 -33.09 0.06 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 66.35 153.79 0.13 Allowed Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 124.497 1.123 . . . . 0.0 110.37 -176.395 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.3 -161.73 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.585 1.524 . . . . 0.0 111.022 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.56 132.26 30.83 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 10.1 m -94.56 146.49 24.08 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.35 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.82 155.1 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.87 124.57 24.35 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 123.685 0.615 . . . . 0.0 109.688 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.253 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 109.166 176.81 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.434 -1.228 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 25.8 p -145.61 177.87 8.56 Favored 'General case' 0 C--N 1.275 -2.631 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -116.7 -141.75 7.16 Favored Glycine 0 N--CA 1.402 -3.616 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.905 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.739 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 18.9 Cg_exo -60.58 146.07 97.67 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.075 2.517 . . . . 0.0 111.887 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 645' ' ' THR . 11.5 Cg_endo -55.57 149.18 49.65 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 123.041 2.494 . . . . 0.0 112.233 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.643 ' HG2' HD21 ' A' ' 681' ' ' LEU . 17.9 Cg_endo -72.58 -168.26 0.39 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.312 2.675 . . . . 0.0 111.999 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -99.29 158.86 15.41 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.047 0.451 . . . . 0.0 110.823 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.8 tt -98.72 145.7 26.64 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.653 HD13 HG23 ' A' ' 683' ' ' VAL . 6.9 tt -33.52 -56.0 0.44 Allowed 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 127.325 2.25 . . . . 0.0 111.238 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.5 t30 -122.6 -47.55 2.09 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.643 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -68.88 -153.08 0.54 Allowed Glycine 0 N--CA 1.476 1.324 0 O-C-N 124.103 0.877 . . . . 0.0 114.681 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -173.43 -172.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.922 0 O-C-N 122.275 -0.544 . . . . 0.0 111.045 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.1 140.97 15.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 C-N-CA 125.921 1.688 . . . . 0.0 110.748 -173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 14.6 ptpt -104.55 -23.83 13.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.564 0.697 . . . . 0.0 109.604 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -69.88 156.26 39.34 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.629 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 59.5 mmtt -93.37 119.37 32.41 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.832 0.825 . . . . 0.0 110.468 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.484 HG22 ' HD2' ' A' ' 633' ' ' PRO . 77.3 p -67.6 121.68 16.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.428 -1.715 . . . . 0.0 112.034 -172.09 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.15 -26.77 25.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.314 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.739 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 43.4 mt-10 75.04 -18.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 112.663 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.33 98.21 6.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 172.673 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.573 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.7 m-85 -118.4 142.47 47.52 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -108.53 -71.07 0.71 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.787 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -160.48 143.25 13.2 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 54.8 m 70.14 13.52 7.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.877 0.871 . . . . 0.0 112.664 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 61.5 mm-40 -74.73 130.24 39.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.5 p -122.68 129.36 75.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.779 0.8 . . . . 0.0 112.46 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 78.8 t -118.84 136.63 55.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.197 -174.281 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.547 ' OE1' ' HE3' ' A' ' 670' ' ' LYS . 36.2 tt0 -100.62 133.63 44.78 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.631 0.729 . . . . 0.0 110.667 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' A' ' 636' ' ' LEU . 42.4 m-85 -104.81 166.11 10.61 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.445 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 35.4 p90 -130.21 151.07 51.14 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 67.2 m -100.1 154.93 18.02 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 11.2 m120 -51.89 162.33 0.8 Allowed Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 125.888 1.675 . . . . 0.0 113.707 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -18.48 40.28 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.369 2.712 . . . . 0.0 113.534 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 19.7 ptt180 -117.67 -3.71 11.26 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.728 0.775 . . . . 0.0 112.171 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.643 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 59.1 m-85 -112.87 137.91 50.51 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.119 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 711' ' ' TYR . 51.8 mt -106.64 143.39 34.8 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.19 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.627 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.6 tpp -70.67 110.95 5.79 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.257 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 683' ' ' VAL . 83.3 tttt -101.66 -31.75 10.66 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -75.83 -175.06 37.76 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.661 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.573 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 40.5 Cg_endo -67.36 -11.24 31.47 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.581 2.854 . . . . 0.0 113.928 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.627 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.8 p30 62.2 -26.72 0.06 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 127.19 2.196 . . . . 0.0 115.15 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.547 ' HE3' ' OE1' ' A' ' 656' ' ' GLU . 88.1 mttt -117.74 134.77 54.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 123.102 0.561 . . . . 0.0 110.409 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.781 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -119.49 167.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.438 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -139.55 138.68 36.48 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 123.491 0.494 . . . . 0.0 110.243 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 43.4 t -84.67 107.03 16.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.78 -173.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -78.42 70.71 4.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.931 1.348 . . . . 0.0 112.719 -175.044 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.88 -54.57 0.22 Allowed Glycine 0 N--CA 1.416 -2.67 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.455 172.641 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -159.17 -166.97 1.95 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 90.6 m95 -80.81 161.64 24.39 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.812 0.339 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -75.46 -176.13 3.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.325 0.65 . . . . 0.0 112.017 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 32.9 m -63.19 115.22 4.31 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.159 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.781 ' HG ' HG21 ' A' ' 671' ' ' ILE . 5.7 mp -71.93 155.29 92.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.26 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.698 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 51.5 Cg_endo -68.55 179.73 2.89 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.142 2.561 . . . . 0.0 115.03 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 637' ' ' LEU . 2.2 p -136.54 137.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.319 -1.764 . . . . 0.0 106.66 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 95.3 m -111.16 133.96 53.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.75 146.39 33.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.273 -2.738 0 CA-C-O 121.291 0.567 . . . . 0.0 110.852 -178.155 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.413 -2.288 0 CA-C-O 122.272 1.034 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.6 m -89.52 -11.84 41.71 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.98 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.75 -89.68 0.57 Allowed Glycine 0 CA--C 1.472 -2.65 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.637 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 t70 -164.41 -167.61 1.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.528 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -68.72 130.79 91.58 Favored Pre-proline 0 N--CA 1.412 -2.33 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.144 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 41.9 Cg_endo -71.61 179.71 4.44 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.197 2.598 . . . . 0.0 111.607 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.76 124.32 49.43 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-O 121.667 0.746 . . . . 0.0 110.694 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.926 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.7 tp -100.06 133.56 44.28 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.8 -36.92 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -133.86 18.01 3.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.572 0.701 . . . . 0.0 111.512 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.926 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -128.02 176.51 18.04 Favored Glycine 0 N--CA 1.427 -1.96 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.841 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -157.3 -151.97 0.34 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.15 158.5 43.83 Favored 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.66 -168.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.515 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 11.8 mp0 -96.47 -61.67 1.39 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.439 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 715' ' ' VAL . 4.0 pp -103.42 153.34 20.6 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.071 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 694' ' ' ILE . 4.4 p -147.04 111.68 5.29 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.461 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 70.8 m -125.01 92.26 47.88 Favored Pre-proline 0 C--N 1.284 -2.239 0 CA-C-O 121.34 0.59 . . . . 0.0 111.747 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.3 154.97 12.54 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.697 2.265 . . . . 0.0 111.205 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.98 136.5 44.26 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.22 0.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.637 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.4 m-85 -82.14 101.48 10.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.445 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 3.3 m-85 -98.37 169.87 9.25 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.591 0.557 . . . . 0.0 109.76 176.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.518 ' HB3' HD21 ' A' ' 664' ' ' LEU . 4.5 t80 -54.6 138.5 41.01 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.296 175.004 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.94 42.74 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 118.894 -1.622 . . . . 0.0 113.905 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.46 172.6 13.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 119.006 -1.077 . . . . 0.0 109.839 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.01 158.71 37.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -173.263 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' A' ' 704' ' ' LEU . 16.1 t -142.51 138.52 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.831 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.405 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 50.7 mt-10 -95.66 122.42 38.41 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 123.406 0.441 . . . . 0.0 110.286 176.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.528 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -99.16 154.96 17.73 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 123.78 0.832 . . . . 0.0 110.024 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.515 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 56.2 t30 -144.8 150.26 36.87 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.0 t -104.57 160.21 15.12 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 27.4 m -67.24 142.66 56.85 Favored 'General case' 0 C--O 1.205 -1.264 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.54 -18.24 64.32 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -167.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 30.1 m -81.62 -3.24 52.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.43 1.11 . . . . 0.0 109.57 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 77.8 m-85 -126.37 151.27 47.86 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -114.96 131.97 56.72 Favored 'General case' 0 C--N 1.265 -3.084 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.507 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -85.29 138.04 32.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.39 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 132.72 -161.14 24.0 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -101.14 174.44 6.0 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.439 0.62 . . . . 0.0 111.101 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.24 -35.97 15.88 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 5.8 m -107.08 138.0 44.09 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.958 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.635 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -113.44 173.75 2.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.062 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 739' ' ' THR . 95.7 m -138.98 137.3 36.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 46.7 t -79.5 121.78 25.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.962 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 733' ' ' CYS . 49.5 mm -126.88 104.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.5 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 63.11 49.11 3.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.116 1.367 . . . . 0.0 112.018 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 83.06 -4.71 79.64 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.637 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.598 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.9 m95 -67.6 165.48 16.92 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.764 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 732' ' ' THR . 20.4 p -44.24 -70.29 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.65 -27.24 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 731' ' ' ILE . 17.9 mt 68.58 150.93 0.12 Allowed Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 124.598 1.159 . . . . 0.0 112.393 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.507 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 96.0 Cg_endo -78.68 -165.82 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.954 1.769 . . . . 0.0 110.361 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.9 143.64 32.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 71.5 m -93.62 151.82 19.42 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.535 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.74 145.04 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.95 127.33 32.46 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.041 0.448 . . . . 0.0 111.415 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.755 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 38.4 m -131.78 153.39 50.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -100.91 -135.22 8.83 Favored Glycine 0 N--CA 1.415 -2.753 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 52.3 Cg_exo -55.44 141.66 81.81 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.314 2.676 . . . . 0.0 112.622 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.15 153.75 74.58 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 123.05 2.5 . . . . 0.0 111.999 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.561 ' HG2' HD11 ' A' ' 681' ' ' LEU . 42.9 Cg_endo -70.31 -166.0 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.268 2.645 . . . . 0.0 111.941 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.99 158.96 15.93 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.28 0.562 . . . . 0.0 110.482 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.679 HD13 ' HG2' ' A' ' 682' ' ' PRO . 20.5 tp -102.09 139.68 37.39 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -39.38 -67.57 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 O-C-N 124.816 1.323 . . . . 0.0 112.263 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.66 -37.44 6.43 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.679 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -95.04 -147.4 22.58 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 640' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 636' ' ' LEU . 1.7 t-20 -169.0 -166.42 0.63 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.372 1.086 . . . . 0.0 111.123 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.07 135.36 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.678 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.6 ptpt -102.53 -10.26 19.48 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.585 0.707 . . . . 0.0 109.597 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -93.79 173.73 7.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -98.11 146.59 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.954 -176.703 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.584 HG22 ' HD2' ' A' ' 633' ' ' PRO . 18.7 p -72.88 126.77 30.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 648' ' ' GLU . 41.5 mtmt -105.38 -12.2 16.13 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 632' ' ' PRO 0.283 10.4 pt-20 58.15 -30.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 127.169 2.188 . . . . 0.0 113.782 -171.504 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.2 tt0 -98.31 95.65 7.51 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.468 ' C ' ' HG3' ' A' ' 653' ' ' GLU . 24.2 m-85 -114.5 -82.63 0.61 Allowed 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.895 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 98.05 -166.44 22.31 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -77.48 142.24 39.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.756 0.278 . . . . 0.0 111.21 -175.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 11.3 t 77.94 0.66 2.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.48 1.512 . . . . 0.0 113.38 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 29.7 mm-40 -70.51 133.68 47.01 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 18.0 t -109.63 150.29 12.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 123.557 0.535 . . . . 0.0 109.681 -176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 633' ' ' PRO . 25.0 t -132.97 134.85 57.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 124.038 0.935 . . . . 0.0 109.302 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -101.73 124.9 48.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.172 0.987 . . . . 0.0 111.524 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 57.3 m-85 -99.3 163.95 12.33 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.189 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.678 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 26.9 p90 -143.42 149.46 37.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.4 m -93.02 158.93 15.54 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.262 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.9 OUTLIER -56.18 156.1 11.39 Favored Pre-proline 0 C--O 1.208 -1.08 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.775 176.432 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 31.5 Cg_endo -59.53 -14.36 25.36 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 123.599 2.866 . . . . 0.0 115.404 -171.53 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.476 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 16.1 ptt180 -108.03 -7.1 16.23 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.409 0.623 . . . . 0.0 111.556 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 35.4 m-85 -109.6 139.33 44.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.178 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.5 mp -99.7 142.08 31.66 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.791 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.59 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.7 tpp -71.71 117.19 12.98 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.441 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.609 ' HB3' HG23 ' A' ' 683' ' ' VAL . 13.2 tmtt? -107.01 -25.23 11.69 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.715 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -103.22 -169.54 25.93 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.197 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.55 105.6 2.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.482 2.122 . . . . 0.0 111.274 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.8 p30 -69.74 -0.15 6.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.288 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 87.1 mttt -127.39 140.36 52.23 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.753 0.311 . . . . 0.0 110.52 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 681' ' ' LEU . 46.0 pt -129.88 165.07 30.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 20.9 tt0 -143.15 140.43 30.8 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 123.266 0.626 . . . . 0.0 110.625 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 18.5 t -78.6 110.54 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.046 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.58 -171.1 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.533 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.31 75.29 8.27 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.812 1.291 . . . . 0.0 111.475 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.95 -43.48 0.47 Allowed Glycine 0 N--CA 1.411 -3.016 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.644 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.11 -171.58 2.7 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -82.69 167.67 17.99 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.6 p -77.77 -172.23 2.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.917 0.389 . . . . 0.0 111.803 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.6 m -68.7 113.54 6.27 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 123.319 0.647 . . . . 0.0 111.759 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -61.77 148.63 87.01 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.78 173.535 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.679 ' HG2' HD13 ' A' ' 636' ' ' LEU . 89.4 Cg_endo -81.12 -177.22 3.56 Favored 'Trans proline' 0 CA--C 1.465 -2.929 0 C-N-CA 123.617 2.878 . . . . 0.0 112.517 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 666' ' ' LYS . 14.5 m -141.37 159.76 22.27 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.798 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.288 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 73.0 m -128.63 139.7 52.13 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.3 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 666' ' ' LYS . 32.1 pt -130.75 148.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--N 1.283 -2.283 0 CA-C-O 122.705 1.241 . . . . 0.0 110.509 179.394 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.412 -2.342 0 CA-C-O 121.368 0.604 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 38.7 m -108.49 -17.0 14.09 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.787 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.57 -80.45 0.27 Allowed Glycine 0 C--N 1.295 -1.745 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.959 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.486 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 10.5 t70 -173.43 -167.0 0.36 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.609 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -69.67 135.35 88.13 Favored Pre-proline 0 N--CA 1.407 -2.603 0 C-N-CA 123.327 0.651 . . . . 0.0 110.097 174.493 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 39.4 Cg_endo -70.67 -163.44 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.605 2.87 . . . . 0.0 111.991 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.99 126.18 51.82 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.141 0.496 . . . . 0.0 109.847 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.783 HD23 ' HA3' ' A' ' 700' ' ' GLY . 29.1 tp -112.58 135.47 53.26 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -39.82 -46.31 1.93 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.998 1.319 . . . . 0.0 113.906 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 94.6 m-70 -142.39 27.87 1.7 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.783 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.71 167.34 23.23 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.949 -177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.403 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 7.1 p-90 -157.15 -154.39 0.46 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.45 162.11 34.55 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.985 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -95.92 -57.23 2.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.518 0.675 . . . . 0.0 109.774 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 704' ' ' LEU . 3.9 pp -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 2.1 m -112.23 125.64 54.37 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 47.9 m -119.75 95.18 49.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-O 121.528 0.68 . . . . 0.0 112.353 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.417 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 7.0 Cg_endo -91.09 154.43 3.85 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.809 2.339 . . . . 0.0 111.964 176.335 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 89.8 Cg_endo -76.39 134.94 37.83 Favored 'Cis proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.753 -1.77 . . . . 0.0 111.043 -0.609 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 16.2 m-85 -76.17 97.82 4.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -102.44 174.93 5.68 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.225 0.536 . . . . 0.0 110.315 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.689 ' HB3' HD11 ' A' ' 664' ' ' LEU . 2.9 t80 -65.78 129.33 39.41 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.151 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.2 -7.68 60.35 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.05 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 713' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 732' ' ' THR . 9.5 t70 -84.49 171.29 12.66 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 3.8 m -136.72 147.39 46.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.226 0.536 . . . . 0.0 110.99 -171.785 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.459 HG11 ' CG1' ' A' ' 694' ' ' ILE . 48.3 t -138.17 144.49 30.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.379 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.0 mt-10 -101.55 131.11 47.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.609 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -105.63 157.93 17.06 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 123.784 0.834 . . . . 0.0 109.169 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -151.83 151.13 30.91 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.564 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.4 m -98.0 157.4 16.14 Favored 'General case' 0 C--N 1.26 -3.285 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 33.5 m -52.18 150.75 4.29 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 123.479 0.487 . . . . 0.0 110.273 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -32.11 62.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 42.7 m -91.09 12.97 18.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.78 0.8 . . . . 0.0 111.409 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 81.8 m-85 -128.12 146.54 50.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 747' ' ' ILE . 10.2 t -113.56 139.29 49.11 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.707 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 7.9 ptm -88.61 142.47 27.67 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.509 0.671 . . . . 0.0 110.97 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 53.8 mt -119.03 117.32 53.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.54 -143.64 14.77 Favored Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.61 135.13 42.53 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.813 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.62 -33.39 72.7 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.51 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.46 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.9 p -123.54 161.29 25.23 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.316 0.579 . . . . 0.0 111.676 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 7.0 pt -131.19 168.09 24.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.114 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 88.9 m -139.23 137.53 36.05 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 42.0 t -78.66 120.66 23.66 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.575 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.1 mm -126.37 105.97 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.304 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 70.29 30.54 3.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.561 1.145 . . . . 0.0 112.672 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.73 3.19 80.85 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.494 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.01 140.35 49.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -79.22 152.24 30.75 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 30.6 p -31.95 -66.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.85 -34.89 0.05 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 32.5 mt 67.98 150.69 0.12 Allowed Pre-proline 0 C--N 1.318 -0.771 0 O-C-N 125.08 1.487 . . . . 0.0 111.282 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.707 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 90.2 Cg_endo -81.55 -172.37 1.46 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.251 1.967 . . . . 0.0 110.547 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 24.5 pt20 -134.61 135.29 42.08 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.0 m -97.95 140.52 32.17 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.673 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.57 141.88 45.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.64 117.62 9.82 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.797 0.685 . . . . 0.0 111.788 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.0 mt . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 49.0 m . . . . . 0 C--O 1.234 0.272 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.29 166.6 12.09 Favored 'General case' 0 C--O 1.263 1.781 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.054 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.3 -130.52 7.03 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.94 147.29 91.99 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.106 2.537 . . . . 0.0 112.857 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' A' ' 655' ' ' VAL . 38.7 Cg_endo -65.1 160.25 42.71 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.74 2.96 . . . . 0.0 112.727 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.457 ' HG2' HD21 ' A' ' 681' ' ' LEU . 51.7 Cg_endo -74.36 -163.47 0.18 Allowed 'Trans proline' 0 C--O 1.253 1.247 0 C-N-CA 122.986 2.457 . . . . 0.0 110.133 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.45 160.24 20.87 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.749 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.663 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.4 tp -89.71 141.17 28.87 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.646 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 684' ' ' CYS . 32.7 tp -30.68 -59.59 0.2 Allowed 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.428 2.291 . . . . 0.0 113.321 172.979 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -119.56 -45.95 2.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.116 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -80.94 -154.74 11.1 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.63 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.1 -174.33 4.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.877 -0.778 . . . . 0.0 111.726 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.35 137.5 21.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 124.248 1.019 . . . . 0.0 109.108 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.3 ptpt -105.06 -7.73 18.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.66 0.743 . . . . 0.0 109.747 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.81 154.07 23.71 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.383 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 644' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 644' ' ' LYS . 18.9 ptmt -81.44 145.8 30.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 173.588 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.9 p -80.57 128.41 33.57 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.355 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.3 mtmt -102.76 -14.25 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 56.13 -16.14 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 C-N-CA 127.424 2.29 . . . . 0.0 115.404 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 646' ' ' LYS . 36.3 tt0 -122.6 85.56 2.44 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 6.3 m-85 -93.61 -77.35 0.45 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.611 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 117.39 -97.36 0.73 Allowed Glycine 0 C--N 1.305 -1.15 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.391 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -155.17 143.03 19.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 12.2 t 72.71 9.97 5.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.357 1.463 . . . . 0.0 110.778 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 20.6 mm-40 -75.94 126.5 31.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.7 m -107.03 143.49 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.389 0.614 . . . . 0.0 112.078 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 43.0 t -125.65 133.47 69.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.784 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.77 125.89 48.52 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.086 0.946 . . . . 0.0 111.043 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 61.9 m-85 -99.89 157.0 16.83 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.687 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.66 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 49.5 p90 -134.61 152.36 51.72 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.638 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.7 t -108.73 169.83 8.41 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.784 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.57 152.89 72.9 Favored Pre-proline 0 C--O 1.194 -1.85 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.918 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.8 16.79 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.821 3.014 . . . . 0.0 113.997 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 19.0 ptt180 -137.38 3.81 2.6 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.918 0.866 . . . . 0.0 110.049 173.201 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.441 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 59.7 m-85 -129.18 135.43 48.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.421 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 711' ' ' TYR . 11.7 mt -95.44 144.64 25.79 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.957 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.606 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.1 tpp -73.39 113.71 10.79 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.175 174.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.556 ' HD2' HD13 ' A' ' 685' ' ' ILE . 62.1 tttm -100.59 -45.93 5.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.382 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.66 -173.77 50.01 Favored Glycine 0 C--O 1.236 0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.089 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.67 107.27 2.15 Favored 'Trans proline' 0 CA--C 1.503 -1.058 0 C-N-CA 122.812 2.341 . . . . 0.0 111.252 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 8.3 p30 -70.58 -7.77 46.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.561 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 55.9 mtmt -118.61 123.29 44.65 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 122.005 0.907 . . . . 0.0 110.388 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 HD23 ' A' ' 681' ' ' LEU . 50.0 pt -110.34 167.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.061 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 22.7 tt0 -138.05 137.12 37.49 Favored 'General case' 0 C--N 1.277 -2.57 0 O-C-N 123.545 0.528 . . . . 0.0 110.207 -175.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.85 104.98 12.61 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.8 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.85 -174.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.924 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.09 83.61 7.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.791 0.805 . . . . 0.0 110.085 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 154.22 -47.0 0.54 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.119 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.92 -172.26 2.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -88.26 168.04 13.05 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -77.95 -172.88 2.88 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.714 0.293 . . . . 0.0 111.451 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 61.9 m -73.25 114.96 12.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.874 0.845 . . . . 0.0 111.088 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.646 HD23 HG21 ' A' ' 671' ' ' ILE . 66.2 mt -57.98 145.93 70.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.663 ' HG2' HD13 ' A' ' 636' ' ' LEU . 18.0 Cg_endo -66.03 177.65 2.9 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.179 1.919 . . . . 0.0 113.273 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 146.83 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.61 ' H ' HD23 ' A' ' 637' ' ' LEU . 34.6 m -119.78 144.26 47.39 Favored 'General case' 0 C--N 1.276 -2.626 0 O-C-N 124.353 1.033 . . . . 0.0 108.34 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.556 HD13 ' HD2' ' A' ' 666' ' ' LYS . 27.8 pt -142.74 143.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.275 -2.665 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.27 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.41 -2.472 0 CA-C-O 121.678 0.751 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.36 -9.84 29.09 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.83 30.64 7.84 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.492 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.697 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.9 t0 68.78 179.6 0.24 Allowed 'General case' 0 C--O 1.241 0.611 0 O-C-N 124.306 0.65 . . . . 0.0 110.241 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.611 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 3.4 mt -69.03 129.76 91.94 Favored Pre-proline 0 N--CA 1.406 -2.644 0 C-N-CA 123.354 0.662 . . . . 0.0 110.58 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.607 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -70.0 -179.52 3.08 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 123.33 2.687 . . . . 0.0 111.795 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.11 115.16 27.86 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.356 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.5 tt -90.19 137.14 32.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 698' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.8 pt-20 -35.9 -43.65 0.32 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.7 1.6 . . . . 0.0 113.039 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 49.1 m80 -144.36 25.7 1.51 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 719' ' ' CYS . . . -128.92 177.72 17.69 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.098 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 701' ' ' TRP . . . . . 0.421 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 16.8 p-90 -161.97 -158.44 0.54 Allowed 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.233 1.413 . . . . 0.0 107.625 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -140.26 156.04 46.63 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.257 -168.347 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.81 -68.0 0.82 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.865 0.728 . . . . 0.0 110.753 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.56 140.78 31.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.873 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.2 p -136.51 116.61 13.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.354 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 42.4 t -124.1 93.86 46.29 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-O 121.286 0.565 . . . . 0.0 110.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.436 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.7 153.04 10.18 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.806 2.337 . . . . 0.0 111.352 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.9 Cg_endo -73.29 135.91 42.07 Favored 'Cis proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.13 0.859 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.697 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 28.4 m-85 -80.31 98.77 7.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -93.65 173.35 7.73 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.951 0.782 . . . . 0.0 110.702 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.483 ' HB3' HD21 ' A' ' 664' ' ' LEU . 2.8 t80 -65.42 138.91 58.43 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.62 -14.15 65.86 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 118.001 -2.047 . . . . 0.0 112.693 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.64 167.2 21.97 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 117.479 0.639 . . . . 0.0 109.813 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -132.71 153.28 51.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.048 0.451 . . . . 0.0 110.172 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 694' ' ' ILE . 37.9 t -142.62 143.17 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.804 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -98.36 124.08 42.83 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.611 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.6 m-85 -104.54 167.91 9.43 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.138 0.975 . . . . 0.0 109.263 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -163.92 167.88 20.08 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.8 m -110.06 162.05 14.94 Favored 'General case' 0 C--N 1.263 -3.192 0 O-C-N 123.147 0.279 . . . . 0.0 111.172 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 32.6 t -56.83 155.19 8.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.917 0.76 . . . . 0.0 110.303 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -55.39 -44.18 75.9 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.144 0.978 . . . . 0.0 112.117 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 9.2 t -77.67 5.72 8.71 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.419 0.688 . . . . 0.0 111.852 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -130.16 156.0 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.761 0.424 . . . . 0.0 109.936 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.2 t -117.15 142.45 46.99 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.509 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -90.39 146.65 24.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.433 0.635 . . . . 0.0 111.163 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.64 118.36 56.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.13 -157.47 16.07 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -112.46 162.24 15.82 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 117.177 0.488 . . . . 0.0 110.56 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -81.59 -33.22 31.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 24.2 p -95.0 137.15 34.44 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.468 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 741' ' ' LEU . 10.0 pt -121.25 166.21 16.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.883 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 732' ' ' THR . . . . . 0.516 ' H ' HG23 ' A' ' 739' ' ' THR . 85.6 m -136.58 139.13 41.93 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 733' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.3 t -78.11 120.47 22.98 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.125 0.488 . . . . 0.0 111.976 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.6 mm -128.26 110.87 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.893 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 69.0 m80 65.81 30.25 10.15 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.602 1.161 . . . . 0.0 112.58 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.15 2.98 65.74 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.744 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.6 p -136.99 148.02 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.1 m95 -77.2 158.2 30.46 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 732' ' ' THR . 39.8 p -32.34 -72.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -28.24 0.03 OUTLIER 'General case' 0 C--O 1.243 0.713 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 731' ' ' ILE . 17.2 mt 69.1 152.02 0.13 Allowed Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.036 1.335 . . . . 0.0 111.578 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.509 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 57.4 Cg_endo -76.11 -169.56 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.964 1.776 . . . . 0.0 109.746 173.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.501 ' HA ' HD21 ' A' ' 697' ' ' LEU . 3.7 pt20 -135.85 150.58 49.44 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.8 m -110.8 134.93 52.09 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 145.66 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 123.335 0.397 . . . . 0.0 110.282 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.19 113.13 3.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 124.723 1.264 . . . . 0.0 111.684 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.311 -1.105 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.502 173.007 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.8 m . . . . . 0 C--O 1.24 0.575 0 CA-C-O 122.006 0.908 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.14 -169.97 1.55 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 631' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -115.46 -138.97 6.66 Favored Glycine 0 N--CA 1.41 -3.076 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.474 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.705 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 21.3 Cg_exo -62.55 150.85 86.24 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.854 2.369 . . . . 0.0 110.88 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.7 158.8 40.15 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.555 2.17 . . . . 0.0 112.083 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 671' ' ' ILE . 18.1 Cg_endo -75.53 -161.5 0.13 Allowed 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.881 2.387 . . . . 0.0 110.231 176.508 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.28 166.87 11.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.003 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.851 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.3 tt -103.55 140.58 37.33 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -36.98 -65.25 0.31 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.878 1.671 . . . . 0.0 111.676 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -108.49 -47.16 3.55 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.521 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -72.79 -155.71 3.02 Favored Glycine 0 C--O 1.242 0.639 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -171.0 0.53 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.73 132.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.416 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.501 ' HB3' ' CD2' ' A' ' 658' ' ' TYR . 18.3 pttp -102.51 -7.89 21.51 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.245 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -81.54 152.01 27.46 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.93 153.07 21.33 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 68.8 p -79.84 111.03 15.76 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.365 1.079 . . . . 0.0 112.081 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 646' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 13.2 mtpp -89.17 -26.7 21.14 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.96 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 53.0 mt-10 70.26 -30.21 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.604 1.562 . . . . 0.0 111.881 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 648' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 646' ' ' LYS . 33.6 mt-10 -91.94 82.91 5.13 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.264 0.554 . . . . 0.0 109.922 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 646' ' ' LYS . 16.2 m-85 -118.31 106.02 12.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -83.14 -67.92 1.45 Allowed Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.973 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -161.12 142.04 11.43 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 122.752 -0.263 . . . . 0.0 110.315 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 2.6 t 70.34 12.29 7.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 111.303 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 13.6 mm-40 -77.73 125.27 29.08 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.219 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 672' ' ' GLN . 15.6 m -110.01 144.96 17.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.196 0.522 . . . . 0.0 111.657 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.0 t -123.73 136.49 60.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -105.42 128.38 53.49 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-O 121.708 0.766 . . . . 0.0 109.415 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 47.4 m-85 -99.0 163.29 12.64 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.583 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 642' ' ' LYS . 45.5 p90 -133.82 155.04 50.53 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 5.8 t -101.78 163.61 12.16 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.109 -1.437 . . . . 0.0 108.863 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.28 155.51 26.2 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.789 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.26 14.53 0.22 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.601 2.867 . . . . 0.0 114.006 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 710' ' ' TYR . 11.8 ptt180 -137.99 -7.08 1.62 Allowed 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 32.8 m-85 -111.59 157.6 20.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.948 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.705 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.6 mp -111.11 135.59 51.41 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.163 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.549 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 54.0 tpp -71.23 119.34 15.22 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.71 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -105.26 -44.99 4.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.02 -171.98 48.36 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.506 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 36.3 Cg_endo -69.0 104.25 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.738 2.292 . . . . 0.0 111.429 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.549 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.5 p30 -71.7 1.07 7.34 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.592 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.5 mttt -128.65 136.74 51.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.2 pt -126.48 162.1 31.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.65 ' HB2' HG12 ' A' ' 654' ' ' VAL . 22.2 tt0 -133.88 139.75 46.39 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 123.344 0.658 . . . . 0.0 110.738 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.86 102.63 12.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.93 -172.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.84 73.7 4.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.673 1.225 . . . . 0.0 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.28 -36.95 0.93 Allowed Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.992 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.51 -178.77 7.59 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -92.23 164.81 13.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.665 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 34.4 p -77.92 176.27 9.27 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.554 0.161 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.0 m -57.05 118.6 5.16 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.413 0.625 . . . . 0.0 112.38 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.476 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -62.1 149.32 86.85 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.745 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.851 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 55.7 Cg_endo -71.51 179.33 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.853 2.368 . . . . 0.0 113.581 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.03 141.89 45.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 5.2 m -120.24 137.47 54.2 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.264 0.352 . . . . 0.0 111.099 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.6 pt -135.73 143.82 35.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 662' ' ' ARG . 14.3 p . . . . . 0 C--N 1.289 -2.025 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.411 -2.378 0 CA-C-O 121.164 0.507 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.2 m -86.84 -7.08 58.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.424 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.58 -78.38 0.64 Allowed Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.756 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.545 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 6.8 p-10 -157.57 174.47 15.31 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.671 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.5 mt -67.79 126.58 92.79 Favored Pre-proline 0 N--CA 1.422 -1.845 0 C-N-CA 123.694 0.797 . . . . 0.0 111.217 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -68.21 173.15 9.95 Favored 'Trans proline' 0 N--CA 1.433 -2.077 0 C-N-CA 123.186 2.59 . . . . 0.0 112.556 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.12 120.28 37.17 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.37 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' A' ' 700' ' ' GLY . 24.3 tp -99.72 129.34 45.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -51.14 -36.39 40.5 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 45.6 m80 -135.35 25.54 3.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.491 0.662 . . . . 0.0 109.875 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -135.79 179.08 18.16 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.919 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -161.1 -154.83 0.38 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.888 1.675 . . . . 0.0 106.499 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.29 150.73 49.04 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.787 -169.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.537 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 12.2 mp0 -88.57 -45.88 9.53 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.39 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.44 154.06 42.55 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.281 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.5 p -136.39 128.18 29.15 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.382 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 30.2 t -124.36 85.85 55.3 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-O 121.442 0.639 . . . . 0.0 109.886 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.557 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 10.9 Cg_endo -93.39 154.64 2.49 Favored 'Trans proline' 0 N--CA 1.431 -2.195 0 C-N-CA 122.994 2.463 . . . . 0.0 112.055 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 37.8 Cg_endo -67.97 133.6 22.97 Favored 'Cis proline' 0 C--O 1.235 0.364 0 C-N-CA 122.795 -1.752 . . . . 0.0 109.963 -3.362 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.545 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 39.9 m-85 -73.28 82.37 1.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -174.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 662' ' ' ARG . 8.1 m-85 -81.77 174.3 11.47 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 122.903 0.481 . . . . 0.0 111.188 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.705 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 39.3 t80 -62.98 140.55 58.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.943 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.38 70.21 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.389 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.39 166.97 22.02 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -132.86 144.4 50.17 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.163 0.506 . . . . 0.0 110.085 -171.393 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.595 HG11 HG12 ' A' ' 694' ' ' ILE . 45.5 t -130.13 138.22 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.913 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.64 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.6 mt-10 -106.17 120.92 43.07 Favored 'General case' 0 N--CA 1.409 -2.511 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.223 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.671 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -96.28 160.72 14.28 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 125.082 1.353 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.537 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -148.12 143.53 27.19 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 78.4 m -88.13 158.86 18.43 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 123.59 0.556 . . . . 0.0 109.661 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.2 t -61.93 148.93 42.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.25 145.57 56.06 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 36.4 m 85.52 -5.41 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 110.144 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.91 153.85 27.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.529 ' HB ' HD11 ' A' ' 747' ' ' ILE . 6.8 t -116.83 143.6 45.49 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.547 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.3 ptm -94.53 138.74 32.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.75 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.1 mt -105.9 116.97 50.77 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.149 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 105.55 -141.43 15.37 Favored Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.593 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -102.39 129.54 48.89 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.316 0.579 . . . . 0.0 110.636 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.144 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 0.2 OUTLIER -103.97 148.51 26.11 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.199 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.553 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -129.6 167.75 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.1 m -138.85 136.94 36.12 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.51 106.75 3.1 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 109.867 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 734' ' ' ILE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 711' ' ' TYR . 52.1 mm -122.61 112.18 33.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.008 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 58.31 29.74 18.54 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.711 0.804 . . . . 0.0 112.724 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.92 6.59 61.84 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.857 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.33 139.05 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -70.01 150.96 46.1 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -39.14 -75.06 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -173.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -29.06 0.07 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -171.155 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 731' ' ' ILE . 23.6 mt 68.49 156.33 0.15 Allowed Pre-proline 0 C--O 1.239 0.546 0 O-C-N 124.619 1.2 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.547 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 46.5 Cg_endo -81.84 -167.9 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.113 1.875 . . . . 0.0 111.47 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -130.21 130.22 44.37 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 21.5 m -98.8 129.17 45.19 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.208 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.89 145.73 34.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -73.81 115.09 12.84 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.608 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.529 HD11 ' HB ' ' A' ' 724' ' ' THR . 60.6 mt . . . . . 0 C--O 1.255 1.348 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 45.9 t . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 630' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 21.0 p -168.25 149.18 4.96 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.97 -139.71 10.9 Favored Glycine 0 N--CA 1.403 -3.515 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.198 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.951 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 44.8 Cg_exo -53.16 142.07 56.61 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.65 2.9 . . . . 0.0 112.824 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 655' ' ' VAL . 27.7 Cg_endo -61.01 151.34 78.97 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 123.073 2.516 . . . . 0.0 112.207 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.526 ' HG2' HD21 ' A' ' 681' ' ' LEU . 9.6 Cg_endo -63.3 179.54 0.84 Allowed 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.12 2.546 . . . . 0.0 112.722 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.1 145.73 24.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.854 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.4 tt -86.84 138.16 31.8 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -33.26 -65.63 0.17 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 126.196 1.798 . . . . 0.0 113.212 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 0.2 OUTLIER -135.77 30.98 3.08 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 123.976 1.846 . . . . 0.0 108.798 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.771 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.7 -156.87 7.07 Favored Glycine 1 C--N 1.241 -4.727 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.489 173.99 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -163.74 177.81 8.38 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.021 0.928 . . . . 0.0 109.965 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.49 140.16 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 123.241 0.616 . . . . 0.0 109.788 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -97.35 -11.98 23.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.077 0.465 . . . . 0.0 111.37 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.16 163.97 14.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.378 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -92.77 149.94 20.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.419 HG22 ' HD2' ' A' ' 633' ' ' PRO . 56.7 p -75.32 119.14 19.02 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.007 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -80.39 -20.71 43.4 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.951 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 65.51 -3.26 0.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.411 1.484 . . . . 0.0 114.993 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -148.93 95.06 2.35 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.419 ' HB2' ' SG ' ' A' ' 630' ' ' CYS . 16.6 m-85 -95.24 -68.84 0.78 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.212 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 111.7 -94.14 0.74 Allowed Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.408 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 31.9 t-80 -148.17 142.96 26.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.897 0.349 . . . . 0.0 110.661 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 59.7 m 69.74 11.15 7.8 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.326 1.45 . . . . 0.0 113.262 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 9.6 mm-40 -77.04 127.75 33.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.6 t -104.45 141.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 123.758 0.661 . . . . 0.0 109.409 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 42.9 t -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 123.28 0.632 . . . . 0.0 109.543 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 656' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 32.2 tt0 -102.98 131.69 49.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 122.096 0.95 . . . . 0.0 112.354 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.854 ' HB3' HD12 ' A' ' 636' ' ' LEU . 63.4 m-85 -110.24 164.99 12.12 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.835 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -139.54 151.13 45.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 99.3 m -89.56 162.45 15.66 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.877 0.37 . . . . 0.0 111.311 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.92 158.72 12.03 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.265 175.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.29 1.11 0.73 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 124.302 3.334 . . . . 0.0 117.134 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.486 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 17.2 ptt-85 -131.98 -2.26 3.65 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.289 173.376 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -100.61 143.72 30.43 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.057 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.695 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.7 mp -100.8 140.14 35.5 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.561 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.57 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 50.9 tpp -69.63 113.74 7.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.416 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.621 ' HB3' ' HB ' ' A' ' 683' ' ' VAL . 28.3 tptp -101.65 -12.2 18.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.993 0.901 . . . . 0.0 109.499 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 667' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -98.62 -171.35 31.73 Favored Glycine 0 C--N 1.293 -1.833 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.416 -177.007 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 668' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 88.6 Cg_endo -80.93 -5.91 13.11 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.068 2.512 . . . . 0.0 111.515 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.514 ' H ' ' HB3' ' A' ' 682' ' ' PRO 0.259 7.6 p30 57.82 -6.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.9 2.48 . . . . 0.0 115.764 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 656' ' ' GLU . 55.5 mtmt -130.92 141.84 50.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 118.283 0.492 . . . . 0.0 110.437 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.9 pt -131.76 169.87 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.897 -175.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.8 tt0 -137.08 140.7 42.16 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 122.843 0.457 . . . . 0.0 111.127 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 45.3 t -81.98 102.19 10.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.793 0.806 . . . . 0.0 109.689 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.99 170.16 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.73 70.95 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.841 1.256 . . . . 0.0 112.415 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 148.7 -30.81 1.25 Allowed Glycine 0 N--CA 1.405 -3.433 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.99 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.39 -177.53 3.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -86.13 174.95 8.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.579 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.3 p -89.38 -167.31 1.83 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.607 0.363 . . . . 0.0 111.419 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.4 m -65.54 112.21 3.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.044 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.3 mp -71.71 154.86 92.86 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.523 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.566 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 45.4 Cg_endo -68.09 175.95 6.0 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.433 2.089 . . . . 0.0 113.472 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 666' ' ' LYS . 50.5 t -129.06 151.08 35.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.606 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.4 m -132.11 123.71 27.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.66 141.64 45.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.408 -2.55 0 CA-C-O 121.421 0.629 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 42.5 m -81.62 -24.44 36.39 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.158 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.99 41.47 3.29 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 113.2 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.626 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 30.4 t70 66.26 176.87 0.22 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.504 0.722 . . . . 0.0 112.498 176.366 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.677 HG12 HG11 ' A' ' 715' ' ' VAL . 2.8 mt -73.87 131.0 82.23 Favored Pre-proline 0 N--CA 1.416 -2.173 0 C-N-CA 123.942 0.897 . . . . 0.0 111.005 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 717' ' ' PHE . 74.1 Cg_endo -73.82 -179.61 4.75 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.943 2.429 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -119.67 116.63 26.38 Favored 'General case' 0 C--N 1.262 -3.221 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.248 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.78 HD23 ' HA3' ' A' ' 700' ' ' GLY . 47.3 tp -82.37 139.81 33.86 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -46.33 -37.3 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -135.78 22.97 3.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.076 0.465 . . . . 0.0 111.259 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.72 167.4 23.21 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.075 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -156.58 -152.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.113 1.365 . . . . 0.0 107.33 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.22 148.46 48.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -167.253 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.539 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 5.3 mp0 -87.69 -42.36 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.946 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.57 160.47 35.2 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.718 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 5.6 m -148.35 117.62 6.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 59.1 m -116.1 98.4 51.2 Favored Pre-proline 0 C--N 1.28 -2.446 0 CA-C-O 121.397 0.617 . . . . 0.0 110.795 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.483 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.5 Cg_endo -93.6 151.83 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.584 0 C-N-CA 122.349 2.033 . . . . 0.0 111.389 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 71.4 Cg_endo -72.97 133.2 29.33 Favored 'Cis proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.122 -1.616 . . . . 0.0 111.444 0.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.626 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 30.9 m-85 -72.74 96.8 2.09 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.486 ' CD2' ' HB2' ' A' ' 662' ' ' ARG . 3.4 m-85 -99.42 175.09 5.97 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.695 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 6.3 t80 -62.1 141.38 58.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.75 71.83 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.685 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.43 169.6 17.95 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -134.02 149.61 51.19 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 110.384 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.677 HG11 HG12 ' A' ' 694' ' ' ILE . 43.7 t -137.9 142.21 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.593 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.81 120.31 41.9 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.496 ' CE1' HG23 ' A' ' 694' ' ' ILE . 1.9 m-85 -96.43 149.66 21.47 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 124.408 1.083 . . . . 0.0 110.36 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 53.1 t30 -136.4 152.3 50.47 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 46.6 t -91.86 166.31 12.8 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 48.5 t -58.42 157.59 8.6 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.254 0.549 . . . . 0.0 109.811 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.79 -35.87 82.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.506 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 15.1 m -90.82 5.42 48.48 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.204 0.525 . . . . 0.0 111.804 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -128.62 158.18 39.21 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.5 t -117.04 145.27 43.82 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.8 ptm -101.8 151.44 22.05 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.407 0.623 . . . . 0.0 110.797 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.0 mt -131.2 127.86 61.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.79 -153.46 16.63 Favored Glycine 0 CA--C 1.472 -2.614 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -98.75 119.01 36.78 Favored 'General case' 0 CA--C 1.465 -2.297 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.919 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -65.53 -27.38 68.41 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.178 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.6 p -107.91 147.73 30.59 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.344 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -127.35 163.41 30.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.324 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 56.7 m -134.62 136.73 43.11 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.49 114.29 15.05 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.466 0.65 . . . . 0.0 111.432 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.04 97.53 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.914 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 68.05 34.14 4.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.735 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 101.19 -15.21 57.99 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.405 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.77 133.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.491 ' CG ' HD12 ' A' ' 731' ' ' ILE . 88.3 m95 -72.35 152.76 41.87 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.2 p -37.43 -66.54 0.24 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -31.01 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 731' ' ' ILE . 21.4 mt 66.09 148.75 0.11 Allowed Pre-proline 0 C--N 1.316 -0.855 0 O-C-N 124.796 1.31 . . . . 0.0 110.992 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.13 -172.13 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.812 1.675 . . . . 0.0 110.089 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 725' ' ' MET . 10.5 pt20 -136.94 145.07 43.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 88.2 m -102.32 153.77 19.68 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.6 144.33 27.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.82 120.7 12.4 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 123.707 0.629 . . . . 0.0 111.199 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.252 1.235 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.165 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.532 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 8.0 p . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 28.6 p -175.91 146.36 0.71 Allowed 'General case' 0 C--O 1.253 1.238 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.62 -132.3 7.63 Favored Glycine 0 N--CA 1.414 -2.781 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.69 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.949 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 52.9 Cg_exo -53.77 140.34 67.37 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 124.002 3.135 . . . . 0.0 113.12 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.672 ' HD2' HG22 ' A' ' 645' ' ' THR . 21.7 Cg_endo -61.97 154.24 63.14 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.575 2.183 . . . . 0.0 111.093 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD11 ' A' ' 681' ' ' LEU . 14.6 Cg_endo -68.02 -168.81 0.21 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 122.517 2.145 . . . . 0.0 111.872 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.08 162.44 13.37 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.538 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.685 HD13 ' HG2' ' A' ' 682' ' ' PRO . 28.8 tp -101.19 138.18 38.56 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.014 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.46 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.5 tm? -27.75 -64.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.584 2.353 . . . . 0.0 111.731 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.36 -40.9 3.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.874 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -79.18 -128.77 0.6 Allowed Glycine 0 CA--C 1.504 -0.627 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.599 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -173.53 -175.6 1.15 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.0 p -99.5 144.64 11.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.5 ptpt -99.7 -16.72 18.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.122 0.487 . . . . 0.0 111.123 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 145.11 24.94 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.38 152.08 27.65 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-O 121.833 0.825 . . . . 0.0 112.543 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.672 HG22 ' HD2' ' A' ' 633' ' ' PRO . 39.9 p -73.65 118.16 16.27 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.679 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -83.79 -22.78 31.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.001 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.949 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 32.0 mt-10 63.69 18.28 11.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.672 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -157.97 101.29 1.77 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.676 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 34.7 m-85 -117.45 -73.48 0.64 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.268 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.08 -88.57 0.65 Allowed Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.739 -1.22 . . . . 0.0 113.885 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -146.61 142.38 27.88 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.22 0.51 . . . . 0.0 110.793 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.3 p 68.18 11.5 8.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.884 1.674 . . . . 0.0 113.102 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 39.0 mm-40 -78.86 129.16 34.26 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.604 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.9 OUTLIER -120.11 131.14 73.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 112.111 -176.474 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 67.4 t -121.41 137.9 53.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.195 -171.953 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.37 134.03 48.27 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 122.508 1.147 . . . . 0.0 112.269 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.0 m-85 -109.9 164.06 12.95 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.158 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 48.9 p90 -137.97 145.72 42.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.488 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 96.3 m -91.5 153.4 19.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 639' ' ' GLY . 4.2 m-20 -51.6 156.79 2.09 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.015 177.529 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.4 12.19 0.41 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 123.646 2.897 . . . . 0.0 112.801 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.642 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 40.4 ptt180 -133.35 0.34 3.35 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.793 0.806 . . . . 0.0 111.573 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 31.4 m-85 -125.03 150.6 46.59 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.57 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.736 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 5.9 mp -103.36 139.91 38.14 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.235 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.546 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.0 tpp -73.93 117.25 15.49 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.782 0.676 . . . . 0.0 109.206 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -101.27 -32.7 10.38 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.6 -174.98 48.84 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 114.981 -1.009 . . . . 0.0 114.1 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.36 -8.67 23.84 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 124.065 3.177 . . . . 0.0 112.854 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.546 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 7.3 p30 58.48 -0.95 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.081 2.153 . . . . 0.0 115.358 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.8 mtmt -136.74 138.41 40.92 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.986 0.357 . . . . 0.0 110.495 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.468 HG21 HD13 ' A' ' 681' ' ' LEU . 44.6 pt -126.13 171.59 14.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.54 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -143.77 141.14 30.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 122.701 0.4 . . . . 0.0 109.994 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 673' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 41.4 t -85.71 105.1 16.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.32 -171.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.24 84.96 3.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.861 1.315 . . . . 0.0 111.614 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.01 0.31 Allowed Glycine 0 N--CA 1.4 -3.744 0 CA-C-N 111.872 -2.422 . . . . 0.0 108.343 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.62 -172.97 4.37 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 678' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.6 m95 -78.42 159.68 28.16 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 41.1 p -75.82 -168.0 0.81 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.504 0.721 . . . . 0.0 112.236 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 91.8 m -77.26 116.85 18.23 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.446 0.641 . . . . 0.0 111.502 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.3 mm? -58.09 145.38 73.33 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.689 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.685 ' HG2' HD13 ' A' ' 636' ' ' LEU . 30.1 Cg_endo -70.31 -172.95 0.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.44 2.093 . . . . 0.0 112.503 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.26 142.41 35.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 70.8 m -115.78 133.01 56.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.43 139.65 51.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 123.372 0.42 . . . . 0.0 109.939 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.7 p . . . . . 0 C--N 1.29 -1.987 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 120.937 0.399 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.5 m -90.86 -3.1 57.63 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.644 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 92.32 -68.94 1.84 Allowed Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.887 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.5 t70 -177.51 -167.29 0.15 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -70.1 130.86 89.29 Favored Pre-proline 0 N--CA 1.413 -2.309 0 O-C-N 123.483 0.489 . . . . 0.0 110.482 174.808 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.558 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.9 Cg_endo -75.22 -176.37 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.42 2.747 . . . . 0.0 111.879 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -104.87 125.6 51.06 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.882 HD23 ' HA3' ' A' ' 700' ' ' GLY . 21.2 tp -104.05 136.27 44.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -52.17 -34.96 47.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 699' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 84.8 m-70 -139.79 22.33 2.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.728 0.775 . . . . 0.0 110.552 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.882 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.24 173.38 20.4 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.205 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -157.54 -154.25 0.44 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.912 1.685 . . . . 0.0 106.845 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -141.13 158.16 44.29 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.983 -168.498 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 718' ' ' ASN . 0.7 OUTLIER -98.92 -56.75 2.34 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -118.96 151.64 37.81 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.0 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.0 p -123.43 160.83 26.02 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.6 t -150.41 86.82 5.02 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-O 121.496 0.665 . . . . 0.0 109.74 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.562 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 12.5 Cg_endo -97.64 151.05 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.432 2.755 . . . . 0.0 113.374 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 58.2 Cg_endo -69.36 135.27 32.17 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.048 -1.647 . . . . 0.0 111.236 -0.145 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.0 m-85 -77.73 73.17 4.3 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.535 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.642 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 29.8 m-85 -84.36 176.97 8.34 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.736 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 20.3 t80 -62.69 139.0 58.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.971 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.37 54.88 Favored Glycine 0 C--N 1.296 -1.671 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.955 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.8 171.13 15.43 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.9 m -137.1 155.84 49.12 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.475 0.655 . . . . 0.0 110.626 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 694' ' ' ILE . 36.2 t -141.33 144.86 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.068 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.1 mt-10 -109.9 128.17 55.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.376 0.607 . . . . 0.0 110.482 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.3 m-85 -101.07 157.12 17.0 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.334 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.402 ' HB2' ' OE1' ' A' ' 703' ' ' GLN . 66.6 t30 -147.86 141.89 25.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.6 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.9 m -87.65 157.33 19.13 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.6 m -51.7 157.29 1.18 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.437 0.46 . . . . 0.0 110.858 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.83 -29.42 69.48 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -169.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 47.3 m -89.18 6.71 38.87 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 121.603 -0.686 . . . . 0.0 111.238 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -126.3 151.26 47.75 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 724' ' ' THR . . . . . 0.436 ' HB ' HD11 ' A' ' 747' ' ' ILE . 11.1 t -119.79 145.92 46.16 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.639 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 6.5 ptm -93.3 147.28 23.06 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.337 0.589 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 726' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 44.5 mt -119.75 127.57 75.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.37 -139.96 15.9 Favored Glycine 0 CA--C 1.479 -2.209 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -109.62 129.8 55.56 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.248 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -65.8 -29.49 69.99 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.277 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -107.98 149.18 28.7 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.698 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 741' ' ' LEU . 7.2 pt -126.42 170.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.339 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 91.7 m -139.28 138.17 36.51 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.7 106.18 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.53 0.519 . . . . 0.0 109.649 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.52 115.82 47.13 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.619 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 735' ' ' HIS . . . . . 0.4 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 55.4 m80 60.96 19.49 9.89 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.813 1.245 . . . . 0.0 113.242 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.74 8.0 54.87 Favored Glycine 0 C--N 1.31 -0.908 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.06 139.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.558 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.6 m95 -66.14 147.63 53.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -34.91 -71.88 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.74 -27.9 0.05 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 731' ' ' ILE . 19.6 mt 68.22 151.26 0.12 Allowed Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 124.51 1.131 . . . . 0.0 111.799 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.639 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 62.5 Cg_endo -80.11 -173.29 1.8 Allowed 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 122.638 2.226 . . . . 0.0 111.74 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 743' ' ' GLN . . . . . 0.553 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 23.6 pt20 -128.88 128.23 43.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 13.8 m -90.68 141.01 29.23 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.783 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.25 147.78 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.11 121.04 21.45 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.232 0.333 . . . . 0.0 111.214 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 747' ' ' ILE . . . . . 0.436 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.1 mt . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 629' ' ' SER . . . . . 0.567 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.7 m . . . . . 0 N--CA 1.436 -1.154 0 CA-C-O 120.813 0.339 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 22.4 p -96.24 162.74 13.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.26 -136.11 8.95 Favored Glycine 0 N--CA 1.407 -3.266 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 632' ' ' PRO . . . . . 0.841 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 33.6 Cg_exo -58.63 147.03 89.37 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.485 2.79 . . . . 0.0 112.607 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 633' ' ' PRO . . . . . 0.657 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.6 Cg_endo -62.07 158.8 37.25 Favored 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 123.408 2.738 . . . . 0.0 112.512 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 634' ' ' PRO . . . . . 0.587 ' HG2' HD21 ' A' ' 681' ' ' LEU . 22.0 Cg_endo -67.0 -156.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.608 2.872 . . . . 0.0 111.462 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -122.58 166.0 15.54 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.221 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.9 tp -103.57 141.74 35.49 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 638' ' ' ASN . 2.2 tm? -40.83 -67.26 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.013 1.446 . . . . 0.0 110.991 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 638' ' ' ASN . . . . . 0.45 ' HB2' HD12 ' A' ' 637' ' ' LEU . 4.9 t-20 -129.13 52.5 1.96 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.16 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 639' ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -176.16 -158.1 18.93 Favored Glycine 1 C--N 1.249 -4.256 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -167.86 -168.99 1.07 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.742 1.271 . . . . 0.0 112.027 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 641' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 643' ' ' GLU . 68.0 t -92.61 132.77 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.299 1.44 . . . . 0.0 110.022 -175.232 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 642' ' ' LYS . . . . . 0.469 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.9 ptpt -104.05 -1.88 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.282 1.039 . . . . 0.0 109.222 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 643' ' ' GLU . . . . . 0.414 ' H ' HG12 ' A' ' 641' ' ' VAL . 10.7 mm-40 -90.61 173.9 7.8 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.247 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -104.03 147.12 27.76 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.151 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 645' ' ' THR . . . . . 0.657 HG22 ' HD2' ' A' ' 633' ' ' PRO . 40.1 p -80.83 117.06 21.16 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.634 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -83.27 -25.97 31.11 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.637 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 647' ' ' GLU . . . . . 0.841 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 44.3 mt-10 73.01 -7.18 1.54 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.843 1.257 . . . . 0.0 113.579 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -145.73 100.73 3.46 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 649' ' ' TYR . . . . . 0.764 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 13.6 m-85 -94.74 -70.0 0.73 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.763 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 650' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.7 -111.13 1.78 Allowed Glycine 0 C--N 1.312 -0.789 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.878 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -142.57 135.11 27.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.8 m 76.33 15.53 2.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.66 1.184 . . . . 0.0 111.88 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 653' ' ' GLU . . . . . 0.764 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 54.9 mm-40 -80.7 135.13 35.96 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.819 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 654' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -114.66 151.16 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 655' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 633' ' ' PRO . 48.0 t -131.92 135.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.177 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -103.13 130.15 50.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.519 0.676 . . . . 0.0 110.785 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 657' ' ' TYR . . . . . 0.592 ' HB3' HD22 ' A' ' 636' ' ' LEU . 71.0 m-85 -106.77 161.4 14.7 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.844 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 658' ' ' TYR . . . . . 0.469 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 53.8 p90 -136.63 152.17 50.13 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 659' ' ' CYS . . . . . 0.623 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.2 m -97.95 169.13 9.85 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 660' ' ' ASN . . . . . 0.421 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.41 157.58 17.48 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 661' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 66.0 Cg_endo -72.04 7.6 1.66 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.778 2.985 . . . . 0.0 113.84 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 662' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 15.7 ptt180 -120.0 -9.58 9.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.766 0.793 . . . . 0.0 110.049 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 41.9 m-85 -119.93 161.34 21.05 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 664' ' ' LEU . . . . . 0.738 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.318 0.0 OUTLIER -130.26 141.35 50.63 Favored 'General case' 0 C--N 1.256 -3.493 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.732 179.895 . . . . . . . . 4 4 . 1 . 020 nuclear build core ' A' A ' 665' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.7 tpp -61.65 124.54 20.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.171 -177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 63.5 tttm -106.35 -49.77 3.28 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.18 -163.52 39.02 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.951 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.87 105.27 2.05 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.601 2.2 . . . . 0.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 669' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 6.5 p30 -72.49 4.99 3.28 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.199 -173.051 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 670' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 41.2 mtmt -132.27 128.98 38.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 671' ' ' ILE . . . . . 0.583 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -118.72 166.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 672' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 33.1 tt0 -134.52 137.61 44.0 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 123.657 0.598 . . . . 0.0 110.606 -175.532 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.47 110.18 17.97 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.955 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.96 -168.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.78 78.87 9.32 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.849 1.309 . . . . 0.0 111.66 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 146.45 -45.3 0.8 Allowed Glycine 0 N--CA 1.401 -3.668 0 CA-C-N 113.177 -1.829 . . . . 0.0 111.708 170.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.66 -168.78 3.0 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -102.0 168.4 9.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.7 p -78.67 -170.21 2.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.723 0.297 . . . . 0.0 111.194 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.1 m -71.14 112.56 7.38 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 121.267 0.556 . . . . 0.0 110.215 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 681' ' ' LEU . . . . . 0.587 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.5 mp -68.98 153.48 96.06 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.884 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 75.7 Cg_endo -73.19 -176.35 2.4 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.031 2.487 . . . . 0.0 112.442 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 11.2 p -145.27 146.65 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 684' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 636' ' ' LEU . 63.7 m -114.29 138.54 50.38 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 685' ' ' ILE . . . . . 0.44 HD13 ' HD2' ' A' ' 666' ' ' LYS . 21.9 pt -130.17 146.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 686' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 662' ' ' ARG . 9.1 p . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 26.2 m -93.21 -4.5 51.88 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.912 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 104.07 -90.21 0.72 Allowed Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 693' ' ' ASP . . . . . 0.476 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 p-10 -168.65 -172.89 1.75 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.476 1.11 . . . . 0.0 108.107 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 694' ' ' ILE . . . . . 0.627 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -64.87 126.73 91.67 Favored Pre-proline 0 N--CA 1.434 -1.258 0 CA-C-O 121.555 0.693 . . . . 0.0 112.559 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 695' ' ' PRO . . . . . 0.546 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 50.6 Cg_endo -71.28 -174.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.511 2.807 . . . . 0.0 112.065 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -108.44 113.87 27.26 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.297 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 697' ' ' LEU . . . . . 0.915 HD23 ' HA3' ' A' ' 700' ' ' GLY . 20.3 tp -92.04 135.83 33.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.0 -34.37 69.94 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -137.0 18.41 3.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.856 0.836 . . . . 0.0 110.376 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 700' ' ' GLY . . . . . 0.915 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -127.32 176.33 17.88 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.746 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -158.33 -154.41 0.43 Allowed 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 702' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.79 156.09 47.64 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 118.819 0.736 . . . . 0.0 112.611 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 703' ' ' GLN . . . . . 0.526 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 11.4 mp0 -96.37 -59.3 1.86 Allowed 'General case' 0 CA--C 1.496 -1.131 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.494 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 704' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.3 pp -114.6 127.71 55.93 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 694' ' ' ILE . 1.8 p -106.38 124.06 49.02 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.569 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.4 p -125.67 90.78 49.86 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 707' ' ' PRO . . . . . 0.46 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 5.9 Cg_endo -90.74 150.35 4.11 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.644 2.229 . . . . 0.0 111.657 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 708' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.1 Cg_endo -74.31 134.05 33.91 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.639 -1.817 . . . . 0.0 110.995 -1.222 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 709' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.2 m-85 -77.7 82.51 4.1 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 710' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 5.9 m-30 -87.46 166.53 14.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.257 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 711' ' ' TYR . . . . . 0.738 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 3.3 t80 -61.13 135.99 57.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.06 -22.28 41.66 Favored Glycine 0 C--N 1.296 -1.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.504 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.69 163.62 27.5 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 117.817 0.808 . . . . 0.0 109.095 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.3 m -136.41 147.91 47.51 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.122 0.487 . . . . 0.0 110.144 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 715' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 730' ' ' SER . 33.6 t -130.59 140.46 48.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.911 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 716' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.2 mt-10 -102.33 128.27 48.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.164 0.506 . . . . 0.0 111.029 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 717' ' ' PHE . . . . . 0.627 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -98.45 158.46 15.57 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 124.717 1.207 . . . . 0.0 109.707 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 718' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 63.2 t30 -144.61 145.16 31.64 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 719' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 96.9 m -96.25 158.06 15.61 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -57.28 150.9 16.99 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.47 -39.46 61.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -172.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.8 t -78.39 1.83 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.668 0.747 . . . . 0.0 111.149 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 723' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 80.3 m-85 -123.59 147.96 46.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -114.43 143.0 45.64 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 725' ' ' MET . . . . . 0.522 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.2 ptm -92.74 141.89 27.95 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.483 0.659 . . . . 0.0 110.489 -176.367 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 44.3 mt -114.81 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 123.53 -155.77 17.66 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.031 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -95.34 136.66 35.42 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 122.283 1.039 . . . . 0.0 108.407 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -70.32 -37.1 74.65 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.291 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 730' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.5 p -102.33 138.36 39.36 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-O 122.168 0.985 . . . . 0.0 113.368 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 731' ' ' ILE . . . . . 0.781 HG21 HD23 ' A' ' 741' ' ' LEU . 10.9 pt -115.97 167.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.3 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 44.0 m -134.02 137.33 44.65 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.32 103.94 1.38 Allowed 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.882 0.739 . . . . 0.0 109.778 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.9 mm -128.49 110.59 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.084 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 49.8 m80 68.63 21.4 7.95 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.73 18.93 39.05 Favored Glycine 0 N--CA 1.434 -1.433 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.365 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.15 154.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 738' ' ' TRP . . . . . 0.546 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.6 m95 -76.21 169.72 17.67 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 739' ' ' THR . . . . . 0.598 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 9.2 p -49.98 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 740' ' ' GLN . . . . . 0.598 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -161.54 -30.67 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.066 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 741' ' ' LEU . . . . . 0.781 HD23 HG21 ' A' ' 731' ' ' ILE . 22.2 mt 70.79 153.58 0.15 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.685 1.24 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 742' ' ' PRO . . . . . 0.522 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 73.4 Cg_endo -81.8 -166.41 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.622 0 C-N-CA 121.927 1.751 . . . . 0.0 110.034 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.71 147.25 38.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 744' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 8.8 m -104.21 143.83 32.42 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.89 137.16 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.35 117.09 6.16 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 110.387 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.311 -1.091 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.523 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -95.29 82.28 3.71 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -45.03 86.86 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.613 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -150.47 18.53 0.83 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -68.38 98.12 0.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -90.8 -27.12 20.41 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 163.326 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' A' ' 651' ' ' HIS 0.305 13.8 p 43.89 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 127.231 2.213 . . . . 0.0 115.402 172.99 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.484 ' CD ' ' H ' ' A' ' 629' ' ' SER . 0.2 OUTLIER -66.54 -90.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.47 172.381 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.484 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 15.8 p 166.48 133.9 0.01 OUTLIER 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.963 1.705 . . . . 0.0 109.584 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 30.5 p -137.83 142.11 40.79 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -94.6 -134.16 7.38 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.777 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 78.2 Cg_exo -53.56 146.54 42.64 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.818 3.012 . . . . 0.0 113.162 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 645' ' ' THR . 31.3 Cg_endo -65.71 158.07 55.44 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.537 2.158 . . . . 0.0 111.421 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.559 ' HG2' HD21 ' A' ' 681' ' ' LEU . 25.0 Cg_endo -71.79 -169.24 0.42 Allowed 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.96 2.44 . . . . 0.0 112.054 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.86 146.73 33.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 639' ' ' GLY . 2.9 tt -81.97 141.49 33.24 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -33.28 -69.83 0.08 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.859 1.663 . . . . 0.0 111.142 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 16.7 t-20 -108.81 -38.32 5.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.011 -1.075 . . . . 0.0 109.924 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -76.42 -151.28 3.71 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.166 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -169.28 179.51 3.91 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.681 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.9 p -98.92 142.6 14.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 123.312 0.645 . . . . 0.0 110.006 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.4 ptpt -97.01 -27.46 14.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.071 0.463 . . . . 0.0 110.777 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.29 142.62 35.97 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.637 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -83.56 159.47 21.65 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.398 0.618 . . . . 0.0 111.003 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 633' ' ' PRO . 21.3 p -73.42 122.81 22.7 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.759 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -96.76 -29.27 13.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.777 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 40.8 mt-10 71.47 -26.2 0.17 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 125.984 1.714 . . . . 0.0 113.041 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.17 42.21 1.09 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.041 0.536 . . . . 0.0 110.987 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.437 ' CA ' ' HG3' ' A' ' 653' ' ' GLU . 80.0 m-85 -69.85 -73.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 92.74 -68.09 1.81 Allowed Glycine 0 C--N 1.293 -1.809 0 C-N-CA 120.387 -0.911 . . . . 0.0 114.499 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.515 ' HB2' HG23 ' A' ' 627' ' ' VAL . 86.4 t60 -161.51 138.57 8.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 117.196 0.498 . . . . 0.0 112.168 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 26.1 m 63.9 13.86 7.92 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.904 1.681 . . . . 0.0 113.282 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 8.6 mm-40 -78.54 136.29 37.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.426 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 t -110.46 143.28 20.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 56.7 t -132.26 135.76 57.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.259 0.624 . . . . 0.0 109.866 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.92 132.48 49.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 122.174 0.987 . . . . 0.0 111.783 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.686 ' HB3' HD12 ' A' ' 636' ' ' LEU . 41.7 m-85 -108.52 166.74 10.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.596 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 45.6 p90 -137.13 160.09 39.98 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 69.6 m -98.31 169.36 9.62 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.653 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.49 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.53 165.27 3.14 Favored Pre-proline 0 C--O 1.2 -1.539 0 C-N-CA 124.329 1.052 . . . . 0.0 109.367 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 72.6 Cg_endo -75.59 12.88 1.26 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.749 2.299 . . . . 0.0 112.577 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.491 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 25.4 ptt180 -144.21 10.6 1.5 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.896 0.855 . . . . 0.0 110.041 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.491 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 45.5 m-85 -134.81 138.22 44.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.202 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 11.3 mt -104.28 154.75 19.42 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.332 0.586 . . . . 0.0 110.048 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.52 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 55.0 tpp -73.52 124.61 26.2 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.022 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -110.82 -25.76 9.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.969 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.05 -172.92 46.35 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.45 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.43 -9.76 24.58 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.377 2.718 . . . . 0.0 112.345 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.503 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 8.4 p30 55.96 -0.25 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 127.6 2.36 . . . . 0.0 115.947 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 31.8 mtmt -130.24 144.36 51.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.0 pt -136.11 167.64 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 123.425 0.453 . . . . 0.0 109.897 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.8 tt0 -135.87 140.56 44.23 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 123.751 0.821 . . . . 0.0 110.461 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.8 t -85.14 99.2 10.91 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.756 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.64 165.35 2.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.307 2.2 p30 -75.5 80.51 2.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 118.426 -1.31 . . . . 0.0 113.763 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.84 -40.26 0.5 Allowed Glycine 0 N--CA 1.419 -2.451 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.249 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -165.12 175.76 9.09 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -81.55 171.2 14.95 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.691 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 23.0 p -82.89 -165.62 1.11 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.59 0.234 . . . . 0.0 111.493 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 94.8 m -66.69 111.98 3.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -69.52 154.4 94.87 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.487 175.199 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.676 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 56.0 Cg_endo -69.62 -178.76 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.502 2.134 . . . . 0.0 114.444 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.7 145.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 86.7 m -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.55 140.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.3 p -74.58 127.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.594 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -76.55 -24.6 53.59 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.745 0.783 . . . . 0.0 109.946 179.501 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 61.69 46.28 7.25 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.524 1.53 . . . . 0.0 108.256 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.478 ' HB2' ' HG2' ' A' ' 687' ' ' GLU . 20.2 m -131.65 155.5 47.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.054 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 690' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 709' ' ' TYR . 18.7 p -127.05 154.9 44.08 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 120.978 0.418 . . . . 0.0 111.9 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 8.7 m -93.27 -2.75 54.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 99.2 -87.3 0.76 Allowed Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.765 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.6 t70 -158.45 -167.56 2.2 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.618 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -73.63 133.17 80.12 Favored Pre-proline 0 N--CA 1.407 -2.615 0 C-N-CA 123.899 0.879 . . . . 0.0 109.998 175.427 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.591 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 66.9 Cg_endo -73.68 -164.89 0.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.248 2.632 . . . . 0.0 111.301 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -117.7 142.08 47.65 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 3.5 tt -117.09 137.46 52.26 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.41 ' HG2' HD23 ' A' ' 697' ' ' LEU . 14.4 pt-20 -41.69 -40.01 1.84 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 113.113 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 97.1 m-70 -145.32 29.38 1.16 Allowed 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.567 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -133.3 170.38 22.28 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.567 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -158.54 -155.41 0.48 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -136.79 152.16 49.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -167.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 9.4 mp0 -92.44 -48.95 6.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.859 178.462 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.7 pp -124.83 152.92 43.33 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 12.4 p -147.88 124.17 10.89 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.319 1.048 . . . . 0.0 109.096 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.4 t -131.78 92.0 31.8 Favored Pre-proline 0 C--N 1.289 -2.052 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.601 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.415 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.7 Cg_endo -87.16 149.47 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 122.634 2.223 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 67.6 Cg_endo -74.82 132.94 29.17 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.133 -1.611 . . . . 0.0 112.493 0.272 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.765 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 46.6 m-85 -76.48 92.38 3.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.035 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 689' ' ' SER . 3.3 m-85 -79.68 166.72 21.54 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 123.548 0.53 . . . . 0.0 111.656 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.594 ' HB3' ' HG3' ' A' ' 687' ' ' GLU . 3.6 t80 -66.91 135.28 53.59 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.31 60.34 Favored Glycine 0 N--CA 1.402 -3.617 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.95 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.66 166.22 19.34 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.502 0.651 . . . . 0.0 110.885 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 0.9 OUTLIER -127.62 158.24 38.06 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.414 0.626 . . . . 0.0 111.157 -172.82 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.599 HG11 HG12 ' A' ' 694' ' ' ILE . 26.2 t -142.04 142.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.606 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -102.33 126.12 49.25 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 120.802 0.334 . . . . 0.0 110.102 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.6 m-85 -97.7 154.98 17.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.929 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.453 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 43.6 t-20 -137.23 135.74 37.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -177.502 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 95.6 m -93.48 144.24 25.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 177.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 63.1 m -56.68 161.77 2.62 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.91 140.37 55.49 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.762 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.7 m 79.12 -2.19 2.25 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 125.962 1.705 . . . . 0.0 111.712 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -116.56 140.17 49.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.947 -0.471 . . . . 0.0 110.419 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 9.2 t -108.24 141.73 39.57 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.59 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -91.03 137.98 31.95 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.23 0.538 . . . . 0.0 110.7 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.49 115.0 44.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.06 -154.38 20.24 Favored Glycine 0 CA--C 1.472 -2.623 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -94.63 130.2 41.19 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -63.19 -29.95 71.2 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.121 0.888 . . . . 0.0 111.624 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 6.0 p -113.95 152.9 30.18 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 121.602 0.715 . . . . 0.0 112.073 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 741' ' ' LEU . 7.7 pt -127.73 167.27 23.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.481 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 739' ' ' THR . 82.9 m -133.49 135.92 44.76 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.7 t -67.29 109.04 2.96 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.768 0.827 . . . . 0.0 110.471 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.6 mm -126.83 99.01 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.46 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 67.5 m80 66.56 30.07 8.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.525 1.13 . . . . 0.0 112.172 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 97.02 0.37 60.1 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.559 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.39 143.61 38.54 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.591 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -78.3 166.05 23.14 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 732' ' ' THR . 38.0 p -48.67 -69.46 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.19 -30.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 731' ' ' ILE . 20.2 mt 67.73 148.91 0.12 Allowed Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 124.856 1.347 . . . . 0.0 111.564 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.59 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 77.7 Cg_endo -80.77 175.28 10.17 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.016 1.811 . . . . 0.0 109.693 174.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 13.4 pt20 -121.88 134.93 54.87 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 4.4 m -102.47 122.72 44.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.72 149.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.55 112.62 4.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 124.161 0.913 . . . . 0.0 111.239 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 724' ' ' THR . 56.6 mt . . . . . 0 C--O 1.249 1.038 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 120.641 0.258 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -134.84 24.45 3.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.686 0.755 . . . . 0.0 108.993 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.55 -20.94 56.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.305 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -95.89 -49.58 5.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -162.68 142.1 9.12 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -91.0 -123.82 2.88 Favored Glycine 0 N--CA 1.426 -2.004 0 O-C-N 123.649 0.593 . . . . 0.0 112.007 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.586 HG13 ' CB ' ' A' ' 651' ' ' HIS . 58.8 t 57.26 80.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 122.46 1.124 . . . . 0.0 108.566 -172.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.522 ' OE1' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -82.39 -94.4 0.05 Allowed 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.353 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.1 p 173.08 152.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.89 0.876 . . . . 0.0 109.104 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.6 p -168.61 152.38 5.63 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.16 -138.41 9.66 Favored Glycine 1 N--CA 1.392 -4.253 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.422 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 51.0 Cg_exo -54.6 144.38 64.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.6 2.866 . . . . 0.0 112.891 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.7 Cg_endo -61.51 162.68 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.269 2.646 . . . . 0.0 112.895 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.528 ' HG2' HD21 ' A' ' 681' ' ' LEU . 32.2 Cg_endo -75.5 -165.42 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.548 2.165 . . . . 0.0 111.194 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.44 174.69 5.75 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.686 HD13 ' HG2' ' A' ' 682' ' ' PRO . 17.2 tp -109.36 144.55 37.39 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.75 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -32.66 -59.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.547 1.939 . . . . 0.0 111.784 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.3 t30 -120.2 -44.75 2.48 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.316 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -76.83 -152.79 4.89 Favored Glycine 0 CA--C 1.495 -1.19 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.393 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 658' ' ' TYR . 39.4 t30 -156.86 -178.25 7.22 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.364 -1.334 . . . . 0.0 110.152 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.26 146.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -111.0 -13.38 14.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.836 0.827 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 655' ' ' VAL . 15.6 mm-40 -79.89 134.94 36.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.635 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 644' ' ' LYS . 9.3 mmpt? -67.5 158.47 31.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.842 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 633' ' ' PRO . 65.4 p -107.11 151.09 25.84 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.318 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -99.5 -87.93 0.35 Allowed 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.933 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 12.1 pt-20 156.88 -36.21 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.434 0 C-N-CA 125.713 1.605 . . . . 0.0 107.956 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -126.07 107.87 10.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.854 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 7.7 m-85 -101.73 -72.19 0.69 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.753 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 114.85 -105.49 1.5 Allowed Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.545 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.586 ' CB ' HG13 ' A' ' 627' ' ' VAL . 27.2 t-80 -138.58 140.98 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.644 0.222 . . . . 0.0 110.494 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 41.3 m 72.82 15.8 4.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.006 1.322 . . . . 0.0 112.987 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.854 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 14.5 mm-40 -75.11 133.92 41.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 671' ' ' ILE 0.263 0.5 OUTLIER -125.91 134.28 66.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.824 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 53.7 t -125.14 143.38 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.136 0.974 . . . . 0.0 111.239 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.423 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 30.2 tt0 -104.62 133.49 49.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.865 0.841 . . . . 0.0 111.461 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 46.8 m-85 -105.48 166.58 10.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.415 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 640' ' ' ASN . 49.7 p90 -138.95 144.46 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 60.4 m -102.46 151.04 22.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.127 0.489 . . . . 0.0 110.183 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 15.0 m120 -52.48 159.96 1.48 Allowed Pre-proline 0 C--N 1.305 -1.358 0 C-N-CA 126.268 1.827 . . . . 0.0 114.739 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 56.6 Cg_endo -68.24 6.89 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 124.008 3.139 . . . . 0.0 113.737 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 18.7 ptt180 -140.54 -2.15 1.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.642 0.734 . . . . 0.0 111.535 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.708 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 51.9 m-85 -116.62 122.8 45.65 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.405 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 11.0 mt -85.73 142.05 29.28 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.524 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 35.8 ttm -77.96 110.34 12.8 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.105 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.682 ' HD2' HD13 ' A' ' 685' ' ' ILE . 55.5 tttm -99.3 -39.04 8.62 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.018 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.34 -153.56 9.04 Favored Glycine 0 CA--C 1.503 -0.669 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.806 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.689 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 39.9 Cg_endo -70.07 -148.84 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.229 1.953 . . . . 0.0 110.252 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.449 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 3.0 p30 -166.39 -28.31 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.888 -0.507 . . . . 0.0 110.096 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 97.3 mttt -112.75 124.15 51.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.166 176.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 681' ' ' LEU . 44.5 pt -109.24 166.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.656 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -137.78 141.57 40.89 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 123.052 0.541 . . . . 0.0 110.58 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.9 t -79.51 93.47 5.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.224 1.011 . . . . 0.0 108.429 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.19 163.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.232 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.522 ' HA ' ' OE1' ' A' ' 628' ' ' GLN . 6.0 p-10 -70.33 86.62 0.6 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.901 1.334 . . . . 0.0 111.484 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 149.64 -47.92 0.61 Allowed Glycine 0 N--CA 1.407 -3.284 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.34 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -158.36 -179.79 8.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.375 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -78.4 166.77 22.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.5 p -76.98 -174.94 3.32 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 120.998 0.428 . . . . 0.0 111.555 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 29.6 m -69.94 120.02 15.03 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.919 0.866 . . . . 0.0 111.263 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 671' ' ' ILE . 82.8 mt -66.87 146.56 99.11 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.153 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.689 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 34.8 Cg_endo -67.79 -173.87 0.53 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.051 2.501 . . . . 0.0 113.415 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.21 137.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 57.5 m -115.9 133.44 56.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.682 HD13 ' HD2' ' A' ' 666' ' ' LYS . 38.5 pt -130.27 136.57 58.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 122.917 0.487 . . . . 0.0 110.127 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.86 109.83 17.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.729 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' A' ' 711' ' ' TYR . 0.0 OUTLIER -64.29 -26.02 68.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.452 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.577 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 21.3 tt0 71.81 25.7 3.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.094 1.358 . . . . 0.0 112.192 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 6.7 t -122.27 163.31 19.88 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.1 p -121.18 155.78 33.8 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.446 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.89 -16.32 18.06 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.446 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 109.55 -79.85 0.26 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.44 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.408 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 15.9 t70 -173.61 -169.2 0.49 Allowed 'General case' 0 C--O 1.25 1.085 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.518 HG13 HG11 ' A' ' 715' ' ' VAL . 1.1 mp -67.75 138.35 93.15 Favored Pre-proline 0 C--N 1.285 -2.211 0 C-N-CA 124.141 0.976 . . . . 0.0 110.366 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.667 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -75.41 -165.74 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.659 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -123.73 122.05 37.07 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.739 -0.6 . . . . 0.0 110.046 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.703 HD23 ' HA3' ' A' ' 700' ' ' GLY . 31.6 tp -97.54 155.26 17.03 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.619 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 7.1 pt-20 -43.4 -40.9 3.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.551 1.14 . . . . 0.0 112.188 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.619 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 20.9 m80 -136.25 -40.78 0.65 Allowed 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.878 -173.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.703 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -75.65 168.27 54.79 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.479 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -150.71 -148.3 0.26 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.85 154.33 50.54 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.774 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.424 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 9.2 mp0 -90.9 -43.92 9.7 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 121.736 0.779 . . . . 0.0 109.437 -178.294 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.26 149.15 45.45 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.44 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 2.4 p -117.13 146.35 43.23 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.7 t -130.81 86.63 51.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-O 121.669 0.747 . . . . 0.0 111.896 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.448 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.8 Cg_endo -92.89 147.42 2.57 Favored 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.855 2.37 . . . . 0.0 111.984 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 98.6 Cg_endo -76.9 131.26 23.7 Favored 'Cis proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.604 -1.832 . . . . 0.0 111.161 0.825 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 27.0 m-85 -73.79 94.88 2.32 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 3.1 m-85 -98.91 172.43 7.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.651 ' HB3' ' HG2' ' A' ' 687' ' ' GLU . 1.1 t80 -65.92 138.11 57.62 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.47 68.74 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.266 -1.445 . . . . 0.0 112.416 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 732' ' ' THR . 23.8 t70 -76.17 165.71 24.51 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.4 m -134.24 146.08 49.74 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.199 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.518 HG11 HG13 ' A' ' 694' ' ' ILE . 40.8 t -135.58 147.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.448 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 29.5 mt-10 -111.1 127.29 55.51 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.738 176.683 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.7 m-85 -95.58 146.65 24.3 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 65.3 t30 -124.64 133.6 53.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 50.5 t -82.69 164.79 20.48 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.4 m -69.93 152.91 43.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.51 146.19 46.98 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.7 t 83.44 -2.16 1.17 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.886 1.674 . . . . 0.0 109.7 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -121.36 148.81 43.86 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.449 ' HB ' HD11 ' A' ' 747' ' ' ILE . 8.8 t -114.39 137.15 52.18 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.796 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.1 ptm -92.33 141.83 28.11 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.223 0.535 . . . . 0.0 109.944 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.28 120.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 130.34 -147.6 18.27 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -98.53 129.37 45.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.411 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -65.92 -27.88 68.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.293 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.568 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -115.18 157.48 23.59 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.065 0.459 . . . . 0.0 111.071 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 741' ' ' LEU . 6.6 pt -130.32 166.87 26.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.118 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 85.1 m -136.31 137.06 40.27 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -75.34 119.67 19.75 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.869 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.8 mm -127.58 110.15 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.601 -179.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 72.3 m80 70.75 26.99 3.71 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.415 1.086 . . . . 0.0 112.697 178.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.21 77.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.298 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.98 152.8 38.17 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.667 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 83.3 m95 -85.89 154.31 21.61 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 118.97 0.805 . . . . 0.0 109.721 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 732' ' ' THR . 31.9 p -33.56 -69.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.18 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 731' ' ' ILE . 29.9 mt 69.49 154.88 0.15 Allowed Pre-proline 0 C--N 1.322 -0.614 0 O-C-N 124.517 1.136 . . . . 0.0 111.47 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.568 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 68.7 Cg_endo -84.5 -163.71 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.407 2.071 . . . . 0.0 111.55 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 725' ' ' MET . 25.0 pt20 -139.94 155.27 47.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.45 141.59 44.81 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.931 0.396 . . . . 0.0 111.317 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.85 140.89 46.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.34 119.03 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.587 0.554 . . . . 0.0 111.446 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.449 HD11 ' HB ' ' A' ' 724' ' ' THR . 65.7 mt . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--O 1.24 0.562 0 CA-C-O 121.088 0.47 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -100.0 -163.06 0.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.704 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.922 ' HB3' ' HA ' ' A' ' 628' ' ' GLN . 10.1 tp10 -147.75 155.35 41.61 Favored 'General case' 0 C--O 1.251 1.143 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 57.18 -95.64 0.06 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.048 1.339 . . . . 0.0 112.631 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -161.57 88.06 0.7 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.258 0.623 . . . . 0.0 109.477 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 62.53 40.28 98.91 Favored Glycine 0 CA--C 1.505 -0.538 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 5.9 p -170.3 80.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 122.541 1.162 . . . . 0.0 108.116 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.922 ' HA ' ' HB3' ' A' ' 623' ' ' GLU 0.255 1.9 pp0? -67.64 -88.89 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.691 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.489 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 54.8 m -179.25 136.57 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.833 1.253 . . . . 0.0 109.944 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 31.5 p -164.36 135.83 4.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.12 -125.28 5.58 Favored Glycine 1 N--CA 1.386 -4.633 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.601 ' HB3' HG21 ' A' ' 645' ' ' THR . 32.4 Cg_exo -54.91 142.4 75.63 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.657 2.904 . . . . 0.0 114.232 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 645' ' ' THR . 38.1 Cg_endo -64.79 161.65 35.2 Favored 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.598 2.866 . . . . 0.0 112.239 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.514 ' HG2' HD11 ' A' ' 681' ' ' LEU . 32.6 Cg_endo -72.18 -164.15 0.17 Allowed 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 111.493 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.6 178.53 4.6 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 682' ' ' PRO . 27.6 tp -121.15 145.32 47.94 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 636' ' ' LEU . 14.0 tp -34.01 -68.66 0.11 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 126.056 1.743 . . . . 0.0 113.868 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -137.44 42.05 2.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 124.416 2.055 . . . . 0.0 107.848 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.22 -168.17 17.97 Favored Glycine 1 C--N 1.237 -4.932 0 CA-C-N 111.064 -2.789 . . . . 0.0 109.377 176.454 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 55.4 m-20 -155.97 178.45 10.26 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.142 0.471 . . . . 0.0 110.483 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 90.9 t -83.41 134.23 27.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.936 0.894 . . . . 0.0 108.66 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.641 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 15.0 ptpt -92.98 -20.75 20.28 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.297 0.57 . . . . 0.0 110.651 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.27 169.31 10.69 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.243 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 27.4 mmtp -109.11 147.59 32.19 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.908 0.385 . . . . 0.0 110.398 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.674 HG22 ' HD2' ' A' ' 633' ' ' PRO . 82.8 p -76.04 140.04 41.73 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -170.392 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -96.76 -8.54 31.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.94 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.44 ' OE2' ' HG3' ' A' ' 632' ' ' PRO . 27.6 mm-40 68.06 -24.73 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.787 1.635 . . . . 0.0 113.437 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.3 mt-10 -124.89 102.93 7.78 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 31.5 m-85 -113.27 -73.61 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 102.45 -68.61 0.35 Allowed Glycine 0 C--N 1.309 -0.954 0 C-N-CA 121.016 -0.612 . . . . 0.0 114.033 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -167.28 150.3 6.27 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 79.2 p 65.56 13.3 8.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.219 1.807 . . . . 0.0 112.893 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.5 mm-40 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.829 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.0 m -116.74 145.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 20.9 t -129.39 133.21 65.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.352 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.422 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 30.3 tt0 -101.14 126.52 47.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.963 0.887 . . . . 0.0 111.597 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.556 ' HB3' HD22 ' A' ' 636' ' ' LEU . 60.6 m-85 -97.54 158.53 15.43 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.005 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.641 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.3 p90 -137.14 146.98 45.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.538 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.3 m -92.1 160.76 15.05 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 33.1 m-20 -55.15 163.19 1.69 Allowed Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.03 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.35 8.43 1.82 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.759 2.972 . . . . 0.0 113.221 -173.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 15.5 ptt180 -128.07 -5.64 5.55 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.673 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 47.6 m-85 -117.81 144.17 45.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.431 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 4.8 mp -100.66 140.08 35.44 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.283 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.553 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 50.6 tpp -72.78 114.59 11.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -99.57 -34.17 10.34 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.51 -177.95 49.31 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.915 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.589 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 59.3 Cg_endo -70.71 -6.54 19.29 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 123.847 3.032 . . . . 0.0 113.734 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.295 6.8 p30 57.06 -35.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.916 2.486 . . . . 0.0 116.537 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 54.7 mtmt -103.4 135.87 44.22 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 111.477 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 681' ' ' LEU . 51.2 pt -121.35 166.37 15.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.812 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 31.2 tt0 -137.31 137.97 39.51 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 123.95 0.9 . . . . 0.0 109.676 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 45.3 t -83.0 113.99 20.96 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.63 -171.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.215 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.98 48.75 1.27 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -173.38 -42.03 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.934 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 678' ' ' TRP . 0.0 OUTLIER -166.9 -174.45 2.72 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 677' ' ' GLU . 89.7 m95 -79.76 169.08 18.46 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 679' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 672' ' ' GLN . 27.7 p -82.33 -176.0 5.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 21.0 m -60.13 114.2 2.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.197 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 671' ' ' ILE . 0.8 OUTLIER -63.08 153.82 79.73 Favored Pre-proline 0 N--CA 1.413 -2.315 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.372 177.93 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.715 ' HG2' HD13 ' A' ' 636' ' ' LEU . 36.4 Cg_endo -77.53 -176.14 3.06 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.558 2.172 . . . . 0.0 113.347 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.28 144.72 29.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.42 ' H ' HD23 ' A' ' 637' ' ' LEU . 83.3 m -119.62 136.86 54.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.69 143.31 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.4 p -87.3 136.28 23.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.852 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.45 ' HG2' HD21 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -68.48 -53.27 24.47 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.276 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 33.9 tt0 72.26 20.16 4.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.104 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 59.4 p -121.96 165.31 16.18 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 690' ' ' THR . . . . . 0.411 HG22 ' HD1' ' A' ' 710' ' ' TYR . 61.3 p -122.03 169.46 10.81 Favored 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.878 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 5.4 m -90.5 6.44 43.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.155 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 85.08 -82.1 1.71 Allowed Glycine 0 CA--C 1.489 -1.581 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.498 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.721 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.3 t0 -158.34 -173.42 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.661 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.7 mt -72.97 131.33 83.92 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 123.91 0.884 . . . . 0.0 111.875 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.601 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -73.97 -168.94 0.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.627 2.884 . . . . 0.0 112.371 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.41 122.19 46.5 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.384 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.585 HD13 ' HA3' ' A' ' 700' ' ' GLY . 5.0 tt -93.84 136.62 33.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.592 ' OE2' ' HB2' ' A' ' 743' ' ' GLN . 13.2 pt-20 -48.12 -38.43 17.79 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 39.7 m80 -142.48 34.07 1.46 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.14 -170.59 12.06 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.534 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -163.32 -152.26 0.2 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.022 1.729 . . . . 0.0 107.389 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.22 156.96 45.84 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.442 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -94.92 -70.63 0.7 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.45 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -98.65 139.53 34.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.672 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.5 m -132.48 122.3 24.69 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.9 t -128.77 94.88 33.52 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 0.0 110.551 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.454 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.4 Cg_endo -89.78 152.64 5.06 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 122.351 2.034 . . . . 0.0 111.885 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 59.1 Cg_endo -71.95 134.22 32.48 Favored 'Cis proline' 0 C--O 1.24 0.618 0 C-N-CA 123.151 -1.604 . . . . 0.0 111.15 -2.016 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.721 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.6 m-85 -79.38 88.87 4.98 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 4.8 m-30 -82.6 168.33 17.43 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.105 0.479 . . . . 0.0 111.391 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.6 t80 -60.84 133.97 56.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.88 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.7 -21.8 44.14 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.025 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.38 163.99 26.44 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-N 117.67 0.735 . . . . 0.0 110.014 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 4.8 m -125.46 161.95 25.96 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.21 0.528 . . . . 0.0 110.385 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.579 HG11 HG12 ' A' ' 694' ' ' ILE . 25.0 t -142.88 139.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.564 175.219 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.437 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 43.0 mt-10 -101.88 123.57 46.03 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.661 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.42 158.59 15.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.442 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 18.5 t-20 -134.39 147.81 50.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 34.5 t -102.76 141.79 34.99 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 37.6 m -58.47 143.76 44.54 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.7 -33.27 68.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.6 m -82.2 4.96 21.41 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.693 -0.629 . . . . 0.0 111.339 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 97.6 m-85 -125.35 158.99 32.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 5.4 t -116.87 131.79 56.86 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.712 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.5 ptm -87.96 136.75 32.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.587 0.708 . . . . 0.0 110.283 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 55.4 mt -107.74 116.21 50.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.362 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.29 -151.19 18.54 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 17.0 p80 -108.44 156.04 19.9 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 32.0 ptt180 -86.08 -28.33 24.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 6.7 m -91.42 145.25 24.79 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.557 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.656 HG21 HD23 ' A' ' 741' ' ' LEU . 6.0 pt -125.61 174.07 10.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.342 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 86.7 m -141.37 136.28 31.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.29 108.79 3.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.418 0.687 . . . . 0.0 111.011 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.4 mm -123.3 104.04 13.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 121.257 0.551 . . . . 0.0 111.093 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 66.76 19.9 10.69 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.644 1.178 . . . . 0.0 112.368 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 104.14 -3.6 44.39 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.917 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.11 133.19 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.601 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -68.33 153.91 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 35.8 p -37.05 -69.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.56 -32.05 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.656 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 68.34 153.25 0.13 Allowed Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 124.753 1.283 . . . . 0.0 111.392 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.28 -173.4 1.64 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.767 1.644 . . . . 0.0 109.657 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.592 ' HB2' ' OE2' ' A' ' 698' ' ' GLU . 24.0 pt20 -134.39 153.58 51.83 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 86.7 m -117.08 134.81 54.3 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 123.309 0.38 . . . . 0.0 110.963 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.18 143.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.12 116.41 5.36 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 124.225 0.953 . . . . 0.0 110.893 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.045 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -119.03 -26.78 5.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.94 -38.2 61.81 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.289 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -86.57 98.63 11.19 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.596 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -82.01 120.71 25.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -73.28 -88.7 0.17 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 40.2 t 50.62 70.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 123.179 1.466 . . . . 0.0 108.802 -167.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -80.06 -97.1 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 112.332 -2.213 . . . . 0.0 112.149 -175.485 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.492 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 34.8 p 176.62 159.58 0.34 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 14.0 p -171.66 142.62 1.61 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -88.52 -144.15 9.76 Favored Glycine 0 N--CA 1.396 -3.975 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.898 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.727 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 41.1 Cg_exo -54.11 148.02 41.59 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 123.788 2.992 . . . . 0.0 112.117 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.629 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.3 Cg_endo -62.76 156.05 55.79 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.578 2.186 . . . . 0.0 111.784 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.503 ' HG2' HD11 ' A' ' 681' ' ' LEU . 23.1 Cg_endo -67.76 -172.61 0.41 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 122.482 2.121 . . . . 0.0 111.038 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.16 152.96 22.78 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -89.07 134.09 34.13 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 56.7 tp -22.16 -56.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.554 2.342 . . . . 0.0 113.757 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.4 t30 -125.94 -39.64 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -71.27 -155.17 1.82 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.405 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -168.84 177.76 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.04 -0.683 . . . . 0.0 111.033 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.66 147.17 5.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 124.823 1.249 . . . . 0.0 109.05 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -109.27 -12.17 14.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.052 0.453 . . . . 0.0 111.12 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.75 165.79 13.96 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.364 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -77.7 150.8 34.44 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.308 0.575 . . . . 0.0 110.874 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.629 HG22 ' HD2' ' A' ' 633' ' ' PRO . 28.7 p -84.52 114.36 21.9 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.785 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 45.7 mtmt -86.8 -15.17 40.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.382 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.727 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.0 mt-10 65.88 -6.53 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.68 86.29 1.39 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.438 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 17.5 m-85 -83.88 -74.13 0.39 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.045 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 117.52 -104.79 1.2 Allowed Glycine 0 C--O 1.211 -1.334 0 C-N-CA 119.84 -1.172 . . . . 0.0 113.252 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.753 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 34.7 t-80 -137.68 138.1 39.05 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.864 0.332 . . . . 0.0 110.337 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.5 m 69.32 16.34 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.205 . . . . 0.0 112.467 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 16.2 mm-40 -82.73 126.07 31.96 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.1 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.9 m -107.4 149.82 10.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.135 0.493 . . . . 0.0 111.881 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 45.3 t -130.65 132.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.478 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 34.4 tt0 -98.95 130.38 45.31 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 122.096 0.951 . . . . 0.0 112.236 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.72 ' HB3' HD12 ' A' ' 636' ' ' LEU . 59.4 m-85 -107.81 169.25 8.72 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.688 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -140.94 155.65 46.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 68.2 m -99.05 159.47 14.94 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.298 0.571 . . . . 0.0 110.061 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.86 157.76 28.05 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.832 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.43 -2.22 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 123.281 2.654 . . . . 0.0 115.117 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.29 -0.51 5.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.356 1.074 . . . . 0.0 110.972 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 31.1 m-85 -112.68 137.78 50.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.592 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 711' ' ' TYR . 9.8 mt -104.77 146.41 29.01 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 43.0 ttm -79.91 123.65 27.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.967 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -112.53 -34.79 5.74 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.02 -149.01 8.13 Favored Glycine 0 CA--C 1.504 -0.617 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.031 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.591 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 55.5 Cg_endo -72.93 -147.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.277 1.985 . . . . 0.0 109.361 171.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.48 ' HB3' ' SD ' ' A' ' 665' ' ' MET . 4.9 p30 -161.45 -28.4 0.05 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 122.104 -0.373 . . . . 0.0 110.505 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.9 mtmt -115.64 134.52 54.96 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.242 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.5 pt -117.43 169.12 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.3 tt0 -137.15 139.06 40.91 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 123.338 0.398 . . . . 0.0 110.222 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.07 103.55 14.85 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.87 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 628' ' ' GLN 0.291 3.0 p-10 -77.71 80.15 4.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.004 1.383 . . . . 0.0 113.492 -177.729 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 153.87 -54.33 0.44 Allowed Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.391 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.11 -171.15 3.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.53 -176.85 6.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.103 0.478 . . . . 0.0 112.009 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.7 p -97.94 -166.77 1.42 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.11 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 23.1 m -69.78 117.36 11.27 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.195 0.521 . . . . 0.0 111.362 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.503 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.6 mm? -68.66 151.08 97.44 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.414 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.591 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 71.3 Cg_endo -80.73 176.94 8.55 Favored 'Trans proline' 0 CA--C 1.474 -2.516 0 C-N-CA 123.456 2.77 . . . . 0.0 111.787 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.81 151.89 35.19 Favored 'Isoleucine or valine' 1 N--CA 1.352 -5.361 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.638 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 71.3 m -123.58 136.01 54.29 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.26 140.19 49.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 688' ' ' GLU . 12.5 p -76.64 127.47 37.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 664' ' ' LEU . 7.9 pt-20 -73.93 -18.49 60.89 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 116.012 -2.275 . . . . 0.0 110.409 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.52 ' H ' HG22 ' A' ' 686' ' ' VAL . 5.4 tp10 63.72 21.15 12.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.085 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 687' ' ' GLU . 15.7 m -127.29 165.07 20.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 37.6 p -129.59 174.48 9.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.36 -1.47 44.41 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.366 0.667 . . . . 0.0 111.079 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 91.32 -82.15 1.26 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 27.9 t70 -159.98 178.09 10.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.602 HG12 HG11 ' A' ' 715' ' ' VAL . 3.5 mt -68.73 131.43 91.25 Favored Pre-proline 0 N--CA 1.42 -1.943 0 C-N-CA 124.454 1.101 . . . . 0.0 111.556 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.4 Cg_endo -74.14 -176.43 2.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.296 2.664 . . . . 0.0 111.24 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.57 136.75 52.47 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 121.255 0.55 . . . . 0.0 109.683 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.9 tt -109.97 142.54 41.21 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.8 pt-20 -46.19 -36.65 6.21 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.672 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 34.7 m80 -146.48 21.55 1.33 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.239 0.542 . . . . 0.0 109.889 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -127.33 175.4 18.18 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.549 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -163.26 -159.38 0.53 Allowed 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -138.58 145.92 41.18 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.613 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -88.65 -51.87 5.45 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.632 0.729 . . . . 0.0 109.388 -178.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.43 150.69 32.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.074 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.1 p -137.85 127.46 25.13 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 124.391 1.076 . . . . 0.0 108.936 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.9 m -123.78 81.32 55.5 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.514 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.501 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.3 Cg_endo -91.87 144.15 2.9 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 123.111 2.541 . . . . 0.0 112.024 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.5 Cg_endo -71.89 129.01 15.65 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.006 -1.664 . . . . 0.0 111.239 -0.241 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 23.6 m-85 -74.43 94.07 2.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.223 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.08 161.15 19.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 117.923 0.328 . . . . 0.0 111.403 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.659 ' CD1' HD22 ' A' ' 664' ' ' LEU . 0.1 OUTLIER -61.16 135.07 57.64 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.77 -12.36 59.37 Favored Glycine 0 N--CA 1.403 -3.521 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.821 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -92.81 179.81 5.36 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -140.62 161.94 36.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.618 0.723 . . . . 0.0 111.783 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.602 HG11 HG12 ' A' ' 694' ' ' ILE . 20.4 t -139.21 145.15 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.146 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 35.8 mt-10 -105.82 129.2 54.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.308 0.575 . . . . 0.0 110.526 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.59 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -109.12 153.08 24.21 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.957 1.703 . . . . 0.0 108.69 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -150.4 160.41 43.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 92.2 m -96.56 156.51 16.31 Favored 'General case' 0 C--N 1.27 -2.877 0 O-C-N 123.68 0.612 . . . . 0.0 110.484 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 25.8 m -67.25 162.56 22.4 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.868 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.83 147.24 53.51 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 35.2 t 87.35 -10.97 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.57 1.948 . . . . 0.0 108.413 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 71.7 m-85 -120.97 147.01 46.06 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-O 121.399 0.619 . . . . 0.0 110.73 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.9 t -115.5 147.14 41.0 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.485 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.0 ptm -96.57 146.85 24.45 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.067 0.46 . . . . 0.0 111.001 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 29.2 mt -126.22 116.61 46.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.4 -139.65 11.12 Favored Glycine 0 CA--C 1.479 -2.181 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.987 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -111.69 131.94 54.95 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.987 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -62.69 -32.78 73.92 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 124.303 1.002 . . . . 0.0 111.699 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 32.4 p -108.54 149.35 28.97 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.886 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 12.7 pt -125.25 166.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.393 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 739' ' ' THR . 45.1 m -131.85 136.87 47.79 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 48.4 t -71.21 107.2 4.11 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.909 0.756 . . . . 0.0 109.306 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 737' ' ' VAL . 51.4 mm -127.74 108.8 18.71 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 36.8 m80 68.98 20.2 7.91 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.46 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.06 60.82 Favored Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.462 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 734' ' ' ILE . 3.5 m -122.57 150.27 26.26 Favored 'Isoleucine or valine' 1 N--CA 1.37 -4.432 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.778 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.4 m95 -83.9 153.79 23.77 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 732' ' ' THR . 37.8 p -35.71 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -175.26 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.29 -29.27 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 17.8 mt 70.2 149.61 0.12 Allowed Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 124.65 1.219 . . . . 0.0 111.863 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 61.5 Cg_endo -77.38 -178.67 4.76 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.282 1.988 . . . . 0.0 110.479 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.53 140.26 51.89 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 20.3 m -100.78 142.57 32.06 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.823 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.99 141.92 43.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.02 118.4 10.42 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 123.721 0.638 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--O 1.261 1.679 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.206 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -79.8 -38.44 33.0 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.35 98.54 8.89 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -100.74 120.22 39.77 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.352 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -102.06 96.3 6.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -93.74 92.4 1.59 Allowed Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.752 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 85.8 t -156.05 68.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.424 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -69.9 -29.87 67.16 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.183 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 18.0 t 79.19 120.82 0.05 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 126.309 1.843 . . . . 0.0 110.449 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.6 p -110.59 171.79 7.25 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.025 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -106.38 -132.71 7.2 Favored Glycine 0 N--CA 1.4 -3.722 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 23.5 Cg_exo -63.94 145.04 89.58 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 123.281 2.654 . . . . 0.0 112.603 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.75 157.08 49.49 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 123.158 2.572 . . . . 0.0 112.29 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.539 ' HG2' HD11 ' A' ' 681' ' ' LEU . 34.3 Cg_endo -68.8 -164.58 0.11 Allowed 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 123.192 2.595 . . . . 0.0 111.627 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.57 164.83 11.75 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.795 -0.566 . . . . 0.0 110.516 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.735 HD13 ' HG2' ' A' ' 682' ' ' PRO . 31.9 tp -104.13 147.74 27.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 636' ' ' LEU . 6.0 tt -35.54 -65.8 0.22 Allowed 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 127.503 2.321 . . . . 0.0 111.286 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 18.0 t-20 -115.7 -43.44 3.02 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.38 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -88.54 -146.01 11.9 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -165.37 -170.51 1.89 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.204 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.5 p -101.23 143.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 123.691 0.796 . . . . 0.0 110.575 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.1 ptpt -101.34 -16.67 16.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.344 0.592 . . . . 0.0 110.515 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -81.75 128.71 34.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.351 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 150.85 48.67 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.559 0.695 . . . . 0.0 111.997 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 31.8 p -76.5 124.96 28.38 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.832 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 648' ' ' GLU . 47.5 mtmt -99.82 -12.28 20.03 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.105 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 43.4 mt-10 67.92 -12.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.11 1.364 . . . . 0.0 113.841 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.1 tt0 -148.91 108.49 3.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.834 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 4.5 m-85 -105.75 -65.85 1.03 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 127.81 -117.55 2.65 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 26.2 t-80 -138.38 157.32 46.46 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.6 p 62.59 12.16 5.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.408 1.483 . . . . 0.0 113.104 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.834 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 9.0 mm-40 -76.5 136.64 39.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.297 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 t -112.27 139.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 9.7 t -126.3 137.7 56.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 123.679 0.792 . . . . 0.0 109.585 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.5 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 32.8 tt0 -109.15 127.49 54.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.818 0.818 . . . . 0.0 111.342 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 64.8 m-85 -97.45 164.32 12.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.288 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 31.6 p90 -135.4 149.48 49.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.501 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.3 m -95.52 160.03 14.71 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.21 155.33 9.31 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.888 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.05 11.01 0.34 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 123.388 2.725 . . . . 0.0 113.3 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.721 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 22.0 ptt180 -126.51 -6.48 6.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.858 0.837 . . . . 0.0 111.37 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.415 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 40.4 m-85 -122.36 146.45 47.31 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.514 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 711' ' ' TYR . 6.4 mp -105.14 146.45 29.17 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.983 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.4 tpp -75.07 116.89 16.31 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.489 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 685' ' ' ILE . 63.8 tttm -102.45 -37.51 7.98 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.339 0.59 . . . . 0.0 110.62 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.73 -172.25 42.43 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.374 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.6 108.87 2.65 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.312 2.008 . . . . 0.0 110.49 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 24.5 p-10 -71.96 -10.24 59.5 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.309 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 35.7 mtmt -114.92 129.45 56.71 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.351 0.596 . . . . 0.0 110.69 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.707 HG21 HD12 ' A' ' 681' ' ' LEU . 48.5 pt -124.72 165.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.878 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.5 tt0 -137.53 139.83 40.72 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.092 0.557 . . . . 0.0 110.381 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.43 105.88 14.73 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.81 -171.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.42 77.97 1.9 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.084 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 140.4 -39.3 1.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.359 172.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.92 -179.53 7.08 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 122.634 -0.333 . . . . 0.0 110.281 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.81 161.62 15.2 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.1 p -71.74 -170.36 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.339 0.59 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 18.9 m -69.21 112.75 6.0 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.939 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.707 HD12 HG21 ' A' ' 671' ' ' ILE . 1.8 mp -61.19 149.86 81.13 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.508 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 636' ' ' LEU . 37.2 Cg_endo -75.65 -173.49 1.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.249 2.632 . . . . 0.0 114.414 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.2 t -140.18 138.79 37.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 81.0 m -111.55 136.72 50.35 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.501 HG21 ' HD2' ' A' ' 666' ' ' LYS . 30.1 pt -132.83 139.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 123.536 0.523 . . . . 0.0 110.047 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 688' ' ' GLU . 12.0 p -84.04 128.04 39.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 664' ' ' LEU . 4.1 pt-20 -77.28 -18.94 57.15 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 118.9 -1.12 . . . . 0.0 109.333 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.693 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.261 11.4 pt-20 61.16 1.75 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 128.269 2.628 . . . . 0.0 115.149 176.75 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 23.2 m -97.15 144.79 26.64 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 59.2 p -113.34 165.89 12.01 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.364 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.3 m -91.21 -8.66 47.87 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.734 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.86 -73.41 1.17 Allowed Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.802 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.542 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.8 t70 -176.38 -171.45 0.41 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.637 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -66.35 132.08 94.33 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 123.926 0.89 . . . . 0.0 110.509 175.729 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.636 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.8 Cg_endo -73.72 -176.82 2.75 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 123.725 2.95 . . . . 0.0 112.066 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.65 126.71 49.84 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.831 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 698' ' ' GLU . 3.8 tt -108.05 136.87 47.02 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.599 ' HG2' HD23 ' A' ' 697' ' ' LEU . 13.8 pt-20 -39.72 -42.82 1.3 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.712 1.605 . . . . 0.0 112.901 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 43.9 m80 -145.36 29.29 1.16 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -176.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.9 168.65 25.22 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.779 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -154.53 -153.93 0.48 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 125.636 1.574 . . . . 0.0 106.835 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.68 158.66 43.84 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.631 -167.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.543 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -99.22 -55.34 2.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.988 -178.953 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.68 143.1 48.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.9 m -130.21 137.33 50.0 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 29.6 t -127.44 92.4 43.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 121.666 -0.646 . . . . 0.0 112.47 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.2 Cg_endo -93.15 144.58 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 C-N-CA 122.865 2.377 . . . . 0.0 112.054 174.013 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 97.3 Cg_endo -74.22 132.24 26.45 Favored 'Cis proline' 0 C--O 1.248 1.012 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.001 0.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -75.12 98.08 3.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.721 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 26.7 m-85 -100.99 -177.31 3.42 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.46 0.648 . . . . 0.0 111.277 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 664' ' ' LEU . 11.4 t80 -70.61 135.14 48.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.209 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.4 0.86 81.92 Favored Glycine 0 C--N 1.291 -1.965 0 CA-C-N 115.535 -0.757 . . . . 0.0 113.788 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.88 173.16 12.5 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -136.76 143.83 43.47 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.872 0.368 . . . . 0.0 110.207 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.494 HG11 HG13 ' A' ' 694' ' ' ILE . 39.9 t -136.93 140.28 43.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.224 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 50.6 mt-10 -103.48 122.92 45.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.637 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.9 m-85 -97.79 152.16 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 124.199 1.0 . . . . 0.0 111.512 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.543 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.2 t30 -138.23 147.79 44.1 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 725' ' ' MET . 90.1 m -98.24 160.84 14.03 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 720' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 723' ' ' PHE . 60.1 m -56.62 147.15 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.12 -28.05 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.368 0.667 . . . . 0.0 111.858 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 6.9 m -80.81 -2.38 46.97 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.201 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 720' ' ' SER . 83.7 m-85 -124.8 151.63 44.93 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 10.4 t -112.86 140.14 47.91 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.504 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 0.8 OUTLIER -87.05 128.88 35.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.459 0.647 . . . . 0.0 112.154 -176.109 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.423 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 38.1 mt -106.2 99.59 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 135.79 -155.99 22.59 Favored Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -112.23 168.15 9.85 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 123.79 0.347 . . . . 0.0 110.489 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 716' ' ' GLU . 18.2 ptt180 -82.1 -37.78 25.8 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.6 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.8 p -99.34 132.24 44.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -170.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.668 HG21 HD23 ' A' ' 741' ' ' LEU . 8.3 pt -112.28 169.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.768 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 27.6 m -136.01 139.82 43.41 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 44.4 t -82.03 118.63 23.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.626 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -125.8 104.45 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.145 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 73.9 m80 71.58 33.59 1.8 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.925 0.89 . . . . 0.0 112.41 177.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.16 -8.77 79.08 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.922 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.3 m -118.25 148.39 21.12 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.707 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.636 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 87.4 m95 -86.81 152.46 22.46 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.4 p -33.02 -71.39 0.06 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.42 -30.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.668 HD23 HG21 ' A' ' 731' ' ' ILE . 17.5 mt 67.91 147.23 0.11 Allowed Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 124.92 1.388 . . . . 0.0 111.816 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.431 ' HG2' HD11 ' A' ' 697' ' ' LEU . 60.2 Cg_endo -76.73 -179.65 5.58 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.217 1.945 . . . . 0.0 110.683 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 20.2 pt20 -123.12 129.73 51.84 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.7 m -100.76 120.52 40.22 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.5 151.18 17.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 123.509 0.506 . . . . 0.0 109.926 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.78 114.36 4.98 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 124.311 1.007 . . . . 0.0 110.71 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.608 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.402 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -123.51 112.91 18.05 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -86.62 116.26 24.62 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.129 0.49 . . . . 0.0 110.733 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -78.35 136.94 37.8 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -65.03 112.25 3.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.126 0.489 . . . . 0.0 110.936 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -134.43 52.94 0.8 Allowed Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 5.8 m -155.71 66.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 124.521 1.129 . . . . 0.0 110.688 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.485 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 1.7 pp0? -80.31 -153.21 0.08 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.2 p -157.58 158.74 36.15 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.156 0.503 . . . . 0.0 111.314 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 10.2 p -142.05 -170.96 3.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -122.6 -136.24 4.82 Favored Glycine 0 N--CA 1.402 -3.588 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.598 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 25.1 Cg_exo -61.26 142.19 95.48 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 122.45 2.1 . . . . 0.0 111.411 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 645' ' ' THR . 18.6 Cg_endo -58.72 154.49 42.95 Favored 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.929 2.419 . . . . 0.0 111.849 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.5 Cg_endo -65.08 -167.23 0.1 OUTLIER 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.042 2.494 . . . . 0.0 111.546 176.075 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.43 159.79 17.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.104 -1.039 . . . . 0.0 109.709 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.651 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.7 tp -95.96 140.89 30.05 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.651 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.9 tt -32.74 -62.16 0.25 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.258 2.223 . . . . 0.0 111.556 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.454 ' OD1' ' HB2' ' A' ' 660' ' ' ASN . 19.7 t-20 -123.2 -33.97 3.21 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.831 -178.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -90.14 -142.94 10.0 Favored Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.727 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.63 -173.34 2.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 117.563 0.681 . . . . 0.0 109.577 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.4 p -101.82 131.05 50.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 123.746 0.818 . . . . 0.0 109.815 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.485 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 7.7 ptpt -91.75 -13.03 32.26 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.54 0.686 . . . . 0.0 109.563 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 10.5 mm-40 -76.67 144.2 39.57 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.991 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -66.77 152.2 45.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.558 HG22 ' HD2' ' A' ' 633' ' ' PRO . 37.1 p -95.01 120.05 34.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.241 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.99 -20.73 32.31 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.058 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 35.5 mt-10 70.22 -13.77 0.42 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.265 1.426 . . . . 0.0 113.105 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -132.49 103.49 6.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.449 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.8 m-85 -116.36 -173.51 2.38 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 653' ' ' GLU . . . -156.18 -155.91 7.6 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -78.02 135.79 37.83 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 120.528 0.204 . . . . 0.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 23.5 m 75.23 18.11 2.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.579 1.152 . . . . 0.0 112.903 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 650' ' ' GLY . 11.1 mm-40 -84.98 130.87 34.55 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 672' ' ' GLN . 12.9 m -111.89 147.65 15.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.819 0.819 . . . . 0.0 112.995 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.5 t -128.12 135.11 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.775 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.628 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 40.2 tt0 -107.26 132.32 53.22 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.07 0.938 . . . . 0.0 111.393 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 68.3 m-85 -106.44 166.37 10.59 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.069 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.485 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 46.0 p90 -140.0 151.47 45.51 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.773 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 91.4 m -96.46 162.1 13.63 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.457 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.5 OUTLIER -54.78 152.99 11.87 Favored Pre-proline 0 C--O 1.216 -0.668 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.346 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.534 ' HB2' ' OD2' ' A' ' 713' ' ' ASP . 64.5 Cg_endo -66.14 1.91 2.14 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.676 2.917 . . . . 0.0 114.995 -171.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -119.97 -4.73 10.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.837 0.827 . . . . 0.0 111.044 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 32.4 m-85 -115.11 142.42 46.68 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.241 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.679 ' HG ' ' HB2' ' A' ' 687' ' ' GLU . 16.3 mt -98.98 140.27 33.38 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.644 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.1 tpp -70.64 109.76 5.09 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.697 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.561 ' HD2' HD13 ' A' ' 685' ' ' ILE . 61.7 tttm -96.14 -34.47 11.67 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.581 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.64 -172.98 39.37 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.917 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.75 -4.91 15.85 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.359 2.706 . . . . 0.0 113.419 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.653 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 7.1 p30 52.11 3.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 127.339 2.255 . . . . 0.0 115.864 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 85.9 mttt -137.81 137.26 38.0 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.586 HG21 ' HG ' ' A' ' 681' ' ' LEU . 42.3 pt -129.09 166.26 27.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.508 ' HB2' HG12 ' A' ' 654' ' ' VAL . 29.1 tt0 -137.41 139.89 40.98 Favored 'General case' 0 C--N 1.28 -2.44 0 O-C-N 123.717 0.635 . . . . 0.0 109.334 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.6 t -85.01 108.16 17.48 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.83 -166.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.485 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 6.0 p-10 -79.29 58.76 2.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.976 0.893 . . . . 0.0 112.188 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 166.12 -38.39 0.26 Allowed Glycine 0 N--CA 1.415 -2.73 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.415 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -160.69 -178.53 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -85.46 158.29 20.23 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 40.6 p -76.87 -174.72 3.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 41.7 m -60.06 114.79 3.03 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.341 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -73.12 151.13 90.27 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.653 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 91.2 Cg_endo -74.1 178.32 7.07 Favored 'Trans proline' 0 CA--C 1.468 -2.803 0 C-N-CA 123.626 2.884 . . . . 0.0 113.032 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.9 m -139.11 163.25 26.94 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.293 -175.094 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 82.4 m -129.11 142.35 50.91 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.561 HD13 ' HD2' ' A' ' 666' ' ' LYS . 25.9 pt -134.77 148.59 29.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.54 117.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 122.673 1.225 . . . . 0.0 111.573 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.679 ' HB2' ' HG ' ' A' ' 664' ' ' LEU . 6.1 tp10 -60.09 -46.61 89.03 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.813 -1.994 . . . . 0.0 109.954 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.615 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 0.0 OUTLIER 63.56 61.53 1.01 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.237 -178.492 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 56.0 m -157.5 143.78 17.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 690' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 710' ' ' TYR . 26.0 p -121.94 159.66 26.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 123.396 0.435 . . . . 0.0 111.569 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.59 -21.38 28.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 110.63 -78.95 0.25 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.645 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.8 t0 -162.6 -168.01 1.71 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.632 HG12 HG11 ' A' ' 715' ' ' VAL . 2.9 mt -77.81 132.31 68.38 Favored Pre-proline 0 C--N 1.282 -2.339 0 C-N-CA 125.11 1.364 . . . . 0.0 111.079 176.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 69.7 Cg_endo -72.94 -169.04 0.45 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.39 2.727 . . . . 0.0 111.584 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.11 136.04 53.55 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.7 HD23 ' HA3' ' A' ' 700' ' ' GLY . 26.4 tp -116.2 145.21 43.29 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.5 pt-20 -45.33 -45.35 12.3 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.4 m80 -142.97 27.38 1.63 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.743 0.782 . . . . 0.0 109.055 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.7 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.27 168.28 24.13 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.799 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -156.14 -151.49 0.34 Allowed 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.46 144.7 46.57 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.095 -168.819 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.556 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 9.6 mp0 -83.58 -59.78 2.33 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.604 0.716 . . . . 0.0 109.301 177.6 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.41 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.0 pp -115.97 139.87 49.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.456 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 707' ' ' PRO . 12.9 m -118.16 122.85 44.09 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 6.0 m -115.44 87.03 15.91 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.511 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 705' ' ' SER . 12.8 Cg_endo -95.86 150.75 1.4 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 123.07 2.513 . . . . 0.0 112.805 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 56.5 Cg_endo -70.9 130.61 18.34 Favored 'Cis proline' 0 C--O 1.237 0.472 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.047 -1.582 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.645 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 18.5 m-85 -75.43 91.44 2.75 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.615 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 9.3 m-85 -85.26 170.22 13.02 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 122.542 0.337 . . . . 0.0 111.427 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.557 ' HB3' ' HG2' ' A' ' 687' ' ' GLU . 2.0 t80 -62.41 132.5 52.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.19 69.74 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.041 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 661' ' ' PRO . 3.8 t70 -75.97 173.27 11.44 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 714' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.0 OUTLIER -139.72 147.44 40.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.51 0.671 . . . . 0.0 110.912 -173.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 694' ' ' ILE . 38.8 t -138.32 142.95 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.219 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 43.6 mt-10 -110.36 121.43 45.28 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.501 0.667 . . . . 0.0 110.464 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.6 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -92.9 147.54 22.76 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 125.163 1.385 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.556 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.8 t30 -129.33 130.86 46.65 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.1 m -88.28 143.37 27.06 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.352 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 28.9 m -50.95 139.8 16.65 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 123.647 0.592 . . . . 0.0 109.504 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -49.97 -35.7 25.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.8 m -76.61 0.19 21.06 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.787 0.803 . . . . 0.0 111.655 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -117.99 147.94 42.7 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.462 ' HB ' HG12 ' A' ' 747' ' ' ILE . 9.3 t -109.38 138.29 45.96 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.661 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 2.6 ptm -90.04 135.47 33.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.259 0.552 . . . . 0.0 110.672 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.446 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 43.7 mt -115.37 113.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.67 -156.27 16.09 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -109.89 139.64 44.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.684 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -61.27 -35.11 76.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.887 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 12.9 p -94.56 148.53 22.16 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.937 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.664 HG21 HD23 ' A' ' 741' ' ' LEU . 9.0 pt -131.19 165.45 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.546 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 739' ' ' THR . 36.2 m -132.64 134.26 44.64 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.48 111.73 6.23 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.815 0.446 . . . . 0.0 111.375 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.5 110.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 52.2 m80 68.73 13.31 8.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.667 1.187 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.79 2.79 46.27 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.316 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.73 130.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 84.8 m95 -63.32 156.86 24.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 732' ' ' THR . 25.2 p -37.87 -71.69 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.54 -26.89 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.664 HD23 HG21 ' A' ' 731' ' ' ILE . 20.8 mt 69.42 153.33 0.14 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 111.908 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 67.3 Cg_endo -81.61 -168.65 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.642 2.228 . . . . 0.0 111.589 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.446 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 27.9 pt20 -131.93 137.31 47.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.3 m -110.15 121.15 44.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.32 146.31 25.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.31 117.73 7.03 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.407 0.442 . . . . 0.0 110.566 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.462 HG12 ' HB ' ' A' ' 724' ' ' THR . 68.7 mt . . . . . 0 C--O 1.252 1.213 0 O-C-N 124.398 1.061 . . . . 0.0 110.782 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.241 0.635 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 72.75 -75.48 0.08 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.321 1.448 . . . . 0.0 111.036 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 623' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 624' ' ' ALA . 0.0 OUTLIER -145.83 -62.89 0.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 624' ' ' ALA . . . . . 0.408 ' H ' ' CD ' ' A' ' 623' ' ' GLU . . . -177.84 -34.55 0.01 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.822 0.449 . . . . 0.0 110.77 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . 55.79 69.19 0.76 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.615 1.166 . . . . 0.0 111.554 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -80.3 40.33 2.36 Favored Glycine 0 C--N 1.311 -0.855 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.584 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 8.4 p 179.64 52.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 123.16 1.457 . . . . 0.0 108.099 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -54.56 -26.0 29.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.854 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 629' ' ' SER . . . . . 1.009 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.1 m 85.66 121.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.828 1.651 . . . . 0.0 113.971 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 27.4 p -120.55 154.8 34.86 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.32 -136.84 9.05 Favored Glycine 0 N--CA 1.413 -2.872 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.602 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.987 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 35.1 Cg_exo -56.35 148.74 59.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.077 3.185 . . . . 0.0 114.135 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 655' ' ' VAL . 29.6 Cg_endo -64.8 153.14 79.37 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 122.877 2.385 . . . . 0.0 112.468 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.538 ' HG2' HD21 ' A' ' 681' ' ' LEU . 20.9 Cg_endo -67.95 -170.76 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 123.288 2.659 . . . . 0.0 112.249 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -109.65 144.47 37.96 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.0 tp -84.01 147.17 27.58 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.6 tm? -34.37 -66.17 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.809 1.644 . . . . 0.0 111.152 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 13.1 t-20 -110.63 -51.77 2.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.109 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -81.48 -147.56 5.86 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.535 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.6 t-20 -166.4 -167.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.928 0.864 . . . . 0.0 110.592 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 655' ' ' VAL . 83.7 t -90.32 133.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 125.53 1.532 . . . . 0.0 109.425 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.0 ptpt -94.05 -12.08 29.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.683 0.754 . . . . 0.0 109.971 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 158.07 18.88 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.676 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -88.18 165.43 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.432 ' HB ' ' HG3' ' A' ' 647' ' ' GLU . 38.0 p -82.49 118.02 22.93 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-O 121.319 0.581 . . . . 0.0 110.628 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -86.83 -29.31 22.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.987 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.8 mt-10 67.13 -3.68 0.95 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.678 1.591 . . . . 0.0 113.441 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.85 82.78 2.0 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.59 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 16.2 m-85 -95.08 -72.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.104 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 1.009 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.77 -71.82 0.27 Allowed Glycine 0 C--N 1.295 -1.73 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.844 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.584 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 86.4 t60 -165.9 145.3 6.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 78.4 p 62.48 14.63 7.14 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.313 1.845 . . . . 0.0 113.019 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 16.1 mm-40 -83.71 142.07 30.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.173 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 14.7 m -120.81 153.7 24.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.274 0.559 . . . . 0.0 111.744 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.6 t -135.03 134.44 53.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.154 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -100.76 128.68 46.71 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 121.942 0.877 . . . . 0.0 110.8 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 56.8 m-85 -100.94 157.44 16.74 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.942 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.55 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.1 p90 -133.21 151.0 51.95 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 98.9 m -94.19 154.31 17.63 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 171.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -49.97 156.43 1.31 Allowed Pre-proline 0 C--O 1.193 -1.881 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.54 -30.53 12.22 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 123.883 3.055 . . . . 0.0 114.052 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 41.1 ptt180 -97.6 -9.96 25.99 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 55.6 m-85 -111.8 150.31 30.51 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.933 0.873 . . . . 0.0 112.531 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 711' ' ' TYR . 11.0 mp -112.61 151.09 30.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.412 0.625 . . . . 0.0 110.99 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.626 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.1 tpp -76.93 127.99 33.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.048 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 61.5 tttp -112.35 -45.14 3.29 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.088 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.05 -171.57 47.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.353 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.49 104.04 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.847 2.364 . . . . 0.0 111.374 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 6.3 p30 -72.47 6.18 2.53 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.663 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 91.6 mttt -132.97 136.19 45.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.471 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.4 pt -122.75 167.37 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -135.06 139.2 44.58 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.671 0.607 . . . . 0.0 110.971 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 48.5 t -82.03 104.13 12.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.381 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.22 171.24 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -75.64 72.35 2.58 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.6 1.19 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 160.58 -41.73 0.43 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.742 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.5 179.48 7.74 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -90.44 169.95 10.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.6 p -84.19 -168.32 2.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 123.14 0.576 . . . . 0.0 112.238 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 48.1 m -69.85 113.34 6.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.053 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 634' ' ' PRO . 7.2 mp -69.88 153.59 95.36 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.913 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 43.2 Cg_endo -70.88 -167.09 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.997 2.465 . . . . 0.0 113.523 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 14.4 p -150.59 149.55 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 73.3 m -116.27 143.66 45.23 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.461 0.475 . . . . 0.0 110.503 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.42 HD13 ' HD2' ' A' ' 666' ' ' LYS . 28.4 pt -136.39 147.89 27.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.736 0.814 . . . . 0.0 108.918 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 688' ' ' GLU . 9.1 p -87.43 130.38 37.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.837 1.303 . . . . 0.0 110.294 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.577 ' HB2' HD13 ' A' ' 664' ' ' LEU . 7.9 tp10 -74.57 -37.75 62.86 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 112.836 -1.983 . . . . 0.0 108.959 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.835 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 27.1 mt-10 66.89 5.86 4.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 113.706 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' A' ' 687' ' ' GLU . 7.0 t -96.46 149.04 22.18 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 23.0 p -136.08 159.47 41.62 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.8 -174.163 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.46 -13.35 30.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.061 0.458 . . . . 0.0 111.356 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.63 -63.56 1.33 Allowed Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.7 t70 -173.95 -168.93 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.615 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -68.63 137.55 90.66 Favored Pre-proline 0 C--N 1.276 -2.602 0 C-N-CA 123.469 0.708 . . . . 0.0 109.745 172.272 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.687 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -73.85 -168.64 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.296 2.664 . . . . 0.0 110.903 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.33 119.14 33.74 Favored 'General case' 0 N--CA 1.408 -2.541 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.223 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 1.004 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -94.23 144.49 25.47 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.593 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.2 pt-20 -44.89 -46.33 10.82 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.154 0.982 . . . . 0.0 112.872 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 45.5 m80 -143.29 15.67 1.86 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.521 0.677 . . . . 0.0 109.854 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 1.004 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -122.65 -179.14 15.77 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -162.47 -153.77 0.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 125.405 1.482 . . . . 0.0 107.138 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.5 161.95 36.66 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.242 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.46 ' OE1' ' HB2' ' A' ' 718' ' ' ASN . 1.0 OUTLIER -98.04 -54.85 2.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.61 147.07 36.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.048 -175.234 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.454 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 5.4 p -128.52 117.97 22.22 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.243 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.6 p -116.71 94.7 44.48 Favored Pre-proline 0 C--N 1.288 -2.091 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.463 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.6 Cg_endo -93.02 152.61 2.63 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 123.149 2.566 . . . . 0.0 111.806 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.3 Cg_endo -72.92 134.12 33.54 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.963 -1.682 . . . . 0.0 111.047 -1.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.454 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 18.6 m-85 -76.78 78.76 3.39 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.835 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 14.4 m-85 -92.48 174.01 7.5 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.963 ' HB3' HD11 ' A' ' 664' ' ' LEU . 9.6 t80 -60.47 128.94 39.16 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.765 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.34 58.3 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.566 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.37 175.86 8.01 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -141.36 150.64 42.69 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.538 0.685 . . . . 0.0 111.147 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 694' ' ' ILE . 42.4 t -134.49 143.51 37.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.388 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 25.3 mt-10 -105.7 127.64 53.19 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.161 0.505 . . . . 0.0 109.966 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.615 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -101.6 153.83 19.4 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 124.933 1.293 . . . . 0.0 110.312 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.46 ' HB2' ' OE1' ' A' ' 703' ' ' GLN . 29.2 t-20 -143.25 169.51 17.49 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 48.2 t -117.36 160.56 20.94 Favored 'General case' 0 C--N 1.253 -3.614 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 56.6 m -61.37 145.12 52.64 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.39 -21.32 64.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.5 m -78.48 -2.0 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.244 1.021 . . . . 0.0 110.392 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.416 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 97.5 m-85 -127.48 159.49 34.38 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.6 t -120.2 138.74 53.46 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.2 ptm -91.41 145.78 24.35 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.561 0.696 . . . . 0.0 110.174 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.71 112.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 131.37 -153.51 20.44 Favored Glycine 0 C--N 1.287 -2.16 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -113.08 159.61 19.02 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 122.673 1.225 . . . . 0.0 111.418 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -74.87 -51.03 14.95 Favored 'General case' 1 N--CA 1.376 -4.162 0 CA-C-N 111.253 -2.703 . . . . 0.0 110.535 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.495 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 28.7 p -89.43 139.74 30.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -167.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.672 HG21 HD23 ' A' ' 741' ' ' LEU . 12.2 pt -124.06 162.9 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.246 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 739' ' ' THR . 28.5 m -128.05 135.7 50.21 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 54.0 t -71.67 105.6 3.76 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.551 0.532 . . . . 0.0 110.795 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.2 96.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-O 122.154 0.978 . . . . 0.0 111.405 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 735' ' ' HIS . . . . . 0.499 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 95.4 m-70 67.58 18.06 9.95 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.042 1.737 . . . . 0.0 112.496 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 114.62 -2.17 23.33 Favored Glycine 0 C--N 1.291 -1.929 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.423 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 27.3 t -129.27 135.6 61.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.687 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.4 m95 -72.64 161.15 31.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 21.3 p -43.12 -74.17 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.522 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -162.28 -28.23 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.068 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 731' ' ' ILE . 20.1 mt 69.71 157.99 0.15 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.531 1.144 . . . . 0.0 111.477 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.412 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.6 Cg_endo -77.29 -162.9 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.875 1.717 . . . . 0.0 110.737 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 12.8 pt20 -146.39 140.98 26.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 80.2 m -100.19 156.92 16.94 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.214 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.33 147.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.31 126.9 31.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.729 0.3 . . . . 0.0 111.6 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.308 -1.211 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.253 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.517 -0.317 0 N-CA-C 110.472 -0.195 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 58.45 83.84 0.11 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.318 1.047 . . . . 0.0 113.456 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.99 146.6 47.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 62.7 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.463 1.105 . . . . 0.0 111.513 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -83.55 90.46 7.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 111.97 113.48 3.31 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.442 HG23 ' CB ' ' A' ' 651' ' ' HIS 0.296 11.3 p 47.99 51.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 123.757 1.741 . . . . 0.0 113.184 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.43 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -58.52 -28.04 65.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.781 -2.008 . . . . 0.0 112.647 177.734 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.679 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 51.9 m 74.17 108.12 0.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 114.242 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.0 164.77 12.05 Favored 'General case' 0 C--O 1.265 1.895 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.387 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.02 -134.95 8.52 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.62 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 50.1 Cg_exo -53.75 144.05 55.88 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.679 2.919 . . . . 0.0 113.28 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.577 ' HB3' HG21 ' A' ' 655' ' ' VAL . 28.7 Cg_endo -63.92 158.71 45.77 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 123.296 2.664 . . . . 0.0 112.459 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 681' ' ' LEU . 12.4 Cg_endo -72.49 -169.91 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.425 2.083 . . . . 0.0 112.062 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.85 165.69 11.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.403 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.6 tp -112.9 140.6 47.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.7 tt -28.16 -64.78 0.09 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.597 2.359 . . . . 0.0 112.105 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.48 -33.53 3.01 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.406 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.726 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.46 -146.05 8.4 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.418 175.48 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -170.31 -169.91 0.89 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 118.02 0.91 . . . . 0.0 111.412 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.66 133.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.695 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.6 ptpt -94.83 -16.57 22.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.405 0.621 . . . . 0.0 110.07 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.82 160.07 15.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.11 168.41 14.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.928 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 73.0 p -83.93 125.61 32.19 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.82 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -86.08 -25.6 25.76 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.752 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.62 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.0 mt-10 73.49 -17.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.698 1.199 . . . . 0.0 112.574 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -129.66 99.91 5.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.469 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.9 m-85 -104.57 -67.32 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 107.1 -95.32 0.99 Allowed Glycine 0 C--N 1.289 -2.046 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.09 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.442 ' CB ' HG23 ' A' ' 627' ' ' VAL . 83.9 t60 -148.26 149.06 31.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.28 23.3 p 64.52 14.12 8.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.07 1.748 . . . . 0.0 113.706 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 37.9 mm-40 -85.55 138.82 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.656 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.9 m -118.42 146.54 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.568 0.699 . . . . 0.0 112.244 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 633' ' ' PRO . 60.9 t -126.02 135.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.61 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.29 123.05 42.17 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.936 0.874 . . . . 0.0 110.262 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 59.2 m-85 -97.92 160.65 14.17 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.796 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.695 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 39.0 p90 -136.12 143.99 44.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.726 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 60.4 m -84.54 161.45 20.2 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.582 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -55.66 154.05 14.05 Favored Pre-proline 0 C--O 1.207 -1.163 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.582 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 27.4 Cg_endo -58.81 -13.75 19.45 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.727 2.952 . . . . 0.0 115.136 -170.536 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 12.9 ptt180 -108.67 -4.09 17.35 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.888 0.852 . . . . 0.0 111.76 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.461 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 43.2 m-85 -110.3 148.74 31.33 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.277 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.955 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.8 mp -106.25 145.48 31.53 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.589 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 48.9 tpp -77.03 113.85 15.19 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.625 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.552 ' HB3' HG23 ' A' ' 683' ' ' VAL . 21.6 tptm -101.9 -25.16 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.61 50.04 Favored Glycine 0 C--N 1.307 -1.036 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.36 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.07 8.81 3.31 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 123.05 2.5 . . . . 0.0 113.812 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.589 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.31 10.1 p-10 49.92 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 128.72 2.808 . . . . 0.0 116.925 -177.946 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.6 mttt -94.93 142.24 27.71 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 123.796 0.839 . . . . 0.0 110.278 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 681' ' ' LEU . 41.2 pt -129.88 164.56 32.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.897 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.3 tt0 -129.44 135.97 49.33 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.957 0.903 . . . . 0.0 110.254 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.8 t -82.8 98.74 9.29 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 3.3 p -91.5 -178.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.079 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.41 74.65 3.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.506 1.146 . . . . 0.0 113.161 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 159.23 -39.67 0.49 Allowed Glycine 0 N--CA 1.417 -2.6 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.249 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -167.01 -174.01 2.54 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.428 ' CE3' HG13 ' A' ' 671' ' ' ILE . 85.5 m95 -84.16 164.98 18.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.4 p -76.9 -174.76 3.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 122.707 0.403 . . . . 0.0 111.292 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.2 m -64.58 111.19 2.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.388 0.613 . . . . 0.0 110.83 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.694 ' HG ' HG21 ' A' ' 671' ' ' ILE . 4.0 mp -68.15 151.17 97.4 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.696 ' HG2' HD13 ' A' ' 636' ' ' LEU . 72.7 Cg_endo -72.23 176.63 8.29 Favored 'Trans proline' 0 CA--C 1.468 -2.795 0 C-N-CA 123.425 2.75 . . . . 0.0 113.754 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.8 m -136.81 159.0 37.34 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.937 0 CA-C-N 112.156 -2.293 . . . . 0.0 107.71 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 92.1 m -121.54 150.14 42.08 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.319 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.93 147.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.9 p -91.27 123.56 43.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.511 1.148 . . . . 0.0 110.026 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 689' ' ' SER . 9.5 tp10 -65.39 -38.5 90.16 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.154 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 686' ' ' VAL . 30.5 tt0 66.26 21.51 11.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.417 1.103 . . . . 0.0 109.579 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.499 ' HB2' ' HG3' ' A' ' 687' ' ' GLU . 16.8 m -122.08 142.96 49.83 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 21.0 p -114.02 168.7 9.58 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.779 0.323 . . . . 0.0 110.806 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.5 m -100.26 -16.15 17.82 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.824 0.821 . . . . 0.0 110.607 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 107.68 -89.99 0.61 Allowed Glycine 0 CA--C 1.484 -1.845 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.898 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.708 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t0 -152.46 -172.23 4.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.629 HG12 HG11 ' A' ' 715' ' ' VAL . 1.4 mt -72.83 132.7 82.82 Favored Pre-proline 0 N--CA 1.406 -2.648 0 C-N-CA 125.129 1.372 . . . . 0.0 109.308 173.622 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.701 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 38.8 Cg_endo -68.35 177.01 4.96 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.271 2.647 . . . . 0.0 112.857 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.84 98.61 8.17 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.769 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.939 HD23 ' HA3' ' A' ' 700' ' ' GLY . 33.5 tp -81.4 135.66 35.67 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.7 pt-20 -43.51 -42.67 5.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.568 1.147 . . . . 0.0 112.758 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.53 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 41.2 m80 -141.77 24.18 2.05 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.571 0.701 . . . . 0.0 109.966 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.939 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.26 170.54 21.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.835 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -157.95 -152.14 0.33 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 126.158 1.783 . . . . 0.0 106.489 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -142.1 156.13 45.38 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 119.254 0.934 . . . . 0.0 111.366 -168.935 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.405 ' OE1' ' HB2' ' A' ' 718' ' ' ASN . 1.0 OUTLIER -90.07 -48.79 6.97 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.31 148.81 38.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.059 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 22.8 p -126.92 136.87 52.88 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 1.9 p -130.8 78.31 73.92 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-O 121.532 0.682 . . . . 0.0 112.628 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.7 Cg_endo -91.71 147.8 3.32 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.949 2.432 . . . . 0.0 112.653 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 81.4 Cg_endo -74.88 130.86 22.32 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.669 -1.805 . . . . 0.0 110.898 -0.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.708 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 25.5 m-85 -73.06 106.84 5.09 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.53 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 17.2 m-85 -100.59 173.56 6.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.909 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.955 ' HB3' HD11 ' A' ' 664' ' ' LEU . 3.7 t80 -62.95 134.62 56.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.477 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.44 -14.74 64.73 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.039 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.6 167.09 22.44 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.2 m -131.2 155.32 47.27 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 694' ' ' ILE . 25.4 t -144.65 134.69 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 730' ' ' SER . 17.2 mt-10 -100.06 122.79 43.48 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.733 0.778 . . . . 0.0 110.711 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.612 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -94.85 154.73 17.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.52 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.405 ' HB2' ' OE1' ' A' ' 703' ' ' GLN . 64.9 t30 -134.93 152.22 51.55 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 45.1 t -99.07 162.9 12.81 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 42.9 t -60.65 142.57 55.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.95 -20.05 65.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.131 0.491 . . . . 0.0 111.76 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 0.26 55.8 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.94 0.876 . . . . 0.0 110.341 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 51.1 m-85 -125.82 162.12 25.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.4 t -118.57 137.75 53.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.4 ptm -95.45 138.49 33.06 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.329 0.585 . . . . 0.0 109.718 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.37 112.25 39.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 122.07 -160.67 16.44 Favored Glycine 0 CA--C 1.478 -2.28 0 O-C-N 123.418 0.449 . . . . 0.0 112.61 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -91.53 129.09 37.57 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 13.4 ptt180 -68.96 -28.94 67.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.825 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.2 t -102.3 150.41 23.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.31 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.639 HG21 HD23 ' A' ' 741' ' ' LEU . 2.9 pt -128.46 175.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.451 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 70.3 m -143.76 135.13 25.92 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.0 t -74.56 114.59 13.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.5 mm -117.46 103.45 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.39 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 61.5 41.8 12.15 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.309 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 91.68 -11.67 71.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.965 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.68 123.34 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.289 -0.536 . . . . 0.0 109.62 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.701 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.5 m95 -63.83 142.4 58.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.0 p -28.72 -70.3 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.96 -28.99 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 731' ' ' ILE . 23.8 mt 69.01 156.25 0.15 Allowed Pre-proline 0 C--O 1.237 0.429 0 O-C-N 124.612 1.195 . . . . 0.0 110.988 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.58 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 72.5 Cg_endo -80.29 -166.16 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.718 1.612 . . . . 0.0 109.842 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -137.58 135.53 36.73 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.0 m -94.5 138.56 32.27 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.359 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.66 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.23 119.83 12.77 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.501 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.257 1.48 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.733 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -87.92 142.86 27.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.045 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -117.87 91.6 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -74.95 115.41 14.52 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.741 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -88.03 97.29 10.88 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -114.11 69.17 0.24 Allowed Glycine 0 N--CA 1.41 -3.096 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.7 p -177.3 85.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-O 123.163 1.458 . . . . 0.0 110.065 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.505 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -88.29 -21.85 24.22 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.675 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 67.7 m 81.7 106.52 0.06 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.764 1.625 . . . . 0.0 113.724 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.55 155.95 20.27 Favored 'General case' 0 C--O 1.268 2.047 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.55 -134.53 6.98 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.797 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 39.2 Cg_exo -58.19 143.76 96.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.847 2.364 . . . . 0.0 112.322 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.718 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.71 150.75 87.68 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.602 2.202 . . . . 0.0 112.691 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.3 Cg_endo -69.69 -173.05 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.762 2.974 . . . . 0.0 112.857 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.07 146.73 27.07 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.849 HD12 ' HB3' ' A' ' 657' ' ' TYR . 4.5 tt -87.35 142.23 28.04 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.642 ' N ' HD23 ' A' ' 636' ' ' LEU . 0.7 OUTLIER -33.26 -71.92 0.05 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.847 1.659 . . . . 0.0 110.16 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -133.73 41.09 3.06 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.569 1.652 . . . . 0.0 110.13 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -133.2 -148.79 5.99 Favored Glycine 1 C--N 1.234 -5.139 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.862 177.579 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -172.22 178.33 2.89 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.83 HG22 ' CE2' ' A' ' 657' ' ' TYR . 9.9 t -102.39 137.97 28.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 124.168 0.987 . . . . 0.0 108.655 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -100.37 -10.54 21.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.014 0.911 . . . . 0.0 109.339 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 641' ' ' VAL . 7.8 mm-40 -92.85 135.32 34.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.534 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -75.75 150.71 37.73 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.718 HG22 ' HD2' ' A' ' 633' ' ' PRO . 58.5 p -71.6 127.85 33.9 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.617 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -90.76 -20.96 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.797 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 69.43 -20.53 0.17 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.276 1.431 . . . . 0.0 113.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.64 94.83 4.06 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.582 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 14.7 m-85 -102.89 -62.98 1.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.233 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 109.6 -102.17 1.56 Allowed Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -149.14 154.54 39.35 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 53.6 p 65.93 16.57 10.52 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.254 1.422 . . . . 0.0 112.648 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 7.4 mm-40 -88.45 139.33 30.59 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.897 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 672' ' ' GLN . 6.9 m -118.36 145.9 23.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.607 0.717 . . . . 0.0 112.513 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 633' ' ' PRO . 77.5 t -128.74 135.43 62.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.645 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -101.01 133.54 45.35 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.552 0.692 . . . . 0.0 110.508 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.849 ' HB3' HD12 ' A' ' 636' ' ' LEU . 53.3 m-85 -111.16 164.19 13.12 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.313 1.045 . . . . 0.0 110.632 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -137.68 158.07 45.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 96.2 m -95.01 165.56 12.38 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 118.189 0.45 . . . . 0.0 110.041 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.527 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -59.61 156.53 32.24 Favored Pre-proline 0 C--O 1.216 -0.705 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 73.2 Cg_endo -72.91 14.59 0.51 Allowed 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 123.878 3.052 . . . . 0.0 113.348 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 686' ' ' VAL . 14.4 ptt180 -129.58 -6.29 4.67 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.68 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.421 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 38.2 m-85 -122.91 150.31 43.1 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.644 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.359 0.0 OUTLIER -114.9 137.65 51.72 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.069 -179.948 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.514 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 57.3 tpp -60.98 114.0 2.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.492 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -102.84 -33.56 9.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.226 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.1 -172.57 37.18 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.621 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 83.2 Cg_endo -76.37 -5.64 16.36 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.107 2.538 . . . . 0.0 112.786 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 4.7 p30 56.45 -5.94 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 128.025 2.53 . . . . 0.0 115.662 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 670' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -133.06 133.87 43.6 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.272 0.629 . . . . 0.0 109.616 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.63 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -121.32 166.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.563 ' HB2' HG12 ' A' ' 654' ' ' VAL . 9.1 tt0 -142.0 140.29 32.63 Favored 'General case' 0 N--CA 1.414 -2.268 0 O-C-N 123.753 0.658 . . . . 0.0 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 8.9 t -80.04 108.67 13.81 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.783 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.61 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -89.12 73.19 8.2 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.439 1.114 . . . . 0.0 111.251 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.505 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 167.13 -55.95 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.18 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.03 -168.96 2.92 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -86.17 167.56 14.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 28.7 p -78.18 -176.0 4.4 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 122.876 0.471 . . . . 0.0 110.864 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 78.1 m -68.45 113.25 5.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.408 0.623 . . . . 0.0 110.794 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.63 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.9 mp -63.28 151.94 85.91 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.522 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 669' ' ' ASN . 40.6 Cg_endo -66.31 172.23 9.24 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 122.531 2.154 . . . . 0.0 113.627 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.62 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.159 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 74.5 m -118.87 135.37 54.59 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.511 HG13 HD22 ' A' ' 664' ' ' LEU . 27.0 pt -128.61 143.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 662' ' ' ARG . 8.4 p -93.63 129.48 43.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -94.07 -11.34 30.86 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 117.219 -1.792 . . . . 0.0 109.91 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.44 ' H ' HG22 ' A' ' 686' ' ' VAL . 6.5 mm-40 55.55 55.91 6.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.079 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 8.7 t -154.94 167.05 31.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 19.3 p -126.54 159.87 32.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 691' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 9.1 m -88.62 -9.14 53.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.581 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 100.27 -81.73 0.51 Allowed Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.678 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.5 t70 -161.89 -173.0 3.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 715' ' ' VAL . 2.4 mt -70.72 135.59 85.79 Favored Pre-proline 0 N--CA 1.4 -2.959 0 C-N-CA 125.522 1.529 . . . . 0.0 110.917 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.678 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 61.4 Cg_endo -74.29 -177.3 3.18 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 123.181 2.587 . . . . 0.0 110.371 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.09 123.29 45.24 Favored 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.698 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.5 tp -86.21 138.51 31.82 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 11.2 pt-20 -41.61 -37.63 1.19 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.389 1.476 . . . . 0.0 113.163 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 54.4 m80 -145.26 27.52 1.26 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -139.26 173.43 22.72 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.193 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -155.2 -150.52 0.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 125.977 1.711 . . . . 0.0 106.828 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.63 152.14 43.72 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 119.256 0.935 . . . . 0.0 112.04 -169.684 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -83.47 -56.66 3.62 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.3 144.97 35.09 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.626 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.412 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 4.5 p -142.71 116.49 9.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.926 -1.033 . . . . 0.0 108.67 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.2 m -128.34 91.75 43.19 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-O 121.182 0.515 . . . . 0.0 111.462 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.414 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.25 150.29 10.57 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.59 2.193 . . . . 0.0 111.351 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 72.3 Cg_endo -74.96 134.79 37.53 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.233 -1.569 . . . . 0.0 112.41 1.132 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 34.0 m-85 -81.19 92.28 6.29 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.51 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 4.6 m-30 -85.48 163.54 18.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.378 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.644 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.0 t80 -62.14 139.53 58.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.96 -24.22 29.52 Favored Glycine 0 C--N 1.295 -1.721 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.282 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -76.44 167.33 22.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 118.073 0.936 . . . . 0.0 110.284 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.3 m -131.61 158.08 41.98 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.101 0.477 . . . . 0.0 110.41 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.638 HG11 HG12 ' A' ' 694' ' ' ILE . 41.3 t -137.87 145.76 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.101 176.422 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.56 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 39.2 mt-10 -111.73 121.94 46.45 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 121.57 0.7 . . . . 0.0 110.419 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.517 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -93.32 146.86 23.41 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.307 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 7.5 t30 -127.67 134.59 49.61 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.3 t -92.92 142.63 27.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 52.4 m -52.94 138.57 29.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.482 0.489 . . . . 0.0 109.747 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.11 -29.17 65.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.67 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 41.5 m -79.68 -1.62 39.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.013 0.911 . . . . 0.0 111.03 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.43 159.25 24.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.4 t -118.79 139.35 51.72 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 8.1 ptm -93.04 141.21 28.66 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.355 0.598 . . . . 0.0 109.916 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 52.1 mt -111.18 100.91 11.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.91 -165.48 24.26 Favored Glycine 0 C--N 1.284 -2.347 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 19.8 p80 -101.31 171.54 7.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -93.81 -27.75 16.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.7 p -96.03 133.52 40.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 741' ' ' LEU . 8.5 pt -120.03 166.31 14.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.289 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 739' ' ' THR . 60.9 m -133.17 135.34 45.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 40.5 t -68.25 108.23 3.1 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.004 0.815 . . . . 0.0 110.317 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 737' ' ' VAL . 48.6 mm -130.2 104.2 9.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 123.859 0.864 . . . . 0.0 109.904 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.0 m80 69.93 23.94 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 96.65 -3.6 63.21 Favored Glycine 0 CA--C 1.481 -2.088 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.413 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 734' ' ' ILE . 4.1 m -126.03 153.26 34.05 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.553 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.678 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.4 m95 -87.91 169.08 12.32 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 732' ' ' THR . 41.5 p -47.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -162.33 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 731' ' ' ILE . 21.8 mt 68.58 156.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.493 0 O-C-N 124.691 1.244 . . . . 0.0 111.132 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.2 -159.68 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.851 1.701 . . . . 0.0 109.431 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -143.67 142.1 30.85 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 88.7 m -101.13 144.13 30.39 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.194 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.9 148.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -74.33 125.75 29.17 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.411 0.444 . . . . 0.0 110.521 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.044 175.572 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 77.83 11.78 1.97 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.079 1.352 . . . . 0.0 110.723 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -91.46 153.19 19.99 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 68.74 20.09 8.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.919 0.887 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -134.51 94.15 3.16 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 132.93 -77.82 0.37 Allowed Glycine 0 C--N 1.282 -2.446 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.536 ' HA ' ' HB3' ' A' ' 675' ' ' ASP 0.262 26.7 m 45.97 72.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 125.038 1.335 . . . . 0.0 112.669 175.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 0.9 OUTLIER -72.66 -153.07 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.933 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 17.2 t -157.5 163.8 38.06 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 14.9 p -147.49 -173.32 4.24 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -115.94 -135.27 5.65 Favored Glycine 0 N--CA 1.405 -3.4 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.758 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 17.1 Cg_exo -65.43 144.29 79.21 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.658 2.238 . . . . 0.0 110.492 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.9 Cg_endo -60.3 154.15 54.68 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.572 2.181 . . . . 0.0 112.307 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 681' ' ' LEU . 14.9 Cg_endo -64.2 -164.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.561 2.841 . . . . 0.0 113.265 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.19 165.61 12.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.299 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 682' ' ' PRO . 52.2 tp -113.36 147.52 37.53 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.371 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 636' ' ' LEU . 12.5 tp -40.59 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.988 1.715 . . . . 0.0 113.315 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.8 t-20 -126.08 50.25 1.89 Allowed 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 123.534 1.635 . . . . 0.0 108.834 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -164.8 -154.43 7.94 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 111.358 -2.656 . . . . 0.0 108.962 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 45.0 t30 -166.93 -178.09 4.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.1 p -92.02 138.68 19.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 9.7 ptpt -98.08 -17.26 19.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.38 144.0 28.29 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.335 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 43.4 mmtm -85.45 134.32 34.06 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-O 121.915 0.864 . . . . 0.0 112.718 -173.736 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 633' ' ' PRO . 11.0 p -64.99 122.1 16.23 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 113.193 -1.822 . . . . 0.0 113.658 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -89.53 -22.98 22.14 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.654 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.758 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 73.08 -7.71 1.45 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.164 1.386 . . . . 0.0 112.334 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.3 93.7 3.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.511 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.2 m-85 -121.54 132.97 55.0 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -101.52 -153.83 25.97 Favored Glycine 0 C--N 1.277 -2.745 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.272 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -75.91 149.62 37.71 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.283 76.2 p 71.13 11.19 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.653 1.581 . . . . 0.0 114.072 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 17.4 mm-40 -79.26 121.34 24.96 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.8 OUTLIER -109.15 139.69 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.14 0.495 . . . . 0.0 111.488 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.9 t -126.92 135.84 62.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.92 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -101.89 129.37 48.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.46 1.124 . . . . 0.0 112.614 -178.58 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 45.9 m-85 -105.27 164.61 11.71 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.728 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.493 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 40.0 p90 -142.02 150.81 41.8 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.587 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 89.9 m -98.05 163.57 12.71 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.3 OUTLIER -59.25 159.04 16.66 Favored Pre-proline 0 N--CA 1.482 1.131 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 61.6 Cg_endo -68.12 -9.8 26.9 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.074 2.516 . . . . 0.0 113.441 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 21.6 ptt180 -101.68 -6.67 23.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.708 0.766 . . . . 0.0 111.16 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 48.2 m-85 -121.25 140.92 51.41 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 687' ' ' GLU . 17.5 mt -99.66 139.68 34.96 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.831 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.607 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.2 tpp -72.3 109.03 5.75 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.238 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.629 ' HD2' HD13 ' A' ' 685' ' ' ILE . 81.3 tttt -94.97 -29.2 14.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -79.61 -173.05 44.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.618 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.74 -3.77 13.53 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.277 2.651 . . . . 0.0 113.13 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.607 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.263 6.3 p30 58.65 -27.57 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 127.474 2.31 . . . . 0.0 116.167 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.2 mttt -108.5 139.6 43.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 121.937 -0.477 . . . . 0.0 110.346 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.6 pt -124.99 171.57 13.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.0 tt0 -142.39 140.6 32.08 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.85 100.0 8.61 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.316 1.055 . . . . 0.0 108.804 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.79 171.38 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.17 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 627' ' ' VAL . 7.0 p-10 -76.05 72.36 2.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.448 1.118 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 158.23 -39.82 0.52 Allowed Glycine 0 N--CA 1.409 -3.145 0 CA-C-N 113.914 -1.493 . . . . 0.0 111.73 172.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.93 -178.94 6.41 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -84.04 164.77 19.07 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.9 p -74.67 -174.89 2.26 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.821 0.343 . . . . 0.0 111.749 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.5 m -71.1 111.15 6.23 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.184 0.516 . . . . 0.0 110.111 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.646 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -64.81 151.47 92.67 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.225 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 636' ' ' LEU . 44.1 Cg_endo -67.71 -176.53 0.97 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.129 2.553 . . . . 0.0 114.115 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.09 142.92 27.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 85.0 m -114.12 133.09 55.8 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.629 HD13 ' HD2' ' A' ' 666' ' ' LYS . 26.1 pt -128.25 145.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 688' ' ' GLU . 12.0 p -81.59 126.55 39.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 122.354 1.073 . . . . 0.0 108.578 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.594 ' HB2' ' HG ' ' A' ' 664' ' ' LEU . 7.8 tp10 -60.05 -44.04 94.95 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 113.021 -1.899 . . . . 0.0 110.191 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.671 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 21.3 mt-10 65.22 14.87 9.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.413 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.481 ' H ' ' HG3' ' A' ' 687' ' ' GLU . 13.4 m -119.08 133.1 56.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 27.4 p -121.08 164.13 17.3 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.965 -176.134 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 31.5 m -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 67.88 53.66 22.11 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.257 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.2 t70 71.51 172.94 0.31 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.017 0.927 . . . . 0.0 113.25 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.558 ' CG1' HG11 ' A' ' 715' ' ' VAL . 1.3 mp -66.37 132.99 94.38 Favored Pre-proline 0 N--CA 1.434 -1.275 0 C-N-CA 124.18 0.992 . . . . 0.0 111.626 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.5 Cg_endo -75.58 -171.22 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.961 3.107 . . . . 0.0 111.683 176.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.17 139.28 49.48 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.373 0.606 . . . . 0.0 110.084 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.72 HD23 ' HA3' ' A' ' 700' ' ' GLY . 48.9 tp -107.61 148.27 29.53 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -43.14 -47.34 6.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.75 1.22 . . . . 0.0 112.758 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -142.86 30.73 1.45 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.042 0.925 . . . . 0.0 109.154 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.72 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -138.25 171.1 23.57 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.894 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.411 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 5.0 p-90 -156.55 -150.88 0.3 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.847 1.659 . . . . 0.0 106.607 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.09 162.46 35.43 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.715 -169.46 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.523 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.03 -68.31 0.81 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.64 142.01 32.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.833 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.51 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 6.4 m -133.72 99.53 4.5 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 172.604 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.0 m -117.51 98.34 51.67 Favored Pre-proline 0 C--N 1.271 -2.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.002 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.04 159.45 15.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.241 2.628 . . . . 0.0 110.95 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 138.84 57.95 Favored 'Cis proline' 0 C--O 1.243 0.763 0 C-N-CA 123.89 -1.296 . . . . 0.0 112.261 0.458 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -86.38 78.06 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.671 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 30.2 m-85 -79.59 161.6 25.83 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.738 0.304 . . . . 0.0 111.67 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.468 ' CB ' ' HG2' ' A' ' 687' ' ' GLU . 1.7 t80 -55.87 131.33 46.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -17.18 57.72 Favored Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.753 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.78 173.95 12.07 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -139.66 151.34 45.86 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.452 0.644 . . . . 0.0 111.045 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.558 HG11 ' CG1' ' A' ' 694' ' ' ILE . 32.6 t -135.02 142.07 41.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.809 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 33.0 mt-10 -104.17 128.89 51.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.606 0.717 . . . . 0.0 110.675 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.4 m-85 -97.42 156.66 16.37 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.232 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.523 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -137.05 145.88 44.54 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 44.3 t -94.94 158.98 15.24 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 51.1 m -69.35 158.81 34.34 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.16 144.94 48.39 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 34.5 m 85.0 -5.75 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.325 1.85 . . . . 0.0 109.38 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 52.4 m-85 -119.31 148.41 43.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.6 t -116.65 140.89 48.89 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.0 ptm -91.91 141.5 28.57 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.01 127.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 112.75 -133.75 11.54 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 6.9 p80 -115.4 163.08 16.24 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.8 -29.17 16.91 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 3.9 p -99.94 131.92 45.61 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.661 HG21 HD23 ' A' ' 741' ' ' LEU . 7.3 pt -109.09 171.27 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.005 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 58.1 m -135.21 135.71 41.2 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.41 108.68 4.96 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.7 0.625 . . . . 0.0 110.163 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -128.39 111.7 24.59 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.702 0 C-N-CA 123.792 0.837 . . . . 0.0 110.579 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 58.9 m80 67.01 17.08 10.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.97 49.93 Favored Glycine 0 CA--C 1.479 -2.186 0 C-N-CA 119.32 -1.419 . . . . 0.0 111.483 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 734' ' ' ILE . 9.9 m -125.12 152.89 31.97 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.201 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.579 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.3 m95 -83.26 159.17 22.0 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 11.3 p -38.82 -70.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.04 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 731' ' ' ILE . 20.3 mt 71.16 154.15 0.15 Allowed Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.441 1.096 . . . . 0.0 112.694 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 47.3 Cg_endo -74.36 -171.1 0.83 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.781 1.654 . . . . 0.0 109.02 172.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 697' ' ' LEU . 17.5 pt20 -147.57 142.24 26.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 89.2 m -92.17 153.97 18.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.546 0.529 . . . . 0.0 112.358 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.4 144.61 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -72.07 123.98 23.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.363 0.414 . . . . 0.0 111.318 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.983 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 621' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 622' ' ' ALA . 1.6 tm-20 . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 622' ' ' ALA . . . . . 0.537 ' H ' ' CD ' ' A' ' 621' ' ' GLU . . . -70.99 -23.21 62.15 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.344 0.975 . . . . 0.0 109.357 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 73.1 89.09 0.09 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 126.009 1.724 . . . . 0.0 111.108 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -81.44 -24.67 36.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.409 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . 78.67 -53.96 0.47 Allowed 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 126.48 1.912 . . . . 0.0 110.328 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -140.22 159.99 26.26 Favored Glycine 2 C--N 1.251 -4.183 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 651' ' ' HIS . 5.1 p -174.68 82.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 123.026 1.393 . . . . 0.0 110.493 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.438 ' CD ' ' H ' ' A' ' 629' ' ' SER . 0.0 OUTLIER -79.23 -88.01 0.06 Allowed 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.621 177.619 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.438 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 34.8 t 167.65 137.71 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.678 1.191 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 67.3 m -131.81 136.07 47.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.82 -132.59 7.58 Favored Glycine 0 N--CA 1.41 -3.08 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.887 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -63.12 135.89 53.3 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.901 2.4 . . . . 0.0 111.874 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.866 ' HD2' HG22 ' A' ' 645' ' ' THR . 26.9 Cg_endo -60.22 157.23 36.04 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.348 2.698 . . . . 0.0 113.444 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 681' ' ' LEU . 31.4 Cg_endo -71.52 -159.42 0.07 OUTLIER 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.509 2.806 . . . . 0.0 112.643 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 635' ' ' GLU . . . . . 0.415 ' O ' HD13 ' A' ' 681' ' ' LEU . 13.8 pt-20 -104.35 174.78 5.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.408 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -117.86 142.03 47.77 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 169.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -35.67 -68.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 127.437 2.295 . . . . 0.0 112.869 176.077 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 21.8 t-20 -116.9 -31.0 5.56 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.31 1.052 . . . . 0.0 109.331 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -78.86 -157.04 10.39 Favored Glycine 0 C--N 1.298 -1.555 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.265 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -169.5 -177.01 2.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.3 p -101.08 140.53 19.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 123.398 0.679 . . . . 0.0 109.687 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 8.6 ptpt -95.77 -30.9 13.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.56 149.44 34.86 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.649 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 38.9 mmtm -86.94 161.7 18.09 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.789 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.866 HG22 ' HD2' ' A' ' 633' ' ' PRO . 14.5 p -84.0 122.68 29.1 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.767 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -82.31 -23.74 34.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.424 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.887 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.9 mt-10 67.62 -13.86 0.23 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.168 1.387 . . . . 0.0 113.648 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -133.28 87.38 2.39 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.412 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 11.9 m-85 -91.43 -65.53 1.0 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 112.02 -88.45 0.5 Allowed Glycine 0 C--N 1.296 -1.65 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.934 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.538 ' HB2' HG23 ' A' ' 627' ' ' VAL . 80.9 t60 -161.49 144.57 12.4 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 73.82 3.13 4.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.161 1.384 . . . . 0.0 111.391 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 65.4 mm-40 -74.88 140.79 44.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 3.4 m -115.71 151.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 123.993 0.808 . . . . 0.0 112.3 -176.886 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 52.2 t -133.24 134.59 57.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.441 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 125.28 48.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.091 0.948 . . . . 0.0 111.66 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.766 ' HB3' HD12 ' A' ' 636' ' ' LEU . 62.8 m-85 -100.68 168.84 9.43 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.832 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 41.0 p90 -138.94 153.15 48.19 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 63.6 m -94.41 163.31 13.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -63.81 155.78 75.68 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.321 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 68.1 Cg_endo -69.41 9.81 0.5 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 123.672 2.915 . . . . 0.0 114.849 -172.968 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.514 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 32.2 ptt180 -131.83 5.72 4.27 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.864 0.84 . . . . 0.0 109.753 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 39.3 m-85 -123.95 143.07 50.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.698 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 711' ' ' TYR . 12.2 mt -97.51 145.82 25.84 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.095 0.474 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.0 tpp -76.5 113.2 13.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.109 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' A' ' 685' ' ' ILE . 40.3 ttmt -93.31 -48.95 6.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.386 0.612 . . . . 0.0 109.775 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.53 -168.13 43.82 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.727 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.04 107.4 2.43 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.694 2.262 . . . . 0.0 111.182 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.55 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.0 p30 -72.97 -5.01 35.83 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.056 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 48.7 mtmt -126.48 117.51 23.02 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.154 0.502 . . . . 0.0 110.28 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 681' ' ' LEU . 47.5 pt -108.78 168.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.427 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 21.3 tt0 -140.36 140.54 35.58 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 123.597 0.759 . . . . 0.0 110.845 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.0 106.98 7.9 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.756 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.18 -177.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.86 81.27 2.77 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.932 1.348 . . . . 0.0 111.691 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.87 -39.78 0.82 Allowed Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.393 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -165.69 -171.22 2.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.89 165.98 14.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 18.6 p -75.01 -179.78 4.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.271 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 47.2 m -62.7 115.7 4.54 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.671 0.748 . . . . 0.0 112.046 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 671' ' ' ILE . 78.2 mt -64.37 146.24 97.99 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.17 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.625 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 60.0 Cg_endo -70.4 -174.39 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.916 2.411 . . . . 0.0 113.757 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 67.8 t -139.43 136.17 40.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.0 m -111.98 127.89 56.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' A' ' 666' ' ' LYS . 29.3 pt -125.41 147.71 30.06 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.1 p -92.26 116.66 33.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.704 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.3 OUTLIER -78.16 -24.71 47.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.44 0.638 . . . . 0.0 109.509 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.551 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 8.4 tt0 58.34 47.75 13.46 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.834 1.653 . . . . 0.0 109.58 175.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 710' ' ' TYR . 33.0 m -128.88 149.56 50.72 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.821 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p -124.18 147.01 48.32 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.0 m -83.43 -4.73 58.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.189 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 96.14 -87.37 0.97 Allowed Glycine 0 CA--C 1.486 -1.756 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 5.9 p-10 -154.25 -173.8 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.636 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.8 mt -71.27 133.04 85.62 Favored Pre-proline 0 N--CA 1.42 -1.933 0 C-N-CA 123.623 0.769 . . . . 0.0 112.115 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 63.0 Cg_endo -71.91 -177.77 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.417 2.745 . . . . 0.0 112.154 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.82 118.04 35.05 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.244 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 698' ' ' GLU . 5.2 tt -93.6 140.97 29.01 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 175.747 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.556 ' HG2' HD23 ' A' ' 697' ' ' LEU . 9.4 pt-20 -45.67 -36.42 4.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.39 1.076 . . . . 0.0 113.042 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 95.3 m-70 -147.09 37.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -146.07 171.57 26.95 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.384 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -156.47 -152.23 0.36 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 126.247 1.819 . . . . 0.0 106.709 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -134.58 152.76 52.0 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.581 -1.248 . . . . 0.0 113.854 -167.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 12.6 mp0 -87.57 -47.53 8.64 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.031 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -119.69 129.89 54.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.29 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 3.5 m -126.97 126.19 42.77 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 12.3 t -135.24 92.72 17.59 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.737 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 3.5 Cg_endo -87.03 153.24 8.36 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.63 2.22 . . . . 0.0 111.717 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 60.6 Cg_endo -72.84 136.75 45.65 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.069 -1.638 . . . . 0.0 111.887 0.16 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 44.5 m-85 -81.9 93.92 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 689' ' ' SER . 3.2 m-85 -78.01 166.08 23.26 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.594 0.558 . . . . 0.0 111.526 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.593 ' HB3' ' HG3' ' A' ' 687' ' ' GLU . 0.7 OUTLIER -67.15 137.74 56.52 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.517 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.99 -16.31 61.38 Favored Glycine 0 N--CA 1.422 -2.287 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.036 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 661' ' ' PRO . 22.1 t0 -77.79 164.79 24.9 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.8 m -128.12 156.02 43.5 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.22 0.533 . . . . 0.0 109.875 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.537 HG11 HG12 ' A' ' 694' ' ' ILE . 38.6 t -137.51 137.7 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.969 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -106.51 120.35 41.68 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.636 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.35 147.51 22.85 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.541 1.136 . . . . 0.0 111.962 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.427 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.5 t30 -118.81 138.53 52.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.716 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 37.7 t -83.1 155.06 24.04 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.6 t -63.17 147.27 51.37 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.02 137.78 45.59 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 60.8 m 86.75 5.76 0.34 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 126.278 1.831 . . . . 0.0 110.665 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 69.1 m-85 -122.5 152.07 40.7 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 747' ' ' ILE . 9.9 t -114.42 137.43 51.84 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.716 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.3 ptm -91.11 139.33 30.86 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.278 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 26.9 mt -121.66 119.29 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 124.38 -154.52 17.92 Favored Glycine 0 CA--C 1.475 -2.415 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -98.69 118.49 35.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.548 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -58.96 -24.65 62.79 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.72 -1.582 . . . . 0.0 113.049 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 6.7 m -117.29 149.36 40.59 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.305 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.605 HG21 HD23 ' A' ' 741' ' ' LEU . 5.8 pt -128.64 173.77 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.656 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 90.3 m -140.7 136.91 33.09 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.8 t -69.06 109.04 3.8 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.511 0.724 . . . . 0.0 110.124 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.7 mm -127.46 104.25 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.996 0.427 . . . . 0.0 111.602 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 70.7 m80 65.73 27.71 11.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.946 . . . . 0.0 111.894 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.42 5.11 62.06 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.648 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.7 t -135.2 140.83 44.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.696 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.6 m95 -79.91 148.45 31.27 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.1 p -33.38 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.78 -29.9 0.07 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -171.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.605 HD23 HG21 ' A' ' 731' ' ' ILE . 25.6 mt 65.72 156.83 0.13 Allowed Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 124.505 1.128 . . . . 0.0 111.725 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.424 ' HG2' HD11 ' A' ' 697' ' ' LEU . 72.1 Cg_endo -86.58 -179.28 2.97 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 121.782 1.654 . . . . 0.0 110.21 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -126.32 142.49 51.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.548 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 92.2 m -105.37 139.76 39.52 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.317 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.15 144.86 36.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -70.46 115.85 10.12 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.499 0.499 . . . . 0.0 112.146 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' A' ' 724' ' ' THR . 64.6 mt . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -174.1 149.11 1.41 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.06 -155.16 0.34 Allowed 'General case' 0 C--O 1.254 1.33 0 O-C-N 123.805 0.691 . . . . 0.0 109.882 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -129.25 148.43 51.18 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.43 19.39 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 109.74 -130.23 9.83 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . 0.314 14.4 p 46.3 81.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 123.405 1.574 . . . . 0.0 113.273 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -100.05 0.09 Allowed 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.363 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 47.7 t 178.8 140.53 0.1 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.898 ' HB2' ' HB2' ' A' ' 649' ' ' TYR . 14.4 m -131.8 158.48 41.13 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -107.18 -150.57 16.89 Favored Glycine 1 N--CA 1.387 -4.628 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 176.466 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.98 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -60.28 149.17 87.06 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 645' ' ' THR . 28.1 Cg_endo -63.77 149.55 90.5 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.754 1.636 . . . . 0.0 110.992 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.537 ' HG2' HD11 ' A' ' 681' ' ' LEU . 28.8 Cg_endo -68.28 -167.27 0.17 Allowed 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 122.823 2.349 . . . . 0.0 111.863 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.95 151.41 25.84 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.531 -0.731 . . . . 0.0 110.749 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 657' ' ' TYR . 3.7 tt -92.69 136.82 32.9 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 636' ' ' LEU . 46.3 tp -32.01 -68.31 0.09 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.815 2.046 . . . . 0.0 113.958 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 14.0 t-20 -134.33 33.66 3.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.939 1.828 . . . . 0.0 108.795 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.67 -156.28 6.88 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.814 174.041 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -174.8 -178.92 1.35 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.23 139.77 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 123.838 0.855 . . . . 0.0 111.202 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -96.0 -23.01 17.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.31 172.16 14.12 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -96.79 165.24 12.21 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.266 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.602 HG22 ' HD2' ' A' ' 633' ' ' PRO . 33.5 p -91.14 120.79 32.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.374 0.607 . . . . 0.0 111.586 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.33 -24.91 21.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.759 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.98 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 67.55 -12.91 0.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.496 1.518 . . . . 0.0 114.395 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -132.0 93.49 3.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 630' ' ' CYS . 3.1 m-85 -110.33 -179.46 3.78 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.101 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -151.08 -150.31 5.28 Favored Glycine 0 N--CA 1.402 -3.578 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.251 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -80.1 134.02 36.14 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.0 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 75.66 17.87 2.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.877 1.271 . . . . 0.0 111.798 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 69.7 mm-40 -79.87 129.22 34.31 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.693 -0.629 . . . . 0.0 109.508 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 10.4 m -110.97 151.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 123.366 0.416 . . . . 0.0 111.461 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 633' ' ' PRO . 26.2 t -135.2 131.8 52.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.442 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -100.49 128.89 46.42 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.122 0.963 . . . . 0.0 112.089 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.733 ' HB3' HD12 ' A' ' 636' ' ' LEU . 52.8 m-85 -106.72 165.75 11.08 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.486 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -136.18 156.81 48.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 75.8 m -93.08 165.13 12.99 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -53.95 157.5 4.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.75 10.43 0.49 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.846 3.031 . . . . 0.0 114.009 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.558 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 11.2 ptt85 -133.25 -1.16 3.24 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.996 0.903 . . . . 0.0 111.61 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 46.0 m-85 -116.7 158.18 24.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.025 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.708 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.3 mp -115.33 140.72 48.87 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.386 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.547 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 56.6 tpp -75.45 118.43 18.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 683' ' ' VAL . 38.0 ttmt -98.24 -47.09 5.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.077 0.465 . . . . 0.0 110.46 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.43 -170.95 46.03 Favored Glycine 0 C--O 1.242 0.629 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.405 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 104.52 1.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.494 2.129 . . . . 0.0 110.934 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 6.9 p30 -69.32 -2.44 10.78 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.318 -177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 46.6 mtmt -121.91 128.79 51.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.139 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 681' ' ' LEU . 43.7 pt -116.96 166.25 11.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.623 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 20.2 tt0 -138.46 139.57 38.88 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.75 0.656 . . . . 0.0 109.657 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 13.7 t -89.67 115.06 26.76 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 674' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 677' ' ' GLU . 20.0 m -89.58 -171.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.252 4.8 p-10 -78.75 76.97 5.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.477 1.132 . . . . 0.0 111.684 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.5 0.38 Allowed Glycine 0 N--CA 1.414 -2.804 0 CA-C-N 113.534 -1.666 . . . . 0.0 111.145 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 677' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 674' ' ' VAL . 10.9 pt-20 -149.79 -175.28 4.97 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 85.9 m95 -85.05 175.1 9.24 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.238 0.542 . . . . 0.0 111.469 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 30.5 p -88.81 -174.64 4.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.833 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 88.5 m -61.63 116.66 4.94 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 123.883 0.873 . . . . 0.0 111.927 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -68.4 143.48 95.56 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.581 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.524 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 84.4 Cg_endo -76.31 170.03 20.8 Favored 'Trans proline' 0 CA--C 1.461 -3.153 0 C-N-CA 123.585 2.857 . . . . 0.0 111.928 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 666' ' ' LYS . 18.6 m -131.75 156.52 42.65 Favored 'Isoleucine or valine' 1 N--CA 1.356 -5.167 0 CA-C-N 112.048 -2.342 . . . . 0.0 108.482 -174.499 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 95.8 m -128.33 138.0 52.19 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.22 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.39 152.35 36.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 688' ' ' GLU . 11.4 p -97.52 132.1 42.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' A' ' 664' ' ' LEU . 13.2 pt-20 -79.93 -20.72 45.04 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.454 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.968 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.502 15.2 pt-20 38.65 61.46 1.19 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 123.687 1.708 . . . . 0.0 114.859 -176.255 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 56.9 m -148.36 154.91 40.58 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 62.1 p -118.6 175.22 5.83 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.519 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 691' ' ' CYS . . . . . 0.486 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 32.7 m -95.02 -12.17 27.1 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 103.64 -77.74 0.29 Allowed Glycine 0 CA--C 1.478 -2.251 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.415 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t70 -170.58 -165.24 0.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.3 mt -80.15 136.65 53.44 Favored Pre-proline 0 C--N 1.272 -2.793 0 C-N-CA 125.296 1.439 . . . . 0.0 111.315 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.597 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.5 Cg_endo -74.64 -177.22 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.252 2.635 . . . . 0.0 111.309 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.46 118.54 33.48 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.61 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -89.35 143.39 26.87 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 10.2 pt-20 -39.01 -47.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.03 1.332 . . . . 0.0 113.239 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 53.9 m80 -143.41 30.76 1.37 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.61 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -133.12 176.53 19.52 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.066 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -164.62 -156.03 0.3 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.306 1.842 . . . . 0.0 106.913 -174.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.41 150.69 47.84 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -167.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.445 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.5 -41.8 13.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.765 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.07 146.98 50.82 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.674 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.53 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 13.0 m -120.41 130.54 54.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.313 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.57 87.77 49.41 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.45 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.4 Cg_endo -91.28 147.84 3.59 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.914 2.409 . . . . 0.0 112.152 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.4 Cg_endo -74.84 128.33 16.1 Favored 'Cis proline' 0 C--O 1.241 0.671 0 C-N-CA 122.648 -1.814 . . . . 0.0 110.955 -0.585 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.53 ' OH ' ' HB3' ' A' ' 705' ' ' SER . 12.7 m-85 -72.78 97.06 2.15 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.968 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 13.6 m-85 -97.11 176.83 5.79 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.326 0.584 . . . . 0.0 111.883 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.708 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 11.3 t80 -67.09 137.75 56.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.16 -1.53 88.65 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.369 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -84.78 174.17 10.09 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.3 m -143.04 153.31 42.82 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.144 0.497 . . . . 0.0 110.614 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.578 HG11 HG12 ' A' ' 694' ' ' ILE . 39.6 t -138.28 141.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.503 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 34.3 mt-10 -100.73 121.14 41.16 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.605 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.1 m-85 -98.38 161.52 13.64 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.611 1.164 . . . . 0.0 110.461 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.445 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 34.3 t-20 -149.45 163.21 38.42 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.6 m -108.23 154.72 21.36 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 19.3 m -61.22 154.14 24.29 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.255 0.347 . . . . 0.0 111.598 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.46 138.64 58.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.5 m 88.18 -0.83 0.45 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 126.929 2.092 . . . . 0.0 110.118 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.31 149.26 40.77 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -117.15 145.31 43.91 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.67 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -93.79 138.48 31.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.684 0.754 . . . . 0.0 111.729 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 51.9 mt -113.08 116.9 53.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 119.37 -139.67 14.35 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 18.7 p80 -128.19 167.54 16.69 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 120.895 0.379 . . . . 0.0 110.402 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -87.51 -33.83 18.84 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.0 p -93.57 133.78 36.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -118.1 166.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.507 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 739' ' ' THR . 75.2 m -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.05 121.68 25.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.551 0.691 . . . . 0.0 112.206 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 737' ' ' VAL . 49.7 mm -128.43 108.38 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 30.6 m80 70.63 27.07 3.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 736' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 95.17 -13.72 66.44 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.32 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 737' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.6 m -113.73 158.51 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -173.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.597 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.8 m95 -96.12 158.61 15.36 Favored 'General case' 0 C--N 1.271 -2.835 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 732' ' ' THR . 42.5 p -39.59 -70.4 0.1 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -163.2 -28.38 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 731' ' ' ILE . 17.4 mt 68.98 157.78 0.15 Allowed Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.466 1.107 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.67 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.2 Cg_endo -77.51 -172.05 1.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.776 1.65 . . . . 0.0 111.577 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -125.1 130.38 52.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 9.6 m -107.39 126.07 52.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.64 147.07 28.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.66 114.87 8.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.903 0.752 . . . . 0.0 111.254 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.58 175.66 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 63.45 85.66 0.13 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.417 1.087 . . . . 0.0 112.201 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.78 -40.62 20.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.08 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -141.37 -48.57 0.4 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -81.12 172.88 13.13 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 626' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 675' ' ' ASP . . . 88.01 59.57 1.67 Allowed Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.65 ' HB ' ' HB2' ' A' ' 651' ' ' HIS . 33.7 m -128.7 -13.73 2.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 114.898 -0.651 . . . . 0.0 111.53 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . 0.254 2.9 pp0? 25.61 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 130.282 3.433 . . . . 0.0 118.868 -167.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.652 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 47.8 m 78.98 127.06 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 126.745 2.018 . . . . 0.0 112.057 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 12.9 p -116.33 -172.08 2.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.076 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.67 -136.82 5.66 Favored Glycine 0 N--CA 1.398 -3.84 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.04 147.54 82.08 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 123.685 2.923 . . . . 0.0 114.028 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.9 Cg_endo -64.66 157.34 56.22 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.137 2.558 . . . . 0.0 112.658 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.57 ' HG2' HD21 ' A' ' 681' ' ' LEU . 19.1 Cg_endo -66.73 -164.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.405 2.736 . . . . 0.0 111.421 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -114.75 159.23 20.81 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.461 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 657' ' ' TYR . 1.0 OUTLIER -93.94 136.2 34.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.365 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -32.11 -65.55 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.563 1.945 . . . . 0.0 111.189 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 16.2 t-20 -110.63 -33.53 6.55 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.448 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.748 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -83.18 -147.12 6.99 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.691 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 63.6 t30 -162.04 -172.85 3.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.75 HG22 ' CE1' ' A' ' 657' ' ' TYR . 21.3 t -105.16 140.21 23.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 124.64 1.176 . . . . 0.0 109.215 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.0 ptpt -107.32 -11.68 15.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.666 0.746 . . . . 0.0 109.482 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.498 ' CG ' ' H ' ' A' ' 656' ' ' GLU . 20.0 mm-40 -78.51 154.09 30.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.927 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.93 144.82 25.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.171 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.496 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 20.9 p -78.78 119.97 22.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.998 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -103.02 -13.82 16.71 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.045 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 66.79 -29.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.148 1.379 . . . . 0.0 112.013 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.9 tt0 -112.66 102.49 10.55 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 6.7 m-85 -117.55 -160.04 0.76 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -176.03 -165.57 32.07 Favored Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.137 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.65 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 69.1 t60 -69.8 137.12 51.59 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.4 m 75.85 4.33 3.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 124.694 1.246 . . . . 0.0 113.252 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 53.9 mm-40 -70.98 140.27 50.81 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.295 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.4 m -121.12 139.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.3 t -121.71 132.59 70.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.743 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.498 ' H ' ' CG ' ' A' ' 643' ' ' GLU . 38.5 tt0 -102.42 127.73 49.32 Favored 'General case' 0 N--CA 1.414 -2.231 0 O-C-N 124.109 0.881 . . . . 0.0 110.236 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.774 ' HB3' HD12 ' A' ' 636' ' ' LEU . 81.2 m-85 -101.96 161.27 13.8 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.604 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.503 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 51.6 p90 -136.89 142.23 42.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 79.9 m -85.24 163.33 18.72 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.617 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.6 OUTLIER -60.98 154.4 60.41 Favored Pre-proline 0 C--O 1.211 -0.923 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.251 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.617 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 58.6 Cg_endo -66.53 -4.04 10.16 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.975 3.117 . . . . 0.0 114.628 -172.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.582 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 13.3 ptt180 -110.6 -4.71 15.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.021 0.915 . . . . 0.0 111.111 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.494 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 38.9 m-85 -117.07 149.95 39.46 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.065 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.1 mp -108.71 146.54 33.32 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.617 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.495 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 51.7 tpp -71.04 123.22 21.59 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.647 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -99.57 -49.21 4.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -94.5 -162.42 35.14 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.497 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.64 106.2 2.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.538 2.159 . . . . 0.0 110.431 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 25.3 p-10 -68.96 -8.82 48.15 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.333 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.7 mttt -118.68 130.45 55.84 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.54 HG21 ' HG ' ' A' ' 681' ' ' LEU . 46.7 pt -120.22 165.46 15.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.903 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.1 tt0 -136.81 138.18 40.56 Favored 'General case' 0 C--N 1.283 -2.288 0 O-C-N 123.848 0.717 . . . . 0.0 110.196 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 47.5 t -84.29 107.92 16.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.78 -163.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 626' ' ' GLY . 13.7 p-10 -74.05 79.83 1.72 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.334 1.064 . . . . 0.0 110.419 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.33 -51.2 0.73 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.681 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -155.6 -170.52 3.46 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -86.81 162.53 17.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.8 p -76.45 -178.21 4.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 86.6 m -58.87 113.93 2.3 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.798 0.839 . . . . 0.0 111.335 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 634' ' ' PRO . 6.6 mp -71.46 156.21 91.76 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.534 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.438 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -73.64 -178.45 3.75 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 123.036 2.491 . . . . 0.0 113.539 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.54 149.55 31.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 83.9 m -119.67 128.83 54.19 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 35.8 pt -123.59 158.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 688' ' ' GLU . 12.5 p -103.38 118.77 50.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.493 0 CA-C-O 123.077 1.417 . . . . 0.0 110.421 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.591 ' HB2' HD13 ' A' ' 664' ' ' LEU . 7.8 tp10 -62.26 -36.93 83.57 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.388 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.89 ' HA ' ' HE2' ' A' ' 710' ' ' TYR 0.251 24.1 mt-10 52.47 45.85 27.78 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.654 1.216 . . . . 0.0 113.609 -178.328 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 30.0 m -146.48 137.27 24.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 43.5 p -120.26 174.99 6.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.246 0.546 . . . . 0.0 111.095 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.0 m -90.11 -2.63 58.12 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.668 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 89.74 -75.93 1.77 Allowed Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.778 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 3.2 t70 -159.57 -166.78 1.85 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.649 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.3 mt -79.78 133.72 58.28 Favored Pre-proline 0 C--N 1.28 -2.438 0 C-N-CA 124.275 1.03 . . . . 0.0 111.043 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.9 Cg_endo -74.29 -176.58 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.075 2.516 . . . . 0.0 111.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.09 120.35 42.28 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.44 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.677 HD23 ' HA3' ' A' ' 700' ' ' GLY . 30.2 tp -90.46 138.63 31.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -41.61 -40.8 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.3 m-70 -142.19 27.44 1.76 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.677 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.52 -179.85 16.5 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.162 -0.927 . . . . 0.0 113.465 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -160.25 -152.53 0.29 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.982 2.113 . . . . 0.0 106.553 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.75 150.95 46.68 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 118.816 0.735 . . . . 0.0 112.506 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.486 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 12.3 mp0 -84.43 -43.43 14.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.761 -179.563 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.23 147.87 51.11 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.575 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 6.9 p -126.17 121.47 32.9 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.333 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.05 85.65 46.17 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.471 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.8 Cg_endo -92.23 146.66 2.93 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 123.114 2.543 . . . . 0.0 111.827 176.069 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 64.6 Cg_endo -72.73 130.11 18.98 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.037 -1.651 . . . . 0.0 111.456 -0.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.778 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 19.3 m-85 -78.05 83.6 4.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.89 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 20.9 m-85 -83.0 168.54 16.89 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 121.157 0.503 . . . . 0.0 111.536 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 1.004 ' HB3' HD11 ' A' ' 664' ' ' LEU . 1.9 t80 -59.89 127.2 30.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.084 176.339 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.33 -20.5 42.38 Favored Glycine 0 C--N 1.299 -1.515 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.537 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.31 170.18 16.6 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.5 m -138.87 148.98 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.451 0.643 . . . . 0.0 111.291 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.563 HG11 HG12 ' A' ' 694' ' ' ILE . 42.5 t -131.83 143.07 41.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.995 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.1 mt-10 -109.97 122.29 47.21 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.649 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.3 m-85 -95.32 161.1 14.23 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 124.686 1.194 . . . . 0.0 111.399 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 55.6 t30 -150.1 147.86 28.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.4 m -91.37 165.06 13.61 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 720' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 723' ' ' PHE . 47.3 t -50.69 147.01 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.64 -31.24 62.15 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 20.3 m -93.68 11.37 29.21 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 121.173 0.511 . . . . 0.0 111.89 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 720' ' ' SER . 75.9 m-85 -127.26 154.83 44.39 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -119.93 145.09 47.06 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.451 ' HB3' ' SG ' ' A' ' 719' ' ' CYS . 9.0 ptp -90.74 161.07 15.48 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-O 121.474 0.654 . . . . 0.0 109.954 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.18 122.94 66.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.65 -144.47 18.18 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.5 p80 -118.75 169.7 9.61 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 729' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 33.7 ptt180 -94.49 -28.67 15.33 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.543 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.4 p -86.19 146.43 26.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -130.34 168.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.262 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 99.2 m -137.49 136.26 37.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.15 109.15 4.46 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.507 0.504 . . . . 0.0 110.312 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.3 mm -123.89 107.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.361 0.6 . . . . 0.0 110.729 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 57.6 m80 68.16 18.83 9.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.42 1.088 . . . . 0.0 113.211 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.3 55.57 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.665 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.03 142.47 40.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.53 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.2 m95 -75.53 163.09 27.73 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.0 p -46.33 -71.59 0.07 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.33 -33.09 0.06 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 66.35 153.79 0.13 Allowed Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 124.497 1.123 . . . . 0.0 110.37 -176.395 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.3 -161.73 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.585 1.524 . . . . 0.0 111.022 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.56 132.26 30.83 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 10.1 m -94.56 146.49 24.08 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.35 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.82 155.1 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.87 124.57 24.35 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 123.685 0.615 . . . . 0.0 109.688 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.253 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 109.166 176.81 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -78.14 127.76 32.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.683 0.278 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.66 15.87 26.77 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.165 0.507 . . . . 0.0 109.854 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 624' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 628' ' ' GLN . . . -154.55 143.17 20.74 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.36 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -88.38 -29.93 19.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 166.894 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 165.6 41.76 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.779 176.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 651' ' ' HIS . 3.3 p 179.11 82.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.597 1.559 . . . . 0.0 107.721 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 624' ' ' ALA . 0.0 OUTLIER -74.71 -96.4 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.919 178.817 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.7 t 166.92 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 25.8 p -145.61 177.87 8.56 Favored 'General case' 0 C--N 1.275 -2.631 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -116.7 -141.75 7.16 Favored Glycine 0 N--CA 1.402 -3.616 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.905 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.739 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 18.9 Cg_exo -60.58 146.07 97.67 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.075 2.517 . . . . 0.0 111.887 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 645' ' ' THR . 11.5 Cg_endo -55.57 149.18 49.65 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 123.041 2.494 . . . . 0.0 112.233 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.643 ' HG2' HD21 ' A' ' 681' ' ' LEU . 17.9 Cg_endo -72.58 -168.26 0.39 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.312 2.675 . . . . 0.0 111.999 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -99.29 158.86 15.41 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.047 0.451 . . . . 0.0 110.823 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.8 tt -98.72 145.7 26.64 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.653 HD13 HG23 ' A' ' 683' ' ' VAL . 6.9 tt -33.52 -56.0 0.44 Allowed 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 127.325 2.25 . . . . 0.0 111.238 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.5 t30 -122.6 -47.55 2.09 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.643 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -68.88 -153.08 0.54 Allowed Glycine 0 N--CA 1.476 1.324 0 O-C-N 124.103 0.877 . . . . 0.0 114.681 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -173.43 -172.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.922 0 O-C-N 122.275 -0.544 . . . . 0.0 111.045 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.1 140.97 15.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 C-N-CA 125.921 1.688 . . . . 0.0 110.748 -173.567 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 14.6 ptpt -104.55 -23.83 13.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.564 0.697 . . . . 0.0 109.604 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -69.88 156.26 39.34 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.629 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 59.5 mmtt -93.37 119.37 32.41 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.832 0.825 . . . . 0.0 110.468 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.484 HG22 ' HD2' ' A' ' 633' ' ' PRO . 77.3 p -67.6 121.68 16.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.428 -1.715 . . . . 0.0 112.034 -172.09 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.15 -26.77 25.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.314 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.739 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 43.4 mt-10 75.04 -18.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 112.663 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.33 98.21 6.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 172.673 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.573 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.7 m-85 -118.4 142.47 47.52 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -108.53 -71.07 0.71 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.787 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.543 ' HB2' HG23 ' A' ' 627' ' ' VAL . 80.6 t60 -160.48 143.25 13.2 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 54.8 m 70.14 13.52 7.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.877 0.871 . . . . 0.0 112.664 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 61.5 mm-40 -74.73 130.24 39.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.5 p -122.68 129.36 75.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.779 0.8 . . . . 0.0 112.46 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 78.8 t -118.84 136.63 55.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.197 -174.281 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.547 ' OE1' ' HE3' ' A' ' 670' ' ' LYS . 36.2 tt0 -100.62 133.63 44.78 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.631 0.729 . . . . 0.0 110.667 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' A' ' 636' ' ' LEU . 42.4 m-85 -104.81 166.11 10.61 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.445 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 35.4 p90 -130.21 151.07 51.14 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 67.2 m -100.1 154.93 18.02 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 11.2 m120 -51.89 162.33 0.8 Allowed Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 125.888 1.675 . . . . 0.0 113.707 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -18.48 40.28 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.369 2.712 . . . . 0.0 113.534 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 19.7 ptt180 -117.67 -3.71 11.26 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.728 0.775 . . . . 0.0 112.171 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.643 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 59.1 m-85 -112.87 137.91 50.51 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.119 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 687' ' ' GLU . 51.8 mt -106.64 143.39 34.8 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.19 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.627 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.6 tpp -70.67 110.95 5.79 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.257 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 683' ' ' VAL . 83.3 tttt -101.66 -31.75 10.66 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -75.83 -175.06 37.76 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.661 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.573 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 40.5 Cg_endo -67.36 -11.24 31.47 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.581 2.854 . . . . 0.0 113.928 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.627 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.8 p30 62.2 -26.72 0.06 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 127.19 2.196 . . . . 0.0 115.15 179.47 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.547 ' HE3' ' OE1' ' A' ' 656' ' ' GLU . 88.1 mttt -117.74 134.77 54.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 123.102 0.561 . . . . 0.0 110.409 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.781 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -119.49 167.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.438 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -139.55 138.68 36.48 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 123.491 0.494 . . . . 0.0 110.243 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 43.4 t -84.67 107.03 16.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.78 -173.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.411 ' HA ' ' OE1' ' A' ' 628' ' ' GLN . 16.3 p-10 -78.42 70.71 4.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.931 1.348 . . . . 0.0 112.719 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.88 -54.57 0.22 Allowed Glycine 0 N--CA 1.416 -2.67 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.455 172.641 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -159.17 -166.97 1.95 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 90.6 m95 -80.81 161.64 24.39 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.812 0.339 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -75.46 -176.13 3.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.325 0.65 . . . . 0.0 112.017 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 32.9 m -63.19 115.22 4.31 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.159 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.781 ' HG ' HG21 ' A' ' 671' ' ' ILE . 5.7 mp -71.93 155.29 92.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.26 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.698 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 51.5 Cg_endo -68.55 179.73 2.89 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.142 2.561 . . . . 0.0 115.03 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 637' ' ' LEU . 2.2 p -136.54 137.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.319 -1.764 . . . . 0.0 106.66 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 95.3 m -111.16 133.96 53.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.75 146.39 33.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' A' ' 688' ' ' GLU . 10.9 p -77.91 130.86 35.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 121.291 0.567 . . . . 0.0 110.852 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.559 ' HG3' HD11 ' A' ' 664' ' ' LEU . 13.9 tt0 -57.38 -41.58 80.49 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.761 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.538 ' HG2' HG13 ' A' ' 686' ' ' VAL . 10.1 mm-40 61.77 32.85 18.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.022 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 67.1 m -150.81 165.93 32.05 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 12.9 p -125.89 162.14 25.85 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-O 122.272 1.034 . . . . 0.0 112.736 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.6 m -89.52 -11.84 41.71 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.98 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.75 -89.68 0.57 Allowed Glycine 0 CA--C 1.472 -2.65 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.637 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 t70 -164.41 -167.61 1.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.528 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -68.72 130.79 91.58 Favored Pre-proline 0 N--CA 1.412 -2.33 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.144 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 41.9 Cg_endo -71.61 179.71 4.44 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.197 2.598 . . . . 0.0 111.607 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.76 124.32 49.43 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-O 121.667 0.746 . . . . 0.0 110.694 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.926 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.7 tp -100.06 133.56 44.28 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.8 -36.92 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -133.86 18.01 3.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.572 0.701 . . . . 0.0 111.512 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.926 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -128.02 176.51 18.04 Favored Glycine 0 N--CA 1.427 -1.96 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.841 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -157.3 -151.97 0.34 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.15 158.5 43.83 Favored 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.66 -168.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.515 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 11.8 mp0 -96.47 -61.67 1.39 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.439 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 715' ' ' VAL . 4.0 pp -103.42 153.34 20.6 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.071 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 694' ' ' ILE . 4.4 p -147.04 111.68 5.29 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.461 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 70.8 m -125.01 92.26 47.88 Favored Pre-proline 0 C--N 1.284 -2.239 0 CA-C-O 121.34 0.59 . . . . 0.0 111.747 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.3 154.97 12.54 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.697 2.265 . . . . 0.0 111.205 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.98 136.5 44.26 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.22 0.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.637 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.4 m-85 -82.14 101.48 10.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.445 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 3.3 m-85 -98.37 169.87 9.25 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.591 0.557 . . . . 0.0 109.76 176.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.518 ' HB3' HD21 ' A' ' 664' ' ' LEU . 4.5 t80 -54.6 138.5 41.01 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.296 175.004 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.94 42.74 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 118.894 -1.622 . . . . 0.0 113.905 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.46 172.6 13.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 119.006 -1.077 . . . . 0.0 109.839 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.01 158.71 37.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -173.263 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' A' ' 704' ' ' LEU . 16.1 t -142.51 138.52 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.831 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.405 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 50.7 mt-10 -95.66 122.42 38.41 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 123.406 0.441 . . . . 0.0 110.286 176.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.528 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -99.16 154.96 17.73 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 123.78 0.832 . . . . 0.0 110.024 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.515 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 56.2 t30 -144.8 150.26 36.87 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.0 t -104.57 160.21 15.12 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 27.4 m -67.24 142.66 56.85 Favored 'General case' 0 C--O 1.205 -1.264 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.54 -18.24 64.32 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -167.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 30.1 m -81.62 -3.24 52.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.43 1.11 . . . . 0.0 109.57 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 77.8 m-85 -126.37 151.27 47.86 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -114.96 131.97 56.72 Favored 'General case' 0 C--N 1.265 -3.084 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.507 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -85.29 138.04 32.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.39 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 132.72 -161.14 24.0 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -101.14 174.44 6.0 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.439 0.62 . . . . 0.0 111.101 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.24 -35.97 15.88 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 5.8 m -107.08 138.0 44.09 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.958 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.635 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -113.44 173.75 2.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.062 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 739' ' ' THR . 95.7 m -138.98 137.3 36.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 46.7 t -79.5 121.78 25.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.962 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 733' ' ' CYS . 49.5 mm -126.88 104.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.5 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 63.11 49.11 3.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.116 1.367 . . . . 0.0 112.018 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 83.06 -4.71 79.64 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.637 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.598 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.9 m95 -67.6 165.48 16.92 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.764 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 732' ' ' THR . 20.4 p -44.24 -70.29 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.65 -27.24 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 731' ' ' ILE . 17.9 mt 68.58 150.93 0.12 Allowed Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 124.598 1.159 . . . . 0.0 112.393 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.507 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 96.0 Cg_endo -78.68 -165.82 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.954 1.769 . . . . 0.0 110.361 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.9 143.64 32.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 71.5 m -93.62 151.82 19.42 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.535 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.74 145.04 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.95 127.33 32.46 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.041 0.448 . . . . 0.0 111.415 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.755 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--O 1.238 0.49 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 66.16 -168.53 0.21 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.764 0.826 . . . . 0.0 110.246 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -78.65 -71.32 0.44 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -121.8 -57.09 1.83 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -116.46 148.14 41.03 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.323 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -80.42 79.15 1.77 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.654 HG23 ' CB ' ' A' ' 651' ' ' HIS . 4.5 p -169.83 79.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.881 1.324 . . . . 0.0 110.831 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 1.9 pp0? -90.52 -151.56 0.25 Allowed 'General case' 0 C--N 1.268 -2.95 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 173.721 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 20.7 m -144.46 147.25 33.07 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 120.892 0.377 . . . . 0.0 111.172 -171.212 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 38.4 m -131.78 153.39 50.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -100.91 -135.22 8.83 Favored Glycine 0 N--CA 1.415 -2.753 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 52.3 Cg_exo -55.44 141.66 81.81 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.314 2.676 . . . . 0.0 112.622 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.15 153.75 74.58 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 123.05 2.5 . . . . 0.0 111.999 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.561 ' HG2' HD11 ' A' ' 681' ' ' LEU . 42.9 Cg_endo -70.31 -166.0 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.268 2.645 . . . . 0.0 111.941 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.99 158.96 15.93 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.28 0.562 . . . . 0.0 110.482 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.679 HD13 ' HG2' ' A' ' 682' ' ' PRO . 20.5 tp -102.09 139.68 37.39 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -39.38 -67.57 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 O-C-N 124.816 1.323 . . . . 0.0 112.263 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -106.66 -37.44 6.43 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.679 -175.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -95.04 -147.4 22.58 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 640' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 636' ' ' LEU . 1.7 t-20 -169.0 -166.42 0.63 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.372 1.086 . . . . 0.0 111.123 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.07 135.36 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.678 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.6 ptpt -102.53 -10.26 19.48 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.585 0.707 . . . . 0.0 109.597 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -93.79 173.73 7.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -98.11 146.59 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.954 -176.703 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.584 HG22 ' HD2' ' A' ' 633' ' ' PRO . 18.7 p -72.88 126.77 30.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 648' ' ' GLU . 41.5 mtmt -105.38 -12.2 16.13 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.057 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 632' ' ' PRO 0.283 10.4 pt-20 58.15 -30.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 127.169 2.188 . . . . 0.0 113.782 -171.504 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.2 tt0 -98.31 95.65 7.51 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.468 ' C ' ' HG3' ' A' ' 653' ' ' GLU . 24.2 m-85 -114.5 -82.63 0.61 Allowed 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.895 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 98.05 -166.44 22.31 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.654 ' CB ' HG23 ' A' ' 627' ' ' VAL . 77.2 t60 -77.48 142.24 39.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.756 0.278 . . . . 0.0 111.21 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 11.3 t 77.94 0.66 2.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.48 1.512 . . . . 0.0 113.38 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 29.7 mm-40 -70.51 133.68 47.01 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 18.0 t -109.63 150.29 12.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 123.557 0.535 . . . . 0.0 109.681 -176.696 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 633' ' ' PRO . 25.0 t -132.97 134.85 57.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 124.038 0.935 . . . . 0.0 109.302 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -101.73 124.9 48.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.172 0.987 . . . . 0.0 111.524 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 57.3 m-85 -99.3 163.95 12.33 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.189 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.678 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 26.9 p90 -143.42 149.46 37.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.4 m -93.02 158.93 15.54 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.262 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.413 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.9 OUTLIER -56.18 156.1 11.39 Favored Pre-proline 0 C--O 1.208 -1.08 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.775 176.432 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 31.5 Cg_endo -59.53 -14.36 25.36 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 123.599 2.866 . . . . 0.0 115.404 -171.53 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.476 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 16.1 ptt180 -108.03 -7.1 16.23 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.409 0.623 . . . . 0.0 111.556 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 35.4 m-85 -109.6 139.33 44.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.178 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.5 mp -99.7 142.08 31.66 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.791 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.59 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.7 tpp -71.71 117.19 12.98 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.441 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.609 ' HB3' HG23 ' A' ' 683' ' ' VAL . 13.2 tmtt? -107.01 -25.23 11.69 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.715 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -103.22 -169.54 25.93 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.197 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.55 105.6 2.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.482 2.122 . . . . 0.0 111.274 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.8 p30 -69.74 -0.15 6.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.288 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 87.1 mttt -127.39 140.36 52.23 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.753 0.311 . . . . 0.0 110.52 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 681' ' ' LEU . 46.0 pt -129.88 165.07 30.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 20.9 tt0 -143.15 140.43 30.8 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 123.266 0.626 . . . . 0.0 110.625 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 18.5 t -78.6 110.54 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.046 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.58 -171.1 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.533 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.548 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 8.5 p-10 -81.31 75.29 8.27 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.812 1.291 . . . . 0.0 111.475 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.51 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 158.95 -43.48 0.47 Allowed Glycine 0 N--CA 1.411 -3.016 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.644 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.11 -171.58 2.7 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -82.69 167.67 17.99 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.6 p -77.77 -172.23 2.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.917 0.389 . . . . 0.0 111.803 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.6 m -68.7 113.54 6.27 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 123.319 0.647 . . . . 0.0 111.759 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -61.77 148.63 87.01 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.78 173.535 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.679 ' HG2' HD13 ' A' ' 636' ' ' LEU . 89.4 Cg_endo -81.12 -177.22 3.56 Favored 'Trans proline' 0 CA--C 1.465 -2.929 0 C-N-CA 123.617 2.878 . . . . 0.0 112.517 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 666' ' ' LYS . 14.5 m -141.37 159.76 22.27 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.798 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.288 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 73.0 m -128.63 139.7 52.13 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.3 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 666' ' ' LYS . 32.1 pt -130.75 148.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.3 p -92.26 118.13 37.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.705 1.241 . . . . 0.0 110.509 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 664' ' ' LEU . 10.7 tp10 -64.66 -43.07 94.79 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.947 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.889 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 30.2 tt0 67.59 8.84 6.63 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.076 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 23.9 m -98.36 139.18 34.51 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 36.8 p -113.26 168.9 9.34 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.368 0.604 . . . . 0.0 112.089 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 38.7 m -108.49 -17.0 14.09 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.787 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.57 -80.45 0.27 Allowed Glycine 0 C--N 1.295 -1.745 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.959 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.486 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 10.5 t70 -173.43 -167.0 0.36 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.609 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -69.67 135.35 88.13 Favored Pre-proline 0 N--CA 1.407 -2.603 0 C-N-CA 123.327 0.651 . . . . 0.0 110.097 174.493 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 39.4 Cg_endo -70.67 -163.44 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.605 2.87 . . . . 0.0 111.991 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.99 126.18 51.82 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.141 0.496 . . . . 0.0 109.847 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.783 HD23 ' HA3' ' A' ' 700' ' ' GLY . 29.1 tp -112.58 135.47 53.26 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -39.82 -46.31 1.93 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.998 1.319 . . . . 0.0 113.906 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 94.6 m-70 -142.39 27.87 1.7 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.783 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.71 167.34 23.23 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.949 -177.993 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.403 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 7.1 p-90 -157.15 -154.39 0.46 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.45 162.11 34.55 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.985 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 13.3 mp0 -95.92 -57.23 2.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.518 0.675 . . . . 0.0 109.774 -179.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 704' ' ' LEU . 3.9 pp -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 2.1 m -112.23 125.64 54.37 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 47.9 m -119.75 95.18 49.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-O 121.528 0.68 . . . . 0.0 112.353 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.417 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 7.0 Cg_endo -91.09 154.43 3.85 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.809 2.339 . . . . 0.0 111.964 176.335 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 89.8 Cg_endo -76.39 134.94 37.83 Favored 'Cis proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.753 -1.77 . . . . 0.0 111.043 -0.609 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 16.2 m-85 -76.17 97.82 4.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.97 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.889 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 23.4 m-85 -102.44 174.93 5.68 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.225 0.536 . . . . 0.0 110.315 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.689 ' HB3' HD11 ' A' ' 664' ' ' LEU . 2.9 t80 -65.78 129.33 39.41 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.151 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.2 -7.68 60.35 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.05 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 713' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 732' ' ' THR . 9.5 t70 -84.49 171.29 12.66 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 3.8 m -136.72 147.39 46.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.226 0.536 . . . . 0.0 110.99 -171.785 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.459 HG11 ' CG1' ' A' ' 694' ' ' ILE . 48.3 t -138.17 144.49 30.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.379 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.0 mt-10 -101.55 131.11 47.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.609 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -105.63 157.93 17.06 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 123.784 0.834 . . . . 0.0 109.169 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -151.83 151.13 30.91 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.564 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.4 m -98.0 157.4 16.14 Favored 'General case' 0 C--N 1.26 -3.285 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 33.5 m -52.18 150.75 4.29 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 123.479 0.487 . . . . 0.0 110.273 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -32.11 62.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 42.7 m -91.09 12.97 18.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.78 0.8 . . . . 0.0 111.409 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 81.8 m-85 -128.12 146.54 50.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 747' ' ' ILE . 10.2 t -113.56 139.29 49.11 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.707 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 7.9 ptm -88.61 142.47 27.67 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.509 0.671 . . . . 0.0 110.97 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 53.8 mt -119.03 117.32 53.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.54 -143.64 14.77 Favored Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.61 135.13 42.53 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.813 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.62 -33.39 72.7 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.51 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.46 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.9 p -123.54 161.29 25.23 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.316 0.579 . . . . 0.0 111.676 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 7.0 pt -131.19 168.09 24.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.114 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 88.9 m -139.23 137.53 36.05 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 42.0 t -78.66 120.66 23.66 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.575 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.1 mm -126.37 105.97 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.304 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 70.29 30.54 3.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.561 1.145 . . . . 0.0 112.672 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.73 3.19 80.85 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.494 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.01 140.35 49.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -79.22 152.24 30.75 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 30.6 p -31.95 -66.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.85 -34.89 0.05 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 32.5 mt 67.98 150.69 0.12 Allowed Pre-proline 0 C--N 1.318 -0.771 0 O-C-N 125.08 1.487 . . . . 0.0 111.282 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.707 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 90.2 Cg_endo -81.55 -172.37 1.46 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.251 1.967 . . . . 0.0 110.547 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 24.5 pt20 -134.61 135.29 42.08 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.0 m -97.95 140.52 32.17 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.673 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.57 141.88 45.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.64 117.62 9.82 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.797 0.685 . . . . 0.0 111.788 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.0 mt . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -129.95 9.14 5.31 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.669 -0.644 . . . . 0.0 112.189 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -9.64 40.48 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 67.83 -68.01 0.17 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.067 1.347 . . . . 0.0 111.72 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -85.51 131.77 34.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 105.82 155.56 21.75 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.611 HG23 ' CB ' ' A' ' 651' ' ' HIS . 10.0 p 44.97 50.18 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 CA-C-O 123.175 1.464 . . . . 0.0 111.108 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -47.68 -33.16 6.5 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.343 -1.753 . . . . 0.0 113.811 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 49.0 m 76.55 129.0 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.13 1.372 . . . . 0.0 114.582 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.29 166.6 12.09 Favored 'General case' 0 C--O 1.263 1.781 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.054 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.3 -130.52 7.03 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.94 147.29 91.99 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.106 2.537 . . . . 0.0 112.857 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' A' ' 655' ' ' VAL . 38.7 Cg_endo -65.1 160.25 42.71 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.74 2.96 . . . . 0.0 112.727 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.457 ' HG2' HD21 ' A' ' 681' ' ' LEU . 51.7 Cg_endo -74.36 -163.47 0.18 Allowed 'Trans proline' 0 C--O 1.253 1.247 0 C-N-CA 122.986 2.457 . . . . 0.0 110.133 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.45 160.24 20.87 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.749 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.663 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.4 tp -89.71 141.17 28.87 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.646 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 684' ' ' CYS . 32.7 tp -30.68 -59.59 0.2 Allowed 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.428 2.291 . . . . 0.0 113.321 172.979 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 17.1 t-20 -119.56 -45.95 2.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.116 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -80.94 -154.74 11.1 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.63 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.1 -174.33 4.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.877 -0.778 . . . . 0.0 111.726 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.35 137.5 21.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 124.248 1.019 . . . . 0.0 109.108 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.3 ptpt -105.06 -7.73 18.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.66 0.743 . . . . 0.0 109.747 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.81 154.07 23.71 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.383 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 644' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 644' ' ' LYS . 18.9 ptmt -81.44 145.8 30.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 173.588 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.9 p -80.57 128.41 33.57 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.355 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.3 mtmt -102.76 -14.25 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 56.13 -16.14 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 C-N-CA 127.424 2.29 . . . . 0.0 115.404 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 646' ' ' LYS . 36.3 tt0 -122.6 85.56 2.44 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 6.3 m-85 -93.61 -77.35 0.45 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.611 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 117.39 -97.36 0.73 Allowed Glycine 0 C--N 1.305 -1.15 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.391 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.611 ' CB ' HG23 ' A' ' 627' ' ' VAL . 86.4 t60 -155.17 143.03 19.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 12.2 t 72.71 9.97 5.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.357 1.463 . . . . 0.0 110.778 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 20.6 mm-40 -75.94 126.5 31.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.7 m -107.03 143.49 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.389 0.614 . . . . 0.0 112.078 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 43.0 t -125.65 133.47 69.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.784 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.4 tt0 -101.77 125.89 48.52 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.086 0.946 . . . . 0.0 111.043 -178.081 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 61.9 m-85 -99.89 157.0 16.83 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.687 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.66 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 49.5 p90 -134.61 152.36 51.72 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.638 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.7 t -108.73 169.83 8.41 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.784 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.2 m-80 -61.57 152.89 72.9 Favored Pre-proline 0 C--O 1.194 -1.85 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.918 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.8 16.79 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.821 3.014 . . . . 0.0 113.997 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 19.0 ptt180 -137.38 3.81 2.6 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.918 0.866 . . . . 0.0 110.049 173.201 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.441 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 59.7 m-85 -129.18 135.43 48.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.421 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 11.7 mt -95.44 144.64 25.79 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.957 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.606 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.1 tpp -73.39 113.71 10.79 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.175 174.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.556 ' HD2' HD13 ' A' ' 685' ' ' ILE . 62.1 tttm -100.59 -45.93 5.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.382 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.66 -173.77 50.01 Favored Glycine 0 C--O 1.236 0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.089 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.67 107.27 2.15 Favored 'Trans proline' 0 CA--C 1.503 -1.058 0 C-N-CA 122.812 2.341 . . . . 0.0 111.252 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 8.3 p30 -70.58 -7.77 46.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.561 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 55.9 mtmt -118.61 123.29 44.65 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 122.005 0.907 . . . . 0.0 110.388 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 HD23 ' A' ' 681' ' ' LEU . 50.0 pt -110.34 167.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.061 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 22.7 tt0 -138.05 137.12 37.49 Favored 'General case' 0 C--N 1.277 -2.57 0 O-C-N 123.545 0.528 . . . . 0.0 110.207 -175.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.85 104.98 12.61 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.8 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.85 -174.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.924 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.09 83.61 7.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.791 0.805 . . . . 0.0 110.085 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 154.22 -47.0 0.54 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.119 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.92 -172.26 2.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -88.26 168.04 13.05 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -77.95 -172.88 2.88 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.714 0.293 . . . . 0.0 111.451 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 61.9 m -73.25 114.96 12.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.874 0.845 . . . . 0.0 111.088 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.646 HD23 HG21 ' A' ' 671' ' ' ILE . 66.2 mt -57.98 145.93 70.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.663 ' HG2' HD13 ' A' ' 636' ' ' LEU . 18.0 Cg_endo -66.03 177.65 2.9 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.179 1.919 . . . . 0.0 113.273 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 146.83 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.61 ' H ' HD23 ' A' ' 637' ' ' LEU . 34.6 m -119.78 144.26 47.39 Favored 'General case' 0 C--N 1.276 -2.626 0 O-C-N 124.353 1.033 . . . . 0.0 108.34 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.556 HD13 ' HD2' ' A' ' 666' ' ' LYS . 27.8 pt -142.74 143.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.49 125.19 39.56 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.638 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -77.12 -22.42 52.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.107 -178.72 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 62.1 35.55 15.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.564 1.546 . . . . 0.0 108.755 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 689' ' ' SER . . . . . 0.457 ' HB2' ' HG2' ' A' ' 687' ' ' GLU . 16.2 m -121.19 130.55 53.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.502 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 3.7 p -102.7 149.5 24.39 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-O 121.678 0.751 . . . . 0.0 112.635 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.36 -9.84 29.09 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.83 30.64 7.84 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.492 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.697 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.9 t0 68.78 179.6 0.24 Allowed 'General case' 0 C--O 1.241 0.611 0 O-C-N 124.306 0.65 . . . . 0.0 110.241 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.611 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 3.4 mt -69.03 129.76 91.94 Favored Pre-proline 0 N--CA 1.406 -2.644 0 C-N-CA 123.354 0.662 . . . . 0.0 110.58 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.607 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -70.0 -179.52 3.08 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 123.33 2.687 . . . . 0.0 111.795 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.11 115.16 27.86 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.356 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.5 tt -90.19 137.14 32.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 698' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.8 pt-20 -35.9 -43.65 0.32 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.7 1.6 . . . . 0.0 113.039 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 49.1 m80 -144.36 25.7 1.51 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 719' ' ' CYS . . . -128.92 177.72 17.69 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.098 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 701' ' ' TRP . . . . . 0.421 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 16.8 p-90 -161.97 -158.44 0.54 Allowed 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.233 1.413 . . . . 0.0 107.625 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -140.26 156.04 46.63 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.257 -168.347 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.81 -68.0 0.82 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.865 0.728 . . . . 0.0 110.753 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.56 140.78 31.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.873 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.2 p -136.51 116.61 13.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.354 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 42.4 t -124.1 93.86 46.29 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-O 121.286 0.565 . . . . 0.0 110.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.436 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.7 153.04 10.18 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.806 2.337 . . . . 0.0 111.352 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.9 Cg_endo -73.29 135.91 42.07 Favored 'Cis proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.13 0.859 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.697 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 28.4 m-85 -80.31 98.77 7.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -93.65 173.35 7.73 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.951 0.782 . . . . 0.0 110.702 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.638 ' HB3' ' HG3' ' A' ' 687' ' ' GLU . 2.8 t80 -65.42 138.91 58.43 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.62 -14.15 65.86 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 118.001 -2.047 . . . . 0.0 112.693 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.64 167.2 21.97 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 117.479 0.639 . . . . 0.0 109.813 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -132.71 153.28 51.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.048 0.451 . . . . 0.0 110.172 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 694' ' ' ILE . 37.9 t -142.62 143.17 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.804 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -98.36 124.08 42.83 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.611 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.6 m-85 -104.54 167.91 9.43 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.138 0.975 . . . . 0.0 109.263 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -163.92 167.88 20.08 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.8 m -110.06 162.05 14.94 Favored 'General case' 0 C--N 1.263 -3.192 0 O-C-N 123.147 0.279 . . . . 0.0 111.172 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 32.6 t -56.83 155.19 8.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.917 0.76 . . . . 0.0 110.303 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -55.39 -44.18 75.9 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.144 0.978 . . . . 0.0 112.117 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 9.2 t -77.67 5.72 8.71 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.419 0.688 . . . . 0.0 111.852 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -130.16 156.0 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.761 0.424 . . . . 0.0 109.936 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.2 t -117.15 142.45 46.99 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.509 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -90.39 146.65 24.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.433 0.635 . . . . 0.0 111.163 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.5 mt -119.64 118.36 56.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.13 -157.47 16.07 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -112.46 162.24 15.82 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 117.177 0.488 . . . . 0.0 110.56 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -81.59 -33.22 31.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 24.2 p -95.0 137.15 34.44 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.468 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 741' ' ' LEU . 10.0 pt -121.25 166.21 16.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.883 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 732' ' ' THR . . . . . 0.516 ' H ' HG23 ' A' ' 739' ' ' THR . 85.6 m -136.58 139.13 41.93 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 733' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.3 t -78.11 120.47 22.98 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.125 0.488 . . . . 0.0 111.976 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.6 mm -128.26 110.87 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.893 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 69.0 m80 65.81 30.25 10.15 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.602 1.161 . . . . 0.0 112.58 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.15 2.98 65.74 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.744 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.6 p -136.99 148.02 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.1 m95 -77.2 158.2 30.46 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 732' ' ' THR . 39.8 p -32.34 -72.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -166.89 -28.24 0.03 OUTLIER 'General case' 0 C--O 1.243 0.713 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 731' ' ' ILE . 17.2 mt 69.1 152.02 0.13 Allowed Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.036 1.335 . . . . 0.0 111.578 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.509 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 57.4 Cg_endo -76.11 -169.56 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.964 1.776 . . . . 0.0 109.746 173.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.501 ' HA ' HD21 ' A' ' 697' ' ' LEU . 3.7 pt20 -135.85 150.58 49.44 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.8 m -110.8 134.93 52.09 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 145.66 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 123.335 0.397 . . . . 0.0 110.282 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.19 113.13 3.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 124.723 1.264 . . . . 0.0 111.684 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.311 -1.105 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.502 173.007 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -129.37 144.71 51.35 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.44 -5.84 55.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.131 0.491 . . . . 0.0 111.164 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -154.3 135.29 13.84 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.074 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -131.79 91.96 3.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -72.5 72.57 0.99 Allowed Glycine 0 CA--C 1.486 -1.753 0 CA-C-N 115.067 -0.969 . . . . 0.0 115.248 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.2 p -179.95 93.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 123.052 1.406 . . . . 0.0 108.255 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 676' ' ' GLY . 2.6 pp0? -99.63 -25.29 14.46 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.856 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.8 m 72.44 123.87 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 O-C-N 124.961 1.413 . . . . 0.0 112.373 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.14 -169.97 1.55 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 631' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -115.46 -138.97 6.66 Favored Glycine 0 N--CA 1.41 -3.076 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.474 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.705 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 21.3 Cg_exo -62.55 150.85 86.24 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.854 2.369 . . . . 0.0 110.88 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.7 158.8 40.15 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.555 2.17 . . . . 0.0 112.083 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 671' ' ' ILE . 18.1 Cg_endo -75.53 -161.5 0.13 Allowed 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.881 2.387 . . . . 0.0 110.231 176.508 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.28 166.87 11.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.003 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.851 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.3 tt -103.55 140.58 37.33 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -36.98 -65.25 0.31 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.878 1.671 . . . . 0.0 111.676 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -108.49 -47.16 3.55 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.521 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -72.79 -155.71 3.02 Favored Glycine 0 C--O 1.242 0.639 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -171.0 0.53 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.73 132.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.416 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.501 ' HB3' ' CD2' ' A' ' 658' ' ' TYR . 18.3 pttp -102.51 -7.89 21.51 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.245 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -81.54 152.01 27.46 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.93 153.07 21.33 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 68.8 p -79.84 111.03 15.76 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.365 1.079 . . . . 0.0 112.081 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 646' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 13.2 mtpp -89.17 -26.7 21.14 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.96 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 53.0 mt-10 70.26 -30.21 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.604 1.562 . . . . 0.0 111.881 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 648' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 646' ' ' LYS . 33.6 mt-10 -91.94 82.91 5.13 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.264 0.554 . . . . 0.0 109.922 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 646' ' ' LYS . 16.2 m-85 -118.31 106.02 12.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -83.14 -67.92 1.45 Allowed Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.973 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -161.12 142.04 11.43 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 122.752 -0.263 . . . . 0.0 110.315 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 2.6 t 70.34 12.29 7.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 111.303 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 13.6 mm-40 -77.73 125.27 29.08 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.219 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 672' ' ' GLN . 15.6 m -110.01 144.96 17.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.196 0.522 . . . . 0.0 111.657 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.0 t -123.73 136.49 60.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -105.42 128.38 53.49 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-O 121.708 0.766 . . . . 0.0 109.415 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 47.4 m-85 -99.0 163.29 12.64 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.583 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 642' ' ' LYS . 45.5 p90 -133.82 155.04 50.53 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 5.8 t -101.78 163.61 12.16 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.109 -1.437 . . . . 0.0 108.863 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.28 155.51 26.2 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.789 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.26 14.53 0.22 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.601 2.867 . . . . 0.0 114.006 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 710' ' ' TYR . 11.8 ptt180 -137.99 -7.08 1.62 Allowed 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 32.8 m-85 -111.59 157.6 20.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.948 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.705 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.6 mp -111.11 135.59 51.41 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.163 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.549 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 54.0 tpp -71.23 119.34 15.22 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.71 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -105.26 -44.99 4.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.02 -171.98 48.36 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.506 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 36.3 Cg_endo -69.0 104.25 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.738 2.292 . . . . 0.0 111.429 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.549 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.5 p30 -71.7 1.07 7.34 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.592 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.5 mttt -128.65 136.74 51.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.2 pt -126.48 162.1 31.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.65 ' HB2' HG12 ' A' ' 654' ' ' VAL . 22.2 tt0 -133.88 139.75 46.39 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 123.344 0.658 . . . . 0.0 110.738 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.86 102.63 12.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.93 -172.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.84 73.7 4.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.673 1.225 . . . . 0.0 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 150.28 -36.95 0.93 Allowed Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.992 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.51 -178.77 7.59 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -92.23 164.81 13.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.665 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 34.4 p -77.92 176.27 9.27 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.554 0.161 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.0 m -57.05 118.6 5.16 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.413 0.625 . . . . 0.0 112.38 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.476 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -62.1 149.32 86.85 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.745 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.851 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 55.7 Cg_endo -71.51 179.33 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.853 2.368 . . . . 0.0 113.581 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.03 141.89 45.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 5.2 m -120.24 137.47 54.2 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.264 0.352 . . . . 0.0 111.099 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.6 pt -135.73 143.82 35.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 688' ' ' GLU . 14.3 p -94.69 126.88 47.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.49 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.0 pt-20 -78.07 -17.5 56.92 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 118.844 -1.143 . . . . 0.0 109.182 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.569 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 63.8 tt0 51.22 63.25 2.32 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.102 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 50.6 m -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 7.4 p -108.05 160.51 15.74 Favored 'General case' 0 N--CA 1.411 -2.378 0 O-C-N 123.688 0.618 . . . . 0.0 111.711 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.2 m -86.84 -7.08 58.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.424 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.58 -78.38 0.64 Allowed Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.756 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.545 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 6.8 p-10 -157.57 174.47 15.31 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.671 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.5 mt -67.79 126.58 92.79 Favored Pre-proline 0 N--CA 1.422 -1.845 0 C-N-CA 123.694 0.797 . . . . 0.0 111.217 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -68.21 173.15 9.95 Favored 'Trans proline' 0 N--CA 1.433 -2.077 0 C-N-CA 123.186 2.59 . . . . 0.0 112.556 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.12 120.28 37.17 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.37 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' A' ' 700' ' ' GLY . 24.3 tp -99.72 129.34 45.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -51.14 -36.39 40.5 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 45.6 m80 -135.35 25.54 3.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.491 0.662 . . . . 0.0 109.875 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -135.79 179.08 18.16 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.919 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -161.1 -154.83 0.38 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.888 1.675 . . . . 0.0 106.499 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.29 150.73 49.04 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.787 -169.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.537 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 12.2 mp0 -88.57 -45.88 9.53 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.39 -179.865 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.44 154.06 42.55 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.281 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.5 p -136.39 128.18 29.15 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.382 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 30.2 t -124.36 85.85 55.3 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-O 121.442 0.639 . . . . 0.0 109.886 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.557 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 10.9 Cg_endo -93.39 154.64 2.49 Favored 'Trans proline' 0 N--CA 1.431 -2.195 0 C-N-CA 122.994 2.463 . . . . 0.0 112.055 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 37.8 Cg_endo -67.97 133.6 22.97 Favored 'Cis proline' 0 C--O 1.235 0.364 0 C-N-CA 122.795 -1.752 . . . . 0.0 109.963 -3.362 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.545 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 39.9 m-85 -73.28 82.37 1.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -174.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 8.1 m-85 -81.77 174.3 11.47 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 122.903 0.481 . . . . 0.0 111.188 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.705 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 39.3 t80 -62.98 140.55 58.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.943 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.38 70.21 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.389 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.39 166.97 22.02 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -132.86 144.4 50.17 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.163 0.506 . . . . 0.0 110.085 -171.393 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.595 HG11 HG12 ' A' ' 694' ' ' ILE . 45.5 t -130.13 138.22 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.913 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.64 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.6 mt-10 -106.17 120.92 43.07 Favored 'General case' 0 N--CA 1.409 -2.511 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.223 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.671 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -96.28 160.72 14.28 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 125.082 1.353 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.537 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -148.12 143.53 27.19 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 78.4 m -88.13 158.86 18.43 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 123.59 0.556 . . . . 0.0 109.661 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.2 t -61.93 148.93 42.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.25 145.57 56.06 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 36.4 m 85.52 -5.41 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 110.144 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.91 153.85 27.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.529 ' HB ' HD11 ' A' ' 747' ' ' ILE . 6.8 t -116.83 143.6 45.49 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.547 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.3 ptm -94.53 138.74 32.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.75 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.1 mt -105.9 116.97 50.77 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.149 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 105.55 -141.43 15.37 Favored Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.593 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -102.39 129.54 48.89 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.316 0.579 . . . . 0.0 110.636 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.144 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 0.2 OUTLIER -103.97 148.51 26.11 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.199 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.553 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -129.6 167.75 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.1 m -138.85 136.94 36.12 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.51 106.75 3.1 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 109.867 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 734' ' ' ILE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 711' ' ' TYR . 52.1 mm -122.61 112.18 33.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.008 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 58.31 29.74 18.54 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.711 0.804 . . . . 0.0 112.724 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.92 6.59 61.84 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.857 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.33 139.05 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -70.01 150.96 46.1 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -39.14 -75.06 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -173.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.03 -29.06 0.07 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -171.155 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 731' ' ' ILE . 23.6 mt 68.49 156.33 0.15 Allowed Pre-proline 0 C--O 1.239 0.546 0 O-C-N 124.619 1.2 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.547 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 46.5 Cg_endo -81.84 -167.9 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.113 1.875 . . . . 0.0 111.47 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -130.21 130.22 44.37 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 21.5 m -98.8 129.17 45.19 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.208 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.89 145.73 34.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -73.81 115.09 12.84 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.608 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.529 HD11 ' HB ' ' A' ' 724' ' ' THR . 60.6 mt . . . . . 0 C--O 1.255 1.348 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -142.65 -171.78 3.5 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.11 31.0 20.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.269 0.628 . . . . 0.0 110.698 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 65.88 -78.65 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.774 1.23 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -126.61 -2.47 6.72 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.915 0.388 . . . . 0.0 110.524 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 81.16 102.75 0.34 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -172.109 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.618 HG13 ' CB ' ' A' ' 651' ' ' HIS . 87.4 t -153.23 90.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -90.56 0.09 Allowed 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.598 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 45.9 t 168.21 158.08 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 630' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 21.0 p -168.25 149.18 4.96 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.97 -139.71 10.9 Favored Glycine 0 N--CA 1.403 -3.515 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.198 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.951 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 44.8 Cg_exo -53.16 142.07 56.61 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.65 2.9 . . . . 0.0 112.824 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 655' ' ' VAL . 27.7 Cg_endo -61.01 151.34 78.97 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 123.073 2.516 . . . . 0.0 112.207 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.526 ' HG2' HD21 ' A' ' 681' ' ' LEU . 9.6 Cg_endo -63.3 179.54 0.84 Allowed 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.12 2.546 . . . . 0.0 112.722 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.1 145.73 24.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.854 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.4 tt -86.84 138.16 31.8 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -33.26 -65.63 0.17 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 126.196 1.798 . . . . 0.0 113.212 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 0.2 OUTLIER -135.77 30.98 3.08 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 123.976 1.846 . . . . 0.0 108.798 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.771 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.7 -156.87 7.07 Favored Glycine 1 C--N 1.241 -4.727 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.489 173.99 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 33.2 m-20 -163.74 177.81 8.38 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.021 0.928 . . . . 0.0 109.965 -178.389 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.49 140.16 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 123.241 0.616 . . . . 0.0 109.788 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -97.35 -11.98 23.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.077 0.465 . . . . 0.0 111.37 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.16 163.97 14.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.378 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -92.77 149.94 20.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.419 HG22 ' HD2' ' A' ' 633' ' ' PRO . 56.7 p -75.32 119.14 19.02 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.007 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -80.39 -20.71 43.4 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.951 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 65.51 -3.26 0.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.411 1.484 . . . . 0.0 114.993 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -148.93 95.06 2.35 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.419 ' HB2' ' SG ' ' A' ' 630' ' ' CYS . 16.6 m-85 -95.24 -68.84 0.78 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.212 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 111.7 -94.14 0.74 Allowed Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.408 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.618 ' CB ' HG13 ' A' ' 627' ' ' VAL . 31.9 t-80 -148.17 142.96 26.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.897 0.349 . . . . 0.0 110.661 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 59.7 m 69.74 11.15 7.8 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.326 1.45 . . . . 0.0 113.262 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 9.6 mm-40 -77.04 127.75 33.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.6 t -104.45 141.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 123.758 0.661 . . . . 0.0 109.409 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 42.9 t -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 123.28 0.632 . . . . 0.0 109.543 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 656' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 32.2 tt0 -102.98 131.69 49.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 122.096 0.95 . . . . 0.0 112.354 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.854 ' HB3' HD12 ' A' ' 636' ' ' LEU . 63.4 m-85 -110.24 164.99 12.12 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.835 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -139.54 151.13 45.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 99.3 m -89.56 162.45 15.66 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.877 0.37 . . . . 0.0 111.311 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -57.92 158.72 12.03 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.265 175.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.29 1.11 0.73 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 124.302 3.334 . . . . 0.0 117.134 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.486 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 17.2 ptt-85 -131.98 -2.26 3.65 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.289 173.376 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -100.61 143.72 30.43 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.057 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.695 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.7 mp -100.8 140.14 35.5 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.561 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.57 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 50.9 tpp -69.63 113.74 7.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.416 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.621 ' HB3' ' HB ' ' A' ' 683' ' ' VAL . 28.3 tptp -101.65 -12.2 18.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.993 0.901 . . . . 0.0 109.499 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 667' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -98.62 -171.35 31.73 Favored Glycine 0 C--N 1.293 -1.833 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.416 -177.007 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 668' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 88.6 Cg_endo -80.93 -5.91 13.11 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.068 2.512 . . . . 0.0 111.515 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.514 ' H ' ' HB3' ' A' ' 682' ' ' PRO 0.259 7.6 p30 57.82 -6.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.9 2.48 . . . . 0.0 115.764 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 656' ' ' GLU . 55.5 mtmt -130.92 141.84 50.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 118.283 0.492 . . . . 0.0 110.437 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.9 pt -131.76 169.87 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.897 -175.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.8 tt0 -137.08 140.7 42.16 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 122.843 0.457 . . . . 0.0 111.127 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 45.3 t -81.98 102.19 10.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.793 0.806 . . . . 0.0 109.689 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.99 170.16 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.73 70.95 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.841 1.256 . . . . 0.0 112.415 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 148.7 -30.81 1.25 Allowed Glycine 0 N--CA 1.405 -3.433 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.99 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.39 -177.53 3.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -86.13 174.95 8.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.579 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.3 p -89.38 -167.31 1.83 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.607 0.363 . . . . 0.0 111.419 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.4 m -65.54 112.21 3.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.044 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.3 mp -71.71 154.86 92.86 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.523 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.566 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 45.4 Cg_endo -68.09 175.95 6.0 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.433 2.089 . . . . 0.0 113.472 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 666' ' ' LYS . 50.5 t -129.06 151.08 35.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.606 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.4 m -132.11 123.71 27.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.66 141.64 45.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 688' ' ' GLU . 10.4 p -87.06 124.35 40.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.7 pt-20 -73.67 -20.77 60.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.417 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.604 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 27.3 tt0 62.21 40.21 11.85 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.056 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 17.3 m -122.68 156.78 33.66 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.2 p -115.66 145.44 42.72 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.421 0.629 . . . . 0.0 111.663 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 42.5 m -81.62 -24.44 36.39 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.158 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.99 41.47 3.29 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 113.2 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.626 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 30.4 t70 66.26 176.87 0.22 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.504 0.722 . . . . 0.0 112.498 176.366 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.677 HG12 HG11 ' A' ' 715' ' ' VAL . 2.8 mt -73.87 131.0 82.23 Favored Pre-proline 0 N--CA 1.416 -2.173 0 C-N-CA 123.942 0.897 . . . . 0.0 111.005 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 717' ' ' PHE . 74.1 Cg_endo -73.82 -179.61 4.75 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.943 2.429 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -119.67 116.63 26.38 Favored 'General case' 0 C--N 1.262 -3.221 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.248 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.78 HD23 ' HA3' ' A' ' 700' ' ' GLY . 47.3 tp -82.37 139.81 33.86 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -46.33 -37.3 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -135.78 22.97 3.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.076 0.465 . . . . 0.0 111.259 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.72 167.4 23.21 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.075 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -156.58 -152.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.113 1.365 . . . . 0.0 107.33 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.22 148.46 48.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -167.253 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.539 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 5.3 mp0 -87.69 -42.36 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.946 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.57 160.47 35.2 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.718 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 5.6 m -148.35 117.62 6.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 59.1 m -116.1 98.4 51.2 Favored Pre-proline 0 C--N 1.28 -2.446 0 CA-C-O 121.397 0.617 . . . . 0.0 110.795 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.483 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.5 Cg_endo -93.6 151.83 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.584 0 C-N-CA 122.349 2.033 . . . . 0.0 111.389 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 71.4 Cg_endo -72.97 133.2 29.33 Favored 'Cis proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.122 -1.616 . . . . 0.0 111.444 0.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.626 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 30.9 m-85 -72.74 96.8 2.09 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 3.4 m-85 -99.42 175.09 5.97 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.695 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 6.3 t80 -62.1 141.38 58.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.75 71.83 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.685 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.43 169.6 17.95 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -134.02 149.61 51.19 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 110.384 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.677 HG11 HG12 ' A' ' 694' ' ' ILE . 43.7 t -137.9 142.21 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.593 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.81 120.31 41.9 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.496 ' CE1' HG23 ' A' ' 694' ' ' ILE . 1.9 m-85 -96.43 149.66 21.47 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 124.408 1.083 . . . . 0.0 110.36 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 53.1 t30 -136.4 152.3 50.47 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 46.6 t -91.86 166.31 12.8 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 48.5 t -58.42 157.59 8.6 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.254 0.549 . . . . 0.0 109.811 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.79 -35.87 82.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.506 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 15.1 m -90.82 5.42 48.48 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.204 0.525 . . . . 0.0 111.804 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -128.62 158.18 39.21 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.5 t -117.04 145.27 43.82 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.8 ptm -101.8 151.44 22.05 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.407 0.623 . . . . 0.0 110.797 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.0 mt -131.2 127.86 61.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.79 -153.46 16.63 Favored Glycine 0 CA--C 1.472 -2.614 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -98.75 119.01 36.78 Favored 'General case' 0 CA--C 1.465 -2.297 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.919 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -65.53 -27.38 68.41 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.178 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.6 p -107.91 147.73 30.59 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.344 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -127.35 163.41 30.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.324 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 56.7 m -134.62 136.73 43.11 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.49 114.29 15.05 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.466 0.65 . . . . 0.0 111.432 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.04 97.53 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.914 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 68.05 34.14 4.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.735 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 101.19 -15.21 57.99 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.405 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.77 133.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.491 ' CG ' HD12 ' A' ' 731' ' ' ILE . 88.3 m95 -72.35 152.76 41.87 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.2 p -37.43 -66.54 0.24 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -31.01 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 731' ' ' ILE . 21.4 mt 66.09 148.75 0.11 Allowed Pre-proline 0 C--N 1.316 -0.855 0 O-C-N 124.796 1.31 . . . . 0.0 110.992 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.13 -172.13 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.812 1.675 . . . . 0.0 110.089 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 725' ' ' MET . 10.5 pt20 -136.94 145.07 43.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 88.2 m -102.32 153.77 19.68 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.6 144.33 27.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.82 120.7 12.4 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 123.707 0.629 . . . . 0.0 111.199 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.252 1.235 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.165 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 120.373 0.13 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -153.42 163.93 39.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -84.66 -17.55 38.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.301 0.572 . . . . 0.0 110.398 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -142.99 147.05 34.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -87.98 -10.28 50.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.661 0.743 . . . . 0.0 110.527 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 99.38 113.97 3.5 Favored Glycine 0 C--N 1.297 -1.584 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . 0.331 22.6 m 48.07 73.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 123.748 1.737 . . . . 0.0 111.492 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.436 ' CD ' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -73.68 -105.96 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 112.181 -2.281 . . . . 0.0 114.338 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.532 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 8.0 p 179.87 155.51 0.59 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.207 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 28.6 p -175.91 146.36 0.71 Allowed 'General case' 0 C--O 1.253 1.238 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.62 -132.3 7.63 Favored Glycine 0 N--CA 1.414 -2.781 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.69 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.949 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 52.9 Cg_exo -53.77 140.34 67.37 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 124.002 3.135 . . . . 0.0 113.12 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.672 ' HD2' HG22 ' A' ' 645' ' ' THR . 21.7 Cg_endo -61.97 154.24 63.14 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.575 2.183 . . . . 0.0 111.093 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD11 ' A' ' 681' ' ' LEU . 14.6 Cg_endo -68.02 -168.81 0.21 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 122.517 2.145 . . . . 0.0 111.872 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.08 162.44 13.37 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.538 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.685 HD13 ' HG2' ' A' ' 682' ' ' PRO . 28.8 tp -101.19 138.18 38.56 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.014 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.46 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.5 tm? -27.75 -64.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.584 2.353 . . . . 0.0 111.731 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 15.2 t-20 -117.36 -40.9 3.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.874 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -79.18 -128.77 0.6 Allowed Glycine 0 CA--C 1.504 -0.627 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.599 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 50.2 t30 -173.53 -175.6 1.15 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.0 p -99.5 144.64 11.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.5 ptpt -99.7 -16.72 18.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.122 0.487 . . . . 0.0 111.123 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 145.11 24.94 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.38 152.08 27.65 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-O 121.833 0.825 . . . . 0.0 112.543 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.672 HG22 ' HD2' ' A' ' 633' ' ' PRO . 39.9 p -73.65 118.16 16.27 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.679 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -83.79 -22.78 31.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.001 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.949 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 32.0 mt-10 63.69 18.28 11.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.672 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -157.97 101.29 1.77 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.676 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 34.7 m-85 -117.45 -73.48 0.64 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.268 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.08 -88.57 0.65 Allowed Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.739 -1.22 . . . . 0.0 113.885 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -146.61 142.38 27.88 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.22 0.51 . . . . 0.0 110.793 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.3 p 68.18 11.5 8.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.884 1.674 . . . . 0.0 113.102 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 39.0 mm-40 -78.86 129.16 34.26 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.604 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.9 OUTLIER -120.11 131.14 73.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 112.111 -176.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 67.4 t -121.41 137.9 53.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.195 -171.953 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -104.37 134.03 48.27 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 122.508 1.147 . . . . 0.0 112.269 -179.355 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.0 m-85 -109.9 164.06 12.95 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.158 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 48.9 p90 -137.97 145.72 42.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.488 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 96.3 m -91.5 153.4 19.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 639' ' ' GLY . 4.2 m-20 -51.6 156.79 2.09 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.015 177.529 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.4 12.19 0.41 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 123.646 2.897 . . . . 0.0 112.801 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.642 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 40.4 ptt180 -133.35 0.34 3.35 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.793 0.806 . . . . 0.0 111.573 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 31.4 m-85 -125.03 150.6 46.59 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.57 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.736 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 5.9 mp -103.36 139.91 38.14 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.235 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.546 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.0 tpp -73.93 117.25 15.49 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.782 0.676 . . . . 0.0 109.206 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -101.27 -32.7 10.38 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.6 -174.98 48.84 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 114.981 -1.009 . . . . 0.0 114.1 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.36 -8.67 23.84 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 124.065 3.177 . . . . 0.0 112.854 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.546 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 7.3 p30 58.48 -0.95 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.081 2.153 . . . . 0.0 115.358 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.8 mtmt -136.74 138.41 40.92 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.986 0.357 . . . . 0.0 110.495 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.468 HG21 HD13 ' A' ' 681' ' ' LEU . 44.6 pt -126.13 171.59 14.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.54 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -143.77 141.14 30.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 122.701 0.4 . . . . 0.0 109.994 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 673' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 41.4 t -85.71 105.1 16.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.32 -171.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 628' ' ' GLN . 6.0 p-10 -77.24 84.96 3.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.861 1.315 . . . . 0.0 111.614 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.01 0.31 Allowed Glycine 0 N--CA 1.4 -3.744 0 CA-C-N 111.872 -2.422 . . . . 0.0 108.343 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.62 -172.97 4.37 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 678' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.6 m95 -78.42 159.68 28.16 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 41.1 p -75.82 -168.0 0.81 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.504 0.721 . . . . 0.0 112.236 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 91.8 m -77.26 116.85 18.23 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.446 0.641 . . . . 0.0 111.502 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.3 mm? -58.09 145.38 73.33 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.689 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.685 ' HG2' HD13 ' A' ' 636' ' ' LEU . 30.1 Cg_endo -70.31 -172.95 0.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.44 2.093 . . . . 0.0 112.503 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.26 142.41 35.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 70.8 m -115.78 133.01 56.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.43 139.65 51.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 123.372 0.42 . . . . 0.0 109.939 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.7 p -88.33 118.48 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.539 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.9 pt-20 -68.7 -19.3 64.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.664 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 688' ' ' GLU . . . . . 0.649 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 33.7 tt0 71.89 -2.28 2.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.431 1.892 . . . . 0.0 112.929 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 25.2 t -100.45 155.47 17.81 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 47.9 p -131.46 173.59 10.94 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 120.937 0.399 . . . . 0.0 111.093 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.5 m -90.86 -3.1 57.63 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.644 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 92.32 -68.94 1.84 Allowed Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.887 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.5 t70 -177.51 -167.29 0.15 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -70.1 130.86 89.29 Favored Pre-proline 0 N--CA 1.413 -2.309 0 O-C-N 123.483 0.489 . . . . 0.0 110.482 174.808 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.558 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.9 Cg_endo -75.22 -176.37 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.42 2.747 . . . . 0.0 111.879 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -104.87 125.6 51.06 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.882 HD23 ' HA3' ' A' ' 700' ' ' GLY . 21.2 tp -104.05 136.27 44.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -52.17 -34.96 47.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 699' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 84.8 m-70 -139.79 22.33 2.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.728 0.775 . . . . 0.0 110.552 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.882 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.24 173.38 20.4 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.205 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -157.54 -154.25 0.44 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.912 1.685 . . . . 0.0 106.845 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -141.13 158.16 44.29 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.983 -168.498 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.402 ' OE1' ' HB2' ' A' ' 718' ' ' ASN . 0.7 OUTLIER -98.92 -56.75 2.34 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -118.96 151.64 37.81 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.0 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.0 p -123.43 160.83 26.02 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.6 t -150.41 86.82 5.02 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-O 121.496 0.665 . . . . 0.0 109.74 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.562 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 12.5 Cg_endo -97.64 151.05 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.432 2.755 . . . . 0.0 113.374 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 58.2 Cg_endo -69.36 135.27 32.17 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.048 -1.647 . . . . 0.0 111.236 -0.145 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.0 m-85 -77.73 73.17 4.3 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.535 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.649 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 29.8 m-85 -84.36 176.97 8.34 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.736 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 20.3 t80 -62.69 139.0 58.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.971 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.37 54.88 Favored Glycine 0 C--N 1.296 -1.671 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.955 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.8 171.13 15.43 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.9 m -137.1 155.84 49.12 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.475 0.655 . . . . 0.0 110.626 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 694' ' ' ILE . 36.2 t -141.33 144.86 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.068 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.1 mt-10 -109.9 128.17 55.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.376 0.607 . . . . 0.0 110.482 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.3 m-85 -101.07 157.12 17.0 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.334 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.402 ' HB2' ' OE1' ' A' ' 703' ' ' GLN . 66.6 t30 -147.86 141.89 25.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.6 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.9 m -87.65 157.33 19.13 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.6 m -51.7 157.29 1.18 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.437 0.46 . . . . 0.0 110.858 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.83 -29.42 69.48 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -169.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 47.3 m -89.18 6.71 38.87 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 121.603 -0.686 . . . . 0.0 111.238 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -126.3 151.26 47.75 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 724' ' ' THR . . . . . 0.436 ' HB ' HD11 ' A' ' 747' ' ' ILE . 11.1 t -119.79 145.92 46.16 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.639 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 6.5 ptm -93.3 147.28 23.06 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.337 0.589 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 726' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 44.5 mt -119.75 127.57 75.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.37 -139.96 15.9 Favored Glycine 0 CA--C 1.479 -2.209 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -109.62 129.8 55.56 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.248 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -65.8 -29.49 69.99 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.277 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -107.98 149.18 28.7 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.698 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 741' ' ' LEU . 7.2 pt -126.42 170.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.339 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 91.7 m -139.28 138.17 36.51 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.7 106.18 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.53 0.519 . . . . 0.0 109.649 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.52 115.82 47.13 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.619 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 735' ' ' HIS . . . . . 0.4 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 55.4 m80 60.96 19.49 9.89 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.813 1.245 . . . . 0.0 113.242 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.74 8.0 54.87 Favored Glycine 0 C--N 1.31 -0.908 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.06 139.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.558 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.6 m95 -66.14 147.63 53.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -34.91 -71.88 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -161.74 -27.9 0.05 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 731' ' ' ILE . 19.6 mt 68.22 151.26 0.12 Allowed Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 124.51 1.131 . . . . 0.0 111.799 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.639 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 62.5 Cg_endo -80.11 -173.29 1.8 Allowed 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 122.638 2.226 . . . . 0.0 111.74 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 743' ' ' GLN . . . . . 0.553 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 23.6 pt20 -128.88 128.23 43.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 13.8 m -90.68 141.01 29.23 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.783 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.25 147.78 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.11 121.04 21.45 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.232 0.333 . . . . 0.0 111.214 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 747' ' ' ILE . . . . . 0.436 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.1 mt . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -150.46 92.99 1.92 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.38 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.42 22.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.618 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -131.86 148.88 52.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.0 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -171.98 -70.12 0.04 OUTLIER Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.993 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 627' ' ' VAL . . . . . 0.68 HG22 ' CD2' ' A' ' 651' ' ' HIS . 93.5 t 58.5 82.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.336 1.065 . . . . 0.0 111.961 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 628' ' ' GLN . . . . . 0.548 ' HG2' ' N ' ' A' ' 676' ' ' GLY . 1.3 pp0? -84.16 -147.47 0.09 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.884 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 629' ' ' SER . . . . . 0.567 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.7 m -157.56 111.76 2.62 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 122.115 -0.366 . . . . 0.0 110.794 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 22.4 p -96.24 162.74 13.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.26 -136.11 8.95 Favored Glycine 0 N--CA 1.407 -3.266 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 632' ' ' PRO . . . . . 0.841 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 33.6 Cg_exo -58.63 147.03 89.37 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.485 2.79 . . . . 0.0 112.607 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 633' ' ' PRO . . . . . 0.657 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.6 Cg_endo -62.07 158.8 37.25 Favored 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 123.408 2.738 . . . . 0.0 112.512 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 634' ' ' PRO . . . . . 0.587 ' HG2' HD21 ' A' ' 681' ' ' LEU . 22.0 Cg_endo -67.0 -156.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.608 2.872 . . . . 0.0 111.462 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -122.58 166.0 15.54 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.221 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.9 tp -103.57 141.74 35.49 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 638' ' ' ASN . 2.2 tm? -40.83 -67.26 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.013 1.446 . . . . 0.0 110.991 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 638' ' ' ASN . . . . . 0.45 ' HB2' HD12 ' A' ' 637' ' ' LEU . 4.9 t-20 -129.13 52.5 1.96 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.16 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 639' ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -176.16 -158.1 18.93 Favored Glycine 1 C--N 1.249 -4.256 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -167.86 -168.99 1.07 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.742 1.271 . . . . 0.0 112.027 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 641' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 643' ' ' GLU . 68.0 t -92.61 132.77 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.299 1.44 . . . . 0.0 110.022 -175.232 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 642' ' ' LYS . . . . . 0.469 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.9 ptpt -104.05 -1.88 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.282 1.039 . . . . 0.0 109.222 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 643' ' ' GLU . . . . . 0.414 ' H ' HG12 ' A' ' 641' ' ' VAL . 10.7 mm-40 -90.61 173.9 7.8 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.247 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -104.03 147.12 27.76 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.151 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 645' ' ' THR . . . . . 0.657 HG22 ' HD2' ' A' ' 633' ' ' PRO . 40.1 p -80.83 117.06 21.16 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.634 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -83.27 -25.97 31.11 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.637 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 647' ' ' GLU . . . . . 0.841 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 44.3 mt-10 73.01 -7.18 1.54 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.843 1.257 . . . . 0.0 113.579 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -145.73 100.73 3.46 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 649' ' ' TYR . . . . . 0.764 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 13.6 m-85 -94.74 -70.0 0.73 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.763 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 650' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.7 -111.13 1.78 Allowed Glycine 0 C--N 1.312 -0.789 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.878 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 651' ' ' HIS . . . . . 0.68 ' CD2' HG22 ' A' ' 627' ' ' VAL . 84.8 t60 -142.57 135.11 27.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.8 m 76.33 15.53 2.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.66 1.184 . . . . 0.0 111.88 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 653' ' ' GLU . . . . . 0.764 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 54.9 mm-40 -80.7 135.13 35.96 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.819 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 654' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -114.66 151.16 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 655' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 633' ' ' PRO . 48.0 t -131.92 135.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.177 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -103.13 130.15 50.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.519 0.676 . . . . 0.0 110.785 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 657' ' ' TYR . . . . . 0.592 ' HB3' HD22 ' A' ' 636' ' ' LEU . 71.0 m-85 -106.77 161.4 14.7 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.844 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 658' ' ' TYR . . . . . 0.469 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 53.8 p90 -136.63 152.17 50.13 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 659' ' ' CYS . . . . . 0.623 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.2 m -97.95 169.13 9.85 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 660' ' ' ASN . . . . . 0.421 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.41 157.58 17.48 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 661' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 66.0 Cg_endo -72.04 7.6 1.66 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.778 2.985 . . . . 0.0 113.84 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 662' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 15.7 ptt180 -120.0 -9.58 9.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.766 0.793 . . . . 0.0 110.049 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 41.9 m-85 -119.93 161.34 21.05 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 664' ' ' LEU . . . . . 0.738 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.318 0.0 OUTLIER -130.26 141.35 50.63 Favored 'General case' 0 C--N 1.256 -3.493 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.732 179.895 . . . . . . . . 4 4 . 1 . 020 nuclear build full ' A' A ' 665' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.7 tpp -61.65 124.54 20.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.171 -177.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 63.5 tttm -106.35 -49.77 3.28 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.18 -163.52 39.02 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.951 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.87 105.27 2.05 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.601 2.2 . . . . 0.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 669' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 6.5 p30 -72.49 4.99 3.28 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.199 -173.051 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 670' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 41.2 mtmt -132.27 128.98 38.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 671' ' ' ILE . . . . . 0.583 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -118.72 166.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 672' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 33.1 tt0 -134.52 137.61 44.0 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 123.657 0.598 . . . . 0.0 110.606 -175.532 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.47 110.18 17.97 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.955 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.96 -168.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 675' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' A' ' 628' ' ' GLN . 9.8 p-10 -82.78 78.87 9.32 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.849 1.309 . . . . 0.0 111.66 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 676' ' ' GLY . . . . . 0.548 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 146.45 -45.3 0.8 Allowed Glycine 0 N--CA 1.401 -3.668 0 CA-C-N 113.177 -1.829 . . . . 0.0 111.708 170.535 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.66 -168.78 3.0 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -102.0 168.4 9.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.7 p -78.67 -170.21 2.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.723 0.297 . . . . 0.0 111.194 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.1 m -71.14 112.56 7.38 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 121.267 0.556 . . . . 0.0 110.215 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 681' ' ' LEU . . . . . 0.587 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.5 mp -68.98 153.48 96.06 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.884 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 75.7 Cg_endo -73.19 -176.35 2.4 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.031 2.487 . . . . 0.0 112.442 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 11.2 p -145.27 146.65 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 684' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 636' ' ' LEU . 63.7 m -114.29 138.54 50.38 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 685' ' ' ILE . . . . . 0.44 HD13 ' HD2' ' A' ' 666' ' ' LYS . 21.9 pt -130.17 146.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 686' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 662' ' ' ARG . 9.1 p -98.06 118.22 44.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 687' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.3 pt-20 -85.6 -13.69 47.99 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.043 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . 0.27 12.3 pt-20 45.3 63.23 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.281 1.833 . . . . 0.0 113.922 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 8.8 t -147.38 156.84 43.26 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p -115.64 155.84 26.94 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.17 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 26.2 m -93.21 -4.5 51.88 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.912 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 104.07 -90.21 0.72 Allowed Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 693' ' ' ASP . . . . . 0.476 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 p-10 -168.65 -172.89 1.75 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.476 1.11 . . . . 0.0 108.107 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 694' ' ' ILE . . . . . 0.627 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -64.87 126.73 91.67 Favored Pre-proline 0 N--CA 1.434 -1.258 0 CA-C-O 121.555 0.693 . . . . 0.0 112.559 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 695' ' ' PRO . . . . . 0.546 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 50.6 Cg_endo -71.28 -174.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.511 2.807 . . . . 0.0 112.065 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -108.44 113.87 27.26 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.297 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 697' ' ' LEU . . . . . 0.915 HD23 ' HA3' ' A' ' 700' ' ' GLY . 20.3 tp -92.04 135.83 33.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.0 -34.37 69.94 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -137.0 18.41 3.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.856 0.836 . . . . 0.0 110.376 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 700' ' ' GLY . . . . . 0.915 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -127.32 176.33 17.88 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.746 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -158.33 -154.41 0.43 Allowed 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 702' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.79 156.09 47.64 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 118.819 0.736 . . . . 0.0 112.611 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 703' ' ' GLN . . . . . 0.526 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 11.4 mp0 -96.37 -59.3 1.86 Allowed 'General case' 0 CA--C 1.496 -1.131 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.494 -178.057 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 704' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.3 pp -114.6 127.71 55.93 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 694' ' ' ILE . 1.8 p -106.38 124.06 49.02 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.569 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.4 p -125.67 90.78 49.86 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 707' ' ' PRO . . . . . 0.46 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 5.9 Cg_endo -90.74 150.35 4.11 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.644 2.229 . . . . 0.0 111.657 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 708' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.1 Cg_endo -74.31 134.05 33.91 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.639 -1.817 . . . . 0.0 110.995 -1.222 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 709' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.2 m-85 -77.7 82.51 4.1 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 710' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 5.9 m-30 -87.46 166.53 14.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.257 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 711' ' ' TYR . . . . . 0.738 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 3.3 t80 -61.13 135.99 57.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.06 -22.28 41.66 Favored Glycine 0 C--N 1.296 -1.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.504 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.69 163.62 27.5 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 117.817 0.808 . . . . 0.0 109.095 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.3 m -136.41 147.91 47.51 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.122 0.487 . . . . 0.0 110.144 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 715' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 730' ' ' SER . 33.6 t -130.59 140.46 48.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.911 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 716' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.2 mt-10 -102.33 128.27 48.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.164 0.506 . . . . 0.0 111.029 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 717' ' ' PHE . . . . . 0.627 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -98.45 158.46 15.57 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 124.717 1.207 . . . . 0.0 109.707 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 718' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 63.2 t30 -144.61 145.16 31.64 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 719' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 96.9 m -96.25 158.06 15.61 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -57.28 150.9 16.99 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.47 -39.46 61.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -172.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.8 t -78.39 1.83 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.668 0.747 . . . . 0.0 111.149 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 723' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 80.3 m-85 -123.59 147.96 46.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -114.43 143.0 45.64 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 725' ' ' MET . . . . . 0.522 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.2 ptm -92.74 141.89 27.95 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.483 0.659 . . . . 0.0 110.489 -176.367 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 44.3 mt -114.81 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 123.53 -155.77 17.66 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.031 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -95.34 136.66 35.42 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 122.283 1.039 . . . . 0.0 108.407 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -70.32 -37.1 74.65 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.291 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 730' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.5 p -102.33 138.36 39.36 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-O 122.168 0.985 . . . . 0.0 113.368 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 731' ' ' ILE . . . . . 0.781 HG21 HD23 ' A' ' 741' ' ' LEU . 10.9 pt -115.97 167.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.3 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 44.0 m -134.02 137.33 44.65 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.32 103.94 1.38 Allowed 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.882 0.739 . . . . 0.0 109.778 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.9 mm -128.49 110.59 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.084 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 49.8 m80 68.63 21.4 7.95 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.73 18.93 39.05 Favored Glycine 0 N--CA 1.434 -1.433 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.365 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.15 154.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 738' ' ' TRP . . . . . 0.546 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.6 m95 -76.21 169.72 17.67 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 739' ' ' THR . . . . . 0.598 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 9.2 p -49.98 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 740' ' ' GLN . . . . . 0.598 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -161.54 -30.67 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.066 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 741' ' ' LEU . . . . . 0.781 HD23 HG21 ' A' ' 731' ' ' ILE . 22.2 mt 70.79 153.58 0.15 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.685 1.24 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 742' ' ' PRO . . . . . 0.522 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 73.4 Cg_endo -81.8 -166.41 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.622 0 C-N-CA 121.927 1.751 . . . . 0.0 110.034 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.71 147.25 38.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 744' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 8.8 m -104.21 143.83 32.42 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.89 137.16 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.35 117.09 6.16 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 110.387 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.311 -1.091 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.523 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 15.8 p . . . . . 0 N--CA 1.468 0.459 0 N-CA-C 109.584 -0.524 . . . . 0.0 109.584 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 30.5 p -137.83 142.11 40.79 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -94.6 -134.16 7.38 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.777 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 78.2 Cg_exo -53.56 146.54 42.64 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.818 3.012 . . . . 0.0 113.162 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 645' ' ' THR . 31.3 Cg_endo -65.71 158.07 55.44 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.537 2.158 . . . . 0.0 111.421 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.559 ' HG2' HD21 ' A' ' 681' ' ' LEU . 25.0 Cg_endo -71.79 -169.24 0.42 Allowed 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.96 2.44 . . . . 0.0 112.054 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.86 146.73 33.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 639' ' ' GLY . 2.9 tt -81.97 141.49 33.24 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -33.28 -69.83 0.08 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.859 1.663 . . . . 0.0 111.142 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 3.1 t30 -108.81 -38.32 5.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.011 -1.075 . . . . 0.0 109.924 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -76.42 -151.28 3.71 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.166 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -169.28 179.51 3.91 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.681 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.9 p -98.92 142.6 14.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 123.312 0.645 . . . . 0.0 110.006 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.4 ptpt -97.01 -27.46 14.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.071 0.463 . . . . 0.0 110.777 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.29 142.62 35.97 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.637 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -83.56 159.47 21.65 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.398 0.618 . . . . 0.0 111.003 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 633' ' ' PRO . 21.3 p -73.42 122.81 22.7 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.759 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -96.76 -29.27 13.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.777 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 40.8 mt-10 71.47 -26.2 0.17 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 125.984 1.714 . . . . 0.0 113.041 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.17 42.21 1.09 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.041 0.536 . . . . 0.0 110.987 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.437 ' CA ' ' HG3' ' A' ' 653' ' ' GLU . 80.0 m-85 -69.85 -73.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 92.74 -68.09 1.81 Allowed Glycine 0 C--N 1.293 -1.809 0 C-N-CA 120.387 -0.911 . . . . 0.0 114.499 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -161.51 138.57 8.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 117.196 0.498 . . . . 0.0 112.168 -176.35 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 26.1 m 63.9 13.86 7.92 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.904 1.681 . . . . 0.0 113.282 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 8.6 mm-40 -78.54 136.29 37.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.426 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 t -110.46 143.28 20.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 56.7 t -132.26 135.76 57.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.259 0.624 . . . . 0.0 109.866 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.92 132.48 49.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 122.174 0.987 . . . . 0.0 111.783 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.686 ' HB3' HD12 ' A' ' 636' ' ' LEU . 41.7 m-85 -108.52 166.74 10.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.596 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 45.6 p90 -137.13 160.09 39.98 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 69.6 m -98.31 169.36 9.62 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.653 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.49 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.53 165.27 3.14 Favored Pre-proline 0 C--O 1.2 -1.539 0 C-N-CA 124.329 1.052 . . . . 0.0 109.367 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 72.6 Cg_endo -75.59 12.88 1.26 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.749 2.299 . . . . 0.0 112.577 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.491 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 25.4 ptt180 -144.21 10.6 1.5 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.896 0.855 . . . . 0.0 110.041 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.491 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 45.5 m-85 -134.81 138.22 44.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.202 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.561 HD21 ' HB3' ' A' ' 711' ' ' TYR . 11.3 mt -104.28 154.75 19.42 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.332 0.586 . . . . 0.0 110.048 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.52 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 55.0 tpp -73.52 124.61 26.2 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.022 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -110.82 -25.76 9.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.969 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.05 -172.92 46.35 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.45 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.43 -9.76 24.58 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.377 2.718 . . . . 0.0 112.345 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.503 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 2.2 p-10 55.96 -0.25 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 127.6 2.36 . . . . 0.0 115.947 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 31.8 mtmt -130.24 144.36 51.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.0 pt -136.11 167.64 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 123.425 0.453 . . . . 0.0 109.897 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.8 tt0 -135.87 140.56 44.23 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 123.751 0.821 . . . . 0.0 110.461 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.8 t -85.14 99.2 10.91 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.756 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.64 165.35 2.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.307 2.2 p30 -75.5 80.51 2.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 118.426 -1.31 . . . . 0.0 113.763 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.84 -40.26 0.5 Allowed Glycine 0 N--CA 1.419 -2.451 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.249 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -165.12 175.76 9.09 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -81.55 171.2 14.95 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.691 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 23.0 p -82.89 -165.62 1.11 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.59 0.234 . . . . 0.0 111.493 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 94.8 m -66.69 111.98 3.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -69.52 154.4 94.87 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.487 175.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.676 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 56.0 Cg_endo -69.62 -178.76 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.502 2.134 . . . . 0.0 114.444 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.7 145.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 86.7 m -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.55 140.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.3 p . . . . . 0 C--N 1.295 -1.763 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 709' ' ' TYR . 18.7 p . . . . . 0 N--CA 1.436 -1.137 0 CA-C-O 120.978 0.418 . . . . 0.0 111.9 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 8.7 m -93.27 -2.75 54.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 99.2 -87.3 0.76 Allowed Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.765 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.6 t70 -158.45 -167.56 2.2 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.618 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -73.63 133.17 80.12 Favored Pre-proline 0 N--CA 1.407 -2.615 0 C-N-CA 123.899 0.879 . . . . 0.0 109.998 175.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.591 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 66.9 Cg_endo -73.68 -164.89 0.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.248 2.632 . . . . 0.0 111.301 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -117.7 142.08 47.65 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 3.5 tt -117.09 137.46 52.26 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.41 ' HG2' HD23 ' A' ' 697' ' ' LEU . 14.4 pt-20 -41.69 -40.01 1.84 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 113.113 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 97.1 m-70 -145.32 29.38 1.16 Allowed 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.567 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -133.3 170.38 22.28 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.567 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -158.54 -155.41 0.48 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -136.79 152.16 49.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -167.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -92.44 -48.95 6.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.859 178.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.7 pp -124.83 152.92 43.33 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 12.4 p -147.88 124.17 10.89 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.319 1.048 . . . . 0.0 109.096 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.4 t -131.78 92.0 31.8 Favored Pre-proline 0 C--N 1.289 -2.052 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.601 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.415 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.7 Cg_endo -87.16 149.47 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 122.634 2.223 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 67.6 Cg_endo -74.82 132.94 29.17 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.133 -1.611 . . . . 0.0 112.493 0.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.765 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 46.6 m-85 -76.48 92.38 3.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.035 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -79.68 166.72 21.54 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 123.548 0.53 . . . . 0.0 111.656 179.899 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.561 ' HB3' HD21 ' A' ' 664' ' ' LEU . 3.6 t80 -66.91 135.28 53.59 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.31 60.34 Favored Glycine 0 N--CA 1.402 -3.617 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.95 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.66 166.22 19.34 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.502 0.651 . . . . 0.0 110.885 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 0.9 OUTLIER -127.62 158.24 38.06 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.414 0.626 . . . . 0.0 111.157 -172.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.599 HG11 HG12 ' A' ' 694' ' ' ILE . 26.2 t -142.04 142.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.606 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -102.33 126.12 49.25 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 120.802 0.334 . . . . 0.0 110.102 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.6 m-85 -97.7 154.98 17.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.929 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 719' ' ' CYS . 0.2 OUTLIER -137.23 135.74 37.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -177.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.544 ' N ' HD22 ' A' ' 718' ' ' ASN . 95.6 m -93.48 144.24 25.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 63.1 m -56.68 161.77 2.62 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.91 140.37 55.49 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.762 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.7 m 79.12 -2.19 2.25 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 125.962 1.705 . . . . 0.0 111.712 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -116.56 140.17 49.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.947 -0.471 . . . . 0.0 110.419 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 9.2 t -108.24 141.73 39.57 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.59 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -91.03 137.98 31.95 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.23 0.538 . . . . 0.0 110.7 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.49 115.0 44.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.06 -154.38 20.24 Favored Glycine 0 CA--C 1.472 -2.623 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -94.63 130.2 41.19 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -63.19 -29.95 71.2 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.121 0.888 . . . . 0.0 111.624 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 6.0 p -113.95 152.9 30.18 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 121.602 0.715 . . . . 0.0 112.073 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 741' ' ' LEU . 7.7 pt -127.73 167.27 23.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.481 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 739' ' ' THR . 82.9 m -133.49 135.92 44.76 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.7 t -67.29 109.04 2.96 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.768 0.827 . . . . 0.0 110.471 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.6 mm -126.83 99.01 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.46 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 66.56 30.07 8.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.525 1.13 . . . . 0.0 112.172 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 97.02 0.37 60.1 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.559 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.39 143.61 38.54 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.591 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -78.3 166.05 23.14 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 732' ' ' THR . 38.0 p -48.67 -69.46 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.19 -30.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 731' ' ' ILE . 20.2 mt 67.73 148.91 0.12 Allowed Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 124.856 1.347 . . . . 0.0 111.564 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.59 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 77.7 Cg_endo -80.77 175.28 10.17 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.016 1.811 . . . . 0.0 109.693 174.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.88 134.93 54.87 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 4.4 m -102.47 122.72 44.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.72 149.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.55 112.62 4.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 124.161 0.913 . . . . 0.0 111.239 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 724' ' ' THR . 56.6 mt . . . . . 0 C--O 1.249 1.038 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 N--CA 1.439 -0.98 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.6 p -168.61 152.38 5.63 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.16 -138.41 9.66 Favored Glycine 1 N--CA 1.392 -4.253 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.422 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 51.0 Cg_exo -54.6 144.38 64.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.6 2.866 . . . . 0.0 112.891 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.7 Cg_endo -61.51 162.68 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.269 2.646 . . . . 0.0 112.895 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.528 ' HG2' HD21 ' A' ' 681' ' ' LEU . 32.2 Cg_endo -75.5 -165.42 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.548 2.165 . . . . 0.0 111.194 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.44 174.69 5.75 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.686 HD13 ' HG2' ' A' ' 682' ' ' PRO . 17.2 tp -109.36 144.55 37.39 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.75 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -32.66 -59.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.547 1.939 . . . . 0.0 111.784 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.3 t30 -120.2 -44.75 2.48 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.316 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -76.83 -152.79 4.89 Favored Glycine 0 CA--C 1.495 -1.19 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.393 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 658' ' ' TYR . 2.5 t-20 -156.86 -178.25 7.22 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.364 -1.334 . . . . 0.0 110.152 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.26 146.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -111.0 -13.38 14.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.836 0.827 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 655' ' ' VAL . 15.6 mm-40 -79.89 134.94 36.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.635 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 644' ' ' LYS . 9.3 mmpt? -67.5 158.47 31.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.842 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 633' ' ' PRO . 65.4 p -107.11 151.09 25.84 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.318 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -99.5 -87.93 0.35 Allowed 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.933 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 12.1 pt-20 156.88 -36.21 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.434 0 C-N-CA 125.713 1.605 . . . . 0.0 107.956 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -126.07 107.87 10.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.854 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 7.7 m-85 -101.73 -72.19 0.69 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.753 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 114.85 -105.49 1.5 Allowed Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.545 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 81.1 t60 -138.58 140.98 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.644 0.222 . . . . 0.0 110.494 179.287 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 41.3 m 72.82 15.8 4.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.006 1.322 . . . . 0.0 112.987 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.854 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 14.5 mm-40 -75.11 133.92 41.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 671' ' ' ILE 0.263 0.5 OUTLIER -125.91 134.28 66.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.824 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 53.7 t -125.14 143.38 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.136 0.974 . . . . 0.0 111.239 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.462 ' HG3' ' ND2' ' A' ' 669' ' ' ASN . 30.2 tt0 -104.62 133.49 49.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.865 0.841 . . . . 0.0 111.461 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 46.8 m-85 -105.48 166.58 10.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.415 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 640' ' ' ASN . 49.7 p90 -138.95 144.46 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 60.4 m -102.46 151.04 22.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.127 0.489 . . . . 0.0 110.183 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 15.0 m120 -52.48 159.96 1.48 Allowed Pre-proline 0 C--N 1.305 -1.358 0 C-N-CA 126.268 1.827 . . . . 0.0 114.739 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 56.6 Cg_endo -68.24 6.89 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 124.008 3.139 . . . . 0.0 113.737 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 18.7 ptt180 -140.54 -2.15 1.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.642 0.734 . . . . 0.0 111.535 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.708 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 51.9 m-85 -116.62 122.8 45.65 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.405 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 11.0 mt -85.73 142.05 29.28 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.524 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 35.8 ttm -77.96 110.34 12.8 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.105 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.682 ' HD2' HD13 ' A' ' 685' ' ' ILE . 55.5 tttm -99.3 -39.04 8.62 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.018 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.34 -153.56 9.04 Favored Glycine 0 CA--C 1.503 -0.669 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.806 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.689 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 39.9 Cg_endo -70.07 -148.84 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.229 1.953 . . . . 0.0 110.252 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.462 ' ND2' ' HG3' ' A' ' 656' ' ' GLU . 2.0 p-10 -166.39 -28.31 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.888 -0.507 . . . . 0.0 110.096 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 97.3 mttt -112.75 124.15 51.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.166 176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 681' ' ' LEU . 44.5 pt -109.24 166.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.656 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -137.78 141.57 40.89 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 123.052 0.541 . . . . 0.0 110.58 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.9 t -79.51 93.47 5.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.224 1.011 . . . . 0.0 108.429 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.19 163.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.232 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -70.33 86.62 0.6 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.901 1.334 . . . . 0.0 111.484 -178.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 149.64 -47.92 0.61 Allowed Glycine 0 N--CA 1.407 -3.284 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.34 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -158.36 -179.79 8.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -78.4 166.77 22.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.5 p -76.98 -174.94 3.32 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 120.998 0.428 . . . . 0.0 111.555 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 29.6 m -69.94 120.02 15.03 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.919 0.866 . . . . 0.0 111.263 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 671' ' ' ILE . 82.8 mt -66.87 146.56 99.11 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.153 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.689 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 34.8 Cg_endo -67.79 -173.87 0.53 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.051 2.501 . . . . 0.0 113.415 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.21 137.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 57.5 m -115.9 133.44 56.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.682 HD13 ' HD2' ' A' ' 666' ' ' LYS . 38.5 pt -130.27 136.57 58.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 122.917 0.487 . . . . 0.0 110.127 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.291 -1.964 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.729 179.184 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.1 p . . . . . 0 N--CA 1.418 -2.055 0 CA-C-O 121.4 0.619 . . . . 0.0 112.446 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.89 -16.32 18.06 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.446 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 109.55 -79.85 0.26 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.44 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.408 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 15.9 t70 -173.61 -169.2 0.49 Allowed 'General case' 0 C--O 1.25 1.085 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.518 HG13 HG11 ' A' ' 715' ' ' VAL . 1.1 mp -67.75 138.35 93.15 Favored Pre-proline 0 C--N 1.285 -2.211 0 C-N-CA 124.141 0.976 . . . . 0.0 110.366 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.667 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -75.41 -165.74 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.659 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -123.73 122.05 37.07 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.739 -0.6 . . . . 0.0 110.046 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.703 HD23 ' HA3' ' A' ' 700' ' ' GLY . 31.6 tp -97.54 155.26 17.03 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.619 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 7.1 pt-20 -43.4 -40.9 3.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.551 1.14 . . . . 0.0 112.188 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.619 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 20.9 m80 -136.25 -40.78 0.65 Allowed 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.878 -173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.703 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -75.65 168.27 54.79 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.479 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -150.71 -148.3 0.26 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.85 154.33 50.54 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.774 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.424 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -90.9 -43.92 9.7 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 121.736 0.779 . . . . 0.0 109.437 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.26 149.15 45.45 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.44 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 2.4 p -117.13 146.35 43.23 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.7 t -130.81 86.63 51.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-O 121.669 0.747 . . . . 0.0 111.896 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.448 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.8 Cg_endo -92.89 147.42 2.57 Favored 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.855 2.37 . . . . 0.0 111.984 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 98.6 Cg_endo -76.9 131.26 23.7 Favored 'Cis proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.604 -1.832 . . . . 0.0 111.161 0.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 27.0 m-85 -73.79 94.88 2.32 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 -98.91 172.43 7.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.492 ' CD1' HD22 ' A' ' 664' ' ' LEU . 1.1 t80 -65.92 138.11 57.62 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.47 68.74 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.266 -1.445 . . . . 0.0 112.416 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 732' ' ' THR . 23.8 t70 -76.17 165.71 24.51 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.4 m -134.24 146.08 49.74 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.199 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.518 HG11 HG13 ' A' ' 694' ' ' ILE . 40.8 t -135.58 147.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.448 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 29.5 mt-10 -111.1 127.29 55.51 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.738 176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.7 m-85 -95.58 146.65 24.3 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -124.64 133.6 53.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 50.5 t -82.69 164.79 20.48 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.4 m -69.93 152.91 43.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.51 146.19 46.98 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.7 t 83.44 -2.16 1.17 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.886 1.674 . . . . 0.0 109.7 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -121.36 148.81 43.86 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.449 ' HB ' HD11 ' A' ' 747' ' ' ILE . 8.8 t -114.39 137.15 52.18 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.796 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.1 ptm -92.33 141.83 28.11 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.223 0.535 . . . . 0.0 109.944 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.28 120.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 130.34 -147.6 18.27 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -98.53 129.37 45.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.411 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -65.92 -27.88 68.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.293 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.568 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -115.18 157.48 23.59 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.065 0.459 . . . . 0.0 111.071 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 741' ' ' LEU . 6.6 pt -130.32 166.87 26.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.118 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 85.1 m -136.31 137.06 40.27 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -75.34 119.67 19.75 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.869 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.41 HG22 ' HD2' ' A' ' 735' ' ' HIS . 48.8 mm -127.58 110.15 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.601 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . 0.41 ' HD2' HG22 ' A' ' 734' ' ' ILE . 72.5 m-70 70.75 26.99 3.71 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.415 1.086 . . . . 0.0 112.697 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.21 77.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.298 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.98 152.8 38.17 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.667 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 83.3 m95 -85.89 154.31 21.61 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 118.97 0.805 . . . . 0.0 109.721 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 732' ' ' THR . 31.9 p -33.56 -69.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.14 -32.18 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 731' ' ' ILE . 29.9 mt 69.49 154.88 0.15 Allowed Pre-proline 0 C--N 1.322 -0.614 0 O-C-N 124.517 1.136 . . . . 0.0 111.47 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.568 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 68.7 Cg_endo -84.5 -163.71 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.407 2.071 . . . . 0.0 111.55 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 725' ' ' MET . 3.1 pt20 -139.94 155.27 47.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.45 141.59 44.81 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.931 0.396 . . . . 0.0 111.317 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.85 140.89 46.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.34 119.03 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.587 0.554 . . . . 0.0 111.446 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.449 HD11 ' HB ' ' A' ' 724' ' ' THR . 65.7 mt . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 54.8 m . . . . . 0 N--CA 1.48 1.069 0 N-CA-C 109.944 -0.391 . . . . 0.0 109.944 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 31.5 p -164.36 135.83 4.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.12 -125.28 5.58 Favored Glycine 1 N--CA 1.386 -4.633 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.601 ' HB3' HG21 ' A' ' 645' ' ' THR . 32.4 Cg_exo -54.91 142.4 75.63 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.657 2.904 . . . . 0.0 114.232 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 645' ' ' THR . 38.1 Cg_endo -64.79 161.65 35.2 Favored 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.598 2.866 . . . . 0.0 112.239 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.514 ' HG2' HD11 ' A' ' 681' ' ' LEU . 32.6 Cg_endo -72.18 -164.15 0.17 Allowed 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 111.493 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.6 178.53 4.6 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 682' ' ' PRO . 27.6 tp -121.15 145.32 47.94 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 636' ' ' LEU . 14.0 tp -34.01 -68.66 0.11 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 126.056 1.743 . . . . 0.0 113.868 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.44 42.05 2.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 124.416 2.055 . . . . 0.0 107.848 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.22 -168.17 17.97 Favored Glycine 1 C--N 1.237 -4.932 0 CA-C-N 111.064 -2.789 . . . . 0.0 109.377 176.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -155.97 178.45 10.26 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.142 0.471 . . . . 0.0 110.483 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 90.9 t -83.41 134.23 27.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.936 0.894 . . . . 0.0 108.66 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.641 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 15.0 ptpt -92.98 -20.75 20.28 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.297 0.57 . . . . 0.0 110.651 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.27 169.31 10.69 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.243 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 27.4 mmtp -109.11 147.59 32.19 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.908 0.385 . . . . 0.0 110.398 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.674 HG22 ' HD2' ' A' ' 633' ' ' PRO . 82.8 p -76.04 140.04 41.73 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -170.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -96.76 -8.54 31.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.94 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.44 ' OE2' ' HG3' ' A' ' 632' ' ' PRO . 27.6 mm-40 68.06 -24.73 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.787 1.635 . . . . 0.0 113.437 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.3 mt-10 -124.89 102.93 7.78 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 31.5 m-85 -113.27 -73.61 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 102.45 -68.61 0.35 Allowed Glycine 0 C--N 1.309 -0.954 0 C-N-CA 121.016 -0.612 . . . . 0.0 114.033 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -167.28 150.3 6.27 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 79.2 p 65.56 13.3 8.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.219 1.807 . . . . 0.0 112.893 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.5 mm-40 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.829 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.0 m -116.74 145.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 20.9 t -129.39 133.21 65.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.352 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.52 ' HG3' HD22 ' A' ' 669' ' ' ASN . 30.3 tt0 -101.14 126.52 47.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.963 0.887 . . . . 0.0 111.597 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.556 ' HB3' HD22 ' A' ' 636' ' ' LEU . 60.6 m-85 -97.54 158.53 15.43 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.005 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.641 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.3 p90 -137.14 146.98 45.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.538 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.3 m -92.1 160.76 15.05 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -55.15 163.19 1.69 Allowed Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.03 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.35 8.43 1.82 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.759 2.972 . . . . 0.0 113.221 -173.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 15.5 ptt180 -128.07 -5.64 5.55 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.673 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 47.6 m-85 -117.81 144.17 45.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.431 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 4.8 mp -100.66 140.08 35.44 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.283 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.553 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 50.6 tpp -72.78 114.59 11.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -99.57 -34.17 10.34 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.51 -177.95 49.31 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.915 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.589 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 59.3 Cg_endo -70.71 -6.54 19.29 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 123.847 3.032 . . . . 0.0 113.734 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.295 3.0 p-10 57.06 -35.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.916 2.486 . . . . 0.0 116.537 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 54.7 mtmt -103.4 135.87 44.22 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 111.477 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 681' ' ' LEU . 51.2 pt -121.35 166.37 15.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.812 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 31.2 tt0 -137.31 137.97 39.51 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 123.95 0.9 . . . . 0.0 109.676 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 45.3 t -83.0 113.99 20.96 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.63 -171.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.215 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.98 48.75 1.27 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -173.38 -42.03 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.934 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 678' ' ' TRP . 0.0 OUTLIER -166.9 -174.45 2.72 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 677' ' ' GLU . 89.7 m95 -79.76 169.08 18.46 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 672' ' ' GLN . 27.7 p -82.33 -176.0 5.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 21.0 m -60.13 114.2 2.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.197 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 671' ' ' ILE . 0.8 OUTLIER -63.08 153.82 79.73 Favored Pre-proline 0 N--CA 1.413 -2.315 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.372 177.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.715 ' HG2' HD13 ' A' ' 636' ' ' LEU . 36.4 Cg_endo -77.53 -176.14 3.06 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.558 2.172 . . . . 0.0 113.347 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.28 144.72 29.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.42 ' H ' HD23 ' A' ' 637' ' ' LEU . 83.3 m -119.62 136.86 54.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.69 143.31 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.4 p . . . . . 0 C--N 1.286 -2.188 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.852 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . 0.411 HG22 ' HD1' ' A' ' 710' ' ' TYR . 61.3 p . . . . . 0 N--CA 1.413 -2.32 0 CA-C-O 121.59 0.71 . . . . 0.0 111.878 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 5.4 m -90.5 6.44 43.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.155 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 85.08 -82.1 1.71 Allowed Glycine 0 CA--C 1.489 -1.581 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.498 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.721 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.3 t0 -158.34 -173.42 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.661 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.7 mt -72.97 131.33 83.92 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 123.91 0.884 . . . . 0.0 111.875 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.601 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -73.97 -168.94 0.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.627 2.884 . . . . 0.0 112.371 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.41 122.19 46.5 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.384 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.585 HD13 ' HA3' ' A' ' 700' ' ' GLY . 5.0 tt -93.84 136.62 33.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.592 ' OE2' ' HB2' ' A' ' 743' ' ' GLN . 13.2 pt-20 -48.12 -38.43 17.79 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 39.7 m80 -142.48 34.07 1.46 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.14 -170.59 12.06 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.534 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -163.32 -152.26 0.2 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.022 1.729 . . . . 0.0 107.389 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.22 156.96 45.84 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.442 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -94.92 -70.63 0.7 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.45 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -98.65 139.53 34.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.672 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.5 m -132.48 122.3 24.69 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.9 t -128.77 94.88 33.52 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 0.0 110.551 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.454 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.4 Cg_endo -89.78 152.64 5.06 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 122.351 2.034 . . . . 0.0 111.885 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 59.1 Cg_endo -71.95 134.22 32.48 Favored 'Cis proline' 0 C--O 1.24 0.618 0 C-N-CA 123.151 -1.604 . . . . 0.0 111.15 -2.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.721 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.6 m-85 -79.38 88.87 4.98 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.411 ' HD1' HG22 ' A' ' 690' ' ' THR . 4.8 m-30 -82.6 168.33 17.43 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.105 0.479 . . . . 0.0 111.391 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.6 t80 -60.84 133.97 56.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.88 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.7 -21.8 44.14 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.025 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.38 163.99 26.44 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-N 117.67 0.735 . . . . 0.0 110.014 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 4.8 m -125.46 161.95 25.96 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.21 0.528 . . . . 0.0 110.385 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.579 HG11 HG12 ' A' ' 694' ' ' ILE . 25.0 t -142.88 139.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.564 175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.437 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 43.0 mt-10 -101.88 123.57 46.03 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.661 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.42 158.59 15.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.442 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 18.5 t-20 -134.39 147.81 50.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 34.5 t -102.76 141.79 34.99 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 37.6 m -58.47 143.76 44.54 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.7 -33.27 68.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.6 m -82.2 4.96 21.41 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.693 -0.629 . . . . 0.0 111.339 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 97.6 m-85 -125.35 158.99 32.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 5.4 t -116.87 131.79 56.86 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.712 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.5 ptm -87.96 136.75 32.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.587 0.708 . . . . 0.0 110.283 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 55.4 mt -107.74 116.21 50.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.362 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.29 -151.19 18.54 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -108.44 156.04 19.9 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 32.0 ptt180 -86.08 -28.33 24.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 6.7 m -91.42 145.25 24.79 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.557 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.656 HG21 HD23 ' A' ' 741' ' ' LEU . 6.0 pt -125.61 174.07 10.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.342 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 86.7 m -141.37 136.28 31.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.29 108.79 3.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.418 0.687 . . . . 0.0 111.011 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.4 mm -123.3 104.04 13.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 121.257 0.551 . . . . 0.0 111.093 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 66.76 19.9 10.69 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.644 1.178 . . . . 0.0 112.368 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 104.14 -3.6 44.39 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.917 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.11 133.19 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.601 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -68.33 153.91 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 35.8 p -37.05 -69.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.56 -32.05 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.656 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 68.34 153.25 0.13 Allowed Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 124.753 1.283 . . . . 0.0 111.392 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.28 -173.4 1.64 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.767 1.644 . . . . 0.0 109.657 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.592 ' HB2' ' OE2' ' A' ' 698' ' ' GLU . 2.8 pt20 -134.39 153.58 51.83 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 86.7 m -117.08 134.81 54.3 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 123.309 0.38 . . . . 0.0 110.963 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.18 143.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.12 116.41 5.36 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 124.225 0.953 . . . . 0.0 110.893 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.045 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.492 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 34.8 p . . . . . 0 N--CA 1.434 -1.255 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 14.0 p -171.66 142.62 1.61 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -88.52 -144.15 9.76 Favored Glycine 0 N--CA 1.396 -3.975 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.898 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.727 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 41.1 Cg_exo -54.11 148.02 41.59 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 123.788 2.992 . . . . 0.0 112.117 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.629 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.3 Cg_endo -62.76 156.05 55.79 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.578 2.186 . . . . 0.0 111.784 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.503 ' HG2' HD11 ' A' ' 681' ' ' LEU . 23.1 Cg_endo -67.76 -172.61 0.41 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 122.482 2.121 . . . . 0.0 111.038 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.16 152.96 22.78 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -89.07 134.09 34.13 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 56.7 tp -22.16 -56.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.554 2.342 . . . . 0.0 113.757 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.4 t30 -125.94 -39.64 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -71.27 -155.17 1.82 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.405 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -168.84 177.76 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.04 -0.683 . . . . 0.0 111.033 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.66 147.17 5.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 124.823 1.249 . . . . 0.0 109.05 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -109.27 -12.17 14.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.052 0.453 . . . . 0.0 111.12 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.75 165.79 13.96 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.364 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -77.7 150.8 34.44 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.308 0.575 . . . . 0.0 110.874 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.629 HG22 ' HD2' ' A' ' 633' ' ' PRO . 28.7 p -84.52 114.36 21.9 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.785 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 45.7 mtmt -86.8 -15.17 40.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.382 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.727 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.0 mt-10 65.88 -6.53 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.68 86.29 1.39 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.438 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 17.5 m-85 -83.88 -74.13 0.39 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.045 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 117.52 -104.79 1.2 Allowed Glycine 0 C--O 1.211 -1.334 0 C-N-CA 119.84 -1.172 . . . . 0.0 113.252 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.0 t60 -137.68 138.1 39.05 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.864 0.332 . . . . 0.0 110.337 -177.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.5 m 69.32 16.34 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.205 . . . . 0.0 112.467 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 16.2 mm-40 -82.73 126.07 31.96 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.1 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.9 m -107.4 149.82 10.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.135 0.493 . . . . 0.0 111.881 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 45.3 t -130.65 132.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.493 ' HG3' HD22 ' A' ' 669' ' ' ASN . 34.4 tt0 -98.95 130.38 45.31 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 122.096 0.951 . . . . 0.0 112.236 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.72 ' HB3' HD12 ' A' ' 636' ' ' LEU . 59.4 m-85 -107.81 169.25 8.72 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.688 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -140.94 155.65 46.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 68.2 m -99.05 159.47 14.94 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.298 0.571 . . . . 0.0 110.061 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.86 157.76 28.05 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.832 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.43 -2.22 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 123.281 2.654 . . . . 0.0 115.117 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.29 -0.51 5.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.356 1.074 . . . . 0.0 110.972 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 31.1 m-85 -112.68 137.78 50.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.592 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 711' ' ' TYR . 9.8 mt -104.77 146.41 29.01 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 43.0 ttm -79.91 123.65 27.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.967 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -112.53 -34.79 5.74 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.02 -149.01 8.13 Favored Glycine 0 CA--C 1.504 -0.617 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.031 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.591 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 55.5 Cg_endo -72.93 -147.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.277 1.985 . . . . 0.0 109.361 171.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.493 HD22 ' HG3' ' A' ' 656' ' ' GLU . 2.2 p-10 -161.45 -28.4 0.05 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 122.104 -0.373 . . . . 0.0 110.505 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.9 mtmt -115.64 134.52 54.96 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.242 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.5 pt -117.43 169.12 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.3 tt0 -137.15 139.06 40.91 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 123.338 0.398 . . . . 0.0 110.222 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.07 103.55 14.85 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.87 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.291 3.0 p-10 -77.71 80.15 4.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.004 1.383 . . . . 0.0 113.492 -177.729 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 153.87 -54.33 0.44 Allowed Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.391 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.11 -171.15 3.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.53 -176.85 6.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.103 0.478 . . . . 0.0 112.009 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.7 p -97.94 -166.77 1.42 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.11 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 23.1 m -69.78 117.36 11.27 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.195 0.521 . . . . 0.0 111.362 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.503 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.6 mm? -68.66 151.08 97.44 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.414 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.591 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 71.3 Cg_endo -80.73 176.94 8.55 Favored 'Trans proline' 0 CA--C 1.474 -2.516 0 C-N-CA 123.456 2.77 . . . . 0.0 111.787 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.81 151.89 35.19 Favored 'Isoleucine or valine' 1 N--CA 1.352 -5.361 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.638 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 71.3 m -123.58 136.01 54.29 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.26 140.19 49.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.5 p . . . . . 0 C--N 1.286 -2.164 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.534 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 37.6 p . . . . . 0 N--CA 1.428 -1.537 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.36 -1.47 44.41 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.366 0.667 . . . . 0.0 111.079 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 91.32 -82.15 1.26 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 27.9 t70 -159.98 178.09 10.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.602 HG12 HG11 ' A' ' 715' ' ' VAL . 3.5 mt -68.73 131.43 91.25 Favored Pre-proline 0 N--CA 1.42 -1.943 0 C-N-CA 124.454 1.101 . . . . 0.0 111.556 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.4 Cg_endo -74.14 -176.43 2.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.296 2.664 . . . . 0.0 111.24 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.57 136.75 52.47 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 121.255 0.55 . . . . 0.0 109.683 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.9 tt -109.97 142.54 41.21 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.8 pt-20 -46.19 -36.65 6.21 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 34.7 m80 -146.48 21.55 1.33 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.239 0.542 . . . . 0.0 109.889 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -127.33 175.4 18.18 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.549 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -163.26 -159.38 0.53 Allowed 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -138.58 145.92 41.18 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.613 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.409 HE22 ' C ' ' A' ' 717' ' ' PHE . 0.2 OUTLIER -88.65 -51.87 5.45 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.632 0.729 . . . . 0.0 109.388 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.43 150.69 32.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.074 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.1 p -137.85 127.46 25.13 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 124.391 1.076 . . . . 0.0 108.936 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.9 m -123.78 81.32 55.5 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.514 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.501 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.3 Cg_endo -91.87 144.15 2.9 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 123.111 2.541 . . . . 0.0 112.024 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.5 Cg_endo -71.89 129.01 15.65 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.006 -1.664 . . . . 0.0 111.239 -0.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 23.6 m-85 -74.43 94.07 2.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.223 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.08 161.15 19.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 117.923 0.328 . . . . 0.0 111.403 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.659 ' CD1' HD22 ' A' ' 664' ' ' LEU . 0.1 OUTLIER -61.16 135.07 57.64 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.77 -12.36 59.37 Favored Glycine 0 N--CA 1.403 -3.521 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.821 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -92.81 179.81 5.36 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -140.62 161.94 36.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.618 0.723 . . . . 0.0 111.783 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.602 HG11 HG12 ' A' ' 694' ' ' ILE . 20.4 t -139.21 145.15 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.146 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 35.8 mt-10 -105.82 129.2 54.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.308 0.575 . . . . 0.0 110.526 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.59 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -109.12 153.08 24.21 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.957 1.703 . . . . 0.0 108.69 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -150.4 160.41 43.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 92.2 m -96.56 156.51 16.31 Favored 'General case' 0 C--N 1.27 -2.877 0 O-C-N 123.68 0.612 . . . . 0.0 110.484 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 25.8 m -67.25 162.56 22.4 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.868 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.83 147.24 53.51 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 35.2 t 87.35 -10.97 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.57 1.948 . . . . 0.0 108.413 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 71.7 m-85 -120.97 147.01 46.06 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-O 121.399 0.619 . . . . 0.0 110.73 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.9 t -115.5 147.14 41.0 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.485 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.0 ptm -96.57 146.85 24.45 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.067 0.46 . . . . 0.0 111.001 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 29.2 mt -126.22 116.61 46.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.4 -139.65 11.12 Favored Glycine 0 CA--C 1.479 -2.181 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.987 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -111.69 131.94 54.95 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.987 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -62.69 -32.78 73.92 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 124.303 1.002 . . . . 0.0 111.699 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 32.4 p -108.54 149.35 28.97 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.886 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 12.7 pt -125.25 166.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.393 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 739' ' ' THR . 45.1 m -131.85 136.87 47.79 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 48.4 t -71.21 107.2 4.11 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.909 0.756 . . . . 0.0 109.306 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 737' ' ' VAL . 51.4 mm -127.74 108.8 18.71 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 68.98 20.2 7.91 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.46 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.06 60.82 Favored Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.462 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 734' ' ' ILE . 3.5 m -122.57 150.27 26.26 Favored 'Isoleucine or valine' 1 N--CA 1.37 -4.432 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.4 m95 -83.9 153.79 23.77 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 732' ' ' THR . 37.8 p -35.71 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -175.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -160.29 -29.27 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 17.8 mt 70.2 149.61 0.12 Allowed Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 124.65 1.219 . . . . 0.0 111.863 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 61.5 Cg_endo -77.38 -178.67 4.76 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.282 1.988 . . . . 0.0 110.479 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.53 140.26 51.89 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 20.3 m -100.78 142.57 32.06 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.823 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.99 141.92 43.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.02 118.4 10.42 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 123.721 0.638 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--O 1.261 1.679 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.206 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 18.0 t . . . . . 0 N--CA 1.438 -1.043 0 CA-C-O 122.133 0.968 . . . . 0.0 110.449 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.6 p -110.59 171.79 7.25 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.025 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -106.38 -132.71 7.2 Favored Glycine 0 N--CA 1.4 -3.722 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 23.5 Cg_exo -63.94 145.04 89.58 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 123.281 2.654 . . . . 0.0 112.603 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.75 157.08 49.49 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 123.158 2.572 . . . . 0.0 112.29 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.539 ' HG2' HD11 ' A' ' 681' ' ' LEU . 34.3 Cg_endo -68.8 -164.58 0.11 Allowed 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 123.192 2.595 . . . . 0.0 111.627 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.57 164.83 11.75 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.795 -0.566 . . . . 0.0 110.516 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.735 HD13 ' HG2' ' A' ' 682' ' ' PRO . 31.9 tp -104.13 147.74 27.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 636' ' ' LEU . 6.0 tt -35.54 -65.8 0.22 Allowed 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 127.503 2.321 . . . . 0.0 111.286 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -115.7 -43.44 3.02 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.38 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -88.54 -146.01 11.9 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -165.37 -170.51 1.89 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.204 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.5 p -101.23 143.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 123.691 0.796 . . . . 0.0 110.575 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.1 ptpt -101.34 -16.67 16.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.344 0.592 . . . . 0.0 110.515 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -81.75 128.71 34.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.351 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 150.85 48.67 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.559 0.695 . . . . 0.0 111.997 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 31.8 p -76.5 124.96 28.38 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.832 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 648' ' ' GLU . 47.5 mtmt -99.82 -12.28 20.03 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.105 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 43.4 mt-10 67.92 -12.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.11 1.364 . . . . 0.0 113.841 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.1 tt0 -148.91 108.49 3.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.834 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 4.5 m-85 -105.75 -65.85 1.03 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 127.81 -117.55 2.65 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 75.6 t60 -138.38 157.32 46.46 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.6 p 62.59 12.16 5.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.408 1.483 . . . . 0.0 113.104 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.834 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 9.0 mm-40 -76.5 136.64 39.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.297 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 t -112.27 139.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 9.7 t -126.3 137.7 56.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 123.679 0.792 . . . . 0.0 109.585 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.5 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 32.8 tt0 -109.15 127.49 54.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.818 0.818 . . . . 0.0 111.342 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 64.8 m-85 -97.45 164.32 12.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.288 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 31.6 p90 -135.4 149.48 49.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.501 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.3 m -95.52 160.03 14.71 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.21 155.33 9.31 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.888 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.05 11.01 0.34 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 123.388 2.725 . . . . 0.0 113.3 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.721 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 22.0 ptt180 -126.51 -6.48 6.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.858 0.837 . . . . 0.0 111.37 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.415 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 40.4 m-85 -122.36 146.45 47.31 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.514 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 711' ' ' TYR . 6.4 mp -105.14 146.45 29.17 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.983 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.4 tpp -75.07 116.89 16.31 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.489 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 685' ' ' ILE . 63.8 tttm -102.45 -37.51 7.98 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.339 0.59 . . . . 0.0 110.62 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.73 -172.25 42.43 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.374 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.6 108.87 2.65 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.312 2.008 . . . . 0.0 110.49 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 24.5 p-10 -71.96 -10.24 59.5 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.309 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 35.7 mtmt -114.92 129.45 56.71 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.351 0.596 . . . . 0.0 110.69 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.707 HG21 HD12 ' A' ' 681' ' ' LEU . 48.5 pt -124.72 165.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.878 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.5 tt0 -137.53 139.83 40.72 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.092 0.557 . . . . 0.0 110.381 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.43 105.88 14.73 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.81 -171.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.42 77.97 1.9 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.084 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.4 -39.3 1.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.359 172.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.92 -179.53 7.08 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 122.634 -0.333 . . . . 0.0 110.281 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.81 161.62 15.2 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.1 p -71.74 -170.36 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.339 0.59 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 18.9 m -69.21 112.75 6.0 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.939 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.707 HD12 HG21 ' A' ' 671' ' ' ILE . 1.8 mp -61.19 149.86 81.13 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.508 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 636' ' ' LEU . 37.2 Cg_endo -75.65 -173.49 1.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.249 2.632 . . . . 0.0 114.414 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.2 t -140.18 138.79 37.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 81.0 m -111.55 136.72 50.35 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.501 HG21 ' HD2' ' A' ' 666' ' ' LYS . 30.1 pt -132.83 139.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 123.536 0.523 . . . . 0.0 110.047 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.0 p . . . . . 0 C--N 1.285 -2.205 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.638 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 59.2 p . . . . . 0 N--CA 1.414 -2.274 0 CA-C-O 121.83 0.824 . . . . 0.0 112.364 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.3 m -91.21 -8.66 47.87 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.734 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.86 -73.41 1.17 Allowed Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.802 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.542 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.8 t70 -176.38 -171.45 0.41 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.637 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -66.35 132.08 94.33 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 123.926 0.89 . . . . 0.0 110.509 175.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.636 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.8 Cg_endo -73.72 -176.82 2.75 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 123.725 2.95 . . . . 0.0 112.066 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.65 126.71 49.84 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.831 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 698' ' ' GLU . 3.8 tt -108.05 136.87 47.02 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.599 ' HG2' HD23 ' A' ' 697' ' ' LEU . 13.8 pt-20 -39.72 -42.82 1.3 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.712 1.605 . . . . 0.0 112.901 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 43.9 m80 -145.36 29.29 1.16 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -176.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.9 168.65 25.22 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.779 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -154.53 -153.93 0.48 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 125.636 1.574 . . . . 0.0 106.835 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.68 158.66 43.84 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.631 -167.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.543 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -99.22 -55.34 2.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.988 -178.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.68 143.1 48.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.9 m -130.21 137.33 50.0 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 29.6 t -127.44 92.4 43.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 121.666 -0.646 . . . . 0.0 112.47 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.2 Cg_endo -93.15 144.58 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 C-N-CA 122.865 2.377 . . . . 0.0 112.054 174.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 97.3 Cg_endo -74.22 132.24 26.45 Favored 'Cis proline' 0 C--O 1.248 1.012 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.001 0.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -75.12 98.08 3.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.721 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 26.7 m-85 -100.99 -177.31 3.42 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.46 0.648 . . . . 0.0 111.277 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 664' ' ' LEU . 11.4 t80 -70.61 135.14 48.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.209 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.4 0.86 81.92 Favored Glycine 0 C--N 1.291 -1.965 0 CA-C-N 115.535 -0.757 . . . . 0.0 113.788 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.88 173.16 12.5 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -136.76 143.83 43.47 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.872 0.368 . . . . 0.0 110.207 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.494 HG11 HG13 ' A' ' 694' ' ' ILE . 39.9 t -136.93 140.28 43.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.224 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 50.6 mt-10 -103.48 122.92 45.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.637 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.9 m-85 -97.79 152.16 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 124.199 1.0 . . . . 0.0 111.512 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.543 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.2 t30 -138.23 147.79 44.1 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 725' ' ' MET . 90.1 m -98.24 160.84 14.03 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 723' ' ' PHE . 60.1 m -56.62 147.15 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.12 -28.05 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.368 0.667 . . . . 0.0 111.858 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 6.9 m -80.81 -2.38 46.97 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.201 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 720' ' ' SER . 83.7 m-85 -124.8 151.63 44.93 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 10.4 t -112.86 140.14 47.91 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.504 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 0.8 OUTLIER -87.05 128.88 35.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.459 0.647 . . . . 0.0 112.154 -176.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.423 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 38.1 mt -106.2 99.59 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 135.79 -155.99 22.59 Favored Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -112.23 168.15 9.85 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 123.79 0.347 . . . . 0.0 110.489 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 716' ' ' GLU . 18.2 ptt180 -82.1 -37.78 25.8 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.6 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.8 p -99.34 132.24 44.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -170.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.668 HG21 HD23 ' A' ' 741' ' ' LEU . 8.3 pt -112.28 169.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.768 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 27.6 m -136.01 139.82 43.41 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 44.4 t -82.03 118.63 23.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.626 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -125.8 104.45 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.145 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . 0.453 ' HD2' HG22 ' A' ' 734' ' ' ILE . 88.2 m-70 71.58 33.59 1.8 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.925 0.89 . . . . 0.0 112.41 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.16 -8.77 79.08 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.922 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.3 m -118.25 148.39 21.12 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.636 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 87.4 m95 -86.81 152.46 22.46 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.4 p -33.02 -71.39 0.06 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.42 -30.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.668 HD23 HG21 ' A' ' 731' ' ' ILE . 17.5 mt 67.91 147.23 0.11 Allowed Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 124.92 1.388 . . . . 0.0 111.816 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.431 ' HG2' HD11 ' A' ' 697' ' ' LEU . 60.2 Cg_endo -76.73 -179.65 5.58 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.217 1.945 . . . . 0.0 110.683 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 20.2 pt20 -123.12 129.73 51.84 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.7 m -100.76 120.52 40.22 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.5 151.18 17.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 123.509 0.506 . . . . 0.0 109.926 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.78 114.36 4.98 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 124.311 1.007 . . . . 0.0 110.71 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.608 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.2 p . . . . . 0 N--CA 1.43 -1.463 0 CA-C-O 121.156 0.503 . . . . 0.0 111.314 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 10.2 p -142.05 -170.96 3.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -122.6 -136.24 4.82 Favored Glycine 0 N--CA 1.402 -3.588 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.598 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 25.1 Cg_exo -61.26 142.19 95.48 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 122.45 2.1 . . . . 0.0 111.411 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 645' ' ' THR . 18.6 Cg_endo -58.72 154.49 42.95 Favored 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.929 2.419 . . . . 0.0 111.849 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.5 Cg_endo -65.08 -167.23 0.1 OUTLIER 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.042 2.494 . . . . 0.0 111.546 176.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.43 159.79 17.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.104 -1.039 . . . . 0.0 109.709 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.651 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.7 tp -95.96 140.89 30.05 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.651 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.9 tt -32.74 -62.16 0.25 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.258 2.223 . . . . 0.0 111.556 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.604 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.7 t30 -123.2 -33.97 3.21 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.831 -178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -90.14 -142.94 10.0 Favored Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.727 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.63 -173.34 2.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 117.563 0.681 . . . . 0.0 109.577 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.4 p -101.82 131.05 50.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 123.746 0.818 . . . . 0.0 109.815 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.485 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 7.7 ptpt -91.75 -13.03 32.26 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.54 0.686 . . . . 0.0 109.563 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 10.5 mm-40 -76.67 144.2 39.57 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.991 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -66.77 152.2 45.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.558 HG22 ' HD2' ' A' ' 633' ' ' PRO . 37.1 p -95.01 120.05 34.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.241 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.99 -20.73 32.31 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.058 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 35.5 mt-10 70.22 -13.77 0.42 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.265 1.426 . . . . 0.0 113.105 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -132.49 103.49 6.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.449 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.8 m-85 -116.36 -173.51 2.38 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 653' ' ' GLU . . . -156.18 -155.91 7.6 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -78.02 135.79 37.83 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 120.528 0.204 . . . . 0.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 23.5 m 75.23 18.11 2.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.579 1.152 . . . . 0.0 112.903 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 650' ' ' GLY . 11.1 mm-40 -84.98 130.87 34.55 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 672' ' ' GLN . 12.9 m -111.89 147.65 15.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.819 0.819 . . . . 0.0 112.995 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.5 t -128.12 135.11 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.775 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.628 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 40.2 tt0 -107.26 132.32 53.22 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.07 0.938 . . . . 0.0 111.393 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 68.3 m-85 -106.44 166.37 10.59 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.069 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.485 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 46.0 p90 -140.0 151.47 45.51 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.773 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 91.4 m -96.46 162.1 13.63 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.604 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.5 OUTLIER -54.78 152.99 11.87 Favored Pre-proline 0 C--O 1.216 -0.668 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.534 ' HB2' ' OD2' ' A' ' 713' ' ' ASP . 64.5 Cg_endo -66.14 1.91 2.14 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.676 2.917 . . . . 0.0 114.995 -171.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -119.97 -4.73 10.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.837 0.827 . . . . 0.0 111.044 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 32.4 m-85 -115.11 142.42 46.68 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.241 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . . . . . . . . . 16.3 mt -98.98 140.27 33.38 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.644 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.1 tpp -70.64 109.76 5.09 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.697 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.561 ' HD2' HD13 ' A' ' 685' ' ' ILE . 61.7 tttm -96.14 -34.47 11.67 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.581 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.64 -172.98 39.37 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.917 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.75 -4.91 15.85 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.359 2.706 . . . . 0.0 113.419 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.653 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 2.6 p-10 52.11 3.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 127.339 2.255 . . . . 0.0 115.864 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 85.9 mttt -137.81 137.26 38.0 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.586 HG21 ' HG ' ' A' ' 681' ' ' LEU . 42.3 pt -129.09 166.26 27.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.508 ' HB2' HG12 ' A' ' 654' ' ' VAL . 29.1 tt0 -137.41 139.89 40.98 Favored 'General case' 0 C--N 1.28 -2.44 0 O-C-N 123.717 0.635 . . . . 0.0 109.334 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.6 t -85.01 108.16 17.48 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.83 -166.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -79.29 58.76 2.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.976 0.893 . . . . 0.0 112.188 -179.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 166.12 -38.39 0.26 Allowed Glycine 0 N--CA 1.415 -2.73 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.415 172.163 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -160.69 -178.53 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -85.46 158.29 20.23 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 40.6 p -76.87 -174.72 3.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 41.7 m -60.06 114.79 3.03 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.341 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -73.12 151.13 90.27 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.653 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 91.2 Cg_endo -74.1 178.32 7.07 Favored 'Trans proline' 0 CA--C 1.468 -2.803 0 C-N-CA 123.626 2.884 . . . . 0.0 113.032 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.9 m -139.11 163.25 26.94 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.293 -175.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 82.4 m -129.11 142.35 50.91 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.561 HD13 ' HD2' ' A' ' 666' ' ' LYS . 25.9 pt -134.77 148.59 29.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.292 -1.912 0 CA-C-O 122.673 1.225 . . . . 0.0 111.573 -178.469 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 710' ' ' TYR . 26.0 p . . . . . 0 N--CA 1.439 -0.996 0 CA-C-O 120.578 0.228 . . . . 0.0 111.569 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.59 -21.38 28.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 110.63 -78.95 0.25 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.645 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.8 t0 -162.6 -168.01 1.71 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.632 HG12 HG11 ' A' ' 715' ' ' VAL . 2.9 mt -77.81 132.31 68.38 Favored Pre-proline 0 C--N 1.282 -2.339 0 C-N-CA 125.11 1.364 . . . . 0.0 111.079 176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 69.7 Cg_endo -72.94 -169.04 0.45 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.39 2.727 . . . . 0.0 111.584 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.11 136.04 53.55 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.7 HD23 ' HA3' ' A' ' 700' ' ' GLY . 26.4 tp -116.2 145.21 43.29 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.5 pt-20 -45.33 -45.35 12.3 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.4 m80 -142.97 27.38 1.63 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.743 0.782 . . . . 0.0 109.055 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.7 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.27 168.28 24.13 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.799 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -156.14 -151.49 0.34 Allowed 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.46 144.7 46.57 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.095 -168.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.556 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -83.58 -59.78 2.33 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.604 0.716 . . . . 0.0 109.301 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.41 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.0 pp -115.97 139.87 49.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.456 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 707' ' ' PRO . 12.9 m -118.16 122.85 44.09 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 6.0 m -115.44 87.03 15.91 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.511 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 705' ' ' SER . 12.8 Cg_endo -95.86 150.75 1.4 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 123.07 2.513 . . . . 0.0 112.805 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 56.5 Cg_endo -70.9 130.61 18.34 Favored 'Cis proline' 0 C--O 1.237 0.472 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.047 -1.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.645 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 18.5 m-85 -75.43 91.44 2.75 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 690' ' ' THR . 9.3 m-85 -85.26 170.22 13.02 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 122.542 0.337 . . . . 0.0 111.427 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -62.41 132.5 52.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.19 69.74 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.041 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 661' ' ' PRO . 3.8 t70 -75.97 173.27 11.44 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.0 OUTLIER -139.72 147.44 40.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.51 0.671 . . . . 0.0 110.912 -173.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 694' ' ' ILE . 38.8 t -138.32 142.95 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.219 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 43.6 mt-10 -110.36 121.43 45.28 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.501 0.667 . . . . 0.0 110.464 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.6 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -92.9 147.54 22.76 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 125.163 1.385 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.556 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -129.33 130.86 46.65 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.1 m -88.28 143.37 27.06 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 28.9 m -50.95 139.8 16.65 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 123.647 0.592 . . . . 0.0 109.504 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -49.97 -35.7 25.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.8 m -76.61 0.19 21.06 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.787 0.803 . . . . 0.0 111.655 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -117.99 147.94 42.7 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.462 ' HB ' HG12 ' A' ' 747' ' ' ILE . 9.3 t -109.38 138.29 45.96 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.661 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 2.6 ptm -90.04 135.47 33.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.259 0.552 . . . . 0.0 110.672 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.446 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 43.7 mt -115.37 113.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.67 -156.27 16.09 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -109.89 139.64 44.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.684 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -61.27 -35.11 76.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.887 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 12.9 p -94.56 148.53 22.16 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.937 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.664 HG21 HD23 ' A' ' 741' ' ' LEU . 9.0 pt -131.19 165.45 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.546 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 739' ' ' THR . 36.2 m -132.64 134.26 44.64 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.48 111.73 6.23 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.815 0.446 . . . . 0.0 111.375 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.5 110.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 68.73 13.31 8.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.667 1.187 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.79 2.79 46.27 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.316 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.73 130.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 84.8 m95 -63.32 156.86 24.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 732' ' ' THR . 25.2 p -37.87 -71.69 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.54 -26.89 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.664 HD23 HG21 ' A' ' 731' ' ' ILE . 20.8 mt 69.42 153.33 0.14 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 111.908 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 67.3 Cg_endo -81.61 -168.65 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.642 2.228 . . . . 0.0 111.589 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.446 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 27.9 pt20 -131.93 137.31 47.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.3 m -110.15 121.15 44.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.32 146.31 25.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.31 117.73 7.03 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.407 0.442 . . . . 0.0 110.566 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.462 HG12 ' HB ' ' A' ' 724' ' ' THR . 68.7 mt . . . . . 0 C--O 1.252 1.213 0 O-C-N 124.398 1.061 . . . . 0.0 110.782 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 1.009 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.1 m . . . . . 0 C--O 1.238 0.492 0 N-CA-C 113.971 1.1 . . . . 0.0 113.971 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 27.4 p -120.55 154.8 34.86 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.32 -136.84 9.05 Favored Glycine 0 N--CA 1.413 -2.872 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.602 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.987 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 35.1 Cg_exo -56.35 148.74 59.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.077 3.185 . . . . 0.0 114.135 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 655' ' ' VAL . 29.6 Cg_endo -64.8 153.14 79.37 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 122.877 2.385 . . . . 0.0 112.468 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.538 ' HG2' HD21 ' A' ' 681' ' ' LEU . 20.9 Cg_endo -67.95 -170.76 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 123.288 2.659 . . . . 0.0 112.249 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -109.65 144.47 37.96 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.0 tp -84.01 147.17 27.58 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.6 tm? -34.37 -66.17 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.809 1.644 . . . . 0.0 111.152 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -110.63 -51.77 2.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.109 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -81.48 -147.56 5.86 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.535 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.6 t-20 -166.4 -167.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.928 0.864 . . . . 0.0 110.592 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 655' ' ' VAL . 83.7 t -90.32 133.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 125.53 1.532 . . . . 0.0 109.425 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.0 ptpt -94.05 -12.08 29.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.683 0.754 . . . . 0.0 109.971 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 158.07 18.88 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.676 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -88.18 165.43 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.432 ' HB ' ' HG3' ' A' ' 647' ' ' GLU . 38.0 p -82.49 118.02 22.93 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-O 121.319 0.581 . . . . 0.0 110.628 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -86.83 -29.31 22.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.987 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.8 mt-10 67.13 -3.68 0.95 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.678 1.591 . . . . 0.0 113.441 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.85 82.78 2.0 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.59 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 16.2 m-85 -95.08 -72.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.104 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 1.009 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.77 -71.82 0.27 Allowed Glycine 0 C--N 1.295 -1.73 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.844 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -165.9 145.3 6.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -178.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 78.4 p 62.48 14.63 7.14 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.313 1.845 . . . . 0.0 113.019 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 16.1 mm-40 -83.71 142.07 30.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.173 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 14.7 m -120.81 153.7 24.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.274 0.559 . . . . 0.0 111.744 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.6 t -135.03 134.44 53.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.154 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -100.76 128.68 46.71 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 121.942 0.877 . . . . 0.0 110.8 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 56.8 m-85 -100.94 157.44 16.74 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.942 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.55 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.1 p90 -133.21 151.0 51.95 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 98.9 m -94.19 154.31 17.63 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 171.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -49.97 156.43 1.31 Allowed Pre-proline 0 C--O 1.193 -1.881 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.54 -30.53 12.22 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 123.883 3.055 . . . . 0.0 114.052 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 41.1 ptt180 -97.6 -9.96 25.99 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 55.6 m-85 -111.8 150.31 30.51 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.933 0.873 . . . . 0.0 112.531 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 711' ' ' TYR . 11.0 mp -112.61 151.09 30.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.412 0.625 . . . . 0.0 110.99 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.626 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.1 tpp -76.93 127.99 33.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.048 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 61.5 tttp -112.35 -45.14 3.29 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.088 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.05 -171.57 47.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.353 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.49 104.04 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.847 2.364 . . . . 0.0 111.374 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -72.47 6.18 2.53 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.663 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 91.6 mttt -132.97 136.19 45.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.471 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.4 pt -122.75 167.37 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -135.06 139.2 44.58 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.671 0.607 . . . . 0.0 110.971 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 48.5 t -82.03 104.13 12.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.381 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.22 171.24 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -75.64 72.35 2.58 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.6 1.19 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 160.58 -41.73 0.43 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.742 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.5 179.48 7.74 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -90.44 169.95 10.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.6 p -84.19 -168.32 2.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 123.14 0.576 . . . . 0.0 112.238 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 48.1 m -69.85 113.34 6.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.053 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 634' ' ' PRO . 7.2 mp -69.88 153.59 95.36 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.913 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 43.2 Cg_endo -70.88 -167.09 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.997 2.465 . . . . 0.0 113.523 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 14.4 p -150.59 149.55 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 73.3 m -116.27 143.66 45.23 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.461 0.475 . . . . 0.0 110.503 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.42 HD13 ' HD2' ' A' ' 666' ' ' LYS . 28.4 pt -136.39 147.89 27.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.736 0.814 . . . . 0.0 108.918 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--N 1.284 -2.271 0 CA-C-O 122.837 1.303 . . . . 0.0 110.294 179.041 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 23.0 p . . . . . 0 N--CA 1.443 -0.808 0 CA-C-O 120.354 0.121 . . . . 0.0 110.8 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.46 -13.35 30.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.061 0.458 . . . . 0.0 111.356 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.63 -63.56 1.33 Allowed Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.7 t70 -173.95 -168.93 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.615 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -68.63 137.55 90.66 Favored Pre-proline 0 C--N 1.276 -2.602 0 C-N-CA 123.469 0.708 . . . . 0.0 109.745 172.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.687 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -73.85 -168.64 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.296 2.664 . . . . 0.0 110.903 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.33 119.14 33.74 Favored 'General case' 0 N--CA 1.408 -2.541 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.223 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 1.004 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -94.23 144.49 25.47 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.593 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.2 pt-20 -44.89 -46.33 10.82 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.154 0.982 . . . . 0.0 112.872 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 45.5 m80 -143.29 15.67 1.86 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.521 0.677 . . . . 0.0 109.854 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 1.004 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -122.65 -179.14 15.77 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -162.47 -153.77 0.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 125.405 1.482 . . . . 0.0 107.138 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.5 161.95 36.66 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.242 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.61 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -98.04 -54.85 2.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.61 147.07 36.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.048 -175.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.454 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 5.4 p -128.52 117.97 22.22 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.243 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.6 p -116.71 94.7 44.48 Favored Pre-proline 0 C--N 1.288 -2.091 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.463 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.6 Cg_endo -93.02 152.61 2.63 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 123.149 2.566 . . . . 0.0 111.806 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.3 Cg_endo -72.92 134.12 33.54 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.963 -1.682 . . . . 0.0 111.047 -1.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.454 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 18.6 m-85 -76.78 78.76 3.39 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.59 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 14.4 m-85 -92.48 174.01 7.5 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.963 ' HB3' HD11 ' A' ' 664' ' ' LEU . 9.6 t80 -60.47 128.94 39.16 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.765 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.34 58.3 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.566 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.37 175.86 8.01 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -141.36 150.64 42.69 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.538 0.685 . . . . 0.0 111.147 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 694' ' ' ILE . 42.4 t -134.49 143.51 37.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.388 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 25.3 mt-10 -105.7 127.64 53.19 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.161 0.505 . . . . 0.0 109.966 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.615 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -101.6 153.83 19.4 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 124.933 1.293 . . . . 0.0 110.312 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.61 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 29.2 t-20 -143.25 169.51 17.49 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 48.2 t -117.36 160.56 20.94 Favored 'General case' 0 C--N 1.253 -3.614 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 56.6 m -61.37 145.12 52.64 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.39 -21.32 64.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.5 m -78.48 -2.0 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.244 1.021 . . . . 0.0 110.392 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.416 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 97.5 m-85 -127.48 159.49 34.38 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.6 t -120.2 138.74 53.46 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.2 ptm -91.41 145.78 24.35 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.561 0.696 . . . . 0.0 110.174 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.71 112.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 131.37 -153.51 20.44 Favored Glycine 0 C--N 1.287 -2.16 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -113.08 159.61 19.02 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 122.673 1.225 . . . . 0.0 111.418 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -74.87 -51.03 14.95 Favored 'General case' 1 N--CA 1.376 -4.162 0 CA-C-N 111.253 -2.703 . . . . 0.0 110.535 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.495 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 28.7 p -89.43 139.74 30.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -167.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.672 HG21 HD23 ' A' ' 741' ' ' LEU . 12.2 pt -124.06 162.9 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.246 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 739' ' ' THR . 28.5 m -128.05 135.7 50.21 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 54.0 t -71.67 105.6 3.76 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.551 0.532 . . . . 0.0 110.795 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.2 96.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-O 122.154 0.978 . . . . 0.0 111.405 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . 0.499 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 95.4 m-70 67.58 18.06 9.95 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.042 1.737 . . . . 0.0 112.496 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 114.62 -2.17 23.33 Favored Glycine 0 C--N 1.291 -1.929 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.423 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 27.3 t -129.27 135.6 61.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.687 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.4 m95 -72.64 161.15 31.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 21.3 p -43.12 -74.17 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.611 HE21 ' N ' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -162.28 -28.23 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 731' ' ' ILE . 20.1 mt 69.71 157.99 0.15 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.531 1.144 . . . . 0.0 111.477 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.412 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.6 Cg_endo -77.29 -162.9 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.875 1.717 . . . . 0.0 110.737 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 743' ' ' GLN . 3.0 pt20 -146.39 140.98 26.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 80.2 m -100.19 156.92 16.94 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.214 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.33 147.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.31 126.9 31.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.729 0.3 . . . . 0.0 111.6 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.308 -1.211 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.253 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.679 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 51.9 m . . . . . 0 C--O 1.239 0.517 0 N-CA-C 114.242 1.201 . . . . 0.0 114.242 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.0 164.77 12.05 Favored 'General case' 0 C--O 1.265 1.895 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.387 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.02 -134.95 8.52 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.62 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 50.1 Cg_exo -53.75 144.05 55.88 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.679 2.919 . . . . 0.0 113.28 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.577 ' HB3' HG21 ' A' ' 655' ' ' VAL . 28.7 Cg_endo -63.92 158.71 45.77 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 123.296 2.664 . . . . 0.0 112.459 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 681' ' ' LEU . 12.4 Cg_endo -72.49 -169.91 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.425 2.083 . . . . 0.0 112.062 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.85 165.69 11.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.403 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.6 tp -112.9 140.6 47.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.7 tt -28.16 -64.78 0.09 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.597 2.359 . . . . 0.0 112.105 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.48 -33.53 3.01 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.406 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.726 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.46 -146.05 8.4 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.418 175.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -170.31 -169.91 0.89 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 118.02 0.91 . . . . 0.0 111.412 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.66 133.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.695 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.6 ptpt -94.83 -16.57 22.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.405 0.621 . . . . 0.0 110.07 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.82 160.07 15.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.11 168.41 14.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.928 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 73.0 p -83.93 125.61 32.19 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.82 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -86.08 -25.6 25.76 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.752 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.62 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.0 mt-10 73.49 -17.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.698 1.199 . . . . 0.0 112.574 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -129.66 99.91 5.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.469 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.9 m-85 -104.57 -67.32 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 107.1 -95.32 0.99 Allowed Glycine 0 C--N 1.289 -2.046 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.09 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.9 t60 -148.26 149.06 31.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.12 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.28 23.3 p 64.52 14.12 8.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.07 1.748 . . . . 0.0 113.706 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 37.9 mm-40 -85.55 138.82 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.656 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.9 m -118.42 146.54 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.568 0.699 . . . . 0.0 112.244 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 633' ' ' PRO . 60.9 t -126.02 135.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.61 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.29 123.05 42.17 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.936 0.874 . . . . 0.0 110.262 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 59.2 m-85 -97.92 160.65 14.17 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.796 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.695 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 39.0 p90 -136.12 143.99 44.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.726 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 60.4 m -84.54 161.45 20.2 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.582 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -55.66 154.05 14.05 Favored Pre-proline 0 C--O 1.207 -1.163 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.582 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 27.4 Cg_endo -58.81 -13.75 19.45 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.727 2.952 . . . . 0.0 115.136 -170.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 12.9 ptt180 -108.67 -4.09 17.35 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.888 0.852 . . . . 0.0 111.76 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.461 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 43.2 m-85 -110.3 148.74 31.33 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.277 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.955 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.8 mp -106.25 145.48 31.53 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.589 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 48.9 tpp -77.03 113.85 15.19 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.625 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.552 ' HB3' HG23 ' A' ' 683' ' ' VAL . 21.6 tptm -101.9 -25.16 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.61 50.04 Favored Glycine 0 C--N 1.307 -1.036 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.36 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.07 8.81 3.31 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 123.05 2.5 . . . . 0.0 113.812 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.589 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.31 10.1 p-10 49.92 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 128.72 2.808 . . . . 0.0 116.925 -177.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.6 mttt -94.93 142.24 27.71 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 123.796 0.839 . . . . 0.0 110.278 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 681' ' ' LEU . 41.2 pt -129.88 164.56 32.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.897 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.3 tt0 -129.44 135.97 49.33 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.957 0.903 . . . . 0.0 110.254 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.8 t -82.8 98.74 9.29 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 3.3 p -91.5 -178.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.079 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.41 74.65 3.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.506 1.146 . . . . 0.0 113.161 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 159.23 -39.67 0.49 Allowed Glycine 0 N--CA 1.417 -2.6 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.249 173.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -167.01 -174.01 2.54 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.428 ' CE3' HG13 ' A' ' 671' ' ' ILE . 85.5 m95 -84.16 164.98 18.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.4 p -76.9 -174.76 3.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 122.707 0.403 . . . . 0.0 111.292 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.2 m -64.58 111.19 2.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.388 0.613 . . . . 0.0 110.83 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.694 ' HG ' HG21 ' A' ' 671' ' ' ILE . 4.0 mp -68.15 151.17 97.4 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.696 ' HG2' HD13 ' A' ' 636' ' ' LEU . 72.7 Cg_endo -72.23 176.63 8.29 Favored 'Trans proline' 0 CA--C 1.468 -2.795 0 C-N-CA 123.425 2.75 . . . . 0.0 113.754 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.8 m -136.81 159.0 37.34 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.937 0 CA-C-N 112.156 -2.293 . . . . 0.0 107.71 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 92.1 m -121.54 150.14 42.08 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.319 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.93 147.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.9 p . . . . . 0 C--N 1.286 -2.166 0 CA-C-O 122.511 1.148 . . . . 0.0 110.026 177.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 21.0 p . . . . . 0 N--CA 1.425 -1.694 0 CA-C-O 120.779 0.323 . . . . 0.0 110.806 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.5 m -100.26 -16.15 17.82 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.824 0.821 . . . . 0.0 110.607 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 107.68 -89.99 0.61 Allowed Glycine 0 CA--C 1.484 -1.845 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.898 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.708 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t0 -152.46 -172.23 4.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.629 HG12 HG11 ' A' ' 715' ' ' VAL . 1.4 mt -72.83 132.7 82.82 Favored Pre-proline 0 N--CA 1.406 -2.648 0 C-N-CA 125.129 1.372 . . . . 0.0 109.308 173.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.701 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 38.8 Cg_endo -68.35 177.01 4.96 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.271 2.647 . . . . 0.0 112.857 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.84 98.61 8.17 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.769 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.939 HD23 ' HA3' ' A' ' 700' ' ' GLY . 33.5 tp -81.4 135.66 35.67 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.7 pt-20 -43.51 -42.67 5.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.568 1.147 . . . . 0.0 112.758 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.53 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 41.2 m80 -141.77 24.18 2.05 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.571 0.701 . . . . 0.0 109.966 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.939 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.26 170.54 21.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.835 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -157.95 -152.14 0.33 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 126.158 1.783 . . . . 0.0 106.489 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -142.1 156.13 45.38 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 119.254 0.934 . . . . 0.0 111.366 -168.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.547 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.2 OUTLIER -90.07 -48.79 6.97 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.31 148.81 38.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.059 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 22.8 p -126.92 136.87 52.88 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 1.9 p -130.8 78.31 73.92 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-O 121.532 0.682 . . . . 0.0 112.628 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.7 Cg_endo -91.71 147.8 3.32 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.949 2.432 . . . . 0.0 112.653 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 81.4 Cg_endo -74.88 130.86 22.32 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.669 -1.805 . . . . 0.0 110.898 -0.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.708 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 25.5 m-85 -73.06 106.84 5.09 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.53 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 17.2 m-85 -100.59 173.56 6.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.909 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.955 ' HB3' HD11 ' A' ' 664' ' ' LEU . 3.7 t80 -62.95 134.62 56.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.477 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.44 -14.74 64.73 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.039 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.6 167.09 22.44 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.2 m -131.2 155.32 47.27 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 694' ' ' ILE . 25.4 t -144.65 134.69 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 730' ' ' SER . 17.2 mt-10 -100.06 122.79 43.48 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.733 0.778 . . . . 0.0 110.711 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.612 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -94.85 154.73 17.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.52 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.547 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 64.9 t30 -134.93 152.22 51.55 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 45.1 t -99.07 162.9 12.81 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 42.9 t -60.65 142.57 55.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.95 -20.05 65.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.131 0.491 . . . . 0.0 111.76 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 0.26 55.8 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.94 0.876 . . . . 0.0 110.341 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 51.1 m-85 -125.82 162.12 25.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.4 t -118.57 137.75 53.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.4 ptm -95.45 138.49 33.06 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.329 0.585 . . . . 0.0 109.718 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.37 112.25 39.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 122.07 -160.67 16.44 Favored Glycine 0 CA--C 1.478 -2.28 0 O-C-N 123.418 0.449 . . . . 0.0 112.61 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -91.53 129.09 37.57 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 13.4 ptt180 -68.96 -28.94 67.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.825 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.2 t -102.3 150.41 23.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.31 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.639 HG21 HD23 ' A' ' 741' ' ' LEU . 2.9 pt -128.46 175.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.451 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 70.3 m -143.76 135.13 25.92 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.0 t -74.56 114.59 13.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.5 mm -117.46 103.45 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.39 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 61.5 41.8 12.15 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.309 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 91.68 -11.67 71.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.965 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.68 123.34 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.289 -0.536 . . . . 0.0 109.62 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.701 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.5 m95 -63.83 142.4 58.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.0 p -28.72 -70.3 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.96 -28.99 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 731' ' ' ILE . 23.8 mt 69.01 156.25 0.15 Allowed Pre-proline 0 C--O 1.237 0.429 0 O-C-N 124.612 1.195 . . . . 0.0 110.988 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.58 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 72.5 Cg_endo -80.29 -166.16 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.718 1.612 . . . . 0.0 109.842 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -137.58 135.53 36.73 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.0 m -94.5 138.56 32.27 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.359 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.66 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.23 119.83 12.77 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.501 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.257 1.48 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.733 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 67.7 m . . . . . 0 N--CA 1.452 -0.341 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.55 155.95 20.27 Favored 'General case' 0 C--O 1.268 2.047 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.55 -134.53 6.98 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.797 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 39.2 Cg_exo -58.19 143.76 96.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.847 2.364 . . . . 0.0 112.322 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.718 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.71 150.75 87.68 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.602 2.202 . . . . 0.0 112.691 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.3 Cg_endo -69.69 -173.05 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.762 2.974 . . . . 0.0 112.857 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.07 146.73 27.07 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.849 HD12 ' HB3' ' A' ' 657' ' ' TYR . 4.5 tt -87.35 142.23 28.04 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.642 ' N ' HD23 ' A' ' 636' ' ' LEU . 0.7 OUTLIER -33.26 -71.92 0.05 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.847 1.659 . . . . 0.0 110.16 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.73 41.09 3.06 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.569 1.652 . . . . 0.0 110.13 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -133.2 -148.79 5.99 Favored Glycine 1 C--N 1.234 -5.139 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.862 177.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.4 t-20 -172.22 178.33 2.89 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.83 HG22 ' CE2' ' A' ' 657' ' ' TYR . 9.9 t -102.39 137.97 28.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 124.168 0.987 . . . . 0.0 108.655 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -100.37 -10.54 21.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.014 0.911 . . . . 0.0 109.339 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 641' ' ' VAL . 7.8 mm-40 -92.85 135.32 34.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.534 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -75.75 150.71 37.73 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.718 HG22 ' HD2' ' A' ' 633' ' ' PRO . 58.5 p -71.6 127.85 33.9 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.617 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -90.76 -20.96 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.797 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 69.43 -20.53 0.17 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.276 1.431 . . . . 0.0 113.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.64 94.83 4.06 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.582 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 14.7 m-85 -102.89 -62.98 1.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.233 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 109.6 -102.17 1.56 Allowed Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -149.14 154.54 39.35 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 53.6 p 65.93 16.57 10.52 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.254 1.422 . . . . 0.0 112.648 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 7.4 mm-40 -88.45 139.33 30.59 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.897 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 672' ' ' GLN . 6.9 m -118.36 145.9 23.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.607 0.717 . . . . 0.0 112.513 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 633' ' ' PRO . 77.5 t -128.74 135.43 62.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.645 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -101.01 133.54 45.35 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.552 0.692 . . . . 0.0 110.508 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.849 ' HB3' HD12 ' A' ' 636' ' ' LEU . 53.3 m-85 -111.16 164.19 13.12 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.313 1.045 . . . . 0.0 110.632 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -137.68 158.07 45.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 96.2 m -95.01 165.56 12.38 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 118.189 0.45 . . . . 0.0 110.041 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.527 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -59.61 156.53 32.24 Favored Pre-proline 0 C--O 1.216 -0.705 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 73.2 Cg_endo -72.91 14.59 0.51 Allowed 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 123.878 3.052 . . . . 0.0 113.348 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 686' ' ' VAL . 14.4 ptt180 -129.58 -6.29 4.67 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.68 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.421 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 38.2 m-85 -122.91 150.31 43.1 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.644 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.359 0.0 OUTLIER -114.9 137.65 51.72 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.069 -179.948 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.514 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 57.3 tpp -60.98 114.0 2.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.492 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -102.84 -33.56 9.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.226 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.1 -172.57 37.18 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.621 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 83.2 Cg_endo -76.37 -5.64 16.36 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.107 2.538 . . . . 0.0 112.786 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 1.4 p-10 56.45 -5.94 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 128.025 2.53 . . . . 0.0 115.662 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -133.06 133.87 43.6 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.272 0.629 . . . . 0.0 109.616 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.63 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -121.32 166.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.563 ' HB2' HG12 ' A' ' 654' ' ' VAL . 54.3 tt0 -142.0 140.29 32.63 Favored 'General case' 0 N--CA 1.414 -2.268 0 O-C-N 123.753 0.658 . . . . 0.0 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 8.9 t -80.04 108.67 13.81 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.783 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.61 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -89.12 73.19 8.2 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.439 1.114 . . . . 0.0 111.251 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.13 -55.95 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.18 176.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.03 -168.96 2.92 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -86.17 167.56 14.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 28.7 p -78.18 -176.0 4.4 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 122.876 0.471 . . . . 0.0 110.864 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 78.1 m -68.45 113.25 5.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.408 0.623 . . . . 0.0 110.794 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.63 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.9 mp -63.28 151.94 85.91 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.522 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 669' ' ' ASN . 40.6 Cg_endo -66.31 172.23 9.24 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 122.531 2.154 . . . . 0.0 113.627 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.62 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.159 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 74.5 m -118.87 135.37 54.59 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.511 HG13 HD22 ' A' ' 664' ' ' LEU . 27.0 pt -128.61 143.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 662' ' ' ARG . 8.4 p . . . . . 0 C--N 1.29 -2.014 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.951 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 19.3 p . . . . . 0 N--CA 1.449 -0.516 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 9.1 m -88.62 -9.14 53.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.581 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 100.27 -81.73 0.51 Allowed Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.678 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.5 t70 -161.89 -173.0 3.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 715' ' ' VAL . 2.4 mt -70.72 135.59 85.79 Favored Pre-proline 0 N--CA 1.4 -2.959 0 C-N-CA 125.522 1.529 . . . . 0.0 110.917 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.678 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 61.4 Cg_endo -74.29 -177.3 3.18 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 123.181 2.587 . . . . 0.0 110.371 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.09 123.29 45.24 Favored 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.698 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.5 tp -86.21 138.51 31.82 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 11.2 pt-20 -41.61 -37.63 1.19 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.389 1.476 . . . . 0.0 113.163 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 54.4 m80 -145.26 27.52 1.26 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -139.26 173.43 22.72 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.193 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -155.2 -150.52 0.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 125.977 1.711 . . . . 0.0 106.828 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.63 152.14 43.72 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 119.256 0.935 . . . . 0.0 112.04 -169.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -83.47 -56.66 3.62 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.3 144.97 35.09 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.626 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.412 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 4.5 p -142.71 116.49 9.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.926 -1.033 . . . . 0.0 108.67 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.2 m -128.34 91.75 43.19 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-O 121.182 0.515 . . . . 0.0 111.462 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.414 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.25 150.29 10.57 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.59 2.193 . . . . 0.0 111.351 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 72.3 Cg_endo -74.96 134.79 37.53 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.233 -1.569 . . . . 0.0 112.41 1.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 34.0 m-85 -81.19 92.28 6.29 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.51 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 4.6 m-30 -85.48 163.54 18.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.378 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.644 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.0 t80 -62.14 139.53 58.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.96 -24.22 29.52 Favored Glycine 0 C--N 1.295 -1.721 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.282 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -76.44 167.33 22.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 118.073 0.936 . . . . 0.0 110.284 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.3 m -131.61 158.08 41.98 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.101 0.477 . . . . 0.0 110.41 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.638 HG11 HG12 ' A' ' 694' ' ' ILE . 41.3 t -137.87 145.76 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.101 176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.56 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 39.2 mt-10 -111.73 121.94 46.45 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 121.57 0.7 . . . . 0.0 110.419 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.517 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -93.32 146.86 23.41 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.307 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.467 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 7.5 t30 -127.67 134.59 49.61 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.3 t -92.92 142.63 27.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 52.4 m -52.94 138.57 29.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.482 0.489 . . . . 0.0 109.747 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.11 -29.17 65.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 41.5 m -79.68 -1.62 39.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.013 0.911 . . . . 0.0 111.03 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.43 159.25 24.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.4 t -118.79 139.35 51.72 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 8.1 ptm -93.04 141.21 28.66 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.355 0.598 . . . . 0.0 109.916 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 52.1 mt -111.18 100.91 11.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.91 -165.48 24.26 Favored Glycine 0 C--N 1.284 -2.347 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -101.31 171.54 7.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -93.81 -27.75 16.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.7 p -96.03 133.52 40.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 741' ' ' LEU . 8.5 pt -120.03 166.31 14.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.289 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 739' ' ' THR . 60.9 m -133.17 135.34 45.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 40.5 t -68.25 108.23 3.1 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.004 0.815 . . . . 0.0 110.317 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 737' ' ' VAL . 48.6 mm -130.2 104.2 9.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 123.859 0.864 . . . . 0.0 109.904 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 69.93 23.94 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 96.65 -3.6 63.21 Favored Glycine 0 CA--C 1.481 -2.088 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.413 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 734' ' ' ILE . 4.1 m -126.03 153.26 34.05 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.678 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.4 m95 -87.91 169.08 12.32 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 732' ' ' THR . 41.5 p -47.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 731' ' ' ILE . 21.8 mt 68.58 156.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.493 0 O-C-N 124.691 1.244 . . . . 0.0 111.132 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.2 -159.68 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.851 1.701 . . . . 0.0 109.431 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -143.67 142.1 30.85 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 88.7 m -101.13 144.13 30.39 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.194 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.9 148.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -74.33 125.75 29.17 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.411 0.444 . . . . 0.0 110.521 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.044 175.572 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 17.2 t . . . . . 0 N--CA 1.421 -1.886 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 14.9 p -147.49 -173.32 4.24 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -115.94 -135.27 5.65 Favored Glycine 0 N--CA 1.405 -3.4 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.758 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 17.1 Cg_exo -65.43 144.29 79.21 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.658 2.238 . . . . 0.0 110.492 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.9 Cg_endo -60.3 154.15 54.68 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.572 2.181 . . . . 0.0 112.307 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 681' ' ' LEU . 14.9 Cg_endo -64.2 -164.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.561 2.841 . . . . 0.0 113.265 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.19 165.61 12.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.299 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 682' ' ' PRO . 52.2 tp -113.36 147.52 37.53 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.371 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 636' ' ' LEU . 12.5 tp -40.59 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.988 1.715 . . . . 0.0 113.315 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -126.08 50.25 1.89 Allowed 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 123.534 1.635 . . . . 0.0 108.834 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -164.8 -154.43 7.94 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 111.358 -2.656 . . . . 0.0 108.962 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -166.93 -178.09 4.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.1 p -92.02 138.68 19.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 9.7 ptpt -98.08 -17.26 19.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.38 144.0 28.29 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.335 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 43.4 mmtm -85.45 134.32 34.06 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-O 121.915 0.864 . . . . 0.0 112.718 -173.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 633' ' ' PRO . 11.0 p -64.99 122.1 16.23 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 113.193 -1.822 . . . . 0.0 113.658 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -89.53 -22.98 22.14 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.654 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.758 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 73.08 -7.71 1.45 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.164 1.386 . . . . 0.0 112.334 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.3 93.7 3.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.511 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.2 m-85 -121.54 132.97 55.0 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -101.52 -153.83 25.97 Favored Glycine 0 C--N 1.277 -2.745 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.272 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -75.91 149.62 37.71 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.283 76.2 p 71.13 11.19 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.653 1.581 . . . . 0.0 114.072 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 17.4 mm-40 -79.26 121.34 24.96 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.8 OUTLIER -109.15 139.69 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.14 0.495 . . . . 0.0 111.488 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.9 t -126.92 135.84 62.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.92 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.532 ' HG3' HD22 ' A' ' 669' ' ' ASN . 39.5 tt0 -101.89 129.37 48.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.46 1.124 . . . . 0.0 112.614 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 45.9 m-85 -105.27 164.61 11.71 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.728 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.493 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 40.0 p90 -142.02 150.81 41.8 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.587 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 89.9 m -98.05 163.57 12.71 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.3 OUTLIER -59.25 159.04 16.66 Favored Pre-proline 0 N--CA 1.482 1.131 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 61.6 Cg_endo -68.12 -9.8 26.9 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.074 2.516 . . . . 0.0 113.441 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 21.6 ptt180 -101.68 -6.67 23.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.708 0.766 . . . . 0.0 111.16 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 48.2 m-85 -121.25 140.92 51.41 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.444 HD21 ' HB3' ' A' ' 711' ' ' TYR . 17.5 mt -99.66 139.68 34.96 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.831 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.607 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.2 tpp -72.3 109.03 5.75 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.238 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.629 ' HD2' HD13 ' A' ' 685' ' ' ILE . 81.3 tttt -94.97 -29.2 14.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -79.61 -173.05 44.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.618 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.74 -3.77 13.53 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.277 2.651 . . . . 0.0 113.13 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.607 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.263 2.8 p-10 58.65 -27.57 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 127.474 2.31 . . . . 0.0 116.167 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.2 mttt -108.5 139.6 43.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 121.937 -0.477 . . . . 0.0 110.346 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.6 pt -124.99 171.57 13.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.0 tt0 -142.39 140.6 32.08 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.85 100.0 8.61 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.316 1.055 . . . . 0.0 108.804 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.79 171.38 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.17 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.05 72.36 2.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.448 1.118 . . . . 0.0 111.029 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.23 -39.82 0.52 Allowed Glycine 0 N--CA 1.409 -3.145 0 CA-C-N 113.914 -1.493 . . . . 0.0 111.73 172.631 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.93 -178.94 6.41 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -84.04 164.77 19.07 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.9 p -74.67 -174.89 2.26 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.821 0.343 . . . . 0.0 111.749 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.5 m -71.1 111.15 6.23 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.184 0.516 . . . . 0.0 110.111 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.646 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -64.81 151.47 92.67 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.225 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 636' ' ' LEU . 44.1 Cg_endo -67.71 -176.53 0.97 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.129 2.553 . . . . 0.0 114.115 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.09 142.92 27.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 85.0 m -114.12 133.09 55.8 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.629 HD13 ' HD2' ' A' ' 666' ' ' LYS . 26.1 pt -128.25 145.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 662' ' ' ARG . 12.0 p . . . . . 0 C--N 1.281 -2.371 0 CA-C-O 122.354 1.073 . . . . 0.0 108.578 177.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 27.4 p . . . . . 0 N--CA 1.426 -1.63 0 CA-C-O 120.999 0.428 . . . . 0.0 111.965 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 31.5 m -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 67.88 53.66 22.11 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.257 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.2 t70 71.51 172.94 0.31 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.017 0.927 . . . . 0.0 113.25 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.558 ' CG1' HG11 ' A' ' 715' ' ' VAL . 1.3 mp -66.37 132.99 94.38 Favored Pre-proline 0 N--CA 1.434 -1.275 0 C-N-CA 124.18 0.992 . . . . 0.0 111.626 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.5 Cg_endo -75.58 -171.22 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.961 3.107 . . . . 0.0 111.683 176.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.17 139.28 49.48 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.373 0.606 . . . . 0.0 110.084 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.72 HD23 ' HA3' ' A' ' 700' ' ' GLY . 48.9 tp -107.61 148.27 29.53 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -43.14 -47.34 6.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.75 1.22 . . . . 0.0 112.758 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -142.86 30.73 1.45 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.042 0.925 . . . . 0.0 109.154 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.72 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -138.25 171.1 23.57 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.894 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.411 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 5.0 p-90 -156.55 -150.88 0.3 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.847 1.659 . . . . 0.0 106.607 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.09 162.46 35.43 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.715 -169.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.523 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.03 -68.31 0.81 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.64 142.01 32.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.833 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.51 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 6.4 m -133.72 99.53 4.5 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 172.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.0 m -117.51 98.34 51.67 Favored Pre-proline 0 C--N 1.271 -2.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.002 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.04 159.45 15.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.241 2.628 . . . . 0.0 110.95 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 138.84 57.95 Favored 'Cis proline' 0 C--O 1.243 0.763 0 C-N-CA 123.89 -1.296 . . . . 0.0 112.261 0.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -86.38 78.06 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.525 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 30.2 m-85 -79.59 161.6 25.83 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.738 0.304 . . . . 0.0 111.67 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.444 ' HB3' HD21 ' A' ' 664' ' ' LEU . 1.7 t80 -55.87 131.33 46.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -17.18 57.72 Favored Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.753 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.78 173.95 12.07 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -139.66 151.34 45.86 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.452 0.644 . . . . 0.0 111.045 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.558 HG11 ' CG1' ' A' ' 694' ' ' ILE . 32.6 t -135.02 142.07 41.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.809 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 33.0 mt-10 -104.17 128.89 51.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.606 0.717 . . . . 0.0 110.675 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.4 m-85 -97.42 156.66 16.37 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.232 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.523 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -137.05 145.88 44.54 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 44.3 t -94.94 158.98 15.24 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 51.1 m -69.35 158.81 34.34 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.16 144.94 48.39 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 34.5 m 85.0 -5.75 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.325 1.85 . . . . 0.0 109.38 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 52.4 m-85 -119.31 148.41 43.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.6 t -116.65 140.89 48.89 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.0 ptm -91.91 141.5 28.57 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.01 127.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 112.75 -133.75 11.54 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -115.4 163.08 16.24 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.8 -29.17 16.91 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 3.9 p -99.94 131.92 45.61 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.661 HG21 HD23 ' A' ' 741' ' ' LEU . 7.3 pt -109.09 171.27 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.005 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 58.1 m -135.21 135.71 41.2 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.41 108.68 4.96 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.7 0.625 . . . . 0.0 110.163 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -128.39 111.7 24.59 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.702 0 C-N-CA 123.792 0.837 . . . . 0.0 110.579 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 67.01 17.08 10.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.97 49.93 Favored Glycine 0 CA--C 1.479 -2.186 0 C-N-CA 119.32 -1.419 . . . . 0.0 111.483 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 734' ' ' ILE . 9.9 m -125.12 152.89 31.97 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.201 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.579 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.3 m95 -83.26 159.17 22.0 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 11.3 p -38.82 -70.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.04 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 731' ' ' ILE . 20.3 mt 71.16 154.15 0.15 Allowed Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.441 1.096 . . . . 0.0 112.694 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 47.3 Cg_endo -74.36 -171.1 0.83 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.781 1.654 . . . . 0.0 109.02 172.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 697' ' ' LEU . 17.5 pt20 -147.57 142.24 26.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 89.2 m -92.17 153.97 18.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.546 0.529 . . . . 0.0 112.358 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.4 144.61 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -72.07 123.98 23.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.363 0.414 . . . . 0.0 111.318 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 34.8 t . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.382 -0.969 . . . . 0.0 108.382 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 67.3 m -131.81 136.07 47.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.82 -132.59 7.58 Favored Glycine 0 N--CA 1.41 -3.08 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.887 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -63.12 135.89 53.3 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.901 2.4 . . . . 0.0 111.874 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.866 ' HD2' HG22 ' A' ' 645' ' ' THR . 26.9 Cg_endo -60.22 157.23 36.04 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.348 2.698 . . . . 0.0 113.444 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 681' ' ' LEU . 31.4 Cg_endo -71.52 -159.42 0.07 OUTLIER 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.509 2.806 . . . . 0.0 112.643 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . 0.415 ' O ' HD13 ' A' ' 681' ' ' LEU . 13.8 pt-20 -104.35 174.78 5.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.408 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -117.86 142.03 47.77 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 169.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -35.67 -68.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 127.437 2.295 . . . . 0.0 112.869 176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 6.2 t30 -116.9 -31.0 5.56 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.31 1.052 . . . . 0.0 109.331 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -78.86 -157.04 10.39 Favored Glycine 0 C--N 1.298 -1.555 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.265 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -169.5 -177.01 2.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.3 p -101.08 140.53 19.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 123.398 0.679 . . . . 0.0 109.687 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 8.6 ptpt -95.77 -30.9 13.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.56 149.44 34.86 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.649 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 38.9 mmtm -86.94 161.7 18.09 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.789 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.866 HG22 ' HD2' ' A' ' 633' ' ' PRO . 14.5 p -84.0 122.68 29.1 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.767 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -82.31 -23.74 34.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.424 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.887 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.9 mt-10 67.62 -13.86 0.23 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.168 1.387 . . . . 0.0 113.648 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -133.28 87.38 2.39 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.412 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 11.9 m-85 -91.43 -65.53 1.0 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 112.02 -88.45 0.5 Allowed Glycine 0 C--N 1.296 -1.65 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.934 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 80.9 t60 -161.49 144.57 12.4 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 73.82 3.13 4.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.161 1.384 . . . . 0.0 111.391 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 65.4 mm-40 -74.88 140.79 44.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 3.4 m -115.71 151.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 123.993 0.808 . . . . 0.0 112.3 -176.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 52.2 t -133.24 134.59 57.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.441 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 125.28 48.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.091 0.948 . . . . 0.0 111.66 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.766 ' HB3' HD12 ' A' ' 636' ' ' LEU . 62.8 m-85 -100.68 168.84 9.43 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.832 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 41.0 p90 -138.94 153.15 48.19 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 63.6 m -94.41 163.31 13.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.414 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.6 OUTLIER -63.81 155.78 75.68 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 68.1 Cg_endo -69.41 9.81 0.5 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 123.672 2.915 . . . . 0.0 114.849 -172.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.514 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 32.2 ptt180 -131.83 5.72 4.27 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.864 0.84 . . . . 0.0 109.753 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 39.3 m-85 -123.95 143.07 50.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.698 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 711' ' ' TYR . 12.2 mt -97.51 145.82 25.84 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.095 0.474 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.0 tpp -76.5 113.2 13.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.109 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' A' ' 685' ' ' ILE . 40.3 ttmt -93.31 -48.95 6.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.386 0.612 . . . . 0.0 109.775 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.53 -168.13 43.82 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.727 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.04 107.4 2.43 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.694 2.262 . . . . 0.0 111.182 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.55 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.0 p-10 -72.97 -5.01 35.83 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.056 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 48.7 mtmt -126.48 117.51 23.02 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.154 0.502 . . . . 0.0 110.28 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 681' ' ' LEU . 47.5 pt -108.78 168.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.427 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 21.3 tt0 -140.36 140.54 35.58 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 123.597 0.759 . . . . 0.0 110.845 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.0 106.98 7.9 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.756 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.18 -177.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.86 81.27 2.77 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.932 1.348 . . . . 0.0 111.691 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.87 -39.78 0.82 Allowed Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.393 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -165.69 -171.22 2.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.89 165.98 14.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 18.6 p -75.01 -179.78 4.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.271 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 47.2 m -62.7 115.7 4.54 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.671 0.748 . . . . 0.0 112.046 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 671' ' ' ILE . 78.2 mt -64.37 146.24 97.99 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.17 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.625 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 60.0 Cg_endo -70.4 -174.39 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.916 2.411 . . . . 0.0 113.757 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 67.8 t -139.43 136.17 40.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.0 m -111.98 127.89 56.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' A' ' 666' ' ' LYS . 29.3 pt -125.41 147.71 30.06 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.1 p . . . . . 0 C--N 1.288 -2.074 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.704 -178.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.434 -1.239 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.0 m -83.43 -4.73 58.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.189 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 96.14 -87.37 0.97 Allowed Glycine 0 CA--C 1.486 -1.756 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 5.9 p-10 -154.25 -173.8 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.636 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.8 mt -71.27 133.04 85.62 Favored Pre-proline 0 N--CA 1.42 -1.933 0 C-N-CA 123.623 0.769 . . . . 0.0 112.115 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 63.0 Cg_endo -71.91 -177.77 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.417 2.745 . . . . 0.0 112.154 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.82 118.04 35.05 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.244 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 698' ' ' GLU . 5.2 tt -93.6 140.97 29.01 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 175.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.556 ' HG2' HD23 ' A' ' 697' ' ' LEU . 9.4 pt-20 -45.67 -36.42 4.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.39 1.076 . . . . 0.0 113.042 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 95.3 m-70 -147.09 37.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -146.07 171.57 26.95 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.384 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -156.47 -152.23 0.36 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 126.247 1.819 . . . . 0.0 106.709 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -134.58 152.76 52.0 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.581 -1.248 . . . . 0.0 113.854 -167.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.57 -47.53 8.64 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.031 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -119.69 129.89 54.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.29 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 3.5 m -126.97 126.19 42.77 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 12.3 t -135.24 92.72 17.59 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.737 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 3.5 Cg_endo -87.03 153.24 8.36 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.63 2.22 . . . . 0.0 111.717 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 60.6 Cg_endo -72.84 136.75 45.65 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.069 -1.638 . . . . 0.0 111.887 0.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 44.5 m-85 -81.9 93.92 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -78.01 166.08 23.26 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.594 0.558 . . . . 0.0 111.526 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.503 ' HB3' HD21 ' A' ' 664' ' ' LEU . 0.7 OUTLIER -67.15 137.74 56.52 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.99 -16.31 61.38 Favored Glycine 0 N--CA 1.422 -2.287 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.036 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 661' ' ' PRO . 22.1 t0 -77.79 164.79 24.9 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.8 m -128.12 156.02 43.5 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.22 0.533 . . . . 0.0 109.875 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.537 HG11 HG12 ' A' ' 694' ' ' ILE . 38.6 t -137.51 137.7 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.969 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -106.51 120.35 41.68 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.636 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.35 147.51 22.85 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.541 1.136 . . . . 0.0 111.962 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.427 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.5 t30 -118.81 138.53 52.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.716 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 37.7 t -83.1 155.06 24.04 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.6 t -63.17 147.27 51.37 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.02 137.78 45.59 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 60.8 m 86.75 5.76 0.34 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 126.278 1.831 . . . . 0.0 110.665 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 69.1 m-85 -122.5 152.07 40.7 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 747' ' ' ILE . 9.9 t -114.42 137.43 51.84 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.716 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.3 ptm -91.11 139.33 30.86 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.278 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.613 HD12 HE21 ' A' ' 743' ' ' GLN . 26.9 mt -121.66 119.29 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 124.38 -154.52 17.92 Favored Glycine 0 CA--C 1.475 -2.415 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -98.69 118.49 35.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.548 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -58.96 -24.65 62.79 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.72 -1.582 . . . . 0.0 113.049 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 6.7 m -117.29 149.36 40.59 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.305 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.605 HG21 HD23 ' A' ' 741' ' ' LEU . 5.8 pt -128.64 173.77 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.656 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 90.3 m -140.7 136.91 33.09 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.8 t -69.06 109.04 3.8 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.511 0.724 . . . . 0.0 110.124 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.7 mm -127.46 104.25 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.996 0.427 . . . . 0.0 111.602 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 65.73 27.71 11.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.946 . . . . 0.0 111.894 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.42 5.11 62.06 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.648 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.7 t -135.2 140.83 44.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.696 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.6 m95 -79.91 148.45 31.27 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.1 p -33.38 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.78 -29.9 0.07 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -171.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.605 HD23 HG21 ' A' ' 731' ' ' ILE . 25.6 mt 65.72 156.83 0.13 Allowed Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 124.505 1.128 . . . . 0.0 111.725 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.424 ' HG2' HD11 ' A' ' 697' ' ' LEU . 72.1 Cg_endo -86.58 -179.28 2.97 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 121.782 1.654 . . . . 0.0 110.21 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.613 HE21 HD12 ' A' ' 726' ' ' ILE . 12.5 pt20 -126.32 142.49 51.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 92.2 m -105.37 139.76 39.52 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.317 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.15 144.86 36.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -70.46 115.85 10.12 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.499 0.499 . . . . 0.0 112.146 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' A' ' 724' ' ' THR . 64.6 mt . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 47.7 t . . . . . 0 CA--C 1.498 -1.026 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.898 ' HB2' ' HB2' ' A' ' 649' ' ' TYR . 14.4 m -131.8 158.48 41.13 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -107.18 -150.57 16.89 Favored Glycine 1 N--CA 1.387 -4.628 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 176.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.98 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -60.28 149.17 87.06 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 645' ' ' THR . 28.1 Cg_endo -63.77 149.55 90.5 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.754 1.636 . . . . 0.0 110.992 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.537 ' HG2' HD11 ' A' ' 681' ' ' LEU . 28.8 Cg_endo -68.28 -167.27 0.17 Allowed 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 122.823 2.349 . . . . 0.0 111.863 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.95 151.41 25.84 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.531 -0.731 . . . . 0.0 110.749 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 657' ' ' TYR . 3.7 tt -92.69 136.82 32.9 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 636' ' ' LEU . 46.3 tp -32.01 -68.31 0.09 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.815 2.046 . . . . 0.0 113.958 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.33 33.66 3.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.939 1.828 . . . . 0.0 108.795 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.67 -156.28 6.88 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.814 174.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -174.8 -178.92 1.35 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.23 139.77 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 123.838 0.855 . . . . 0.0 111.202 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -96.0 -23.01 17.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.31 172.16 14.12 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -96.79 165.24 12.21 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.266 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.602 HG22 ' HD2' ' A' ' 633' ' ' PRO . 33.5 p -91.14 120.79 32.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.374 0.607 . . . . 0.0 111.586 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.33 -24.91 21.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.759 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.98 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 67.55 -12.91 0.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.496 1.518 . . . . 0.0 114.395 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -132.0 93.49 3.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 630' ' ' CYS . 3.1 m-85 -110.33 -179.46 3.78 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.101 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -151.08 -150.31 5.28 Favored Glycine 0 N--CA 1.402 -3.578 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.251 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -80.1 134.02 36.14 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.0 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 75.66 17.87 2.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.877 1.271 . . . . 0.0 111.798 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 69.7 mm-40 -79.87 129.22 34.31 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.693 -0.629 . . . . 0.0 109.508 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 10.4 m -110.97 151.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 123.366 0.416 . . . . 0.0 111.461 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 633' ' ' PRO . 26.2 t -135.2 131.8 52.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.442 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -100.49 128.89 46.42 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.122 0.963 . . . . 0.0 112.089 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.733 ' HB3' HD12 ' A' ' 636' ' ' LEU . 52.8 m-85 -106.72 165.75 11.08 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.486 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -136.18 156.81 48.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 75.8 m -93.08 165.13 12.99 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.95 157.5 4.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.75 10.43 0.49 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.846 3.031 . . . . 0.0 114.009 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.558 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 11.2 ptt85 -133.25 -1.16 3.24 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.996 0.903 . . . . 0.0 111.61 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 46.0 m-85 -116.7 158.18 24.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.025 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.708 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.3 mp -115.33 140.72 48.87 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.386 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.547 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 56.6 tpp -75.45 118.43 18.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 683' ' ' VAL . 38.0 ttmt -98.24 -47.09 5.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.077 0.465 . . . . 0.0 110.46 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.43 -170.95 46.03 Favored Glycine 0 C--O 1.242 0.629 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.405 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 104.52 1.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.494 2.129 . . . . 0.0 110.934 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.0 p-10 -69.32 -2.44 10.78 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.318 -177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 46.6 mtmt -121.91 128.79 51.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.139 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 681' ' ' LEU . 43.7 pt -116.96 166.25 11.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.623 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.2 tt0 -138.46 139.57 38.88 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.75 0.656 . . . . 0.0 109.657 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 13.7 t -89.67 115.06 26.76 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 677' ' ' GLU . 20.0 m -89.58 -171.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.252 4.8 p-10 -78.75 76.97 5.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.477 1.132 . . . . 0.0 111.684 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.5 0.38 Allowed Glycine 0 N--CA 1.414 -2.804 0 CA-C-N 113.534 -1.666 . . . . 0.0 111.145 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 674' ' ' VAL . 10.9 pt-20 -149.79 -175.28 4.97 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 85.9 m95 -85.05 175.1 9.24 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.238 0.542 . . . . 0.0 111.469 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 30.5 p -88.81 -174.64 4.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.833 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 88.5 m -61.63 116.66 4.94 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 123.883 0.873 . . . . 0.0 111.927 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -68.4 143.48 95.56 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.581 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.524 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 84.4 Cg_endo -76.31 170.03 20.8 Favored 'Trans proline' 0 CA--C 1.461 -3.153 0 C-N-CA 123.585 2.857 . . . . 0.0 111.928 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 666' ' ' LYS . 18.6 m -131.75 156.52 42.65 Favored 'Isoleucine or valine' 1 N--CA 1.356 -5.167 0 CA-C-N 112.048 -2.342 . . . . 0.0 108.482 -174.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 95.8 m -128.33 138.0 52.19 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.22 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.39 152.35 36.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.4 p . . . . . 0 C--N 1.274 -2.678 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.835 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 62.1 p . . . . . 0 N--CA 1.402 -2.836 0 CA-C-O 121.49 0.662 . . . . 0.0 110.519 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . 0.486 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 32.7 m -95.02 -12.17 27.1 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 103.64 -77.74 0.29 Allowed Glycine 0 CA--C 1.478 -2.251 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.415 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t70 -170.58 -165.24 0.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.3 mt -80.15 136.65 53.44 Favored Pre-proline 0 C--N 1.272 -2.793 0 C-N-CA 125.296 1.439 . . . . 0.0 111.315 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.597 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.5 Cg_endo -74.64 -177.22 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.252 2.635 . . . . 0.0 111.309 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.46 118.54 33.48 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.61 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -89.35 143.39 26.87 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 10.2 pt-20 -39.01 -47.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.03 1.332 . . . . 0.0 113.239 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 53.9 m80 -143.41 30.76 1.37 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.61 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -133.12 176.53 19.52 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.066 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -164.62 -156.03 0.3 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.306 1.842 . . . . 0.0 106.913 -174.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.41 150.69 47.84 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -167.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.445 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.5 -41.8 13.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.765 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.07 146.98 50.82 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.674 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.53 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 13.0 m -120.41 130.54 54.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.57 87.77 49.41 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.45 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.4 Cg_endo -91.28 147.84 3.59 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.914 2.409 . . . . 0.0 112.152 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.4 Cg_endo -74.84 128.33 16.1 Favored 'Cis proline' 0 C--O 1.241 0.671 0 C-N-CA 122.648 -1.814 . . . . 0.0 110.955 -0.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.53 ' OH ' ' HB3' ' A' ' 705' ' ' SER . 12.7 m-85 -72.78 97.06 2.15 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.558 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 13.6 m-85 -97.11 176.83 5.79 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.326 0.584 . . . . 0.0 111.883 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.708 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 11.3 t80 -67.09 137.75 56.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.16 -1.53 88.65 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.369 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -84.78 174.17 10.09 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.3 m -143.04 153.31 42.82 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.144 0.497 . . . . 0.0 110.614 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.578 HG11 HG12 ' A' ' 694' ' ' ILE . 39.6 t -138.28 141.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.503 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 34.3 mt-10 -100.73 121.14 41.16 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.605 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.1 m-85 -98.38 161.52 13.64 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.611 1.164 . . . . 0.0 110.461 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.445 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 34.3 t-20 -149.45 163.21 38.42 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.6 m -108.23 154.72 21.36 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 19.3 m -61.22 154.14 24.29 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.255 0.347 . . . . 0.0 111.598 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.46 138.64 58.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.5 m 88.18 -0.83 0.45 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 126.929 2.092 . . . . 0.0 110.118 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.31 149.26 40.77 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -117.15 145.31 43.91 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.67 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -93.79 138.48 31.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.684 0.754 . . . . 0.0 111.729 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 51.9 mt -113.08 116.9 53.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 119.37 -139.67 14.35 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -128.19 167.54 16.69 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 120.895 0.379 . . . . 0.0 110.402 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -87.51 -33.83 18.84 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.0 p -93.57 133.78 36.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -118.1 166.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.507 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 739' ' ' THR . 75.2 m -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.05 121.68 25.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.551 0.691 . . . . 0.0 112.206 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 737' ' ' VAL . 49.7 mm -128.43 108.38 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 70.63 27.07 3.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 95.17 -13.72 66.44 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.32 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.6 m -113.73 158.51 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -173.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.597 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.8 m95 -96.12 158.61 15.36 Favored 'General case' 0 C--N 1.271 -2.835 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 732' ' ' THR . 42.5 p -39.59 -70.4 0.1 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.2 -28.38 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 731' ' ' ILE . 17.4 mt 68.98 157.78 0.15 Allowed Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.466 1.107 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.67 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.2 Cg_endo -77.51 -172.05 1.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.776 1.65 . . . . 0.0 111.577 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -125.1 130.38 52.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 9.6 m -107.39 126.07 52.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.64 147.07 28.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.66 114.87 8.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.903 0.752 . . . . 0.0 111.254 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.58 175.66 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.652 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 47.8 m . . . . . 0 N--CA 1.453 -0.315 0 CA-C-O 121.771 0.796 . . . . 0.0 112.057 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 12.9 p -116.33 -172.08 2.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.076 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.67 -136.82 5.66 Favored Glycine 0 N--CA 1.398 -3.84 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.04 147.54 82.08 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 123.685 2.923 . . . . 0.0 114.028 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.9 Cg_endo -64.66 157.34 56.22 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.137 2.558 . . . . 0.0 112.658 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.57 ' HG2' HD21 ' A' ' 681' ' ' LEU . 19.1 Cg_endo -66.73 -164.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.405 2.736 . . . . 0.0 111.421 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -114.75 159.23 20.81 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.461 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 657' ' ' TYR . 1.0 OUTLIER -93.94 136.2 34.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -32.11 -65.55 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.563 1.945 . . . . 0.0 111.189 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.2 t30 -110.63 -33.53 6.55 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.448 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.748 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -83.18 -147.12 6.99 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.691 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.04 -172.85 3.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.75 HG22 ' CE1' ' A' ' 657' ' ' TYR . 21.3 t -105.16 140.21 23.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 124.64 1.176 . . . . 0.0 109.215 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.0 ptpt -107.32 -11.68 15.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.666 0.746 . . . . 0.0 109.482 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.498 ' CG ' ' H ' ' A' ' 656' ' ' GLU . 20.0 mm-40 -78.51 154.09 30.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.927 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.93 144.82 25.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.171 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.496 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 20.9 p -78.78 119.97 22.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.998 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -103.02 -13.82 16.71 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.045 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 66.79 -29.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.148 1.379 . . . . 0.0 112.013 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.9 tt0 -112.66 102.49 10.55 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 6.7 m-85 -117.55 -160.04 0.76 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -176.03 -165.57 32.07 Favored Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.137 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . 0.494 ' HA ' ' O ' ' A' ' 673' ' ' CYS . 69.1 t60 -69.8 137.12 51.59 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.4 m 75.85 4.33 3.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 124.694 1.246 . . . . 0.0 113.252 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 53.9 mm-40 -70.98 140.27 50.81 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.4 m -121.12 139.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.3 t -121.71 132.59 70.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.743 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.498 ' H ' ' CG ' ' A' ' 643' ' ' GLU . 38.5 tt0 -102.42 127.73 49.32 Favored 'General case' 0 N--CA 1.414 -2.231 0 O-C-N 124.109 0.881 . . . . 0.0 110.236 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.774 ' HB3' HD12 ' A' ' 636' ' ' LEU . 81.2 m-85 -101.96 161.27 13.8 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.604 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.503 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 51.6 p90 -136.89 142.23 42.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 79.9 m -85.24 163.33 18.72 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.617 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.6 OUTLIER -60.98 154.4 60.41 Favored Pre-proline 0 C--O 1.211 -0.923 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.617 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 58.6 Cg_endo -66.53 -4.04 10.16 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.975 3.117 . . . . 0.0 114.628 -172.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.582 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 13.3 ptt180 -110.6 -4.71 15.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.021 0.915 . . . . 0.0 111.111 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.494 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 38.9 m-85 -117.07 149.95 39.46 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.065 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.1 mp -108.71 146.54 33.32 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.617 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.495 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 51.7 tpp -71.04 123.22 21.59 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.647 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -99.57 -49.21 4.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -94.5 -162.42 35.14 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.497 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.64 106.2 2.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.538 2.159 . . . . 0.0 110.431 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 25.3 p-10 -68.96 -8.82 48.15 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.333 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.7 mttt -118.68 130.45 55.84 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.54 HG21 ' HG ' ' A' ' 681' ' ' LEU . 46.7 pt -120.22 165.46 15.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.903 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.1 tt0 -136.81 138.18 40.56 Favored 'General case' 0 C--N 1.283 -2.288 0 O-C-N 123.848 0.717 . . . . 0.0 110.196 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 47.5 t -84.29 107.92 16.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.78 -163.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 13.7 p-10 -74.05 79.83 1.72 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.334 1.064 . . . . 0.0 110.419 179.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.33 -51.2 0.73 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.681 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -155.6 -170.52 3.46 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -86.81 162.53 17.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.8 p -76.45 -178.21 4.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 86.6 m -58.87 113.93 2.3 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.798 0.839 . . . . 0.0 111.335 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 634' ' ' PRO . 6.6 mp -71.46 156.21 91.76 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.534 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.438 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -73.64 -178.45 3.75 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 123.036 2.491 . . . . 0.0 113.539 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.54 149.55 31.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 83.9 m -119.67 128.83 54.19 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 35.8 pt -123.59 158.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 662' ' ' ARG . 12.5 p . . . . . 0 C--N 1.279 -2.493 0 CA-C-O 123.077 1.417 . . . . 0.0 110.421 179.339 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 43.5 p . . . . . 0 N--CA 1.425 -1.682 0 CA-C-O 121.246 0.546 . . . . 0.0 111.095 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.0 m -90.11 -2.63 58.12 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.668 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 89.74 -75.93 1.77 Allowed Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.778 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 3.2 t70 -159.57 -166.78 1.85 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.649 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.3 mt -79.78 133.72 58.28 Favored Pre-proline 0 C--N 1.28 -2.438 0 C-N-CA 124.275 1.03 . . . . 0.0 111.043 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.9 Cg_endo -74.29 -176.58 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.075 2.516 . . . . 0.0 111.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.09 120.35 42.28 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.44 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.677 HD23 ' HA3' ' A' ' 700' ' ' GLY . 30.2 tp -90.46 138.63 31.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -41.61 -40.8 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.3 m-70 -142.19 27.44 1.76 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.677 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.52 -179.85 16.5 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.162 -0.927 . . . . 0.0 113.465 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -160.25 -152.53 0.29 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.982 2.113 . . . . 0.0 106.553 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.75 150.95 46.68 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 118.816 0.735 . . . . 0.0 112.506 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.486 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -84.43 -43.43 14.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.761 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.23 147.87 51.11 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.575 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 6.9 p -126.17 121.47 32.9 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.333 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.05 85.65 46.17 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.471 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.8 Cg_endo -92.23 146.66 2.93 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 123.114 2.543 . . . . 0.0 111.827 176.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 64.6 Cg_endo -72.73 130.11 18.98 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.037 -1.651 . . . . 0.0 111.456 -0.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.778 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 19.3 m-85 -78.05 83.6 4.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.582 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 20.9 m-85 -83.0 168.54 16.89 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 121.157 0.503 . . . . 0.0 111.536 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 1.004 ' HB3' HD11 ' A' ' 664' ' ' LEU . 1.9 t80 -59.89 127.2 30.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.084 176.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.33 -20.5 42.38 Favored Glycine 0 C--N 1.299 -1.515 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.537 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.31 170.18 16.6 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.5 m -138.87 148.98 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.451 0.643 . . . . 0.0 111.291 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.563 HG11 HG12 ' A' ' 694' ' ' ILE . 42.5 t -131.83 143.07 41.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.995 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.1 mt-10 -109.97 122.29 47.21 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.649 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.3 m-85 -95.32 161.1 14.23 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 124.686 1.194 . . . . 0.0 111.399 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 55.6 t30 -150.1 147.86 28.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.4 m -91.37 165.06 13.61 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 723' ' ' PHE . 47.3 t -50.69 147.01 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.64 -31.24 62.15 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 20.3 m -93.68 11.37 29.21 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 121.173 0.511 . . . . 0.0 111.89 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 720' ' ' SER . 75.9 m-85 -127.26 154.83 44.39 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -119.93 145.09 47.06 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.451 ' HB3' ' SG ' ' A' ' 719' ' ' CYS . 9.0 ptp -90.74 161.07 15.48 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-O 121.474 0.654 . . . . 0.0 109.954 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.18 122.94 66.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.65 -144.47 18.18 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -118.75 169.7 9.61 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 33.7 ptt180 -94.49 -28.67 15.33 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.543 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.4 p -86.19 146.43 26.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -130.34 168.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.262 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 99.2 m -137.49 136.26 37.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.15 109.15 4.46 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.507 0.504 . . . . 0.0 110.312 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.3 mm -123.89 107.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.361 0.6 . . . . 0.0 110.729 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 68.16 18.83 9.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.42 1.088 . . . . 0.0 113.211 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.3 55.57 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.665 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.03 142.47 40.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.53 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.2 m95 -75.53 163.09 27.73 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.0 p -46.33 -71.59 0.07 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -33.09 0.06 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 66.35 153.79 0.13 Allowed Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 124.497 1.123 . . . . 0.0 110.37 -176.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.3 -161.73 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.585 1.524 . . . . 0.0 111.022 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.56 132.26 30.83 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 10.1 m -94.56 146.49 24.08 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.35 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.82 155.1 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.87 124.57 24.35 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 123.685 0.615 . . . . 0.0 109.688 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.253 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 109.166 176.81 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.7 t . . . . . 0 N--CA 1.434 -1.228 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 25.8 p -145.61 177.87 8.56 Favored 'General case' 0 C--N 1.275 -2.631 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -116.7 -141.75 7.16 Favored Glycine 0 N--CA 1.402 -3.616 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.905 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.739 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 18.9 Cg_exo -60.58 146.07 97.67 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.075 2.517 . . . . 0.0 111.887 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 645' ' ' THR . 11.5 Cg_endo -55.57 149.18 49.65 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 123.041 2.494 . . . . 0.0 112.233 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.643 ' HG2' HD21 ' A' ' 681' ' ' LEU . 17.9 Cg_endo -72.58 -168.26 0.39 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.312 2.675 . . . . 0.0 111.999 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -99.29 158.86 15.41 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.047 0.451 . . . . 0.0 110.823 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.8 tt -98.72 145.7 26.64 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.653 HD13 HG23 ' A' ' 683' ' ' VAL . 6.9 tt -33.52 -56.0 0.44 Allowed 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 127.325 2.25 . . . . 0.0 111.238 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.5 t30 -122.6 -47.55 2.09 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.643 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -68.88 -153.08 0.54 Allowed Glycine 0 N--CA 1.476 1.324 0 O-C-N 124.103 0.877 . . . . 0.0 114.681 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -173.43 -172.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.922 0 O-C-N 122.275 -0.544 . . . . 0.0 111.045 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.1 140.97 15.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 C-N-CA 125.921 1.688 . . . . 0.0 110.748 -173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 14.6 ptpt -104.55 -23.83 13.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.564 0.697 . . . . 0.0 109.604 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -69.88 156.26 39.34 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.629 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 59.5 mmtt -93.37 119.37 32.41 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.832 0.825 . . . . 0.0 110.468 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.484 HG22 ' HD2' ' A' ' 633' ' ' PRO . 77.3 p -67.6 121.68 16.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.428 -1.715 . . . . 0.0 112.034 -172.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.15 -26.77 25.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.314 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.739 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 43.4 mt-10 75.04 -18.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 112.663 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.33 98.21 6.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 172.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.573 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.7 m-85 -118.4 142.47 47.52 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -108.53 -71.07 0.71 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.787 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 80.6 t60 -160.48 143.25 13.2 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.705 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 54.8 m 70.14 13.52 7.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.877 0.871 . . . . 0.0 112.664 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 61.5 mm-40 -74.73 130.24 39.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.5 p -122.68 129.36 75.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.779 0.8 . . . . 0.0 112.46 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 78.8 t -118.84 136.63 55.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.197 -174.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.547 ' OE1' ' HE3' ' A' ' 670' ' ' LYS . 36.2 tt0 -100.62 133.63 44.78 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.631 0.729 . . . . 0.0 110.667 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' A' ' 636' ' ' LEU . 42.4 m-85 -104.81 166.11 10.61 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.445 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 35.4 p90 -130.21 151.07 51.14 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 67.2 m -100.1 154.93 18.02 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 11.2 m120 -51.89 162.33 0.8 Allowed Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 125.888 1.675 . . . . 0.0 113.707 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -18.48 40.28 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.369 2.712 . . . . 0.0 113.534 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 19.7 ptt180 -117.67 -3.71 11.26 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.728 0.775 . . . . 0.0 112.171 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.643 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 59.1 m-85 -112.87 137.91 50.51 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.119 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.518 HD21 ' HB3' ' A' ' 711' ' ' TYR . 51.8 mt -106.64 143.39 34.8 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.19 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.627 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.6 tpp -70.67 110.95 5.79 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.257 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 683' ' ' VAL . 83.3 tttt -101.66 -31.75 10.66 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -75.83 -175.06 37.76 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.661 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.573 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 40.5 Cg_endo -67.36 -11.24 31.47 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.581 2.854 . . . . 0.0 113.928 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.627 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 0.9 OUTLIER 62.2 -26.72 0.06 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 127.19 2.196 . . . . 0.0 115.15 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.547 ' HE3' ' OE1' ' A' ' 656' ' ' GLU . 88.1 mttt -117.74 134.77 54.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 123.102 0.561 . . . . 0.0 110.409 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.781 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -119.49 167.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.438 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -139.55 138.68 36.48 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 123.491 0.494 . . . . 0.0 110.243 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 43.4 t -84.67 107.03 16.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.78 -173.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 16.3 p-10 -78.42 70.71 4.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.931 1.348 . . . . 0.0 112.719 -175.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.88 -54.57 0.22 Allowed Glycine 0 N--CA 1.416 -2.67 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.455 172.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -159.17 -166.97 1.95 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 90.6 m95 -80.81 161.64 24.39 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.812 0.339 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -75.46 -176.13 3.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.325 0.65 . . . . 0.0 112.017 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 32.9 m -63.19 115.22 4.31 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.159 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.781 ' HG ' HG21 ' A' ' 671' ' ' ILE . 5.7 mp -71.93 155.29 92.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.26 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.698 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 51.5 Cg_endo -68.55 179.73 2.89 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.142 2.561 . . . . 0.0 115.03 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 637' ' ' LEU . 2.2 p -136.54 137.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.319 -1.764 . . . . 0.0 106.66 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 95.3 m -111.16 133.96 53.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.75 146.39 33.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p . . . . . 0 C--N 1.273 -2.738 0 CA-C-O 121.291 0.567 . . . . 0.0 110.852 -178.155 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 12.9 p . . . . . 0 N--CA 1.413 -2.288 0 CA-C-O 122.272 1.034 . . . . 0.0 112.736 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.6 m -89.52 -11.84 41.71 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.98 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.75 -89.68 0.57 Allowed Glycine 0 CA--C 1.472 -2.65 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.637 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 t70 -164.41 -167.61 1.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.528 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -68.72 130.79 91.58 Favored Pre-proline 0 N--CA 1.412 -2.33 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 41.9 Cg_endo -71.61 179.71 4.44 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.197 2.598 . . . . 0.0 111.607 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.76 124.32 49.43 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-O 121.667 0.746 . . . . 0.0 110.694 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.926 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.7 tp -100.06 133.56 44.28 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.8 -36.92 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -133.86 18.01 3.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.572 0.701 . . . . 0.0 111.512 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.926 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -128.02 176.51 18.04 Favored Glycine 0 N--CA 1.427 -1.96 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.841 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -157.3 -151.97 0.34 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.15 158.5 43.83 Favored 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.66 -168.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.47 -61.67 1.39 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.439 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 715' ' ' VAL . 4.0 pp -103.42 153.34 20.6 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.071 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 694' ' ' ILE . 4.4 p -147.04 111.68 5.29 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.461 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 70.8 m -125.01 92.26 47.88 Favored Pre-proline 0 C--N 1.284 -2.239 0 CA-C-O 121.34 0.59 . . . . 0.0 111.747 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.3 154.97 12.54 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.697 2.265 . . . . 0.0 111.205 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.98 136.5 44.26 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.22 0.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.637 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.4 m-85 -82.14 101.48 10.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.445 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 3.3 m-85 -98.37 169.87 9.25 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.591 0.557 . . . . 0.0 109.76 176.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.518 ' HB3' HD21 ' A' ' 664' ' ' LEU . 4.5 t80 -54.6 138.5 41.01 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.296 175.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.94 42.74 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 118.894 -1.622 . . . . 0.0 113.905 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.46 172.6 13.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 119.006 -1.077 . . . . 0.0 109.839 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.01 158.71 37.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -173.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' A' ' 704' ' ' LEU . 16.1 t -142.51 138.52 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.831 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.405 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 50.7 mt-10 -95.66 122.42 38.41 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 123.406 0.441 . . . . 0.0 110.286 176.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.528 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -99.16 154.96 17.73 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 123.78 0.832 . . . . 0.0 110.024 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.453 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 56.2 t30 -144.8 150.26 36.87 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.0 t -104.57 160.21 15.12 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 27.4 m -67.24 142.66 56.85 Favored 'General case' 0 C--O 1.205 -1.264 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.54 -18.24 64.32 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -167.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 30.1 m -81.62 -3.24 52.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.43 1.11 . . . . 0.0 109.57 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 77.8 m-85 -126.37 151.27 47.86 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -114.96 131.97 56.72 Favored 'General case' 0 C--N 1.265 -3.084 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.507 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -85.29 138.04 32.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.39 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 132.72 -161.14 24.0 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -101.14 174.44 6.0 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.439 0.62 . . . . 0.0 111.101 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.24 -35.97 15.88 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 5.8 m -107.08 138.0 44.09 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.958 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.635 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -113.44 173.75 2.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.062 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 739' ' ' THR . 95.7 m -138.98 137.3 36.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 46.7 t -79.5 121.78 25.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.962 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 733' ' ' CYS . 49.5 mm -126.88 104.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.5 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 63.11 49.11 3.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.116 1.367 . . . . 0.0 112.018 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 83.06 -4.71 79.64 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.637 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.598 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.9 m95 -67.6 165.48 16.92 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.764 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 732' ' ' THR . 20.4 p -44.24 -70.29 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.65 -27.24 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 731' ' ' ILE . 17.9 mt 68.58 150.93 0.12 Allowed Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 124.598 1.159 . . . . 0.0 112.393 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.507 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 96.0 Cg_endo -78.68 -165.82 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.954 1.769 . . . . 0.0 110.361 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.9 143.64 32.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 71.5 m -93.62 151.82 19.42 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.535 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.74 145.04 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.95 127.33 32.46 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.041 0.448 . . . . 0.0 111.415 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.755 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 20.7 m . . . . . 0 N--CA 1.442 -0.873 0 CA-C-O 120.892 0.377 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 38.4 m -131.78 153.39 50.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -100.91 -135.22 8.83 Favored Glycine 0 N--CA 1.415 -2.753 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 52.3 Cg_exo -55.44 141.66 81.81 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.314 2.676 . . . . 0.0 112.622 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.15 153.75 74.58 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 123.05 2.5 . . . . 0.0 111.999 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.561 ' HG2' HD11 ' A' ' 681' ' ' LEU . 42.9 Cg_endo -70.31 -166.0 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.268 2.645 . . . . 0.0 111.941 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.99 158.96 15.93 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.28 0.562 . . . . 0.0 110.482 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.679 HD13 ' HG2' ' A' ' 682' ' ' PRO . 20.5 tp -102.09 139.68 37.39 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -39.38 -67.57 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 O-C-N 124.816 1.323 . . . . 0.0 112.263 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.1 t30 -106.66 -37.44 6.43 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.679 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -95.04 -147.4 22.58 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 636' ' ' LEU . 1.7 t-20 -169.0 -166.42 0.63 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.372 1.086 . . . . 0.0 111.123 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.07 135.36 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.678 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.6 ptpt -102.53 -10.26 19.48 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.585 0.707 . . . . 0.0 109.597 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -93.79 173.73 7.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -98.11 146.59 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.954 -176.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.584 HG22 ' HD2' ' A' ' 633' ' ' PRO . 18.7 p -72.88 126.77 30.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 648' ' ' GLU . 41.5 mtmt -105.38 -12.2 16.13 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 632' ' ' PRO 0.283 10.4 pt-20 58.15 -30.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 127.169 2.188 . . . . 0.0 113.782 -171.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.2 tt0 -98.31 95.65 7.51 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.468 ' C ' ' HG3' ' A' ' 653' ' ' GLU . 24.2 m-85 -114.5 -82.63 0.61 Allowed 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.895 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 98.05 -166.44 22.31 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 77.2 t60 -77.48 142.24 39.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.756 0.278 . . . . 0.0 111.21 -175.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 11.3 t 77.94 0.66 2.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.48 1.512 . . . . 0.0 113.38 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 29.7 mm-40 -70.51 133.68 47.01 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 18.0 t -109.63 150.29 12.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 123.557 0.535 . . . . 0.0 109.681 -176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 633' ' ' PRO . 25.0 t -132.97 134.85 57.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 124.038 0.935 . . . . 0.0 109.302 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -101.73 124.9 48.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.172 0.987 . . . . 0.0 111.524 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 57.3 m-85 -99.3 163.95 12.33 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.189 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.678 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 26.9 p90 -143.42 149.46 37.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.4 m -93.02 158.93 15.54 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.529 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -56.18 156.1 11.39 Favored Pre-proline 0 C--O 1.208 -1.08 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.775 176.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 31.5 Cg_endo -59.53 -14.36 25.36 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 123.599 2.866 . . . . 0.0 115.404 -171.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.476 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 16.1 ptt180 -108.03 -7.1 16.23 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.409 0.623 . . . . 0.0 111.556 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 35.4 m-85 -109.6 139.33 44.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.178 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.5 mp -99.7 142.08 31.66 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.791 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.59 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.7 tpp -71.71 117.19 12.98 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.441 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.609 ' HB3' HG23 ' A' ' 683' ' ' VAL . 13.2 tmtt? -107.01 -25.23 11.69 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.715 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -103.22 -169.54 25.93 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.197 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.55 105.6 2.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.482 2.122 . . . . 0.0 111.274 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.9 p-10 -69.74 -0.15 6.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.288 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 87.1 mttt -127.39 140.36 52.23 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.753 0.311 . . . . 0.0 110.52 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 681' ' ' LEU . 46.0 pt -129.88 165.07 30.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 26.3 tt0 -143.15 140.43 30.8 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 123.266 0.626 . . . . 0.0 110.625 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 18.5 t -78.6 110.54 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.046 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.58 -171.1 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.533 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -81.31 75.29 8.27 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.812 1.291 . . . . 0.0 111.475 -178.63 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.95 -43.48 0.47 Allowed Glycine 0 N--CA 1.411 -3.016 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.644 170.984 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.11 -171.58 2.7 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -82.69 167.67 17.99 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.6 p -77.77 -172.23 2.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.917 0.389 . . . . 0.0 111.803 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.6 m -68.7 113.54 6.27 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 123.319 0.647 . . . . 0.0 111.759 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -61.77 148.63 87.01 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.78 173.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.679 ' HG2' HD13 ' A' ' 636' ' ' LEU . 89.4 Cg_endo -81.12 -177.22 3.56 Favored 'Trans proline' 0 CA--C 1.465 -2.929 0 C-N-CA 123.617 2.878 . . . . 0.0 112.517 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 666' ' ' LYS . 14.5 m -141.37 159.76 22.27 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.798 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.288 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 73.0 m -128.63 139.7 52.13 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.3 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 666' ' ' LYS . 32.1 pt -130.75 148.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.3 p . . . . . 0 C--N 1.283 -2.283 0 CA-C-O 122.705 1.241 . . . . 0.0 110.509 179.394 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 36.8 p . . . . . 0 N--CA 1.412 -2.342 0 CA-C-O 121.368 0.604 . . . . 0.0 112.089 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 38.7 m -108.49 -17.0 14.09 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.787 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.57 -80.45 0.27 Allowed Glycine 0 C--N 1.295 -1.745 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.959 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.486 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 10.5 t70 -173.43 -167.0 0.36 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.609 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -69.67 135.35 88.13 Favored Pre-proline 0 N--CA 1.407 -2.603 0 C-N-CA 123.327 0.651 . . . . 0.0 110.097 174.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 39.4 Cg_endo -70.67 -163.44 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.605 2.87 . . . . 0.0 111.991 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.99 126.18 51.82 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.141 0.496 . . . . 0.0 109.847 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.783 HD23 ' HA3' ' A' ' 700' ' ' GLY . 29.1 tp -112.58 135.47 53.26 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -39.82 -46.31 1.93 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.998 1.319 . . . . 0.0 113.906 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 94.6 m-70 -142.39 27.87 1.7 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.783 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.71 167.34 23.23 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.949 -177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.403 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 7.1 p-90 -157.15 -154.39 0.46 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.45 162.11 34.55 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.985 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.572 ' N ' HE21 ' A' ' 703' ' ' GLN . 0.0 OUTLIER -95.92 -57.23 2.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.518 0.675 . . . . 0.0 109.774 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 704' ' ' LEU . 3.9 pp -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 2.1 m -112.23 125.64 54.37 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 47.9 m -119.75 95.18 49.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-O 121.528 0.68 . . . . 0.0 112.353 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.417 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 7.0 Cg_endo -91.09 154.43 3.85 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.809 2.339 . . . . 0.0 111.964 176.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 89.8 Cg_endo -76.39 134.94 37.83 Favored 'Cis proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.753 -1.77 . . . . 0.0 111.043 -0.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 16.2 m-85 -76.17 97.82 4.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 23.4 m-85 -102.44 174.93 5.68 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.225 0.536 . . . . 0.0 110.315 176.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.689 ' HB3' HD11 ' A' ' 664' ' ' LEU . 2.9 t80 -65.78 129.33 39.41 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.2 -7.68 60.35 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.05 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 732' ' ' THR . 9.5 t70 -84.49 171.29 12.66 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 3.8 m -136.72 147.39 46.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.226 0.536 . . . . 0.0 110.99 -171.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.459 HG11 ' CG1' ' A' ' 694' ' ' ILE . 48.3 t -138.17 144.49 30.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.379 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.0 mt-10 -101.55 131.11 47.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.609 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -105.63 157.93 17.06 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 123.784 0.834 . . . . 0.0 109.169 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -151.83 151.13 30.91 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.564 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.4 m -98.0 157.4 16.14 Favored 'General case' 0 C--N 1.26 -3.285 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 33.5 m -52.18 150.75 4.29 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 123.479 0.487 . . . . 0.0 110.273 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -32.11 62.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 42.7 m -91.09 12.97 18.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.78 0.8 . . . . 0.0 111.409 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 81.8 m-85 -128.12 146.54 50.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 747' ' ' ILE . 10.2 t -113.56 139.29 49.11 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.707 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 7.9 ptm -88.61 142.47 27.67 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.509 0.671 . . . . 0.0 110.97 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 53.8 mt -119.03 117.32 53.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.54 -143.64 14.77 Favored Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.61 135.13 42.53 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.813 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.62 -33.39 72.7 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.51 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.46 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.9 p -123.54 161.29 25.23 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.316 0.579 . . . . 0.0 111.676 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 7.0 pt -131.19 168.09 24.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.114 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 88.9 m -139.23 137.53 36.05 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 42.0 t -78.66 120.66 23.66 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.575 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.1 mm -126.37 105.97 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.304 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 70.29 30.54 3.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.561 1.145 . . . . 0.0 112.672 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.73 3.19 80.85 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.494 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.01 140.35 49.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -79.22 152.24 30.75 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 30.6 p -31.95 -66.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.85 -34.89 0.05 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 32.5 mt 67.98 150.69 0.12 Allowed Pre-proline 0 C--N 1.318 -0.771 0 O-C-N 125.08 1.487 . . . . 0.0 111.282 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.707 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 90.2 Cg_endo -81.55 -172.37 1.46 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.251 1.967 . . . . 0.0 110.547 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 3.8 pt20 -134.61 135.29 42.08 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.0 m -97.95 140.52 32.17 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.673 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.57 141.88 45.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.64 117.62 9.82 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.797 0.685 . . . . 0.0 111.788 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.0 mt . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 49.0 m . . . . . 0 C--O 1.234 0.272 0 N-CA-C 114.582 1.327 . . . . 0.0 114.582 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.29 166.6 12.09 Favored 'General case' 0 C--O 1.263 1.781 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.054 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.3 -130.52 7.03 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.94 147.29 91.99 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.106 2.537 . . . . 0.0 112.857 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' A' ' 655' ' ' VAL . 38.7 Cg_endo -65.1 160.25 42.71 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.74 2.96 . . . . 0.0 112.727 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.457 ' HG2' HD21 ' A' ' 681' ' ' LEU . 51.7 Cg_endo -74.36 -163.47 0.18 Allowed 'Trans proline' 0 C--O 1.253 1.247 0 C-N-CA 122.986 2.457 . . . . 0.0 110.133 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.45 160.24 20.87 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.749 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.663 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.4 tp -89.71 141.17 28.87 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.646 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 684' ' ' CYS . 32.7 tp -30.68 -59.59 0.2 Allowed 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.428 2.291 . . . . 0.0 113.321 172.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -119.56 -45.95 2.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.116 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -80.94 -154.74 11.1 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.63 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.1 -174.33 4.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.877 -0.778 . . . . 0.0 111.726 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.35 137.5 21.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 124.248 1.019 . . . . 0.0 109.108 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.3 ptpt -105.06 -7.73 18.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.66 0.743 . . . . 0.0 109.747 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.81 154.07 23.71 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.383 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 644' ' ' LYS . 18.9 ptmt -81.44 145.8 30.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 173.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.9 p -80.57 128.41 33.57 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.355 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.3 mtmt -102.76 -14.25 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 56.13 -16.14 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 C-N-CA 127.424 2.29 . . . . 0.0 115.404 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 646' ' ' LYS . 36.3 tt0 -122.6 85.56 2.44 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 6.3 m-85 -93.61 -77.35 0.45 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.611 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 117.39 -97.36 0.73 Allowed Glycine 0 C--N 1.305 -1.15 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.391 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -155.17 143.03 19.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -177.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 12.2 t 72.71 9.97 5.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.357 1.463 . . . . 0.0 110.778 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 20.6 mm-40 -75.94 126.5 31.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.7 m -107.03 143.49 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.389 0.614 . . . . 0.0 112.078 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 43.0 t -125.65 133.47 69.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.784 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.489 ' HG3' HD22 ' A' ' 669' ' ' ASN . 33.4 tt0 -101.77 125.89 48.52 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.086 0.946 . . . . 0.0 111.043 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 61.9 m-85 -99.89 157.0 16.83 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.687 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.66 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 49.5 p90 -134.61 152.36 51.72 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.638 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.7 t -108.73 169.83 8.41 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.784 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -61.57 152.89 72.9 Favored Pre-proline 0 C--O 1.194 -1.85 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.918 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.8 16.79 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.821 3.014 . . . . 0.0 113.997 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 19.0 ptt180 -137.38 3.81 2.6 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.918 0.866 . . . . 0.0 110.049 173.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.441 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 59.7 m-85 -129.18 135.43 48.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.421 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.483 HD21 ' HB3' ' A' ' 711' ' ' TYR . 11.7 mt -95.44 144.64 25.79 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.957 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.606 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.1 tpp -73.39 113.71 10.79 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.175 174.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.556 ' HD2' HD13 ' A' ' 685' ' ' ILE . 62.1 tttm -100.59 -45.93 5.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.382 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.66 -173.77 50.01 Favored Glycine 0 C--O 1.236 0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.089 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.67 107.27 2.15 Favored 'Trans proline' 0 CA--C 1.503 -1.058 0 C-N-CA 122.812 2.341 . . . . 0.0 111.252 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -70.58 -7.77 46.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.561 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 55.9 mtmt -118.61 123.29 44.65 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 122.005 0.907 . . . . 0.0 110.388 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 HD23 ' A' ' 681' ' ' LEU . 50.0 pt -110.34 167.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.061 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 30.0 tt0 -138.05 137.12 37.49 Favored 'General case' 0 C--N 1.277 -2.57 0 O-C-N 123.545 0.528 . . . . 0.0 110.207 -175.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.85 104.98 12.61 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.8 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.85 -174.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.924 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.09 83.61 7.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.791 0.805 . . . . 0.0 110.085 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 154.22 -47.0 0.54 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.119 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.92 -172.26 2.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -88.26 168.04 13.05 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -77.95 -172.88 2.88 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.714 0.293 . . . . 0.0 111.451 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 61.9 m -73.25 114.96 12.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.874 0.845 . . . . 0.0 111.088 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.646 HD23 HG21 ' A' ' 671' ' ' ILE . 66.2 mt -57.98 145.93 70.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.663 ' HG2' HD13 ' A' ' 636' ' ' LEU . 18.0 Cg_endo -66.03 177.65 2.9 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.179 1.919 . . . . 0.0 113.273 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 146.83 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.61 ' H ' HD23 ' A' ' 637' ' ' LEU . 34.6 m -119.78 144.26 47.39 Favored 'General case' 0 C--N 1.276 -2.626 0 O-C-N 124.353 1.033 . . . . 0.0 108.34 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.556 HD13 ' HD2' ' A' ' 666' ' ' LYS . 27.8 pt -142.74 143.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p . . . . . 0 C--N 1.275 -2.665 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.27 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 3.7 p . . . . . 0 N--CA 1.41 -2.472 0 CA-C-O 121.678 0.751 . . . . 0.0 112.635 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.36 -9.84 29.09 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.83 30.64 7.84 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.492 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.697 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.9 t0 68.78 179.6 0.24 Allowed 'General case' 0 C--O 1.241 0.611 0 O-C-N 124.306 0.65 . . . . 0.0 110.241 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.611 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 3.4 mt -69.03 129.76 91.94 Favored Pre-proline 0 N--CA 1.406 -2.644 0 C-N-CA 123.354 0.662 . . . . 0.0 110.58 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.607 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -70.0 -179.52 3.08 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 123.33 2.687 . . . . 0.0 111.795 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.11 115.16 27.86 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.356 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.5 tt -90.19 137.14 32.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.8 pt-20 -35.9 -43.65 0.32 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.7 1.6 . . . . 0.0 113.039 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 49.1 m80 -144.36 25.7 1.51 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 719' ' ' CYS . . . -128.92 177.72 17.69 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.098 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . 0.421 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 16.8 p-90 -161.97 -158.44 0.54 Allowed 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.233 1.413 . . . . 0.0 107.625 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -140.26 156.04 46.63 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.257 -168.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.81 -68.0 0.82 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.865 0.728 . . . . 0.0 110.753 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.56 140.78 31.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.873 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.2 p -136.51 116.61 13.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.354 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 42.4 t -124.1 93.86 46.29 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-O 121.286 0.565 . . . . 0.0 110.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.436 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.7 153.04 10.18 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.806 2.337 . . . . 0.0 111.352 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.9 Cg_endo -73.29 135.91 42.07 Favored 'Cis proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.13 0.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.697 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 28.4 m-85 -80.31 98.77 7.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -93.65 173.35 7.73 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.951 0.782 . . . . 0.0 110.702 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.483 ' HB3' HD21 ' A' ' 664' ' ' LEU . 2.8 t80 -65.42 138.91 58.43 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.62 -14.15 65.86 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 118.001 -2.047 . . . . 0.0 112.693 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.64 167.2 21.97 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 117.479 0.639 . . . . 0.0 109.813 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -132.71 153.28 51.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.048 0.451 . . . . 0.0 110.172 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 694' ' ' ILE . 37.9 t -142.62 143.17 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.804 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -98.36 124.08 42.83 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.611 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.6 m-85 -104.54 167.91 9.43 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.138 0.975 . . . . 0.0 109.263 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -163.92 167.88 20.08 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.8 m -110.06 162.05 14.94 Favored 'General case' 0 C--N 1.263 -3.192 0 O-C-N 123.147 0.279 . . . . 0.0 111.172 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 32.6 t -56.83 155.19 8.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.917 0.76 . . . . 0.0 110.303 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -55.39 -44.18 75.9 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.144 0.978 . . . . 0.0 112.117 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 9.2 t -77.67 5.72 8.71 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.419 0.688 . . . . 0.0 111.852 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -130.16 156.0 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.761 0.424 . . . . 0.0 109.936 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.2 t -117.15 142.45 46.99 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.509 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -90.39 146.65 24.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.433 0.635 . . . . 0.0 111.163 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.686 HD12 HE21 ' A' ' 743' ' ' GLN . 39.5 mt -119.64 118.36 56.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.13 -157.47 16.07 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -112.46 162.24 15.82 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 117.177 0.488 . . . . 0.0 110.56 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -81.59 -33.22 31.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 24.2 p -95.0 137.15 34.44 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 741' ' ' LEU . 10.0 pt -121.25 166.21 16.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.883 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . 0.516 ' H ' HG23 ' A' ' 739' ' ' THR . 85.6 m -136.58 139.13 41.93 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.3 t -78.11 120.47 22.98 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.125 0.488 . . . . 0.0 111.976 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.6 mm -128.26 110.87 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.893 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 65.81 30.25 10.15 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.602 1.161 . . . . 0.0 112.58 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.15 2.98 65.74 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.744 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.6 p -136.99 148.02 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.1 m95 -77.2 158.2 30.46 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 732' ' ' THR . 39.8 p -32.34 -72.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -28.24 0.03 OUTLIER 'General case' 0 C--O 1.243 0.713 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 731' ' ' ILE . 17.2 mt 69.1 152.02 0.13 Allowed Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.036 1.335 . . . . 0.0 111.578 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.509 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 57.4 Cg_endo -76.11 -169.56 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.964 1.776 . . . . 0.0 109.746 173.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.686 HE21 HD12 ' A' ' 726' ' ' ILE . 9.4 pt20 -135.85 150.58 49.44 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.8 m -110.8 134.93 52.09 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 145.66 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 123.335 0.397 . . . . 0.0 110.282 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.19 113.13 3.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 124.723 1.264 . . . . 0.0 111.684 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.311 -1.105 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.502 173.007 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.8 m . . . . . 0 C--O 1.24 0.575 0 CA-C-O 122.006 0.908 . . . . 0.0 112.373 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.14 -169.97 1.55 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -115.46 -138.97 6.66 Favored Glycine 0 N--CA 1.41 -3.076 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.474 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.705 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 21.3 Cg_exo -62.55 150.85 86.24 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.854 2.369 . . . . 0.0 110.88 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.7 158.8 40.15 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.555 2.17 . . . . 0.0 112.083 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 671' ' ' ILE . 18.1 Cg_endo -75.53 -161.5 0.13 Allowed 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.881 2.387 . . . . 0.0 110.231 176.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.28 166.87 11.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.003 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.851 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.3 tt -103.55 140.58 37.33 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -36.98 -65.25 0.31 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.878 1.671 . . . . 0.0 111.676 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -108.49 -47.16 3.55 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.521 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -72.79 -155.71 3.02 Favored Glycine 0 C--O 1.242 0.639 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -171.0 0.53 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.73 132.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.416 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.501 ' HB3' ' CD2' ' A' ' 658' ' ' TYR . 18.3 pttp -102.51 -7.89 21.51 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.245 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -81.54 152.01 27.46 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.93 153.07 21.33 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 68.8 p -79.84 111.03 15.76 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.365 1.079 . . . . 0.0 112.081 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 13.2 mtpp -89.17 -26.7 21.14 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.96 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 53.0 mt-10 70.26 -30.21 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.604 1.562 . . . . 0.0 111.881 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 646' ' ' LYS . 33.6 mt-10 -91.94 82.91 5.13 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.264 0.554 . . . . 0.0 109.922 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 646' ' ' LYS . 16.2 m-85 -118.31 106.02 12.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -83.14 -67.92 1.45 Allowed Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.973 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -161.12 142.04 11.43 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 122.752 -0.263 . . . . 0.0 110.315 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 2.6 t 70.34 12.29 7.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 111.303 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 13.6 mm-40 -77.73 125.27 29.08 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.219 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 672' ' ' GLN . 15.6 m -110.01 144.96 17.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.196 0.522 . . . . 0.0 111.657 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.0 t -123.73 136.49 60.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -105.42 128.38 53.49 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-O 121.708 0.766 . . . . 0.0 109.415 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 47.4 m-85 -99.0 163.29 12.64 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.583 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 642' ' ' LYS . 45.5 p90 -133.82 155.04 50.53 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 5.8 t -101.78 163.61 12.16 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.109 -1.437 . . . . 0.0 108.863 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.28 155.51 26.2 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.789 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.26 14.53 0.22 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.601 2.867 . . . . 0.0 114.006 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 710' ' ' TYR . 11.8 ptt180 -137.99 -7.08 1.62 Allowed 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 32.8 m-85 -111.59 157.6 20.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.948 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.705 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.6 mp -111.11 135.59 51.41 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.163 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.549 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 54.0 tpp -71.23 119.34 15.22 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.71 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -105.26 -44.99 4.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.02 -171.98 48.36 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.506 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 36.3 Cg_endo -69.0 104.25 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.738 2.292 . . . . 0.0 111.429 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.549 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.2 p-10 -71.7 1.07 7.34 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.592 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.5 mttt -128.65 136.74 51.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.2 pt -126.48 162.1 31.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.65 ' HB2' HG12 ' A' ' 654' ' ' VAL . 28.4 tt0 -133.88 139.75 46.39 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 123.344 0.658 . . . . 0.0 110.738 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.86 102.63 12.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.93 -172.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.84 73.7 4.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.673 1.225 . . . . 0.0 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.28 -36.95 0.93 Allowed Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.992 173.745 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.51 -178.77 7.59 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -92.23 164.81 13.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 34.4 p -77.92 176.27 9.27 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.554 0.161 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.0 m -57.05 118.6 5.16 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.413 0.625 . . . . 0.0 112.38 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.476 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -62.1 149.32 86.85 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.745 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.851 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 55.7 Cg_endo -71.51 179.33 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.853 2.368 . . . . 0.0 113.581 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.03 141.89 45.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 5.2 m -120.24 137.47 54.2 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.264 0.352 . . . . 0.0 111.099 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.6 pt -135.73 143.82 35.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 662' ' ' ARG . 14.3 p . . . . . 0 C--N 1.289 -2.025 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.425 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 7.4 p . . . . . 0 N--CA 1.411 -2.378 0 CA-C-O 121.164 0.507 . . . . 0.0 111.711 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.2 m -86.84 -7.08 58.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.424 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.58 -78.38 0.64 Allowed Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.756 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.545 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 6.8 p-10 -157.57 174.47 15.31 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.671 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.5 mt -67.79 126.58 92.79 Favored Pre-proline 0 N--CA 1.422 -1.845 0 C-N-CA 123.694 0.797 . . . . 0.0 111.217 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -68.21 173.15 9.95 Favored 'Trans proline' 0 N--CA 1.433 -2.077 0 C-N-CA 123.186 2.59 . . . . 0.0 112.556 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.12 120.28 37.17 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.37 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' A' ' 700' ' ' GLY . 24.3 tp -99.72 129.34 45.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -51.14 -36.39 40.5 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 89.2 m-70 -135.35 25.54 3.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.491 0.662 . . . . 0.0 109.875 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -135.79 179.08 18.16 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.919 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -161.1 -154.83 0.38 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.888 1.675 . . . . 0.0 106.499 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.29 150.73 49.04 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.787 -169.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.537 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -88.57 -45.88 9.53 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.39 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.44 154.06 42.55 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.281 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.5 p -136.39 128.18 29.15 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.382 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 30.2 t -124.36 85.85 55.3 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-O 121.442 0.639 . . . . 0.0 109.886 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.557 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 10.9 Cg_endo -93.39 154.64 2.49 Favored 'Trans proline' 0 N--CA 1.431 -2.195 0 C-N-CA 122.994 2.463 . . . . 0.0 112.055 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 37.8 Cg_endo -67.97 133.6 22.97 Favored 'Cis proline' 0 C--O 1.235 0.364 0 C-N-CA 122.795 -1.752 . . . . 0.0 109.963 -3.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.545 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 39.9 m-85 -73.28 82.37 1.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -174.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.432 ' HB3' ' HA ' ' A' ' 662' ' ' ARG . 8.1 m-85 -81.77 174.3 11.47 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 122.903 0.481 . . . . 0.0 111.188 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.705 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 39.3 t80 -62.98 140.55 58.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.943 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.38 70.21 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.389 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.39 166.97 22.02 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -132.86 144.4 50.17 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.163 0.506 . . . . 0.0 110.085 -171.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.595 HG11 HG12 ' A' ' 694' ' ' ILE . 45.5 t -130.13 138.22 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.913 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.64 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.6 mt-10 -106.17 120.92 43.07 Favored 'General case' 0 N--CA 1.409 -2.511 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.223 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.671 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -96.28 160.72 14.28 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 125.082 1.353 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.537 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -148.12 143.53 27.19 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 78.4 m -88.13 158.86 18.43 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 123.59 0.556 . . . . 0.0 109.661 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.2 t -61.93 148.93 42.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.25 145.57 56.06 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 36.4 m 85.52 -5.41 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 110.144 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.91 153.85 27.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.529 ' HB ' HD11 ' A' ' 747' ' ' ILE . 6.8 t -116.83 143.6 45.49 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.547 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.3 ptm -94.53 138.74 32.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.75 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.1 mt -105.9 116.97 50.77 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.149 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 105.55 -141.43 15.37 Favored Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.593 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -102.39 129.54 48.89 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.316 0.579 . . . . 0.0 110.636 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.144 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 0.2 OUTLIER -103.97 148.51 26.11 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.553 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -129.6 167.75 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.1 m -138.85 136.94 36.12 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.51 106.75 3.1 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 109.867 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 711' ' ' TYR . 52.1 mm -122.61 112.18 33.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.008 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 58.31 29.74 18.54 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.711 0.804 . . . . 0.0 112.724 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.92 6.59 61.84 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.857 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.33 139.05 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -70.01 150.96 46.1 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -39.14 -75.06 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -173.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.03 -29.06 0.07 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -171.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 731' ' ' ILE . 23.6 mt 68.49 156.33 0.15 Allowed Pre-proline 0 C--O 1.239 0.546 0 O-C-N 124.619 1.2 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.547 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 46.5 Cg_endo -81.84 -167.9 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.113 1.875 . . . . 0.0 111.47 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -130.21 130.22 44.37 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 21.5 m -98.8 129.17 45.19 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.208 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.89 145.73 34.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -73.81 115.09 12.84 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.608 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.529 HD11 ' HB ' ' A' ' 724' ' ' THR . 60.6 mt . . . . . 0 C--O 1.255 1.348 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 45.9 t . . . . . 0 CA--C 1.512 -0.501 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 21.0 p -168.25 149.18 4.96 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.97 -139.71 10.9 Favored Glycine 0 N--CA 1.403 -3.515 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.198 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.951 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 44.8 Cg_exo -53.16 142.07 56.61 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.65 2.9 . . . . 0.0 112.824 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 655' ' ' VAL . 27.7 Cg_endo -61.01 151.34 78.97 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 123.073 2.516 . . . . 0.0 112.207 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.526 ' HG2' HD21 ' A' ' 681' ' ' LEU . 9.6 Cg_endo -63.3 179.54 0.84 Allowed 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.12 2.546 . . . . 0.0 112.722 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.1 145.73 24.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.854 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.4 tt -86.84 138.16 31.8 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -33.26 -65.63 0.17 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 126.196 1.798 . . . . 0.0 113.212 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 0.2 OUTLIER -135.77 30.98 3.08 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 123.976 1.846 . . . . 0.0 108.798 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.771 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.7 -156.87 7.07 Favored Glycine 1 C--N 1.241 -4.727 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.489 173.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 640' ' ' ASN . 1.4 m120 -163.74 177.81 8.38 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.021 0.928 . . . . 0.0 109.965 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.49 140.16 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 123.241 0.616 . . . . 0.0 109.788 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -97.35 -11.98 23.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.077 0.465 . . . . 0.0 111.37 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.16 163.97 14.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.378 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -92.77 149.94 20.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.419 HG22 ' HD2' ' A' ' 633' ' ' PRO . 56.7 p -75.32 119.14 19.02 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.007 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -80.39 -20.71 43.4 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.951 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 65.51 -3.26 0.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.411 1.484 . . . . 0.0 114.993 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -148.93 95.06 2.35 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.419 ' HB2' ' SG ' ' A' ' 630' ' ' CYS . 16.6 m-85 -95.24 -68.84 0.78 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.212 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 111.7 -94.14 0.74 Allowed Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.408 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.5 t60 -148.17 142.96 26.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.897 0.349 . . . . 0.0 110.661 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 59.7 m 69.74 11.15 7.8 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.326 1.45 . . . . 0.0 113.262 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 9.6 mm-40 -77.04 127.75 33.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.6 t -104.45 141.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 123.758 0.661 . . . . 0.0 109.409 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 42.9 t -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 123.28 0.632 . . . . 0.0 109.543 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 32.2 tt0 -102.98 131.69 49.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 122.096 0.95 . . . . 0.0 112.354 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.854 ' HB3' HD12 ' A' ' 636' ' ' LEU . 63.4 m-85 -110.24 164.99 12.12 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.835 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -139.54 151.13 45.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 99.3 m -89.56 162.45 15.66 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.877 0.37 . . . . 0.0 111.311 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.92 158.72 12.03 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.265 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.29 1.11 0.73 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 124.302 3.334 . . . . 0.0 117.134 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.486 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 17.2 ptt-85 -131.98 -2.26 3.65 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.289 173.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -100.61 143.72 30.43 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.057 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.695 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.7 mp -100.8 140.14 35.5 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.561 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.57 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 50.9 tpp -69.63 113.74 7.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.416 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.621 ' HB3' ' HB ' ' A' ' 683' ' ' VAL . 28.3 tptp -101.65 -12.2 18.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.993 0.901 . . . . 0.0 109.499 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -98.62 -171.35 31.73 Favored Glycine 0 C--N 1.293 -1.833 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.416 -177.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 88.6 Cg_endo -80.93 -5.91 13.11 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.068 2.512 . . . . 0.0 111.515 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.514 ' H ' ' HB3' ' A' ' 682' ' ' PRO 0.259 2.3 p-10 57.82 -6.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.9 2.48 . . . . 0.0 115.764 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 656' ' ' GLU . 55.5 mtmt -130.92 141.84 50.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 118.283 0.492 . . . . 0.0 110.437 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.9 pt -131.76 169.87 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.897 -175.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.8 tt0 -137.08 140.7 42.16 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 122.843 0.457 . . . . 0.0 111.127 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 45.3 t -81.98 102.19 10.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.793 0.806 . . . . 0.0 109.689 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.99 170.16 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.73 70.95 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.841 1.256 . . . . 0.0 112.415 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 148.7 -30.81 1.25 Allowed Glycine 0 N--CA 1.405 -3.433 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.99 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.39 -177.53 3.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -86.13 174.95 8.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.579 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.3 p -89.38 -167.31 1.83 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.607 0.363 . . . . 0.0 111.419 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.4 m -65.54 112.21 3.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.044 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.3 mp -71.71 154.86 92.86 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.523 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.566 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 45.4 Cg_endo -68.09 175.95 6.0 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.433 2.089 . . . . 0.0 113.472 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 666' ' ' LYS . 50.5 t -129.06 151.08 35.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.606 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.4 m -132.11 123.71 27.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.66 141.64 45.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.4 p . . . . . 0 C--N 1.286 -2.169 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.269 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.2 p . . . . . 0 N--CA 1.408 -2.55 0 CA-C-O 121.421 0.629 . . . . 0.0 111.663 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 42.5 m -81.62 -24.44 36.39 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.158 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.99 41.47 3.29 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 113.2 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.626 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 30.4 t70 66.26 176.87 0.22 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.504 0.722 . . . . 0.0 112.498 176.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.677 HG12 HG11 ' A' ' 715' ' ' VAL . 2.8 mt -73.87 131.0 82.23 Favored Pre-proline 0 N--CA 1.416 -2.173 0 C-N-CA 123.942 0.897 . . . . 0.0 111.005 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 717' ' ' PHE . 74.1 Cg_endo -73.82 -179.61 4.75 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.943 2.429 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -119.67 116.63 26.38 Favored 'General case' 0 C--N 1.262 -3.221 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.248 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.78 HD23 ' HA3' ' A' ' 700' ' ' GLY . 47.3 tp -82.37 139.81 33.86 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -46.33 -37.3 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -135.78 22.97 3.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.076 0.465 . . . . 0.0 111.259 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.72 167.4 23.21 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.075 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -156.58 -152.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.113 1.365 . . . . 0.0 107.33 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.22 148.46 48.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -167.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.539 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.69 -42.36 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.946 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.57 160.47 35.2 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.718 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 5.6 m -148.35 117.62 6.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 59.1 m -116.1 98.4 51.2 Favored Pre-proline 0 C--N 1.28 -2.446 0 CA-C-O 121.397 0.617 . . . . 0.0 110.795 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.483 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.5 Cg_endo -93.6 151.83 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.584 0 C-N-CA 122.349 2.033 . . . . 0.0 111.389 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 71.4 Cg_endo -72.97 133.2 29.33 Favored 'Cis proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.122 -1.616 . . . . 0.0 111.444 0.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.626 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 30.9 m-85 -72.74 96.8 2.09 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.486 ' CD2' ' HB2' ' A' ' 662' ' ' ARG . 3.4 m-85 -99.42 175.09 5.97 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.695 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 6.3 t80 -62.1 141.38 58.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.75 71.83 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.685 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.43 169.6 17.95 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -134.02 149.61 51.19 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 110.384 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.677 HG11 HG12 ' A' ' 694' ' ' ILE . 43.7 t -137.9 142.21 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.593 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.81 120.31 41.9 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.496 ' CE1' HG23 ' A' ' 694' ' ' ILE . 1.9 m-85 -96.43 149.66 21.47 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 124.408 1.083 . . . . 0.0 110.36 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 53.1 t30 -136.4 152.3 50.47 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 46.6 t -91.86 166.31 12.8 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 48.5 t -58.42 157.59 8.6 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.254 0.549 . . . . 0.0 109.811 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.79 -35.87 82.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.506 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 15.1 m -90.82 5.42 48.48 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.204 0.525 . . . . 0.0 111.804 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -128.62 158.18 39.21 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.5 t -117.04 145.27 43.82 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.8 ptm -101.8 151.44 22.05 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.407 0.623 . . . . 0.0 110.797 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.0 mt -131.2 127.86 61.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.79 -153.46 16.63 Favored Glycine 0 CA--C 1.472 -2.614 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -98.75 119.01 36.78 Favored 'General case' 0 CA--C 1.465 -2.297 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.919 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -65.53 -27.38 68.41 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.178 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.6 p -107.91 147.73 30.59 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.344 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -127.35 163.41 30.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.324 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 56.7 m -134.62 136.73 43.11 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.49 114.29 15.05 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.466 0.65 . . . . 0.0 111.432 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.04 97.53 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.914 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 68.05 34.14 4.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.735 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 101.19 -15.21 57.99 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.405 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.77 133.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.491 ' CG ' HD12 ' A' ' 731' ' ' ILE . 88.3 m95 -72.35 152.76 41.87 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.2 p -37.43 -66.54 0.24 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -31.01 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 731' ' ' ILE . 21.4 mt 66.09 148.75 0.11 Allowed Pre-proline 0 C--N 1.316 -0.855 0 O-C-N 124.796 1.31 . . . . 0.0 110.992 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.13 -172.13 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.812 1.675 . . . . 0.0 110.089 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 725' ' ' MET . 10.5 pt20 -136.94 145.07 43.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 88.2 m -102.32 153.77 19.68 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.6 144.33 27.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.82 120.7 12.4 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 123.707 0.629 . . . . 0.0 111.199 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.252 1.235 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.165 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.532 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 8.0 p . . . . . 0 N--CA 1.445 -0.685 0 N-CA-C 110.207 -0.294 . . . . 0.0 110.207 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 28.6 p -175.91 146.36 0.71 Allowed 'General case' 0 C--O 1.253 1.238 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.62 -132.3 7.63 Favored Glycine 0 N--CA 1.414 -2.781 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.69 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.949 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 52.9 Cg_exo -53.77 140.34 67.37 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 124.002 3.135 . . . . 0.0 113.12 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.672 ' HD2' HG22 ' A' ' 645' ' ' THR . 21.7 Cg_endo -61.97 154.24 63.14 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.575 2.183 . . . . 0.0 111.093 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD11 ' A' ' 681' ' ' LEU . 14.6 Cg_endo -68.02 -168.81 0.21 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 122.517 2.145 . . . . 0.0 111.872 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.08 162.44 13.37 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.538 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.685 HD13 ' HG2' ' A' ' 682' ' ' PRO . 28.8 tp -101.19 138.18 38.56 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.46 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.5 tm? -27.75 -64.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.584 2.353 . . . . 0.0 111.731 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -117.36 -40.9 3.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.874 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -79.18 -128.77 0.6 Allowed Glycine 0 CA--C 1.504 -0.627 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.599 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -173.53 -175.6 1.15 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.0 p -99.5 144.64 11.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.5 ptpt -99.7 -16.72 18.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.122 0.487 . . . . 0.0 111.123 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 145.11 24.94 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.38 152.08 27.65 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-O 121.833 0.825 . . . . 0.0 112.543 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.672 HG22 ' HD2' ' A' ' 633' ' ' PRO . 39.9 p -73.65 118.16 16.27 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.679 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -83.79 -22.78 31.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.001 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.949 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 32.0 mt-10 63.69 18.28 11.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.672 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -157.97 101.29 1.77 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.676 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 34.7 m-85 -117.45 -73.48 0.64 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.268 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.08 -88.57 0.65 Allowed Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.739 -1.22 . . . . 0.0 113.885 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -146.61 142.38 27.88 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.22 0.51 . . . . 0.0 110.793 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.3 p 68.18 11.5 8.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.884 1.674 . . . . 0.0 113.102 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 39.0 mm-40 -78.86 129.16 34.26 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.604 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.9 OUTLIER -120.11 131.14 73.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 112.111 -176.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 67.4 t -121.41 137.9 53.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.195 -171.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . 0.47 ' HG3' HD22 ' A' ' 669' ' ' ASN . 32.8 tt0 -104.37 134.03 48.27 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 122.508 1.147 . . . . 0.0 112.269 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.0 m-85 -109.9 164.06 12.95 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.158 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 48.9 p90 -137.97 145.72 42.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.488 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 96.3 m -91.5 153.4 19.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 639' ' ' GLY . 4.2 m-20 -51.6 156.79 2.09 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.015 177.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.4 12.19 0.41 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 123.646 2.897 . . . . 0.0 112.801 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.642 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 40.4 ptt180 -133.35 0.34 3.35 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.793 0.806 . . . . 0.0 111.573 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 31.4 m-85 -125.03 150.6 46.59 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.57 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.736 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 5.9 mp -103.36 139.91 38.14 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.235 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.546 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.0 tpp -73.93 117.25 15.49 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.782 0.676 . . . . 0.0 109.206 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -101.27 -32.7 10.38 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.6 -174.98 48.84 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 114.981 -1.009 . . . . 0.0 114.1 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.36 -8.67 23.84 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 124.065 3.177 . . . . 0.0 112.854 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.546 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.0 p-10 58.48 -0.95 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.081 2.153 . . . . 0.0 115.358 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.8 mtmt -136.74 138.41 40.92 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.986 0.357 . . . . 0.0 110.495 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.468 HG21 HD13 ' A' ' 681' ' ' LEU . 44.6 pt -126.13 171.59 14.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.54 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -143.77 141.14 30.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 122.701 0.4 . . . . 0.0 109.994 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 41.4 t -85.71 105.1 16.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.32 -171.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.0 p-10 -77.24 84.96 3.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.861 1.315 . . . . 0.0 111.614 179.342 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.01 0.31 Allowed Glycine 0 N--CA 1.4 -3.744 0 CA-C-N 111.872 -2.422 . . . . 0.0 108.343 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.62 -172.97 4.37 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.6 m95 -78.42 159.68 28.16 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 41.1 p -75.82 -168.0 0.81 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.504 0.721 . . . . 0.0 112.236 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 91.8 m -77.26 116.85 18.23 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.446 0.641 . . . . 0.0 111.502 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.3 mm? -58.09 145.38 73.33 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.689 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.685 ' HG2' HD13 ' A' ' 636' ' ' LEU . 30.1 Cg_endo -70.31 -172.95 0.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.44 2.093 . . . . 0.0 112.503 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.26 142.41 35.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 70.8 m -115.78 133.01 56.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.43 139.65 51.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 123.372 0.42 . . . . 0.0 109.939 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.7 p . . . . . 0 C--N 1.29 -1.987 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 47.9 p . . . . . 0 N--CA 1.429 -1.513 0 CA-C-O 120.937 0.399 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.5 m -90.86 -3.1 57.63 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.644 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 92.32 -68.94 1.84 Allowed Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.887 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.5 t70 -177.51 -167.29 0.15 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -70.1 130.86 89.29 Favored Pre-proline 0 N--CA 1.413 -2.309 0 O-C-N 123.483 0.489 . . . . 0.0 110.482 174.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.558 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.9 Cg_endo -75.22 -176.37 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.42 2.747 . . . . 0.0 111.879 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -104.87 125.6 51.06 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.882 HD23 ' HA3' ' A' ' 700' ' ' GLY . 21.2 tp -104.05 136.27 44.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -52.17 -34.96 47.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 84.8 m-70 -139.79 22.33 2.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.728 0.775 . . . . 0.0 110.552 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.882 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.24 173.38 20.4 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.205 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -157.54 -154.25 0.44 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.912 1.685 . . . . 0.0 106.845 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -141.13 158.16 44.29 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.983 -168.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.548 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -98.92 -56.75 2.34 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -118.96 151.64 37.81 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.0 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.0 p -123.43 160.83 26.02 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.6 t -150.41 86.82 5.02 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-O 121.496 0.665 . . . . 0.0 109.74 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.562 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 12.5 Cg_endo -97.64 151.05 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.432 2.755 . . . . 0.0 113.374 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 58.2 Cg_endo -69.36 135.27 32.17 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.048 -1.647 . . . . 0.0 111.236 -0.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.0 m-85 -77.73 73.17 4.3 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.535 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.642 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 29.8 m-85 -84.36 176.97 8.34 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.736 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 20.3 t80 -62.69 139.0 58.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.971 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.37 54.88 Favored Glycine 0 C--N 1.296 -1.671 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.955 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.8 171.13 15.43 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.9 m -137.1 155.84 49.12 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.475 0.655 . . . . 0.0 110.626 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 694' ' ' ILE . 36.2 t -141.33 144.86 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.068 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.1 mt-10 -109.9 128.17 55.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.376 0.607 . . . . 0.0 110.482 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.3 m-85 -101.07 157.12 17.0 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.334 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.548 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 66.6 t30 -147.86 141.89 25.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.6 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.9 m -87.65 157.33 19.13 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.6 m -51.7 157.29 1.18 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.437 0.46 . . . . 0.0 110.858 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.83 -29.42 69.48 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -169.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 47.3 m -89.18 6.71 38.87 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 121.603 -0.686 . . . . 0.0 111.238 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -126.3 151.26 47.75 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . 0.436 ' HB ' HD11 ' A' ' 747' ' ' ILE . 11.1 t -119.79 145.92 46.16 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.639 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 6.5 ptm -93.3 147.28 23.06 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.337 0.589 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 44.5 mt -119.75 127.57 75.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.37 -139.96 15.9 Favored Glycine 0 CA--C 1.479 -2.209 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -109.62 129.8 55.56 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.248 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -65.8 -29.49 69.99 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.277 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -107.98 149.18 28.7 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.698 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 741' ' ' LEU . 7.2 pt -126.42 170.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.339 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 91.7 m -139.28 138.17 36.51 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.7 106.18 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.53 0.519 . . . . 0.0 109.649 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.52 115.82 47.13 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.619 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . 0.4 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 42.2 m-70 60.96 19.49 9.89 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.813 1.245 . . . . 0.0 113.242 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.74 8.0 54.87 Favored Glycine 0 C--N 1.31 -0.908 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.06 139.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.558 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.6 m95 -66.14 147.63 53.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -34.91 -71.88 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -27.9 0.05 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 731' ' ' ILE . 19.6 mt 68.22 151.26 0.12 Allowed Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 124.51 1.131 . . . . 0.0 111.799 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.639 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 62.5 Cg_endo -80.11 -173.29 1.8 Allowed 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 122.638 2.226 . . . . 0.0 111.74 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . 0.553 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 23.6 pt20 -128.88 128.23 43.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 13.8 m -90.68 141.01 29.23 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.783 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.25 147.78 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.11 121.04 21.45 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.232 0.333 . . . . 0.0 111.214 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . 0.436 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.1 mt . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 629' ' ' SER . . . . . 0.567 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.7 m . . . . . 0 N--CA 1.436 -1.154 0 CA-C-O 120.813 0.339 . . . . 0.0 110.794 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 22.4 p -96.24 162.74 13.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.26 -136.11 8.95 Favored Glycine 0 N--CA 1.407 -3.266 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 632' ' ' PRO . . . . . 0.841 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 33.6 Cg_exo -58.63 147.03 89.37 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.485 2.79 . . . . 0.0 112.607 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 633' ' ' PRO . . . . . 0.657 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.6 Cg_endo -62.07 158.8 37.25 Favored 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 123.408 2.738 . . . . 0.0 112.512 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 634' ' ' PRO . . . . . 0.587 ' HG2' HD21 ' A' ' 681' ' ' LEU . 22.0 Cg_endo -67.0 -156.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.608 2.872 . . . . 0.0 111.462 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -122.58 166.0 15.54 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.221 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.9 tp -103.57 141.74 35.49 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 638' ' ' ASN . 2.2 tm? -40.83 -67.26 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.013 1.446 . . . . 0.0 110.991 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 638' ' ' ASN . . . . . 0.501 HD22 ' HB2' ' A' ' 660' ' ' ASN . 1.3 t30 -129.13 52.5 1.96 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.16 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 639' ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -176.16 -158.1 18.93 Favored Glycine 1 C--N 1.249 -4.256 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -167.86 -168.99 1.07 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.742 1.271 . . . . 0.0 112.027 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 641' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 643' ' ' GLU . 68.0 t -92.61 132.77 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.299 1.44 . . . . 0.0 110.022 -175.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 642' ' ' LYS . . . . . 0.469 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.9 ptpt -104.05 -1.88 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.282 1.039 . . . . 0.0 109.222 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 643' ' ' GLU . . . . . 0.414 ' H ' HG12 ' A' ' 641' ' ' VAL . 10.7 mm-40 -90.61 173.9 7.8 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.247 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -104.03 147.12 27.76 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.151 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 645' ' ' THR . . . . . 0.657 HG22 ' HD2' ' A' ' 633' ' ' PRO . 40.1 p -80.83 117.06 21.16 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.634 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -83.27 -25.97 31.11 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.637 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 647' ' ' GLU . . . . . 0.841 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 44.3 mt-10 73.01 -7.18 1.54 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.843 1.257 . . . . 0.0 113.579 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -145.73 100.73 3.46 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 649' ' ' TYR . . . . . 0.764 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 13.6 m-85 -94.74 -70.0 0.73 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.763 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 650' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.7 -111.13 1.78 Allowed Glycine 0 C--N 1.312 -0.789 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.878 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.8 t60 -142.57 135.11 27.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.546 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.8 m 76.33 15.53 2.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.66 1.184 . . . . 0.0 111.88 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 653' ' ' GLU . . . . . 0.764 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 54.9 mm-40 -80.7 135.13 35.96 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.819 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 654' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -114.66 151.16 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 655' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 633' ' ' PRO . 48.0 t -131.92 135.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.177 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -103.13 130.15 50.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.519 0.676 . . . . 0.0 110.785 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 657' ' ' TYR . . . . . 0.592 ' HB3' HD22 ' A' ' 636' ' ' LEU . 71.0 m-85 -106.77 161.4 14.7 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.844 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 658' ' ' TYR . . . . . 0.469 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 53.8 p90 -136.63 152.17 50.13 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 659' ' ' CYS . . . . . 0.623 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.2 m -97.95 169.13 9.85 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 660' ' ' ASN . . . . . 0.501 ' HB2' HD22 ' A' ' 638' ' ' ASN . 0.2 OUTLIER -58.41 157.58 17.48 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 661' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 66.0 Cg_endo -72.04 7.6 1.66 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.778 2.985 . . . . 0.0 113.84 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 662' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 15.7 ptt180 -120.0 -9.58 9.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.766 0.793 . . . . 0.0 110.049 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 41.9 m-85 -119.93 161.34 21.05 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 664' ' ' LEU . . . . . 0.738 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.318 0.0 OUTLIER -130.26 141.35 50.63 Favored 'General case' 0 C--N 1.256 -3.493 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.732 179.895 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild core ' A' A ' 665' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.7 tpp -61.65 124.54 20.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.171 -177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 63.5 tttm -106.35 -49.77 3.28 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.18 -163.52 39.02 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.951 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.87 105.27 2.05 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.601 2.2 . . . . 0.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 669' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.7 p-10 -72.49 4.99 3.28 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.199 -173.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 670' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 41.2 mtmt -132.27 128.98 38.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 671' ' ' ILE . . . . . 0.583 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -118.72 166.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 672' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 33.1 tt0 -134.52 137.61 44.0 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 123.657 0.598 . . . . 0.0 110.606 -175.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.47 110.18 17.97 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.955 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.96 -168.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.8 p-10 -82.78 78.87 9.32 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.849 1.309 . . . . 0.0 111.66 -178.081 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 146.45 -45.3 0.8 Allowed Glycine 0 N--CA 1.401 -3.668 0 CA-C-N 113.177 -1.829 . . . . 0.0 111.708 170.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.66 -168.78 3.0 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -102.0 168.4 9.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.7 p -78.67 -170.21 2.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.723 0.297 . . . . 0.0 111.194 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.1 m -71.14 112.56 7.38 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 121.267 0.556 . . . . 0.0 110.215 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 681' ' ' LEU . . . . . 0.587 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.5 mp -68.98 153.48 96.06 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.884 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 75.7 Cg_endo -73.19 -176.35 2.4 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.031 2.487 . . . . 0.0 112.442 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 11.2 p -145.27 146.65 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 684' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 636' ' ' LEU . 63.7 m -114.29 138.54 50.38 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 685' ' ' ILE . . . . . 0.44 HD13 ' HD2' ' A' ' 666' ' ' LYS . 21.9 pt -130.17 146.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 686' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 662' ' ' ARG . 9.1 p . . . . . 0 C--N 1.294 -1.805 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p . . . . . 0 N--CA 1.432 -1.354 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 26.2 m -93.21 -4.5 51.88 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.912 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 104.07 -90.21 0.72 Allowed Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 693' ' ' ASP . . . . . 0.476 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 p-10 -168.65 -172.89 1.75 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.476 1.11 . . . . 0.0 108.107 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 694' ' ' ILE . . . . . 0.627 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -64.87 126.73 91.67 Favored Pre-proline 0 N--CA 1.434 -1.258 0 CA-C-O 121.555 0.693 . . . . 0.0 112.559 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 695' ' ' PRO . . . . . 0.546 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 50.6 Cg_endo -71.28 -174.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.511 2.807 . . . . 0.0 112.065 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -108.44 113.87 27.26 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.297 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 697' ' ' LEU . . . . . 0.915 HD23 ' HA3' ' A' ' 700' ' ' GLY . 20.3 tp -92.04 135.83 33.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.0 -34.37 69.94 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -137.0 18.41 3.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.856 0.836 . . . . 0.0 110.376 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 700' ' ' GLY . . . . . 0.915 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -127.32 176.33 17.88 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.746 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -158.33 -154.41 0.43 Allowed 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 702' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.79 156.09 47.64 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 118.819 0.736 . . . . 0.0 112.611 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 703' ' ' GLN . . . . . 0.526 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.37 -59.3 1.86 Allowed 'General case' 0 CA--C 1.496 -1.131 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.494 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 704' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.3 pp -114.6 127.71 55.93 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 694' ' ' ILE . 1.8 p -106.38 124.06 49.02 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.569 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.4 p -125.67 90.78 49.86 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 707' ' ' PRO . . . . . 0.46 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 5.9 Cg_endo -90.74 150.35 4.11 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.644 2.229 . . . . 0.0 111.657 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 708' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.1 Cg_endo -74.31 134.05 33.91 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.639 -1.817 . . . . 0.0 110.995 -1.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 709' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.2 m-85 -77.7 82.51 4.1 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 710' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 5.9 m-30 -87.46 166.53 14.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.257 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 711' ' ' TYR . . . . . 0.738 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 3.3 t80 -61.13 135.99 57.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.06 -22.28 41.66 Favored Glycine 0 C--N 1.296 -1.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.504 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.69 163.62 27.5 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 117.817 0.808 . . . . 0.0 109.095 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.3 m -136.41 147.91 47.51 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.122 0.487 . . . . 0.0 110.144 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 715' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 730' ' ' SER . 33.6 t -130.59 140.46 48.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.911 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 716' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.2 mt-10 -102.33 128.27 48.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.164 0.506 . . . . 0.0 111.029 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 717' ' ' PHE . . . . . 0.627 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -98.45 158.46 15.57 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 124.717 1.207 . . . . 0.0 109.707 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 718' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 4.0 t-20 -144.61 145.16 31.64 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 719' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 96.9 m -96.25 158.06 15.61 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -57.28 150.9 16.99 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.47 -39.46 61.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -172.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.8 t -78.39 1.83 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.668 0.747 . . . . 0.0 111.149 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 723' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 80.3 m-85 -123.59 147.96 46.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -114.43 143.0 45.64 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 725' ' ' MET . . . . . 0.522 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.2 ptm -92.74 141.89 27.95 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.483 0.659 . . . . 0.0 110.489 -176.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 44.3 mt -114.81 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 123.53 -155.77 17.66 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.031 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -95.34 136.66 35.42 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 122.283 1.039 . . . . 0.0 108.407 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -70.32 -37.1 74.65 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.291 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 730' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.5 p -102.33 138.36 39.36 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-O 122.168 0.985 . . . . 0.0 113.368 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 731' ' ' ILE . . . . . 0.781 HG21 HD23 ' A' ' 741' ' ' LEU . 10.9 pt -115.97 167.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.3 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 44.0 m -134.02 137.33 44.65 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.32 103.94 1.38 Allowed 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.882 0.739 . . . . 0.0 109.778 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.9 mm -128.49 110.59 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.084 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 68.63 21.4 7.95 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.73 18.93 39.05 Favored Glycine 0 N--CA 1.434 -1.433 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.365 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.15 154.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 738' ' ' TRP . . . . . 0.546 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.6 m95 -76.21 169.72 17.67 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 739' ' ' THR . . . . . 0.598 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 9.2 p -49.98 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 740' ' ' GLN . . . . . 0.598 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -161.54 -30.67 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.066 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 741' ' ' LEU . . . . . 0.781 HD23 HG21 ' A' ' 731' ' ' ILE . 22.2 mt 70.79 153.58 0.15 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.685 1.24 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 742' ' ' PRO . . . . . 0.522 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 73.4 Cg_endo -81.8 -166.41 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.622 0 C-N-CA 121.927 1.751 . . . . 0.0 110.034 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.71 147.25 38.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 744' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 8.8 m -104.21 143.83 32.42 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.89 137.16 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.35 117.09 6.16 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 110.387 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.311 -1.091 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.523 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.633 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -95.29 82.28 3.71 Favored 'General case' 0 N--CA 1.421 -1.89 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 176.672 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -65.1 -45.03 86.86 Favored 'General case' 0 C--N 1.314 -0.966 0 CA-C-N 115.571 -0.74 . . . . 0.0 112.613 -177.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -150.47 18.53 0.83 Allowed 'General case' 0 C--N 1.289 -2.041 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -68.38 98.12 0.81 Allowed 'General case' 0 N--CA 1.435 -1.2 0 N-CA-C 115.671 1.73 . . . . 0.0 115.671 -169.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -90.8 -27.12 20.41 Favored Glycine 0 C--N 1.302 -1.343 0 N-CA-C 105.668 -2.973 . . . . 0.0 105.668 163.326 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.515 HG23 ' HB2' ' A' ' 651' ' ' HIS 0.305 13.8 p 43.89 76.8 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.35 0.619 0 C-N-CA 127.231 2.213 . . . . 0.0 115.402 172.99 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.484 ' CD ' ' H ' ' A' ' 629' ' ' SER . 0.2 OUTLIER -66.54 -90.12 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.481 0 CA-C-N 114.448 -1.251 . . . . 0.0 110.47 172.381 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.484 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 15.8 p 166.48 133.9 0.01 OUTLIER 'General case' 0 C--N 1.348 0.505 0 C-N-CA 125.963 1.705 . . . . 0.0 109.584 175.135 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 30.5 p -137.83 142.11 40.79 Favored 'General case' 0 C--O 1.257 1.456 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 176.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.614 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -94.6 -134.16 7.38 Favored Glycine 0 N--CA 1.416 -2.634 0 N-CA-C 111.534 -0.627 . . . . 0.0 111.534 178.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.777 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 78.2 Cg_exo -53.56 146.54 42.64 Favored 'Trans proline' 0 C--O 1.242 0.691 0 C-N-CA 123.818 3.012 . . . . 0.0 113.162 179.321 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.499 ' HD2' HG22 ' A' ' 645' ' ' THR . 31.3 Cg_endo -65.71 158.07 55.44 Favored 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 122.537 2.158 . . . . 0.0 111.421 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.559 ' HG2' HD21 ' A' ' 681' ' ' LEU . 25.0 Cg_endo -71.79 -169.24 0.42 Allowed 'Trans proline' 0 C--O 1.25 1.092 0 C-N-CA 122.96 2.44 . . . . 0.0 112.054 178.178 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -108.86 146.73 33.23 Favored 'General case' 0 C--N 1.305 -1.359 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.692 HD13 ' HA3' ' A' ' 639' ' ' GLY . 2.9 tt -81.97 141.49 33.24 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 105.528 -2.027 . . . . 0.0 105.528 175.692 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -33.28 -69.83 0.08 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 125.859 1.663 . . . . 0.0 111.142 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.489 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 3.1 t30 -108.81 -38.32 5.65 Favored 'General case' 0 N--CA 1.441 -0.895 0 C-N-CA 119.011 -1.075 . . . . 0.0 109.924 -178.616 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.692 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -76.42 -151.28 3.71 Favored Glycine 0 N--CA 1.443 -0.841 0 CA-C-N 115.128 -0.942 . . . . 0.0 113.166 -179.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -169.28 179.51 3.91 Favored 'General case' 0 C--O 1.215 -0.742 0 C-N-CA 120.792 -0.363 . . . . 0.0 110.681 -179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.483 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.9 p -98.92 142.6 14.57 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.627 0 C-N-CA 123.312 0.645 . . . . 0.0 110.006 -175.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.428 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.4 ptpt -97.01 -27.46 14.6 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-O 121.071 0.463 . . . . 0.0 110.777 -178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.5 mt-10 -79.29 142.62 35.97 Favored 'General case' 0 N--CA 1.433 -1.297 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.637 -178.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.8 mmmt -83.56 159.47 21.65 Favored 'General case' 0 C--N 1.294 -1.825 0 CA-C-O 121.398 0.618 . . . . 0.0 111.003 -175.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.499 HG22 ' HD2' ' A' ' 633' ' ' PRO . 21.3 p -73.42 122.81 22.7 Favored 'General case' 0 N--CA 1.413 -2.28 0 CA-C-N 115.159 -0.928 . . . . 0.0 112.759 -174.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 43.3 mtmt -96.76 -29.27 13.86 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 175.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.777 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 40.8 mt-10 71.47 -26.2 0.17 Allowed 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 125.984 1.714 . . . . 0.0 113.041 -179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 -95.17 42.21 1.09 Allowed 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 123.041 0.536 . . . . 0.0 110.987 -178.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.437 ' CA ' ' HG3' ' A' ' 653' ' ' GLU . 80.0 m-85 -69.85 -73.44 0.16 Allowed 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 92.74 -68.09 1.81 Allowed Glycine 0 C--N 1.293 -1.809 0 C-N-CA 120.387 -0.911 . . . . 0.0 114.499 171.464 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.515 ' HB2' HG23 ' A' ' 627' ' ' VAL . 86.4 t60 -161.51 138.57 8.64 Favored 'General case' 0 N--CA 1.447 -0.585 0 CA-C-N 117.196 0.498 . . . . 0.0 112.168 -176.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 26.1 m 63.9 13.86 7.92 Favored 'General case' 0 N--CA 1.469 0.483 0 C-N-CA 125.904 1.681 . . . . 0.0 113.282 176.155 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.589 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 8.6 mm-40 -78.54 136.29 37.52 Favored 'General case' 0 C--N 1.309 -1.168 0 CA-C-N 114.757 -1.11 . . . . 0.0 109.426 177.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.595 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.8 t -110.46 143.28 20.73 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 -177.15 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.503 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 56.7 t -132.26 135.76 57.54 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.221 0 C-N-CA 123.259 0.624 . . . . 0.0 109.866 -179.277 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -102.92 132.48 49.12 Favored 'General case' 0 N--CA 1.427 -1.602 0 CA-C-O 122.174 0.987 . . . . 0.0 111.783 179.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.686 ' HB3' HD12 ' A' ' 636' ' ' LEU . 41.7 m-85 -108.52 166.74 10.56 Favored 'General case' 0 C--N 1.297 -1.689 0 CA-C-N 114.701 -1.136 . . . . 0.0 110.596 178.61 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.428 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 45.6 p90 -137.13 160.09 39.98 Favored 'General case' 0 C--N 1.31 -1.15 0 N-CA-C 107.175 -1.417 . . . . 0.0 107.175 176.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.52 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 69.6 m -98.31 169.36 9.62 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 120.15 -0.62 . . . . 0.0 111.653 174.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.49 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.2 OUTLIER -58.53 165.27 3.14 Favored Pre-proline 0 C--O 1.2 -1.539 0 C-N-CA 124.329 1.052 . . . . 0.0 109.367 -179.78 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.49 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 72.6 Cg_endo -75.59 12.88 1.26 Allowed 'Trans proline' 0 CA--C 1.548 1.184 0 C-N-CA 122.749 2.299 . . . . 0.0 112.577 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.491 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 25.4 ptt180 -144.21 10.6 1.5 Allowed 'General case' 0 C--N 1.306 -1.324 0 CA-C-O 121.896 0.855 . . . . 0.0 110.041 179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.491 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 45.5 m-85 -134.81 138.22 44.06 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.202 177.099 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.566 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 11.3 mt -104.28 154.75 19.42 Favored 'General case' 0 C--N 1.277 -2.571 0 CA-C-O 121.332 0.586 . . . . 0.0 110.048 -178.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.52 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 55.0 tpp -73.52 124.61 26.2 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.564 -1.198 . . . . 0.0 111.022 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 56.4 tptt -110.82 -25.76 9.71 Favored 'General case' 0 C--N 1.304 -1.395 0 CA-C-N 115.652 -0.704 . . . . 0.0 109.969 177.909 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -89.05 -172.92 46.35 Favored Glycine 0 C--N 1.311 -0.834 0 CA-C-N 115.489 -0.778 . . . . 0.0 113.45 -175.74 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_endo -72.43 -9.76 24.58 Favored 'Trans proline' 0 C--N 1.359 1.112 0 C-N-CA 123.377 2.718 . . . . 0.0 112.345 -179.304 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.503 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 2.2 p-10 55.96 -0.25 0.05 OUTLIER 'General case' 0 N--CA 1.497 1.895 0 C-N-CA 127.6 2.36 . . . . 0.0 115.947 178.328 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.503 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 31.8 mtmt -130.24 144.36 51.32 Favored 'General case' 0 C--N 1.294 -1.838 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.595 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 44.0 pt -136.11 167.64 24.16 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.26 0 O-C-N 123.425 0.453 . . . . 0.0 109.897 -177.268 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.589 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.8 tt0 -135.87 140.56 44.23 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 123.751 0.821 . . . . 0.0 110.461 -177.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.8 t -85.14 99.2 10.91 Favored 'General case' 0 C--N 1.303 -1.416 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.756 177.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -80.64 165.35 2.78 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.179 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 176.811 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.307 2.2 p30 -75.5 80.51 2.53 Favored 'General case' 0 N--CA 1.431 -1.401 0 C-N-CA 118.426 -1.31 . . . . 0.0 113.763 179.26 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 158.84 -40.26 0.5 Allowed Glycine 0 N--CA 1.419 -2.451 0 CA-C-N 114.225 -1.352 . . . . 0.0 110.249 174.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -165.12 175.76 9.09 Favored 'General case' 0 N--CA 1.439 -0.984 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.007 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 86.4 m95 -81.55 171.2 14.95 Favored 'General case' 0 C--N 1.297 -1.688 0 CA-C-N 115.925 -0.58 . . . . 0.0 109.691 176.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 23.0 p -82.89 -165.62 1.11 Allowed 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 120.59 0.234 . . . . 0.0 111.493 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 94.8 m -66.69 111.98 3.96 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 120.873 0.368 . . . . 0.0 110.824 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.559 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -69.52 154.4 94.87 Favored Pre-proline 0 N--CA 1.444 -0.773 0 CA-C-N 115.73 -0.668 . . . . 0.0 111.487 175.199 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.676 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 56.0 Cg_endo -69.62 -178.76 2.44 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.502 2.134 . . . . 0.0 114.444 179.374 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -131.7 145.85 34.38 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.206 0 N-CA-C 107.115 -1.439 . . . . 0.0 107.115 -178.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 86.7 m -123.13 127.85 49.27 Favored 'General case' 0 C--N 1.306 -1.312 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 178.964 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 34.4 pt -127.55 140.66 48.51 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.439 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -178.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.3 p -74.58 127.52 36.32 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.763 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.594 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -76.55 -24.6 53.59 Favored 'General case' 0 C--N 1.315 -0.903 0 CA-C-O 121.745 0.783 . . . . 0.0 109.946 179.501 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 23.8 tt0 61.69 46.28 7.25 Favored 'General case' 0 N--CA 1.442 -0.84 0 C-N-CA 125.524 1.53 . . . . 0.0 108.256 177.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.478 ' HB2' ' HG2' ' A' ' 687' ' ' GLU . 20.2 m -131.65 155.5 47.49 Favored 'General case' 0 C--N 1.312 -1.065 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.054 -177.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . 0.401 ' HA ' ' O ' ' A' ' 709' ' ' TYR . 18.7 p -127.05 154.9 44.08 Favored 'General case' 0 C--N 1.307 -1.245 0 CA-C-O 120.978 0.418 . . . . 0.0 111.9 -178.744 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 8.7 m -93.27 -2.75 54.67 Favored 'General case' 0 C--N 1.318 -0.796 0 N-CA-C 112.419 0.526 . . . . 0.0 112.419 175.258 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 99.2 -87.3 0.76 Allowed Glycine 0 CA--C 1.489 -1.579 0 N-CA-C 110.064 -1.215 . . . . 0.0 110.064 178.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.765 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.6 t70 -158.45 -167.56 2.2 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 176.318 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.618 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -73.63 133.17 80.12 Favored Pre-proline 0 N--CA 1.407 -2.615 0 C-N-CA 123.899 0.879 . . . . 0.0 109.998 175.427 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.591 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 66.9 Cg_endo -73.68 -164.89 0.22 Allowed 'Trans proline' 0 N--CA 1.447 -1.234 0 C-N-CA 123.248 2.632 . . . . 0.0 111.301 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -117.7 142.08 47.65 Favored 'General case' 0 C--N 1.273 -2.731 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 177.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 3.5 tt -117.09 137.46 52.26 Favored 'General case' 0 C--N 1.272 -2.777 0 N-CA-C 104.029 -2.582 . . . . 0.0 104.029 177.044 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.41 ' HG2' HD23 ' A' ' 697' ' ' LEU . 14.4 pt-20 -41.69 -40.01 1.84 Allowed 'General case' 0 N--CA 1.479 0.984 0 C-N-CA 125.038 1.335 . . . . 0.0 113.113 -176.188 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 97.1 m-70 -145.32 29.38 1.16 Allowed 'General case' 0 C--O 1.242 0.684 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 -179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.567 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -133.3 170.38 22.28 Favored Glycine 0 N--CA 1.438 -1.197 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.567 -178.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.4 p-90 -158.54 -155.41 0.48 Allowed 'General case' 0 N--CA 1.421 -1.899 0 N-CA-C 106.435 -1.691 . . . . 0.0 106.435 -176.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -136.79 152.16 49.99 Favored 'General case' 0 C--N 1.286 -2.188 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 -167.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -92.44 -48.95 6.38 Favored 'General case' 0 N--CA 1.468 0.469 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.859 178.462 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.7 pp -124.83 152.92 43.33 Favored 'General case' 0 N--CA 1.439 -1.007 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.922 -176.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 12.4 p -147.88 124.17 10.89 Favored 'General case' 0 N--CA 1.422 -1.852 0 C-N-CA 124.319 1.048 . . . . 0.0 109.096 -178.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 9.4 t -131.78 92.0 31.8 Favored Pre-proline 0 C--N 1.289 -2.052 0 C-N-CA 119.805 -0.758 . . . . 0.0 110.601 178.523 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.415 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.7 Cg_endo -87.16 149.47 8.02 Favored 'Trans proline' 0 N--CA 1.437 -1.839 0 C-N-CA 122.634 2.223 . . . . 0.0 111.454 175.717 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.415 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 67.6 Cg_endo -74.82 132.94 29.17 Favored 'Cis proline' 0 CA--C 1.538 0.719 0 C-N-CA 123.133 -1.611 . . . . 0.0 112.493 0.272 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.765 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 46.6 m-85 -76.48 92.38 3.41 Favored 'General case' 0 C--N 1.315 -0.928 0 CA-C-N 115.386 -0.825 . . . . 0.0 109.035 -178.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.457 ' HA ' ' O ' ' A' ' 689' ' ' SER . 3.3 m-85 -79.68 166.72 21.54 Favored 'General case' 0 C--O 1.248 0.979 0 O-C-N 123.548 0.53 . . . . 0.0 111.656 179.899 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.594 ' HB3' ' HG3' ' A' ' 687' ' ' GLU . 3.6 t80 -66.91 135.28 53.59 Favored 'General case' 0 CA--C 1.494 -1.211 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 178.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -14.31 60.34 Favored Glycine 0 N--CA 1.402 -3.617 0 C-N-CA 118.61 -1.757 . . . . 0.0 111.95 178.587 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -82.66 166.22 19.34 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 117.502 0.651 . . . . 0.0 110.885 178.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 0.9 OUTLIER -127.62 158.24 38.06 Favored 'General case' 0 C--N 1.313 -0.999 0 CA-C-O 121.414 0.626 . . . . 0.0 111.157 -172.82 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.599 HG11 HG12 ' A' ' 694' ' ' ILE . 26.2 t -142.04 142.42 27.88 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-N 115.094 -0.957 . . . . 0.0 109.606 177.132 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 53.0 mt-10 -102.33 126.12 49.25 Favored 'General case' 0 C--O 1.257 1.461 0 CA-C-O 120.802 0.334 . . . . 0.0 110.102 175.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.618 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.6 m-85 -97.7 154.98 17.22 Favored 'General case' 0 C--N 1.295 -1.798 0 CA-C-N 115.667 -0.697 . . . . 0.0 109.929 175.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.544 HD22 ' N ' ' A' ' 719' ' ' CYS . 0.2 OUTLIER -137.23 135.74 37.49 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 -177.502 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.544 ' N ' HD22 ' A' ' 718' ' ' ASN . 95.6 m -93.48 144.24 25.54 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 110.57 -0.159 . . . . 0.0 110.57 177.816 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 63.1 m -56.68 161.77 2.62 Favored 'General case' 0 C--N 1.314 -0.969 0 N-CA-C 113.748 1.018 . . . . 0.0 113.748 -178.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.1 tp10 -58.91 140.37 55.49 Favored 'General case' 0 N--CA 1.425 -1.716 0 CA-C-N 115.285 -0.871 . . . . 0.0 108.762 176.01 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.7 m 79.12 -2.19 2.25 Favored 'General case' 0 C--N 1.306 -1.293 0 C-N-CA 125.962 1.705 . . . . 0.0 111.712 -176.936 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -116.56 140.17 49.67 Favored 'General case' 0 N--CA 1.429 -1.504 0 O-C-N 121.947 -0.471 . . . . 0.0 110.419 173.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.459 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 9.2 t -108.24 141.73 39.57 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 108.252 -1.018 . . . . 0.0 108.252 179.538 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.59 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -91.03 137.98 31.95 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.23 0.538 . . . . 0.0 110.7 -177.428 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 31.7 mt -123.49 115.0 44.06 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.807 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 176.886 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.06 -154.38 20.24 Favored Glycine 0 CA--C 1.472 -2.623 0 N-CA-C 111.136 -0.785 . . . . 0.0 111.136 -178.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.2 t-160 -94.63 130.2 41.19 Favored 'General case' 0 N--CA 1.42 -1.957 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 -176.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 6.6 ptp180 -63.19 -29.95 71.2 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 124.121 0.888 . . . . 0.0 111.624 178.995 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.447 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 6.0 p -113.95 152.9 30.18 Favored 'General case' 0 N--CA 1.408 -2.544 0 CA-C-O 121.602 0.715 . . . . 0.0 112.073 -175.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 741' ' ' LEU . 7.7 pt -127.73 167.27 23.03 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.874 0 CA-C-N 114.694 -1.139 . . . . 0.0 109.481 179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.427 ' H ' HG23 ' A' ' 739' ' ' THR . 82.9 m -133.49 135.92 44.76 Favored 'General case' 0 C--N 1.284 -2.24 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 179.606 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.7 t -67.29 109.04 2.96 Favored 'General case' 0 C--N 1.311 -1.083 0 C-N-CA 123.768 0.827 . . . . 0.0 110.471 178.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.6 mm -126.83 99.01 5.12 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.46 -176.555 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 66.56 30.07 8.65 Favored 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.525 1.13 . . . . 0.0 112.172 173.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 97.02 0.37 60.1 Favored Glycine 0 C--N 1.304 -1.222 0 CA-C-N 115.34 -0.845 . . . . 0.0 112.559 178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 38.4 t -133.39 143.61 38.54 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 N-CA-C 106.908 -1.516 . . . . 0.0 106.908 -178.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.591 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -78.3 166.05 23.14 Favored 'General case' 0 C--N 1.286 -2.19 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 176.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.427 HG23 ' H ' ' A' ' 732' ' ' THR . 38.0 p -48.67 -69.46 0.12 Allowed 'General case' 0 C--N 1.316 -0.886 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -174.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.19 -30.89 0.06 Allowed 'General case' 0 C--N 1.301 -1.542 0 N-CA-C 114.932 1.456 . . . . 0.0 114.932 -172.147 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 731' ' ' ILE . 20.2 mt 67.73 148.91 0.12 Allowed Pre-proline 0 C--N 1.319 -0.72 0 O-C-N 124.856 1.347 . . . . 0.0 111.564 -177.074 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.59 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 77.7 Cg_endo -80.77 175.28 10.17 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 122.016 1.811 . . . . 0.0 109.693 174.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 4.1 pt20 -121.88 134.93 54.87 Favored 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 178.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.662 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 4.4 m -102.47 122.72 44.88 Favored 'General case' 0 C--N 1.284 -2.27 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 -177.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.6 m -117.72 149.76 19.98 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 -176.319 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.55 112.62 4.22 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 124.161 0.913 . . . . 0.0 111.239 -178.764 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.413 HD11 ' HB ' ' A' ' 724' ' ' THR . 56.6 mt . . . . . 0 C--O 1.249 1.038 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 174.367 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 29.7 mm-40 . . . . . 0 C--O 1.244 0.779 0 CA-C-O 120.641 0.258 . . . . 0.0 111.603 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -134.84 24.45 3.64 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-O 121.686 0.755 . . . . 0.0 108.993 -178.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 2.6 mp0 -76.55 -20.94 56.33 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 114.957 -1.019 . . . . 0.0 111.305 -174.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -95.89 -49.58 5.25 Favored 'General case' 0 C--N 1.314 -0.975 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 176.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -162.68 142.1 9.12 Favored 'General case' 0 C--N 1.31 -1.139 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 177.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -91.0 -123.82 2.88 Favored Glycine 0 N--CA 1.426 -2.004 0 O-C-N 123.649 0.593 . . . . 0.0 112.007 -178.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.653 HG22 ' CD2' ' A' ' 651' ' ' HIS . 58.8 t 57.26 80.38 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.47 0.541 0 CA-C-O 122.46 1.124 . . . . 0.0 108.566 -172.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.522 ' OE1' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -82.39 -94.4 0.05 Allowed 'General case' 0 C--N 1.279 -2.491 0 CA-C-N 113.926 -1.488 . . . . 0.0 111.353 -177.334 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.1 p 173.08 152.76 0.08 Allowed 'General case' 0 C--N 1.312 -1.063 0 C-N-CA 123.89 0.876 . . . . 0.0 109.104 -176.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.6 p -168.61 152.38 5.63 Favored 'General case' 0 C--N 1.298 -1.641 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 177.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.16 -138.41 9.66 Favored Glycine 1 N--CA 1.392 -4.253 0 C-N-CA 120.413 -0.899 . . . . 0.0 111.422 177.002 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.472 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 51.0 Cg_exo -54.6 144.38 64.07 Favored 'Trans proline' 0 CA--C 1.539 0.766 0 C-N-CA 123.6 2.866 . . . . 0.0 112.891 -178.528 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.777 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.7 Cg_endo -61.51 162.68 20.16 Favored 'Trans proline' 0 CA--C 1.543 0.929 0 C-N-CA 123.269 2.646 . . . . 0.0 112.895 -178.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.528 ' HG2' HD21 ' A' ' 681' ' ' LEU . 32.2 Cg_endo -75.5 -165.42 0.29 Allowed 'Trans proline' 0 C--O 1.25 1.084 0 C-N-CA 122.548 2.165 . . . . 0.0 111.194 176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -109.44 174.69 5.75 Favored 'General case' 0 C--N 1.287 -2.136 0 N-CA-C 109.762 -0.458 . . . . 0.0 109.762 176.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.686 HD13 ' HG2' ' A' ' 682' ' ' PRO . 17.2 tp -109.36 144.55 37.39 Favored 'General case' 0 C--N 1.292 -1.901 0 CA-C-N 116.16 -0.473 . . . . 0.0 109.75 178.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.514 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -32.66 -59.78 0.32 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.547 1.939 . . . . 0.0 111.784 179.064 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.538 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.3 t30 -120.2 -44.75 2.48 Favored 'General case' 0 N--CA 1.417 -2.089 0 C-N-CA 118.917 -1.113 . . . . 0.0 109.316 -179.092 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.422 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -76.83 -152.79 4.89 Favored Glycine 0 CA--C 1.495 -1.19 0 CA-C-N 114.903 -1.044 . . . . 0.0 112.393 -179.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.481 ' HB3' ' CZ ' ' A' ' 658' ' ' TYR . 2.5 t-20 -156.86 -178.25 7.22 Favored 'General case' 0 C--N 1.29 -1.983 0 C-N-CA 118.364 -1.334 . . . . 0.0 110.152 -173.717 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 5.6 p -102.26 146.41 10.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.876 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 178.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 12.3 ptpt -111.0 -13.38 14.1 Favored 'General case' 0 C--N 1.309 -1.173 0 CA-C-O 121.836 0.827 . . . . 0.0 110.032 -179.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.489 ' HB2' HG13 ' A' ' 655' ' ' VAL . 15.6 mm-40 -79.89 134.94 36.33 Favored 'General case' 0 N--CA 1.423 -1.802 0 CA-C-N 114.657 -1.156 . . . . 0.0 111.635 -175.48 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.604 ' HE2' ' HA ' ' A' ' 644' ' ' LYS . 9.3 mmpt? -67.5 158.47 31.84 Favored 'General case' 0 C--N 1.316 -0.873 0 CA-C-N 114.876 -1.056 . . . . 0.0 108.842 178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.777 HG22 ' HD2' ' A' ' 633' ' ' PRO . 65.4 p -107.11 151.09 25.84 Favored 'General case' 0 C--N 1.284 -2.261 0 C-N-CA 119.897 -0.721 . . . . 0.0 112.318 -175.493 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 58.9 mtmt -99.5 -87.93 0.35 Allowed 'General case' 0 N--CA 1.421 -1.914 0 CA-C-N 115.453 -0.794 . . . . 0.0 108.933 173.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.472 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 12.1 pt-20 156.88 -36.21 0.0 OUTLIER 'General case' 0 C--O 1.202 -1.434 0 C-N-CA 125.713 1.605 . . . . 0.0 107.956 -176.014 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 72.8 mm-40 -126.07 107.87 10.83 Favored 'General case' 0 C--N 1.296 -1.754 0 N-CA-C 108.677 -0.86 . . . . 0.0 108.677 178.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.854 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 7.7 m-85 -101.73 -72.19 0.69 Allowed 'General case' 0 C--N 1.282 -2.347 0 CA-C-N 114.893 -1.049 . . . . 0.0 109.753 178.3 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 114.85 -105.49 1.5 Allowed Glycine 0 C--N 1.309 -0.93 0 C-N-CA 120.206 -0.997 . . . . 0.0 112.545 175.383 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.653 ' CD2' HG22 ' A' ' 627' ' ' VAL . 81.1 t60 -138.58 140.98 39.21 Favored 'General case' 0 C--N 1.311 -1.072 0 CA-C-N 116.644 0.222 . . . . 0.0 110.494 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 41.3 m 72.82 15.8 4.67 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 125.006 1.322 . . . . 0.0 112.987 174.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.854 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 14.5 mm-40 -75.11 133.92 41.42 Favored 'General case' 0 C--N 1.302 -1.463 0 N-CA-C 107.713 -1.218 . . . . 0.0 107.713 176.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.515 ' HA ' ' O ' ' A' ' 671' ' ' ILE 0.263 0.5 OUTLIER -125.91 134.28 66.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.576 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -174.824 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.577 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 53.7 t -125.14 143.38 38.92 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 124.136 0.974 . . . . 0.0 111.239 -172.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.462 ' HG3' ' ND2' ' A' ' 669' ' ' ASN . 30.2 tt0 -104.62 133.49 49.37 Favored 'General case' 0 N--CA 1.43 -1.442 0 CA-C-O 121.865 0.841 . . . . 0.0 111.461 -179.288 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.457 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 46.8 m-85 -105.48 166.58 10.34 Favored 'General case' 0 C--N 1.295 -1.783 0 CA-C-N 114.565 -1.198 . . . . 0.0 111.415 178.373 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.481 ' CZ ' ' HB3' ' A' ' 640' ' ' ASN . 49.7 p90 -138.95 144.46 39.01 Favored 'General case' 0 C--N 1.319 -0.755 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 176.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 60.4 m -102.46 151.04 22.76 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.127 0.489 . . . . 0.0 110.183 173.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.546 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 15.0 m120 -52.48 159.96 1.48 Allowed Pre-proline 0 C--N 1.305 -1.358 0 C-N-CA 126.268 1.827 . . . . 0.0 114.739 -177.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.415 ' HD2' ' HB3' ' A' ' 660' ' ' ASN . 56.6 Cg_endo -68.24 6.89 0.75 Allowed 'Trans proline' 0 N--CA 1.496 1.648 0 C-N-CA 124.008 3.139 . . . . 0.0 113.737 -178.111 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.404 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 18.7 ptt180 -140.54 -2.15 1.42 Allowed 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.642 0.734 . . . . 0.0 111.535 175.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.708 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 51.9 m-85 -116.62 122.8 45.65 Favored 'General case' 0 N--CA 1.419 -1.977 0 CA-C-N 115.375 -0.829 . . . . 0.0 110.405 178.624 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.507 ' O ' ' HA ' ' A' ' 684' ' ' CYS . 11.0 mt -85.73 142.05 29.28 Favored 'General case' 0 C--N 1.278 -2.503 0 CA-C-N 115.559 -0.746 . . . . 0.0 109.524 -176.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.449 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 35.8 ttm -77.96 110.34 12.8 Favored 'General case' 0 C--N 1.266 -3.061 0 CA-C-N 114.933 -1.031 . . . . 0.0 109.105 174.556 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.682 ' HD2' HD13 ' A' ' 685' ' ' ILE . 55.5 tttm -99.3 -39.04 8.62 Favored 'General case' 0 C--N 1.301 -1.507 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.018 -175.333 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.34 -153.56 9.04 Favored Glycine 0 CA--C 1.503 -0.669 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.806 -179.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.689 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 39.9 Cg_endo -70.07 -148.84 0.02 OUTLIER 'Trans proline' 0 CA--C 1.544 0.981 0 C-N-CA 122.229 1.953 . . . . 0.0 110.252 173.629 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.462 ' ND2' ' HG3' ' A' ' 656' ' ' GLU . 2.0 p-10 -166.39 -28.31 0.03 OUTLIER 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.888 -0.507 . . . . 0.0 110.096 -178.674 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.577 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 97.3 mttt -112.75 124.15 51.93 Favored 'General case' 0 N--CA 1.43 -1.46 0 CA-C-O 120.9 0.381 . . . . 0.0 110.166 176.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.667 HG21 HD23 ' A' ' 681' ' ' LEU . 44.5 pt -109.24 166.79 4.54 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.656 -179.343 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.578 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -137.78 141.57 40.89 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 123.052 0.541 . . . . 0.0 110.58 -176.225 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.9 t -79.51 93.47 5.43 Favored 'General case' 0 N--CA 1.422 -1.873 0 CA-C-O 122.224 1.011 . . . . 0.0 108.429 176.212 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 1.8 t -76.19 163.12 4.08 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.56 0 CA-C-N 114.024 -1.444 . . . . 0.0 108.232 177.756 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.522 ' HA ' ' OE1' ' A' ' 628' ' ' GLN . 6.0 p-10 -70.33 86.62 0.6 Allowed 'General case' 0 N--CA 1.439 -1.021 0 CA-C-O 122.901 1.334 . . . . 0.0 111.484 -178.725 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 149.64 -47.92 0.61 Allowed Glycine 0 N--CA 1.407 -3.284 0 CA-C-N 112.987 -1.915 . . . . 0.0 110.34 172.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -158.36 -179.79 8.42 Favored 'General case' 0 C--N 1.316 -0.861 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -178.375 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.1 m95 -78.4 166.77 22.25 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 177.525 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.5 p -76.98 -174.94 3.32 Favored 'General case' 0 C--N 1.298 -1.637 0 CA-C-O 120.998 0.428 . . . . 0.0 111.555 -178.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 29.6 m -69.94 120.02 15.03 Favored 'General case' 0 N--CA 1.416 -2.146 0 CA-C-O 121.919 0.866 . . . . 0.0 111.263 -177.658 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.667 HD23 HG21 ' A' ' 671' ' ' ILE . 82.8 mt -66.87 146.56 99.11 Favored Pre-proline 0 C--N 1.296 -1.739 0 CA-C-N 113.655 -1.611 . . . . 0.0 112.153 178.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.689 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 34.8 Cg_endo -67.79 -173.87 0.53 Allowed 'Trans proline' 0 CA--C 1.54 0.777 0 C-N-CA 123.051 2.501 . . . . 0.0 113.415 177.336 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.8 t -140.21 137.51 37.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.876 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -175.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.708 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 57.5 m -115.9 133.44 56.02 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 107.256 -1.386 . . . . 0.0 107.256 177.154 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.682 HD13 ' HD2' ' A' ' 666' ' ' LYS . 38.5 pt -130.27 136.57 58.35 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 C-N-CA 122.917 0.487 . . . . 0.0 110.127 -176.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p -82.86 109.83 17.18 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 C-N-CA 119.842 -0.743 . . . . 0.0 109.729 179.184 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.651 ' HG2' ' HB3' ' A' ' 711' ' ' TYR . 0.0 OUTLIER -64.29 -26.02 68.3 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.538 -0.756 . . . . 0.0 112.452 -179.544 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.577 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 21.3 tt0 71.81 25.7 3.13 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.094 1.358 . . . . 0.0 112.192 169.597 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 6.7 t -122.27 163.31 19.88 Favored 'General case' 0 C--N 1.304 -1.394 0 N-CA-C 108.188 -1.042 . . . . 0.0 108.188 -179.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 34.1 p -121.18 155.78 33.8 Favored 'General case' 0 N--CA 1.418 -2.055 0 C-N-CA 119.7 -0.8 . . . . 0.0 112.446 -176.593 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 27.7 m -99.89 -16.32 18.06 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.446 -177.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 109.55 -79.85 0.26 Allowed Glycine 0 N--CA 1.427 -1.961 0 CA-C-N 115.251 -0.886 . . . . 0.0 112.44 175.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.408 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 15.9 t70 -173.61 -169.2 0.49 Allowed 'General case' 0 C--O 1.25 1.085 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 -178.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.518 HG13 HG11 ' A' ' 715' ' ' VAL . 1.1 mp -67.75 138.35 93.15 Favored Pre-proline 0 C--N 1.285 -2.211 0 C-N-CA 124.141 0.976 . . . . 0.0 110.366 176.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.667 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -75.41 -165.74 0.31 Allowed 'Trans proline' 0 CA--C 1.539 0.738 0 C-N-CA 123.449 2.766 . . . . 0.0 111.659 176.247 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -123.73 122.05 37.07 Favored 'General case' 0 C--N 1.296 -1.759 0 O-C-N 121.739 -0.6 . . . . 0.0 110.046 179.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.703 HD23 ' HA3' ' A' ' 700' ' ' GLY . 31.6 tp -97.54 155.26 17.03 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 178.124 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.619 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 7.1 pt-20 -43.4 -40.9 3.93 Favored 'General case' 0 N--CA 1.485 1.305 0 C-N-CA 124.551 1.14 . . . . 0.0 112.188 176.842 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.619 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 20.9 m80 -136.25 -40.78 0.65 Allowed 'General case' 0 N--CA 1.416 -2.14 0 CA-C-N 114.903 -1.044 . . . . 0.0 110.878 -173.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.703 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -75.65 168.27 54.79 Favored Glycine 0 N--CA 1.429 -1.824 0 CA-C-N 115.664 -0.698 . . . . 0.0 114.479 -177.038 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 2.3 p-90 -150.71 -148.3 0.26 Allowed 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 105.211 -2.144 . . . . 0.0 105.211 -177.258 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.439 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.85 154.33 50.54 Favored 'General case' 0 C--N 1.275 -2.669 0 C-N-CA 118.97 -1.092 . . . . 0.0 111.774 -169.127 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.424 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -90.9 -43.92 9.7 Favored 'General case' 0 CA--C 1.488 -1.414 0 CA-C-O 121.736 0.779 . . . . 0.0 109.437 -178.294 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 2.7 pp -138.26 149.15 45.45 Favored 'General case' 0 N--CA 1.414 -2.252 0 CA-C-N 114.461 -1.245 . . . . 0.0 109.44 -176.308 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.486 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 2.4 p -117.13 146.35 43.23 Favored 'General case' 0 C--N 1.279 -2.469 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 178.167 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.7 t -130.81 86.63 51.76 Favored Pre-proline 0 C--N 1.304 -1.4 0 CA-C-O 121.669 0.747 . . . . 0.0 111.896 -176.674 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.448 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.8 Cg_endo -92.89 147.42 2.57 Favored 'Trans proline' 0 N--CA 1.436 -1.892 0 C-N-CA 122.855 2.37 . . . . 0.0 111.984 175.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.448 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 98.6 Cg_endo -76.9 131.26 23.7 Favored 'Cis proline' 0 N--CA 1.45 -1.03 0 C-N-CA 122.604 -1.832 . . . . 0.0 111.161 0.825 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.486 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 27.0 m-85 -73.79 94.88 2.32 Favored 'General case' 0 C--N 1.306 -1.296 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 -178.476 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.577 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 3.1 m-85 -98.91 172.43 7.43 Favored 'General case' 0 C--N 1.289 -2.061 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 177.733 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.651 ' HB3' ' HG2' ' A' ' 687' ' ' GLU . 1.1 t80 -65.92 138.11 57.62 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 106.092 -1.818 . . . . 0.0 106.092 174.471 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.56 -12.47 68.74 Favored Glycine 0 N--CA 1.428 -1.882 0 C-N-CA 119.266 -1.445 . . . . 0.0 112.416 -178.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.451 ' O ' ' HA ' ' A' ' 732' ' ' THR . 23.8 t70 -76.17 165.71 24.51 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 177.47 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.435 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.4 m -134.24 146.08 49.74 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.252 0.549 . . . . 0.0 110.199 -175.365 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.518 HG11 HG13 ' A' ' 694' ' ' ILE . 40.8 t -135.58 147.94 28.5 Favored 'Isoleucine or valine' 0 N--CA 1.412 -2.328 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.448 178.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.568 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 29.5 mt-10 -111.1 127.29 55.51 Favored 'General case' 0 N--CA 1.423 -1.807 0 C-N-CA 120.249 -0.58 . . . . 0.0 110.738 176.683 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.468 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.7 m-85 -95.58 146.65 24.3 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-N 114.494 -1.23 . . . . 0.0 110.699 -179.77 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.424 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -124.64 133.6 53.19 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 178.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.796 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 50.5 t -82.69 164.79 20.48 Favored 'General case' 0 C--N 1.284 -2.266 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.4 m -69.93 152.91 43.94 Favored 'General case' 0 N--CA 1.43 -1.431 0 N-CA-C 109.405 -0.591 . . . . 0.0 109.405 179.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -72.51 146.19 46.98 Favored 'General case' 0 N--CA 1.423 -1.798 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 175.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.7 t 83.44 -2.16 1.17 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.886 1.674 . . . . 0.0 109.7 -175.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 60.7 m-85 -121.36 148.81 43.86 Favored 'General case' 0 N--CA 1.42 -1.932 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 175.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.449 ' HB ' HD11 ' A' ' 747' ' ' ILE . 8.8 t -114.39 137.15 52.18 Favored 'General case' 0 C--N 1.275 -2.655 0 N-CA-C 107.796 -1.187 . . . . 0.0 107.796 177.609 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.796 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.1 ptm -92.33 141.83 28.11 Favored 'General case' 0 N--CA 1.419 -1.986 0 CA-C-O 121.223 0.535 . . . . 0.0 109.944 -176.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 24.6 mt -119.28 120.73 64.63 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.668 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 178.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 130.34 -147.6 18.27 Favored Glycine 0 CA--C 1.472 -2.636 0 N-CA-C 111.106 -0.798 . . . . 0.0 111.106 179.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.6 t-160 -98.53 129.37 45.09 Favored 'General case' 0 N--CA 1.415 -2.175 0 C-N-CA 119.926 -0.71 . . . . 0.0 109.411 -177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 ptm180 -65.92 -27.88 68.51 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 114.97 -1.013 . . . . 0.0 111.293 177.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.568 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -115.18 157.48 23.59 Favored 'General case' 0 N--CA 1.423 -1.793 0 CA-C-O 121.065 0.459 . . . . 0.0 111.071 -178.352 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.706 HG21 HD23 ' A' ' 741' ' ' LEU . 6.6 pt -130.32 166.87 26.83 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.887 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.118 178.984 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.451 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 85.1 m -136.31 137.06 40.27 Favored 'General case' 0 C--N 1.281 -2.395 0 N-CA-C 107.298 -1.371 . . . . 0.0 107.298 179.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -75.34 119.67 19.75 Favored 'General case' 0 C--N 1.295 -1.784 0 C-N-CA 120.243 -0.583 . . . . 0.0 111.869 -179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.41 HG22 ' HD2' ' A' ' 735' ' ' HIS . 48.8 mm -127.58 110.15 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.417 -2.096 0 CA-C-N 114.415 -1.266 . . . . 0.0 108.601 -179.801 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . 0.41 ' HD2' HG22 ' A' ' 734' ' ' ILE . 72.5 m-70 70.75 26.99 3.71 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.415 1.086 . . . . 0.0 112.697 178.198 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 88.71 3.21 77.7 Favored Glycine 0 N--CA 1.444 -0.79 0 C-N-CA 120.491 -0.861 . . . . 0.0 111.298 179.31 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.4 t -130.98 152.8 38.17 Favored 'Isoleucine or valine' 0 C--O 1.194 -1.863 0 N-CA-C 106.094 -1.817 . . . . 0.0 106.094 -177.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.667 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 83.3 m95 -85.89 154.31 21.61 Favored 'General case' 0 C--N 1.282 -2.343 0 CA-C-N 118.97 0.805 . . . . 0.0 109.721 -179.055 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.422 HG23 ' O ' ' A' ' 732' ' ' THR . 31.9 p -33.56 -69.24 0.09 Allowed 'General case' 0 N--CA 1.479 0.995 0 N-CA-C 116.164 1.913 . . . . 0.0 116.164 -174.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.14 -32.18 0.04 OUTLIER 'General case' 0 CA--C 1.49 -1.346 0 N-CA-C 114.449 1.277 . . . . 0.0 114.449 -174.039 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 731' ' ' ILE . 29.9 mt 69.49 154.88 0.15 Allowed Pre-proline 0 C--N 1.322 -0.614 0 O-C-N 124.517 1.136 . . . . 0.0 111.47 -176.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.568 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 68.7 Cg_endo -84.5 -163.71 0.21 Allowed 'Trans proline' 0 CA--C 1.544 1.016 0 C-N-CA 122.407 2.071 . . . . 0.0 111.55 176.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.509 ' O ' ' HA ' ' A' ' 725' ' ' MET . 3.1 pt20 -139.94 155.27 47.23 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 175.469 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 97.1 m -111.45 141.59 44.81 Favored 'General case' 0 C--N 1.288 -2.103 0 CA-C-O 120.931 0.396 . . . . 0.0 111.317 177.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -131.85 140.89 46.99 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.505 0 N-CA-C 108.092 -1.077 . . . . 0.0 108.092 175.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -66.34 119.03 10.86 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 123.587 0.554 . . . . 0.0 111.446 -177.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.449 HD11 ' HB ' ' A' ' 724' ' ' THR . 65.7 mt . . . . . 0 C--N 1.311 -1.076 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 175.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 . . . . . 0 C--O 1.24 0.562 0 CA-C-O 121.088 0.47 . . . . 0.0 110.786 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -100.0 -163.06 0.99 Allowed 'General case' 0 C--N 1.309 -1.186 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.704 179.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.922 ' HB3' ' HA ' ' A' ' 628' ' ' GLN . 10.1 tp10 -147.75 155.35 41.61 Favored 'General case' 0 C--O 1.251 1.143 0 N-CA-C 107.335 -1.358 . . . . 0.0 107.335 -177.56 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 57.18 -95.64 0.06 Allowed 'General case' 0 C--O 1.242 0.659 0 C-N-CA 125.048 1.339 . . . . 0.0 112.631 179.852 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -161.57 88.06 0.7 Allowed 'General case' 0 C--N 1.321 -0.652 0 C-N-CA 123.258 0.623 . . . . 0.0 109.477 179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 62.53 40.28 98.91 Favored Glycine 0 CA--C 1.505 -0.538 0 CA-C-N 115.718 -0.674 . . . . 0.0 112.455 179.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 5.9 p -170.3 80.95 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.347 0 CA-C-O 122.541 1.162 . . . . 0.0 108.116 -177.913 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.922 ' HA ' ' HB3' ' A' ' 623' ' ' GLU 0.255 1.9 pp0? -67.64 -88.89 0.01 OUTLIER 'General case' 0 C--N 1.299 -1.612 0 CA-C-N 114.265 -1.334 . . . . 0.0 113.691 -179.219 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.489 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 54.8 m -179.25 136.57 0.13 Allowed 'General case' 0 N--CA 1.48 1.069 0 C-N-CA 124.833 1.253 . . . . 0.0 109.944 178.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 31.5 p -164.36 135.83 4.48 Favored 'General case' 0 C--N 1.299 -1.624 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 175.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -104.12 -125.28 5.58 Favored Glycine 1 N--CA 1.386 -4.633 0 N-CA-C 109.527 -1.429 . . . . 0.0 109.527 174.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.601 ' HB3' HG21 ' A' ' 645' ' ' THR . 32.4 Cg_exo -54.91 142.4 75.63 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 123.657 2.904 . . . . 0.0 114.232 -177.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.674 ' HD2' HG22 ' A' ' 645' ' ' THR . 38.1 Cg_endo -64.79 161.65 35.2 Favored 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.598 2.866 . . . . 0.0 112.239 177.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.514 ' HG2' HD11 ' A' ' 681' ' ' LEU . 32.6 Cg_endo -72.18 -164.15 0.17 Allowed 'Trans proline' 0 C--O 1.247 0.933 0 C-N-CA 123.071 2.514 . . . . 0.0 111.493 175.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.6 178.53 4.6 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -179.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.715 HD13 ' HG2' ' A' ' 682' ' ' PRO . 27.6 tp -121.15 145.32 47.94 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 173.296 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.531 ' H ' HD12 ' A' ' 636' ' ' LEU . 14.0 tp -34.01 -68.66 0.11 Allowed 'General case' 0 C--N 1.319 -0.758 0 C-N-CA 126.056 1.743 . . . . 0.0 113.868 174.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -137.44 42.05 2.37 Favored 'General case' 0 C--N 1.305 -1.363 0 CA-C-O 124.416 2.055 . . . . 0.0 107.848 -179.089 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.538 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -155.22 -168.17 17.97 Favored Glycine 1 C--N 1.237 -4.932 0 CA-C-N 111.064 -2.789 . . . . 0.0 109.377 176.454 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -155.97 178.45 10.26 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-N 117.142 0.471 . . . . 0.0 110.483 -176.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 90.9 t -83.41 134.23 27.39 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.284 0 C-N-CA 123.936 0.894 . . . . 0.0 108.66 176.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.641 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 15.0 ptpt -92.98 -20.75 20.28 Favored 'General case' 0 C--N 1.316 -0.866 0 CA-C-O 121.297 0.57 . . . . 0.0 110.651 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -92.27 169.31 10.69 Favored 'General case' 0 C--N 1.298 -1.642 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.243 -176.735 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.485 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 27.4 mmtp -109.11 147.59 32.19 Favored 'General case' 0 C--N 1.292 -1.911 0 CA-C-O 120.908 0.385 . . . . 0.0 110.398 -179.133 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.674 HG22 ' HD2' ' A' ' 633' ' ' PRO . 82.8 p -76.04 140.04 41.73 Favored 'General case' 0 C--N 1.295 -1.761 0 N-CA-C 113.285 0.846 . . . . 0.0 113.285 -170.392 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.407 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -96.76 -8.54 31.01 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.492 -0.776 . . . . 0.0 109.94 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.44 ' OE2' ' HG3' ' A' ' 632' ' ' PRO . 27.6 mm-40 68.06 -24.73 0.13 Allowed 'General case' 0 N--CA 1.489 1.513 0 C-N-CA 125.787 1.635 . . . . 0.0 113.437 -178.285 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.407 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.3 mt-10 -124.89 102.93 7.78 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 108.911 -0.774 . . . . 0.0 108.911 179.849 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.601 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 31.5 m-85 -113.27 -73.61 0.66 Allowed 'General case' 0 C--N 1.303 -1.421 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 178.854 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 102.45 -68.61 0.35 Allowed Glycine 0 C--N 1.309 -0.954 0 C-N-CA 121.016 -0.612 . . . . 0.0 114.033 173.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 78.8 t60 -167.28 150.3 6.27 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 -177.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 79.2 p 65.56 13.3 8.81 Favored 'General case' 0 N--CA 1.472 0.66 0 C-N-CA 126.219 1.807 . . . . 0.0 112.893 176.563 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.575 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 5.5 mm-40 -89.4 137.61 32.17 Favored 'General case' 0 C--N 1.308 -1.21 0 CA-C-N 114.78 -1.1 . . . . 0.0 109.829 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 5.0 m -116.74 145.15 22.87 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.163 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -177.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.459 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 20.9 t -129.39 133.21 65.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.37 0 CA-C-N 115.07 -0.968 . . . . 0.0 109.352 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.52 ' HG3' HD22 ' A' ' 669' ' ' ASN . 30.3 tt0 -101.14 126.52 47.86 Favored 'General case' 0 N--CA 1.425 -1.695 0 CA-C-O 121.963 0.887 . . . . 0.0 111.597 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.556 ' HB3' HD22 ' A' ' 636' ' ' LEU . 60.6 m-85 -97.54 158.53 15.43 Favored 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 114.414 -1.267 . . . . 0.0 111.005 177.576 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.641 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.3 p90 -137.14 146.98 45.65 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 173.834 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.538 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.3 m -92.1 160.76 15.05 Favored 'General case' 0 C--N 1.278 -2.502 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 174.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 1.4 m120 -55.15 163.19 1.69 Allowed Pre-proline 0 C--N 1.298 -1.646 0 CA-C-N 115.395 -0.821 . . . . 0.0 113.03 178.384 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_endo -73.35 8.43 1.82 Allowed 'Trans proline' 0 N--CA 1.502 1.988 0 C-N-CA 123.759 2.972 . . . . 0.0 113.221 -173.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.564 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 15.5 ptt180 -128.07 -5.64 5.55 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.673 178.004 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.564 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 47.6 m-85 -117.81 144.17 45.6 Favored 'General case' 0 N--CA 1.436 -1.173 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.431 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.561 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 4.8 mp -100.66 140.08 35.44 Favored 'General case' 0 C--N 1.277 -2.566 0 CA-C-N 115.451 -0.795 . . . . 0.0 109.283 -178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.553 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 50.6 tpp -72.78 114.59 11.09 Favored 'General case' 0 N--CA 1.428 -1.537 0 N-CA-C 108.858 -0.793 . . . . 0.0 108.858 174.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 48.3 tttm -99.57 -34.17 10.34 Favored 'General case' 0 C--N 1.295 -1.786 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -78.51 -177.95 49.31 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 114.685 -1.143 . . . . 0.0 113.915 -176.062 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.589 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 59.3 Cg_endo -70.71 -6.54 19.29 Favored 'Trans proline' 0 N--CA 1.489 1.218 0 C-N-CA 123.847 3.032 . . . . 0.0 113.734 -175.549 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.553 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.295 3.0 p-10 57.06 -35.29 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 C-N-CA 127.916 2.486 . . . . 0.0 116.537 179.59 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.459 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 54.7 mtmt -103.4 135.87 44.22 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.657 -0.652 . . . . 0.0 111.477 176.682 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.761 HG21 HD12 ' A' ' 681' ' ' LEU . 51.2 pt -121.35 166.37 15.96 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.863 0 CA-C-N 114.99 -1.005 . . . . 0.0 108.812 179.615 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.575 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 31.2 tt0 -137.31 137.97 39.51 Favored 'General case' 0 C--N 1.286 -2.172 0 C-N-CA 123.95 0.9 . . . . 0.0 109.676 -176.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.437 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 45.3 t -83.0 113.99 20.96 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 177.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -99.63 -171.4 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.325 0 C-N-CA 119.866 -0.734 . . . . 0.0 110.215 177.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -81.98 48.75 1.27 Allowed 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 112.731 0.641 . . . . 0.0 112.731 -174.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . -173.38 -42.03 0.04 OUTLIER Glycine 0 N--CA 1.434 -1.471 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.934 174.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.441 ' HG2' ' O ' ' A' ' 678' ' ' TRP . 0.0 OUTLIER -166.9 -174.45 2.72 Favored 'General case' 0 C--N 1.308 -1.202 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 -179.445 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.441 ' O ' ' HG2' ' A' ' 677' ' ' GLU . 89.7 m95 -79.76 169.08 18.46 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 175.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . 0.404 HG23 ' O ' ' A' ' 672' ' ' GLN . 27.7 p -82.33 -176.0 5.98 Favored 'General case' 0 C--N 1.298 -1.661 0 N-CA-C 112.64 0.607 . . . . 0.0 112.64 -178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 21.0 m -60.13 114.2 2.74 Favored 'General case' 0 N--CA 1.439 -1.001 0 CA-C-N 115.186 -0.915 . . . . 0.0 111.197 -178.575 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.761 HD12 HG21 ' A' ' 671' ' ' ILE . 0.8 OUTLIER -63.08 153.82 79.73 Favored Pre-proline 0 N--CA 1.413 -2.315 0 CA-C-N 114.31 -1.314 . . . . 0.0 112.372 177.93 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.715 ' HG2' HD13 ' A' ' 636' ' ' LEU . 36.4 Cg_endo -77.53 -176.14 3.06 Favored 'Trans proline' 0 N--CA 1.433 -2.071 0 C-N-CA 122.558 2.172 . . . . 0.0 113.347 178.098 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.6 t -138.28 144.72 29.8 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.379 0 N-CA-C 106.899 -1.519 . . . . 0.0 106.899 -175.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.42 ' H ' HD23 ' A' ' 637' ' ' LEU . 83.3 m -119.62 136.86 54.21 Favored 'General case' 0 C--N 1.297 -1.71 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 178.148 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.0 pt -129.69 143.31 41.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.551 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.4 p -87.3 136.28 23.39 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.188 0 C-N-CA 120.262 -0.575 . . . . 0.0 109.852 -179.569 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.45 ' HG2' HD21 ' A' ' 664' ' ' LEU . 0.0 OUTLIER -68.48 -53.27 24.47 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 107.011 -1.477 . . . . 0.0 107.011 174.276 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.446 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 33.9 tt0 72.26 20.16 4.21 Favored 'General case' 0 N--CA 1.444 -0.761 0 CA-C-N 112.305 -2.225 . . . . 0.0 110.104 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 59.4 p -121.96 165.31 16.18 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 105.359 -2.089 . . . . 0.0 105.359 175.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . 0.411 HG22 ' HD1' ' A' ' 710' ' ' TYR . 61.3 p -122.03 169.46 10.81 Favored 'General case' 0 C--N 1.283 -2.322 0 C-N-CA 119.861 -0.736 . . . . 0.0 111.878 -176.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 5.4 m -90.5 6.44 43.49 Favored 'General case' 0 C--N 1.302 -1.48 0 CA-C-N 114.667 -1.151 . . . . 0.0 110.155 170.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 85.08 -82.1 1.71 Allowed Glycine 0 CA--C 1.489 -1.581 0 CA-C-N 115.112 -0.949 . . . . 0.0 111.498 175.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.721 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.3 t0 -158.34 -173.42 4.31 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 -178.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.661 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.7 mt -72.97 131.33 83.92 Favored Pre-proline 0 C--N 1.271 -2.808 0 C-N-CA 123.91 0.884 . . . . 0.0 111.875 176.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.601 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.9 Cg_endo -73.97 -168.94 0.5 Allowed 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 123.627 2.884 . . . . 0.0 112.371 -178.711 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 36.8 tt0 -108.41 122.19 46.5 Favored 'General case' 0 N--CA 1.403 -2.803 0 CA-C-N 114.202 -1.363 . . . . 0.0 110.384 -178.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.585 HD13 ' HA3' ' A' ' 700' ' ' GLY . 5.0 tt -93.84 136.62 33.93 Favored 'General case' 0 C--N 1.292 -1.923 0 N-CA-C 101.973 -3.343 . . . . 0.0 101.973 171.306 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.592 ' OE2' ' HB2' ' A' ' 743' ' ' GLN . 13.2 pt-20 -48.12 -38.43 17.79 Favored 'General case' 0 N--CA 1.476 0.857 0 N-CA-C 112.893 0.701 . . . . 0.0 112.893 -172.517 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 39.7 m80 -142.48 34.07 1.46 Allowed 'General case' 0 C--N 1.318 -0.776 0 N-CA-C 108.901 -0.778 . . . . 0.0 108.901 -179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.585 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.14 -170.59 12.06 Favored Glycine 0 N--CA 1.451 -0.36 0 CA-C-N 115.342 -0.845 . . . . 0.0 111.534 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -163.32 -152.26 0.2 Allowed 'General case' 0 N--CA 1.442 -0.86 0 C-N-CA 126.022 1.729 . . . . 0.0 107.389 -176.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.448 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.22 156.96 45.84 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 113.711 1.004 . . . . 0.0 113.711 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.442 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -94.92 -70.63 0.7 Allowed 'General case' 0 CA--C 1.507 -0.697 0 CA-C-N 115.767 -0.651 . . . . 0.0 110.45 178.538 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.415 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -98.65 139.53 34.23 Favored 'General case' 0 N--CA 1.432 -1.332 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.672 -176.871 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.5 m -132.48 122.3 24.69 Favored 'General case' 0 N--CA 1.421 -1.881 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 177.527 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 43.9 t -128.77 94.88 33.52 Favored Pre-proline 0 C--N 1.297 -1.717 0 CA-C-O 121.303 0.573 . . . . 0.0 110.551 178.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.454 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.4 Cg_endo -89.78 152.64 5.06 Favored 'Trans proline' 0 N--CA 1.438 -1.775 0 C-N-CA 122.351 2.034 . . . . 0.0 111.885 176.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.454 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 59.1 Cg_endo -71.95 134.22 32.48 Favored 'Cis proline' 0 C--O 1.24 0.618 0 C-N-CA 123.151 -1.604 . . . . 0.0 111.15 -2.016 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.721 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.6 m-85 -79.38 88.87 4.98 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 -179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.446 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 4.8 m-30 -82.6 168.33 17.43 Favored 'General case' 0 CA--C 1.504 -0.818 0 CA-C-O 121.105 0.479 . . . . 0.0 111.391 179.084 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.561 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.6 t80 -60.84 133.97 56.63 Favored 'General case' 0 N--CA 1.445 -0.703 0 CA-C-N 114.925 -1.034 . . . . 0.0 108.88 177.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.7 -21.8 44.14 Favored Glycine 0 N--CA 1.43 -1.765 0 CA-C-N 115.141 -0.936 . . . . 0.0 113.025 -179.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -76.38 163.99 26.44 Favored 'General case' 0 C--O 1.247 0.961 0 CA-C-N 117.67 0.735 . . . . 0.0 110.014 179.275 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 4.8 m -125.46 161.95 25.96 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-O 121.21 0.528 . . . . 0.0 110.385 -173.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.579 HG11 HG12 ' A' ' 694' ' ' ILE . 25.0 t -142.88 139.01 27.85 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.049 0 CA-C-N 114.812 -1.085 . . . . 0.0 108.564 175.219 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.437 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 43.0 mt-10 -101.88 123.57 46.03 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 176.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.661 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.42 158.59 15.97 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-N 115.721 -0.672 . . . . 0.0 110.7 178.547 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.442 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 18.5 t-20 -134.39 147.81 50.56 Favored 'General case' 0 C--N 1.286 -2.168 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.712 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 34.5 t -102.76 141.79 34.99 Favored 'General case' 0 C--N 1.277 -2.554 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 -179.226 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 37.6 m -58.47 143.76 44.54 Favored 'General case' 0 N--CA 1.441 -0.916 0 N-CA-C 109.788 -0.449 . . . . 0.0 109.788 177.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.3 tt0 -57.7 -33.27 68.22 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 114.783 1.401 . . . . 0.0 114.783 -171.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.6 m -82.2 4.96 21.41 Favored 'General case' 0 C--N 1.307 -1.25 0 O-C-N 121.693 -0.629 . . . . 0.0 111.339 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.579 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 97.6 m-85 -125.35 158.99 32.88 Favored 'General case' 0 N--CA 1.436 -1.173 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 -179.198 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 5.4 t -116.87 131.79 56.86 Favored 'General case' 0 C--N 1.29 -1.987 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.712 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.5 ptm -87.96 136.75 32.83 Favored 'General case' 0 N--CA 1.429 -1.483 0 CA-C-O 121.587 0.708 . . . . 0.0 110.283 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 55.4 mt -107.74 116.21 50.67 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.083 0 CA-C-N 115.36 -0.837 . . . . 0.0 109.362 179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.29 -151.19 18.54 Favored Glycine 0 N--CA 1.429 -1.776 0 N-CA-C 110.761 -0.936 . . . . 0.0 110.761 -179.427 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 4.4 p-80 -108.44 156.04 19.9 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 179.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.599 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 32.0 ptt180 -86.08 -28.33 24.14 Favored 'General case' 0 C--N 1.285 -2.22 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 -175.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.437 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 6.7 m -91.42 145.25 24.79 Favored 'General case' 0 C--N 1.278 -2.532 0 C-N-CA 118.17 -1.412 . . . . 0.0 113.557 -169.706 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.656 HG21 HD23 ' A' ' 741' ' ' LEU . 6.0 pt -125.61 174.07 10.3 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.814 0 CA-C-N 115.213 -0.903 . . . . 0.0 110.342 -179.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 86.7 m -141.37 136.28 31.29 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 108.564 -0.902 . . . . 0.0 108.564 179.675 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.4 t -69.29 108.79 3.82 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 123.418 0.687 . . . . 0.0 111.011 -179.357 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.4 mm -123.3 104.04 13.79 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.517 0 CA-C-O 121.257 0.551 . . . . 0.0 111.093 -178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 95.3 m-70 66.76 19.9 10.69 Favored 'General case' 0 N--CA 1.48 1.063 0 C-N-CA 124.644 1.178 . . . . 0.0 112.368 175.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 104.14 -3.6 44.39 Favored Glycine 0 N--CA 1.435 -1.396 0 C-N-CA 120.543 -0.837 . . . . 0.0 111.917 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 44.8 t -127.11 133.19 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.043 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 -179.529 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.601 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.9 m95 -68.33 153.91 42.81 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.852 -0.795 . . . . 0.0 108.852 177.252 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 35.8 p -37.05 -69.71 0.11 Allowed 'General case' 0 N--CA 1.474 0.752 0 N-CA-C 116.31 1.967 . . . . 0.0 116.31 -174.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.56 -32.05 0.04 OUTLIER 'General case' 0 C--N 1.314 -0.947 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -174.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.656 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 68.34 153.25 0.13 Allowed Pre-proline 0 N--CA 1.472 0.645 0 O-C-N 124.753 1.283 . . . . 0.0 111.392 -177.242 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -83.28 -173.4 1.64 Allowed 'Trans proline' 0 N--CA 1.442 -1.557 0 C-N-CA 121.767 1.644 . . . . 0.0 109.657 172.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.592 ' HB2' ' OE2' ' A' ' 698' ' ' GLU . 2.8 pt20 -134.39 153.58 51.83 Favored 'General case' 0 N--CA 1.423 -1.814 0 N-CA-C 108.461 -0.941 . . . . 0.0 108.461 176.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.79 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 86.7 m -117.08 134.81 54.3 Favored 'General case' 0 C--N 1.284 -2.277 0 O-C-N 123.309 0.38 . . . . 0.0 110.963 -178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.5 m -120.18 143.73 31.09 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.77 0 N-CA-C 108.499 -0.926 . . . . 0.0 108.499 -177.881 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.12 116.41 5.36 Favored 'General case' 0 C--N 1.297 -1.699 0 O-C-N 124.225 0.953 . . . . 0.0 110.893 -178.579 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.8 mt . . . . . 0 C--N 1.299 -1.592 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 173.045 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.538 0.508 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -119.03 -26.78 5.88 Favored 'General case' 0 C--O 1.237 0.441 0 N-CA-C 114.365 1.246 . . . . 0.0 114.365 -173.425 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -74.94 -38.2 61.81 Favored 'General case' 0 C--O 1.242 0.696 0 C-N-CA 119.012 -1.075 . . . . 0.0 110.289 -176.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -86.57 98.63 11.19 Favored 'General case' 0 N--CA 1.418 -2.038 0 CA-C-N 115.738 -0.665 . . . . 0.0 109.596 177.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -82.01 120.71 25.61 Favored 'General case' 0 N--CA 1.429 -1.497 0 N-CA-C 106.505 -1.665 . . . . 0.0 106.505 175.407 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -73.28 -88.7 0.17 Allowed Glycine 0 N--CA 1.421 -2.336 0 N-CA-C 115.517 0.967 . . . . 0.0 115.517 -170.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.753 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 40.2 t 50.62 70.38 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 123.179 1.466 . . . . 0.0 108.802 -167.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -80.06 -97.1 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.01 0 CA-C-N 112.332 -2.213 . . . . 0.0 112.149 -175.485 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.492 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 34.8 p 176.62 159.58 0.34 Allowed 'General case' 0 C--N 1.306 -1.322 0 N-CA-C 108.064 -1.088 . . . . 0.0 108.064 -174.336 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.421 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 14.0 p -171.66 142.62 1.61 Allowed 'General case' 0 C--N 1.282 -2.343 0 N-CA-C 107.443 -1.317 . . . . 0.0 107.443 176.707 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -88.52 -144.15 9.76 Favored Glycine 0 N--CA 1.396 -3.975 0 C-N-CA 119.878 -1.153 . . . . 0.0 111.898 -178.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.727 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 41.1 Cg_exo -54.11 148.02 41.59 Favored 'Trans proline' 0 C--N 1.317 -1.097 0 C-N-CA 123.788 2.992 . . . . 0.0 112.117 179.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.629 ' HD2' HG22 ' A' ' 645' ' ' THR . 30.3 Cg_endo -62.76 156.05 55.79 Favored 'Trans proline' 0 C--O 1.249 1.043 0 C-N-CA 122.578 2.186 . . . . 0.0 111.784 -179.573 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.503 ' HG2' HD11 ' A' ' 681' ' ' LEU . 23.1 Cg_endo -67.76 -172.61 0.41 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 122.482 2.121 . . . . 0.0 111.038 175.825 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.16 152.96 22.78 Favored 'General case' 0 C--N 1.284 -2.258 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.944 -179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.72 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -89.07 134.09 34.13 Favored 'General case' 0 C--N 1.286 -2.171 0 N-CA-C 105.855 -1.905 . . . . 0.0 105.855 176.647 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 56.7 tp -22.16 -56.91 0.03 OUTLIER 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 127.554 2.342 . . . . 0.0 113.757 175.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.536 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.4 t30 -125.94 -39.64 2.09 Favored 'General case' 0 C--N 1.305 -1.361 0 N-CA-C 108.331 -0.988 . . . . 0.0 108.331 176.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.63 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -71.27 -155.17 1.82 Allowed Glycine 0 CA--C 1.52 0.355 0 CA-C-N 114.901 -1.045 . . . . 0.0 113.405 179.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -168.84 177.76 4.89 Favored 'General case' 0 C--N 1.319 -0.751 0 O-C-N 122.04 -0.683 . . . . 0.0 111.033 -179.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 2.3 p -94.66 147.17 5.9 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.338 0 C-N-CA 124.823 1.249 . . . . 0.0 109.05 -178.015 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 10.3 ptpt -109.27 -12.17 14.8 Favored 'General case' 0 C--N 1.315 -0.892 0 CA-C-O 121.052 0.453 . . . . 0.0 111.12 -177.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -89.75 165.79 13.96 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.364 -177.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -77.7 150.8 34.44 Favored 'General case' 0 C--N 1.311 -1.088 0 CA-C-O 121.308 0.575 . . . . 0.0 110.874 -178.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.629 HG22 ' HD2' ' A' ' 633' ' ' PRO . 28.7 p -84.52 114.36 21.9 Favored 'General case' 0 N--CA 1.414 -2.232 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.785 176.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.401 ' HE2' ' CE2' ' A' ' 649' ' ' TYR . 45.7 mtmt -86.8 -15.17 40.1 Favored 'General case' 0 C--N 1.303 -1.434 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.382 -177.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.727 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.0 mt-10 65.88 -6.53 0.43 Allowed 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 115.304 1.594 . . . . 0.0 115.304 176.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -150.68 86.29 1.39 Allowed 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.604 -0.887 . . . . 0.0 108.604 173.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.438 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 17.5 m-85 -83.88 -74.13 0.39 Allowed 'General case' 0 C--N 1.294 -1.834 0 CA-C-N 114.322 -1.308 . . . . 0.0 111.045 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.492 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 117.52 -104.79 1.2 Allowed Glycine 0 C--O 1.211 -1.334 0 C-N-CA 119.84 -1.172 . . . . 0.0 113.252 176.689 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.753 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 83.0 t60 -137.68 138.1 39.05 Favored 'General case' 0 C--N 1.307 -1.258 0 CA-C-N 116.864 0.332 . . . . 0.0 110.337 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 44.5 m 69.32 16.34 8.38 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 124.714 1.205 . . . . 0.0 112.467 176.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.438 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 16.2 mm-40 -82.73 126.07 31.96 Favored 'General case' 0 C--N 1.302 -1.469 0 CA-C-N 114.568 -1.197 . . . . 0.0 109.1 177.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.534 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 8.9 m -107.4 149.82 10.48 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 CA-C-O 121.135 0.493 . . . . 0.0 111.881 -178.915 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.562 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 45.3 t -130.65 132.33 64.38 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.517 0 CA-C-N 115.568 -0.742 . . . . 0.0 109.728 -179.903 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.493 ' HG3' HD22 ' A' ' 669' ' ' ASN . 34.4 tt0 -98.95 130.38 45.31 Favored 'General case' 0 N--CA 1.427 -1.59 0 CA-C-O 122.096 0.951 . . . . 0.0 112.236 -178.823 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.72 ' HB3' HD12 ' A' ' 636' ' ' LEU . 59.4 m-85 -107.81 169.25 8.72 Favored 'General case' 0 C--N 1.295 -1.776 0 CA-C-N 114.465 -1.243 . . . . 0.0 111.688 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 47.2 p90 -140.94 155.65 46.22 Favored 'General case' 0 C--N 1.304 -1.397 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 175.57 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.406 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 68.2 m -99.05 159.47 14.94 Favored 'General case' 0 C--N 1.287 -2.119 0 CA-C-O 121.298 0.571 . . . . 0.0 110.061 172.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -59.86 157.76 28.05 Favored Pre-proline 0 C--N 1.293 -1.858 0 CA-C-N 114.485 -1.234 . . . . 0.0 111.832 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_endo -65.43 -2.22 5.78 Favored 'Trans proline' 0 N--CA 1.492 1.413 0 C-N-CA 123.281 2.654 . . . . 0.0 115.117 -174.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 34.7 ptt180 -129.29 -0.51 5.1 Favored 'General case' 0 C--N 1.304 -1.394 0 CA-C-O 122.356 1.074 . . . . 0.0 110.972 175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.475 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 31.1 m-85 -112.68 137.78 50.45 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-N 114.37 -1.286 . . . . 0.0 110.592 176.887 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.659 HD22 ' CD1' ' A' ' 711' ' ' TYR . 9.8 mt -104.77 146.41 29.01 Favored 'General case' 0 C--N 1.273 -2.722 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 -176.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.48 ' SD ' ' HB3' ' A' ' 669' ' ' ASN . 43.0 ttm -79.91 123.65 27.97 Favored 'General case' 0 C--N 1.275 -2.633 0 CA-C-N 115.173 -0.921 . . . . 0.0 109.967 177.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 27.8 tptp -112.53 -34.79 5.74 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.32 -177.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -83.02 -149.01 8.13 Favored Glycine 0 CA--C 1.504 -0.617 0 CA-C-N 115.853 -0.612 . . . . 0.0 112.031 -179.469 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.591 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 55.5 Cg_endo -72.93 -147.91 0.03 OUTLIER 'Trans proline' 0 CA--C 1.546 1.121 0 C-N-CA 122.277 1.985 . . . . 0.0 109.361 171.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.493 HD22 ' HG3' ' A' ' 656' ' ' GLU . 2.2 p-10 -161.45 -28.4 0.05 Allowed 'General case' 0 C--N 1.296 -1.72 0 O-C-N 122.104 -0.373 . . . . 0.0 110.505 179.645 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.562 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.9 mtmt -115.64 134.52 54.96 Favored 'General case' 0 CA--C 1.486 -1.493 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.242 176.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.534 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.5 pt -117.43 169.12 8.24 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -179.564 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.433 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.3 tt0 -137.15 139.06 40.91 Favored 'General case' 0 C--N 1.288 -2.066 0 O-C-N 123.338 0.398 . . . . 0.0 110.222 -175.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.5 t -86.07 103.55 14.85 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 27.1 m -87.87 -172.05 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 N-CA-C 108.523 -0.917 . . . . 0.0 108.523 179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.443 ' HA ' ' OE1' ' A' ' 628' ' ' GLN 0.291 3.0 p-10 -77.71 80.15 4.18 Favored 'General case' 0 C--N 1.313 -0.98 0 CA-C-O 123.004 1.383 . . . . 0.0 113.492 -177.729 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 153.87 -54.33 0.44 Allowed Glycine 0 N--CA 1.404 -3.486 0 CA-C-N 112.559 -2.11 . . . . 0.0 110.391 171.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -153.11 -171.15 3.83 Favored 'General case' 0 C--N 1.305 -1.346 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 -177.231 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 88.3 m95 -83.53 -176.85 6.5 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-O 121.103 0.478 . . . . 0.0 112.009 -177.716 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.7 p -97.94 -166.77 1.42 Allowed 'General case' 0 C--N 1.314 -0.947 0 CA-C-N 116.016 -0.538 . . . . 0.0 111.11 179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 23.1 m -69.78 117.36 11.27 Favored 'General case' 0 N--CA 1.433 -1.316 0 CA-C-O 121.195 0.521 . . . . 0.0 111.362 -178.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.503 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.6 mm? -68.66 151.08 97.44 Favored Pre-proline 0 C--N 1.304 -1.385 0 CA-C-N 115.248 -0.887 . . . . 0.0 111.414 176.033 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.591 ' HA ' ' HD2' ' A' ' 668' ' ' PRO . 71.3 Cg_endo -80.73 176.94 8.55 Favored 'Trans proline' 0 CA--C 1.474 -2.516 0 C-N-CA 123.456 2.77 . . . . 0.0 111.787 172.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 3.2 m -132.81 151.89 35.19 Favored 'Isoleucine or valine' 1 N--CA 1.352 -5.361 0 CA-C-N 113.181 -1.827 . . . . 0.0 107.638 -175.536 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.536 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 71.3 m -123.58 136.01 54.29 Favored 'General case' 0 C--N 1.286 -2.166 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 178.373 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 33.5 pt -128.26 140.19 49.85 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.97 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 -178.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.52 HG22 ' H ' ' A' ' 688' ' ' GLU . 12.5 p -76.64 127.47 37.79 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.164 0 N-CA-C 107.213 -1.403 . . . . 0.0 107.213 177.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.493 ' HB3' ' CD1' ' A' ' 664' ' ' LEU . 7.9 pt-20 -73.93 -18.49 60.89 Favored 'General case' 0 CA--C 1.505 -0.77 0 C-N-CA 116.012 -2.275 . . . . 0.0 110.409 176.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.52 ' H ' HG22 ' A' ' 686' ' ' VAL . 5.4 tp10 63.72 21.15 12.57 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 114.312 -1.313 . . . . 0.0 109.085 175.3 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.434 ' HB2' ' OE2' ' A' ' 687' ' ' GLU . 15.7 m -127.29 165.07 20.37 Favored 'General case' 0 N--CA 1.423 -1.82 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 -176.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 37.6 p -129.59 174.48 9.63 Favored 'General case' 0 C--N 1.295 -1.768 0 CA-C-O 121.144 0.497 . . . . 0.0 111.761 -174.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.8 m -97.36 -1.47 44.41 Favored 'General case' 0 C--N 1.314 -0.977 0 C-N-CA 123.366 0.667 . . . . 0.0 111.079 172.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 91.32 -82.15 1.26 Allowed Glycine 0 N--CA 1.436 -1.353 0 N-CA-C 111.436 -0.666 . . . . 0.0 111.436 177.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.667 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 27.9 t70 -159.98 178.09 10.08 Favored 'General case' 0 C--N 1.308 -1.204 0 N-CA-C 108.579 -0.897 . . . . 0.0 108.579 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.602 HG12 HG11 ' A' ' 715' ' ' VAL . 3.5 mt -68.73 131.43 91.25 Favored Pre-proline 0 N--CA 1.42 -1.943 0 C-N-CA 124.454 1.101 . . . . 0.0 111.556 176.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.537 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.4 Cg_endo -74.14 -176.43 2.66 Favored 'Trans proline' 0 N--CA 1.451 -0.984 0 C-N-CA 123.296 2.664 . . . . 0.0 111.24 -179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -113.57 136.75 52.47 Favored 'General case' 0 C--N 1.275 -2.655 0 CA-C-O 121.255 0.55 . . . . 0.0 109.683 178.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.635 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.9 tt -109.97 142.54 41.21 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 103.748 -2.686 . . . . 0.0 103.748 178.08 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.51 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.8 pt-20 -46.19 -36.65 6.21 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.196 0.813 . . . . 0.0 113.196 -175.672 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 34.7 m80 -146.48 21.55 1.33 Allowed 'General case' 0 N--CA 1.439 -1.016 0 CA-C-O 121.239 0.542 . . . . 0.0 109.889 -176.593 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.635 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -127.33 175.4 18.18 Favored Glycine 0 N--CA 1.447 -0.607 0 CA-C-N 115.122 -0.944 . . . . 0.0 111.549 -178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 18.2 p-90 -163.26 -159.38 0.53 Allowed 'General case' 0 N--CA 1.429 -1.507 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -175.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -138.58 145.92 41.18 Favored 'General case' 0 C--N 1.284 -2.266 0 C-N-CA 121.059 -0.256 . . . . 0.0 110.613 -169.516 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.409 HE22 ' C ' ' A' ' 717' ' ' PHE . 0.2 OUTLIER -88.65 -51.87 5.45 Favored 'General case' 0 CA--C 1.496 -1.1 0 CA-C-O 121.632 0.729 . . . . 0.0 109.388 -178.821 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -113.43 150.69 32.39 Favored 'General case' 0 N--CA 1.422 -1.83 0 CA-C-N 114.724 -1.126 . . . . 0.0 111.074 -175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 12.1 p -137.85 127.46 25.13 Favored 'General case' 0 C--N 1.287 -2.138 0 C-N-CA 124.391 1.076 . . . . 0.0 108.936 -179.002 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.9 m -123.78 81.32 55.5 Favored Pre-proline 0 C--N 1.296 -1.759 0 C-N-CA 120.47 -0.492 . . . . 0.0 111.514 -179.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.501 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.3 Cg_endo -91.87 144.15 2.9 Favored 'Trans proline' 0 N--CA 1.44 -1.618 0 C-N-CA 123.111 2.541 . . . . 0.0 112.024 177.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.501 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.5 Cg_endo -71.89 129.01 15.65 Favored 'Cis proline' 0 N--CA 1.46 -0.479 0 C-N-CA 123.006 -1.664 . . . . 0.0 111.239 -0.241 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.667 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 23.6 m-85 -74.43 94.07 2.52 Favored 'General case' 0 C--N 1.308 -1.22 0 CA-C-N 115.736 -0.666 . . . . 0.0 109.223 -177.271 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -85.08 161.15 19.8 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 117.923 0.328 . . . . 0.0 111.403 179.163 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.659 ' CD1' HD22 ' A' ' 664' ' ' LEU . 0.1 OUTLIER -61.16 135.07 57.64 Favored 'General case' 0 CA--C 1.493 -1.213 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 175.172 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.77 -12.36 59.37 Favored Glycine 0 N--CA 1.403 -3.521 0 C-N-CA 119.625 -1.274 . . . . 0.0 111.821 177.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.0 t70 -92.81 179.81 5.36 Favored 'General case' 0 C--O 1.25 1.123 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -140.62 161.94 36.55 Favored 'General case' 0 C--N 1.302 -1.472 0 CA-C-O 121.618 0.723 . . . . 0.0 111.783 -173.19 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.602 HG11 HG12 ' A' ' 694' ' ' ILE . 20.4 t -139.21 145.15 27.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 CA-C-N 114.769 -1.105 . . . . 0.0 109.146 177.25 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.476 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 35.8 mt-10 -105.82 129.2 54.05 Favored 'General case' 0 N--CA 1.432 -1.358 0 CA-C-O 121.308 0.575 . . . . 0.0 110.526 174.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.59 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -109.12 153.08 24.21 Favored 'General case' 0 C--N 1.29 -1.989 0 C-N-CA 125.957 1.703 . . . . 0.0 108.69 178.702 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 59.1 t30 -150.4 160.41 43.77 Favored 'General case' 0 C--N 1.285 -2.216 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.468 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 92.2 m -96.56 156.51 16.31 Favored 'General case' 0 C--N 1.27 -2.877 0 O-C-N 123.68 0.612 . . . . 0.0 110.484 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 25.8 m -67.25 162.56 22.4 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-N 115.312 -0.858 . . . . 0.0 110.868 178.279 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -66.83 147.24 53.51 Favored 'General case' 0 N--CA 1.412 -2.368 0 N-CA-C 108.158 -1.053 . . . . 0.0 108.158 175.254 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 35.2 t 87.35 -10.97 0.56 Allowed 'General case' 0 C--N 1.326 -0.429 0 C-N-CA 126.57 1.948 . . . . 0.0 108.413 -173.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.415 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 71.7 m-85 -120.97 147.01 46.06 Favored 'General case' 0 N--CA 1.421 -1.914 0 CA-C-O 121.399 0.619 . . . . 0.0 110.73 178.06 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.9 t -115.5 147.14 41.0 Favored 'General case' 0 C--N 1.278 -2.513 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 176.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.485 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.0 ptm -96.57 146.85 24.45 Favored 'General case' 0 N--CA 1.432 -1.347 0 CA-C-O 121.067 0.46 . . . . 0.0 111.001 -176.304 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 29.2 mt -126.22 116.61 46.15 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.967 0 N-CA-C 107.948 -1.131 . . . . 0.0 107.948 175.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.4 -139.65 11.12 Favored Glycine 0 CA--C 1.479 -2.181 0 C-N-CA 121.105 -0.569 . . . . 0.0 111.987 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 11.0 t-160 -111.69 131.94 54.95 Favored 'General case' 0 N--CA 1.42 -1.974 0 C-N-CA 119.449 -0.9 . . . . 0.0 108.987 179.3 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.4 ptm180 -62.69 -32.78 73.92 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 124.303 1.002 . . . . 0.0 111.699 177.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.476 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 32.4 p -108.54 149.35 28.97 Favored 'General case' 0 N--CA 1.423 -1.79 0 C-N-CA 118.519 -1.272 . . . . 0.0 111.886 -176.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 12.7 pt -125.25 166.72 20.52 Favored 'Isoleucine or valine' 0 N--CA 1.432 -1.349 0 CA-C-N 114.89 -1.05 . . . . 0.0 109.393 179.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.439 ' H ' HG23 ' A' ' 739' ' ' THR . 45.1 m -131.85 136.87 47.79 Favored 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 108.648 -0.871 . . . . 0.0 108.648 -177.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 48.4 t -71.21 107.2 4.11 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 123.909 0.756 . . . . 0.0 109.306 178.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.545 ' O ' HG22 ' A' ' 737' ' ' VAL . 51.4 mm -127.74 108.8 18.71 Favored 'Isoleucine or valine' 0 C--O 1.201 -1.496 0 C-N-CA 123.615 0.766 . . . . 0.0 110.292 -176.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 27.3 m-70 68.98 20.2 7.91 Favored 'General case' 0 N--CA 1.486 1.328 0 C-N-CA 123.938 0.895 . . . . 0.0 112.46 176.073 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.51 -6.06 60.82 Favored Glycine 0 CA--C 1.483 -1.95 0 C-N-CA 119.629 -1.272 . . . . 0.0 111.462 -178.713 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.545 HG22 ' O ' ' A' ' 734' ' ' ILE . 3.5 m -122.57 150.27 26.26 Favored 'Isoleucine or valine' 1 N--CA 1.37 -4.432 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 -176.778 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.537 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.4 m95 -83.9 153.79 23.77 Favored 'General case' 0 C--N 1.267 -2.984 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 174.176 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.439 HG23 ' H ' ' A' ' 732' ' ' THR . 37.8 p -35.71 -74.19 0.04 OUTLIER 'General case' 0 N--CA 1.483 1.206 0 N-CA-C 115.804 1.779 . . . . 0.0 115.804 -175.26 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -160.29 -29.27 0.06 Allowed 'General case' 0 C--N 1.315 -0.925 0 N-CA-C 114.311 1.226 . . . . 0.0 114.311 -172.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 17.8 mt 70.2 149.61 0.12 Allowed Pre-proline 0 N--CA 1.466 0.369 0 O-C-N 124.65 1.219 . . . . 0.0 111.863 -179.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.485 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 61.5 Cg_endo -77.38 -178.67 4.76 Favored 'Trans proline' 0 N--CA 1.451 -1.016 0 C-N-CA 122.282 1.988 . . . . 0.0 110.479 175.378 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.7 pt20 -128.53 140.26 51.89 Favored 'General case' 0 C--N 1.292 -1.907 0 N-CA-C 108.117 -1.068 . . . . 0.0 108.117 177.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.538 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 20.3 m -100.78 142.57 32.06 Favored 'General case' 0 C--N 1.291 -1.941 0 C-N-CA 120.427 -0.509 . . . . 0.0 109.823 179.272 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 23.2 m -132.99 141.92 43.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.258 -1.015 . . . . 0.0 108.258 177.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.02 118.4 10.42 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 123.721 0.638 . . . . 0.0 110.119 179.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 39.2 mt . . . . . 0 C--O 1.261 1.679 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 178.206 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 . . . . . 0 CA--C 1.52 -0.195 0 N-CA-C 108.835 -0.802 . . . . 0.0 108.835 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -79.8 -38.44 33.0 Favored 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -82.35 98.54 8.89 Favored 'General case' 0 C--N 1.309 -1.165 0 N-CA-C 108.003 -1.11 . . . . 0.0 108.003 177.105 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -100.74 120.22 39.77 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-N 116.453 -0.34 . . . . 0.0 111.352 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -102.06 96.3 6.92 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 174.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -93.74 92.4 1.59 Allowed Glycine 0 N--CA 1.42 -2.409 0 CA-C-N 115.727 -0.67 . . . . 0.0 111.752 -176.431 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.598 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 85.8 t -156.05 68.99 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.671 0 N-CA-C 105.449 -2.056 . . . . 0.0 105.449 -176.543 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.424 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -69.9 -29.87 67.16 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 113.356 -1.747 . . . . 0.0 112.183 -179.157 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 18.0 t 79.19 120.82 0.05 Allowed 'General case' 0 C--N 1.308 -1.208 0 C-N-CA 126.309 1.843 . . . . 0.0 110.449 -179.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.6 p -110.59 171.79 7.25 Favored 'General case' 0 C--N 1.267 -2.993 0 CA-C-N 114.683 -1.144 . . . . 0.0 108.025 175.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -106.38 -132.71 7.2 Favored Glycine 0 N--CA 1.4 -3.722 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 178.584 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.498 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 23.5 Cg_exo -63.94 145.04 89.58 Favored 'Trans proline' 0 C--N 1.323 -0.767 0 C-N-CA 123.281 2.654 . . . . 0.0 112.603 -177.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_endo -62.75 157.08 49.49 Favored 'Trans proline' 0 C--O 1.24 0.584 0 C-N-CA 123.158 2.572 . . . . 0.0 112.29 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.539 ' HG2' HD11 ' A' ' 681' ' ' LEU . 34.3 Cg_endo -68.8 -164.58 0.11 Allowed 'Trans proline' 0 C--O 1.255 1.37 0 C-N-CA 123.192 2.595 . . . . 0.0 111.627 176.248 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -106.57 164.83 11.75 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.795 -0.566 . . . . 0.0 110.516 -179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.735 HD13 ' HG2' ' A' ' 682' ' ' PRO . 31.9 tp -104.13 147.74 27.09 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.747 175.484 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.6 ' H ' HD12 ' A' ' 636' ' ' LEU . 6.0 tt -35.54 -65.8 0.22 Allowed 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 127.503 2.321 . . . . 0.0 111.286 175.599 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -115.7 -43.44 3.02 Favored 'General case' 0 C--N 1.308 -1.214 0 C-N-CA 119.461 -0.896 . . . . 0.0 110.38 -178.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.501 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -88.54 -146.01 11.9 Favored Glycine 0 N--CA 1.441 -1.03 0 N-CA-C 110.91 -0.876 . . . . 0.0 110.91 -179.019 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -165.37 -170.51 1.89 Allowed 'General case' 0 C--N 1.311 -1.078 0 C-N-CA 120.282 -0.567 . . . . 0.0 110.204 -177.074 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.521 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.5 p -101.23 143.71 13.98 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.728 0 C-N-CA 123.691 0.796 . . . . 0.0 110.575 -176.135 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.1 ptpt -101.34 -16.67 16.84 Favored 'General case' 0 C--N 1.317 -0.842 0 CA-C-O 121.344 0.592 . . . . 0.0 110.515 -178.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 17.9 mm-40 -81.75 128.71 34.27 Favored 'General case' 0 C--N 1.306 -1.321 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.351 -178.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.01 150.85 48.67 Favored 'General case' 0 N--CA 1.435 -1.215 0 CA-C-O 121.559 0.695 . . . . 0.0 111.997 -177.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 31.8 p -76.5 124.96 28.38 Favored 'General case' 0 C--N 1.285 -2.235 0 CA-C-N 114.841 -1.072 . . . . 0.0 110.832 -176.581 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.439 ' C ' ' H ' ' A' ' 648' ' ' GLU . 47.5 mtmt -99.82 -12.28 20.03 Favored 'General case' 0 C--N 1.303 -1.437 0 C-N-CA 120.418 -0.513 . . . . 0.0 110.105 178.597 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.498 ' HA ' ' HD3' ' A' ' 632' ' ' PRO . 43.4 mt-10 67.92 -12.94 0.28 Allowed 'General case' 0 N--CA 1.486 1.362 0 C-N-CA 125.11 1.364 . . . . 0.0 113.841 176.803 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.439 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.1 tt0 -148.91 108.49 3.99 Favored 'General case' 0 N--CA 1.411 -2.405 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 176.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.834 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 4.5 m-85 -105.75 -65.85 1.03 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 121.035 0.445 . . . . 0.0 110.201 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.491 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 127.81 -117.55 2.65 Favored Glycine 0 N--CA 1.419 -2.448 0 N-CA-C 109.868 -1.293 . . . . 0.0 109.868 -179.688 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.598 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 75.6 t60 -138.38 157.32 46.46 Favored 'General case' 0 C--N 1.284 -2.274 0 N-CA-C 108.227 -1.027 . . . . 0.0 108.227 179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.6 p 62.59 12.16 5.29 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.408 1.483 . . . . 0.0 113.104 176.589 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.834 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 9.0 mm-40 -76.5 136.64 39.35 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 114.984 -1.007 . . . . 0.0 109.297 178.6 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.589 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 11.6 t -112.27 139.59 36.18 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.95 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 -176.855 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.508 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 9.7 t -126.3 137.7 56.96 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 C-N-CA 123.679 0.792 . . . . 0.0 109.585 -179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.5 ' HG3' ' HG3' ' A' ' 670' ' ' LYS . 32.8 tt0 -109.15 127.49 54.23 Favored 'General case' 0 N--CA 1.434 -1.254 0 CA-C-O 121.818 0.818 . . . . 0.0 111.342 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.576 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 64.8 m-85 -97.45 164.32 12.5 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.698 -1.137 . . . . 0.0 110.288 176.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 31.6 p90 -135.4 149.48 49.65 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 107.202 -1.407 . . . . 0.0 107.202 175.401 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.501 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.3 m -95.52 160.03 14.71 Favored 'General case' 0 C--N 1.277 -2.55 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 171.291 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -55.21 155.33 9.31 Favored Pre-proline 0 C--N 1.3 -1.571 0 CA-C-N 115.326 -0.852 . . . . 0.0 111.888 177.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.05 11.01 0.34 Allowed 'Trans proline' 0 N--CA 1.487 1.095 0 C-N-CA 123.388 2.725 . . . . 0.0 113.3 -177.721 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.721 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 22.0 ptt180 -126.51 -6.48 6.38 Favored 'General case' 0 N--CA 1.433 -1.279 0 CA-C-O 121.858 0.837 . . . . 0.0 111.37 175.162 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.415 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 40.4 m-85 -122.36 146.45 47.31 Favored 'General case' 0 C--N 1.299 -1.623 0 CA-C-N 114.996 -1.002 . . . . 0.0 111.514 179.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.647 HD11 ' HB3' ' A' ' 711' ' ' TYR . 6.4 mp -105.14 146.45 29.17 Favored 'General case' 0 C--N 1.277 -2.556 0 CA-C-N 115.763 -0.653 . . . . 0.0 109.983 -178.169 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.445 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.4 tpp -75.07 116.89 16.31 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.489 178.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.501 ' HD2' HG21 ' A' ' 685' ' ' ILE . 63.8 tttm -102.45 -37.51 7.98 Favored 'General case' 0 C--N 1.311 -1.102 0 CA-C-O 121.339 0.59 . . . . 0.0 110.62 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -91.73 -172.25 42.43 Favored Glycine 0 C--N 1.308 -0.977 0 C-N-CA 120.713 -0.756 . . . . 0.0 112.374 -178.094 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -77.6 108.87 2.65 Favored 'Trans proline' 0 N--CA 1.447 -1.246 0 C-N-CA 122.312 2.008 . . . . 0.0 110.49 177.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.555 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 24.5 p-10 -71.96 -10.24 59.5 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-N 114.923 -1.035 . . . . 0.0 112.309 -176.287 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.508 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 35.7 mtmt -114.92 129.45 56.71 Favored 'General case' 0 C--N 1.283 -2.315 0 CA-C-O 121.351 0.596 . . . . 0.0 110.69 -178.823 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.707 HG21 HD12 ' A' ' 681' ' ' LEU . 48.5 pt -124.72 165.83 21.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.369 0 CA-C-N 115.299 -0.864 . . . . 0.0 109.878 -174.918 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.579 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 28.5 tt0 -137.53 139.83 40.72 Favored 'General case' 0 C--N 1.283 -2.317 0 C-N-CA 123.092 0.557 . . . . 0.0 110.381 -176.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.2 t -83.43 105.88 14.73 Favored 'General case' 0 C--N 1.295 -1.801 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 177.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 30.9 m -90.81 -171.03 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.674 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.753 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -74.42 77.97 1.9 Allowed 'General case' 0 C--N 1.311 -1.087 0 CA-C-O 122.498 1.142 . . . . 0.0 112.084 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.424 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 140.4 -39.3 1.49 Allowed Glycine 0 N--CA 1.432 -1.601 0 CA-C-N 114.683 -1.144 . . . . 0.0 113.359 172.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.92 -179.53 7.08 Favored 'General case' 0 C--N 1.31 -1.131 0 O-C-N 122.634 -0.333 . . . . 0.0 110.281 -177.112 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -90.81 161.62 15.2 Favored 'General case' 0 C--N 1.3 -1.546 0 N-CA-C 108.673 -0.862 . . . . 0.0 108.673 174.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 35.1 p -71.74 -170.36 0.55 Allowed 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.339 0.59 . . . . 0.0 112.327 -178.594 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 18.9 m -69.21 112.75 6.0 Favored 'General case' 0 N--CA 1.427 -1.608 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.939 -176.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.707 HD12 HG21 ' A' ' 671' ' ' ILE . 1.8 mp -61.19 149.86 81.13 Favored Pre-proline 0 N--CA 1.431 -1.393 0 CA-C-N 114.539 -1.209 . . . . 0.0 112.508 175.341 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.735 ' HG2' HD13 ' A' ' 636' ' ' LEU . 37.2 Cg_endo -75.65 -173.49 1.66 Allowed 'Trans proline' 0 N--CA 1.445 -1.373 0 C-N-CA 123.249 2.632 . . . . 0.0 114.414 -179.928 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 85.2 t -140.18 138.79 37.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.875 0 N-CA-C 106.222 -1.769 . . . . 0.0 106.222 -176.519 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 81.0 m -111.55 136.72 50.35 Favored 'General case' 0 C--N 1.306 -1.3 0 N-CA-C 108.728 -0.842 . . . . 0.0 108.728 178.177 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.501 HG21 ' HD2' ' A' ' 666' ' ' LYS . 30.1 pt -132.83 139.85 48.72 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.52 0 O-C-N 123.536 0.523 . . . . 0.0 110.047 -178.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.471 HG22 ' H ' ' A' ' 688' ' ' GLU . 12.0 p -84.04 128.04 39.23 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.205 0 N-CA-C 108.793 -0.817 . . . . 0.0 108.793 178.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.475 ' HG2' HD11 ' A' ' 664' ' ' LEU . 4.1 pt-20 -77.28 -18.94 57.15 Favored 'General case' 0 N--CA 1.476 0.831 0 C-N-CA 118.9 -1.12 . . . . 0.0 109.333 176.912 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.693 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.261 11.4 pt-20 61.16 1.75 0.52 Allowed 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 128.269 2.628 . . . . 0.0 115.149 176.75 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 23.2 m -97.15 144.79 26.64 Favored 'General case' 0 C--N 1.281 -2.407 0 N-CA-C 105.422 -2.066 . . . . 0.0 105.422 175.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 59.2 p -113.34 165.89 12.01 Favored 'General case' 0 N--CA 1.414 -2.274 0 C-N-CA 119.615 -0.834 . . . . 0.0 112.364 -172.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.3 m -91.21 -8.66 47.87 Favored 'General case' 0 C--N 1.285 -2.22 0 CA-C-N 114.584 -1.189 . . . . 0.0 110.734 -175.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 93.86 -73.41 1.17 Allowed Glycine 0 CA--C 1.481 -2.041 0 CA-C-N 114.725 -1.125 . . . . 0.0 111.802 171.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.542 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.8 t70 -176.38 -171.45 0.41 Allowed 'General case' 0 C--N 1.31 -1.126 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 -179.453 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.637 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -66.35 132.08 94.33 Favored Pre-proline 0 N--CA 1.408 -2.569 0 C-N-CA 123.926 0.89 . . . . 0.0 110.509 175.729 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.636 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.8 Cg_endo -73.72 -176.82 2.75 Favored 'Trans proline' 0 C--N 1.32 -0.96 0 C-N-CA 123.725 2.95 . . . . 0.0 112.066 178.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.8 tt0 -102.65 126.71 49.84 Favored 'General case' 0 N--CA 1.404 -2.751 0 CA-C-N 115.058 -0.974 . . . . 0.0 108.831 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.599 HD23 ' HG2' ' A' ' 698' ' ' GLU . 3.8 tt -108.05 136.87 47.02 Favored 'General case' 0 C--N 1.286 -2.161 0 N-CA-C 104.597 -2.371 . . . . 0.0 104.597 174.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.599 ' HG2' HD23 ' A' ' 697' ' ' LEU . 13.8 pt-20 -39.72 -42.82 1.3 Allowed 'General case' 0 N--CA 1.475 0.807 0 C-N-CA 125.712 1.605 . . . . 0.0 112.901 -177.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 43.9 m80 -145.36 29.29 1.16 Allowed 'General case' 0 C--O 1.244 0.81 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 -176.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.489 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -140.9 168.65 25.22 Favored Glycine 0 N--CA 1.431 -1.681 0 CA-C-N 115.417 -0.811 . . . . 0.0 111.779 -177.53 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.4 p-90 -154.53 -153.93 0.48 Allowed 'General case' 0 C--N 1.294 -1.839 0 C-N-CA 125.636 1.574 . . . . 0.0 106.835 -177.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.495 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.68 158.66 43.84 Favored 'General case' 0 C--N 1.281 -2.391 0 C-N-CA 118.812 -1.155 . . . . 0.0 113.631 -167.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.543 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -99.22 -55.34 2.72 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.202 -0.908 . . . . 0.0 109.988 -178.953 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -120.68 143.1 48.91 Favored 'General case' 0 N--CA 1.429 -1.482 0 CA-C-N 115.617 -0.719 . . . . 0.0 110.024 -177.953 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 4.9 m -130.21 137.33 50.0 Favored 'General case' 0 N--CA 1.42 -1.954 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -176.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 29.6 t -127.44 92.4 43.44 Favored Pre-proline 0 C--N 1.316 -0.87 0 O-C-N 121.666 -0.646 . . . . 0.0 112.47 -178.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 9.2 Cg_endo -93.15 144.58 2.23 Favored 'Trans proline' 0 N--CA 1.433 -2.086 0 C-N-CA 122.865 2.377 . . . . 0.0 112.054 174.013 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 97.3 Cg_endo -74.22 132.24 26.45 Favored 'Cis proline' 0 C--O 1.248 1.012 0 C-N-CA 122.662 -1.807 . . . . 0.0 111.001 0.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.542 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -75.12 98.08 3.61 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 -178.141 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.721 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 26.7 m-85 -100.99 -177.31 3.42 Favored 'General case' 0 C--N 1.298 -1.66 0 CA-C-O 121.46 0.648 . . . . 0.0 111.277 176.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.647 ' HB3' HD11 ' A' ' 664' ' ' LEU . 11.4 t80 -70.61 135.14 48.21 Favored 'General case' 0 N--CA 1.433 -1.302 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.209 179.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 88.4 0.86 81.92 Favored Glycine 0 C--N 1.291 -1.965 0 CA-C-N 115.535 -0.757 . . . . 0.0 113.788 -179.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.8 t70 -81.88 173.16 12.5 Favored 'General case' 0 C--O 1.249 1.056 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 176.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -136.76 143.83 43.47 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-O 120.872 0.368 . . . . 0.0 110.207 -172.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.494 HG11 HG13 ' A' ' 694' ' ' ILE . 39.9 t -136.93 140.28 43.1 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.379 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.224 178.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.6 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 50.6 mt-10 -103.48 122.92 45.9 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.937 177.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.637 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.9 m-85 -97.79 152.16 19.44 Favored 'General case' 0 C--N 1.304 -1.403 0 C-N-CA 124.199 1.0 . . . . 0.0 111.512 178.497 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.543 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 54.2 t30 -138.23 147.79 44.1 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 107.306 -1.368 . . . . 0.0 107.306 179.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.504 ' SG ' ' HB2' ' A' ' 725' ' ' MET . 90.1 m -98.24 160.84 14.03 Favored 'General case' 0 C--N 1.273 -2.724 0 N-CA-C 109.803 -0.443 . . . . 0.0 109.803 -179.843 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . 0.413 ' HB2' ' HD1' ' A' ' 723' ' ' PHE . 60.1 m -56.62 147.15 23.17 Favored 'General case' 0 N--CA 1.44 -0.944 0 N-CA-C 109.018 -0.734 . . . . 0.0 109.018 172.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 28.6 tt0 -61.12 -28.05 68.82 Favored 'General case' 0 C--N 1.305 -1.327 0 C-N-CA 123.368 0.667 . . . . 0.0 111.858 -174.46 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 6.9 m -80.81 -2.38 46.97 Favored 'General case' 0 CA--C 1.554 1.112 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.201 178.517 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.413 ' HD1' ' HB2' ' A' ' 720' ' ' SER . 83.7 m-85 -124.8 151.63 44.93 Favored 'General case' 0 N--CA 1.435 -1.177 0 N-CA-C 109.612 -0.514 . . . . 0.0 109.612 -176.491 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.447 ' O ' ' HA ' ' A' ' 744' ' ' CYS . 10.4 t -112.86 140.14 47.91 Favored 'General case' 0 C--N 1.28 -2.453 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 -179.415 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.504 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 0.8 OUTLIER -87.05 128.88 35.09 Favored 'General case' 0 C--N 1.311 -1.1 0 CA-C-O 121.459 0.647 . . . . 0.0 112.154 -176.109 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.423 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 38.1 mt -106.2 99.59 8.84 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.842 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 135.79 -155.99 22.59 Favored Glycine 0 N--CA 1.418 -2.511 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -176.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.3 p-80 -112.23 168.15 9.85 Favored 'General case' 0 C--N 1.291 -1.949 0 O-C-N 123.79 0.347 . . . . 0.0 110.489 179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.466 ' HD2' ' OE1' ' A' ' 716' ' ' GLU . 18.2 ptt180 -82.1 -37.78 25.8 Favored 'General case' 0 C--N 1.291 -1.959 0 N-CA-C 113.672 0.99 . . . . 0.0 113.672 -177.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.6 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.8 p -99.34 132.24 44.8 Favored 'General case' 0 C--N 1.314 -0.943 0 N-CA-C 116.364 1.987 . . . . 0.0 116.364 -170.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.668 HG21 HD23 ' A' ' 741' ' ' LEU . 8.3 pt -112.28 169.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.657 0 CA-C-N 114.569 -1.196 . . . . 0.0 109.768 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 27.6 m -136.01 139.82 43.41 Favored 'General case' 0 C--N 1.286 -2.167 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 -179.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 44.4 t -82.03 118.63 23.16 Favored 'General case' 0 C--N 1.298 -1.674 0 C-N-CA 119.608 -0.837 . . . . 0.0 111.626 178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.599 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -125.8 104.45 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.914 0 CA-C-N 114.085 -1.416 . . . . 0.0 109.145 -179.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . 0.453 ' HD2' HG22 ' A' ' 734' ' ' ILE . 88.2 m-70 71.58 33.59 1.8 Allowed 'General case' 0 N--CA 1.487 1.42 0 C-N-CA 123.925 0.89 . . . . 0.0 112.41 177.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 89.16 -8.77 79.08 Favored Glycine 0 CA--C 1.49 -1.525 0 C-N-CA 120.717 -0.754 . . . . 0.0 111.922 -179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.599 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.3 m -118.25 148.39 21.12 Favored 'Isoleucine or valine' 1 N--CA 1.376 -4.159 0 N-CA-C 107.423 -1.325 . . . . 0.0 107.423 -174.707 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.636 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 87.4 m95 -86.81 152.46 22.46 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 176.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.4 p -33.02 -71.39 0.06 Allowed 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.252 1.945 . . . . 0.0 116.252 -172.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.42 -30.46 0.05 Allowed 'General case' 0 C--N 1.307 -1.268 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -173.603 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.668 HD23 HG21 ' A' ' 731' ' ' ILE . 17.5 mt 67.91 147.23 0.11 Allowed Pre-proline 0 CA--C 1.54 0.579 0 O-C-N 124.92 1.388 . . . . 0.0 111.816 -177.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.431 ' HG2' HD11 ' A' ' 697' ' ' LEU . 60.2 Cg_endo -76.73 -179.65 5.58 Favored 'Trans proline' 0 N--CA 1.448 -1.151 0 C-N-CA 122.217 1.945 . . . . 0.0 110.683 175.846 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.423 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 20.2 pt20 -123.12 129.73 51.84 Favored 'General case' 0 C--N 1.288 -2.097 0 N-CA-C 109.041 -0.725 . . . . 0.0 109.041 175.876 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.957 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.7 m -100.76 120.52 40.22 Favored 'General case' 0 C--N 1.284 -2.244 0 N-CA-C 107.797 -1.186 . . . . 0.0 107.797 -177.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 28.8 m -115.5 151.18 17.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 123.509 0.506 . . . . 0.0 109.926 -172.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.78 114.36 4.98 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 124.311 1.007 . . . . 0.0 110.71 -179.561 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 65.9 mt . . . . . 0 C--N 1.309 -1.161 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 174.608 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.237 0.402 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -123.51 112.91 18.05 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 107.124 -1.436 . . . . 0.0 107.124 175.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 45.9 tt0 -86.62 116.26 24.62 Favored 'General case' 0 C--N 1.294 -1.835 0 CA-C-O 121.129 0.49 . . . . 0.0 110.733 -176.479 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -78.35 136.94 37.8 Favored 'General case' 0 N--CA 1.432 -1.347 0 N-CA-C 107.723 -1.214 . . . . 0.0 107.723 174.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -65.03 112.25 3.25 Favored 'General case' 0 C--N 1.312 -1.03 0 CA-C-O 121.126 0.489 . . . . 0.0 110.936 -177.494 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -134.43 52.94 0.8 Allowed Glycine 0 N--CA 1.423 -2.233 0 N-CA-C 109.321 -1.511 . . . . 0.0 109.321 178.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 5.8 m -155.71 66.74 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 C-N-CA 124.521 1.129 . . . . 0.0 110.688 -173.094 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.485 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 1.7 pp0? -80.31 -153.21 0.08 Allowed 'General case' 0 C--N 1.283 -2.301 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 175.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 44.2 p -157.58 158.74 36.15 Favored 'General case' 0 C--N 1.274 -2.693 0 CA-C-O 121.156 0.503 . . . . 0.0 111.314 -174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.418 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 10.2 p -142.05 -170.96 3.26 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 -176.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -122.6 -136.24 4.82 Favored Glycine 0 N--CA 1.402 -3.588 0 N-CA-C 109.32 -1.512 . . . . 0.0 109.32 179.678 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.598 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 25.1 Cg_exo -61.26 142.19 95.48 Favored 'Trans proline' 0 C--O 1.249 1.041 0 C-N-CA 122.45 2.1 . . . . 0.0 111.411 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HD2' HG22 ' A' ' 645' ' ' THR . 18.6 Cg_endo -58.72 154.49 42.95 Favored 'Trans proline' 0 C--O 1.25 1.083 0 C-N-CA 122.929 2.419 . . . . 0.0 111.849 178.2 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.594 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.5 Cg_endo -65.08 -167.23 0.1 OUTLIER 'Trans proline' 0 C--O 1.253 1.237 0 C-N-CA 123.042 2.494 . . . . 0.0 111.546 176.075 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -110.43 159.79 17.17 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 119.104 -1.039 . . . . 0.0 109.709 -177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.651 ' HB2' ' CD2' ' A' ' 657' ' ' TYR . 33.7 tp -95.96 140.89 30.05 Favored 'General case' 0 C--N 1.287 -2.114 0 C-N-CA 120.398 -0.521 . . . . 0.0 109.651 177.103 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.499 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.9 tt -32.74 -62.16 0.25 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 127.258 2.223 . . . . 0.0 111.556 175.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.604 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.7 t30 -123.2 -33.97 3.21 Favored 'General case' 0 C--N 1.315 -0.916 0 C-N-CA 119.59 -0.844 . . . . 0.0 111.831 -178.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.773 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -90.14 -142.94 10.0 Favored Glycine 0 CA--C 1.502 -0.726 0 C-N-CA 120.251 -0.976 . . . . 0.0 110.727 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -166.63 -173.34 2.42 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-N 117.563 0.681 . . . . 0.0 109.577 -179.624 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.478 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.4 p -101.82 131.05 50.52 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 C-N-CA 123.746 0.818 . . . . 0.0 109.815 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.485 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 7.7 ptpt -91.75 -13.03 32.26 Favored 'General case' 0 C--N 1.312 -1.044 0 CA-C-O 121.54 0.686 . . . . 0.0 109.563 -176.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.628 ' HG3' ' H ' ' A' ' 656' ' ' GLU . 10.5 mm-40 -76.67 144.2 39.57 Favored 'General case' 0 N--CA 1.434 -1.262 0 CA-C-N 114.617 -1.174 . . . . 0.0 108.991 -178.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 19.0 ptmt -66.77 152.2 45.97 Favored 'General case' 0 C--N 1.306 -1.317 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 175.575 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.558 HG22 ' HD2' ' A' ' 633' ' ' PRO . 37.1 p -95.01 120.05 34.55 Favored 'General case' 0 C--N 1.299 -1.625 0 C-N-CA 120.313 -0.555 . . . . 0.0 110.241 177.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.3 mtmt -83.99 -20.73 32.31 Favored 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.058 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.598 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 35.5 mt-10 70.22 -13.77 0.42 Allowed 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 125.265 1.426 . . . . 0.0 113.105 177.797 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -132.49 103.49 6.2 Favored 'General case' 0 N--CA 1.423 -1.807 0 N-CA-C 107.587 -1.264 . . . . 0.0 107.587 174.776 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.449 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.8 m-85 -116.36 -173.51 2.38 Favored 'General case' 0 C--N 1.293 -1.862 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 -179.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.48 ' H ' ' HG3' ' A' ' 653' ' ' GLU . . . -156.18 -155.91 7.6 Favored Glycine 0 N--CA 1.418 -2.562 0 N-CA-C 109.71 -1.356 . . . . 0.0 109.71 -177.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 79.3 t60 -78.02 135.79 37.83 Favored 'General case' 0 C--N 1.285 -2.208 0 CA-C-O 120.528 0.204 . . . . 0.0 111.014 -177.326 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 23.5 m 75.23 18.11 2.47 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.579 1.152 . . . . 0.0 112.903 174.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.48 ' HG3' ' H ' ' A' ' 650' ' ' GLY . 11.1 mm-40 -84.98 130.87 34.55 Favored 'General case' 0 C--N 1.316 -0.875 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 175.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.508 HG12 ' HB2' ' A' ' 672' ' ' GLN . 12.9 m -111.89 147.65 15.61 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.801 0 CA-C-O 121.819 0.819 . . . . 0.0 112.995 -178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.521 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 16.5 t -128.12 135.11 63.63 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.5 0 CA-C-N 114.384 -1.28 . . . . 0.0 109.775 -178.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.628 ' H ' ' HG3' ' A' ' 643' ' ' GLU . 40.2 tt0 -107.26 132.32 53.22 Favored 'General case' 0 N--CA 1.426 -1.651 0 CA-C-O 122.07 0.938 . . . . 0.0 111.393 -179.101 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 68.3 m-85 -106.44 166.37 10.59 Favored 'General case' 0 C--N 1.288 -2.095 0 CA-C-N 114.514 -1.221 . . . . 0.0 111.069 -179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.485 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 46.0 p90 -140.0 151.47 45.51 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 106.033 -1.839 . . . . 0.0 106.033 175.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.773 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 91.4 m -96.46 162.1 13.63 Favored 'General case' 0 C--N 1.284 -2.272 0 N-CA-C 109.028 -0.731 . . . . 0.0 109.028 174.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.604 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.5 OUTLIER -54.78 152.99 11.87 Favored Pre-proline 0 C--O 1.216 -0.668 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 175.346 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.534 ' HB2' ' OD2' ' A' ' 713' ' ' ASP . 64.5 Cg_endo -66.14 1.91 2.14 Favored 'Trans proline' 0 CA--C 1.547 1.144 0 C-N-CA 123.676 2.917 . . . . 0.0 114.995 -171.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . . . . . . . . . 16.5 ptt-85 -119.97 -4.73 10.1 Favored 'General case' 0 C--N 1.315 -0.927 0 CA-C-O 121.837 0.827 . . . . 0.0 111.044 177.85 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.47 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 32.4 m-85 -115.11 142.42 46.68 Favored 'General case' 0 C--N 1.307 -1.251 0 CA-C-N 115.192 -0.913 . . . . 0.0 110.241 177.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.679 ' HG ' ' HB2' ' A' ' 687' ' ' GLU . 16.3 mt -98.98 140.27 33.38 Favored 'General case' 0 C--N 1.287 -2.118 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.644 -177.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.599 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.1 tpp -70.64 109.76 5.09 Favored 'General case' 0 C--N 1.296 -1.726 0 CA-C-N 114.575 -1.193 . . . . 0.0 109.697 175.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.561 ' HD2' HD13 ' A' ' 685' ' ' ILE . 61.7 tttm -96.14 -34.47 11.67 Favored 'General case' 0 C--N 1.287 -2.12 0 CA-C-N 115.46 -0.791 . . . . 0.0 109.581 179.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.64 -172.98 39.37 Favored Glycine 0 CA--C 1.537 1.435 0 CA-C-N 115.388 -0.824 . . . . 0.0 113.917 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 80.2 Cg_endo -75.75 -4.91 15.85 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 123.359 2.706 . . . . 0.0 113.419 -175.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.653 ' HA ' ' HG3' ' A' ' 682' ' ' PRO . 2.6 p-10 52.11 3.88 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.167 0 C-N-CA 127.339 2.255 . . . . 0.0 115.864 179.072 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.521 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 85.9 mttt -137.81 137.26 38.0 Favored 'General case' 0 CA--C 1.473 -2.015 0 N-CA-C 108.876 -0.786 . . . . 0.0 108.876 179.313 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.586 HG21 ' HG ' ' A' ' 681' ' ' LEU . 42.3 pt -129.09 166.26 27.04 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.16 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.508 ' HB2' HG12 ' A' ' 654' ' ' VAL . 29.1 tt0 -137.41 139.89 40.98 Favored 'General case' 0 C--N 1.28 -2.44 0 O-C-N 123.717 0.635 . . . . 0.0 109.334 -176.297 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 38.6 t -85.01 108.16 17.48 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 177.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.1 m -94.83 -166.81 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.996 -0.682 . . . . 0.0 110.194 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.485 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 6.0 p-10 -79.29 58.76 2.65 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.976 0.893 . . . . 0.0 112.188 -179.228 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.417 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 166.12 -38.39 0.26 Allowed Glycine 0 N--CA 1.415 -2.73 0 C-N-CA 120.308 -0.949 . . . . 0.0 112.415 172.163 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.1 pt-20 -160.69 -178.53 6.92 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 110.145 -0.317 . . . . 0.0 110.145 -177.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -85.46 158.29 20.23 Favored 'General case' 0 C--N 1.298 -1.634 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 173.918 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 40.6 p -76.87 -174.72 3.18 Favored 'General case' 0 C--N 1.3 -1.585 0 N-CA-C 112.765 0.654 . . . . 0.0 112.765 -176.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 41.7 m -60.06 114.79 3.03 Favored 'General case' 0 C--O 1.249 1.046 0 CA-C-O 121.181 0.515 . . . . 0.0 111.341 -178.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.594 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.6 mp -73.12 151.13 90.27 Favored Pre-proline 0 C--N 1.304 -1.375 0 N-CA-C 113.493 0.923 . . . . 0.0 113.493 176.608 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.653 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 91.2 Cg_endo -74.1 178.32 7.07 Favored 'Trans proline' 0 CA--C 1.468 -2.803 0 C-N-CA 123.626 2.884 . . . . 0.0 113.032 174.861 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.537 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.9 m -139.11 163.25 26.94 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.965 0 CA-C-N 112.279 -2.237 . . . . 0.0 107.293 -175.094 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.47 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 82.4 m -129.11 142.35 50.91 Favored 'General case' 0 C--N 1.286 -2.154 0 N-CA-C 108.779 -0.822 . . . . 0.0 108.779 -179.694 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.561 HD13 ' HD2' ' A' ' 666' ' ' LYS . 25.9 pt -134.77 148.59 29.26 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.141 0 N-CA-C 109.091 -0.707 . . . . 0.0 109.091 178.528 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 10.9 p -86.54 117.06 30.28 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.912 0 CA-C-O 122.673 1.225 . . . . 0.0 111.573 -178.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.679 ' HB2' ' HG ' ' A' ' 664' ' ' LEU . 6.1 tp10 -60.09 -46.61 89.03 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-N 112.813 -1.994 . . . . 0.0 109.954 175.549 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.615 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 0.0 OUTLIER 63.56 61.53 1.01 Allowed 'General case' 0 N--CA 1.447 -0.616 0 CA-C-N 114.612 -1.176 . . . . 0.0 110.237 -178.492 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 56.0 m -157.5 143.78 17.77 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 177.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . 0.427 ' HA ' ' HA ' ' A' ' 710' ' ' TYR . 26.0 p -121.94 159.66 26.45 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 123.396 0.435 . . . . 0.0 111.569 -177.057 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 1.3 m -85.59 -21.38 28.52 Favored 'General case' 0 C--N 1.32 -0.687 0 N-CA-C 112.215 0.45 . . . . 0.0 112.215 177.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 110.63 -78.95 0.25 Allowed Glycine 0 C--N 1.306 -1.131 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -177.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.645 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 4.8 t0 -162.6 -168.01 1.71 Allowed 'General case' 0 C--N 1.317 -0.823 0 N-CA-C 107.434 -1.321 . . . . 0.0 107.434 177.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.632 HG12 HG11 ' A' ' 715' ' ' VAL . 2.9 mt -77.81 132.31 68.38 Favored Pre-proline 0 C--N 1.282 -2.339 0 C-N-CA 125.11 1.364 . . . . 0.0 111.079 176.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.539 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 69.7 Cg_endo -72.94 -169.04 0.45 Allowed 'Trans proline' 0 N--CA 1.445 -1.357 0 C-N-CA 123.39 2.727 . . . . 0.0 111.584 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -115.11 136.04 53.55 Favored 'General case' 0 C--N 1.272 -2.791 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 -178.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.7 HD23 ' HA3' ' A' ' 700' ' ' GLY . 26.4 tp -116.2 145.21 43.29 Favored 'General case' 0 C--N 1.294 -1.844 0 N-CA-C 106.697 -1.594 . . . . 0.0 106.697 179.068 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.48 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.5 pt-20 -45.33 -45.35 12.3 Favored 'General case' 0 N--CA 1.479 1.017 0 N-CA-C 113.336 0.865 . . . . 0.0 113.336 -175.34 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.4 m80 -142.97 27.38 1.63 Allowed 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 121.743 0.782 . . . . 0.0 109.055 -176.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.7 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -136.27 168.28 24.13 Favored Glycine 0 N--CA 1.436 -1.311 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.799 -178.174 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.7 p-90 -156.14 -151.49 0.34 Allowed 'General case' 0 N--CA 1.418 -2.051 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -176.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.457 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -135.46 144.7 46.57 Favored 'General case' 0 C--N 1.279 -2.465 0 C-N-CA 118.91 -1.116 . . . . 0.0 113.095 -168.819 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.556 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -83.58 -59.78 2.33 Favored 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 121.604 0.716 . . . . 0.0 109.301 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.41 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.0 pp -115.97 139.87 49.82 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 115.384 -0.825 . . . . 0.0 110.456 -178.485 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.533 ' O ' ' HD3' ' A' ' 707' ' ' PRO . 12.9 m -118.16 122.85 44.09 Favored 'General case' 0 C--N 1.282 -2.364 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 6.0 m -115.44 87.03 15.91 Favored Pre-proline 0 C--N 1.301 -1.503 0 C-N-CA 119.819 -0.753 . . . . 0.0 111.511 -176.138 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.533 ' HD3' ' O ' ' A' ' 705' ' ' SER . 12.8 Cg_endo -95.86 150.75 1.4 Allowed 'Trans proline' 0 N--CA 1.439 -1.733 0 C-N-CA 123.07 2.513 . . . . 0.0 112.805 178.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.497 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 56.5 Cg_endo -70.9 130.61 18.34 Favored 'Cis proline' 0 C--O 1.237 0.472 0 C-N-CA 123.101 -1.625 . . . . 0.0 111.047 -1.582 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.645 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 18.5 m-85 -75.43 91.44 2.75 Favored 'General case' 0 C--N 1.311 -1.077 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 -177.069 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.615 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 9.3 m-85 -85.26 170.22 13.02 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 122.542 0.337 . . . . 0.0 111.427 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.557 ' HB3' ' HG2' ' A' ' 687' ' ' GLU . 2.0 t80 -62.41 132.5 52.77 Favored 'General case' 0 C--N 1.325 -0.475 0 N-CA-C 106.269 -1.752 . . . . 0.0 106.269 171.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.19 -10.19 69.74 Favored Glycine 0 N--CA 1.433 -1.552 0 C-N-CA 120.227 -0.987 . . . . 0.0 112.041 -179.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.534 ' OD2' ' HB2' ' A' ' 661' ' ' PRO . 3.8 t70 -75.97 173.27 11.44 Favored 'General case' 0 C--O 1.247 0.964 0 N-CA-C 108.888 -0.782 . . . . 0.0 108.888 178.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . 0.4 ' HA ' ' O ' ' A' ' 731' ' ' ILE . 1.0 OUTLIER -139.72 147.44 40.9 Favored 'General case' 0 C--N 1.3 -1.584 0 CA-C-O 121.51 0.671 . . . . 0.0 110.912 -173.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.632 HG11 HG12 ' A' ' 694' ' ' ILE . 38.8 t -138.32 142.95 33.95 Favored 'Isoleucine or valine' 0 N--CA 1.409 -2.485 0 CA-C-N 114.758 -1.11 . . . . 0.0 109.219 177.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.612 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 43.6 mt-10 -110.36 121.43 45.28 Favored 'General case' 0 N--CA 1.424 -1.747 0 CA-C-O 121.501 0.667 . . . . 0.0 110.464 176.652 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.6 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -92.9 147.54 22.76 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 125.163 1.385 . . . . 0.0 111.128 -179.607 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.556 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 3.3 t-20 -129.33 130.86 46.65 Favored 'General case' 0 C--N 1.295 -1.767 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.428 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.1 m -88.28 143.37 27.06 Favored 'General case' 0 C--N 1.277 -2.547 0 N-CA-C 107.543 -1.281 . . . . 0.0 107.543 174.352 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 28.9 m -50.95 139.8 16.65 Favored 'General case' 0 CA--C 1.539 0.519 0 O-C-N 123.647 0.592 . . . . 0.0 109.504 177.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -49.97 -35.7 25.33 Favored 'General case' 0 CA--C 1.554 1.121 0 N-CA-C 114.649 1.352 . . . . 0.0 114.649 -172.024 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.8 m -76.61 0.19 21.06 Favored 'General case' 0 N--CA 1.477 0.881 0 CA-C-O 121.787 0.803 . . . . 0.0 111.655 178.68 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 93.7 m-85 -117.99 147.94 42.7 Favored 'General case' 0 N--CA 1.414 -2.229 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 178.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.462 ' HB ' HG12 ' A' ' 747' ' ' ILE . 9.3 t -109.38 138.29 45.96 Favored 'General case' 0 C--N 1.269 -2.904 0 N-CA-C 108.107 -1.072 . . . . 0.0 108.107 178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.661 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 2.6 ptm -90.04 135.47 33.63 Favored 'General case' 0 N--CA 1.43 -1.47 0 CA-C-O 121.259 0.552 . . . . 0.0 110.672 -175.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.446 ' HB ' ' CG ' ' A' ' 743' ' ' GLN . 43.7 mt -115.37 113.04 42.31 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 177.066 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.67 -156.27 16.09 Favored Glycine 0 N--CA 1.428 -1.843 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -176.534 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.5 t-160 -109.89 139.64 44.76 Favored 'General case' 0 N--CA 1.43 -1.463 0 C-N-CA 119.208 -0.997 . . . . 0.0 110.684 -177.818 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 22.2 ptt180 -61.27 -35.11 76.39 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-N 114.554 -1.203 . . . . 0.0 112.887 177.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.612 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 12.9 p -94.56 148.53 22.16 Favored 'General case' 0 N--CA 1.425 -1.697 0 C-N-CA 119.031 -1.068 . . . . 0.0 112.937 -174.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.664 HG21 HD23 ' A' ' 741' ' ' LEU . 9.0 pt -131.19 165.45 31.46 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.556 0 CA-C-N 114.725 -1.125 . . . . 0.0 109.546 178.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.463 ' H ' HG23 ' A' ' 739' ' ' THR . 36.2 m -132.64 134.26 44.64 Favored 'General case' 0 C--N 1.29 -1.983 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.9 t -70.48 111.73 6.23 Favored 'General case' 0 C--N 1.31 -1.118 0 C-N-CA 122.815 0.446 . . . . 0.0 111.375 -179.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.5 mm -125.5 110.47 24.43 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.926 0 CA-C-O 121.014 0.435 . . . . 0.0 111.099 -176.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 29.5 m-70 68.73 13.31 8.87 Favored 'General case' 0 N--CA 1.49 1.533 0 C-N-CA 124.667 1.187 . . . . 0.0 112.154 177.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.79 2.79 46.27 Favored Glycine 0 N--CA 1.442 -0.953 0 C-N-CA 120.719 -0.753 . . . . 0.0 111.316 -178.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.73 130.66 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.682 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.539 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 84.8 m95 -63.32 156.86 24.46 Favored 'General case' 0 C--N 1.303 -1.427 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.463 HG23 ' H ' ' A' ' 732' ' ' THR . 25.2 p -37.87 -71.69 0.07 Allowed 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 115.498 1.666 . . . . 0.0 115.498 -174.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -166.54 -26.89 0.03 OUTLIER 'General case' 0 CA--C 1.507 -0.707 0 N-CA-C 114.844 1.424 . . . . 0.0 114.844 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.664 HD23 HG21 ' A' ' 731' ' ' ILE . 20.8 mt 69.42 153.33 0.14 Allowed Pre-proline 0 N--CA 1.475 0.805 0 C-N-CA 124.408 1.083 . . . . 0.0 111.908 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.661 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 67.3 Cg_endo -81.61 -168.65 0.64 Allowed 'Trans proline' 0 CA--C 1.541 0.836 0 C-N-CA 122.642 2.228 . . . . 0.0 111.589 176.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.446 ' CG ' ' HB ' ' A' ' 726' ' ' ILE . 27.9 pt20 -131.93 137.31 47.9 Favored 'General case' 0 C--N 1.306 -1.283 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 175.029 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.877 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.3 m -110.15 121.15 44.58 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 110.002 -0.37 . . . . 0.0 110.002 -177.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.6 m -120.32 146.31 25.35 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.146 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 -175.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.31 117.73 7.03 Favored 'General case' 0 C--N 1.317 -0.828 0 O-C-N 123.407 0.442 . . . . 0.0 110.566 -179.311 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.462 HG12 ' HB ' ' A' ' 724' ' ' THR . 68.7 mt . . . . . 0 C--O 1.252 1.213 0 O-C-N 124.398 1.061 . . . . 0.0 110.782 178.053 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 . . . . . 0 C--O 1.241 0.635 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 72.75 -75.48 0.08 Allowed 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 125.321 1.448 . . . . 0.0 111.036 -178.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . 0.408 ' CD ' ' H ' ' A' ' 624' ' ' ALA . 0.0 OUTLIER -145.83 -62.89 0.33 Allowed 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 179.126 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . 0.408 ' H ' ' CD ' ' A' ' 623' ' ' GLU . . . -177.84 -34.55 0.01 OUTLIER 'General case' 0 C--O 1.24 0.56 0 C-N-CA 122.822 0.449 . . . . 0.0 110.77 -176.786 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . 55.79 69.19 0.76 Allowed 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.615 1.166 . . . . 0.0 111.554 -176.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -80.3 40.33 2.36 Favored Glycine 0 C--N 1.311 -0.855 0 N-CA-C 111.636 -0.586 . . . . 0.0 111.636 179.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.584 ' HA ' ' HB2' ' A' ' 651' ' ' HIS . 8.4 p 179.64 52.12 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.553 1.088 0 CA-C-O 123.16 1.457 . . . . 0.0 108.099 -176.289 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 4.2 pp0? -54.56 -26.0 29.5 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-N 114.449 -1.251 . . . . 0.0 112.854 -178.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 1.009 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 41.1 m 85.66 121.42 0.04 OUTLIER 'General case' 0 C--N 1.322 -0.613 0 C-N-CA 125.828 1.651 . . . . 0.0 113.971 174.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.458 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 27.4 p -120.55 154.8 34.86 Favored 'General case' 0 C--O 1.259 1.591 0 CA-C-N 114.151 -1.386 . . . . 0.0 108.386 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -96.32 -136.84 9.05 Favored Glycine 0 N--CA 1.413 -2.872 0 C-N-CA 120.83 -0.7 . . . . 0.0 111.602 177.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.987 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 35.1 Cg_exo -56.35 148.74 59.9 Favored 'Trans proline' 0 CA--C 1.536 0.591 0 C-N-CA 124.077 3.185 . . . . 0.0 114.135 -178.091 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.573 ' HB3' HG21 ' A' ' 655' ' ' VAL . 29.6 Cg_endo -64.8 153.14 79.37 Favored 'Trans proline' 0 C--O 1.249 1.07 0 C-N-CA 122.877 2.385 . . . . 0.0 112.468 178.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.538 ' HG2' HD21 ' A' ' 681' ' ' LEU . 20.9 Cg_endo -67.95 -170.76 0.3 Allowed 'Trans proline' 0 C--O 1.253 1.241 0 C-N-CA 123.288 2.659 . . . . 0.0 112.249 176.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -109.65 144.47 37.96 Favored 'General case' 0 N--CA 1.435 -1.202 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.237 -179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.0 tp -84.01 147.17 27.58 Favored 'General case' 0 C--N 1.295 -1.8 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 176.862 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.536 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.6 tm? -34.37 -66.17 0.18 Allowed 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 125.809 1.644 . . . . 0.0 111.152 174.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -110.63 -51.77 2.84 Favored 'General case' 0 N--CA 1.431 -1.382 0 C-N-CA 118.614 -1.234 . . . . 0.0 110.109 -177.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.533 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -81.48 -147.56 5.86 Favored Glycine 0 C--N 1.34 0.802 0 C-N-CA 121.389 -0.434 . . . . 0.0 112.535 -176.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.4 ' CG ' ' H ' ' A' ' 641' ' ' VAL . 2.6 t-20 -166.4 -167.3 0.99 Allowed 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 117.928 0.864 . . . . 0.0 110.592 -176.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.447 HG13 HG13 ' A' ' 655' ' ' VAL . 83.7 t -90.32 133.07 33.28 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.647 0 C-N-CA 125.53 1.532 . . . . 0.0 109.425 -176.415 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.55 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.0 ptpt -94.05 -12.08 29.31 Favored 'General case' 0 C--N 1.319 -0.746 0 CA-C-O 121.683 0.754 . . . . 0.0 109.971 179.023 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -87.75 158.07 18.88 Favored 'General case' 0 N--CA 1.426 -1.656 0 CA-C-N 114.149 -1.387 . . . . 0.0 108.676 179.865 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 55.3 mtpt -88.18 165.43 15.09 Favored 'General case' 0 C--N 1.29 -1.993 0 N-CA-C 109.681 -0.488 . . . . 0.0 109.681 179.204 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.432 ' HB ' ' HG3' ' A' ' 647' ' ' GLU . 38.0 p -82.49 118.02 22.93 Favored 'General case' 0 N--CA 1.408 -2.548 0 CA-C-O 121.319 0.581 . . . . 0.0 110.628 -178.881 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -86.83 -29.31 22.34 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 177.455 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.987 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 41.8 mt-10 67.13 -3.68 0.95 Allowed 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 125.678 1.591 . . . . 0.0 113.441 173.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -133.85 82.78 2.0 Allowed 'General case' 0 N--CA 1.432 -1.361 0 N-CA-C 107.353 -1.351 . . . . 0.0 107.353 174.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.59 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 16.2 m-85 -95.08 -72.25 0.63 Allowed 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.104 -179.627 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 1.009 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.77 -71.82 0.27 Allowed Glycine 0 C--N 1.295 -1.73 0 C-N-CA 119.497 -1.335 . . . . 0.0 113.844 172.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.584 ' HB2' ' HA ' ' A' ' 627' ' ' VAL . 86.4 t60 -165.9 145.3 6.22 Favored 'General case' 0 N--CA 1.444 -0.725 0 N-CA-C 110.254 -0.276 . . . . 0.0 110.254 -178.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 78.4 p 62.48 14.63 7.14 Favored 'General case' 0 N--CA 1.473 0.692 0 C-N-CA 126.313 1.845 . . . . 0.0 113.019 176.262 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.462 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 16.1 mm-40 -83.71 142.07 30.99 Favored 'General case' 0 C--N 1.305 -1.335 0 CA-C-N 114.373 -1.285 . . . . 0.0 108.173 178.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 14.7 m -120.81 153.7 24.16 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.818 0 CA-C-O 121.274 0.559 . . . . 0.0 111.744 -178.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.573 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.6 t -135.03 134.44 53.24 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 CA-C-N 115.044 -0.98 . . . . 0.0 109.154 -179.33 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -100.76 128.68 46.71 Favored 'General case' 0 N--CA 1.416 -2.17 0 CA-C-O 121.942 0.877 . . . . 0.0 110.8 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.494 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 56.8 m-85 -100.94 157.44 16.74 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-N 114.262 -1.336 . . . . 0.0 110.942 178.699 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.55 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 44.1 p90 -133.21 151.0 51.95 Favored 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 107.006 -1.479 . . . . 0.0 107.006 174.639 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.533 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 98.9 m -94.19 154.31 17.63 Favored 'General case' 0 C--N 1.264 -3.138 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 171.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -49.97 156.43 1.31 Allowed Pre-proline 0 C--O 1.193 -1.881 0 N-CA-C 113.501 0.926 . . . . 0.0 113.501 -179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_exo -47.54 -30.53 12.22 Favored 'Trans proline' 0 C--O 1.212 -0.809 0 C-N-CA 123.883 3.055 . . . . 0.0 114.052 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.59 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 41.1 ptt180 -97.6 -9.96 25.99 Favored 'General case' 0 C--O 1.238 0.448 0 N-CA-C 113.004 0.742 . . . . 0.0 113.004 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.487 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 55.6 m-85 -111.8 150.31 30.51 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.933 0.873 . . . . 0.0 112.531 -178.801 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.963 HD11 ' HB3' ' A' ' 711' ' ' TYR . 11.0 mp -112.61 151.09 30.51 Favored 'General case' 0 C--N 1.284 -2.256 0 CA-C-O 121.412 0.625 . . . . 0.0 110.99 179.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.626 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.1 tpp -76.93 127.99 33.73 Favored 'General case' 0 C--N 1.286 -2.189 0 CA-C-N 113.825 -1.534 . . . . 0.0 110.048 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 61.5 tttp -112.35 -45.14 3.29 Favored 'General case' 0 C--N 1.303 -1.418 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.088 178.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.05 -171.57 47.66 Favored Glycine 0 CA--C 1.521 0.458 0 C-N-CA 121.055 -0.593 . . . . 0.0 113.353 -176.113 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 38.3 Cg_endo -68.49 104.04 1.05 Allowed 'Trans proline' 0 C--N 1.351 0.697 0 C-N-CA 122.847 2.364 . . . . 0.0 111.374 179.655 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.626 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -72.47 6.18 2.53 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.84 -1.073 . . . . 0.0 113.663 -173.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.47 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 91.6 mttt -132.97 136.19 45.93 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.745 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.471 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.4 pt -122.75 167.37 16.42 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.847 0 N-CA-C 108.714 -0.847 . . . . 0.0 108.714 179.974 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.462 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -135.06 139.2 44.58 Favored 'General case' 0 C--N 1.292 -1.893 0 O-C-N 123.671 0.607 . . . . 0.0 110.971 -176.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 48.5 t -82.03 104.13 12.15 Favored 'General case' 0 C--N 1.3 -1.555 0 CA-C-N 115.335 -0.848 . . . . 0.0 109.381 175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 79.1 t -83.22 171.24 1.25 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.432 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 177.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -75.64 72.35 2.58 Favored 'General case' 0 N--CA 1.439 -1.004 0 CA-C-O 122.6 1.19 . . . . 0.0 110.592 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 160.58 -41.73 0.43 Allowed Glycine 0 N--CA 1.423 -2.204 0 CA-C-N 114.861 -1.063 . . . . 0.0 111.742 175.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -162.5 179.48 7.74 Favored 'General case' 0 C--N 1.308 -1.205 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 -173.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.5 m95 -90.44 169.95 10.63 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.619 -0.512 . . . . 0.0 109.619 177.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.6 p -84.19 -168.32 2.11 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 123.14 0.576 . . . . 0.0 112.238 -178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 48.1 m -69.85 113.34 6.99 Favored 'General case' 0 N--CA 1.429 -1.491 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.053 -179.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.538 HD21 ' HG2' ' A' ' 634' ' ' PRO . 7.2 mp -69.88 153.59 95.36 Favored Pre-proline 0 C--N 1.311 -1.108 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.913 176.09 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 43.2 Cg_endo -70.88 -167.09 0.25 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 122.997 2.465 . . . . 0.0 113.523 179.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 14.4 p -150.59 149.55 14.25 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.206 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 -178.526 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 73.3 m -116.27 143.66 45.23 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 123.461 0.475 . . . . 0.0 110.503 -175.16 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.42 HD13 ' HD2' ' A' ' 666' ' ' LYS . 28.4 pt -136.39 147.89 27.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.598 0 C-N-CA 123.736 0.814 . . . . 0.0 108.918 -179.509 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.421 HG22 ' H ' ' A' ' 688' ' ' GLU . 9.1 p -87.43 130.38 37.3 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.271 0 CA-C-O 122.837 1.303 . . . . 0.0 110.294 179.041 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.577 ' HB2' HD13 ' A' ' 664' ' ' LEU . 7.9 tp10 -74.57 -37.75 62.86 Favored 'General case' 0 C--N 1.273 -2.73 0 CA-C-N 112.836 -1.983 . . . . 0.0 108.959 177.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.835 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 27.1 mt-10 66.89 5.86 4.28 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.887 1.275 . . . . 0.0 113.706 -178.132 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.443 ' H ' ' HG3' ' A' ' 687' ' ' GLU . 7.0 t -96.46 149.04 22.18 Favored 'General case' 0 N--CA 1.426 -1.633 0 N-CA-C 106.545 -1.65 . . . . 0.0 106.545 176.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 23.0 p -136.08 159.47 41.62 Favored 'General case' 0 C--N 1.284 -2.244 0 CA-C-N 116.566 -0.288 . . . . 0.0 110.8 -174.163 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 22.2 m -92.46 -13.35 30.09 Favored 'General case' 0 C--N 1.304 -1.378 0 CA-C-O 121.061 0.458 . . . . 0.0 111.356 177.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.63 -63.56 1.33 Allowed Glycine 0 N--CA 1.437 -1.264 0 C-N-CA 120.775 -0.726 . . . . 0.0 112.474 175.145 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.421 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.7 t70 -173.95 -168.93 0.44 Allowed 'General case' 0 C--N 1.302 -1.46 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 -177.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.615 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -68.63 137.55 90.66 Favored Pre-proline 0 C--N 1.276 -2.602 0 C-N-CA 123.469 0.708 . . . . 0.0 109.745 172.272 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.687 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -73.85 -168.64 0.47 Allowed 'Trans proline' 0 N--CA 1.46 -0.466 0 C-N-CA 123.296 2.664 . . . . 0.0 110.903 177.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -118.33 119.14 33.74 Favored 'General case' 0 N--CA 1.408 -2.541 0 C-N-CA 119.7 -0.8 . . . . 0.0 110.223 -178.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 1.004 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -94.23 144.49 25.47 Favored 'General case' 0 N--CA 1.417 -2.105 0 N-CA-C 106.209 -1.775 . . . . 0.0 106.209 177.161 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.593 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 8.2 pt-20 -44.89 -46.33 10.82 Favored 'General case' 0 C--N 1.318 -0.779 0 C-N-CA 124.154 0.982 . . . . 0.0 112.872 -178.321 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 45.5 m80 -143.29 15.67 1.86 Allowed 'General case' 0 N--CA 1.437 -1.092 0 CA-C-O 121.521 0.677 . . . . 0.0 109.854 -174.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 1.004 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -122.65 -179.14 15.77 Favored Glycine 0 N--CA 1.432 -1.574 0 CA-C-N 115.085 -0.961 . . . . 0.0 111.649 -179.102 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.2 p-90 -162.47 -153.77 0.28 Allowed 'General case' 0 C--N 1.304 -1.384 0 C-N-CA 125.405 1.482 . . . . 0.0 107.138 -173.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.5 161.95 36.66 Favored 'General case' 0 C--N 1.284 -2.27 0 C-N-CA 120.22 -0.592 . . . . 0.0 111.242 -168.888 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.61 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.3 OUTLIER -98.04 -54.85 2.96 Favored 'General case' 0 CA--C 1.489 -1.371 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 179.53 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.0 pp -111.61 147.07 36.26 Favored 'General case' 0 N--CA 1.415 -2.185 0 CA-C-N 114.288 -1.324 . . . . 0.0 111.048 -175.234 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.454 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 5.4 p -128.52 117.97 22.22 Favored 'General case' 0 N--CA 1.412 -2.348 0 CA-C-N 114.941 -1.027 . . . . 0.0 108.243 175.436 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.6 p -116.71 94.7 44.48 Favored Pre-proline 0 C--N 1.288 -2.091 0 N-CA-C 113.558 0.947 . . . . 0.0 113.558 -175.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.463 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 6.6 Cg_endo -93.02 152.61 2.63 Favored 'Trans proline' 0 N--CA 1.437 -1.803 0 C-N-CA 123.149 2.566 . . . . 0.0 111.806 175.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.463 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.3 Cg_endo -72.92 134.12 33.54 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 C-N-CA 122.963 -1.682 . . . . 0.0 111.047 -1.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.454 ' OH ' ' HB2' ' A' ' 705' ' ' SER . 18.6 m-85 -76.78 78.76 3.39 Favored 'General case' 0 C--N 1.313 -1.006 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -178.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.835 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 14.4 m-85 -92.48 174.01 7.5 Favored 'General case' 0 C--N 1.295 -1.767 0 CA-C-N 116.072 -0.513 . . . . 0.0 110.724 177.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.963 ' HB3' HD11 ' A' ' 664' ' ' LEU . 9.6 t80 -60.47 128.94 39.16 Favored 'General case' 0 N--CA 1.429 -1.507 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.765 -179.076 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 100.15 -16.34 58.3 Favored Glycine 0 N--CA 1.429 -1.817 0 C-N-CA 120.426 -0.893 . . . . 0.0 113.566 176.646 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -75.37 175.86 8.01 Favored 'General case' 0 C--O 1.252 1.215 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 178.152 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -141.36 150.64 42.69 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-O 121.538 0.685 . . . . 0.0 111.147 -170.526 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.503 HG11 HG13 ' A' ' 694' ' ' ILE . 42.4 t -134.49 143.51 37.67 Favored 'Isoleucine or valine' 0 C--N 1.277 -2.571 0 CA-C-N 114.929 -1.032 . . . . 0.0 109.388 177.01 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.495 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 25.3 mt-10 -105.7 127.64 53.19 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-O 121.161 0.505 . . . . 0.0 109.966 175.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.615 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.5 m-85 -101.6 153.83 19.4 Favored 'General case' 0 C--N 1.294 -1.812 0 C-N-CA 124.933 1.293 . . . . 0.0 110.312 179.708 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.61 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 29.2 t-20 -143.25 169.51 17.49 Favored 'General case' 0 C--N 1.288 -2.104 0 N-CA-C 104.741 -2.318 . . . . 0.0 104.741 177.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.513 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 48.2 t -117.36 160.56 20.94 Favored 'General case' 0 C--N 1.253 -3.614 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 -178.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 56.6 m -61.37 145.12 52.64 Favored 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 173.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 41.8 tt0 -68.39 -21.32 64.7 Favored 'General case' 0 CA--C 1.546 0.813 0 N-CA-C 113.678 0.992 . . . . 0.0 113.678 -171.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 49.5 m -78.48 -2.0 36.45 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-O 122.244 1.021 . . . . 0.0 110.392 175.738 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.416 ' HB2' ' SG ' ' A' ' 719' ' ' CYS . 97.5 m-85 -127.48 159.49 34.38 Favored 'General case' 0 N--CA 1.41 -2.473 0 N-CA-C 107.926 -1.138 . . . . 0.0 107.926 179.127 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.6 t -120.2 138.74 53.46 Favored 'General case' 0 C--N 1.267 -2.987 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 175.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.513 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 12.2 ptm -91.41 145.78 24.35 Favored 'General case' 0 N--CA 1.42 -1.944 0 CA-C-O 121.561 0.696 . . . . 0.0 110.174 -176.534 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 49.5 mt -118.71 112.83 39.6 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.616 0 N-CA-C 107.424 -1.325 . . . . 0.0 107.424 176.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 131.37 -153.51 20.44 Favored Glycine 0 C--N 1.287 -2.16 0 N-CA-C 111.156 -0.778 . . . . 0.0 111.156 179.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -113.08 159.61 19.02 Favored 'General case' 0 CA--C 1.443 -3.147 0 CA-C-O 122.673 1.225 . . . . 0.0 111.418 -179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.7 mtp180 -74.87 -51.03 14.95 Favored 'General case' 1 N--CA 1.376 -4.162 0 CA-C-N 111.253 -2.703 . . . . 0.0 110.535 -175.196 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.495 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 28.7 p -89.43 139.74 30.21 Favored 'General case' 0 C--N 1.287 -2.138 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -167.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.672 HG21 HD23 ' A' ' 741' ' ' LEU . 12.2 pt -124.06 162.9 24.61 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.787 0 CA-C-N 114.361 -1.291 . . . . 0.0 109.246 178.572 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.407 ' H ' HG23 ' A' ' 739' ' ' THR . 28.5 m -128.05 135.7 50.21 Favored 'General case' 0 C--N 1.287 -2.114 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 -177.462 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 54.0 t -71.67 105.6 3.76 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.551 0.532 . . . . 0.0 110.795 -179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.5 mm -115.2 96.34 4.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.101 0 CA-C-O 122.154 0.978 . . . . 0.0 111.405 -177.876 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . 0.499 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 95.4 m-70 67.58 18.06 9.95 Favored 'General case' 0 N--CA 1.487 1.395 0 C-N-CA 126.042 1.737 . . . . 0.0 112.496 173.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 114.62 -2.17 23.33 Favored Glycine 0 C--N 1.291 -1.929 0 CA-C-N 114.681 -1.145 . . . . 0.0 112.423 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 27.3 t -129.27 135.6 61.44 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.93 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 178.667 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.687 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 86.4 m95 -72.64 161.15 31.14 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.777 -0.823 . . . . 0.0 108.777 176.633 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.522 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 21.3 p -43.12 -74.17 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.896 0 N-CA-C 116.545 2.054 . . . . 0.0 116.545 -173.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.611 HE21 ' N ' ' A' ' 741' ' ' LEU . 0.0 OUTLIER -162.28 -28.23 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.128 0 N-CA-C 114.418 1.266 . . . . 0.0 114.418 -172.068 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.672 HD23 HG21 ' A' ' 731' ' ' ILE . 20.1 mt 69.71 157.99 0.15 Allowed Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 124.531 1.144 . . . . 0.0 111.477 178.113 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.412 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.6 Cg_endo -77.29 -162.9 0.18 Allowed 'Trans proline' 0 CA--C 1.543 0.939 0 C-N-CA 121.875 1.717 . . . . 0.0 110.737 174.642 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.417 HE21 ' HB3' ' A' ' 743' ' ' GLN . 3.0 pt20 -146.39 140.98 26.74 Favored 'General case' 0 C--N 1.304 -1.413 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 176.333 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.601 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 80.2 m -100.19 156.92 16.94 Favored 'General case' 0 C--N 1.297 -1.675 0 C-N-CA 120.516 -0.473 . . . . 0.0 112.214 -179.063 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 4.8 m -145.33 147.96 18.15 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 175.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.31 126.9 31.95 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-O 120.729 0.3 . . . . 0.0 111.6 -175.275 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.9 mt . . . . . 0 C--N 1.308 -1.211 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 176.253 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.517 -0.317 0 N-CA-C 110.472 -0.195 . . . . 0.0 110.472 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 58.45 83.84 0.11 Allowed 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 124.318 1.047 . . . . 0.0 113.456 177.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -122.99 146.6 47.48 Favored 'General case' 0 C--N 1.303 -1.441 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 62.7 -78.74 0.03 OUTLIER 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 124.463 1.105 . . . . 0.0 111.513 -176.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -83.55 90.46 7.24 Favored 'General case' 0 N--CA 1.438 -1.064 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 176.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 111.97 113.48 3.31 Favored Glycine 0 N--CA 1.428 -1.883 0 N-CA-C 110.27 -1.132 . . . . 0.0 110.27 -177.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.442 HG23 ' CB ' ' A' ' 651' ' ' HIS 0.296 11.3 p 47.99 51.72 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-O 123.757 1.741 . . . . 0.0 113.184 178.997 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.43 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -58.52 -28.04 65.07 Favored 'General case' 0 C--N 1.305 -1.369 0 CA-C-N 112.781 -2.008 . . . . 0.0 112.647 177.734 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.679 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 51.9 m 74.17 108.12 0.07 Allowed 'General case' 0 C--N 1.313 -1.003 0 C-N-CA 124.779 1.232 . . . . 0.0 114.242 173.861 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 29.0 p -99.0 164.77 12.05 Favored 'General case' 0 C--O 1.265 1.895 0 CA-C-N 115.673 -0.694 . . . . 0.0 109.387 176.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -103.02 -134.95 8.52 Favored Glycine 0 N--CA 1.42 -2.387 0 N-CA-C 110.699 -0.96 . . . . 0.0 110.699 176.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.62 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 50.1 Cg_exo -53.75 144.05 55.88 Favored 'Trans proline' 0 CA--C 1.544 0.976 0 C-N-CA 123.679 2.919 . . . . 0.0 113.28 -178.243 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.577 ' HB3' HG21 ' A' ' 655' ' ' VAL . 28.7 Cg_endo -63.92 158.71 45.77 Favored 'Trans proline' 0 C--O 1.247 0.936 0 C-N-CA 123.296 2.664 . . . . 0.0 112.459 -177.883 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.567 ' HG2' HD21 ' A' ' 681' ' ' LEU . 12.4 Cg_endo -72.49 -169.91 0.53 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.425 2.083 . . . . 0.0 112.062 176.584 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -101.85 165.69 11.06 Favored 'General case' 0 C--N 1.289 -2.058 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.403 -178.284 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.696 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.6 tp -112.9 140.6 47.57 Favored 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 177.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.455 ' H ' HD12 ' A' ' 636' ' ' LEU . 5.7 tt -28.16 -64.78 0.09 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 127.597 2.359 . . . . 0.0 112.105 179.131 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -124.48 -33.53 3.01 Favored 'General case' 0 C--N 1.314 -0.944 0 C-N-CA 120.049 -0.66 . . . . 0.0 110.406 -179.82 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.726 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -85.46 -146.05 8.4 Favored Glycine 0 C--N 1.309 -0.963 0 C-N-CA 120.752 -0.737 . . . . 0.0 111.418 175.48 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -170.31 -169.91 0.89 Allowed 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 118.02 0.91 . . . . 0.0 111.412 179.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 93.5 t -84.66 133.59 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.427 -1.575 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.695 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.6 ptpt -94.83 -16.57 22.84 Favored 'General case' 0 C--N 1.303 -1.419 0 CA-C-O 121.405 0.621 . . . . 0.0 110.07 -179.691 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -90.82 160.07 15.95 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 -179.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 14.9 ptpt -86.11 168.41 14.07 Favored 'General case' 0 C--N 1.295 -1.762 0 C-N-CA 119.471 -0.892 . . . . 0.0 110.928 175.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 73.0 p -83.93 125.61 32.19 Favored 'General case' 0 N--CA 1.404 -2.737 0 CA-C-N 115.157 -0.929 . . . . 0.0 110.82 -176.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 50.1 mtmt -86.08 -25.6 25.76 Favored 'General case' 0 C--N 1.305 -1.335 0 C-N-CA 120.342 -0.543 . . . . 0.0 109.752 177.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.62 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.0 mt-10 73.49 -17.41 0.43 Allowed 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 124.698 1.199 . . . . 0.0 112.574 178.133 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 45.2 tt0 -129.66 99.91 5.32 Favored 'General case' 0 N--CA 1.426 -1.667 0 N-CA-C 107.632 -1.247 . . . . 0.0 107.632 171.9 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.469 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.9 m-85 -104.57 -67.32 0.91 Allowed 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.165 -1.05 . . . . 0.0 108.165 177.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.679 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 107.1 -95.32 0.99 Allowed Glycine 0 C--N 1.289 -2.046 0 CA-C-N 115.292 -0.867 . . . . 0.0 112.09 175.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.442 ' CB ' HG23 ' A' ' 627' ' ' VAL . 83.9 t60 -148.26 149.06 31.2 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 109.224 -0.658 . . . . 0.0 109.224 -179.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.28 23.3 p 64.52 14.12 8.69 Favored 'General case' 0 CA--C 1.543 0.697 0 C-N-CA 126.07 1.748 . . . . 0.0 113.706 176.269 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.402 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 37.9 mm-40 -85.55 138.82 31.93 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 114.782 -1.099 . . . . 0.0 108.656 178.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.51 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.9 m -118.42 146.54 22.83 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 CA-C-O 121.568 0.699 . . . . 0.0 112.244 -177.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.577 HG21 ' HB3' ' A' ' 633' ' ' PRO . 60.9 t -126.02 135.13 64.8 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.318 0 CA-C-N 115.261 -0.881 . . . . 0.0 109.61 179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -98.29 123.05 42.17 Favored 'General case' 0 N--CA 1.419 -1.982 0 CA-C-O 121.936 0.874 . . . . 0.0 110.262 179.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 59.2 m-85 -97.92 160.65 14.17 Favored 'General case' 0 C--N 1.283 -2.292 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.796 177.901 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.695 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 39.0 p90 -136.12 143.99 44.85 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 174.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.726 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 60.4 m -84.54 161.45 20.2 Favored 'General case' 0 C--N 1.278 -2.52 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 174.165 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.582 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -55.66 154.05 14.05 Favored Pre-proline 0 C--O 1.207 -1.163 0 N-CA-C 108.091 -1.077 . . . . 0.0 108.091 179.609 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.582 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 27.4 Cg_endo -58.81 -13.75 19.45 Favored 'Trans proline' 0 N--CA 1.493 1.492 0 C-N-CA 123.727 2.952 . . . . 0.0 115.136 -170.536 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.53 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 12.9 ptt180 -108.67 -4.09 17.35 Favored 'General case' 0 C--N 1.309 -1.164 0 CA-C-O 121.888 0.852 . . . . 0.0 111.76 178.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.461 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 43.2 m-85 -110.3 148.74 31.33 Favored 'General case' 0 C--N 1.294 -1.831 0 CA-C-N 114.978 -1.01 . . . . 0.0 111.277 177.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.955 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.8 mp -106.25 145.48 31.53 Favored 'General case' 0 C--N 1.281 -2.403 0 CA-C-N 115.082 -0.963 . . . . 0.0 110.871 -179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.589 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 48.9 tpp -77.03 113.85 15.19 Favored 'General case' 0 C--N 1.29 -2.012 0 CA-C-N 114.314 -1.312 . . . . 0.0 109.625 178.39 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.552 ' HB3' HG23 ' A' ' 683' ' ' VAL . 21.6 tptm -101.9 -25.16 13.89 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 178.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -82.35 -174.61 50.04 Favored Glycine 0 C--N 1.307 -1.036 0 CA-C-N 115.22 -0.9 . . . . 0.0 112.36 -178.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -78.07 8.81 3.31 Favored 'Trans proline' 0 C--O 1.214 -0.709 0 C-N-CA 123.05 2.5 . . . . 0.0 113.812 -177.208 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.589 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.31 10.1 p-10 49.92 -46.82 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.914 0 C-N-CA 128.72 2.808 . . . . 0.0 116.925 -177.946 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.555 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.6 mttt -94.93 142.24 27.71 Favored 'General case' 0 C--N 1.272 -2.802 0 C-N-CA 123.796 0.839 . . . . 0.0 110.278 -177.971 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.694 HG21 ' HG ' ' A' ' 681' ' ' LEU . 41.2 pt -129.88 164.56 32.26 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.729 0 CA-C-N 115.459 -0.791 . . . . 0.0 108.897 178.325 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.402 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.3 tt0 -129.44 135.97 49.33 Favored 'General case' 0 C--N 1.292 -1.92 0 C-N-CA 123.957 0.903 . . . . 0.0 110.254 -176.506 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 49.8 t -82.8 98.74 9.29 Favored 'General case' 0 N--CA 1.421 -1.915 0 N-CA-C 106.484 -1.673 . . . . 0.0 106.484 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 3.3 p -91.5 -178.72 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.397 -3.079 0 N-CA-C 107.466 -1.309 . . . . 0.0 107.466 -176.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -77.41 74.65 3.97 Favored 'General case' 0 C--N 1.317 -0.829 0 CA-C-O 122.506 1.146 . . . . 0.0 113.161 -175.458 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.43 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 159.23 -39.67 0.49 Allowed Glycine 0 N--CA 1.417 -2.6 0 CA-C-N 114.139 -1.391 . . . . 0.0 112.249 173.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 17.0 pt-20 -167.01 -174.01 2.54 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.428 ' CE3' HG13 ' A' ' 671' ' ' ILE . 85.5 m95 -84.16 164.98 18.82 Favored 'General case' 0 C--N 1.296 -1.733 0 N-CA-C 109.851 -0.426 . . . . 0.0 109.851 177.038 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.4 p -76.9 -174.76 3.21 Favored 'General case' 0 C--N 1.304 -1.405 0 C-N-CA 122.707 0.403 . . . . 0.0 111.292 -179.63 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.2 m -64.58 111.19 2.61 Favored 'General case' 0 N--CA 1.439 -0.981 0 CA-C-O 121.388 0.613 . . . . 0.0 110.83 -179.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.694 ' HG ' HG21 ' A' ' 671' ' ' ILE . 4.0 mp -68.15 151.17 97.4 Favored Pre-proline 0 N--CA 1.435 -1.176 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 179.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.696 ' HG2' HD13 ' A' ' 636' ' ' LEU . 72.7 Cg_endo -72.23 176.63 8.29 Favored 'Trans proline' 0 CA--C 1.468 -2.795 0 C-N-CA 123.425 2.75 . . . . 0.0 113.754 176.72 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.552 HG23 ' HB3' ' A' ' 666' ' ' LYS . 34.8 m -136.81 159.0 37.34 Favored 'Isoleucine or valine' 1 N--CA 1.36 -4.937 0 CA-C-N 112.156 -2.293 . . . . 0.0 107.71 -175.226 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 92.1 m -121.54 150.14 42.08 Favored 'General case' 0 C--N 1.28 -2.435 0 CA-C-N 115.646 -0.707 . . . . 0.0 109.319 -179.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.7 pt -141.93 147.9 21.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.363 0 N-CA-C 108.451 -0.944 . . . . 0.0 108.451 177.812 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.461 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 13.9 p -91.27 123.56 43.46 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.166 0 CA-C-O 122.511 1.148 . . . . 0.0 110.026 177.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.499 ' HG3' ' HB2' ' A' ' 689' ' ' SER . 9.5 tp10 -65.39 -38.5 90.16 Favored 'General case' 0 C--N 1.286 -2.187 0 CA-C-N 113.24 -1.8 . . . . 0.0 109.154 176.235 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.402 ' H ' HG22 ' A' ' 686' ' ' VAL . 30.5 tt0 66.26 21.51 11.02 Favored 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 122.417 1.103 . . . . 0.0 109.579 177.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.499 ' HB2' ' HG3' ' A' ' 687' ' ' GLU . 16.8 m -122.08 142.96 49.83 Favored 'General case' 0 N--CA 1.435 -1.185 0 N-CA-C 106.859 -1.534 . . . . 0.0 106.859 178.798 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 21.0 p -114.02 168.7 9.58 Favored 'General case' 0 C--N 1.295 -1.791 0 CA-C-O 120.779 0.323 . . . . 0.0 110.806 -176.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.5 m -100.26 -16.15 17.82 Favored 'General case' 0 C--N 1.294 -1.822 0 CA-C-O 121.824 0.821 . . . . 0.0 110.607 -177.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 107.68 -89.99 0.61 Allowed Glycine 0 CA--C 1.484 -1.845 0 CA-C-N 114.833 -1.076 . . . . 0.0 110.898 175.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.708 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t0 -152.46 -172.23 4.17 Favored 'General case' 0 C--N 1.289 -2.042 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 178.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.629 HG12 HG11 ' A' ' 715' ' ' VAL . 1.4 mt -72.83 132.7 82.82 Favored Pre-proline 0 N--CA 1.406 -2.648 0 C-N-CA 125.129 1.372 . . . . 0.0 109.308 173.622 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.701 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 38.8 Cg_endo -68.35 177.01 4.96 Favored 'Trans proline' 0 N--CA 1.44 -1.62 0 C-N-CA 123.271 2.647 . . . . 0.0 112.857 -178.17 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.84 98.61 8.17 Favored 'General case' 0 C--N 1.275 -2.638 0 CA-C-N 114.926 -1.033 . . . . 0.0 111.769 -176.964 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.939 HD23 ' HA3' ' A' ' 700' ' ' GLY . 33.5 tp -81.4 135.66 35.67 Favored 'General case' 0 N--CA 1.424 -1.732 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 176.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.53 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.7 pt-20 -43.51 -42.67 5.06 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 124.568 1.147 . . . . 0.0 112.758 -176.915 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.53 ' N ' ' HG3' ' A' ' 698' ' ' GLU . 41.2 m80 -141.77 24.18 2.05 Favored 'General case' 0 N--CA 1.436 -1.164 0 CA-C-O 121.571 0.701 . . . . 0.0 109.966 -175.716 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.939 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.26 170.54 21.8 Favored Glycine 0 N--CA 1.436 -1.303 0 CA-C-N 114.737 -1.12 . . . . 0.0 111.835 177.872 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.1 p-90 -157.95 -152.14 0.33 Allowed 'General case' 0 C--N 1.303 -1.413 0 C-N-CA 126.158 1.783 . . . . 0.0 106.489 -176.07 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.492 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -142.1 156.13 45.38 Favored 'General case' 0 C--N 1.285 -2.209 0 CA-C-N 119.254 0.934 . . . . 0.0 111.366 -168.935 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.547 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.2 OUTLIER -90.07 -48.79 6.97 Favored 'General case' 0 CA--C 1.493 -1.217 0 N-CA-C 108.398 -0.964 . . . . 0.0 108.398 177.818 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.1 pp -115.31 148.81 38.78 Favored 'General case' 0 N--CA 1.419 -1.992 0 CA-C-N 114.395 -1.275 . . . . 0.0 111.059 -175.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 22.8 p -126.92 136.87 52.88 Favored 'General case' 0 C--N 1.289 -2.035 0 N-CA-C 107.01 -1.478 . . . . 0.0 107.01 174.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 1.9 p -130.8 78.31 73.92 Favored Pre-proline 0 C--N 1.293 -1.865 0 CA-C-O 121.532 0.682 . . . . 0.0 112.628 -179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.478 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.7 Cg_endo -91.71 147.8 3.32 Favored 'Trans proline' 0 N--CA 1.435 -1.932 0 C-N-CA 122.949 2.432 . . . . 0.0 112.653 179.091 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.478 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 81.4 Cg_endo -74.88 130.86 22.32 Favored 'Cis proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.669 -1.805 . . . . 0.0 110.898 -0.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.708 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 25.5 m-85 -73.06 106.84 5.09 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 107.906 -1.146 . . . . 0.0 107.906 -178.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.53 ' CB ' ' HA ' ' A' ' 662' ' ' ARG . 17.2 m-85 -100.59 173.56 6.49 Favored 'General case' 0 C--N 1.304 -1.41 0 CA-C-O 121.109 0.48 . . . . 0.0 110.909 177.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.955 ' HB3' HD11 ' A' ' 664' ' ' LEU . 3.7 t80 -62.95 134.62 56.48 Favored 'General case' 0 C--N 1.314 -0.949 0 CA-C-N 115.56 -0.745 . . . . 0.0 109.477 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.44 -14.74 64.73 Favored Glycine 0 N--CA 1.439 -1.136 0 C-N-CA 120.166 -1.016 . . . . 0.0 113.039 177.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.6 167.09 22.44 Favored 'General case' 0 C--O 1.254 1.342 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 179.054 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.2 m -131.2 155.32 47.27 Favored 'General case' 0 C--N 1.301 -1.527 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -173.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.629 HG11 HG12 ' A' ' 694' ' ' ILE . 25.4 t -144.65 134.69 19.54 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.176 0 CA-C-N 115.68 -0.691 . . . . 0.0 109.279 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.524 ' HG2' ' HB2' ' A' ' 730' ' ' SER . 17.2 mt-10 -100.06 122.79 43.48 Favored 'General case' 0 N--CA 1.417 -2.083 0 CA-C-O 121.733 0.778 . . . . 0.0 110.711 176.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.612 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -94.85 154.73 17.11 Favored 'General case' 0 C--N 1.283 -2.285 0 CA-C-N 113.598 -1.637 . . . . 0.0 109.52 178.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.547 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 64.9 t30 -134.93 152.22 51.55 Favored 'General case' 0 C--N 1.281 -2.377 0 N-CA-C 105.94 -1.874 . . . . 0.0 105.94 177.487 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.642 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 45.1 t -99.07 162.9 12.81 Favored 'General case' 0 C--N 1.258 -3.41 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -178.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 42.9 t -60.65 142.57 55.5 Favored 'General case' 0 N--CA 1.434 -1.226 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 170.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -67.95 -20.05 65.02 Favored 'General case' 0 C--N 1.306 -1.309 0 CA-C-O 121.131 0.491 . . . . 0.0 111.76 -174.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 16.3 m -87.48 0.26 55.8 Favored 'General case' 0 C--N 1.309 -1.177 0 CA-C-O 121.94 0.876 . . . . 0.0 110.341 179.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.402 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 51.1 m-85 -125.82 162.12 25.86 Favored 'General case' 0 N--CA 1.426 -1.659 0 N-CA-C 108.145 -1.057 . . . . 0.0 108.145 -178.455 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.4 t -118.57 137.75 53.03 Favored 'General case' 0 C--N 1.286 -2.162 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 176.285 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.642 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.4 ptm -95.45 138.49 33.06 Favored 'General case' 0 N--CA 1.425 -1.722 0 CA-C-O 121.329 0.585 . . . . 0.0 109.718 -175.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 37.4 mt -114.37 112.25 39.36 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.753 0 CA-C-N 115.516 -0.766 . . . . 0.0 108.994 179.084 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 122.07 -160.67 16.44 Favored Glycine 0 CA--C 1.478 -2.28 0 O-C-N 123.418 0.449 . . . . 0.0 112.61 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 12.9 t-160 -91.53 129.09 37.57 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.633 -0.506 . . . . 0.0 109.633 -174.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.435 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 13.4 ptt180 -68.96 -28.94 67.08 Favored 'General case' 0 C--N 1.297 -1.693 0 CA-C-N 114.832 -1.076 . . . . 0.0 110.825 179.799 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.529 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 32.2 t -102.3 150.41 23.35 Favored 'General case' 0 N--CA 1.43 -1.444 0 C-N-CA 119.165 -1.014 . . . . 0.0 110.31 -177.06 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.639 HG21 HD23 ' A' ' 741' ' ' LEU . 2.9 pt -128.46 175.73 9.4 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.613 0 CA-C-N 114.172 -1.376 . . . . 0.0 109.451 -177.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 70.3 m -143.76 135.13 25.92 Favored 'General case' 0 C--N 1.269 -2.891 0 N-CA-C 107.066 -1.457 . . . . 0.0 107.066 178.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.407 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.0 t -74.56 114.59 13.14 Favored 'General case' 0 C--N 1.286 -2.166 0 CA-C-O 120.946 0.403 . . . . 0.0 111.458 -178.765 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.5 mm -117.46 103.45 14.91 Favored 'Isoleucine or valine' 0 N--CA 1.415 -2.197 0 CA-C-N 115.349 -0.841 . . . . 0.0 109.39 179.042 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 91.3 m-70 61.5 41.8 12.15 Favored 'General case' 0 C--N 1.316 -0.871 0 CA-C-N 114.392 -1.276 . . . . 0.0 112.309 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 91.68 -11.67 71.48 Favored Glycine 0 N--CA 1.445 -0.738 0 CA-C-N 115.155 -0.93 . . . . 0.0 111.965 178.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 57.9 t -119.68 123.34 70.83 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.117 0 O-C-N 122.289 -0.536 . . . . 0.0 109.62 -175.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.701 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.5 m95 -63.83 142.4 58.42 Favored 'General case' 0 C--N 1.304 -1.401 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 176.328 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 28.0 p -28.72 -70.3 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 116.51 2.041 . . . . 0.0 116.51 -172.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -164.96 -28.99 0.03 OUTLIER 'General case' 0 CA--C 1.501 -0.922 0 N-CA-C 114.569 1.322 . . . . 0.0 114.569 -173.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.639 HD23 HG21 ' A' ' 731' ' ' ILE . 23.8 mt 69.01 156.25 0.15 Allowed Pre-proline 0 C--O 1.237 0.429 0 O-C-N 124.612 1.195 . . . . 0.0 110.988 -177.295 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.58 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 72.5 Cg_endo -80.29 -166.16 0.39 Allowed 'Trans proline' 0 N--CA 1.441 -1.593 0 C-N-CA 121.718 1.612 . . . . 0.0 109.842 174.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -137.58 135.53 36.73 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 175.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.463 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 89.0 m -94.5 138.56 32.27 Favored 'General case' 0 C--N 1.3 -1.572 0 C-N-CA 120.705 -0.398 . . . . 0.0 111.359 176.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 18.6 m -129.66 140.31 49.37 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.551 0 N-CA-C 108.071 -1.085 . . . . 0.0 108.071 176.588 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.23 119.83 12.77 Favored 'General case' 0 C--N 1.302 -1.489 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.501 -176.079 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 50.5 mt . . . . . 0 C--O 1.257 1.48 0 N-CA-C 108.365 -0.976 . . . . 0.0 108.365 176.733 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 43.5 mt-10 . . . . . 0 N--CA 1.443 -0.792 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -87.92 142.86 27.47 Favored 'General case' 0 C--N 1.301 -1.537 0 CA-C-N 115.523 -0.762 . . . . 0.0 111.045 -176.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -117.87 91.6 3.61 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 107.504 -1.295 . . . . 0.0 107.504 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -74.95 115.41 14.52 Favored 'General case' 0 N--CA 1.429 -1.524 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.741 -177.689 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -88.03 97.29 10.88 Favored 'General case' 0 N--CA 1.425 -1.708 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 177.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -114.11 69.17 0.24 Allowed Glycine 0 N--CA 1.41 -3.096 0 CA-C-N 115.552 -0.749 . . . . 0.0 111.552 -178.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.7 p -177.3 85.51 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.424 -1.739 0 CA-C-O 123.163 1.458 . . . . 0.0 110.065 -178.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.505 ' HG2' ' HA2' ' A' ' 676' ' ' GLY . 0.0 OUTLIER -88.29 -21.85 24.22 Favored 'General case' 0 C--N 1.272 -2.788 0 CA-C-N 113.503 -1.681 . . . . 0.0 111.675 177.25 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.517 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 67.7 m 81.7 106.52 0.06 Allowed 'General case' 0 C--N 1.309 -1.181 0 C-N-CA 125.764 1.625 . . . . 0.0 113.724 178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 57.4 m -86.55 155.95 20.27 Favored 'General case' 0 C--O 1.268 2.047 0 N-CA-C 108.458 -0.942 . . . . 0.0 108.458 172.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -109.55 -134.53 6.98 Favored Glycine 0 N--CA 1.407 -3.262 0 N-CA-C 109.192 -1.563 . . . . 0.0 109.192 178.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.797 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 39.2 Cg_exo -58.19 143.76 96.41 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 122.847 2.364 . . . . 0.0 112.322 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.718 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.71 150.75 87.68 Favored 'Trans proline' 0 CA--C 1.54 0.806 0 C-N-CA 122.602 2.202 . . . . 0.0 112.691 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.59 ' HG2' HD21 ' A' ' 681' ' ' LEU . 18.3 Cg_endo -69.69 -173.05 0.64 Allowed 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.762 2.974 . . . . 0.0 112.857 177.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -101.07 146.73 27.07 Favored 'General case' 0 C--O 1.244 0.786 0 C-N-CA 120.658 -0.417 . . . . 0.0 109.947 -178.361 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.849 HD12 ' HB3' ' A' ' 657' ' ' TYR . 4.5 tt -87.35 142.23 28.04 Favored 'General case' 0 C--N 1.312 -1.059 0 N-CA-C 107.601 -1.259 . . . . 0.0 107.601 177.691 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.642 ' N ' HD23 ' A' ' 636' ' ' LEU . 0.7 OUTLIER -33.26 -71.92 0.05 Allowed 'General case' 0 N--CA 1.486 1.345 0 C-N-CA 125.847 1.659 . . . . 0.0 110.16 173.953 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -133.73 41.09 3.06 Favored 'General case' 0 N--CA 1.429 -1.49 0 CA-C-O 123.569 1.652 . . . . 0.0 110.13 179.11 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.727 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -133.2 -148.79 5.99 Favored Glycine 1 C--N 1.234 -5.139 0 CA-C-N 112.727 -2.033 . . . . 0.0 108.862 177.579 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.408 ' ND2' ' H ' ' A' ' 641' ' ' VAL . 2.4 t-20 -172.22 178.33 2.89 Favored 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 -179.864 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.83 HG22 ' CE2' ' A' ' 657' ' ' TYR . 9.9 t -102.39 137.97 28.38 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.848 0 C-N-CA 124.168 0.987 . . . . 0.0 108.655 -177.186 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 13.6 ptpt -100.37 -10.54 21.1 Favored 'General case' 0 C--N 1.317 -0.834 0 CA-C-O 122.014 0.911 . . . . 0.0 109.339 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.451 ' H ' HG12 ' A' ' 641' ' ' VAL . 7.8 mm-40 -92.85 135.32 34.24 Favored 'General case' 0 C--N 1.301 -1.531 0 CA-C-N 114.202 -1.363 . . . . 0.0 109.534 -179.514 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 13.3 ptmm? -75.75 150.71 37.73 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 175.746 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.718 HG22 ' HD2' ' A' ' 633' ' ' PRO . 58.5 p -71.6 127.85 33.9 Favored 'General case' 0 C--N 1.28 -2.436 0 CA-C-N 115.971 -0.558 . . . . 0.0 110.617 -178.341 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -90.76 -20.96 21.8 Favored 'General case' 0 C--N 1.312 -1.033 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 176.205 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.797 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 69.43 -20.53 0.17 Allowed 'General case' 0 N--CA 1.486 1.352 0 C-N-CA 125.276 1.431 . . . . 0.0 113.509 179.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -127.64 94.83 4.06 Favored 'General case' 0 C--N 1.298 -1.657 0 N-CA-C 107.497 -1.297 . . . . 0.0 107.497 176.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.582 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 14.7 m-85 -102.89 -62.98 1.21 Allowed 'General case' 0 C--N 1.295 -1.799 0 CA-C-N 115.501 -0.772 . . . . 0.0 109.233 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.517 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 109.6 -102.17 1.56 Allowed Glycine 0 N--CA 1.425 -2.068 0 C-N-CA 120.011 -1.09 . . . . 0.0 111.168 178.876 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -149.14 154.54 39.35 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 -178.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 53.6 p 65.93 16.57 10.52 Favored 'General case' 0 N--CA 1.472 0.657 0 C-N-CA 125.254 1.422 . . . . 0.0 112.648 176.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.582 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 7.4 mm-40 -88.45 139.33 30.59 Favored 'General case' 0 C--N 1.309 -1.158 0 CA-C-N 114.143 -1.39 . . . . 0.0 109.897 -177.498 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.563 HG12 ' HB2' ' A' ' 672' ' ' GLN . 6.9 m -118.36 145.9 23.67 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.036 0 CA-C-O 121.607 0.717 . . . . 0.0 112.513 -179.053 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 633' ' ' PRO . 77.5 t -128.74 135.43 62.31 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.432 0 CA-C-N 115.101 -0.954 . . . . 0.0 108.645 178.49 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -101.01 133.54 45.35 Favored 'General case' 0 N--CA 1.421 -1.91 0 CA-C-O 121.552 0.692 . . . . 0.0 110.508 -179.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.849 ' HB3' HD12 ' A' ' 636' ' ' LEU . 53.3 m-85 -111.16 164.19 13.12 Favored 'General case' 0 C--N 1.293 -1.878 0 C-N-CA 124.313 1.045 . . . . 0.0 110.632 -179.451 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -137.68 158.07 45.14 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.881 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.506 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 96.2 m -95.01 165.56 12.38 Favored 'General case' 0 C--N 1.29 -2.005 0 CA-C-N 118.189 0.45 . . . . 0.0 110.041 178.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.527 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.4 OUTLIER -59.61 156.53 32.24 Favored Pre-proline 0 C--O 1.216 -0.705 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 174.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.527 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 73.2 Cg_endo -72.91 14.59 0.51 Allowed 'Trans proline' 0 N--CA 1.507 2.318 0 C-N-CA 123.878 3.052 . . . . 0.0 113.348 -174.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.604 ' O ' HG23 ' A' ' 686' ' ' VAL . 14.4 ptt180 -129.58 -6.29 4.67 Favored 'General case' 0 C--N 1.28 -2.426 0 CA-C-N 114.408 -1.269 . . . . 0.0 110.68 -179.352 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.421 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 38.2 m-85 -122.91 150.31 43.1 Favored 'General case' 0 C--N 1.294 -1.817 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 178.171 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.644 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.359 0.0 OUTLIER -114.9 137.65 51.72 Favored 'General case' 0 C--N 1.264 -3.117 0 CA-C-N 115.332 -0.849 . . . . 0.0 113.069 -179.948 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.514 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 57.3 tpp -60.98 114.0 2.84 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 113.866 -1.515 . . . . 0.0 112.492 -174.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 54.6 tttm -102.84 -33.56 9.31 Favored 'General case' 0 C--N 1.301 -1.51 0 CA-C-N 115.314 -0.857 . . . . 0.0 109.226 178.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -77.1 -172.57 37.18 Favored Glycine 0 CA--C 1.525 0.677 0 CA-C-N 115.149 -0.932 . . . . 0.0 113.621 -177.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.506 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 83.2 Cg_endo -76.37 -5.64 16.36 Favored 'Trans proline' 0 N--CA 1.485 0.998 0 C-N-CA 123.107 2.538 . . . . 0.0 112.786 -177.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.526 ' H ' ' HB3' ' A' ' 682' ' ' PRO . 1.4 p-10 56.45 -5.94 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.954 0 C-N-CA 128.025 2.53 . . . . 0.0 115.662 -179.648 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -133.06 133.87 43.6 Favored 'General case' 0 C--N 1.295 -1.785 0 C-N-CA 123.272 0.629 . . . . 0.0 109.616 179.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.63 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -121.32 166.67 15.59 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.73 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.563 ' HB2' HG12 ' A' ' 654' ' ' VAL . 54.3 tt0 -142.0 140.29 32.63 Favored 'General case' 0 N--CA 1.414 -2.268 0 O-C-N 123.753 0.658 . . . . 0.0 110.855 -175.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 8.9 t -80.04 108.67 13.81 Favored 'General case' 0 C--N 1.285 -2.206 0 CA-C-N 114.919 -1.037 . . . . 0.0 109.783 177.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.4 m -87.61 -165.47 0.1 OUTLIER 'Isoleucine or valine' 0 C--N 1.307 -1.258 0 N-CA-C 107.925 -1.139 . . . . 0.0 107.925 176.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 21.6 p-10 -89.12 73.19 8.2 Favored 'General case' 0 C--N 1.289 -2.026 0 CA-C-O 122.439 1.114 . . . . 0.0 111.251 -179.066 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.505 ' HA2' ' HG2' ' A' ' 628' ' ' GLN . . . 167.13 -55.95 0.23 Allowed Glycine 0 N--CA 1.424 -2.111 0 CA-C-N 113.882 -1.508 . . . . 0.0 111.18 176.244 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -156.03 -168.96 2.92 Favored 'General case' 0 C--N 1.293 -1.849 0 N-CA-C 108.376 -0.972 . . . . 0.0 108.376 -177.526 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.2 m95 -86.17 167.56 14.79 Favored 'General case' 0 C--N 1.294 -1.84 0 CA-C-O 120.925 0.393 . . . . 0.0 110.26 -179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 28.7 p -78.18 -176.0 4.4 Favored 'General case' 0 C--N 1.308 -1.196 0 C-N-CA 122.876 0.471 . . . . 0.0 110.864 179.08 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 78.1 m -68.45 113.25 5.84 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.408 0.623 . . . . 0.0 110.794 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.63 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.9 mp -63.28 151.94 85.91 Favored Pre-proline 0 N--CA 1.435 -1.223 0 CA-C-N 114.752 -1.113 . . . . 0.0 112.522 178.273 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.526 ' HB3' ' H ' ' A' ' 669' ' ' ASN . 40.6 Cg_endo -66.31 172.23 9.24 Favored 'Trans proline' 0 N--CA 1.438 -1.739 0 C-N-CA 122.531 2.154 . . . . 0.0 113.627 -179.248 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 58.2 t -127.62 139.9 50.62 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.307 0 CA-C-N 113.488 -1.687 . . . . 0.0 107.159 -175.732 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 74.5 m -118.87 135.37 54.59 Favored 'General case' 0 C--N 1.287 -2.112 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.511 HG13 HD22 ' A' ' 664' ' ' LEU . 27.0 pt -128.61 143.4 41.22 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.954 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 -178.153 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.604 HG23 ' O ' ' A' ' 662' ' ' ARG . 8.4 p -93.63 129.48 43.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 106.551 -1.648 . . . . 0.0 106.551 179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -94.07 -11.34 30.86 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 117.219 -1.792 . . . . 0.0 109.91 176.413 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.44 ' H ' HG22 ' A' ' 686' ' ' VAL . 6.5 mm-40 55.55 55.91 6.78 Favored 'General case' 0 N--CA 1.448 -0.539 0 CA-C-N 114.883 -1.053 . . . . 0.0 112.079 177.398 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 8.7 t -154.94 167.05 31.6 Favored 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 19.3 p -126.54 159.87 32.22 Favored 'General case' 0 C--N 1.32 -0.696 0 N-CA-C 113.628 0.973 . . . . 0.0 113.628 -172.446 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . 0.556 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 9.1 m -88.62 -9.14 53.22 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.463 -0.789 . . . . 0.0 110.581 170.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 100.27 -81.73 0.51 Allowed Glycine 0 N--CA 1.432 -1.629 0 N-CA-C 110.751 -0.94 . . . . 0.0 110.751 177.383 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.678 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.5 t70 -161.89 -173.0 3.49 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.82 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.638 HG12 HG11 ' A' ' 715' ' ' VAL . 2.4 mt -70.72 135.59 85.79 Favored Pre-proline 0 N--CA 1.4 -2.959 0 C-N-CA 125.522 1.529 . . . . 0.0 110.917 178.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.678 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 61.4 Cg_endo -74.29 -177.3 3.18 Favored 'Trans proline' 0 N--CA 1.437 -1.796 0 C-N-CA 123.181 2.587 . . . . 0.0 110.371 179.026 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -118.09 123.29 45.24 Favored 'General case' 0 C--N 1.263 -3.165 0 C-N-CA 118.407 -1.317 . . . . 0.0 110.698 177.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.817 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.5 tp -86.21 138.51 31.82 Favored 'General case' 0 N--CA 1.404 -2.742 0 N-CA-C 105.365 -2.087 . . . . 0.0 105.365 175.618 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.424 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 11.2 pt-20 -41.61 -37.63 1.19 Allowed 'General case' 0 N--CA 1.477 0.894 0 C-N-CA 125.389 1.476 . . . . 0.0 113.163 -176.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 54.4 m80 -145.26 27.52 1.26 Allowed 'General case' 0 N--CA 1.438 -1.051 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.817 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -139.26 173.43 22.72 Favored Glycine 0 CA--C 1.527 0.804 0 CA-C-N 115.526 -0.761 . . . . 0.0 112.193 -179.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 6.1 p-90 -155.2 -150.52 0.31 Allowed 'General case' 0 N--CA 1.435 -1.218 0 C-N-CA 125.977 1.711 . . . . 0.0 106.828 -177.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.419 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.63 152.14 43.72 Favored 'General case' 0 C--N 1.289 -2.064 0 CA-C-N 119.256 0.935 . . . . 0.0 112.04 -169.684 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.467 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -83.47 -56.66 3.62 Favored 'General case' 0 CA--C 1.498 -1.033 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 178.52 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.5 pp -108.3 144.97 35.09 Favored 'General case' 0 N--CA 1.422 -1.866 0 CA-C-N 114.851 -1.068 . . . . 0.0 111.626 -175.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.412 ' HB2' ' OH ' ' A' ' 709' ' ' TYR . 4.5 p -142.71 116.49 9.26 Favored 'General case' 0 N--CA 1.418 -2.04 0 CA-C-N 114.926 -1.033 . . . . 0.0 108.67 177.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 20.2 m -128.34 91.75 43.19 Favored Pre-proline 0 C--N 1.294 -1.824 0 CA-C-O 121.182 0.515 . . . . 0.0 111.462 -177.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.414 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.25 150.29 10.57 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.59 2.193 . . . . 0.0 111.351 176.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.414 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 72.3 Cg_endo -74.96 134.79 37.53 Favored 'Cis proline' 0 CA--C 1.533 0.461 0 C-N-CA 123.233 -1.569 . . . . 0.0 112.41 1.132 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.678 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 34.0 m-85 -81.19 92.28 6.29 Favored 'General case' 0 C--N 1.312 -1.025 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -179.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.51 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 4.6 m-30 -85.48 163.54 18.38 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.378 179.775 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.644 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 2.0 t80 -62.14 139.53 58.46 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 107.831 -1.174 . . . . 0.0 107.831 177.971 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.96 -24.22 29.52 Favored Glycine 0 C--N 1.295 -1.721 0 CA-C-N 115.767 -0.651 . . . . 0.0 113.282 -176.208 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 33.2 t0 -76.44 167.33 22.03 Favored 'General case' 0 C--O 1.244 0.793 0 CA-C-N 118.073 0.936 . . . . 0.0 110.284 178.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.3 m -131.61 158.08 41.98 Favored 'General case' 0 N--CA 1.431 -1.393 0 CA-C-O 121.101 0.477 . . . . 0.0 110.41 -172.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.638 HG11 HG12 ' A' ' 694' ' ' ILE . 41.3 t -137.87 145.76 28.38 Favored 'Isoleucine or valine' 0 N--CA 1.418 -2.043 0 CA-C-N 114.949 -1.023 . . . . 0.0 109.101 176.422 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.56 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 39.2 mt-10 -111.73 121.94 46.45 Favored 'General case' 0 N--CA 1.42 -1.968 0 CA-C-O 121.57 0.7 . . . . 0.0 110.419 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.517 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -93.32 146.86 23.41 Favored 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 114.403 -1.271 . . . . 0.0 112.307 -177.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.467 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 7.5 t30 -127.67 134.59 49.61 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.418 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.3 t -92.92 142.63 27.09 Favored 'General case' 0 C--N 1.266 -3.057 0 N-CA-C 108.491 -0.929 . . . . 0.0 108.491 -178.755 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 52.4 m -52.94 138.57 29.8 Favored 'General case' 0 N--CA 1.446 -0.673 0 O-C-N 123.482 0.489 . . . . 0.0 109.747 178.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -58.11 -29.17 65.27 Favored 'General case' 0 C--N 1.314 -0.935 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 -168.67 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 41.5 m -79.68 -1.62 39.12 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-O 122.013 0.911 . . . . 0.0 111.03 177.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 97.1 m-85 -119.43 159.25 24.59 Favored 'General case' 0 N--CA 1.417 -2.087 0 N-CA-C 109.119 -0.697 . . . . 0.0 109.119 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.4 t -118.79 139.35 51.72 Favored 'General case' 0 C--N 1.281 -2.406 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 176.221 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.418 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 8.1 ptm -93.04 141.21 28.66 Favored 'General case' 0 N--CA 1.422 -1.864 0 CA-C-O 121.355 0.598 . . . . 0.0 109.916 -175.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 52.1 mt -111.18 100.91 11.74 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.374 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 176.392 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 133.91 -165.48 24.26 Favored Glycine 0 C--N 1.284 -2.347 0 N-CA-C 110.55 -1.02 . . . . 0.0 110.55 -177.797 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -101.31 171.54 7.54 Favored 'General case' 0 C--N 1.296 -1.757 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.707 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.6 ptp180 -93.81 -27.75 16.27 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 113.688 0.996 . . . . 0.0 113.688 -175.829 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.56 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.7 p -96.03 133.52 40.17 Favored 'General case' 0 C--N 1.297 -1.689 0 N-CA-C 115.762 1.764 . . . . 0.0 115.762 -170.386 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.643 HG21 HD23 ' A' ' 741' ' ' LEU . 8.5 pt -120.03 166.31 14.57 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.659 0 CA-C-N 114.335 -1.302 . . . . 0.0 109.289 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.443 ' H ' HG23 ' A' ' 739' ' ' THR . 60.9 m -133.17 135.34 45.06 Favored 'General case' 0 C--N 1.282 -2.368 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 -178.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.42 ' SG ' ' HA ' ' A' ' 711' ' ' TYR . 40.5 t -68.25 108.23 3.1 Favored 'General case' 0 C--N 1.31 -1.12 0 O-C-N 124.004 0.815 . . . . 0.0 110.317 178.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.616 ' O ' HG22 ' A' ' 737' ' ' VAL . 48.6 mm -130.2 104.2 9.69 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.153 0 C-N-CA 123.859 0.864 . . . . 0.0 109.904 -177.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.7 m-70 69.93 23.94 5.34 Favored 'General case' 0 N--CA 1.492 1.628 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 175.501 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.556 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 96.65 -3.6 63.21 Favored Glycine 0 CA--C 1.481 -2.088 0 C-N-CA 119.104 -1.522 . . . . 0.0 111.413 -179.762 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.616 HG22 ' O ' ' A' ' 734' ' ' ILE . 4.1 m -126.03 153.26 34.05 Favored 'Isoleucine or valine' 1 N--CA 1.368 -4.573 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 -177.553 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.678 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.4 m95 -87.91 169.08 12.32 Favored 'General case' 0 C--N 1.266 -3.025 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 174.443 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.443 HG23 ' H ' ' A' ' 732' ' ' THR . 41.5 p -47.43 -71.58 0.07 Allowed 'General case' 0 N--CA 1.473 0.718 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -162.33 -30.73 0.04 OUTLIER 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 114.859 1.429 . . . . 0.0 114.859 -173.395 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.643 HD23 HG21 ' A' ' 731' ' ' ILE . 21.8 mt 68.58 156.0 0.15 Allowed Pre-proline 0 N--CA 1.469 0.493 0 O-C-N 124.691 1.244 . . . . 0.0 111.132 -177.454 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -79.2 -159.68 0.11 Allowed 'Trans proline' 0 CA--C 1.541 0.873 0 C-N-CA 121.851 1.701 . . . . 0.0 109.431 173.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.1 pt20 -143.67 142.1 30.85 Favored 'General case' 0 C--N 1.299 -1.602 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.797 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 88.7 m -101.13 144.13 30.39 Favored 'General case' 0 C--N 1.293 -1.881 0 C-N-CA 120.473 -0.491 . . . . 0.0 112.194 -179.01 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.5 m -133.9 148.45 30.33 Favored 'Isoleucine or valine' 0 N--CA 1.421 -1.905 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 178.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -74.33 125.75 29.17 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 123.411 0.444 . . . . 0.0 110.521 -176.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 70.3 mt . . . . . 0 C--N 1.296 -1.725 0 CA-C-N 115.412 -0.813 . . . . 0.0 109.044 175.572 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.451 -0.413 0 CA-C-O 119.019 -0.515 . . . . 0.0 110.161 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 77.83 11.78 1.97 Allowed 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 125.079 1.352 . . . . 0.0 110.723 -178.433 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -91.46 153.19 19.99 Favored 'General case' 0 N--CA 1.415 -2.179 0 N-CA-C 105.798 -1.927 . . . . 0.0 105.798 177.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 68.74 20.09 8.24 Favored 'General case' 0 N--CA 1.475 0.818 0 C-N-CA 123.919 0.887 . . . . 0.0 109.259 -174.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -134.51 94.15 3.16 Favored 'General case' 0 N--CA 1.431 -1.38 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 177.297 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 132.93 -77.82 0.37 Allowed Glycine 0 C--N 1.282 -2.446 0 N-CA-C 108.395 -1.882 . . . . 0.0 108.395 -175.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.536 ' HA ' ' HB3' ' A' ' 675' ' ' ASP 0.262 26.7 m 45.97 72.98 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.358 0.946 0 C-N-CA 125.038 1.335 . . . . 0.0 112.669 175.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.505 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 0.9 OUTLIER -72.66 -153.07 0.03 OUTLIER 'General case' 0 C--N 1.292 -1.913 0 CA-C-N 113.908 -1.496 . . . . 0.0 109.933 178.703 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 17.2 t -157.5 163.8 38.06 Favored 'General case' 0 C--N 1.276 -2.623 0 N-CA-C 107.791 -1.188 . . . . 0.0 107.791 -170.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 14.9 p -147.49 -173.32 4.24 Favored 'General case' 0 C--N 1.289 -2.046 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -115.94 -135.27 5.65 Favored Glycine 0 N--CA 1.405 -3.4 0 N-CA-C 109.794 -1.322 . . . . 0.0 109.794 -179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.758 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 17.1 Cg_exo -65.43 144.29 79.21 Favored 'Trans proline' 0 C--N 1.316 -1.149 0 C-N-CA 122.658 2.238 . . . . 0.0 110.492 178.488 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.833 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.9 Cg_endo -60.3 154.15 54.68 Favored 'Trans proline' 0 C--O 1.247 0.958 0 C-N-CA 122.572 2.181 . . . . 0.0 112.307 179.48 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.564 ' HG2' HD21 ' A' ' 681' ' ' LEU . 14.9 Cg_endo -64.2 -164.53 0.06 OUTLIER 'Trans proline' 0 CA--C 1.55 1.311 0 C-N-CA 123.561 2.841 . . . . 0.0 113.265 177.85 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -113.19 165.61 12.23 Favored 'General case' 0 C--N 1.301 -1.524 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.299 -179.217 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.756 HD13 ' HG2' ' A' ' 682' ' ' PRO . 52.2 tp -113.36 147.52 37.53 Favored 'General case' 0 C--N 1.302 -1.495 0 CA-C-N 116.269 -0.423 . . . . 0.0 111.371 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.457 ' H ' HD12 ' A' ' 636' ' ' LEU . 12.5 tp -40.59 -78.23 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 125.988 1.715 . . . . 0.0 113.315 176.132 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 2.1 t30 -126.08 50.25 1.89 Allowed 'General case' 0 CA--C 1.488 -1.44 0 CA-C-O 123.534 1.635 . . . . 0.0 108.834 -177.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.587 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -164.8 -154.43 7.94 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 111.358 -2.656 . . . . 0.0 108.962 178.823 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -166.93 -178.09 4.09 Favored 'General case' 0 C--N 1.301 -1.517 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.461 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.1 p -92.02 138.68 19.34 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 174.342 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.493 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 9.7 ptpt -98.08 -17.26 19.2 Favored 'General case' 0 C--N 1.307 -1.252 0 CA-C-O 121.411 0.624 . . . . 0.0 110.114 -176.753 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -85.38 144.0 28.29 Favored 'General case' 0 N--CA 1.431 -1.383 0 CA-C-N 115.365 -0.834 . . . . 0.0 109.335 -177.721 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.452 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 43.4 mmtm -85.45 134.32 34.06 Favored 'General case' 0 N--CA 1.415 -2.217 0 CA-C-O 121.915 0.864 . . . . 0.0 112.718 -173.736 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.833 HG22 ' HD2' ' A' ' 633' ' ' PRO . 11.0 p -64.99 122.1 16.23 Favored 'General case' 0 N--CA 1.41 -2.445 0 CA-C-N 113.193 -1.822 . . . . 0.0 113.658 -173.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 52.5 mtmt -89.53 -22.98 22.14 Favored 'General case' 0 C--N 1.308 -1.2 0 CA-C-N 115.263 -0.88 . . . . 0.0 109.654 178.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.758 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 73.08 -7.71 1.45 Allowed 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 125.164 1.386 . . . . 0.0 112.334 178.594 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -128.3 93.7 3.72 Favored 'General case' 0 C--N 1.302 -1.496 0 N-CA-C 107.87 -1.159 . . . . 0.0 107.87 177.367 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.511 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 7.2 m-85 -121.54 132.97 55.0 Favored 'General case' 0 CA--C 1.483 -1.605 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -101.52 -153.83 25.97 Favored Glycine 0 C--N 1.277 -2.745 0 C-N-CA 120.162 -1.018 . . . . 0.0 111.272 176.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 83.3 t60 -75.91 149.62 37.71 Favored 'General case' 0 C--N 1.289 -2.04 0 N-CA-C 109.238 -0.653 . . . . 0.0 109.238 -179.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . 0.283 76.2 p 71.13 11.19 6.89 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 125.653 1.581 . . . . 0.0 114.072 177.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.482 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 17.4 mm-40 -79.26 121.34 24.96 Favored 'General case' 0 CA--C 1.506 -0.732 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.716 177.179 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.514 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.8 OUTLIER -109.15 139.69 30.9 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.894 0 CA-C-O 121.14 0.495 . . . . 0.0 111.488 -178.177 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.499 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.9 t -126.92 135.84 62.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.978 0 CA-C-N 115.591 -0.731 . . . . 0.0 110.92 -174.969 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.532 ' HG3' HD22 ' A' ' 669' ' ' ASN . 39.5 tt0 -101.89 129.37 48.11 Favored 'General case' 0 N--CA 1.43 -1.435 0 CA-C-O 122.46 1.124 . . . . 0.0 112.614 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.56 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 45.9 m-85 -105.27 164.61 11.71 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 113.981 -1.463 . . . . 0.0 110.728 178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.493 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 40.0 p90 -142.02 150.81 41.8 Favored 'General case' 0 C--N 1.303 -1.43 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 176.271 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.587 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 89.9 m -98.05 163.57 12.71 Favored 'General case' 0 C--N 1.285 -2.214 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 175.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.485 ' CG ' ' HD2' ' A' ' 661' ' ' PRO . 0.3 OUTLIER -59.25 159.04 16.66 Favored Pre-proline 0 N--CA 1.482 1.131 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 175.951 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.485 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 61.6 Cg_endo -68.12 -9.8 26.9 Favored 'Trans proline' 0 N--CA 1.49 1.321 0 C-N-CA 123.074 2.516 . . . . 0.0 113.441 -174.119 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.525 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 21.6 ptt180 -101.68 -6.67 23.45 Favored 'General case' 0 C--N 1.311 -1.073 0 CA-C-O 121.708 0.766 . . . . 0.0 111.16 179.195 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.514 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 48.2 m-85 -121.25 140.92 51.41 Favored 'General case' 0 C--N 1.311 -1.103 0 CA-C-N 115.401 -0.818 . . . . 0.0 111.02 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.594 ' HG ' ' HB2' ' A' ' 687' ' ' GLU . 17.5 mt -99.66 139.68 34.96 Favored 'General case' 0 C--N 1.275 -2.656 0 CA-C-N 115.727 -0.67 . . . . 0.0 110.831 -178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.607 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 49.2 tpp -72.3 109.03 5.75 Favored 'General case' 0 C--N 1.292 -1.921 0 CA-C-N 114.868 -1.06 . . . . 0.0 109.238 176.292 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.629 ' HD2' HD13 ' A' ' 685' ' ' ILE . 81.3 tttt -94.97 -29.2 14.77 Favored 'General case' 0 C--N 1.3 -1.578 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 179.795 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -79.61 -173.05 44.38 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 114.694 -1.139 . . . . 0.0 113.618 -179.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.74 -3.77 13.53 Favored 'Trans proline' 0 C--N 1.353 0.772 0 C-N-CA 123.277 2.651 . . . . 0.0 113.13 -177.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.607 ' HB3' ' HG2' ' A' ' 665' ' ' MET 0.263 2.8 p-10 58.65 -27.57 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.29 0 C-N-CA 127.474 2.31 . . . . 0.0 116.167 179.499 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.499 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 94.2 mttt -108.5 139.6 43.02 Favored 'General case' 0 C--N 1.286 -2.192 0 O-C-N 121.937 -0.477 . . . . 0.0 110.346 176.929 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 ' HG ' ' A' ' 681' ' ' LEU . 45.6 pt -124.99 171.57 13.68 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 N-CA-C 109.031 -0.729 . . . . 0.0 109.031 178.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.482 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.0 tt0 -142.39 140.6 32.08 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 111.916 0.339 . . . . 0.0 111.916 -177.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 33.9 t -80.85 100.0 8.61 Favored 'General case' 0 C--O 1.251 1.132 0 CA-C-O 122.316 1.055 . . . . 0.0 108.804 177.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 71.3 t -86.79 171.38 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.283 -2.312 0 CA-C-N 114.245 -1.343 . . . . 0.0 108.17 -179.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.536 ' HB3' ' HA ' ' A' ' 627' ' ' VAL . 7.0 p-10 -76.05 72.36 2.88 Favored 'General case' 0 C--N 1.307 -1.253 0 CA-C-O 122.448 1.118 . . . . 0.0 111.029 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.429 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 158.23 -39.82 0.52 Allowed Glycine 0 N--CA 1.409 -3.145 0 CA-C-N 113.914 -1.493 . . . . 0.0 111.73 172.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -162.93 -178.94 6.41 Favored 'General case' 0 C--N 1.319 -0.721 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 -178.338 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.5 m95 -84.04 164.77 19.07 Favored 'General case' 0 C--N 1.308 -1.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 174.917 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 22.9 p -74.67 -174.89 2.26 Favored 'General case' 0 C--N 1.299 -1.613 0 CA-C-O 120.821 0.343 . . . . 0.0 111.749 179.887 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 35.5 m -71.1 111.15 6.23 Favored 'General case' 0 N--CA 1.429 -1.523 0 CA-C-O 121.184 0.516 . . . . 0.0 110.111 -179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.646 ' HG ' HG21 ' A' ' 671' ' ' ILE . 6.2 mp -64.81 151.47 92.67 Favored Pre-proline 0 C--N 1.313 -0.982 0 CA-C-N 115.188 -0.914 . . . . 0.0 113.225 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.756 ' HG2' HD13 ' A' ' 636' ' ' LEU . 44.1 Cg_endo -67.71 -176.53 0.97 Allowed 'Trans proline' 0 CA--C 1.54 0.804 0 C-N-CA 123.129 2.553 . . . . 0.0 114.115 178.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 92.2 t -142.09 142.92 27.23 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.94 0 N-CA-C 106.806 -1.553 . . . . 0.0 106.806 -176.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.514 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 85.0 m -114.12 133.09 55.8 Favored 'General case' 0 C--N 1.296 -1.726 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 179.137 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.629 HD13 ' HD2' ' A' ' 666' ' ' LYS . 26.1 pt -128.25 145.1 35.88 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 -179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.443 HG13 ' HG3' ' A' ' 688' ' ' GLU . 12.0 p -81.59 126.55 39.87 Favored 'Isoleucine or valine' 0 C--N 1.281 -2.371 0 CA-C-O 122.354 1.073 . . . . 0.0 108.578 177.036 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.594 ' HB2' ' HG ' ' A' ' 664' ' ' LEU . 7.8 tp10 -60.05 -44.04 94.95 Favored 'General case' 0 C--N 1.275 -2.639 0 CA-C-N 113.021 -1.899 . . . . 0.0 110.191 177.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.671 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 21.3 mt-10 65.22 14.87 9.69 Favored 'General case' 0 N--CA 1.464 0.251 0 CA-C-N 115.086 -0.961 . . . . 0.0 112.413 -177.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.481 ' H ' ' HG3' ' A' ' 687' ' ' GLU . 13.4 m -119.08 133.1 56.0 Favored 'General case' 0 N--CA 1.432 -1.34 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 175.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 27.4 p -121.08 164.13 17.3 Favored 'General case' 0 N--CA 1.426 -1.63 0 C-N-CA 120.599 -0.44 . . . . 0.0 111.965 -176.134 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 31.5 m -85.39 -6.09 59.25 Favored 'General case' 0 C--N 1.315 -0.923 0 N-CA-C 114.798 1.407 . . . . 0.0 114.798 -178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 67.88 53.66 22.11 Favored Glycine 0 C--N 1.311 -0.847 0 C-N-CA 120.57 -0.824 . . . . 0.0 114.257 174.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.608 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 35.2 t70 71.51 172.94 0.31 Allowed 'General case' 0 N--CA 1.483 1.211 0 C-N-CA 124.017 0.927 . . . . 0.0 113.25 175.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.558 ' CG1' HG11 ' A' ' 715' ' ' VAL . 1.3 mp -66.37 132.99 94.38 Favored Pre-proline 0 N--CA 1.434 -1.275 0 C-N-CA 124.18 0.992 . . . . 0.0 111.626 175.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.579 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 60.5 Cg_endo -75.58 -171.22 0.97 Allowed 'Trans proline' 0 C--O 1.234 0.307 0 C-N-CA 123.961 3.107 . . . . 0.0 111.683 176.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -114.17 139.28 49.48 Favored 'General case' 0 N--CA 1.418 -2.051 0 CA-C-O 121.373 0.606 . . . . 0.0 110.084 177.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.72 HD23 ' HA3' ' A' ' 700' ' ' GLY . 48.9 tp -107.61 148.27 29.53 Favored 'General case' 0 C--N 1.283 -2.312 0 N-CA-C 107.241 -1.392 . . . . 0.0 107.241 174.524 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.3 pt-20 -43.14 -47.34 6.17 Favored 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 124.75 1.22 . . . . 0.0 112.758 -178.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 78.2 m-70 -142.86 30.73 1.45 Allowed 'General case' 0 C--N 1.315 -0.905 0 CA-C-O 122.042 0.925 . . . . 0.0 109.154 -178.886 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.72 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -138.25 171.1 23.57 Favored Glycine 0 N--CA 1.427 -1.923 0 CA-C-N 114.366 -1.288 . . . . 0.0 110.894 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.411 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 5.0 p-90 -156.55 -150.88 0.3 Allowed 'General case' 0 C--N 1.3 -1.574 0 C-N-CA 125.847 1.659 . . . . 0.0 106.607 -176.283 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.446 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.09 162.46 35.43 Favored 'General case' 0 C--N 1.277 -2.559 0 C-N-CA 119.091 -1.044 . . . . 0.0 111.715 -169.46 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.523 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.03 -68.31 0.81 Allowed 'General case' 0 C--N 1.31 -1.137 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.362 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 4.4 pp -100.64 142.01 32.71 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.709 -0.678 . . . . 0.0 110.833 -175.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.51 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 6.4 m -133.72 99.53 4.5 Favored 'General case' 0 N--CA 1.413 -2.319 0 N-CA-C 107.093 -1.447 . . . . 0.0 107.093 172.604 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 19.0 m -117.51 98.34 51.67 Favored Pre-proline 0 C--N 1.271 -2.807 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.002 -177.335 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -83.04 159.45 15.6 Favored 'Trans proline' 0 N--CA 1.458 -0.559 0 C-N-CA 123.241 2.628 . . . . 0.0 110.95 178.17 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -75.42 138.84 57.95 Favored 'Cis proline' 0 C--O 1.243 0.763 0 C-N-CA 123.89 -1.296 . . . . 0.0 112.261 0.458 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.608 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.8 m-85 -86.38 78.06 9.35 Favored 'General case' 0 C--N 1.303 -1.448 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 -178.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.671 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 30.2 m-85 -79.59 161.6 25.83 Favored 'General case' 0 CA--C 1.493 -1.241 0 CA-C-O 120.738 0.304 . . . . 0.0 111.67 179.679 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.468 ' CB ' ' HG2' ' A' ' 687' ' ' GLU . 1.7 t80 -55.87 131.33 46.73 Favored 'General case' 0 N--CA 1.443 -0.8 0 N-CA-C 107.59 -1.263 . . . . 0.0 107.59 174.449 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.82 -17.18 57.72 Favored Glycine 0 N--CA 1.423 -2.216 0 C-N-CA 119.74 -1.219 . . . . 0.0 112.753 -179.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.8 t70 -79.78 173.95 12.07 Favored 'General case' 0 C--O 1.252 1.202 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 177.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.0 m -139.66 151.34 45.86 Favored 'General case' 0 C--N 1.291 -1.938 0 CA-C-O 121.452 0.644 . . . . 0.0 111.045 -173.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.558 HG11 ' CG1' ' A' ' 694' ' ' ILE . 32.6 t -135.02 142.07 41.16 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.103 0 CA-C-N 115.166 -0.924 . . . . 0.0 109.809 177.625 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 33.0 mt-10 -104.17 128.89 51.89 Favored 'General case' 0 N--CA 1.416 -2.137 0 CA-C-O 121.606 0.717 . . . . 0.0 110.675 175.748 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.45 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.4 m-85 -97.42 156.66 16.37 Favored 'General case' 0 C--N 1.287 -2.142 0 CA-C-N 114.329 -1.305 . . . . 0.0 110.232 179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.523 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -137.05 145.88 44.54 Favored 'General case' 0 C--N 1.291 -1.953 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 179.011 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.679 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 44.3 t -94.94 158.98 15.24 Favored 'General case' 0 C--N 1.272 -2.8 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 -179.636 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 51.1 m -69.35 158.81 34.34 Favored 'General case' 0 C--N 1.319 -0.753 0 N-CA-C 110.128 -0.323 . . . . 0.0 110.128 177.048 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 -72.16 144.94 48.39 Favored 'General case' 0 N--CA 1.431 -1.401 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 178.122 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 34.5 m 85.0 -5.75 0.93 Allowed 'General case' 0 N--CA 1.471 0.586 0 C-N-CA 126.325 1.85 . . . . 0.0 109.38 -175.351 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 52.4 m-85 -119.31 148.41 43.2 Favored 'General case' 0 N--CA 1.416 -2.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 174.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.6 t -116.65 140.89 48.89 Favored 'General case' 0 C--N 1.278 -2.535 0 N-CA-C 107.917 -1.142 . . . . 0.0 107.917 177.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.679 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.0 ptm -91.91 141.5 28.57 Favored 'General case' 0 N--CA 1.423 -1.786 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -178.469 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 58.1 mt -107.01 127.66 62.49 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.328 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 112.75 -133.75 11.54 Favored Glycine 0 N--CA 1.431 -1.655 0 N-CA-C 111.456 -0.657 . . . . 0.0 111.456 179.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -115.4 163.08 16.24 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -91.8 -29.17 16.91 Favored 'General case' 0 C--N 1.284 -2.281 0 N-CA-C 112.726 0.639 . . . . 0.0 112.726 -179.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 3.9 p -99.94 131.92 45.61 Favored 'General case' 0 C--N 1.299 -1.595 0 N-CA-C 114.766 1.395 . . . . 0.0 114.766 -173.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.661 HG21 HD23 ' A' ' 741' ' ' LEU . 7.3 pt -109.09 171.27 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.488 -1.438 0 CA-C-N 115.223 -0.899 . . . . 0.0 110.005 179.385 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 58.1 m -135.21 135.71 41.2 Favored 'General case' 0 C--N 1.283 -2.295 0 N-CA-C 109.122 -0.696 . . . . 0.0 109.122 -178.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 52.9 t -71.41 108.68 4.96 Favored 'General case' 0 C--N 1.306 -1.292 0 O-C-N 123.7 0.625 . . . . 0.0 110.163 178.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.572 ' O ' HG22 ' A' ' 737' ' ' VAL . 45.4 mm -128.39 111.7 24.59 Favored 'Isoleucine or valine' 0 C--O 1.197 -1.702 0 C-N-CA 123.792 0.837 . . . . 0.0 110.579 -176.472 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 67.01 17.08 10.47 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 113.491 0.923 . . . . 0.0 113.491 176.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 103.23 -5.97 49.93 Favored Glycine 0 CA--C 1.479 -2.186 0 C-N-CA 119.32 -1.419 . . . . 0.0 111.483 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.572 HG22 ' O ' ' A' ' 734' ' ' ILE . 9.9 m -125.12 152.89 31.97 Favored 'Isoleucine or valine' 1 N--CA 1.375 -4.201 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 -177.104 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.579 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.3 m95 -83.26 159.17 22.0 Favored 'General case' 0 C--N 1.278 -2.536 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 174.296 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 11.3 p -38.82 -70.55 0.1 Allowed 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 115.587 1.699 . . . . 0.0 115.587 -174.725 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -174.04 -19.9 0.01 OUTLIER 'General case' 0 N--CA 1.48 1.032 0 N-CA-C 113.926 1.084 . . . . 0.0 113.926 -175.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.661 HD23 HG21 ' A' ' 731' ' ' ILE . 20.3 mt 71.16 154.15 0.15 Allowed Pre-proline 0 N--CA 1.479 1.003 0 C-N-CA 124.441 1.096 . . . . 0.0 112.694 175.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.561 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 47.3 Cg_endo -74.36 -171.1 0.83 Allowed 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.781 1.654 . . . . 0.0 109.02 172.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.411 ' HA ' HD11 ' A' ' 697' ' ' LEU . 17.5 pt20 -147.57 142.24 26.65 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 174.951 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.401 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 89.2 m -92.17 153.97 18.98 Favored 'General case' 0 C--N 1.3 -1.55 0 O-C-N 123.546 0.529 . . . . 0.0 112.358 -175.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.6 m -141.4 144.61 25.91 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 174.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -72.07 123.98 23.99 Favored 'General case' 0 C--N 1.294 -1.816 0 O-C-N 123.363 0.414 . . . . 0.0 111.318 -177.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 69.7 mt . . . . . 0 C--N 1.305 -1.363 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 174.983 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . 0.537 ' CD ' ' H ' ' A' ' 622' ' ' ALA . 1.6 tm-20 . . . . . 0 CA--C 1.55 0.945 0 N-CA-C 105.3 -2.111 . . . . 0.0 105.3 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . 0.537 ' H ' ' CD ' ' A' ' 621' ' ' GLU . . . -70.99 -23.21 62.15 Favored 'General case' 0 C--O 1.236 0.384 0 CA-C-N 119.344 0.975 . . . . 0.0 109.357 177.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 73.1 89.09 0.09 Allowed 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 126.009 1.724 . . . . 0.0 111.108 176.498 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -81.44 -24.67 36.71 Favored 'General case' 0 C--N 1.302 -1.49 0 CA-C-N 114.987 -1.006 . . . . 0.0 108.409 176.762 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . 78.67 -53.96 0.47 Allowed 'General case' 0 CA--C 1.493 -1.249 0 C-N-CA 126.48 1.912 . . . . 0.0 110.328 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -140.22 159.99 26.26 Favored Glycine 2 C--N 1.251 -4.183 0 N-CA-C 108.33 -1.908 . . . . 0.0 108.33 177.201 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.538 HG23 ' HB2' ' A' ' 651' ' ' HIS . 5.1 p -174.68 82.35 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.275 -2.658 0 CA-C-O 123.026 1.393 . . . . 0.0 110.493 -177.311 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.438 ' CD ' ' H ' ' A' ' 629' ' ' SER . 0.0 OUTLIER -79.23 -88.01 0.06 Allowed 'General case' 0 C--N 1.277 -2.544 0 CA-C-N 113.772 -1.558 . . . . 0.0 110.621 177.619 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.438 ' H ' ' CD ' ' A' ' 628' ' ' GLN . 34.8 t 167.65 137.71 0.02 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 124.678 1.191 . . . . 0.0 108.382 179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 67.3 m -131.81 136.07 47.23 Favored 'General case' 0 C--N 1.29 -2.003 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 173.248 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.82 -132.59 7.58 Favored Glycine 0 N--CA 1.41 -3.08 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 177.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.887 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -63.12 135.89 53.3 Favored 'Trans proline' 0 C--N 1.32 -0.946 0 C-N-CA 122.901 2.4 . . . . 0.0 111.874 -179.588 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.866 ' HD2' HG22 ' A' ' 645' ' ' THR . 26.9 Cg_endo -60.22 157.23 36.04 Favored 'Trans proline' 0 CA--C 1.541 0.828 0 C-N-CA 123.348 2.698 . . . . 0.0 113.444 -178.001 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.516 ' HG2' HD21 ' A' ' 681' ' ' LEU . 31.4 Cg_endo -71.52 -159.42 0.07 OUTLIER 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 123.509 2.806 . . . . 0.0 112.643 177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . 0.415 ' O ' HD13 ' A' ' 681' ' ' LEU . 13.8 pt-20 -104.35 174.78 5.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-O 120.884 0.373 . . . . 0.0 110.408 -177.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.766 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.7 tt -117.86 142.03 47.77 Favored 'General case' 0 N--CA 1.424 -1.737 0 N-CA-C 105.642 -1.984 . . . . 0.0 105.642 169.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.463 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -35.67 -68.23 0.13 Allowed 'General case' 0 C--N 1.315 -0.924 0 C-N-CA 127.437 2.295 . . . . 0.0 112.869 176.077 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.506 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 6.2 t30 -116.9 -31.0 5.56 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 122.31 1.052 . . . . 0.0 109.331 179.795 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.715 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -78.86 -157.04 10.39 Favored Glycine 0 C--N 1.298 -1.555 0 CA-C-N 114.41 -1.268 . . . . 0.0 111.265 176.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 3.9 t-20 -169.5 -177.01 2.63 Favored 'General case' 0 C--N 1.307 -1.247 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.518 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.3 p -101.08 140.53 19.65 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.151 0 C-N-CA 123.398 0.679 . . . . 0.0 109.687 -176.383 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.45 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 8.6 ptpt -95.77 -30.9 13.46 Favored 'General case' 0 C--N 1.315 -0.915 0 CA-C-O 120.996 0.427 . . . . 0.0 110.432 -177.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -77.56 149.44 34.86 Favored 'General case' 0 N--CA 1.429 -1.505 0 CA-C-N 115.608 -0.724 . . . . 0.0 109.649 -176.221 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.469 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 38.9 mmtm -86.94 161.7 18.09 Favored 'General case' 0 C--N 1.28 -2.455 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.789 -179.096 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.866 HG22 ' HD2' ' A' ' 633' ' ' PRO . 14.5 p -84.0 122.68 29.1 Favored 'General case' 0 N--CA 1.398 -3.07 0 CA-C-N 115.611 -0.722 . . . . 0.0 112.767 -171.152 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 51.4 mtmt -82.31 -23.74 34.99 Favored 'General case' 0 C--N 1.311 -1.074 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.424 178.445 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.887 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.9 mt-10 67.62 -13.86 0.23 Allowed 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 125.168 1.387 . . . . 0.0 113.648 177.317 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -133.28 87.38 2.39 Favored 'General case' 0 N--CA 1.426 -1.668 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 172.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.412 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 11.9 m-85 -91.43 -65.53 1.0 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 179.022 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 112.02 -88.45 0.5 Allowed Glycine 0 C--N 1.296 -1.65 0 C-N-CA 120.521 -0.847 . . . . 0.0 111.934 175.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.538 ' HB2' HG23 ' A' ' 627' ' ' VAL . 80.9 t60 -161.49 144.57 12.4 Favored 'General case' 0 C--N 1.318 -0.8 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 -179.775 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 73.82 3.13 4.41 Favored 'General case' 0 N--CA 1.471 0.61 0 C-N-CA 125.161 1.384 . . . . 0.0 111.391 177.836 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.496 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 65.4 mm-40 -74.88 140.79 44.07 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.85 179.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.531 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 3.4 m -115.71 151.6 17.46 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.246 0 O-C-N 123.993 0.808 . . . . 0.0 112.3 -176.886 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.532 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 52.2 t -133.24 134.59 57.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 CA-C-N 115.452 -0.794 . . . . 0.0 109.441 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -101.62 125.28 48.25 Favored 'General case' 0 N--CA 1.432 -1.344 0 CA-C-O 122.091 0.948 . . . . 0.0 111.66 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.766 ' HB3' HD12 ' A' ' 636' ' ' LEU . 62.8 m-85 -100.68 168.84 9.43 Favored 'General case' 0 C--N 1.295 -1.804 0 CA-C-N 114.634 -1.166 . . . . 0.0 109.832 176.251 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.45 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 41.0 p90 -138.94 153.15 48.19 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 176.274 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.504 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 63.6 m -94.41 163.31 13.47 Favored 'General case' 0 C--N 1.286 -2.179 0 N-CA-C 109.102 -0.703 . . . . 0.0 109.102 171.394 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.414 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.6 OUTLIER -63.81 155.78 75.68 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 176.321 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.45 ' O ' ' HB2' ' A' ' 713' ' ' ASP . 68.1 Cg_endo -69.41 9.81 0.5 Allowed 'Trans proline' 0 N--CA 1.488 1.177 0 C-N-CA 123.672 2.915 . . . . 0.0 114.849 -172.968 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.514 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 32.2 ptt180 -131.83 5.72 4.27 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-O 121.864 0.84 . . . . 0.0 109.753 175.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.514 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 39.3 m-85 -123.95 143.07 50.61 Favored 'General case' 0 C--N 1.3 -1.554 0 CA-C-N 114.764 -1.107 . . . . 0.0 110.698 176.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.503 HD21 ' HB3' ' A' ' 711' ' ' TYR . 12.2 mt -97.51 145.82 25.84 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.095 0.474 . . . . 0.0 110.06 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.55 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.0 tpp -76.5 113.2 13.84 Favored 'General case' 0 C--N 1.292 -1.917 0 CA-C-N 114.698 -1.137 . . . . 0.0 109.109 173.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.496 ' HE3' HD13 ' A' ' 685' ' ' ILE . 40.3 ttmt -93.31 -48.95 6.18 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 121.386 0.612 . . . . 0.0 109.775 176.792 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.53 -168.13 43.82 Favored Glycine 0 C--N 1.31 -0.888 0 CA-C-N 115.472 -0.785 . . . . 0.0 113.727 -174.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -77.04 107.4 2.43 Favored 'Trans proline' 0 N--CA 1.446 -1.282 0 C-N-CA 122.694 2.262 . . . . 0.0 111.182 178.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.55 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 5.0 p-10 -72.97 -5.01 35.83 Favored 'General case' 0 C--N 1.282 -2.363 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.056 -178.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.532 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 48.7 mtmt -126.48 117.51 23.02 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-O 121.154 0.502 . . . . 0.0 110.28 176.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.641 HG21 HD23 ' A' ' 681' ' ' LEU . 47.5 pt -108.78 168.25 3.72 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 114.793 -1.094 . . . . 0.0 109.427 -175.147 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.496 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 21.3 tt0 -140.36 140.54 35.58 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 123.597 0.759 . . . . 0.0 110.845 -176.309 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 7.7 t -76.0 106.98 7.9 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 114.646 -1.161 . . . . 0.0 109.756 175.005 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.4 m -95.18 -177.92 0.42 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.837 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.409 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 7.9 p-10 -75.86 81.27 2.77 Favored 'General case' 0 C--N 1.304 -1.408 0 CA-C-O 122.932 1.348 . . . . 0.0 111.691 -178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 150.87 -39.78 0.82 Allowed Glycine 0 N--CA 1.419 -2.454 0 CA-C-N 113.993 -1.458 . . . . 0.0 112.393 172.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -165.69 -171.22 2.01 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -177.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 90.9 m95 -87.89 165.98 14.87 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 109.556 -0.535 . . . . 0.0 109.556 177.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 18.6 p -75.01 -179.78 4.5 Favored 'General case' 0 C--N 1.302 -1.474 0 CA-C-N 116.522 -0.308 . . . . 0.0 111.271 179.585 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 47.2 m -62.7 115.7 4.54 Favored 'General case' 0 C--N 1.31 -1.128 0 CA-C-O 121.671 0.748 . . . . 0.0 112.046 -177.442 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.641 HD23 HG21 ' A' ' 671' ' ' ILE . 78.2 mt -64.37 146.24 97.99 Favored Pre-proline 0 N--CA 1.432 -1.346 0 CA-C-N 114.088 -1.415 . . . . 0.0 111.17 177.521 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.625 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 60.0 Cg_endo -70.4 -174.39 1.02 Allowed 'Trans proline' 0 CA--C 1.545 1.04 0 C-N-CA 122.916 2.411 . . . . 0.0 113.757 -177.577 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 67.8 t -139.43 136.17 40.69 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.202 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 -178.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.506 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.0 m -111.98 127.89 56.01 Favored 'General case' 0 C--N 1.299 -1.613 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 178.136 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.496 HD13 ' HE3' ' A' ' 666' ' ' LYS . 29.3 pt -125.41 147.71 30.06 Favored 'Isoleucine or valine' 0 C--O 1.2 -1.536 0 N-CA-C 109.187 -0.672 . . . . 0.0 109.187 -177.033 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.475 HG23 ' O ' ' A' ' 662' ' ' ARG . 7.1 p -92.26 116.66 33.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.074 0 C-N-CA 120.222 -0.591 . . . . 0.0 109.704 -178.469 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.593 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.3 OUTLIER -78.16 -24.71 47.15 Favored 'General case' 0 C--N 1.306 -1.323 0 CA-C-O 121.44 0.638 . . . . 0.0 109.509 -178.977 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.551 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 8.4 tt0 58.34 47.75 13.46 Favored 'General case' 0 N--CA 1.443 -0.799 0 C-N-CA 125.834 1.653 . . . . 0.0 109.58 175.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.566 ' O ' ' HA ' ' A' ' 710' ' ' TYR . 33.0 m -128.88 149.56 50.72 Favored 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.821 -177.276 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p -124.18 147.01 48.32 Favored 'General case' 0 N--CA 1.434 -1.239 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -176.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 6.0 m -83.43 -4.73 58.77 Favored 'General case' 0 C--N 1.313 -0.997 0 CA-C-N 115.604 -0.725 . . . . 0.0 112.189 175.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 96.14 -87.37 0.97 Allowed Glycine 0 CA--C 1.486 -1.756 0 N-CA-C 109.85 -1.3 . . . . 0.0 109.85 179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.714 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 5.9 p-10 -154.25 -173.8 4.72 Favored 'General case' 0 C--N 1.302 -1.485 0 N-CA-C 109.733 -0.469 . . . . 0.0 109.733 178.139 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.636 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.8 mt -71.27 133.04 85.62 Favored Pre-proline 0 N--CA 1.42 -1.933 0 C-N-CA 123.623 0.769 . . . . 0.0 112.115 177.924 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.696 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 63.0 Cg_endo -71.91 -177.77 2.76 Favored 'Trans proline' 0 N--CA 1.452 -0.964 0 C-N-CA 123.417 2.745 . . . . 0.0 112.154 -178.628 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.2 tt0 -110.82 118.04 35.05 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.244 -178.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.556 HD23 ' HG2' ' A' ' 698' ' ' GLU . 5.2 tt -93.6 140.97 29.01 Favored 'General case' 0 C--N 1.304 -1.399 0 N-CA-C 104.317 -2.475 . . . . 0.0 104.317 175.747 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.556 ' HG2' HD23 ' A' ' 697' ' ' LEU . 9.4 pt-20 -45.67 -36.42 4.87 Favored 'General case' 0 N--CA 1.479 0.977 0 C-N-CA 124.39 1.076 . . . . 0.0 113.042 -175.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 95.3 m-70 -147.09 37.58 0.95 Allowed 'General case' 0 C--N 1.318 -0.785 0 N-CA-C 109.029 -0.73 . . . . 0.0 109.029 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.514 ' HA3' HD13 ' A' ' 697' ' ' LEU . . . -146.07 171.57 26.95 Favored Glycine 0 C--N 1.316 -0.56 0 C-N-CA 120.652 -0.785 . . . . 0.0 113.384 178.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.9 p-90 -156.47 -152.23 0.36 Allowed 'General case' 0 CA--C 1.5 -0.974 0 C-N-CA 126.247 1.819 . . . . 0.0 106.709 -177.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -134.58 152.76 52.0 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 118.581 -1.248 . . . . 0.0 113.854 -167.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.427 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.57 -47.53 8.64 Favored 'General case' 0 CA--C 1.501 -0.926 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.031 177.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.48 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.1 pp -119.69 129.89 54.76 Favored 'General case' 0 N--CA 1.431 -1.414 0 CA-C-N 115.988 -0.551 . . . . 0.0 111.29 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 3.5 m -126.97 126.19 42.77 Favored 'General case' 0 N--CA 1.413 -2.314 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.118 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 12.3 t -135.24 92.72 17.59 Favored Pre-proline 0 C--N 1.296 -1.746 0 C-N-CA 119.725 -0.79 . . . . 0.0 109.737 176.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.451 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 3.5 Cg_endo -87.03 153.24 8.36 Favored 'Trans proline' 0 N--CA 1.442 -1.501 0 C-N-CA 122.63 2.22 . . . . 0.0 111.717 177.202 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.451 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 60.6 Cg_endo -72.84 136.75 45.65 Favored 'Cis proline' 0 CA--C 1.535 0.569 0 C-N-CA 123.069 -1.638 . . . . 0.0 111.887 0.16 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.714 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 44.5 m-85 -81.9 93.92 6.99 Favored 'General case' 0 C--N 1.314 -0.94 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -177.366 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.566 ' HA ' ' O ' ' A' ' 689' ' ' SER . 3.2 m-85 -78.01 166.08 23.26 Favored 'General case' 0 C--N 1.31 -1.124 0 O-C-N 123.594 0.558 . . . . 0.0 111.526 -179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.593 ' HB3' ' HG3' ' A' ' 687' ' ' GLU . 0.7 OUTLIER -67.15 137.74 56.52 Favored 'General case' 0 C--N 1.32 -0.712 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 177.517 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 95.99 -16.31 61.38 Favored Glycine 0 N--CA 1.422 -2.287 0 C-N-CA 119.053 -1.546 . . . . 0.0 112.036 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 661' ' ' PRO . 22.1 t0 -77.79 164.79 24.9 Favored 'General case' 0 C--O 1.244 0.802 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 176.089 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.8 m -128.12 156.02 43.5 Favored 'General case' 0 N--CA 1.421 -1.88 0 CA-C-O 121.22 0.533 . . . . 0.0 109.875 -174.222 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.537 HG11 HG12 ' A' ' 694' ' ' ILE . 38.6 t -137.51 137.7 45.47 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.443 0 CA-C-N 114.985 -1.007 . . . . 0.0 108.969 175.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 43.1 mt-10 -106.51 120.35 41.68 Favored 'General case' 0 C--N 1.289 -2.032 0 CA-C-N 115.743 -0.662 . . . . 0.0 109.672 177.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.636 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.2 m-85 -92.35 147.51 22.85 Favored 'General case' 0 C--N 1.299 -1.602 0 C-N-CA 124.541 1.136 . . . . 0.0 111.962 -177.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.427 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.5 t30 -118.81 138.53 52.64 Favored 'General case' 0 CA--C 1.486 -1.516 0 N-CA-C 106.886 -1.524 . . . . 0.0 106.886 178.358 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.716 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 37.7 t -83.1 155.06 24.04 Favored 'General case' 0 C--N 1.274 -2.71 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 13.6 t -63.17 147.27 51.37 Favored 'General case' 0 N--CA 1.437 -1.082 0 N-CA-C 107.44 -1.319 . . . . 0.0 107.44 177.65 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.9 tt0 -73.02 137.78 45.59 Favored 'General case' 0 N--CA 1.407 -2.591 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 60.8 m 86.75 5.76 0.34 Allowed 'General case' 0 C--N 1.314 -0.957 0 C-N-CA 126.278 1.831 . . . . 0.0 110.665 -173.853 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.432 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 69.1 m-85 -122.5 152.07 40.7 Favored 'General case' 0 N--CA 1.428 -1.554 0 N-CA-C 107.977 -1.12 . . . . 0.0 107.977 172.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.443 ' HB ' HD11 ' A' ' 747' ' ' ILE . 9.9 t -114.42 137.43 51.84 Favored 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 108.096 -1.075 . . . . 0.0 108.096 177.603 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.716 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 5.3 ptm -91.11 139.33 30.86 Favored 'General case' 0 N--CA 1.434 -1.246 0 CA-C-O 121.48 0.657 . . . . 0.0 110.278 -176.593 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.613 HD12 HE21 ' A' ' 743' ' ' GLN . 26.9 mt -121.66 119.29 58.45 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.154 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 177.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 124.38 -154.52 17.92 Favored Glycine 0 CA--C 1.475 -2.415 0 N-CA-C 111.428 -0.669 . . . . 0.0 111.428 179.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.9 t-160 -98.69 118.49 35.53 Favored 'General case' 0 N--CA 1.421 -1.88 0 C-N-CA 119.327 -0.949 . . . . 0.0 110.548 -177.216 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 8.9 ptp85 -58.96 -24.65 62.79 Favored 'General case' 0 C--N 1.303 -1.423 0 CA-C-N 113.72 -1.582 . . . . 0.0 113.049 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 6.7 m -117.29 149.36 40.59 Favored 'General case' 0 N--CA 1.415 -2.216 0 C-N-CA 119.076 -1.049 . . . . 0.0 110.305 -173.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.605 HG21 HD23 ' A' ' 741' ' ' LEU . 5.8 pt -128.64 173.77 13.06 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.656 -177.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 90.3 m -140.7 136.91 33.09 Favored 'General case' 0 C--N 1.289 -2.057 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.253 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 38.8 t -69.06 109.04 3.8 Favored 'General case' 0 C--N 1.314 -0.956 0 C-N-CA 123.511 0.724 . . . . 0.0 110.124 179.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.7 mm -127.46 104.25 11.96 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.723 0 CA-C-O 120.996 0.427 . . . . 0.0 111.602 -176.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 53.3 m-70 65.73 27.71 11.17 Favored 'General case' 0 N--CA 1.484 1.254 0 C-N-CA 124.064 0.946 . . . . 0.0 111.894 174.031 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 94.42 5.11 62.06 Favored Glycine 0 N--CA 1.435 -1.401 0 CA-C-N 115.415 -0.811 . . . . 0.0 112.648 179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 45.7 t -135.2 140.83 44.29 Favored 'Isoleucine or valine' 0 C--O 1.21 -0.994 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 -179.346 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.696 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 90.6 m95 -79.91 148.45 31.27 Favored 'General case' 0 C--N 1.29 -1.986 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.197 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 41.1 p -33.38 -73.76 0.04 OUTLIER 'General case' 0 N--CA 1.478 0.937 0 N-CA-C 117.06 2.244 . . . . 0.0 117.06 -173.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -158.78 -29.9 0.07 Allowed 'General case' 0 C--N 1.311 -1.072 0 N-CA-C 115.092 1.515 . . . . 0.0 115.092 -171.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.605 HD23 HG21 ' A' ' 731' ' ' ILE . 25.6 mt 65.72 156.83 0.13 Allowed Pre-proline 0 N--CA 1.475 0.786 0 O-C-N 124.505 1.128 . . . . 0.0 111.725 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.424 ' HG2' HD11 ' A' ' 697' ' ' LEU . 72.1 Cg_endo -86.58 -179.28 2.97 Favored 'Trans proline' 0 N--CA 1.437 -1.845 0 C-N-CA 121.782 1.654 . . . . 0.0 110.21 172.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.613 HE21 HD12 ' A' ' 726' ' ' ILE . 12.5 pt20 -126.32 142.49 51.51 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 178.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.704 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 92.2 m -105.37 139.76 39.52 Favored 'General case' 0 C--N 1.281 -2.385 0 C-N-CA 120.454 -0.498 . . . . 0.0 112.317 178.173 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.7 m -128.15 144.86 36.44 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.701 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 177.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -70.46 115.85 10.12 Favored 'General case' 0 C--N 1.307 -1.26 0 O-C-N 123.499 0.499 . . . . 0.0 112.146 -175.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.443 HD11 ' HB ' ' A' ' 724' ' ' THR . 64.6 mt . . . . . 0 C--O 1.251 1.173 0 N-CA-C 108.25 -1.019 . . . . 0.0 108.25 175.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.451 -0.42 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -174.1 149.11 1.41 Allowed 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 105.176 -2.157 . . . . 0.0 105.176 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 58.06 -155.16 0.34 Allowed 'General case' 0 C--O 1.254 1.33 0 O-C-N 123.805 0.691 . . . . 0.0 109.882 -178.113 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -129.25 148.43 51.18 Favored 'General case' 0 C--N 1.305 -1.336 0 N-CA-C 109.42 -0.585 . . . . 0.0 109.42 177.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -87.02 109.43 19.39 Favored 'General case' 0 C--N 1.303 -1.446 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 109.74 -130.23 9.83 Favored Glycine 0 N--CA 1.415 -2.717 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -176.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . 0.314 14.4 p 46.3 81.13 0.04 OUTLIER 'Isoleucine or valine' 0 CA--C 1.543 0.698 0 CA-C-O 123.405 1.574 . . . . 0.0 113.273 -179.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -88.42 -100.05 0.09 Allowed 'General case' 0 C--N 1.288 -2.075 0 CA-C-N 113.161 -1.836 . . . . 0.0 114.363 -174.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 47.7 t 178.8 140.53 0.1 Allowed 'General case' 0 CA--C 1.498 -1.026 0 N-CA-C 107.347 -1.353 . . . . 0.0 107.347 -173.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.898 ' HB2' ' HB2' ' A' ' 649' ' ' TYR . 14.4 m -131.8 158.48 41.13 Favored 'General case' 0 C--N 1.274 -2.707 0 N-CA-C 107.546 -1.279 . . . . 0.0 107.546 -179.22 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -107.18 -150.57 16.89 Favored Glycine 1 N--CA 1.387 -4.628 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 176.466 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.98 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 24.4 Cg_exo -60.28 149.17 87.06 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 123.242 2.628 . . . . 0.0 110.927 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.602 ' HD2' HG22 ' A' ' 645' ' ' THR . 28.1 Cg_endo -63.77 149.55 90.5 Favored 'Trans proline' 0 N--CA 1.451 -1.026 0 C-N-CA 121.754 1.636 . . . . 0.0 110.992 178.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.537 ' HG2' HD11 ' A' ' 681' ' ' LEU . 28.8 Cg_endo -68.28 -167.27 0.17 Allowed 'Trans proline' 0 C--O 1.252 1.225 0 C-N-CA 122.823 2.349 . . . . 0.0 111.863 178.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -107.95 151.41 25.84 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.531 -0.731 . . . . 0.0 110.749 -178.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.733 HD12 ' HB3' ' A' ' 657' ' ' TYR . 3.7 tt -92.69 136.82 32.9 Favored 'General case' 0 C--N 1.297 -1.712 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 175.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.54 ' N ' HD23 ' A' ' 636' ' ' LEU . 46.3 tp -32.01 -68.31 0.09 Allowed 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 126.815 2.046 . . . . 0.0 113.958 173.783 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -134.33 33.66 3.31 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 123.939 1.828 . . . . 0.0 108.795 -178.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.732 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.67 -156.28 6.88 Favored Glycine 1 C--N 1.234 -5.121 0 CA-C-N 112.109 -2.314 . . . . 0.0 108.814 174.041 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -174.8 -178.92 1.35 Allowed 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.182 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.481 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.23 139.77 20.2 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 C-N-CA 123.838 0.855 . . . . 0.0 111.202 -174.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.5 ptpt -96.0 -23.01 17.03 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.015 0.436 . . . . 0.0 111.101 -177.546 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -80.31 172.16 14.12 Favored 'General case' 0 N--CA 1.441 -0.919 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.3 mmmt -96.79 165.24 12.21 Favored 'General case' 0 C--N 1.301 -1.526 0 C-N-CA 120.034 -0.666 . . . . 0.0 110.266 -175.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.602 HG22 ' HD2' ' A' ' 633' ' ' PRO . 33.5 p -91.14 120.79 32.38 Favored 'General case' 0 C--N 1.305 -1.348 0 CA-C-O 121.374 0.607 . . . . 0.0 111.586 -179.018 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -89.33 -24.91 21.88 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 115.777 -0.647 . . . . 0.0 109.759 178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.98 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 38.7 mt-10 67.55 -12.91 0.25 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 125.496 1.518 . . . . 0.0 114.395 178.013 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -132.0 93.49 3.3 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.898 ' HB2' ' HB2' ' A' ' 630' ' ' CYS . 3.1 m-85 -110.33 -179.46 3.78 Favored 'General case' 0 C--N 1.293 -1.856 0 CA-C-N 114.571 -1.195 . . . . 0.0 108.101 179.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -151.08 -150.31 5.28 Favored Glycine 0 N--CA 1.402 -3.578 0 C-N-CA 120.643 -0.789 . . . . 0.0 111.251 -179.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 73.6 t60 -80.1 134.02 36.14 Favored 'General case' 0 C--N 1.283 -2.287 0 CA-C-N 115.283 -0.458 . . . . 0.0 110.0 -174.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 22.3 t 75.66 17.87 2.29 Favored 'General case' 0 CA--C 1.548 0.881 0 C-N-CA 124.877 1.271 . . . . 0.0 111.798 177.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.515 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 69.7 mm-40 -79.87 129.22 34.31 Favored 'General case' 0 CA--C 1.499 -0.991 0 O-C-N 121.693 -0.629 . . . . 0.0 109.508 174.737 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.517 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 10.4 m -110.97 151.65 13.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 O-C-N 123.366 0.416 . . . . 0.0 111.461 179.233 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.495 HG21 ' HB3' ' A' ' 633' ' ' PRO . 26.2 t -135.2 131.8 52.4 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.601 0 CA-C-N 115.305 -0.861 . . . . 0.0 109.442 179.367 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -100.49 128.89 46.42 Favored 'General case' 0 N--CA 1.428 -1.527 0 CA-C-O 122.122 0.963 . . . . 0.0 112.089 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.733 ' HB3' HD12 ' A' ' 636' ' ' LEU . 52.8 m-85 -106.72 165.75 11.08 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-N 114.521 -1.218 . . . . 0.0 111.486 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -136.18 156.81 48.15 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 106.319 -1.734 . . . . 0.0 106.319 175.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.547 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 75.8 m -93.08 165.13 12.99 Favored 'General case' 0 C--N 1.292 -1.917 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 174.14 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.95 157.5 4.19 Favored Pre-proline 0 CA--C 1.541 0.619 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 175.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.3 Cg_endo -69.75 10.43 0.49 Allowed 'Trans proline' 0 N--CA 1.504 2.112 0 C-N-CA 123.846 3.031 . . . . 0.0 114.009 -174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.558 ' HA ' ' CB ' ' A' ' 710' ' ' TYR . 11.2 ptt85 -133.25 -1.16 3.24 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.996 0.903 . . . . 0.0 111.61 179.154 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.452 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 46.0 m-85 -116.7 158.18 24.24 Favored 'General case' 0 C--N 1.293 -1.863 0 CA-C-N 114.778 -1.101 . . . . 0.0 111.025 -179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.708 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.3 mp -115.33 140.72 48.87 Favored 'General case' 0 C--N 1.301 -1.533 0 CA-C-N 114.948 -1.024 . . . . 0.0 109.386 -177.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.547 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 56.6 tpp -75.45 118.43 18.31 Favored 'General case' 0 C--N 1.305 -1.329 0 CA-C-N 115.552 -0.749 . . . . 0.0 110.588 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.583 ' HB3' HG23 ' A' ' 683' ' ' VAL . 38.0 ttmt -98.24 -47.09 5.59 Favored 'General case' 0 C--N 1.316 -0.879 0 CA-C-O 121.077 0.465 . . . . 0.0 110.46 178.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -88.43 -170.95 46.03 Favored Glycine 0 C--O 1.242 0.629 0 C-N-CA 120.512 -0.851 . . . . 0.0 113.405 -173.305 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 59.0 Cg_endo -73.72 104.52 1.83 Allowed 'Trans proline' 0 N--CA 1.453 -0.893 0 C-N-CA 122.494 2.129 . . . . 0.0 110.934 178.299 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.498 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.0 p-10 -69.32 -2.44 10.78 Favored 'General case' 0 C--N 1.29 -2.016 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.318 -177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.426 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 46.6 mtmt -121.91 128.79 51.96 Favored 'General case' 0 N--CA 1.429 -1.478 0 CA-C-O 121.426 0.631 . . . . 0.0 110.139 175.086 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.525 HG21 HD13 ' A' ' 681' ' ' LEU . 43.7 pt -116.96 166.25 11.47 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.82 0 CA-C-N 115.007 -0.997 . . . . 0.0 108.623 -177.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.515 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.2 tt0 -138.46 139.57 38.88 Favored 'General case' 0 C--N 1.285 -2.217 0 O-C-N 123.75 0.656 . . . . 0.0 109.657 -176.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.569 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 13.7 t -89.67 115.06 26.76 Favored 'General case' 0 N--CA 1.422 -1.871 0 N-CA-C 108.212 -1.032 . . . . 0.0 108.212 175.695 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . 0.456 HG22 ' O ' ' A' ' 677' ' ' GLU . 20.0 m -89.58 -171.99 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.045 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 179.513 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . 0.252 4.8 p-10 -78.75 76.97 5.23 Favored 'General case' 0 C--N 1.319 -0.728 0 CA-C-O 122.477 1.132 . . . . 0.0 111.684 -179.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 157.4 -55.5 0.38 Allowed Glycine 0 N--CA 1.414 -2.804 0 CA-C-N 113.534 -1.666 . . . . 0.0 111.145 173.201 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . 0.456 ' O ' HG22 ' A' ' 674' ' ' VAL . 10.9 pt-20 -149.79 -175.28 4.97 Favored 'General case' 0 C--N 1.314 -0.955 0 N-CA-C 110.026 -0.361 . . . . 0.0 110.026 -178.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.569 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 85.9 m95 -85.05 175.1 9.24 Favored 'General case' 0 C--N 1.311 -1.069 0 CA-C-O 121.238 0.542 . . . . 0.0 111.469 179.631 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 30.5 p -88.81 -174.64 4.59 Favored 'General case' 0 C--N 1.312 -1.035 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.833 -179.443 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 88.5 m -61.63 116.66 4.94 Favored 'General case' 0 N--CA 1.432 -1.354 0 C-N-CA 123.883 0.873 . . . . 0.0 111.927 -179.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.537 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -68.4 143.48 95.56 Favored Pre-proline 0 C--N 1.308 -1.204 0 CA-C-N 114.676 -1.147 . . . . 0.0 111.581 176.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.524 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 84.4 Cg_endo -76.31 170.03 20.8 Favored 'Trans proline' 0 CA--C 1.461 -3.153 0 C-N-CA 123.585 2.857 . . . . 0.0 111.928 177.42 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.583 HG23 ' HB3' ' A' ' 666' ' ' LYS . 18.6 m -131.75 156.52 42.65 Favored 'Isoleucine or valine' 1 N--CA 1.356 -5.167 0 CA-C-N 112.048 -2.342 . . . . 0.0 108.482 -174.499 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 95.8 m -128.33 138.0 52.19 Favored 'General case' 0 C--N 1.272 -2.768 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.22 -175.227 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.7 pt -128.39 152.35 36.4 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.53 HG22 ' H ' ' A' ' 688' ' ' GLU . 11.4 p -97.52 132.1 42.97 Favored 'Isoleucine or valine' 0 C--N 1.274 -2.678 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -178.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.591 ' HG2' HD11 ' A' ' 664' ' ' LEU . 13.2 pt-20 -79.93 -20.72 45.04 Favored 'General case' 0 C--N 1.318 -0.763 0 C-N-CA 119.026 -1.07 . . . . 0.0 109.454 177.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.968 ' HA ' ' HE1' ' A' ' 710' ' ' TYR 0.502 15.2 pt-20 38.65 61.46 1.19 Allowed 'General case' 0 CA--C 1.501 -0.909 0 CA-C-O 123.687 1.708 . . . . 0.0 114.859 -176.255 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 56.9 m -148.36 154.91 40.58 Favored 'General case' 0 N--CA 1.401 -2.903 0 N-CA-C 101.24 -3.615 . . . . 0.0 101.24 173.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 62.1 p -118.6 175.22 5.83 Favored 'General case' 0 C--N 1.265 -3.078 0 C-N-CA 119.452 -0.899 . . . . 0.0 110.519 -174.062 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . 0.486 ' HA ' ' HA2' ' A' ' 736' ' ' GLY . 32.7 m -95.02 -12.17 27.1 Favored 'General case' 0 C--N 1.272 -2.771 0 CA-C-N 115.008 -0.996 . . . . 0.0 110.412 -178.504 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 103.64 -77.74 0.29 Allowed Glycine 0 CA--C 1.478 -2.251 0 CA-C-N 114.784 -1.098 . . . . 0.0 111.415 174.058 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.513 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 9.4 t70 -170.58 -165.24 0.43 Allowed 'General case' 0 C--N 1.301 -1.506 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 179.589 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.605 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.3 mt -80.15 136.65 53.44 Favored Pre-proline 0 C--N 1.272 -2.793 0 C-N-CA 125.296 1.439 . . . . 0.0 111.315 178.5 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.597 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.5 Cg_endo -74.64 -177.22 3.23 Favored 'Trans proline' 0 N--CA 1.45 -1.065 0 C-N-CA 123.252 2.635 . . . . 0.0 111.309 179.519 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -115.46 118.54 33.48 Favored 'General case' 0 C--N 1.276 -2.6 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.61 HD23 ' HA3' ' A' ' 700' ' ' GLY . 25.0 tp -89.35 143.39 26.87 Favored 'General case' 0 C--N 1.288 -2.09 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.507 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 10.2 pt-20 -39.01 -47.34 1.46 Allowed 'General case' 0 N--CA 1.481 1.107 0 C-N-CA 125.03 1.332 . . . . 0.0 113.239 -176.69 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 53.9 m80 -143.41 30.76 1.37 Allowed 'General case' 0 N--CA 1.438 -1.038 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 -177.71 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.61 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -133.12 176.53 19.52 Favored Glycine 0 N--CA 1.431 -1.638 0 CA-C-N 114.231 -1.35 . . . . 0.0 112.066 -176.828 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -164.62 -156.03 0.3 Allowed 'General case' 0 N--CA 1.433 -1.276 0 C-N-CA 126.306 1.842 . . . . 0.0 106.913 -174.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.41 150.69 47.84 Favored 'General case' 0 C--N 1.295 -1.766 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -167.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.445 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.5 -41.8 13.24 Favored 'General case' 0 CA--C 1.506 -0.736 0 CA-C-N 115.78 -0.645 . . . . 0.0 110.765 178.597 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -134.07 146.98 50.82 Favored 'General case' 0 N--CA 1.432 -1.33 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.674 -178.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.53 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 13.0 m -120.41 130.54 54.4 Favored 'General case' 0 C--N 1.295 -1.802 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 173.313 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.57 87.77 49.41 Favored Pre-proline 0 C--N 1.299 -1.588 0 N-CA-C 113.078 0.77 . . . . 0.0 113.078 -177.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.45 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.4 Cg_endo -91.28 147.84 3.59 Favored 'Trans proline' 0 N--CA 1.434 -1.972 0 C-N-CA 122.914 2.409 . . . . 0.0 112.152 176.112 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.45 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 70.4 Cg_endo -74.84 128.33 16.1 Favored 'Cis proline' 0 C--O 1.241 0.671 0 C-N-CA 122.648 -1.814 . . . . 0.0 110.955 -0.585 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.53 ' OH ' ' HB3' ' A' ' 705' ' ' SER . 12.7 m-85 -72.78 97.06 2.15 Favored 'General case' 0 C--N 1.315 -0.93 0 N-CA-C 107.54 -1.282 . . . . 0.0 107.54 -178.113 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.968 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 13.6 m-85 -97.11 176.83 5.79 Favored 'General case' 0 C--N 1.298 -1.659 0 CA-C-O 121.326 0.584 . . . . 0.0 111.883 179.028 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.708 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 11.3 t80 -67.09 137.75 56.6 Favored 'General case' 0 N--CA 1.429 -1.478 0 N-CA-C 107.196 -1.409 . . . . 0.0 107.196 175.555 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.16 -1.53 88.65 Favored Glycine 0 C--N 1.294 -1.791 0 C-N-CA 120.64 -0.791 . . . . 0.0 113.369 -178.313 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -84.78 174.17 10.09 Favored 'General case' 0 C--O 1.251 1.175 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 176.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 14.3 m -143.04 153.31 42.82 Favored 'General case' 0 C--N 1.289 -2.044 0 CA-C-O 121.144 0.497 . . . . 0.0 110.614 -172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.578 HG11 HG12 ' A' ' 694' ' ' ILE . 39.6 t -138.28 141.73 37.15 Favored 'Isoleucine or valine' 0 C--N 1.282 -2.354 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.503 179.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.566 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 34.3 mt-10 -100.73 121.14 41.16 Favored 'General case' 0 N--CA 1.434 -1.265 0 CA-C-O 121.249 0.547 . . . . 0.0 110.445 175.139 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.605 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.1 m-85 -98.38 161.52 13.64 Favored 'General case' 0 C--N 1.298 -1.636 0 C-N-CA 124.611 1.164 . . . . 0.0 110.461 179.534 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.445 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 34.3 t-20 -149.45 163.21 38.42 Favored 'General case' 0 C--N 1.283 -2.283 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 177.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.479 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 84.6 m -108.23 154.72 21.36 Favored 'General case' 0 C--N 1.264 -3.112 0 N-CA-C 109.093 -0.706 . . . . 0.0 109.093 -179.197 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 19.3 m -61.22 154.14 24.29 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.255 0.347 . . . . 0.0 111.598 -179.348 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -64.46 138.64 58.52 Favored 'General case' 0 N--CA 1.43 -1.468 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 175.956 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 43.5 m 88.18 -0.83 0.45 Allowed 'General case' 0 C--N 1.308 -1.203 0 C-N-CA 126.929 2.092 . . . . 0.0 110.118 -174.584 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -117.31 149.26 40.77 Favored 'General case' 0 N--CA 1.422 -1.826 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 172.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -117.15 145.31 43.91 Favored 'General case' 0 C--N 1.277 -2.582 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 177.963 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.67 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.5 ptm -93.79 138.48 31.92 Favored 'General case' 0 N--CA 1.431 -1.386 0 CA-C-O 121.684 0.754 . . . . 0.0 111.729 -176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 51.9 mt -113.08 116.9 53.91 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.323 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 176.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 119.37 -139.67 14.35 Favored Glycine 0 C--N 1.297 -1.587 0 N-CA-C 109.967 -1.253 . . . . 0.0 109.967 -175.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -128.19 167.54 16.69 Favored 'General case' 0 C--N 1.291 -1.971 0 CA-C-O 120.895 0.379 . . . . 0.0 110.402 177.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 4.5 ptt85 -87.51 -33.83 18.84 Favored 'General case' 0 C--N 1.285 -2.233 0 N-CA-C 114.009 1.115 . . . . 0.0 114.009 -177.36 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.566 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.0 p -93.57 133.78 36.53 Favored 'General case' 0 C--N 1.303 -1.451 0 N-CA-C 115.806 1.78 . . . . 0.0 115.806 -173.027 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.634 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -118.1 166.03 12.85 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 CA-C-N 114.667 -1.151 . . . . 0.0 109.507 179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.41 ' H ' HG23 ' A' ' 739' ' ' THR . 75.2 m -132.11 139.56 48.5 Favored 'General case' 0 C--N 1.284 -2.26 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 179.34 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.0 t -79.05 121.68 25.26 Favored 'General case' 0 C--N 1.295 -1.784 0 CA-C-O 121.551 0.691 . . . . 0.0 112.206 178.629 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.605 ' O ' HG22 ' A' ' 737' ' ' VAL . 49.7 mm -128.43 108.38 17.46 Favored 'Isoleucine or valine' 0 N--CA 1.42 -1.939 0 CA-C-N 113.854 -1.521 . . . . 0.0 108.239 179.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 21.6 m-70 70.63 27.07 3.81 Favored 'General case' 0 N--CA 1.496 1.857 0 N-CA-C 112.798 0.666 . . . . 0.0 112.798 175.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . 0.486 ' HA2' ' HA ' ' A' ' 691' ' ' CYS . . . 95.17 -13.72 66.44 Favored Glycine 0 N--CA 1.429 -1.77 0 C-N-CA 120.35 -0.929 . . . . 0.0 111.32 -178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . 0.605 HG22 ' O ' ' A' ' 734' ' ' ILE . 2.6 m -113.73 158.51 14.05 Favored 'Isoleucine or valine' 0 N--CA 1.391 -3.379 0 N-CA-C 107.647 -1.242 . . . . 0.0 107.647 -173.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.597 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.8 m95 -96.12 158.61 15.36 Favored 'General case' 0 C--N 1.271 -2.835 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.692 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.41 HG23 ' H ' ' A' ' 732' ' ' THR . 42.5 p -39.59 -70.4 0.1 Allowed 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 116.208 1.929 . . . . 0.0 116.208 -174.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -163.2 -28.38 0.04 OUTLIER 'General case' 0 C--N 1.317 -0.843 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -173.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.634 HD23 HG21 ' A' ' 731' ' ' ILE . 17.4 mt 68.98 157.78 0.15 Allowed Pre-proline 0 N--CA 1.475 0.812 0 C-N-CA 124.466 1.107 . . . . 0.0 110.749 -179.588 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.67 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 51.2 Cg_endo -77.51 -172.05 1.35 Allowed 'Trans proline' 0 CA--C 1.538 0.712 0 C-N-CA 121.776 1.65 . . . . 0.0 111.577 174.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 48.9 mt-30 -125.1 130.38 52.12 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 106.519 -1.66 . . . . 0.0 106.519 175.09 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.94 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 9.6 m -107.39 126.07 52.01 Favored 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.9 m -123.64 147.07 28.13 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 109.84 -0.43 . . . . 0.0 109.84 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.66 114.87 8.27 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 123.903 0.752 . . . . 0.0 111.254 -178.426 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 75.7 mt . . . . . 0 C--N 1.308 -1.198 0 CA-C-N 115.014 -0.994 . . . . 0.0 109.58 175.66 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.4 mm-40 . . . . . 0 N--CA 1.472 0.647 0 N-CA-C 110.054 -0.351 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 63.45 85.66 0.13 Allowed 'General case' 0 C--O 1.236 0.38 0 C-N-CA 124.417 1.087 . . . . 0.0 112.201 178.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -82.78 -40.62 20.2 Favored 'General case' 0 C--N 1.317 -0.825 0 CA-C-N 116.475 -0.329 . . . . 0.0 111.08 179.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -141.37 -48.57 0.4 Allowed 'General case' 0 C--N 1.312 -1.053 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 176.706 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -81.12 172.88 13.13 Favored 'General case' 0 C--O 1.244 0.789 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . 0.537 ' O ' ' HB3' ' A' ' 675' ' ' ASP . . . 88.01 59.57 1.67 Allowed Glycine 0 N--CA 1.432 -1.57 0 N-CA-C 107.71 -2.156 . . . . 0.0 107.71 -174.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.65 ' HB ' ' HB2' ' A' ' 651' ' ' HIS . 33.7 m -128.7 -13.73 2.76 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.755 0 CA-C-N 114.898 -0.651 . . . . 0.0 111.53 -174.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . 0.254 2.9 pp0? 25.61 -46.12 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.424 0 C-N-CA 130.282 3.433 . . . . 0.0 118.868 -167.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.652 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 47.8 m 78.98 127.06 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.218 0 C-N-CA 126.745 2.018 . . . . 0.0 112.057 -178.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 12.9 p -116.33 -172.08 2.12 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 114.806 -1.088 . . . . 0.0 110.076 -176.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -117.67 -136.82 5.66 Favored Glycine 0 N--CA 1.398 -3.84 0 N-CA-C 110.172 -1.171 . . . . 0.0 110.172 176.283 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -58.04 147.54 82.08 Favored 'Trans proline' 0 C--N 1.329 -0.474 0 C-N-CA 123.685 2.923 . . . . 0.0 114.028 -176.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.558 ' HB3' HG21 ' A' ' 655' ' ' VAL . 31.9 Cg_endo -64.66 157.34 56.22 Favored 'Trans proline' 0 C--O 1.249 1.038 0 C-N-CA 123.137 2.558 . . . . 0.0 112.658 179.371 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.57 ' HG2' HD21 ' A' ' 681' ' ' LEU . 19.1 Cg_endo -66.73 -164.01 0.08 OUTLIER 'Trans proline' 0 CA--C 1.553 1.432 0 C-N-CA 123.405 2.736 . . . . 0.0 111.421 171.541 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -114.75 159.23 20.81 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.819 -0.753 . . . . 0.0 110.461 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.774 HD12 ' HB3' ' A' ' 657' ' ' TYR . 1.0 OUTLIER -93.94 136.2 34.47 Favored 'General case' 0 N--CA 1.435 -1.224 0 N-CA-C 106.452 -1.685 . . . . 0.0 106.452 177.365 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 2.2 tm? -32.11 -65.55 0.14 Allowed 'General case' 0 N--CA 1.471 0.576 0 C-N-CA 126.563 1.945 . . . . 0.0 111.189 174.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.526 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.2 t30 -110.63 -33.53 6.55 Favored 'General case' 0 C--N 1.312 -1.053 0 C-N-CA 119.157 -1.017 . . . . 0.0 110.448 -177.131 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.748 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -83.18 -147.12 6.99 Favored Glycine 0 N--CA 1.445 -0.758 0 CA-C-N 115.313 -0.858 . . . . 0.0 113.691 -179.278 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -162.04 -172.85 3.4 Favored 'General case' 0 C--N 1.313 -1.021 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -178.184 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.75 HG22 ' CE1' ' A' ' 657' ' ' TYR . 21.3 t -105.16 140.21 23.88 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.326 0 C-N-CA 124.64 1.176 . . . . 0.0 109.215 -176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.503 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.0 ptpt -107.32 -11.68 15.51 Favored 'General case' 0 C--N 1.31 -1.126 0 CA-C-O 121.666 0.746 . . . . 0.0 109.482 178.828 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.498 ' CG ' ' H ' ' A' ' 656' ' ' GLU . 20.0 mm-40 -78.51 154.09 30.77 Favored 'General case' 0 C--N 1.316 -0.89 0 CA-C-N 114.738 -1.119 . . . . 0.0 108.927 -179.202 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -90.93 144.82 25.28 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 121.068 0.461 . . . . 0.0 110.171 -179.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.496 ' HA ' ' OH ' ' A' ' 649' ' ' TYR . 20.9 p -78.78 119.97 22.75 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 115.171 -0.922 . . . . 0.0 110.998 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.466 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.2 mtmt -103.02 -13.82 16.71 Favored 'General case' 0 C--N 1.306 -1.312 0 CA-C-N 115.58 -0.736 . . . . 0.0 111.045 -177.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 52.4 mm-40 66.79 -29.08 0.14 Allowed 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 125.148 1.379 . . . . 0.0 112.013 -175.24 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.466 ' H ' ' C ' ' A' ' 646' ' ' LYS . 10.9 tt0 -112.66 102.49 10.55 Favored 'General case' 0 N--CA 1.421 -1.902 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.496 ' OH ' ' HA ' ' A' ' 645' ' ' THR . 6.7 m-85 -117.55 -160.04 0.76 Allowed 'General case' 0 C--N 1.292 -1.908 0 N-CA-C 106.814 -1.55 . . . . 0.0 106.814 174.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.652 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -176.03 -165.57 32.07 Favored Glycine 0 N--CA 1.411 -2.975 0 C-N-CA 120.391 -0.909 . . . . 0.0 111.137 -179.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.65 ' HB2' ' HB ' ' A' ' 627' ' ' VAL . 69.1 t60 -69.8 137.12 51.59 Favored 'General case' 0 C--N 1.292 -1.927 0 N-CA-C 109.469 -0.567 . . . . 0.0 109.469 -178.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 17.4 m 75.85 4.33 3.85 Favored 'General case' 0 C--N 1.308 -1.217 0 O-C-N 124.694 1.246 . . . . 0.0 113.252 177.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.584 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 53.9 mm-40 -70.98 140.27 50.81 Favored 'General case' 0 CA--C 1.503 -0.848 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 176.295 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.528 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 4.4 m -121.12 139.52 48.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.281 0 N-CA-C 112.997 0.74 . . . . 0.0 112.997 -175.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.558 HG21 ' HB3' ' A' ' 633' ' ' PRO . 39.3 t -121.71 132.59 70.46 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.472 0 CA-C-N 115.187 -0.915 . . . . 0.0 109.743 177.835 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.498 ' H ' ' CG ' ' A' ' 643' ' ' GLU . 38.5 tt0 -102.42 127.73 49.32 Favored 'General case' 0 N--CA 1.414 -2.231 0 O-C-N 124.109 0.881 . . . . 0.0 110.236 -178.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.774 ' HB3' HD12 ' A' ' 636' ' ' LEU . 81.2 m-85 -101.96 161.27 13.8 Favored 'General case' 0 C--N 1.283 -2.31 0 CA-C-N 114.834 -1.076 . . . . 0.0 110.604 178.377 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.503 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 51.6 p90 -136.89 142.23 42.74 Favored 'General case' 0 C--N 1.301 -1.51 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 174.357 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.489 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 79.9 m -85.24 163.33 18.72 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 175.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.617 ' OD1' ' HD2' ' A' ' 661' ' ' PRO . 0.6 OUTLIER -60.98 154.4 60.41 Favored Pre-proline 0 C--O 1.211 -0.923 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 175.251 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.617 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 58.6 Cg_endo -66.53 -4.04 10.16 Favored 'Trans proline' 0 N--CA 1.488 1.199 0 C-N-CA 123.975 3.117 . . . . 0.0 114.628 -172.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.582 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 13.3 ptt180 -110.6 -4.71 15.3 Favored 'General case' 0 C--N 1.31 -1.145 0 CA-C-O 122.021 0.915 . . . . 0.0 111.111 177.765 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.494 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 38.9 m-85 -117.07 149.95 39.46 Favored 'General case' 0 C--N 1.294 -1.838 0 CA-C-N 114.578 -1.192 . . . . 0.0 110.065 178.264 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 1.004 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.1 mp -108.71 146.54 33.32 Favored 'General case' 0 C--N 1.277 -2.56 0 CA-C-N 115.193 -0.912 . . . . 0.0 109.617 179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.495 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 51.7 tpp -71.04 123.22 21.59 Favored 'General case' 0 C--N 1.294 -1.842 0 CA-C-N 114.615 -1.175 . . . . 0.0 108.647 177.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -99.57 -49.21 4.48 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 -178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -94.5 -162.42 35.14 Favored Glycine 0 C--N 1.312 -0.773 0 CA-C-N 115.701 -0.682 . . . . 0.0 113.497 -173.616 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 69.4 Cg_endo -75.64 106.2 2.22 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 C-N-CA 122.538 2.159 . . . . 0.0 110.431 178.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.495 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 25.3 p-10 -68.96 -8.82 48.15 Favored 'General case' 0 C--N 1.291 -1.943 0 CA-C-N 115.291 -0.868 . . . . 0.0 112.333 -175.642 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.497 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.7 mttt -118.68 130.45 55.84 Favored 'General case' 0 C--N 1.279 -2.485 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -177.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.54 HG21 ' HG ' ' A' ' 681' ' ' LEU . 46.7 pt -120.22 165.46 15.63 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.858 0 CA-C-N 115.461 -0.791 . . . . 0.0 108.903 -179.237 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.584 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.1 tt0 -136.81 138.18 40.56 Favored 'General case' 0 C--N 1.283 -2.288 0 O-C-N 123.848 0.717 . . . . 0.0 110.196 -175.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 651' ' ' HIS . 47.5 t -84.29 107.92 16.86 Favored 'General case' 0 C--N 1.298 -1.632 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.8 m -97.78 -163.97 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.296 -1.743 0 CA-C-N 116.229 -0.442 . . . . 0.0 111.13 -178.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.537 ' HB3' ' O ' ' A' ' 626' ' ' GLY . 13.7 p-10 -74.05 79.83 1.72 Allowed 'General case' 0 C--N 1.314 -0.942 0 CA-C-O 122.334 1.064 . . . . 0.0 110.419 179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 140.33 -51.2 0.73 Allowed Glycine 0 N--CA 1.422 -2.281 0 CA-C-N 114.648 -1.16 . . . . 0.0 112.681 174.442 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -155.6 -170.52 3.46 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -177.21 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.4 m95 -86.81 162.53 17.75 Favored 'General case' 0 C--N 1.307 -1.255 0 N-CA-C 109.876 -0.416 . . . . 0.0 109.876 177.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.8 p -76.45 -178.21 4.52 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 112.579 0.585 . . . . 0.0 112.579 -178.952 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 86.6 m -58.87 113.93 2.3 Favored 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 123.798 0.839 . . . . 0.0 111.335 178.875 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.57 HD21 ' HG2' ' A' ' 634' ' ' PRO . 6.6 mp -71.46 156.21 91.76 Favored Pre-proline 0 C--N 1.311 -1.086 0 CA-C-N 115.393 -0.822 . . . . 0.0 112.534 177.085 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.438 ' HG3' ' HA ' ' A' ' 669' ' ' ASN . 72.7 Cg_endo -73.64 -178.45 3.75 Favored 'Trans proline' 0 N--CA 1.447 -1.245 0 C-N-CA 123.036 2.491 . . . . 0.0 113.539 -179.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 47.2 t -133.54 149.55 31.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 N-CA-C 105.553 -2.017 . . . . 0.0 105.553 -179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.526 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 83.9 m -119.67 128.83 54.19 Favored 'General case' 0 C--N 1.295 -1.776 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 35.8 pt -123.59 158.31 29.29 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 -176.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.43 HG22 ' HG3' ' A' ' 688' ' ' GLU . 12.5 p -103.38 118.77 50.92 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.493 0 CA-C-O 123.077 1.417 . . . . 0.0 110.421 179.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.591 ' HB2' HD13 ' A' ' 664' ' ' LEU . 7.8 tp10 -62.26 -36.93 83.57 Favored 'General case' 0 C--N 1.279 -2.458 0 CA-C-N 112.322 -2.217 . . . . 0.0 110.388 179.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.89 ' HA ' ' HE2' ' A' ' 710' ' ' TYR 0.251 24.1 mt-10 52.47 45.85 27.78 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-O 122.654 1.216 . . . . 0.0 113.609 -178.328 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 30.0 m -146.48 137.27 24.13 Favored 'General case' 0 C--N 1.293 -1.891 0 N-CA-C 104.492 -2.41 . . . . 0.0 104.492 174.209 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 43.5 p -120.26 174.99 6.17 Favored 'General case' 0 C--N 1.296 -1.73 0 CA-C-O 121.246 0.546 . . . . 0.0 111.095 -174.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 19.0 m -90.11 -2.63 58.12 Favored 'General case' 0 C--N 1.296 -1.735 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.668 174.103 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 89.74 -75.93 1.77 Allowed Glycine 0 CA--C 1.48 -2.11 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 175.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.778 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 3.2 t70 -159.57 -166.78 1.85 Allowed 'General case' 0 C--N 1.305 -1.354 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 178.223 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.649 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.3 mt -79.78 133.72 58.28 Favored Pre-proline 0 C--N 1.28 -2.438 0 C-N-CA 124.275 1.03 . . . . 0.0 111.043 177.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.53 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 62.9 Cg_endo -74.29 -176.58 2.77 Favored 'Trans proline' 0 N--CA 1.445 -1.325 0 C-N-CA 123.075 2.516 . . . . 0.0 111.612 179.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -109.09 120.35 42.28 Favored 'General case' 0 C--N 1.273 -2.759 0 CA-C-N 115.746 -0.661 . . . . 0.0 109.44 179.433 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.677 HD23 ' HA3' ' A' ' 700' ' ' GLY . 30.2 tp -90.46 138.63 31.4 Favored 'General case' 0 C--N 1.292 -1.925 0 N-CA-C 105.635 -1.987 . . . . 0.0 105.635 175.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -41.61 -40.8 2.01 Favored 'General case' 0 N--CA 1.493 1.692 0 N-CA-C 113.73 1.011 . . . . 0.0 113.73 -173.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 46.3 m-70 -142.19 27.44 1.76 Allowed 'General case' 0 C--N 1.313 -1.015 0 N-CA-C 109.051 -0.722 . . . . 0.0 109.051 177.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.677 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.52 -179.85 16.5 Favored Glycine 0 N--CA 1.442 -0.931 0 CA-C-N 115.162 -0.927 . . . . 0.0 113.465 -179.826 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 7.9 p-90 -160.25 -152.53 0.29 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 126.982 2.113 . . . . 0.0 106.553 -176.317 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.555 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.75 150.95 46.68 Favored 'General case' 0 C--N 1.29 -2.019 0 CA-C-N 118.816 0.735 . . . . 0.0 112.506 -169.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.486 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -84.43 -43.43 14.66 Favored 'General case' 0 CA--C 1.505 -0.773 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.761 -179.563 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.6 pp -129.23 147.87 51.11 Favored 'General case' 0 N--CA 1.432 -1.345 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.575 -178.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 6.9 p -126.17 121.47 32.9 Favored 'General case' 0 C--N 1.293 -1.883 0 CA-C-N 115.527 -0.761 . . . . 0.0 109.333 176.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 3.5 p -122.05 85.65 46.17 Favored Pre-proline 0 C--N 1.298 -1.661 0 N-CA-C 113.555 0.946 . . . . 0.0 113.555 -176.653 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.471 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 8.8 Cg_endo -92.23 146.66 2.93 Favored 'Trans proline' 0 N--CA 1.439 -1.724 0 C-N-CA 123.114 2.543 . . . . 0.0 111.827 176.069 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.471 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 64.6 Cg_endo -72.73 130.11 18.98 Favored 'Cis proline' 0 C--O 1.248 0.995 0 C-N-CA 123.037 -1.651 . . . . 0.0 111.456 -0.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.778 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 19.3 m-85 -78.05 83.6 4.34 Favored 'General case' 0 C--N 1.314 -0.971 0 N-CA-C 108.447 -0.945 . . . . 0.0 108.447 -178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.89 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 20.9 m-85 -83.0 168.54 16.89 Favored 'General case' 0 CA--C 1.484 -1.577 0 CA-C-O 121.157 0.503 . . . . 0.0 111.536 179.308 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 1.004 ' HB3' HD11 ' A' ' 664' ' ' LEU . 1.9 t80 -59.89 127.2 30.73 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 114.74 -1.118 . . . . 0.0 108.084 176.339 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 103.33 -20.5 42.38 Favored Glycine 0 C--N 1.299 -1.515 0 C-N-CA 120.611 -0.804 . . . . 0.0 112.537 -179.525 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -75.31 170.18 16.6 Favored 'General case' 0 C--O 1.253 1.243 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 178.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 2.5 m -138.87 148.98 44.35 Favored 'General case' 0 C--N 1.285 -2.203 0 CA-C-O 121.451 0.643 . . . . 0.0 111.291 -172.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.563 HG11 HG12 ' A' ' 694' ' ' ILE . 42.5 t -131.83 143.07 41.36 Favored 'Isoleucine or valine' 0 C--N 1.276 -2.588 0 CA-C-N 115.037 -0.983 . . . . 0.0 108.995 176.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.543 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 36.1 mt-10 -109.97 122.29 47.21 Favored 'General case' 0 N--CA 1.419 -1.995 0 N-CA-C 109.527 -0.545 . . . . 0.0 109.527 176.659 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.649 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.3 m-85 -95.32 161.1 14.23 Favored 'General case' 0 C--N 1.301 -1.514 0 C-N-CA 124.686 1.194 . . . . 0.0 111.399 -176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.486 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 55.6 t30 -150.1 147.86 28.28 Favored 'General case' 0 C--N 1.286 -2.185 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 177.21 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.555 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.4 m -91.37 165.06 13.61 Favored 'General case' 0 C--N 1.27 -2.885 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . 0.417 ' HB3' ' CD1' ' A' ' 723' ' ' PHE . 47.3 t -50.69 147.01 5.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.355 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -55.64 -31.24 62.15 Favored 'General case' 0 C--N 1.313 -1.008 0 N-CA-C 113.151 0.797 . . . . 0.0 113.151 -172.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 20.3 m -93.68 11.37 29.21 Favored 'General case' 0 CA--C 1.559 1.31 0 CA-C-O 121.173 0.511 . . . . 0.0 111.89 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.417 ' CD1' ' HB3' ' A' ' 720' ' ' SER . 75.9 m-85 -127.26 154.83 44.39 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 108.965 -0.754 . . . . 0.0 108.965 178.184 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -119.93 145.09 47.06 Favored 'General case' 0 C--N 1.279 -2.474 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.451 ' HB3' ' SG ' ' A' ' 719' ' ' CYS . 9.0 ptp -90.74 161.07 15.48 Favored 'General case' 0 N--CA 1.417 -2.111 0 CA-C-O 121.474 0.654 . . . . 0.0 109.954 178.31 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 53.3 mt -123.18 122.94 66.65 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.295 0 N-CA-C 106.624 -1.621 . . . . 0.0 106.624 175.614 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 113.65 -144.47 18.18 Favored Glycine 0 N--CA 1.426 -1.998 0 N-CA-C 109.027 -1.629 . . . . 0.0 109.027 -175.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.5 p-80 -118.75 169.7 9.61 Favored 'General case' 0 C--N 1.296 -1.73 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 177.514 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 717' ' ' PHE . 33.7 ptt180 -94.49 -28.67 15.33 Favored 'General case' 0 C--N 1.293 -1.874 0 N-CA-C 112.663 0.616 . . . . 0.0 112.663 -173.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.543 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 11.4 p -86.19 146.43 26.56 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 115.009 1.485 . . . . 0.0 115.009 -172.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.648 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -130.34 168.28 23.64 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.853 0 CA-C-N 115.191 -0.913 . . . . 0.0 109.262 177.05 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 99.2 m -137.49 136.26 37.55 Favored 'General case' 0 C--N 1.278 -2.537 0 N-CA-C 108.547 -0.909 . . . . 0.0 108.547 179.596 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.5 t -70.15 109.15 4.46 Favored 'General case' 0 C--N 1.309 -1.169 0 O-C-N 123.507 0.504 . . . . 0.0 110.312 -179.539 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.3 mm -123.89 107.67 19.22 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.945 0 CA-C-O 121.361 0.6 . . . . 0.0 110.729 -177.87 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 40.1 m-70 68.16 18.83 9.29 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.42 1.088 . . . . 0.0 113.211 176.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 99.24 6.3 55.57 Favored Glycine 0 N--CA 1.443 -0.898 0 C-N-CA 120.501 -0.857 . . . . 0.0 111.665 179.506 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 46.4 t -135.03 142.47 40.02 Favored 'Isoleucine or valine' 0 C--O 1.211 -0.971 0 N-CA-C 106.504 -1.665 . . . . 0.0 106.504 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.53 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.2 m95 -75.53 163.09 27.73 Favored 'General case' 0 C--N 1.292 -1.922 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 31.0 p -46.33 -71.59 0.07 Allowed 'General case' 0 CA--C 1.509 -0.616 0 N-CA-C 115.484 1.661 . . . . 0.0 115.484 -175.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.33 -33.09 0.06 Allowed 'General case' 0 C--N 1.304 -1.412 0 N-CA-C 114.829 1.418 . . . . 0.0 114.829 -172.321 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.648 HD23 HG21 ' A' ' 731' ' ' ILE . 15.2 mt 66.35 153.79 0.13 Allowed Pre-proline 0 N--CA 1.481 1.104 0 O-C-N 124.497 1.123 . . . . 0.0 110.37 -176.395 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 66.4 Cg_endo -79.3 -161.73 0.16 Allowed 'Trans proline' 0 C--N 1.314 -1.25 0 C-N-CA 121.585 1.524 . . . . 0.0 111.022 175.174 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 22.1 pt20 -138.56 132.26 30.83 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 107.267 -1.383 . . . . 0.0 107.267 176.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.519 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 10.1 m -94.56 146.49 24.08 Favored 'General case' 0 C--N 1.313 -1.008 0 C-N-CA 120.346 -0.542 . . . . 0.0 110.35 -177.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 16.2 m -139.82 155.1 24.47 Favored 'Isoleucine or valine' 0 N--CA 1.433 -1.315 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 178.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -69.87 124.57 24.35 Favored 'General case' 0 C--N 1.293 -1.855 0 O-C-N 123.685 0.615 . . . . 0.0 109.688 179.444 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 64.3 mt . . . . . 0 C--O 1.253 1.266 0 O-C-N 123.882 0.739 . . . . 0.0 109.166 176.81 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.235 0.322 0 N-CA-C 112.161 0.43 . . . . 0.0 112.161 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -78.14 127.76 32.77 Favored 'General case' 0 N--CA 1.446 -0.646 0 CA-C-O 120.683 0.278 . . . . 0.0 110.365 178.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -100.66 15.87 26.77 Favored 'General case' 0 C--N 1.313 -1.004 0 CA-C-O 121.165 0.507 . . . . 0.0 109.854 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . 0.545 ' HB2' ' HB3' ' A' ' 628' ' ' GLN . . . -154.55 143.17 20.74 Favored 'General case' 0 N--CA 1.426 -1.661 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.36 -177.886 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -88.38 -29.93 19.89 Favored 'General case' 0 C--N 1.303 -1.419 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 166.894 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 165.6 41.76 0.02 OUTLIER Glycine 0 CA--C 1.488 -1.629 0 CA-C-N 112.929 -1.941 . . . . 0.0 109.779 176.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.543 HG23 ' HB2' ' A' ' 651' ' ' HIS . 3.3 p 179.11 82.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.432 -1.342 0 C-N-CA 125.597 1.559 . . . . 0.0 107.721 -176.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.545 ' HB3' ' HB2' ' A' ' 624' ' ' ALA . 0.0 OUTLIER -74.71 -96.4 0.02 OUTLIER 'General case' 0 C--N 1.279 -2.497 0 CA-C-N 113.94 -1.482 . . . . 0.0 111.919 178.817 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 22.7 t 166.92 142.91 0.02 OUTLIER 'General case' 0 N--CA 1.434 -1.228 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.456 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 25.8 p -145.61 177.87 8.56 Favored 'General case' 0 C--N 1.275 -2.631 0 N-CA-C 107.086 -1.449 . . . . 0.0 107.086 175.495 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -116.7 -141.75 7.16 Favored Glycine 0 N--CA 1.402 -3.616 0 C-N-CA 119.909 -1.138 . . . . 0.0 110.905 -178.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.739 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 18.9 Cg_exo -60.58 146.07 97.67 Favored 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.075 2.517 . . . . 0.0 111.887 179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.484 ' HD2' HG22 ' A' ' 645' ' ' THR . 11.5 Cg_endo -55.57 149.18 49.65 Favored 'Trans proline' 0 C--O 1.25 1.101 0 C-N-CA 123.041 2.494 . . . . 0.0 112.233 177.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.643 ' HG2' HD21 ' A' ' 681' ' ' LEU . 17.9 Cg_endo -72.58 -168.26 0.39 Allowed 'Trans proline' 0 C--O 1.252 1.2 0 C-N-CA 123.312 2.675 . . . . 0.0 111.999 179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -99.29 158.86 15.41 Favored 'General case' 0 C--N 1.297 -1.684 0 CA-C-O 121.047 0.451 . . . . 0.0 110.823 -178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.707 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.8 tt -98.72 145.7 26.64 Favored 'General case' 0 N--CA 1.417 -2.094 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 177.903 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.653 HD13 HG23 ' A' ' 683' ' ' VAL . 6.9 tt -33.52 -56.0 0.44 Allowed 'General case' 0 C--O 1.22 -0.463 0 C-N-CA 127.325 2.25 . . . . 0.0 111.238 176.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.502 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 4.5 t30 -122.6 -47.55 2.09 Favored 'General case' 0 C--N 1.309 -1.182 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 176.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.643 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -68.88 -153.08 0.54 Allowed Glycine 0 N--CA 1.476 1.324 0 O-C-N 124.103 0.877 . . . . 0.0 114.681 179.508 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -173.43 -172.93 0.83 Allowed 'General case' 0 N--CA 1.477 0.922 0 O-C-N 122.275 -0.544 . . . . 0.0 111.045 -178.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 89.5 t -93.1 140.97 15.4 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.029 0 C-N-CA 125.921 1.688 . . . . 0.0 110.748 -173.567 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.419 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 14.6 ptpt -104.55 -23.83 13.08 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-O 121.564 0.697 . . . . 0.0 109.604 176.549 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 52.8 mm-40 -69.88 156.26 39.34 Favored 'General case' 0 N--CA 1.442 -0.872 0 CA-C-N 114.719 -1.128 . . . . 0.0 111.629 -176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.49 ' HA ' ' HD3' ' A' ' 644' ' ' LYS . 59.5 mmtt -93.37 119.37 32.41 Favored 'General case' 0 N--CA 1.427 -1.582 0 CA-C-O 121.832 0.825 . . . . 0.0 110.468 -178.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.484 HG22 ' HD2' ' A' ' 633' ' ' PRO . 77.3 p -67.6 121.68 16.4 Favored 'General case' 0 C--N 1.289 -2.042 0 CA-C-N 113.428 -1.715 . . . . 0.0 112.034 -172.09 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 53.4 mtmt -86.15 -26.77 25.0 Favored 'General case' 0 C--N 1.309 -1.183 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.314 -178.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.739 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 43.4 mt-10 75.04 -18.63 0.43 Allowed 'General case' 0 N--CA 1.474 0.767 0 C-N-CA 124.968 1.307 . . . . 0.0 112.663 -178.836 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -115.33 98.21 6.62 Favored 'General case' 0 N--CA 1.433 -1.321 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 172.673 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.573 ' HE1' ' H ' ' A' ' 647' ' ' GLU . 9.7 m-85 -118.4 142.47 47.52 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 106.749 -1.574 . . . . 0.0 106.749 176.828 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . -108.53 -71.07 0.71 Allowed Glycine 0 N--CA 1.431 -1.679 0 C-N-CA 119.534 -1.317 . . . . 0.0 112.787 -176.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.543 ' HB2' HG23 ' A' ' 627' ' ' VAL . 80.6 t60 -160.48 143.25 13.2 Favored 'General case' 0 C--N 1.311 -1.105 0 N-CA-C 108.645 -0.872 . . . . 0.0 108.645 -177.705 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 54.8 m 70.14 13.52 7.74 Favored 'General case' 0 C--O 1.239 0.546 0 C-N-CA 123.877 0.871 . . . . 0.0 112.664 178.324 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.61 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 61.5 mm-40 -74.73 130.24 39.14 Favored 'General case' 0 N--CA 1.432 -1.341 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 176.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.559 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 1.5 p -122.68 129.36 75.25 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 CA-C-O 121.779 0.8 . . . . 0.0 112.46 -174.527 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.504 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 78.8 t -118.84 136.63 55.42 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.292 0 CA-C-N 114.546 -1.206 . . . . 0.0 110.197 -174.281 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.547 ' OE1' ' HE3' ' A' ' 670' ' ' LYS . 36.2 tt0 -100.62 133.63 44.78 Favored 'General case' 0 N--CA 1.421 -1.888 0 CA-C-O 121.631 0.729 . . . . 0.0 110.667 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.707 ' HB3' HD12 ' A' ' 636' ' ' LEU . 42.4 m-85 -104.81 166.11 10.61 Favored 'General case' 0 C--N 1.292 -1.898 0 CA-C-N 114.938 -1.028 . . . . 0.0 110.445 178.013 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.419 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 35.4 p90 -130.21 151.07 51.14 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 107.916 -1.142 . . . . 0.0 107.916 174.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.505 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 67.2 m -100.1 154.93 18.02 Favored 'General case' 0 C--N 1.278 -2.517 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 170.437 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.526 ' HB2' ' HB2' ' A' ' 663' ' ' PHE . 11.2 m120 -51.89 162.33 0.8 Allowed Pre-proline 0 C--N 1.296 -1.74 0 C-N-CA 125.888 1.675 . . . . 0.0 113.707 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -58.6 -18.48 40.28 Favored 'Trans proline' 0 N--CA 1.486 1.087 0 C-N-CA 123.369 2.712 . . . . 0.0 113.534 -178.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.445 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 19.7 ptt180 -117.67 -3.71 11.26 Favored 'General case' 0 C--N 1.315 -0.914 0 CA-C-O 121.728 0.775 . . . . 0.0 112.171 179.464 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.643 ' HB3' ' HB3' ' A' ' 684' ' ' CYS . 59.1 m-85 -112.87 137.91 50.51 Favored 'General case' 0 C--N 1.294 -1.83 0 CA-C-N 115.408 -0.815 . . . . 0.0 111.119 178.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.559 HD11 ' HG3' ' A' ' 687' ' ' GLU . 51.8 mt -106.64 143.39 34.8 Favored 'General case' 0 C--N 1.267 -2.979 0 CA-C-N 115.723 -0.671 . . . . 0.0 111.19 -177.164 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.627 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.6 tpp -70.67 110.95 5.79 Favored 'General case' 0 C--N 1.283 -2.322 0 CA-C-N 114.021 -1.445 . . . . 0.0 110.257 177.574 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.544 ' HB3' HG13 ' A' ' 683' ' ' VAL . 83.3 tttt -101.66 -31.75 10.66 Favored 'General case' 0 C--N 1.301 -1.516 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 176.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -75.83 -175.06 37.76 Favored Glycine 0 CA--C 1.528 0.865 0 CA-C-N 115.105 -0.952 . . . . 0.0 113.661 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.573 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 40.5 Cg_endo -67.36 -11.24 31.47 Favored 'Trans proline' 0 N--CA 1.487 1.143 0 C-N-CA 123.581 2.854 . . . . 0.0 113.928 -176.684 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.627 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 0.9 OUTLIER 62.2 -26.72 0.06 Allowed 'General case' 0 N--CA 1.501 2.084 0 C-N-CA 127.19 2.196 . . . . 0.0 115.15 179.47 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.547 ' HE3' ' OE1' ' A' ' 656' ' ' GLU . 88.1 mttt -117.74 134.77 54.56 Favored 'General case' 0 C--N 1.289 -2.047 0 C-N-CA 123.102 0.561 . . . . 0.0 110.409 177.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.781 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -119.49 167.41 12.89 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.833 0 CA-C-N 115.514 -0.766 . . . . 0.0 109.438 178.564 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.61 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.9 tt0 -139.55 138.68 36.48 Favored 'General case' 0 N--CA 1.413 -2.288 0 O-C-N 123.491 0.494 . . . . 0.0 110.243 -176.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 43.4 t -84.67 107.03 16.67 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 177.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 25.4 m -93.78 -173.37 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.29 -2.014 0 N-CA-C 108.47 -0.937 . . . . 0.0 108.47 179.573 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.411 ' HA ' ' OE1' ' A' ' 628' ' ' GLN . 16.3 p-10 -78.42 70.71 4.82 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-O 122.931 1.348 . . . . 0.0 112.719 -175.044 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 167.88 -54.57 0.22 Allowed Glycine 0 N--CA 1.416 -2.67 0 CA-C-N 113.507 -1.679 . . . . 0.0 109.455 172.641 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -159.17 -166.97 1.95 Allowed 'General case' 0 C--N 1.308 -1.206 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 177.619 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 90.6 m95 -80.81 161.64 24.39 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-O 120.812 0.339 . . . . 0.0 110.503 -179.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -75.46 -176.13 3.07 Favored 'General case' 0 C--N 1.309 -1.194 0 C-N-CA 123.325 0.65 . . . . 0.0 112.017 -179.078 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 32.9 m -63.19 115.22 4.31 Favored 'General case' 0 N--CA 1.429 -1.496 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.159 176.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.781 ' HG ' HG21 ' A' ' 671' ' ' ILE . 5.7 mp -71.93 155.29 92.16 Favored Pre-proline 0 C--N 1.303 -1.426 0 CA-C-N 115.016 -0.993 . . . . 0.0 113.26 178.056 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.698 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 51.5 Cg_endo -68.55 179.73 2.89 Favored 'Trans proline' 0 N--CA 1.448 -1.159 0 C-N-CA 123.142 2.561 . . . . 0.0 115.03 179.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.653 HG23 HD13 ' A' ' 637' ' ' LEU . 2.2 p -136.54 137.14 48.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.65 0 CA-C-N 113.319 -1.764 . . . . 0.0 106.66 -178.021 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.643 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 95.3 m -111.16 133.96 53.11 Favored 'General case' 0 C--N 1.3 -1.551 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.0 pt -127.75 146.39 33.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.813 0 N-CA-C 109.646 -0.501 . . . . 0.0 109.646 -178.593 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.538 HG13 ' HG2' ' A' ' 688' ' ' GLU . 10.9 p -77.91 130.86 35.69 Favored 'Isoleucine or valine' 0 C--N 1.273 -2.738 0 CA-C-O 121.291 0.567 . . . . 0.0 110.852 -178.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.559 ' HG3' HD11 ' A' ' 664' ' ' LEU . 13.9 tt0 -57.38 -41.58 80.49 Favored 'General case' 0 N--CA 1.441 -0.878 0 CA-C-N 114.59 -1.186 . . . . 0.0 110.761 178.216 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.538 ' HG2' HG13 ' A' ' 686' ' ' VAL . 10.1 mm-40 61.77 32.85 18.12 Favored 'General case' 0 N--CA 1.448 -0.55 0 CA-C-N 114.557 -1.201 . . . . 0.0 113.022 -177.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 67.1 m -150.81 165.93 32.05 Favored 'General case' 0 N--CA 1.421 -1.905 0 N-CA-C 106.879 -1.526 . . . . 0.0 106.879 175.86 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 12.9 p -125.89 162.14 25.85 Favored 'General case' 0 N--CA 1.413 -2.288 0 CA-C-O 122.272 1.034 . . . . 0.0 112.736 178.695 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 34.6 m -89.52 -11.84 41.71 Favored 'General case' 0 C--N 1.287 -2.123 0 CA-C-N 113.789 -1.551 . . . . 0.0 109.98 178.698 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.75 -89.68 0.57 Allowed Glycine 0 CA--C 1.472 -2.65 0 N-CA-C 109.555 -1.418 . . . . 0.0 109.555 175.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.637 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 t70 -164.41 -167.61 1.33 Allowed 'General case' 0 C--N 1.297 -1.68 0 N-CA-C 106.257 -1.757 . . . . 0.0 106.257 179.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.528 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 0.9 OUTLIER -68.72 130.79 91.58 Favored Pre-proline 0 N--CA 1.412 -2.33 0 N-CA-C 109.53 -0.544 . . . . 0.0 109.53 174.144 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.598 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 41.9 Cg_endo -71.61 179.71 4.44 Favored 'Trans proline' 0 N--CA 1.445 -1.364 0 C-N-CA 123.197 2.598 . . . . 0.0 111.607 178.346 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -106.76 124.32 49.43 Favored 'General case' 0 C--N 1.265 -3.076 0 CA-C-O 121.667 0.746 . . . . 0.0 110.694 -178.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.926 HD23 ' HA3' ' A' ' 700' ' ' GLY . 40.7 tp -100.06 133.56 44.28 Favored 'General case' 0 C--N 1.287 -2.117 0 N-CA-C 104.57 -2.382 . . . . 0.0 104.57 173.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -50.8 -36.92 39.57 Favored 'General case' 0 N--CA 1.475 0.776 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -174.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 53.8 m-70 -133.86 18.01 3.85 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 121.572 0.701 . . . . 0.0 111.512 177.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.926 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -128.02 176.51 18.04 Favored Glycine 0 N--CA 1.427 -1.96 0 CA-C-N 115.044 -0.98 . . . . 0.0 111.841 178.308 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -157.3 -151.97 0.34 Allowed 'General case' 0 C--N 1.289 -2.06 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 -175.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.424 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -141.15 158.5 43.83 Favored 'General case' 0 C--N 1.28 -2.448 0 C-N-CA 119.558 -0.857 . . . . 0.0 111.66 -168.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.453 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.47 -61.67 1.39 Allowed 'General case' 0 C--N 1.306 -1.313 0 CA-C-N 115.63 -0.714 . . . . 0.0 109.439 -179.579 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.602 HD11 ' HA ' ' A' ' 715' ' ' VAL . 4.0 pp -103.42 153.34 20.6 Favored 'General case' 0 N--CA 1.426 -1.638 0 CA-C-N 115.833 -0.621 . . . . 0.0 111.071 -178.223 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.515 ' HB3' HD13 ' A' ' 694' ' ' ILE . 4.4 p -147.04 111.68 5.29 Favored 'General case' 0 N--CA 1.41 -2.452 0 CA-C-N 114.659 -1.155 . . . . 0.0 108.461 176.561 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 70.8 m -125.01 92.26 47.88 Favored Pre-proline 0 C--N 1.284 -2.239 0 CA-C-O 121.34 0.59 . . . . 0.0 111.747 -178.838 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -84.3 154.97 12.54 Favored 'Trans proline' 0 N--CA 1.436 -1.862 0 C-N-CA 122.697 2.265 . . . . 0.0 111.205 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -76.98 136.5 44.26 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 C-N-CA 122.718 -1.784 . . . . 0.0 111.22 0.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.637 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.4 m-85 -82.14 101.48 10.45 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.445 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 3.3 m-85 -98.37 169.87 9.25 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 123.591 0.557 . . . . 0.0 109.76 176.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.518 ' HB3' HD21 ' A' ' 664' ' ' LEU . 4.5 t80 -54.6 138.5 41.01 Favored 'General case' 0 C--N 1.305 -1.358 0 CA-C-N 115.061 -0.972 . . . . 0.0 109.296 175.004 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.37 -21.94 42.74 Favored Glycine 0 N--CA 1.421 -2.303 0 C-N-CA 118.894 -1.622 . . . . 0.0 113.905 175.961 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -80.46 172.6 13.55 Favored 'General case' 0 C--O 1.25 1.093 0 C-N-CA 119.006 -1.077 . . . . 0.0 109.839 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.01 158.71 37.15 Favored 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 109.904 -0.406 . . . . 0.0 109.904 -173.263 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.602 ' HA ' HD11 ' A' ' 704' ' ' LEU . 16.1 t -142.51 138.52 28.93 Favored 'Isoleucine or valine' 0 N--CA 1.424 -1.752 0 CA-C-N 115.183 -0.917 . . . . 0.0 109.831 178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.405 ' HG2' ' OG ' ' A' ' 730' ' ' SER . 50.7 mt-10 -95.66 122.42 38.41 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 123.406 0.441 . . . . 0.0 110.286 176.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.528 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -99.16 154.96 17.73 Favored 'General case' 0 C--N 1.295 -1.804 0 C-N-CA 123.78 0.832 . . . . 0.0 110.024 175.063 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.453 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 56.2 t30 -144.8 150.26 36.87 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 178.338 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.459 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 42.0 t -104.57 160.21 15.12 Favored 'General case' 0 C--N 1.267 -3.005 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 -178.976 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 27.4 m -67.24 142.66 56.85 Favored 'General case' 0 C--O 1.205 -1.264 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 175.201 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -68.54 -18.24 64.32 Favored 'General case' 0 C--N 1.31 -1.129 0 N-CA-C 114.21 1.189 . . . . 0.0 114.21 -167.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 30.1 m -81.62 -3.24 52.9 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-O 122.43 1.11 . . . . 0.0 109.57 175.829 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.549 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 77.8 m-85 -126.37 151.27 47.86 Favored 'General case' 0 N--CA 1.415 -2.221 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 8.8 t -114.96 131.97 56.72 Favored 'General case' 0 C--N 1.265 -3.084 0 N-CA-C 108.262 -1.014 . . . . 0.0 108.262 178.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.507 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -85.29 138.04 32.58 Favored 'General case' 0 N--CA 1.424 -1.75 0 N-CA-C 109.045 -0.724 . . . . 0.0 109.045 -177.668 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 57.1 mt -106.39 106.05 19.87 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.655 0 N-CA-C 107.927 -1.138 . . . . 0.0 107.927 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 132.72 -161.14 24.0 Favored Glycine 0 N--CA 1.421 -2.36 0 N-CA-C 108.906 -1.678 . . . . 0.0 108.906 -177.341 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.2 p-80 -101.14 174.44 6.0 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-N 117.439 0.62 . . . . 0.0 111.101 179.803 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.1 ptm180 -89.24 -35.97 15.88 Favored 'General case' 0 C--N 1.288 -2.092 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 -177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.405 ' OG ' ' HG2' ' A' ' 716' ' ' GLU . 5.8 m -107.08 138.0 44.09 Favored 'General case' 0 C--N 1.3 -1.549 0 C-N-CA 117.678 -1.609 . . . . 0.0 113.958 -169.688 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.635 HG21 HD23 ' A' ' 741' ' ' LEU . 7.8 pt -113.44 173.75 2.82 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.193 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.062 -176.798 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.418 ' O ' HG23 ' A' ' 739' ' ' THR . 95.7 m -138.98 137.3 36.24 Favored 'General case' 0 C--N 1.302 -1.5 0 N-CA-C 107.412 -1.329 . . . . 0.0 107.412 -179.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.539 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 46.7 t -79.5 121.78 25.64 Favored 'General case' 0 C--N 1.301 -1.504 0 C-N-CA 120.08 -0.648 . . . . 0.0 111.962 -179.861 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.407 HD13 ' O ' ' A' ' 733' ' ' CYS . 49.5 mm -126.88 104.86 13.28 Favored 'Isoleucine or valine' 0 N--CA 1.428 -1.571 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.5 -179.052 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.4 m-70 63.11 49.11 3.49 Favored 'General case' 0 N--CA 1.476 0.83 0 C-N-CA 125.116 1.367 . . . . 0.0 112.018 177.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 83.06 -4.71 79.64 Favored Glycine 0 N--CA 1.434 -1.44 0 CA-C-N 115.011 -0.995 . . . . 0.0 113.637 177.574 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 42.5 t -131.5 139.45 50.68 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.215 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 -176.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.598 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 85.9 m95 -67.6 165.48 16.92 Favored 'General case' 0 C--N 1.298 -1.652 0 C-N-CA 120.288 -0.565 . . . . 0.0 109.764 176.95 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.418 HG23 ' O ' ' A' ' 732' ' ' THR . 20.4 p -44.24 -70.29 0.11 Allowed 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 115.408 1.632 . . . . 0.0 115.408 -174.162 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 4.7 pp0? -167.65 -27.24 0.02 OUTLIER 'General case' 0 C--N 1.317 -0.842 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 -176.832 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.635 HD23 HG21 ' A' ' 731' ' ' ILE . 17.9 mt 68.58 150.93 0.12 Allowed Pre-proline 0 N--CA 1.485 1.317 0 C-N-CA 124.598 1.159 . . . . 0.0 112.393 179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.507 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 96.0 Cg_endo -78.68 -165.82 0.36 Allowed 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 121.954 1.769 . . . . 0.0 110.361 176.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 21.0 pt20 -142.9 143.64 32.11 Favored 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 175.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 71.5 m -93.62 151.82 19.42 Favored 'General case' 0 C--N 1.291 -1.956 0 C-N-CA 120.632 -0.427 . . . . 0.0 111.535 178.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.5 m -138.74 145.04 28.53 Favored 'Isoleucine or valine' 0 N--CA 1.437 -1.09 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 174.059 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.95 127.33 32.46 Favored 'General case' 0 C--N 1.296 -1.732 0 CA-C-O 121.041 0.448 . . . . 0.0 111.415 -177.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 62.9 mt . . . . . 0 C--N 1.305 -1.354 0 N-CA-C 107.589 -1.263 . . . . 0.0 107.589 173.755 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 . . . . . 0 C--O 1.238 0.49 0 N-CA-C 110.482 -0.192 . . . . 0.0 110.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . 66.16 -168.53 0.21 Allowed 'General case' 0 C--O 1.246 0.9 0 C-N-CA 123.764 0.826 . . . . 0.0 110.246 -177.194 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 19.1 mm-40 -78.65 -71.32 0.44 Allowed 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.567 -0.901 . . . . 0.0 108.567 177.437 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -121.8 -57.09 1.83 Allowed 'General case' 0 C--N 1.305 -1.329 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 175.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -116.46 148.14 41.03 Favored 'General case' 0 C--N 1.308 -1.226 0 CA-C-N 115.597 -0.729 . . . . 0.0 109.323 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -80.42 79.15 1.77 Allowed Glycine 0 N--CA 1.441 -1.017 0 N-CA-C 111.055 -0.818 . . . . 0.0 111.055 179.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.654 HG23 ' CB ' ' A' ' 651' ' ' HIS . 4.5 p -169.83 79.71 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.436 -1.148 0 CA-C-O 122.881 1.324 . . . . 0.0 110.831 -176.84 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.548 ' HG3' ' HA ' ' A' ' 675' ' ' ASP . 1.9 pp0? -90.52 -151.56 0.25 Allowed 'General case' 0 C--N 1.268 -2.95 0 N-CA-C 107.07 -1.456 . . . . 0.0 107.07 173.721 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . . . . . . . . . 20.7 m -144.46 147.25 33.07 Favored 'General case' 0 C--N 1.283 -2.323 0 CA-C-O 120.892 0.377 . . . . 0.0 111.172 -171.212 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 38.4 m -131.78 153.39 50.16 Favored 'General case' 0 C--N 1.3 -1.579 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 175.756 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.411 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -100.91 -135.22 8.83 Favored Glycine 0 N--CA 1.415 -2.753 0 N-CA-C 109.589 -1.404 . . . . 0.0 109.589 175.652 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.419 ' HD3' ' HA ' ' A' ' 647' ' ' GLU . 52.3 Cg_exo -55.44 141.66 81.81 Favored 'Trans proline' 0 C--O 1.242 0.702 0 C-N-CA 123.314 2.676 . . . . 0.0 112.622 179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.584 ' HD2' HG22 ' A' ' 645' ' ' THR . 32.9 Cg_endo -64.15 153.75 74.58 Favored 'Trans proline' 0 C--O 1.243 0.729 0 C-N-CA 123.05 2.5 . . . . 0.0 111.999 179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.561 ' HG2' HD11 ' A' ' 681' ' ' LEU . 42.9 Cg_endo -70.31 -166.0 0.19 Allowed 'Trans proline' 0 C--O 1.251 1.148 0 C-N-CA 123.268 2.645 . . . . 0.0 111.941 177.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -102.99 158.96 15.93 Favored 'General case' 0 C--N 1.298 -1.641 0 CA-C-O 121.28 0.562 . . . . 0.0 110.482 -178.704 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.679 HD13 ' HG2' ' A' ' 682' ' ' PRO . 20.5 tp -102.09 139.68 37.39 Favored 'General case' 0 C--N 1.29 -1.996 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.49 ' H ' HD12 ' A' ' 636' ' ' LEU . 3.1 tm? -39.38 -67.57 0.21 Allowed 'General case' 0 C--N 1.322 -0.629 0 O-C-N 124.816 1.323 . . . . 0.0 112.263 178.415 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.529 ' ND2' ' HB2' ' A' ' 660' ' ' ASN . 6.1 t30 -106.66 -37.44 6.43 Favored 'General case' 0 N--CA 1.443 -0.821 0 C-N-CA 118.604 -1.238 . . . . 0.0 111.679 -175.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.58 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -95.04 -147.4 22.58 Favored Glycine 0 C--O 1.219 -0.843 0 N-CA-C 110.498 -1.041 . . . . 0.0 110.498 177.281 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.417 ' HA ' ' HB3' ' A' ' 636' ' ' LEU . 1.7 t-20 -169.0 -166.42 0.63 Allowed 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 118.372 1.086 . . . . 0.0 111.123 -178.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 58.7 t -87.07 135.36 25.4 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.482 0 N-CA-C 107.667 -1.234 . . . . 0.0 107.667 179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.678 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 12.6 ptpt -102.53 -10.26 19.48 Favored 'General case' 0 C--N 1.303 -1.43 0 CA-C-O 121.585 0.707 . . . . 0.0 109.597 -179.818 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 35.2 mt-10 -93.79 173.73 7.53 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 -179.495 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.412 ' HB2' ' HE2' ' A' ' 644' ' ' LYS . 0.0 OUTLIER -98.11 146.59 25.41 Favored 'General case' 0 C--N 1.297 -1.683 0 C-N-CA 119.992 -0.683 . . . . 0.0 110.954 -176.703 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.584 HG22 ' HD2' ' A' ' 633' ' ' PRO . 18.7 p -72.88 126.77 30.73 Favored 'General case' 0 C--N 1.302 -1.485 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.34 179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.491 ' C ' ' H ' ' A' ' 648' ' ' GLU . 41.5 mtmt -105.38 -12.2 16.13 Favored 'General case' 0 C--N 1.312 -1.026 0 N-CA-C 112.594 0.59 . . . . 0.0 112.594 -176.057 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.419 ' HA ' ' HD3' ' A' ' 632' ' ' PRO 0.283 10.4 pt-20 58.15 -30.83 0.03 OUTLIER 'General case' 0 N--CA 1.514 2.757 0 C-N-CA 127.169 2.188 . . . . 0.0 113.782 -171.504 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.491 ' H ' ' C ' ' A' ' 646' ' ' LYS . 35.2 tt0 -98.31 95.65 7.51 Favored 'General case' 0 N--CA 1.415 -2.213 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 178.002 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.468 ' C ' ' HG3' ' A' ' 653' ' ' GLU . 24.2 m-85 -114.5 -82.63 0.61 Allowed 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 120.137 -0.625 . . . . 0.0 110.895 175.213 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . . . . . . . . . . . 98.05 -166.44 22.31 Favored Glycine 0 C--N 1.298 -1.581 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -176.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.654 ' CB ' HG23 ' A' ' 627' ' ' VAL . 77.2 t60 -77.48 142.24 39.23 Favored 'General case' 0 C--N 1.304 -1.391 0 CA-C-N 116.756 0.278 . . . . 0.0 111.21 -175.142 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 11.3 t 77.94 0.66 2.78 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.48 1.512 . . . . 0.0 113.38 175.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.582 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 29.7 mm-40 -70.51 133.68 47.01 Favored 'General case' 0 C--N 1.315 -0.914 0 N-CA-C 109.621 -0.511 . . . . 0.0 109.621 177.015 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 18.0 t -109.63 150.29 12.33 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.975 0 O-C-N 123.557 0.535 . . . . 0.0 109.681 -176.696 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.544 HG21 ' HB3' ' A' ' 633' ' ' PRO . 25.0 t -132.97 134.85 57.76 Favored 'Isoleucine or valine' 0 C--N 1.309 -1.17 0 C-N-CA 124.038 0.935 . . . . 0.0 109.302 177.999 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -101.73 124.9 48.14 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-O 122.172 0.987 . . . . 0.0 111.524 179.172 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.52 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 57.3 m-85 -99.3 163.95 12.33 Favored 'General case' 0 C--N 1.29 -1.98 0 CA-C-N 114.281 -1.327 . . . . 0.0 110.189 177.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.678 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 26.9 p90 -143.42 149.46 37.66 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.58 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 97.4 m -93.02 158.93 15.54 Favored 'General case' 0 C--N 1.276 -2.619 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 174.262 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.529 ' HB2' ' ND2' ' A' ' 638' ' ' ASN . 0.9 OUTLIER -56.18 156.1 11.39 Favored Pre-proline 0 C--O 1.208 -1.08 0 CA-C-N 115.685 -0.689 . . . . 0.0 109.775 176.432 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.413 ' HD2' ' OD1' ' A' ' 660' ' ' ASN . 31.5 Cg_endo -59.53 -14.36 25.36 Favored 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 123.599 2.866 . . . . 0.0 115.404 -171.53 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.476 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 16.1 ptt180 -108.03 -7.1 16.23 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-O 121.409 0.623 . . . . 0.0 111.556 178.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.476 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 35.4 m-85 -109.6 139.33 44.74 Favored 'General case' 0 C--N 1.303 -1.442 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.178 -179.531 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.689 HD11 ' HB3' ' A' ' 711' ' ' TYR . 10.5 mp -99.7 142.08 31.66 Favored 'General case' 0 C--N 1.282 -2.352 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.791 -179.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.59 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 55.7 tpp -71.71 117.19 12.98 Favored 'General case' 0 C--N 1.303 -1.426 0 CA-C-N 114.616 -1.175 . . . . 0.0 109.441 177.895 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.609 ' HB3' HG23 ' A' ' 683' ' ' VAL . 13.2 tmtt? -107.01 -25.23 11.69 Favored 'General case' 0 C--N 1.3 -1.544 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.715 -177.617 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -103.22 -169.54 25.93 Favored Glycine 0 C--N 1.316 -0.576 0 C-N-CA 120.387 -0.911 . . . . 0.0 112.197 -177.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 50.5 Cg_endo -76.55 105.6 2.11 Favored 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 122.482 2.122 . . . . 0.0 111.274 177.355 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.59 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.9 p-10 -69.74 -0.15 6.57 Favored 'General case' 0 C--N 1.294 -1.826 0 CA-C-N 114.884 -1.053 . . . . 0.0 113.288 -175.799 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.477 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 87.1 mttt -127.39 140.36 52.23 Favored 'General case' 0 C--N 1.298 -1.665 0 CA-C-O 120.753 0.311 . . . . 0.0 110.52 176.148 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.817 HG21 HD12 ' A' ' 681' ' ' LEU . 46.0 pt -129.88 165.07 30.89 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 -178.068 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.582 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 26.3 tt0 -143.15 140.43 30.8 Favored 'General case' 0 C--N 1.285 -2.232 0 C-N-CA 123.266 0.626 . . . . 0.0 110.625 -175.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 18.5 t -78.6 110.54 13.8 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 115.701 -0.681 . . . . 0.0 110.046 176.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 34.9 m -98.58 -171.1 0.23 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.038 0 C-N-CA 120.228 -0.589 . . . . 0.0 109.533 177.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.548 ' HA ' ' HG3' ' A' ' 628' ' ' GLN . 8.5 p-10 -81.31 75.29 8.27 Favored 'General case' 0 C--N 1.292 -1.931 0 CA-C-O 122.812 1.291 . . . . 0.0 111.475 -178.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.51 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 158.95 -43.48 0.47 Allowed Glycine 0 N--CA 1.411 -3.016 0 CA-C-N 113.82 -1.536 . . . . 0.0 111.644 170.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -163.11 -171.58 2.7 Favored 'General case' 0 C--N 1.314 -0.968 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 -178.62 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -82.69 167.67 17.99 Favored 'General case' 0 C--N 1.309 -1.192 0 N-CA-C 108.986 -0.746 . . . . 0.0 108.986 175.354 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.6 p -77.77 -172.23 2.55 Favored 'General case' 0 C--N 1.305 -1.361 0 CA-C-O 120.917 0.389 . . . . 0.0 111.803 -179.958 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 26.6 m -68.7 113.54 6.27 Favored 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 123.319 0.647 . . . . 0.0 111.759 -175.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.817 HD12 HG21 ' A' ' 671' ' ' ILE . 1.0 OUTLIER -61.77 148.63 87.01 Favored Pre-proline 0 N--CA 1.428 -1.567 0 CA-C-N 115.072 -0.967 . . . . 0.0 112.78 173.535 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.679 ' HG2' HD13 ' A' ' 636' ' ' LEU . 89.4 Cg_endo -81.12 -177.22 3.56 Favored 'Trans proline' 0 CA--C 1.465 -2.929 0 C-N-CA 123.617 2.878 . . . . 0.0 112.517 177.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.609 HG23 ' HB3' ' A' ' 666' ' ' LYS . 14.5 m -141.37 159.76 22.27 Favored 'Isoleucine or valine' 1 N--CA 1.363 -4.798 0 CA-C-N 112.388 -2.187 . . . . 0.0 108.288 -175.787 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.425 ' HB3' ' HB3' ' A' ' 663' ' ' PHE . 73.0 m -128.63 139.7 52.13 Favored 'General case' 0 C--N 1.281 -2.401 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.3 -177.167 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.417 HG12 ' HB2' ' A' ' 666' ' ' LYS . 32.1 pt -130.75 148.79 33.08 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.638 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 178.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 12.3 p -92.26 118.13 37.12 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.283 0 CA-C-O 122.705 1.241 . . . . 0.0 110.509 179.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.418 ' HB2' HD13 ' A' ' 664' ' ' LEU . 10.7 tp10 -64.66 -43.07 94.79 Favored 'General case' 0 N--CA 1.415 -2.175 0 CA-C-N 112.676 -2.056 . . . . 0.0 107.947 174.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.889 ' HA ' ' HE2' ' A' ' 710' ' ' TYR . 30.2 tt0 67.59 8.84 6.63 Favored 'General case' 0 CA--C 1.549 0.922 0 CA-C-N 114.105 -1.407 . . . . 0.0 112.076 175.516 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 23.9 m -98.36 139.18 34.51 Favored 'General case' 0 N--CA 1.419 -2.013 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 177.089 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 36.8 p -113.26 168.9 9.34 Favored 'General case' 0 N--CA 1.412 -2.342 0 CA-C-O 121.368 0.604 . . . . 0.0 112.089 -173.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 38.7 m -108.49 -17.0 14.09 Favored 'General case' 0 C--N 1.298 -1.652 0 CA-C-N 115.614 -0.721 . . . . 0.0 112.787 -172.171 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 108.57 -80.45 0.27 Allowed Glycine 0 C--N 1.295 -1.745 0 C-N-CA 121.003 -0.617 . . . . 0.0 111.959 175.376 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.486 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 10.5 t70 -173.43 -167.0 0.36 Allowed 'General case' 0 C--N 1.313 -0.982 0 N-CA-C 105.601 -2.0 . . . . 0.0 105.601 -178.508 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.609 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.0 OUTLIER -69.67 135.35 88.13 Favored Pre-proline 0 N--CA 1.407 -2.603 0 C-N-CA 123.327 0.651 . . . . 0.0 110.097 174.493 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 39.4 Cg_endo -70.67 -163.44 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.417 0 C-N-CA 123.605 2.87 . . . . 0.0 111.991 178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -117.99 126.18 51.82 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-O 121.141 0.496 . . . . 0.0 109.847 -179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.783 HD23 ' HA3' ' A' ' 700' ' ' GLY . 29.1 tp -112.58 135.47 53.26 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 177.651 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.9 pt-20 -39.82 -46.31 1.93 Allowed 'General case' 0 N--CA 1.479 1.012 0 C-N-CA 124.998 1.319 . . . . 0.0 113.906 -175.591 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 94.6 m-70 -142.39 27.87 1.7 Allowed 'General case' 0 N--CA 1.439 -1.022 0 N-CA-C 108.474 -0.935 . . . . 0.0 108.474 -178.57 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.783 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.71 167.34 23.23 Favored Glycine 0 N--CA 1.433 -1.557 0 CA-C-N 114.492 -1.231 . . . . 0.0 111.949 -177.993 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.403 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 7.1 p-90 -157.15 -154.39 0.46 Allowed 'General case' 0 C--N 1.296 -1.752 0 N-CA-C 106.684 -1.598 . . . . 0.0 106.684 -174.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.472 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -137.45 162.11 34.55 Favored 'General case' 0 C--N 1.28 -2.427 0 C-N-CA 119.696 -0.802 . . . . 0.0 112.985 -168.091 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.572 ' N ' HE21 ' A' ' 703' ' ' GLN . 0.0 OUTLIER -95.92 -57.23 2.41 Favored 'General case' 0 CA--C 1.504 -0.826 0 CA-C-O 121.518 0.675 . . . . 0.0 109.774 -179.408 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.44 ' O ' HD12 ' A' ' 704' ' ' LEU . 3.9 pp -125.78 137.98 53.82 Favored 'General case' 0 N--CA 1.419 -2.017 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.76 -178.24 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.406 ' HB3' ' OH ' ' A' ' 709' ' ' TYR . 2.1 m -112.23 125.64 54.37 Favored 'General case' 0 C--N 1.275 -2.656 0 N-CA-C 106.21 -1.774 . . . . 0.0 106.21 176.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 47.9 m -119.75 95.18 49.09 Favored Pre-proline 0 C--N 1.296 -1.75 0 CA-C-O 121.528 0.68 . . . . 0.0 112.353 -176.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.417 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 7.0 Cg_endo -91.09 154.43 3.85 Favored 'Trans proline' 0 N--CA 1.434 -2.001 0 C-N-CA 122.809 2.339 . . . . 0.0 111.964 176.335 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.417 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 89.8 Cg_endo -76.39 134.94 37.83 Favored 'Cis proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.753 -1.77 . . . . 0.0 111.043 -0.609 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.486 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 16.2 m-85 -76.17 97.82 4.23 Favored 'General case' 0 C--N 1.301 -1.533 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -176.97 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.889 ' HE2' ' HA ' ' A' ' 688' ' ' GLU . 23.4 m-85 -102.44 174.93 5.68 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-O 121.225 0.536 . . . . 0.0 110.315 176.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.689 ' HB3' HD11 ' A' ' 664' ' ' LEU . 2.9 t80 -65.78 129.33 39.41 Favored 'General case' 0 N--CA 1.431 -1.4 0 N-CA-C 106.695 -1.594 . . . . 0.0 106.695 174.151 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 99.2 -7.68 60.35 Favored Glycine 0 N--CA 1.433 -1.564 0 C-N-CA 119.6 -1.286 . . . . 0.0 113.05 -179.382 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . 0.414 ' O ' ' HA ' ' A' ' 732' ' ' THR . 9.5 t70 -84.49 171.29 12.66 Favored 'General case' 0 C--O 1.247 0.937 0 N-CA-C 108.188 -1.041 . . . . 0.0 108.188 177.533 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 3.8 m -136.72 147.39 46.73 Favored 'General case' 0 C--N 1.302 -1.491 0 CA-C-O 121.226 0.536 . . . . 0.0 110.99 -171.785 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.459 HG11 ' CG1' ' A' ' 694' ' ' ILE . 48.3 t -138.17 144.49 30.5 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.322 0 CA-C-N 115.773 -0.649 . . . . 0.0 109.379 179.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.46 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.0 mt-10 -101.55 131.11 47.9 Favored 'General case' 0 C--N 1.299 -1.617 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 174.655 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.609 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 2.0 m-85 -105.63 157.93 17.06 Favored 'General case' 0 C--N 1.295 -1.788 0 C-N-CA 123.784 0.834 . . . . 0.0 109.169 177.135 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 62.0 t30 -151.83 151.13 30.91 Favored 'General case' 0 C--N 1.279 -2.461 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 177.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.564 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.4 m -98.0 157.4 16.14 Favored 'General case' 0 C--N 1.26 -3.285 0 N-CA-C 109.014 -0.736 . . . . 0.0 109.014 179.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 33.5 m -52.18 150.75 4.29 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 123.479 0.487 . . . . 0.0 110.273 176.464 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.4 tt0 -55.67 -32.11 62.95 Favored 'General case' 0 C--N 1.312 -1.062 0 N-CA-C 113.724 1.009 . . . . 0.0 113.724 -169.338 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 42.7 m -91.09 12.97 18.2 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.78 0.8 . . . . 0.0 111.409 179.227 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.401 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 81.8 m-85 -128.12 146.54 50.67 Favored 'General case' 0 N--CA 1.43 -1.431 0 CA-C-N 115.758 -0.656 . . . . 0.0 109.331 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.539 ' HB ' HD11 ' A' ' 747' ' ' ILE . 10.2 t -113.56 139.29 49.11 Favored 'General case' 0 C--N 1.277 -2.573 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 177.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.707 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 7.9 ptm -88.61 142.47 27.67 Favored 'General case' 0 N--CA 1.426 -1.639 0 CA-C-O 121.509 0.671 . . . . 0.0 110.97 -177.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.462 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 53.8 mt -119.03 117.32 53.87 Favored 'Isoleucine or valine' 0 C--N 1.279 -2.481 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 176.036 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 129.54 -143.64 14.77 Favored Glycine 0 CA--C 1.478 -2.251 0 N-CA-C 111.054 -0.818 . . . . 0.0 111.054 -179.213 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 8.0 t-160 -100.61 135.13 42.53 Favored 'General case' 0 N--CA 1.423 -1.796 0 C-N-CA 120.176 -0.609 . . . . 0.0 110.813 -176.141 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 13.2 ptt180 -60.62 -33.39 72.7 Favored 'General case' 0 C--N 1.31 -1.116 0 CA-C-N 114.645 -1.161 . . . . 0.0 111.51 177.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.46 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 4.9 p -123.54 161.29 25.23 Favored 'General case' 0 N--CA 1.415 -2.176 0 CA-C-O 121.316 0.579 . . . . 0.0 111.676 -173.585 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.719 HG21 HD23 ' A' ' 741' ' ' LEU . 7.0 pt -131.19 168.09 24.66 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.952 0 CA-C-N 115.23 -0.896 . . . . 0.0 110.114 179.144 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.414 ' HA ' ' O ' ' A' ' 713' ' ' ASP . 88.9 m -139.23 137.53 36.05 Favored 'General case' 0 C--N 1.281 -2.4 0 N-CA-C 106.417 -1.697 . . . . 0.0 106.417 177.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.408 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 42.0 t -78.66 120.66 23.66 Favored 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 119.867 -0.733 . . . . 0.0 111.575 -178.11 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.1 mm -126.37 105.97 15.11 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.676 0 CA-C-N 114.792 -1.095 . . . . 0.0 109.304 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 88.8 m-70 70.29 30.54 3.34 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.561 1.145 . . . . 0.0 112.672 178.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 87.73 3.19 80.85 Favored Glycine 0 N--CA 1.449 -0.461 0 C-N-CA 120.582 -0.818 . . . . 0.0 111.494 178.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 30.2 t -128.01 140.35 49.4 Favored 'Isoleucine or valine' 0 C--O 1.207 -1.144 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 -178.611 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -79.22 152.24 30.75 Favored 'General case' 0 C--N 1.279 -2.463 0 N-CA-C 108.782 -0.822 . . . . 0.0 108.782 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 30.6 p -31.95 -66.07 0.13 Allowed 'General case' 0 N--CA 1.487 1.375 0 N-CA-C 116.399 2.0 . . . . 0.0 116.399 -174.627 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -160.85 -34.89 0.05 Allowed 'General case' 0 CA--C 1.488 -1.436 0 N-CA-C 114.93 1.456 . . . . 0.0 114.93 -172.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.719 HD23 HG21 ' A' ' 731' ' ' ILE . 32.5 mt 67.98 150.69 0.12 Allowed Pre-proline 0 C--N 1.318 -0.771 0 O-C-N 125.08 1.487 . . . . 0.0 111.282 -174.579 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.707 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 90.2 Cg_endo -81.55 -172.37 1.46 Allowed 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 122.251 1.967 . . . . 0.0 110.547 175.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.462 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 3.8 pt20 -134.61 135.29 42.08 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 108.196 -1.039 . . . . 0.0 108.196 175.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 5.0 m -97.95 140.52 32.17 Favored 'General case' 0 C--N 1.292 -1.894 0 C-N-CA 120.177 -0.609 . . . . 0.0 110.673 -176.735 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.8 m -129.57 141.88 45.34 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 176.667 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -67.64 117.62 9.82 Favored 'General case' 0 C--N 1.306 -1.307 0 O-C-N 123.797 0.685 . . . . 0.0 111.788 -176.55 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.539 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.0 mt . . . . . 0 C--N 1.306 -1.306 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 174.696 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 . . . . . 0 N--CA 1.443 -0.78 0 N-CA-C 110.833 -0.062 . . . . 0.0 110.833 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -129.95 9.14 5.31 Favored 'General case' 0 C--O 1.238 0.459 0 O-C-N 121.669 -0.644 . . . . 0.0 112.189 -176.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -92.55 -9.64 40.48 Favored 'General case' 0 C--N 1.306 -1.286 0 N-CA-C 112.227 0.454 . . . . 0.0 112.227 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 67.83 -68.01 0.17 Allowed 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 125.067 1.347 . . . . 0.0 111.72 -178.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -85.51 131.77 34.31 Favored 'General case' 0 C--N 1.309 -1.16 0 N-CA-C 107.378 -1.341 . . . . 0.0 107.378 177.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 105.82 155.56 21.75 Favored Glycine 0 N--CA 1.43 -1.76 0 N-CA-C 108.449 -1.86 . . . . 0.0 108.449 -173.828 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.611 HG23 ' CB ' ' A' ' 651' ' ' HIS . 10.0 p 44.97 50.18 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.558 1.261 0 CA-C-O 123.175 1.464 . . . . 0.0 111.108 -175.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -47.68 -33.16 6.5 Favored 'General case' 0 N--CA 1.479 1.014 0 CA-C-N 113.343 -1.753 . . . . 0.0 113.811 -177.866 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.472 ' HA ' ' O ' ' A' ' 650' ' ' GLY . 49.0 m 76.55 129.0 0.04 OUTLIER 'General case' 0 C--N 1.324 -0.515 0 C-N-CA 125.13 1.372 . . . . 0.0 114.582 175.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 26.5 p -117.29 166.6 12.09 Favored 'General case' 0 C--O 1.263 1.781 0 CA-C-N 114.539 -1.21 . . . . 0.0 109.054 178.065 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.3 -130.52 7.03 Favored Glycine 0 N--CA 1.417 -2.604 0 N-CA-C 111.1 -0.8 . . . . 0.0 111.1 175.499 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_exo -63.94 147.29 91.99 Favored 'Trans proline' 0 CA--C 1.541 0.837 0 C-N-CA 123.106 2.537 . . . . 0.0 112.857 -178.401 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.481 ' HB3' HG21 ' A' ' 655' ' ' VAL . 38.7 Cg_endo -65.1 160.25 42.71 Favored 'Trans proline' 0 C--O 1.243 0.766 0 C-N-CA 123.74 2.96 . . . . 0.0 112.727 -179.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.457 ' HG2' HD21 ' A' ' 681' ' ' LEU . 51.7 Cg_endo -74.36 -163.47 0.18 Allowed 'Trans proline' 0 C--O 1.253 1.247 0 C-N-CA 122.986 2.457 . . . . 0.0 110.133 175.206 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -116.45 160.24 20.87 Favored 'General case' 0 C--N 1.302 -1.499 0 C-N-CA 118.647 -1.221 . . . . 0.0 110.749 178.138 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.663 HD13 ' HG2' ' A' ' 682' ' ' PRO . 19.4 tp -89.71 141.17 28.87 Favored 'General case' 0 N--CA 1.423 -1.789 0 CA-C-N 115.341 -0.845 . . . . 0.0 109.646 177.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.61 HD23 ' H ' ' A' ' 684' ' ' CYS . 32.7 tp -30.68 -59.59 0.2 Allowed 'General case' 0 C--N 1.311 -1.09 0 C-N-CA 127.428 2.291 . . . . 0.0 113.321 172.979 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.8 t30 -119.56 -45.95 2.49 Favored 'General case' 0 C--N 1.316 -0.879 0 C-N-CA 119.537 -0.865 . . . . 0.0 110.116 -179.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.638 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -80.94 -154.74 11.1 Favored Glycine 0 CA--C 1.524 0.626 0 CA-C-N 115.539 -0.755 . . . . 0.0 112.63 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -155.1 -174.33 4.93 Favored 'General case' 0 C--N 1.318 -0.793 0 O-C-N 121.877 -0.778 . . . . 0.0 111.726 -176.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 96.3 t -91.35 137.5 21.72 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.831 0 C-N-CA 124.248 1.019 . . . . 0.0 109.108 -179.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.66 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 14.3 ptpt -105.06 -7.73 18.97 Favored 'General case' 0 C--N 1.317 -0.826 0 CA-C-O 121.66 0.743 . . . . 0.0 109.747 179.446 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 10.6 mm-40 -83.81 154.07 23.71 Favored 'General case' 0 C--N 1.307 -1.246 0 CA-C-N 114.554 -1.203 . . . . 0.0 109.383 -177.279 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . 0.431 ' HE3' ' HB2' ' A' ' 644' ' ' LYS . 18.9 ptmt -81.44 145.8 30.58 Favored 'General case' 0 C--N 1.302 -1.494 0 N-CA-C 108.766 -0.828 . . . . 0.0 108.766 173.588 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 5.9 p -80.57 128.41 33.57 Favored 'General case' 0 C--N 1.298 -1.667 0 CA-C-O 120.834 0.35 . . . . 0.0 111.355 -178.9 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.435 ' C ' ' H ' ' A' ' 648' ' ' GLU . 46.3 mtmt -102.76 -14.25 16.71 Favored 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 112.379 0.511 . . . . 0.0 112.379 -178.172 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 56.13 -16.14 0.01 OUTLIER 'General case' 0 N--CA 1.517 2.881 0 C-N-CA 127.424 2.29 . . . . 0.0 115.404 -175.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.435 ' H ' ' C ' ' A' ' 646' ' ' LYS . 36.3 tt0 -122.6 85.56 2.44 Favored 'General case' 0 C--N 1.292 -1.931 0 N-CA-C 107.899 -1.148 . . . . 0.0 107.899 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.528 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 6.3 m-85 -93.61 -77.35 0.45 Allowed 'General case' 0 C--N 1.309 -1.179 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.611 -177.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.472 ' O ' ' HA ' ' A' ' 629' ' ' SER . . . 117.39 -97.36 0.73 Allowed Glycine 0 C--N 1.305 -1.15 0 C-N-CA 120.045 -1.074 . . . . 0.0 113.391 177.818 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.611 ' CB ' HG23 ' A' ' 627' ' ' VAL . 86.4 t60 -155.17 143.03 19.96 Favored 'General case' 0 C--N 1.318 -0.766 0 N-CA-C 109.457 -0.571 . . . . 0.0 109.457 -177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 12.2 t 72.71 9.97 5.56 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 125.357 1.463 . . . . 0.0 110.778 179.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.528 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 20.6 mm-40 -75.94 126.5 31.11 Favored 'General case' 0 C--N 1.314 -0.957 0 CA-C-N 115.487 -0.779 . . . . 0.0 109.991 179.78 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.6 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 12.7 m -107.03 143.49 17.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.441 0 CA-C-O 121.389 0.614 . . . . 0.0 112.078 -179.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.493 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 43.0 t -125.65 133.47 69.06 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 CA-C-N 114.96 -1.018 . . . . 0.0 108.784 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.489 ' HG3' HD22 ' A' ' 669' ' ' ASN . 33.4 tt0 -101.77 125.89 48.52 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-O 122.086 0.946 . . . . 0.0 111.043 -178.081 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.545 ' CD1' ' HB2' ' A' ' 636' ' ' LEU . 61.9 m-85 -99.89 157.0 16.83 Favored 'General case' 0 C--N 1.285 -2.23 0 CA-C-N 114.26 -1.337 . . . . 0.0 110.687 178.338 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.66 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 49.5 p90 -134.61 152.36 51.72 Favored 'General case' 0 C--N 1.305 -1.358 0 N-CA-C 106.713 -1.588 . . . . 0.0 106.713 174.797 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.638 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 4.7 t -108.73 169.83 8.41 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 118.992 -1.083 . . . . 0.0 109.784 179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -61.57 152.89 72.9 Favored Pre-proline 0 C--O 1.194 -1.85 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.918 179.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -70.8 16.79 0.26 Allowed 'Trans proline' 0 N--CA 1.49 1.312 0 C-N-CA 123.821 3.014 . . . . 0.0 113.997 -178.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.441 ' HG3' ' CD1' ' A' ' 663' ' ' PHE . 19.0 ptt180 -137.38 3.81 2.6 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-O 121.918 0.866 . . . . 0.0 110.049 173.201 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.441 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 59.7 m-85 -129.18 135.43 48.83 Favored 'General case' 0 C--N 1.299 -1.604 0 CA-C-N 114.886 -1.052 . . . . 0.0 110.421 176.245 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.536 ' HG ' ' HB3' ' A' ' 687' ' ' GLU . 11.7 mt -95.44 144.64 25.79 Favored 'General case' 0 C--N 1.269 -2.904 0 CA-C-N 115.699 -0.682 . . . . 0.0 109.957 -177.765 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.606 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.1 tpp -73.39 113.71 10.79 Favored 'General case' 0 C--N 1.288 -2.086 0 CA-C-N 114.684 -1.143 . . . . 0.0 108.175 174.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.556 ' HD2' HD13 ' A' ' 685' ' ' ILE . 62.1 tttm -100.59 -45.93 5.36 Favored 'General case' 0 C--N 1.302 -1.469 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.382 -178.803 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -84.66 -173.77 50.01 Favored Glycine 0 C--O 1.236 0.276 0 CA-C-N 115.741 -0.663 . . . . 0.0 112.089 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -71.67 107.27 2.15 Favored 'Trans proline' 0 CA--C 1.503 -1.058 0 C-N-CA 122.812 2.341 . . . . 0.0 111.252 -179.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.606 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.6 p-10 -70.58 -7.77 46.54 Favored 'General case' 0 C--N 1.296 -1.757 0 CA-C-N 115.155 -0.929 . . . . 0.0 112.561 -176.195 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.493 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 55.9 mtmt -118.61 123.29 44.65 Favored 'General case' 0 N--CA 1.42 -1.96 0 CA-C-O 122.005 0.907 . . . . 0.0 110.388 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.646 HG21 HD23 ' A' ' 681' ' ' LEU . 50.0 pt -110.34 167.01 4.91 Favored 'Isoleucine or valine' 0 C--N 1.288 -2.081 0 CA-C-N 114.338 -1.301 . . . . 0.0 108.061 -178.157 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.528 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 30.0 tt0 -138.05 137.12 37.49 Favored 'General case' 0 C--N 1.277 -2.57 0 O-C-N 123.545 0.528 . . . . 0.0 110.207 -175.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 52.3 t -81.85 104.98 12.61 Favored 'General case' 0 C--N 1.287 -2.146 0 CA-C-N 115.052 -0.976 . . . . 0.0 108.8 176.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 26.7 m -92.85 -174.54 0.28 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.044 0 C-N-CA 119.668 -0.813 . . . . 0.0 108.924 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 22.9 t70 -83.09 83.61 7.78 Favored 'General case' 0 C--N 1.292 -1.918 0 CA-C-O 121.791 0.805 . . . . 0.0 110.085 179.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 154.22 -47.0 0.54 Allowed Glycine 0 N--CA 1.414 -2.769 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.119 175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -163.92 -172.26 2.76 Favored 'General case' 0 C--N 1.316 -0.881 0 N-CA-C 108.995 -0.743 . . . . 0.0 108.995 -178.209 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.2 m95 -88.26 168.04 13.05 Favored 'General case' 0 C--N 1.312 -1.041 0 N-CA-C 109.543 -0.54 . . . . 0.0 109.543 175.564 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 27.2 p -77.95 -172.88 2.88 Favored 'General case' 0 C--N 1.311 -1.085 0 CA-C-O 120.714 0.293 . . . . 0.0 111.451 -179.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 61.9 m -73.25 114.96 12.03 Favored 'General case' 0 N--CA 1.426 -1.657 0 CA-C-O 121.874 0.845 . . . . 0.0 111.088 -179.02 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.646 HD23 HG21 ' A' ' 671' ' ' ILE . 66.2 mt -57.98 145.93 70.38 Favored Pre-proline 0 C--N 1.311 -1.103 0 CA-C-N 113.618 -1.628 . . . . 0.0 112.054 178.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.663 ' HG2' HD13 ' A' ' 636' ' ' LEU . 18.0 Cg_endo -66.03 177.65 2.9 Favored 'Trans proline' 0 N--CA 1.437 -1.841 0 C-N-CA 122.179 1.919 . . . . 0.0 113.273 178.747 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 60.4 t -132.29 146.83 32.42 Favored 'Isoleucine or valine' 0 C--N 1.283 -2.321 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 -176.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.61 ' H ' HD23 ' A' ' 637' ' ' LEU . 34.6 m -119.78 144.26 47.39 Favored 'General case' 0 C--N 1.276 -2.626 0 O-C-N 124.353 1.033 . . . . 0.0 108.34 179.438 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.556 HD13 ' HD2' ' A' ' 666' ' ' LYS . 27.8 pt -142.74 143.64 25.27 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.28 0 N-CA-C 108.264 -1.013 . . . . 0.0 108.264 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . . . . . . . . . 7.4 p -81.49 125.19 39.56 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.665 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 175.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.638 ' HG3' ' HB3' ' A' ' 711' ' ' TYR . 0.1 OUTLIER -77.12 -22.42 52.69 Favored 'General case' 0 N--CA 1.434 -1.23 0 C-N-CA 119.574 -0.85 . . . . 0.0 110.107 -178.72 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . . 20.6 tt0 62.1 35.55 15.72 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 125.564 1.546 . . . . 0.0 108.755 175.216 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . 0.457 ' HB2' ' HG2' ' A' ' 687' ' ' GLU . 16.2 m -121.19 130.55 53.76 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-N 115.607 -0.724 . . . . 0.0 110.502 -175.043 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 3.7 p -102.7 149.5 24.39 Favored 'General case' 0 N--CA 1.41 -2.472 0 CA-C-O 121.678 0.751 . . . . 0.0 112.635 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 57.7 m -96.36 -9.84 29.09 Favored 'General case' 0 C--N 1.293 -1.878 0 N-CA-C 114.961 1.467 . . . . 0.0 114.961 -169.372 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 95.83 30.64 7.84 Favored Glycine 0 C--N 1.287 -2.17 0 C-N-CA 120.888 -0.672 . . . . 0.0 112.492 170.844 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.697 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 18.9 t0 68.78 179.6 0.24 Allowed 'General case' 0 C--O 1.241 0.611 0 O-C-N 124.306 0.65 . . . . 0.0 110.241 -177.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.611 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 3.4 mt -69.03 129.76 91.94 Favored Pre-proline 0 N--CA 1.406 -2.644 0 C-N-CA 123.354 0.662 . . . . 0.0 110.58 175.44 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.607 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 55.8 Cg_endo -70.0 -179.52 3.08 Favored 'Trans proline' 0 N--CA 1.435 -1.941 0 C-N-CA 123.33 2.687 . . . . 0.0 111.795 -177.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -113.11 115.16 27.86 Favored 'General case' 0 C--N 1.268 -2.97 0 CA-C-N 115.184 -0.916 . . . . 0.0 109.356 -177.525 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.567 HD13 ' HA3' ' A' ' 700' ' ' GLY . 2.5 tt -90.19 137.14 32.59 Favored 'General case' 0 C--N 1.293 -1.882 0 N-CA-C 105.394 -2.076 . . . . 0.0 105.394 178.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . 0.492 ' HG3' ' N ' ' A' ' 699' ' ' HIS . 9.8 pt-20 -35.9 -43.65 0.32 Allowed 'General case' 0 N--CA 1.484 1.261 0 C-N-CA 125.7 1.6 . . . . 0.0 113.039 -178.274 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 49.1 m80 -144.36 25.7 1.51 Allowed 'General case' 0 N--CA 1.438 -1.033 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 -178.297 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.575 ' HA2' ' HA ' ' A' ' 719' ' ' CYS . . . -128.92 177.72 17.69 Favored Glycine 0 N--CA 1.443 -0.886 0 CA-C-N 115.071 -0.968 . . . . 0.0 112.098 -178.114 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . 0.421 ' HB2' ' H ' ' A' ' 702' ' ' ALA . 16.8 p-90 -161.97 -158.44 0.54 Allowed 'General case' 0 N--CA 1.431 -1.384 0 C-N-CA 125.233 1.413 . . . . 0.0 107.625 -176.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.523 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -140.26 156.04 46.63 Favored 'General case' 0 N--CA 1.411 -2.385 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.257 -168.347 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -95.81 -68.0 0.82 Allowed 'General case' 0 C--N 1.313 -0.984 0 O-C-N 123.865 0.728 . . . . 0.0 110.753 -179.728 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.8 pp -97.56 140.78 31.48 Favored 'General case' 0 C--N 1.309 -1.187 0 C-N-CA 120.405 -0.518 . . . . 0.0 111.873 -178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.2 p -136.51 116.61 13.39 Favored 'General case' 0 N--CA 1.431 -1.39 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.354 176.496 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 42.4 t -124.1 93.86 46.29 Favored Pre-proline 0 C--N 1.291 -1.955 0 CA-C-O 121.286 0.565 . . . . 0.0 110.505 -179.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.436 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 2.0 Cg_endo -85.7 153.04 10.18 Favored 'Trans proline' 0 N--CA 1.442 -1.556 0 C-N-CA 122.806 2.337 . . . . 0.0 111.352 176.6 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.436 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.9 Cg_endo -73.29 135.91 42.07 Favored 'Cis proline' 0 N--CA 1.458 -0.616 0 C-N-CA 123.202 -1.582 . . . . 0.0 112.13 0.859 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.697 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 28.4 m-85 -80.31 98.77 7.57 Favored 'General case' 0 C--N 1.304 -1.405 0 N-CA-C 106.483 -1.673 . . . . 0.0 106.483 179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . . . . . . . . . 7.6 m-30 -93.65 173.35 7.73 Favored 'General case' 0 C--N 1.29 -1.996 0 O-C-N 123.951 0.782 . . . . 0.0 110.702 179.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.638 ' HB3' ' HG3' ' A' ' 687' ' ' GLU . 2.8 t80 -65.42 138.91 58.43 Favored 'General case' 0 C--N 1.308 -1.214 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 175.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 94.62 -14.15 65.86 Favored Glycine 0 N--CA 1.422 -2.281 0 C-N-CA 118.001 -2.047 . . . . 0.0 112.693 178.686 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -77.64 167.2 21.97 Favored 'General case' 0 C--O 1.253 1.257 0 CA-C-N 117.479 0.639 . . . . 0.0 109.813 178.004 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.2 m -132.71 153.28 51.31 Favored 'General case' 0 C--N 1.309 -1.185 0 CA-C-O 121.048 0.451 . . . . 0.0 110.172 -174.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.589 HG11 HG12 ' A' ' 694' ' ' ILE . 37.9 t -142.62 143.17 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.429 -1.523 0 CA-C-N 115.505 -0.771 . . . . 0.0 110.804 179.501 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 47.9 mt-10 -98.36 124.08 42.83 Favored 'General case' 0 C--O 1.244 0.77 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 173.912 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.611 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 1.6 m-85 -104.54 167.91 9.43 Favored 'General case' 0 C--N 1.289 -2.062 0 C-N-CA 124.138 0.975 . . . . 0.0 109.263 177.603 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . . . . . . . . . 18.1 t-20 -163.92 167.88 20.08 Favored 'General case' 0 C--N 1.291 -1.938 0 N-CA-C 106.289 -1.745 . . . . 0.0 106.289 177.643 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.575 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 90.8 m -110.06 162.05 14.94 Favored 'General case' 0 C--N 1.263 -3.192 0 O-C-N 123.147 0.279 . . . . 0.0 111.172 -178.106 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 32.6 t -56.83 155.19 8.16 Favored 'General case' 0 CA--C 1.542 0.671 0 O-C-N 123.917 0.76 . . . . 0.0 110.303 177.812 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 18.1 tp10 -55.39 -44.18 75.9 Favored 'General case' 0 C--N 1.315 -0.915 0 C-N-CA 124.144 0.978 . . . . 0.0 112.117 -176.445 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 9.2 t -77.67 5.72 8.71 Favored 'General case' 0 CA--C 1.563 1.459 0 C-N-CA 123.419 0.688 . . . . 0.0 111.852 -177.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 91.5 m-85 -130.16 156.0 45.3 Favored 'General case' 0 C--N 1.323 -0.564 0 C-N-CA 122.761 0.424 . . . . 0.0 109.936 -179.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.2 t -117.15 142.45 46.99 Favored 'General case' 0 C--N 1.291 -1.974 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 175.237 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.509 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 9.4 ptm -90.39 146.65 24.0 Favored 'General case' 0 N--CA 1.431 -1.415 0 CA-C-O 121.433 0.635 . . . . 0.0 111.163 -176.41 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.686 HD12 HE21 ' A' ' 743' ' ' GLN . 39.5 mt -119.64 118.36 56.97 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 N-CA-C 107.328 -1.36 . . . . 0.0 107.328 175.612 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 121.13 -157.47 16.07 Favored Glycine 0 N--CA 1.437 -1.292 0 N-CA-C 109.247 -1.541 . . . . 0.0 109.247 -175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.7 p-80 -112.46 162.24 15.82 Favored 'General case' 0 C--N 1.294 -1.836 0 CA-C-N 117.177 0.488 . . . . 0.0 110.56 178.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 11.9 ptp180 -81.59 -33.22 31.68 Favored 'General case' 0 C--N 1.288 -2.067 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 -175.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 715' ' ' VAL . 24.2 p -95.0 137.15 34.44 Favored 'General case' 0 C--N 1.307 -1.257 0 N-CA-C 115.227 1.565 . . . . 0.0 115.227 -169.468 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.674 HG21 HD23 ' A' ' 741' ' ' LEU . 10.0 pt -121.25 166.21 16.0 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.145 0 CA-C-N 114.857 -1.065 . . . . 0.0 109.883 -179.439 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . 0.516 ' H ' HG23 ' A' ' 739' ' ' THR . 85.6 m -136.58 139.13 41.93 Favored 'General case' 0 C--N 1.282 -2.356 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 179.102 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . 0.451 ' HA ' ' HA ' ' A' ' 738' ' ' TRP . 47.3 t -78.11 120.47 22.98 Favored 'General case' 0 C--N 1.297 -1.703 0 CA-C-O 121.125 0.488 . . . . 0.0 111.976 179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 51.6 mm -128.26 110.87 22.5 Favored 'Isoleucine or valine' 0 N--CA 1.431 -1.414 0 CA-C-N 114.81 -1.086 . . . . 0.0 109.893 -179.351 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 94.0 m-70 65.81 30.25 10.15 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 124.602 1.161 . . . . 0.0 112.58 177.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.15 2.98 65.74 Favored Glycine 0 CA--C 1.495 -1.187 0 C-N-CA 120.267 -0.968 . . . . 0.0 112.744 177.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 13.6 p -136.99 148.02 26.74 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 N-CA-C 107.19 -1.411 . . . . 0.0 107.19 179.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.607 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 80.1 m95 -77.2 158.2 30.46 Favored 'General case' 0 C--N 1.278 -2.542 0 N-CA-C 108.839 -0.8 . . . . 0.0 108.839 178.681 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.516 HG23 ' H ' ' A' ' 732' ' ' THR . 39.8 p -32.34 -72.54 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 N-CA-C 115.687 1.736 . . . . 0.0 115.687 -176.849 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -166.89 -28.24 0.03 OUTLIER 'General case' 0 C--O 1.243 0.713 0 N-CA-C 114.348 1.24 . . . . 0.0 114.348 -174.058 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.674 HD23 HG21 ' A' ' 731' ' ' ILE . 17.2 mt 69.1 152.02 0.13 Allowed Pre-proline 0 N--CA 1.473 0.679 0 C-N-CA 125.036 1.335 . . . . 0.0 111.578 -178.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.509 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 57.4 Cg_endo -76.11 -169.56 0.71 Allowed 'Trans proline' 0 C--N 1.319 -1.015 0 C-N-CA 121.964 1.776 . . . . 0.0 109.746 173.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.686 HE21 HD12 ' A' ' 726' ' ' ILE . 9.4 pt20 -135.85 150.58 49.44 Favored 'General case' 0 C--N 1.299 -1.598 0 N-CA-C 108.166 -1.05 . . . . 0.0 108.166 175.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.76 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 3.8 m -110.8 134.93 52.09 Favored 'General case' 0 C--N 1.277 -2.565 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -177.281 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 15.4 m -121.35 145.66 27.58 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.705 0 O-C-N 123.335 0.397 . . . . 0.0 110.282 -177.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -65.19 113.13 3.77 Favored 'General case' 0 C--N 1.3 -1.563 0 O-C-N 124.723 1.264 . . . . 0.0 111.684 -177.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 81.8 mt . . . . . 0 C--N 1.311 -1.105 0 CA-C-N 114.773 -1.103 . . . . 0.0 108.502 173.007 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 . . . . . 0 CA--C 1.513 -0.474 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -129.37 144.71 51.35 Favored 'General case' 0 C--N 1.309 -1.157 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 177.03 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.44 -5.84 55.57 Favored 'General case' 0 C--N 1.316 -0.891 0 CA-C-O 121.131 0.491 . . . . 0.0 111.164 -177.103 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -154.3 135.29 13.84 Favored 'General case' 0 N--CA 1.431 -1.379 0 CA-C-N 115.441 -0.8 . . . . 0.0 109.074 178.677 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -131.79 91.96 3.06 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 106.923 -1.51 . . . . 0.0 106.923 174.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -72.5 72.57 0.99 Allowed Glycine 0 CA--C 1.486 -1.753 0 CA-C-N 115.067 -0.969 . . . . 0.0 115.248 -172.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . . 7.2 p -179.95 93.33 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-O 123.052 1.406 . . . . 0.0 108.255 175.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.44 ' HG2' ' N ' ' A' ' 676' ' ' GLY . 2.6 pp0? -99.63 -25.29 14.46 Favored 'General case' 0 C--N 1.277 -2.574 0 CA-C-N 113.545 -1.661 . . . . 0.0 111.856 -178.907 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.421 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.8 m 72.44 123.87 0.04 OUTLIER 'General case' 0 C--N 1.31 -1.115 0 O-C-N 124.961 1.413 . . . . 0.0 112.373 -179.512 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 24.7 p -111.14 -169.97 1.55 Allowed 'General case' 0 C--N 1.288 -2.106 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . 0.56 ' HA2' ' O ' ' A' ' 647' ' ' GLU . . . -115.46 -138.97 6.66 Favored Glycine 0 N--CA 1.41 -3.076 0 C-N-CA 119.644 -1.265 . . . . 0.0 110.474 179.842 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.705 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 21.3 Cg_exo -62.55 150.85 86.24 Favored 'Trans proline' 0 C--N 1.32 -0.971 0 C-N-CA 122.854 2.369 . . . . 0.0 110.88 176.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -62.7 158.8 40.15 Favored 'Trans proline' 0 C--O 1.252 1.179 0 C-N-CA 122.555 2.17 . . . . 0.0 112.083 -179.233 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.491 ' HD2' HD11 ' A' ' 671' ' ' ILE . 18.1 Cg_endo -75.53 -161.5 0.13 Allowed 'Trans proline' 0 C--O 1.256 1.391 0 C-N-CA 122.881 2.387 . . . . 0.0 110.231 176.508 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -116.28 166.87 11.56 Favored 'General case' 0 C--N 1.284 -2.276 0 C-N-CA 119.048 -1.061 . . . . 0.0 111.003 -178.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.851 ' HG ' ' HG2' ' A' ' 682' ' ' PRO . 2.3 tt -103.55 140.58 37.33 Favored 'General case' 0 N--CA 1.42 -1.948 0 N-CA-C 104.613 -2.366 . . . . 0.0 104.613 177.244 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . . . . . . . . . 3.2 tm? -36.98 -65.25 0.31 Allowed 'General case' 0 C--N 1.317 -0.806 0 C-N-CA 125.878 1.671 . . . . 0.0 111.676 176.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 5.3 t30 -108.49 -47.16 3.55 Favored 'General case' 0 C--N 1.307 -1.26 0 C-N-CA 119.061 -1.056 . . . . 0.0 109.521 -177.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.696 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -72.79 -155.71 3.02 Favored Glycine 0 C--O 1.242 0.639 0 CA-C-N 114.839 -1.073 . . . . 0.0 112.359 178.71 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -174.63 -171.0 0.53 Allowed 'General case' 0 CA--C 1.508 -0.647 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 -177.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . . . . . . . . . 87.2 t -98.73 132.33 44.17 Favored 'Isoleucine or valine' 0 N--CA 1.43 -1.434 0 CA-C-N 114.132 -1.395 . . . . 0.0 110.416 -175.117 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.501 ' HB3' ' CD2' ' A' ' 658' ' ' TYR . 18.3 pttp -102.51 -7.89 21.51 Favored 'General case' 0 C--N 1.301 -1.523 0 CA-C-N 115.233 -0.894 . . . . 0.0 109.245 176.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 60.1 mm-40 -81.54 152.01 27.46 Favored 'General case' 0 N--CA 1.42 -1.949 0 CA-C-N 114.777 -1.101 . . . . 0.0 108.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 20.6 ptmt -88.93 153.07 21.33 Favored 'General case' 0 C--N 1.275 -2.65 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 -179.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . . . . . . . . . 68.8 p -79.84 111.03 15.76 Favored 'General case' 0 N--CA 1.412 -2.335 0 CA-C-O 122.365 1.079 . . . . 0.0 112.081 -178.094 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . 0.483 ' HB2' ' CE1' ' A' ' 649' ' ' TYR . 13.2 mtpp -89.17 -26.7 21.14 Favored 'General case' 0 C--N 1.285 -2.198 0 CA-C-N 114.444 -1.253 . . . . 0.0 109.96 178.501 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.705 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 53.0 mt-10 70.26 -30.21 0.2 Allowed 'General case' 0 N--CA 1.482 1.144 0 C-N-CA 125.604 1.562 . . . . 0.0 111.881 -178.67 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . 0.425 ' H ' ' C ' ' A' ' 646' ' ' LYS . 33.6 mt-10 -91.94 82.91 5.13 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-O 121.264 0.554 . . . . 0.0 109.922 179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.483 ' CE1' ' HB2' ' A' ' 646' ' ' LYS . 16.2 m-85 -118.31 106.02 12.34 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.421 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . -83.14 -67.92 1.45 Allowed Glycine 0 C--N 1.297 -1.616 0 C-N-CA 120.567 -0.825 . . . . 0.0 113.973 -175.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 84.3 t60 -161.12 142.04 11.43 Favored 'General case' 0 N--CA 1.439 -1.016 0 O-C-N 122.752 -0.263 . . . . 0.0 110.315 -177.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 2.6 t 70.34 12.29 7.53 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 125.278 1.431 . . . . 0.0 111.303 177.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.448 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 13.6 mm-40 -77.73 125.27 29.08 Favored 'General case' 0 CA--C 1.497 -1.079 0 CA-C-N 115.432 -0.804 . . . . 0.0 109.219 177.234 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.65 HG12 ' HB2' ' A' ' 672' ' ' GLN . 15.6 m -110.01 144.96 17.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 CA-C-O 121.196 0.522 . . . . 0.0 111.657 -178.386 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.428 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 55.0 t -123.73 136.49 60.01 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.797 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 179.156 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -105.42 128.38 53.49 Favored 'General case' 0 N--CA 1.4 -2.963 0 CA-C-O 121.708 0.766 . . . . 0.0 109.415 -178.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.663 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 47.4 m-85 -99.0 163.29 12.64 Favored 'General case' 0 C--N 1.274 -2.713 0 CA-C-N 114.37 -1.287 . . . . 0.0 109.583 178.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.501 ' CD2' ' HB3' ' A' ' 642' ' ' LYS . 45.5 p90 -133.82 155.04 50.53 Favored 'General case' 0 C--N 1.28 -2.441 0 N-CA-C 106.254 -1.758 . . . . 0.0 106.254 175.387 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . . . . . . . . . 5.8 t -101.78 163.61 12.16 Favored 'General case' 0 N--CA 1.409 -2.48 0 C-N-CA 118.109 -1.437 . . . . 0.0 108.863 174.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 5.8 m-20 -58.28 155.51 26.2 Favored Pre-proline 0 C--N 1.286 -2.18 0 CA-C-N 114.361 -1.29 . . . . 0.0 112.789 -177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -69.26 14.53 0.22 Allowed 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.601 2.867 . . . . 0.0 114.006 -177.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.432 ' HA ' ' HB3' ' A' ' 710' ' ' TYR . 11.8 ptt180 -137.99 -7.08 1.62 Allowed 'General case' 0 N--CA 1.423 -1.776 0 CA-C-O 121.071 0.462 . . . . 0.0 110.764 172.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.418 ' CE2' ' HB ' ' A' ' 686' ' ' VAL . 32.8 m-85 -111.59 157.6 20.21 Favored 'General case' 0 N--CA 1.433 -1.309 0 CA-C-O 121.586 0.708 . . . . 0.0 110.948 179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.705 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.6 mp -111.11 135.59 51.41 Favored 'General case' 0 C--N 1.286 -2.175 0 CA-C-N 115.198 -0.91 . . . . 0.0 110.163 -177.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.549 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 54.0 tpp -71.23 119.34 15.22 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-N 114.926 -1.034 . . . . 0.0 109.71 176.405 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 50.4 tttm -105.26 -44.99 4.61 Favored 'General case' 0 C--N 1.304 -1.398 0 CA-C-N 116.463 -0.335 . . . . 0.0 110.522 178.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -86.02 -171.98 48.36 Favored Glycine 0 C--N 1.318 -0.417 0 CA-C-N 115.749 -0.66 . . . . 0.0 113.506 -174.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.405 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 36.3 Cg_endo -69.0 104.25 1.17 Allowed 'Trans proline' 0 N--CA 1.454 -0.811 0 C-N-CA 122.738 2.292 . . . . 0.0 111.429 178.506 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.549 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 4.2 p-10 -71.7 1.07 7.34 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 114.741 -1.118 . . . . 0.0 112.592 -175.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.428 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 92.5 mttt -128.65 136.74 51.06 Favored 'General case' 0 C--N 1.294 -1.807 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.545 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 41.2 pt -126.48 162.1 31.3 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.968 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 178.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.65 ' HB2' HG12 ' A' ' 654' ' ' VAL . 28.4 tt0 -133.88 139.75 46.39 Favored 'General case' 0 C--N 1.284 -2.272 0 C-N-CA 123.344 0.658 . . . . 0.0 110.738 -175.262 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 42.6 t -83.86 102.63 12.51 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 109.198 -0.667 . . . . 0.0 109.198 176.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 18.7 m -88.93 -172.89 0.19 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.217 0 N-CA-C 109.067 -0.716 . . . . 0.0 109.067 -179.974 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 4.6 p-10 -77.84 73.7 4.4 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 122.673 1.225 . . . . 0.0 112.102 179.766 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.44 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 150.28 -36.95 0.93 Allowed Glycine 0 N--CA 1.434 -1.492 0 CA-C-N 115.114 -0.948 . . . . 0.0 112.992 173.745 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -156.51 -178.77 7.59 Favored 'General case' 0 C--N 1.307 -1.265 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 -176.283 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 87.6 m95 -92.23 164.81 13.41 Favored 'General case' 0 C--N 1.294 -1.808 0 N-CA-C 108.225 -1.028 . . . . 0.0 108.225 173.665 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 34.4 p -77.92 176.27 9.27 Favored 'General case' 0 C--N 1.301 -1.504 0 CA-C-N 117.554 0.161 . . . . 0.0 111.411 179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 28.0 m -57.05 118.6 5.16 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-O 121.413 0.625 . . . . 0.0 112.38 -178.486 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.476 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.4 mm? -62.1 149.32 86.85 Favored Pre-proline 0 C--N 1.307 -1.257 0 CA-C-N 114.458 -1.246 . . . . 0.0 111.745 176.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.851 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 55.7 Cg_endo -71.51 179.33 4.72 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.853 2.368 . . . . 0.0 113.581 178.992 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 53.0 t -130.03 141.89 45.22 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 N-CA-C 107.209 -1.404 . . . . 0.0 107.209 -177.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 5.2 m -120.24 137.47 54.2 Favored 'General case' 0 C--N 1.313 -1.016 0 O-C-N 123.264 0.352 . . . . 0.0 111.099 179.738 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 27.6 pt -135.73 143.82 35.39 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.343 0 N-CA-C 109.511 -0.552 . . . . 0.0 109.511 -178.412 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.489 HG22 ' H ' ' A' ' 688' ' ' GLU . 14.3 p -94.69 126.88 47.02 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.025 0 N-CA-C 108.438 -0.949 . . . . 0.0 108.438 178.425 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.49 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.0 pt-20 -78.07 -17.5 56.92 Favored 'General case' 0 C--O 1.245 0.846 0 C-N-CA 118.844 -1.143 . . . . 0.0 109.182 179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.569 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 63.8 tt0 51.22 63.25 2.32 Favored 'General case' 0 N--CA 1.441 -0.879 0 CA-C-N 113.165 -1.834 . . . . 0.0 111.102 179.311 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 50.6 m -150.91 143.02 24.08 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 7.4 p -108.05 160.51 15.74 Favored 'General case' 0 N--CA 1.411 -2.378 0 O-C-N 123.688 0.618 . . . . 0.0 111.711 -177.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 13.2 m -86.84 -7.08 58.56 Favored 'General case' 0 C--N 1.309 -1.188 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.424 172.061 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.58 -78.38 0.64 Allowed Glycine 0 CA--C 1.474 -2.502 0 CA-C-N 115.336 -0.847 . . . . 0.0 111.756 173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.545 ' HA ' ' CE2' ' A' ' 709' ' ' TYR . 6.8 p-10 -157.57 174.47 15.31 Favored 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 -178.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.671 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 2.5 mt -67.79 126.58 92.79 Favored Pre-proline 0 N--CA 1.422 -1.845 0 C-N-CA 123.694 0.797 . . . . 0.0 111.217 176.26 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.602 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 56.2 Cg_endo -68.21 173.15 9.95 Favored 'Trans proline' 0 N--CA 1.433 -2.077 0 C-N-CA 123.186 2.59 . . . . 0.0 112.556 -177.507 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -97.12 120.28 37.17 Favored 'General case' 0 C--N 1.257 -3.455 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.37 -179.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.83 HD23 ' HA3' ' A' ' 700' ' ' GLY . 24.3 tp -99.72 129.34 45.84 Favored 'General case' 0 C--N 1.287 -2.147 0 N-CA-C 103.704 -2.702 . . . . 0.0 103.704 172.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -51.14 -36.39 40.5 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.009 0.744 . . . . 0.0 113.009 -171.1 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 89.2 m-70 -135.35 25.54 3.49 Favored 'General case' 0 C--N 1.316 -0.852 0 CA-C-O 121.491 0.662 . . . . 0.0 109.875 179.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.83 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -135.79 179.08 18.16 Favored Glycine 0 N--CA 1.429 -1.806 0 CA-C-N 114.788 -1.096 . . . . 0.0 111.919 179.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 9.0 p-90 -161.1 -154.83 0.38 Allowed 'General case' 0 N--CA 1.428 -1.548 0 C-N-CA 125.888 1.675 . . . . 0.0 106.499 -177.633 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.525 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.29 150.73 49.04 Favored 'General case' 0 C--N 1.282 -2.353 0 C-N-CA 120.319 -0.552 . . . . 0.0 111.787 -169.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.537 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -88.57 -45.88 9.53 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.39 -179.865 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.1 pp -125.44 154.06 42.55 Favored 'General case' 0 N--CA 1.428 -1.548 0 CA-C-N 115.848 -0.615 . . . . 0.0 111.281 -177.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 14.5 p -136.39 128.18 29.15 Favored 'General case' 0 N--CA 1.414 -2.256 0 CA-C-N 114.971 -1.013 . . . . 0.0 108.382 177.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 30.2 t -124.36 85.85 55.3 Favored Pre-proline 0 C--N 1.287 -2.11 0 CA-C-O 121.442 0.639 . . . . 0.0 109.886 178.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.557 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 10.9 Cg_endo -93.39 154.64 2.49 Favored 'Trans proline' 0 N--CA 1.431 -2.195 0 C-N-CA 122.994 2.463 . . . . 0.0 112.055 177.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.557 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 37.8 Cg_endo -67.97 133.6 22.97 Favored 'Cis proline' 0 C--O 1.235 0.364 0 C-N-CA 122.795 -1.752 . . . . 0.0 109.963 -3.362 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.545 ' CE2' ' HA ' ' A' ' 693' ' ' ASP . 39.9 m-85 -73.28 82.37 1.37 Allowed 'General case' 0 C--N 1.312 -1.057 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.218 -174.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.569 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 8.1 m-85 -81.77 174.3 11.47 Favored 'General case' 0 C--N 1.307 -1.254 0 C-N-CA 122.903 0.481 . . . . 0.0 111.188 179.038 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.705 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 39.3 t80 -62.98 140.55 58.88 Favored 'General case' 0 N--CA 1.433 -1.308 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.943 178.394 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 87.72 -10.38 70.21 Favored Glycine 0 N--CA 1.433 -1.554 0 CA-C-N 115.284 -0.871 . . . . 0.0 114.389 178.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -78.39 166.97 22.02 Favored 'General case' 0 C--O 1.253 1.274 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 177.415 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -132.86 144.4 50.17 Favored 'General case' 0 C--N 1.285 -2.237 0 CA-C-O 121.163 0.506 . . . . 0.0 110.085 -171.393 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.595 HG11 HG12 ' A' ' 694' ' ' ILE . 45.5 t -130.13 138.22 54.48 Favored 'Isoleucine or valine' 0 N--CA 1.401 -2.913 0 CA-C-N 115.688 -0.687 . . . . 0.0 109.64 177.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.613 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 44.6 mt-10 -106.17 120.92 43.07 Favored 'General case' 0 N--CA 1.409 -2.511 0 CA-C-N 115.55 -0.75 . . . . 0.0 109.223 176.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.671 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -96.28 160.72 14.28 Favored 'General case' 0 C--N 1.294 -1.832 0 C-N-CA 125.082 1.353 . . . . 0.0 109.617 179.881 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.537 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 62.1 t30 -148.12 143.53 27.19 Favored 'General case' 0 C--N 1.281 -2.397 0 N-CA-C 107.216 -1.402 . . . . 0.0 107.216 179.732 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . . . . . . . . . 78.4 m -88.13 158.86 18.43 Favored 'General case' 0 C--N 1.273 -2.755 0 O-C-N 123.59 0.556 . . . . 0.0 109.661 176.862 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 8.2 t -61.93 148.93 42.06 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 179.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 30.1 tt0 -65.25 145.57 56.06 Favored 'General case' 0 N--CA 1.425 -1.688 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 178.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 36.4 m 85.52 -5.41 0.86 Allowed 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 125.763 1.625 . . . . 0.0 110.144 -173.011 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 49.7 m-85 -112.91 153.85 27.31 Favored 'General case' 0 N--CA 1.428 -1.543 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 173.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.529 ' HB ' HD11 ' A' ' 747' ' ' ILE . 6.8 t -116.83 143.6 45.49 Favored 'General case' 0 C--N 1.283 -2.314 0 N-CA-C 108.257 -1.016 . . . . 0.0 108.257 176.208 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.547 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 4.3 ptm -94.53 138.74 32.05 Favored 'General case' 0 N--CA 1.418 -2.052 0 CA-C-N 115.893 -0.594 . . . . 0.0 109.75 -178.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 43.1 mt -105.9 116.97 50.77 Favored 'Isoleucine or valine' 0 C--N 1.275 -2.631 0 CA-C-N 115.423 -0.808 . . . . 0.0 109.149 178.183 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 105.55 -141.43 15.37 Favored Glycine 0 CA--C 1.482 -1.989 0 C-N-CA 120.926 -0.654 . . . . 0.0 113.593 178.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.8 t-160 -102.39 129.54 48.89 Favored 'General case' 0 N--CA 1.419 -1.989 0 CA-C-O 121.316 0.579 . . . . 0.0 110.636 -171.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 12.8 ptp180 -72.23 -25.71 61.74 Favored 'General case' 0 C--N 1.291 -1.972 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.144 179.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.613 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 0.2 OUTLIER -103.97 148.51 26.11 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -176.199 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.553 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -129.6 167.75 24.19 Favored 'Isoleucine or valine' 0 N--CA 1.425 -1.717 0 CA-C-N 114.386 -1.279 . . . . 0.0 109.857 179.743 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 85.1 m -138.85 136.94 36.12 Favored 'General case' 0 C--N 1.281 -2.376 0 N-CA-C 108.424 -0.954 . . . . 0.0 108.424 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 51.8 t -69.51 106.75 3.1 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 109.867 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . 0.461 ' HA ' ' CE2' ' A' ' 711' ' ' TYR . 52.1 mm -122.61 112.18 33.2 Favored 'Isoleucine or valine' 0 C--O 1.216 -0.692 0 CA-C-N 115.931 -0.577 . . . . 0.0 111.008 -176.889 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 37.2 m-70 58.31 29.74 18.54 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 123.711 0.804 . . . . 0.0 112.724 177.247 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 93.92 6.59 61.84 Favored Glycine 0 N--CA 1.443 -0.867 0 C-N-CA 120.487 -0.863 . . . . 0.0 112.857 177.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.4 p -141.33 139.05 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.013 0 N-CA-C 109.251 -0.648 . . . . 0.0 109.251 177.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.602 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 89.2 m95 -70.01 150.96 46.1 Favored 'General case' 0 C--N 1.303 -1.414 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 176.206 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.9 p -39.14 -75.06 0.03 OUTLIER 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 116.739 2.126 . . . . 0.0 116.739 -173.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -159.03 -29.06 0.07 Allowed 'General case' 0 C--N 1.301 -1.534 0 N-CA-C 115.051 1.5 . . . . 0.0 115.051 -171.155 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.553 HD23 HG21 ' A' ' 731' ' ' ILE . 23.6 mt 68.49 156.33 0.15 Allowed Pre-proline 0 C--O 1.239 0.546 0 O-C-N 124.619 1.2 . . . . 0.0 111.973 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.547 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 46.5 Cg_endo -81.84 -167.9 0.55 Allowed 'Trans proline' 0 N--CA 1.446 -1.283 0 C-N-CA 122.113 1.875 . . . . 0.0 111.47 174.825 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 52.5 mt-30 -130.21 130.22 44.37 Favored 'General case' 0 C--N 1.311 -1.073 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 176.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.749 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 21.5 m -98.8 129.17 45.19 Favored 'General case' 0 C--N 1.301 -1.512 0 C-N-CA 119.904 -0.718 . . . . 0.0 110.208 177.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 17.8 m -127.89 145.73 34.66 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.055 0 N-CA-C 109.219 -0.66 . . . . 0.0 109.219 179.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -73.81 115.09 12.84 Favored 'General case' 0 C--N 1.304 -1.409 0 CA-C-N 116.104 -0.498 . . . . 0.0 111.608 -176.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.529 HD11 ' HB ' ' A' ' 724' ' ' THR . 60.6 mt . . . . . 0 C--O 1.255 1.348 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 175.569 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 CA--C 1.537 0.469 0 N-CA-C 111.517 0.192 . . . . 0.0 111.517 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -142.65 -171.78 3.5 Favored 'General case' 0 C--O 1.242 0.676 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 178.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 59.11 31.0 20.91 Favored 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 123.269 0.628 . . . . 0.0 110.698 179.078 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . 65.88 -78.65 0.04 OUTLIER 'General case' 0 CA--C 1.528 0.109 0 C-N-CA 124.774 1.23 . . . . 0.0 111.677 -178.381 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -126.61 -2.47 6.72 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-O 120.915 0.388 . . . . 0.0 110.524 -179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 81.16 102.75 0.34 Allowed Glycine 0 N--CA 1.425 -2.034 0 N-CA-C 108.659 -1.776 . . . . 0.0 108.659 -172.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.618 HG13 ' CB ' ' A' ' 651' ' ' HIS . 87.4 t -153.23 90.06 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.278 -2.531 0 N-CA-C 105.319 -2.104 . . . . 0.0 105.319 -173.68 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -84.72 -90.56 0.09 Allowed 'General case' 0 C--N 1.26 -3.3 0 CA-C-N 113.323 -1.762 . . . . 0.0 110.598 178.625 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.649 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 45.9 t 168.21 158.08 0.04 OUTLIER 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 -176.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 649' ' ' TYR . 21.0 p -168.25 149.18 4.96 Favored 'General case' 0 C--N 1.291 -1.94 0 N-CA-C 106.575 -1.639 . . . . 0.0 106.575 177.1 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -100.97 -139.71 10.9 Favored Glycine 0 N--CA 1.403 -3.515 0 C-N-CA 120.101 -1.047 . . . . 0.0 111.198 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.951 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 44.8 Cg_exo -53.16 142.07 56.61 Favored 'Trans proline' 0 C--O 1.245 0.835 0 C-N-CA 123.65 2.9 . . . . 0.0 112.824 -177.939 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.448 ' HB3' HG21 ' A' ' 655' ' ' VAL . 27.7 Cg_endo -61.01 151.34 78.97 Favored 'Trans proline' 0 C--O 1.249 1.046 0 C-N-CA 123.073 2.516 . . . . 0.0 112.207 -178.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.526 ' HG2' HD21 ' A' ' 681' ' ' LEU . 9.6 Cg_endo -63.3 179.54 0.84 Allowed 'Trans proline' 0 C--O 1.257 1.427 0 C-N-CA 123.12 2.546 . . . . 0.0 112.722 178.485 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -95.1 145.73 24.78 Favored 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.9 -0.778 . . . . 0.0 108.9 -178.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.854 HD12 ' HB3' ' A' ' 657' ' ' TYR . 2.4 tt -86.84 138.16 31.8 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 176.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.497 ' N ' HD23 ' A' ' 636' ' ' LEU . 54.0 tp -33.26 -65.63 0.17 Allowed 'General case' 0 C--N 1.301 -1.524 0 C-N-CA 126.196 1.798 . . . . 0.0 113.212 173.262 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.606 ' HB3' ' HB2' ' A' ' 684' ' ' CYS . 0.2 OUTLIER -135.77 30.98 3.08 Favored 'General case' 0 C--N 1.307 -1.259 0 CA-C-O 123.976 1.846 . . . . 0.0 108.798 -179.231 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.771 ' HA3' HD13 ' A' ' 636' ' ' LEU . . . -139.7 -156.87 7.07 Favored Glycine 1 C--N 1.241 -4.727 0 CA-C-N 112.242 -2.254 . . . . 0.0 110.489 173.99 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . 0.418 HD22 ' HA ' ' A' ' 640' ' ' ASN . 1.4 m120 -163.74 177.81 8.38 Favored 'General case' 0 C--N 1.309 -1.177 0 C-N-CA 124.021 0.928 . . . . 0.0 109.965 -178.389 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 2.0 p -99.49 140.16 19.5 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 123.241 0.616 . . . . 0.0 109.788 178.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . . . . . . . . . 9.4 ptpt -97.35 -11.98 23.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 121.077 0.465 . . . . 0.0 111.37 -175.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -90.16 163.97 14.62 Favored 'General case' 0 N--CA 1.428 -1.526 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.378 -178.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 27.8 mmmt -92.77 149.94 20.97 Favored 'General case' 0 N--CA 1.428 -1.528 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.419 HG22 ' HD2' ' A' ' 633' ' ' PRO . 56.7 p -75.32 119.14 19.02 Favored 'General case' 0 C--N 1.291 -1.968 0 CA-C-N 115.963 -0.562 . . . . 0.0 112.007 -173.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 47.6 mtmt -80.39 -20.71 43.4 Favored 'General case' 0 C--N 1.313 -0.997 0 N-CA-C 109.413 -0.588 . . . . 0.0 109.413 179.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.951 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 39.6 mt-10 65.51 -3.26 0.7 Allowed 'General case' 0 N--CA 1.479 1.011 0 C-N-CA 125.411 1.484 . . . . 0.0 114.993 175.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 16.1 tp10 -148.93 95.06 2.35 Favored 'General case' 0 C--N 1.3 -1.586 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 172.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.419 ' HB2' ' SG ' ' A' ' 630' ' ' CYS . 16.6 m-85 -95.24 -68.84 0.78 Allowed 'General case' 0 C--N 1.292 -1.915 0 CA-C-N 114.614 -1.176 . . . . 0.0 110.212 -178.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.649 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 111.7 -94.14 0.74 Allowed Glycine 0 C--N 1.305 -1.172 0 C-N-CA 120.016 -1.087 . . . . 0.0 112.408 175.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.618 ' CB ' HG13 ' A' ' 627' ' ' VAL . 83.5 t60 -148.17 142.96 26.72 Favored 'General case' 0 C--N 1.317 -0.844 0 CA-C-N 116.897 0.349 . . . . 0.0 110.661 -179.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 59.7 m 69.74 11.15 7.8 Favored 'General case' 0 C--O 1.246 0.896 0 C-N-CA 125.326 1.45 . . . . 0.0 113.262 175.689 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.517 ' O ' ' HA ' ' A' ' 672' ' ' GLN . 9.6 mm-40 -77.04 127.75 33.25 Favored 'General case' 0 N--CA 1.432 -1.37 0 CA-C-N 114.93 -1.032 . . . . 0.0 109.925 179.513 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.624 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 15.6 t -104.45 141.67 19.49 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.966 0 O-C-N 123.758 0.661 . . . . 0.0 109.409 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.475 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 42.9 t -127.94 135.93 61.62 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.557 0 C-N-CA 123.28 0.632 . . . . 0.0 109.543 179.116 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.502 ' HA ' ' HG2' ' A' ' 670' ' ' LYS . 32.2 tt0 -102.98 131.69 49.76 Favored 'General case' 0 N--CA 1.433 -1.323 0 CA-C-O 122.096 0.95 . . . . 0.0 112.354 -179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.854 ' HB3' HD12 ' A' ' 636' ' ' LEU . 63.4 m-85 -110.24 164.99 12.12 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-N 114.562 -1.199 . . . . 0.0 111.835 -179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -139.54 151.13 45.85 Favored 'General case' 0 C--N 1.315 -0.92 0 N-CA-C 107.316 -1.365 . . . . 0.0 107.316 175.798 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.57 ' SG ' ' HA ' ' A' ' 665' ' ' MET . 99.3 m -89.56 162.45 15.66 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-O 120.877 0.37 . . . . 0.0 111.311 176.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -57.92 158.72 12.03 Favored Pre-proline 0 CA--C 1.543 0.707 0 CA-C-N 115.363 -0.835 . . . . 0.0 111.265 175.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -61.29 1.11 0.73 Allowed 'Trans proline' 0 N--CA 1.495 1.563 0 C-N-CA 124.302 3.334 . . . . 0.0 117.134 -172.674 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.486 ' HB2' ' CD2' ' A' ' 710' ' ' TYR . 17.2 ptt-85 -131.98 -2.26 3.65 Favored 'General case' 0 C--N 1.302 -1.459 0 C-N-CA 119.501 -0.88 . . . . 0.0 111.289 173.376 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . . . . . . . . . 56.8 m-85 -100.61 143.72 30.43 Favored 'General case' 0 C--N 1.287 -2.128 0 CA-C-N 114.852 -1.067 . . . . 0.0 112.057 -179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.695 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 6.7 mp -100.8 140.14 35.5 Favored 'General case' 0 N--CA 1.423 -1.786 0 CA-C-N 114.759 -1.109 . . . . 0.0 109.561 -178.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.57 ' HA ' ' SG ' ' A' ' 659' ' ' CYS . 50.9 tpp -69.63 113.74 7.19 Favored 'General case' 0 C--N 1.298 -1.632 0 CA-C-N 115.013 -0.994 . . . . 0.0 110.416 178.357 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.621 ' HB3' ' HB ' ' A' ' 683' ' ' VAL . 28.3 tptp -101.65 -12.2 18.61 Favored 'General case' 0 C--N 1.302 -1.492 0 CA-C-O 121.993 0.901 . . . . 0.0 109.499 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . 0.547 ' HA3' ' HA ' ' A' ' 682' ' ' PRO . . . -98.62 -171.35 31.73 Favored Glycine 0 C--N 1.293 -1.833 0 CA-C-N 115.175 -0.921 . . . . 0.0 113.416 -177.007 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . 0.463 ' HD2' ' HA ' ' A' ' 682' ' ' PRO . 88.6 Cg_endo -80.93 -5.91 13.11 Favored 'Trans proline' 0 N--CA 1.478 0.57 0 C-N-CA 123.068 2.512 . . . . 0.0 111.515 178.537 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.514 ' H ' ' HB3' ' A' ' 682' ' ' PRO 0.259 2.3 p-10 57.82 -6.34 0.04 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 C-N-CA 127.9 2.48 . . . . 0.0 115.764 -179.767 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.502 ' HG2' ' HA ' ' A' ' 656' ' ' GLU . 55.5 mtmt -130.92 141.84 50.31 Favored 'General case' 0 C--N 1.303 -1.436 0 CA-C-N 118.283 0.492 . . . . 0.0 110.437 177.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.624 ' O ' ' HA ' ' A' ' 654' ' ' VAL . 42.9 pt -131.76 169.87 20.94 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.06 0 CA-C-N 116.255 -0.429 . . . . 0.0 109.897 -175.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.517 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 27.8 tt0 -137.08 140.7 42.16 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 122.843 0.457 . . . . 0.0 111.127 -176.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 45.3 t -81.98 102.19 10.78 Favored 'General case' 0 C--N 1.309 -1.172 0 CA-C-O 121.793 0.806 . . . . 0.0 109.689 175.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 38.4 t -86.99 170.16 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.284 -2.243 0 N-CA-C 108.34 -0.985 . . . . 0.0 108.34 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -62.73 70.95 0.02 OUTLIER 'General case' 0 CA--C 1.544 0.748 0 C-N-CA 124.841 1.256 . . . . 0.0 112.415 179.853 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 148.7 -30.81 1.25 Allowed Glycine 0 N--CA 1.405 -3.433 0 CA-C-N 114.46 -1.245 . . . . 0.0 112.99 171.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 16.8 pt-20 -168.39 -177.53 3.24 Favored 'General case' 0 C--N 1.322 -0.616 0 N-CA-C 109.705 -0.48 . . . . 0.0 109.705 -175.118 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 89.9 m95 -86.13 174.95 8.8 Favored 'General case' 0 C--N 1.305 -1.334 0 CA-C-N 116.484 -0.326 . . . . 0.0 110.579 178.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 25.3 p -89.38 -167.31 1.83 Allowed 'General case' 0 C--N 1.303 -1.428 0 C-N-CA 122.607 0.363 . . . . 0.0 111.419 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 56.4 m -65.54 112.21 3.49 Favored 'General case' 0 N--CA 1.434 -1.271 0 CA-C-N 115.87 -0.604 . . . . 0.0 110.044 177.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.526 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.3 mp -71.71 154.86 92.86 Favored Pre-proline 0 N--CA 1.438 -1.057 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.523 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.566 ' HG2' ' HG ' ' A' ' 636' ' ' LEU . 45.4 Cg_endo -68.09 175.95 6.0 Favored 'Trans proline' 0 N--CA 1.44 -1.671 0 C-N-CA 122.433 2.089 . . . . 0.0 113.472 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.621 ' HB ' ' HB3' ' A' ' 666' ' ' LYS . 50.5 t -129.06 151.08 35.27 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.725 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -177.615 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.606 ' HB2' ' HB3' ' A' ' 638' ' ' ASN . 99.4 m -132.11 123.71 27.7 Favored 'General case' 0 C--N 1.288 -2.08 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 179.16 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 28.3 pt -129.66 141.64 45.95 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 N-CA-C 109.65 -0.5 . . . . 0.0 109.65 -177.092 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.44 HG22 ' H ' ' A' ' 688' ' ' GLU . 10.4 p -87.06 124.35 40.5 Favored 'Isoleucine or valine' 0 C--N 1.286 -2.169 0 N-CA-C 109.044 -0.725 . . . . 0.0 109.044 -178.269 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.491 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.7 pt-20 -73.67 -20.77 60.47 Favored 'General case' 0 C--N 1.321 -0.655 0 C-N-CA 118.866 -1.134 . . . . 0.0 109.417 178.363 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.604 ' HA ' ' CE2' ' A' ' 710' ' ' TYR . 27.3 tt0 62.21 40.21 11.85 Favored 'General case' 0 C--O 1.24 0.595 0 CA-C-N 114.392 -1.276 . . . . 0.0 110.056 173.187 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 17.3 m -122.68 156.78 33.66 Favored 'General case' 0 N--CA 1.429 -1.518 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 179.412 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.2 p -115.66 145.44 42.72 Favored 'General case' 0 N--CA 1.408 -2.55 0 CA-C-O 121.421 0.629 . . . . 0.0 111.663 -178.403 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 42.5 m -81.62 -24.44 36.39 Favored 'General case' 0 C--N 1.287 -2.136 0 CA-C-N 114.247 -1.342 . . . . 0.0 113.158 -171.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 97.99 41.47 3.29 Favored Glycine 0 N--CA 1.434 -1.451 0 C-N-CA 119.396 -1.383 . . . . 0.0 113.2 174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.626 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 30.4 t70 66.26 176.87 0.22 Allowed 'General case' 0 C--O 1.247 0.945 0 C-N-CA 123.504 0.722 . . . . 0.0 112.498 176.366 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.677 HG12 HG11 ' A' ' 715' ' ' VAL . 2.8 mt -73.87 131.0 82.23 Favored Pre-proline 0 N--CA 1.416 -2.173 0 C-N-CA 123.942 0.897 . . . . 0.0 111.005 176.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.437 ' HG2' ' CZ ' ' A' ' 717' ' ' PHE . 74.1 Cg_endo -73.82 -179.61 4.75 Favored 'Trans proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.943 2.429 . . . . 0.0 111.191 179.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -119.67 116.63 26.38 Favored 'General case' 0 C--N 1.262 -3.221 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.248 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.78 HD23 ' HA3' ' A' ' 700' ' ' GLY . 47.3 tp -82.37 139.81 33.86 Favored 'General case' 0 N--CA 1.426 -1.671 0 N-CA-C 105.203 -2.147 . . . . 0.0 105.203 173.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 14.5 pt-20 -46.33 -37.3 7.25 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 112.687 0.625 . . . . 0.0 112.687 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.4 m-70 -135.78 22.97 3.35 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.076 0.465 . . . . 0.0 111.259 176.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.78 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -132.72 167.4 23.21 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-N 115.728 -0.669 . . . . 0.0 112.075 177.857 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 10.2 p-90 -156.58 -152.85 0.39 Allowed 'General case' 0 N--CA 1.433 -1.283 0 C-N-CA 125.113 1.365 . . . . 0.0 107.33 -173.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.426 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -136.22 148.46 48.09 Favored 'General case' 0 C--N 1.29 -1.989 0 N-CA-C 114.148 1.166 . . . . 0.0 114.148 -167.253 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.539 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -87.69 -42.36 12.7 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 115.151 -0.932 . . . . 0.0 110.946 179.586 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -131.57 160.47 35.2 Favored 'General case' 0 C--N 1.308 -1.237 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.718 -178.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 5.6 m -148.35 117.62 6.89 Favored 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 179.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 59.1 m -116.1 98.4 51.2 Favored Pre-proline 0 C--N 1.28 -2.446 0 CA-C-O 121.397 0.617 . . . . 0.0 110.795 178.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.483 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 19.5 Cg_endo -93.6 151.83 2.36 Favored 'Trans proline' 0 N--CA 1.424 -2.584 0 C-N-CA 122.349 2.033 . . . . 0.0 111.389 174.465 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.483 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 71.4 Cg_endo -72.97 133.2 29.33 Favored 'Cis proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.122 -1.616 . . . . 0.0 111.444 0.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.626 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 30.9 m-85 -72.74 96.8 2.09 Favored 'General case' 0 C--N 1.312 -1.048 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 -179.019 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.604 ' CE2' ' HA ' ' A' ' 688' ' ' GLU . 3.4 m-85 -99.42 175.09 5.97 Favored 'General case' 0 C--N 1.3 -1.565 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.804 178.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.695 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 6.3 t80 -62.1 141.38 58.16 Favored 'General case' 0 C--N 1.316 -0.85 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 175.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 85.97 -8.75 71.83 Favored Glycine 0 N--CA 1.435 -1.406 0 C-N-CA 120.748 -0.739 . . . . 0.0 113.685 177.603 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -76.43 169.6 17.95 Favored 'General case' 0 C--O 1.259 1.568 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 177.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.4 m -134.02 149.61 51.19 Favored 'General case' 0 C--N 1.286 -2.178 0 CA-C-O 121.261 0.553 . . . . 0.0 110.384 -172.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.677 HG11 HG12 ' A' ' 694' ' ' ILE . 43.7 t -137.9 142.21 36.62 Favored 'Isoleucine or valine' 0 N--CA 1.407 -2.593 0 N-CA-C 108.99 -0.744 . . . . 0.0 108.99 177.743 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -107.81 120.31 41.9 Favored 'General case' 0 C--N 1.286 -2.183 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 176.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.496 ' CE1' HG23 ' A' ' 694' ' ' ILE . 1.9 m-85 -96.43 149.66 21.47 Favored 'General case' 0 C--N 1.292 -1.9 0 C-N-CA 124.408 1.083 . . . . 0.0 110.36 179.423 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.539 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 53.1 t30 -136.4 152.3 50.47 Favored 'General case' 0 C--N 1.285 -2.206 0 N-CA-C 107.268 -1.382 . . . . 0.0 107.268 177.368 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.756 ' HB2' ' HB3' ' A' ' 725' ' ' MET . 46.6 t -91.86 166.31 12.8 Favored 'General case' 0 C--N 1.26 -3.299 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 -177.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 48.5 t -58.42 157.59 8.6 Favored 'General case' 0 N--CA 1.436 -1.144 0 CA-C-O 121.254 0.549 . . . . 0.0 109.811 174.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 44.7 tt0 -63.79 -35.87 82.03 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-N 115.704 -0.68 . . . . 0.0 111.506 -177.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 15.1 m -90.82 5.42 48.48 Favored 'General case' 0 C--N 1.305 -1.345 0 CA-C-O 121.204 0.525 . . . . 0.0 111.804 -176.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 69.5 m-85 -128.62 158.18 39.21 Favored 'General case' 0 C--N 1.313 -0.991 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 -176.678 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 6.5 t -117.04 145.27 43.82 Favored 'General case' 0 C--N 1.292 -1.9 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 178.103 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.756 ' HB3' ' HB2' ' A' ' 719' ' ' CYS . 9.8 ptm -101.8 151.44 22.05 Favored 'General case' 0 N--CA 1.428 -1.566 0 CA-C-O 121.407 0.623 . . . . 0.0 110.797 -173.534 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 39.0 mt -131.2 127.86 61.08 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.839 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 177.754 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 120.79 -153.46 16.63 Favored Glycine 0 CA--C 1.472 -2.614 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 178.15 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 10.7 t-160 -98.75 119.01 36.78 Favored 'General case' 0 CA--C 1.465 -2.297 0 C-N-CA 119.37 -0.932 . . . . 0.0 108.919 -177.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 24.4 ptt180 -65.53 -27.38 68.41 Favored 'General case' 0 C--N 1.291 -1.95 0 CA-C-N 114.078 -1.419 . . . . 0.0 111.178 -178.953 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . . . . . . . . . 4.6 p -107.91 147.73 30.59 Favored 'General case' 0 C--N 1.295 -1.796 0 C-N-CA 119.621 -0.832 . . . . 0.0 111.344 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.665 HG21 HD23 ' A' ' 741' ' ' LEU . 8.4 pt -127.35 163.41 30.54 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.975 0 CA-C-N 115.55 -0.75 . . . . 0.0 110.324 -178.07 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 56.7 m -134.62 136.73 43.11 Favored 'General case' 0 C--N 1.28 -2.45 0 N-CA-C 106.395 -1.706 . . . . 0.0 106.395 179.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 53.4 t -76.49 114.29 15.05 Favored 'General case' 0 C--N 1.29 -2.011 0 CA-C-O 121.466 0.65 . . . . 0.0 111.432 -179.785 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 49.8 mm -116.04 97.53 5.67 Favored 'Isoleucine or valine' 0 N--CA 1.414 -2.27 0 CA-C-N 114.809 -1.087 . . . . 0.0 109.914 -179.415 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 97.2 m-70 68.05 34.14 4.23 Favored 'General case' 0 C--N 1.312 -1.034 0 CA-C-N 113.83 -1.532 . . . . 0.0 111.735 176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 101.19 -15.21 57.99 Favored Glycine 0 N--CA 1.436 -1.306 0 CA-C-N 115.267 -0.878 . . . . 0.0 111.405 178.349 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 58.8 t -118.77 133.59 65.12 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 -175.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.491 ' CG ' HD12 ' A' ' 731' ' ' ILE . 88.3 m95 -72.35 152.76 41.87 Favored 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 108.573 -0.899 . . . . 0.0 108.573 -179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 39.2 p -37.43 -66.54 0.24 Allowed 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 116.254 1.946 . . . . 0.0 116.254 -173.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -161.78 -31.01 0.05 OUTLIER 'General case' 0 C--N 1.303 -1.431 0 N-CA-C 114.833 1.419 . . . . 0.0 114.833 -172.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.665 HD23 HG21 ' A' ' 731' ' ' ILE . 21.4 mt 66.09 148.75 0.11 Allowed Pre-proline 0 C--N 1.316 -0.855 0 O-C-N 124.796 1.31 . . . . 0.0 110.992 -175.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -78.13 -172.13 1.41 Allowed 'Trans proline' 0 C--N 1.303 -1.864 0 C-N-CA 121.812 1.675 . . . . 0.0 110.089 176.733 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.415 ' O ' ' HA ' ' A' ' 725' ' ' MET . 10.5 pt20 -136.94 145.07 43.79 Favored 'General case' 0 C--N 1.288 -2.081 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 177.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . . . . . . . . . 88.2 m -102.32 153.77 19.68 Favored 'General case' 0 C--N 1.282 -2.37 0 N-CA-C 111.679 0.252 . . . . 0.0 111.679 178.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.9 m -140.6 144.33 27.45 Favored 'Isoleucine or valine' 0 C--O 1.254 1.339 0 N-CA-C 107.506 -1.294 . . . . 0.0 107.506 175.894 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.82 120.7 12.4 Favored 'General case' 0 C--N 1.308 -1.198 0 O-C-N 123.707 0.629 . . . . 0.0 111.199 -178.575 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 68.5 mt . . . . . 0 C--O 1.252 1.235 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 176.165 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 . . . . . 0 CA--C 1.538 0.49 0 CA-C-O 120.373 0.13 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -153.42 163.93 39.07 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.311 -0.626 . . . . 0.0 109.311 -178.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -84.66 -17.55 38.2 Favored 'General case' 0 C--N 1.317 -0.813 0 CA-C-O 121.301 0.572 . . . . 0.0 110.398 -179.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -142.99 147.05 34.5 Favored 'General case' 0 N--CA 1.43 -1.44 0 N-CA-C 109.12 -0.696 . . . . 0.0 109.12 177.78 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -87.98 -10.28 50.94 Favored 'General case' 0 C--N 1.307 -1.25 0 CA-C-O 121.661 0.743 . . . . 0.0 110.527 177.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . 99.38 113.97 3.5 Favored Glycine 0 C--N 1.297 -1.584 0 N-CA-C 109.984 -1.246 . . . . 0.0 109.984 -176.617 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . . . . . . . . 0.331 22.6 m 48.07 73.65 0.08 OUTLIER 'Isoleucine or valine' 0 CA--C 1.512 -0.503 0 CA-C-O 123.748 1.737 . . . . 0.0 111.492 -175.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.436 ' CD ' ' HA ' ' A' ' 675' ' ' ASP . 0.0 OUTLIER -73.68 -105.96 0.01 OUTLIER 'General case' 0 C--N 1.282 -2.369 0 CA-C-N 112.181 -2.281 . . . . 0.0 114.338 -174.327 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.532 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 8.0 p 179.87 155.51 0.59 Allowed 'General case' 0 C--N 1.312 -1.044 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.207 -171.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 28.6 p -175.91 146.36 0.71 Allowed 'General case' 0 C--O 1.253 1.238 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 176.891 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -102.62 -132.3 7.63 Favored Glycine 0 N--CA 1.414 -2.781 0 C-N-CA 121.02 -0.609 . . . . 0.0 111.69 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.949 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 52.9 Cg_exo -53.77 140.34 67.37 Favored 'Trans proline' 0 C--O 1.237 0.473 0 C-N-CA 124.002 3.135 . . . . 0.0 113.12 -176.774 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.672 ' HD2' HG22 ' A' ' 645' ' ' THR . 21.7 Cg_endo -61.97 154.24 63.14 Favored 'Trans proline' 0 C--O 1.248 0.979 0 C-N-CA 122.575 2.183 . . . . 0.0 111.093 179.013 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.513 ' HG2' HD11 ' A' ' 681' ' ' LEU . 14.6 Cg_endo -68.02 -168.81 0.21 Allowed 'Trans proline' 0 C--O 1.253 1.227 0 C-N-CA 122.517 2.145 . . . . 0.0 111.872 178.439 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 13.2 pt-20 -105.08 162.44 13.37 Favored 'General case' 0 C--N 1.298 -1.647 0 C-N-CA 120.068 -0.653 . . . . 0.0 109.538 -178.797 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.685 HD13 ' HG2' ' A' ' 682' ' ' PRO . 28.8 tp -101.19 138.18 38.56 Favored 'General case' 0 C--N 1.299 -1.59 0 N-CA-C 109.719 -0.474 . . . . 0.0 109.719 174.014 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.46 ' H ' HD12 ' A' ' 636' ' ' LEU . 2.5 tm? -27.75 -64.71 0.08 Allowed 'General case' 0 N--CA 1.478 0.932 0 C-N-CA 127.584 2.353 . . . . 0.0 111.731 177.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . . . . . . . . . 3.8 t30 -117.36 -40.9 3.02 Favored 'General case' 0 N--CA 1.428 -1.551 0 C-N-CA 118.59 -1.244 . . . . 0.0 110.874 -177.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.543 ' HA2' ' OD1' ' A' ' 660' ' ' ASN . . . -79.18 -128.77 0.6 Allowed Glycine 0 CA--C 1.504 -0.627 0 CA-C-N 115.721 -0.672 . . . . 0.0 112.599 -177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -173.53 -175.6 1.15 Allowed 'General case' 0 C--N 1.314 -0.965 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 179.14 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.453 ' HA ' ' HA ' ' A' ' 657' ' ' TYR . 3.0 p -99.5 144.64 11.79 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.946 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 177.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.426 ' HB3' ' HD2' ' A' ' 658' ' ' TYR . 10.5 ptpt -99.7 -16.72 18.06 Favored 'General case' 0 C--N 1.316 -0.85 0 CA-C-O 121.122 0.487 . . . . 0.0 111.123 -176.632 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . . . . . . . . . 41.1 mt-10 -91.21 145.11 24.94 Favored 'General case' 0 N--CA 1.427 -1.608 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 33.0 mmtp -81.38 152.08 27.65 Favored 'General case' 0 N--CA 1.412 -2.369 0 CA-C-O 121.833 0.825 . . . . 0.0 112.543 -177.535 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.672 HG22 ' HD2' ' A' ' 633' ' ' PRO . 39.9 p -73.65 118.16 16.27 Favored 'General case' 0 N--CA 1.396 -3.136 0 CA-C-N 114.165 -1.38 . . . . 0.0 111.679 -174.832 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 48.6 mtmt -83.79 -22.78 31.73 Favored 'General case' 0 C--N 1.301 -1.511 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.001 178.645 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.949 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 32.0 mt-10 63.69 18.28 11.01 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 114.398 -1.273 . . . . 0.0 111.672 175.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 12.8 tp10 -157.97 101.29 1.77 Allowed 'General case' 0 N--CA 1.427 -1.623 0 CA-C-N 113.486 -1.688 . . . . 0.0 106.676 175.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.552 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 34.7 m-85 -117.45 -73.48 0.64 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.811 -0.631 . . . . 0.0 110.268 178.687 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.532 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 103.08 -88.57 0.65 Allowed Glycine 0 C--N 1.301 -1.388 0 C-N-CA 119.739 -1.22 . . . . 0.0 113.885 174.49 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . . . . . . . . . 76.5 t60 -146.61 142.38 27.88 Favored 'General case' 0 N--CA 1.446 -0.664 0 CA-C-N 117.22 0.51 . . . . 0.0 110.793 -177.15 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 77.3 p 68.18 11.5 8.38 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.884 1.674 . . . . 0.0 113.102 175.8 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.552 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 39.0 mm-40 -78.86 129.16 34.26 Favored 'General case' 0 C--N 1.307 -1.262 0 CA-C-N 114.871 -1.059 . . . . 0.0 108.604 177.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.46 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 0.9 OUTLIER -120.11 131.14 73.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 CA-C-O 121.394 0.616 . . . . 0.0 112.111 -176.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.432 ' O ' ' HA ' ' A' ' 670' ' ' LYS . 67.4 t -121.41 137.9 53.56 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.927 0 CA-C-N 115.035 -0.984 . . . . 0.0 111.195 -171.953 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . 0.47 ' HG3' HD22 ' A' ' 669' ' ' ASN . 32.8 tt0 -104.37 134.03 48.27 Favored 'General case' 0 N--CA 1.425 -1.71 0 CA-C-O 122.508 1.147 . . . . 0.0 112.269 -179.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.651 ' CD2' ' HB2' ' A' ' 636' ' ' LEU . 52.0 m-85 -109.9 164.06 12.95 Favored 'General case' 0 C--N 1.29 -1.979 0 CA-C-N 114.052 -1.431 . . . . 0.0 111.158 -178.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.426 ' HD2' ' HB3' ' A' ' 642' ' ' LYS . 48.9 p90 -137.97 145.72 42.3 Favored 'General case' 0 N--CA 1.439 -0.993 0 N-CA-C 108.64 -0.874 . . . . 0.0 108.64 177.319 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.488 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 96.3 m -91.5 153.4 19.83 Favored 'General case' 0 C--N 1.287 -2.149 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 173.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.543 ' OD1' ' HA2' ' A' ' 639' ' ' GLY . 4.2 m-20 -51.6 156.79 2.09 Favored Pre-proline 0 C--N 1.313 -1.01 0 CA-C-N 114.373 -1.285 . . . . 0.0 112.015 177.529 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . . . . . . . . . 65.1 Cg_endo -70.4 12.19 0.41 Allowed 'Trans proline' 0 N--CA 1.487 1.111 0 C-N-CA 123.646 2.897 . . . . 0.0 112.801 -177.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.642 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 40.4 ptt180 -133.35 0.34 3.35 Favored 'General case' 0 N--CA 1.416 -2.147 0 CA-C-O 121.793 0.806 . . . . 0.0 111.573 177.495 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.46 ' HD1' ' HG3' ' A' ' 662' ' ' ARG . 31.4 m-85 -125.03 150.6 46.59 Favored 'General case' 0 C--N 1.289 -2.046 0 CA-C-N 114.941 -1.027 . . . . 0.0 111.57 177.532 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.736 ' HG ' ' CD1' ' A' ' 711' ' ' TYR . 5.9 mp -103.36 139.91 38.14 Favored 'General case' 0 C--N 1.286 -2.19 0 CA-C-N 114.889 -1.05 . . . . 0.0 110.235 -177.28 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.546 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 52.0 tpp -73.93 117.25 15.49 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 123.782 0.676 . . . . 0.0 109.206 175.681 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . . . . . . . . . 60.5 tttp -101.27 -32.7 10.38 Favored 'General case' 0 C--N 1.294 -1.831 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.252 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -80.6 -174.98 48.84 Favored Glycine 0 CA--C 1.532 1.121 0 CA-C-N 114.981 -1.009 . . . . 0.0 114.1 -176.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo -71.36 -8.67 23.84 Favored 'Trans proline' 0 N--CA 1.491 1.359 0 C-N-CA 124.065 3.177 . . . . 0.0 112.854 -177.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.546 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 2.0 p-10 58.48 -0.95 0.11 Allowed 'General case' 0 N--CA 1.49 1.54 0 C-N-CA 127.081 2.153 . . . . 0.0 115.358 179.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.432 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 53.8 mtmt -136.74 138.41 40.92 Favored 'General case' 0 C--N 1.31 -1.114 0 CA-C-N 117.986 0.357 . . . . 0.0 110.495 178.246 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.468 HG21 HD13 ' A' ' 681' ' ' LEU . 44.6 pt -126.13 171.59 14.59 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.313 0 CA-C-N 115.685 -0.688 . . . . 0.0 109.54 -179.393 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.499 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 25.6 tt0 -143.77 141.14 30.29 Favored 'General case' 0 C--N 1.294 -1.831 0 C-N-CA 122.701 0.4 . . . . 0.0 109.994 -177.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . 0.517 ' HA ' ' HA ' ' A' ' 678' ' ' TRP . 41.4 t -85.71 105.1 16.0 Favored 'General case' 0 N--CA 1.426 -1.645 0 N-CA-C 107.325 -1.361 . . . . 0.0 107.325 176.754 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 33.1 m -91.32 -171.51 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.292 -1.898 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 -179.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.436 ' HA ' ' CD ' ' A' ' 628' ' ' GLN . 6.0 p-10 -77.24 84.96 3.7 Favored 'General case' 0 C--N 1.306 -1.289 0 CA-C-O 122.861 1.315 . . . . 0.0 111.614 179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . . . . . . . . . . . 155.2 -67.01 0.31 Allowed Glycine 0 N--CA 1.4 -3.744 0 CA-C-N 111.872 -2.422 . . . . 0.0 108.343 173.364 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -151.62 -172.97 4.37 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -178.067 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . 0.517 ' HA ' ' HA ' ' A' ' 673' ' ' CYS . 89.6 m95 -78.42 159.68 28.16 Favored 'General case' 0 C--N 1.309 -1.162 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 41.1 p -75.82 -168.0 0.81 Allowed 'General case' 0 C--N 1.312 -1.036 0 C-N-CA 123.504 0.721 . . . . 0.0 112.236 -178.478 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 91.8 m -77.26 116.85 18.23 Favored 'General case' 0 N--CA 1.428 -1.53 0 CA-C-O 121.446 0.641 . . . . 0.0 111.502 -174.844 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.513 HD11 ' HG2' ' A' ' 634' ' ' PRO . 4.3 mm? -58.09 145.38 73.33 Favored Pre-proline 0 C--N 1.312 -1.028 0 CA-C-N 113.995 -1.457 . . . . 0.0 111.689 177.309 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.685 ' HG2' HD13 ' A' ' 636' ' ' LEU . 30.1 Cg_endo -70.31 -172.95 0.69 Allowed 'Trans proline' 0 N--CA 1.449 -1.094 0 C-N-CA 122.44 2.093 . . . . 0.0 112.503 177.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . . . . . . . . . 90.0 t -138.26 142.41 35.43 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.234 0 N-CA-C 107.653 -1.24 . . . . 0.0 107.653 -175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . . . . . . . . . 70.8 m -115.78 133.01 56.46 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 177.034 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . . . . . . . . . 26.2 pt -127.43 139.65 51.31 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.76 0 O-C-N 123.372 0.42 . . . . 0.0 109.939 -178.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.452 ' HB ' ' CE2' ' A' ' 663' ' ' PHE . 11.7 p -88.33 118.48 33.97 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.987 0 N-CA-C 108.307 -0.997 . . . . 0.0 108.307 177.861 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.539 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.9 pt-20 -68.7 -19.3 64.37 Favored 'General case' 0 C--N 1.321 -0.656 0 C-N-CA 118.965 -1.094 . . . . 0.0 110.664 -179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . 0.649 ' HA ' ' HE1' ' A' ' 710' ' ' TYR . 33.7 tt0 71.89 -2.28 2.56 Favored 'General case' 0 N--CA 1.472 0.637 0 C-N-CA 126.431 1.892 . . . . 0.0 112.929 173.375 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 25.2 t -100.45 155.47 17.81 Favored 'General case' 0 C--N 1.28 -2.439 0 N-CA-C 105.483 -2.043 . . . . 0.0 105.483 175.505 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 47.9 p -131.46 173.59 10.94 Favored 'General case' 0 C--N 1.278 -2.518 0 CA-C-O 120.937 0.399 . . . . 0.0 111.093 -173.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 23.5 m -90.86 -3.1 57.63 Favored 'General case' 0 C--N 1.3 -1.579 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.644 176.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 92.32 -68.94 1.84 Allowed Glycine 0 CA--C 1.492 -1.378 0 CA-C-N 115.568 -0.742 . . . . 0.0 111.887 173.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.56 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 7.5 t70 -177.51 -167.29 0.15 Allowed 'General case' 0 CA--C 1.495 -1.141 0 N-CA-C 105.418 -2.067 . . . . 0.0 105.418 -179.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.613 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -70.1 130.86 89.29 Favored Pre-proline 0 N--CA 1.413 -2.309 0 O-C-N 123.483 0.489 . . . . 0.0 110.482 174.808 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.558 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 59.9 Cg_endo -75.22 -176.37 2.88 Favored 'Trans proline' 0 N--CA 1.456 -0.696 0 C-N-CA 123.42 2.747 . . . . 0.0 111.879 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -104.87 125.6 51.06 Favored 'General case' 0 C--N 1.285 -2.233 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.197 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.882 HD23 ' HA3' ' A' ' 700' ' ' GLY . 21.2 tp -104.05 136.27 44.01 Favored 'General case' 0 C--N 1.288 -2.071 0 N-CA-C 105.131 -2.174 . . . . 0.0 105.131 175.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -52.17 -34.96 47.38 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 744' ' ' CYS . 84.8 m-70 -139.79 22.33 2.48 Favored 'General case' 0 CA--C 1.51 -0.589 0 CA-C-O 121.728 0.775 . . . . 0.0 110.552 177.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.882 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -131.24 173.38 20.4 Favored Glycine 0 N--CA 1.433 -1.548 0 CA-C-N 114.606 -1.179 . . . . 0.0 112.205 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.3 p-90 -157.54 -154.25 0.44 Allowed 'General case' 0 C--N 1.301 -1.525 0 C-N-CA 125.912 1.685 . . . . 0.0 106.845 -175.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . . . . . . . . . . . -141.13 158.16 44.29 Favored 'General case' 0 C--N 1.286 -2.165 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.983 -168.498 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.548 ' NE2' ' HB2' ' A' ' 718' ' ' ASN . 0.4 OUTLIER -98.92 -56.75 2.34 Favored 'General case' 0 CA--C 1.49 -1.336 0 N-CA-C 108.263 -1.014 . . . . 0.0 108.263 -179.882 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . . . . . . . . . 3.4 pp -118.96 151.64 37.81 Favored 'General case' 0 N--CA 1.409 -2.5 0 CA-C-N 113.801 -1.545 . . . . 0.0 111.0 -174.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . . . . . . . . . 2.0 p -123.43 160.83 26.02 Favored 'General case' 0 C--N 1.278 -2.504 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 175.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 33.6 t -150.41 86.82 5.02 Favored Pre-proline 0 C--N 1.302 -1.493 0 CA-C-O 121.496 0.665 . . . . 0.0 109.74 178.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.562 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 12.5 Cg_endo -97.64 151.05 0.9 Allowed 'Trans proline' 0 N--CA 1.438 -1.773 0 C-N-CA 123.432 2.755 . . . . 0.0 113.374 179.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.562 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 58.2 Cg_endo -69.36 135.27 32.17 Favored 'Cis proline' 0 C--O 1.244 0.777 0 C-N-CA 123.048 -1.647 . . . . 0.0 111.236 -0.145 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.56 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 20.0 m-85 -77.73 73.17 4.3 Favored 'General case' 0 C--N 1.313 -1.009 0 CA-C-N 115.809 -0.632 . . . . 0.0 109.535 -177.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.649 ' HE1' ' HA ' ' A' ' 688' ' ' GLU . 29.8 m-85 -84.36 176.97 8.34 Favored 'General case' 0 C--N 1.302 -1.483 0 N-CA-C 109.723 -0.473 . . . . 0.0 109.723 177.148 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.736 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 20.3 t80 -62.69 139.0 58.64 Favored 'General case' 0 N--CA 1.43 -1.448 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.971 178.818 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 96.4 -19.37 54.88 Favored Glycine 0 C--N 1.296 -1.671 0 CA-C-N 114.983 -1.008 . . . . 0.0 113.955 178.237 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 4.4 t0 -77.8 171.13 15.43 Favored 'General case' 0 C--O 1.252 1.196 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.9 m -137.1 155.84 49.12 Favored 'General case' 0 C--N 1.29 -1.988 0 CA-C-O 121.475 0.655 . . . . 0.0 110.626 -171.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.498 HG11 HG13 ' A' ' 694' ' ' ILE . 36.2 t -141.33 144.86 25.62 Favored 'Isoleucine or valine' 0 N--CA 1.413 -2.316 0 CA-C-N 115.0 -1.0 . . . . 0.0 109.068 177.712 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.556 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.1 mt-10 -109.9 128.17 55.19 Favored 'General case' 0 N--CA 1.422 -1.867 0 CA-C-O 121.376 0.607 . . . . 0.0 110.482 176.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.613 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.3 m-85 -101.07 157.12 17.0 Favored 'General case' 0 C--N 1.293 -1.852 0 CA-C-N 114.19 -1.368 . . . . 0.0 109.334 179.163 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.548 ' HB2' ' NE2' ' A' ' 703' ' ' GLN . 66.6 t30 -147.86 141.89 25.96 Favored 'General case' 0 C--N 1.293 -1.871 0 N-CA-C 106.793 -1.558 . . . . 0.0 106.793 177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.6 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 89.9 m -87.65 157.33 19.13 Favored 'General case' 0 C--N 1.272 -2.772 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.522 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 38.6 m -51.7 157.29 1.18 Allowed 'General case' 0 CA--C 1.544 0.729 0 O-C-N 123.437 0.46 . . . . 0.0 110.858 177.613 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 5.8 tp10 -60.83 -29.42 69.48 Favored 'General case' 0 CA--C 1.553 1.075 0 N-CA-C 112.756 0.651 . . . . 0.0 112.756 -169.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 47.3 m -89.18 6.71 38.87 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 121.603 -0.686 . . . . 0.0 111.238 179.351 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . . . . . . . . . 80.1 m-85 -126.3 151.26 47.75 Favored 'General case' 0 N--CA 1.433 -1.28 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 -178.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . 0.436 ' HB ' HD11 ' A' ' 747' ' ' ILE . 11.1 t -119.79 145.92 46.16 Favored 'General case' 0 C--N 1.277 -2.579 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.061 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.639 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 6.5 ptm -93.3 147.28 23.06 Favored 'General case' 0 C--N 1.292 -1.904 0 CA-C-O 121.337 0.589 . . . . 0.0 110.879 -177.109 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . 0.553 ' HB ' ' HG3' ' A' ' 743' ' ' GLN . 44.5 mt -119.75 127.57 75.88 Favored 'Isoleucine or valine' 0 C--N 1.289 -2.06 0 N-CA-C 107.79 -1.189 . . . . 0.0 107.79 175.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 115.37 -139.96 15.9 Favored Glycine 0 CA--C 1.479 -2.209 0 N-CA-C 111.456 -0.658 . . . . 0.0 111.456 -178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 7.6 t-160 -109.62 129.8 55.56 Favored 'General case' 0 N--CA 1.423 -1.801 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.248 -177.707 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 36.9 ptt180 -65.8 -29.49 69.99 Favored 'General case' 0 C--N 1.298 -1.663 0 CA-C-N 114.617 -1.174 . . . . 0.0 111.277 178.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.556 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 21.0 p -107.98 149.18 28.7 Favored 'General case' 0 N--CA 1.415 -2.182 0 C-N-CA 119.814 -0.754 . . . . 0.0 111.698 -174.872 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.613 HG21 HD23 ' A' ' 741' ' ' LEU . 7.2 pt -126.42 170.4 16.46 Favored 'Isoleucine or valine' 0 N--CA 1.422 -1.83 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.339 178.91 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 91.7 m -139.28 138.17 36.51 Favored 'General case' 0 C--N 1.283 -2.313 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 -179.192 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 49.1 t -70.7 106.18 3.44 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 123.53 0.519 . . . . 0.0 109.649 179.052 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 50.2 mm -122.52 115.82 47.13 Favored 'Isoleucine or valine' 0 C--O 1.214 -0.793 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.619 -176.665 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . 0.4 ' H ' ' HD2' ' A' ' 711' ' ' TYR . 42.2 m-70 60.96 19.49 9.89 Favored 'General case' 0 N--CA 1.479 1.0 0 C-N-CA 124.813 1.245 . . . . 0.0 113.242 -179.713 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 98.74 8.0 54.87 Favored Glycine 0 C--N 1.31 -0.908 0 C-N-CA 120.515 -0.85 . . . . 0.0 112.553 179.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 12.2 p -142.06 139.88 30.08 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 176.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.558 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 88.6 m95 -66.14 147.63 53.04 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 179.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . . . . . . . . . 34.4 p -34.91 -71.88 0.06 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 116.274 1.953 . . . . 0.0 116.274 -174.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -161.74 -27.9 0.05 Allowed 'General case' 0 C--N 1.311 -1.086 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 -171.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.613 HD23 HG21 ' A' ' 731' ' ' ILE . 19.6 mt 68.22 151.26 0.12 Allowed Pre-proline 0 CA--C 1.546 0.789 0 O-C-N 124.51 1.131 . . . . 0.0 111.799 -179.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.639 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 62.5 Cg_endo -80.11 -173.29 1.8 Allowed 'Trans proline' 0 C--N 1.328 -0.506 0 C-N-CA 122.638 2.226 . . . . 0.0 111.74 178.049 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . 0.553 ' HG3' ' HB ' ' A' ' 726' ' ' ILE . 23.6 pt20 -128.88 128.23 43.43 Favored 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 109.291 -0.633 . . . . 0.0 109.291 176.727 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.549 ' HB2' ' HB2' ' A' ' 699' ' ' HIS . 13.8 m -90.68 141.01 29.23 Favored 'General case' 0 C--N 1.298 -1.665 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.783 -179.771 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 12.4 m -132.25 147.78 32.09 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.876 0 N-CA-C 107.639 -1.245 . . . . 0.0 107.639 176.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -75.11 121.04 21.45 Favored 'General case' 0 C--N 1.295 -1.801 0 O-C-N 123.232 0.333 . . . . 0.0 111.214 -175.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . 0.436 HD11 ' HB ' ' A' ' 724' ' ' THR . 58.1 mt . . . . . 0 C--N 1.303 -1.426 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 174.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 621' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 . . . . . 0 CA--C 1.538 0.501 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 622' ' ' ALA . . . . . . . . . . . . . . . -150.46 92.99 1.92 Allowed 'General case' 0 N--CA 1.438 -1.065 0 N-CA-C 109.503 -0.554 . . . . 0.0 109.503 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 623' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -105.38 -42.95 5.1 Favored 'General case' 0 C--N 1.304 -1.41 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 179.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 624' ' ' ALA . . . . . . . . . . . . . . . -105.05 18.42 22.38 Favored 'General case' 0 C--N 1.321 -0.652 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.618 178.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 625' ' ' ALA . . . . . . . . . . . . . . . -131.86 148.88 52.57 Favored 'General case' 0 C--N 1.308 -1.239 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.0 -178.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 626' ' ' GLY . . . . . . . . . . . . . . . -171.98 -70.12 0.04 OUTLIER Glycine 0 N--CA 1.441 -1.028 0 C-N-CA 120.543 -0.837 . . . . 0.0 112.993 -179.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 627' ' ' VAL . . . . . 0.68 HG22 ' CD2' ' A' ' 651' ' ' HIS . 93.5 t 58.5 82.94 0.06 OUTLIER 'Isoleucine or valine' 0 C--O 1.24 0.556 0 CA-C-O 122.336 1.065 . . . . 0.0 111.961 -178.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 628' ' ' GLN . . . . . 0.548 ' HG2' ' N ' ' A' ' 676' ' ' GLY . 1.3 pp0? -84.16 -147.47 0.09 Allowed 'General case' 0 C--N 1.293 -1.853 0 N-CA-C 107.416 -1.327 . . . . 0.0 107.416 173.884 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 629' ' ' SER . . . . . 0.567 ' HA ' ' HA2' ' A' ' 650' ' ' GLY . 50.7 m -157.56 111.76 2.62 Favored 'General case' 0 C--N 1.282 -2.348 0 O-C-N 122.115 -0.366 . . . . 0.0 110.794 -176.61 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 630' ' ' CYS . . . . . . . . . . . . . 22.4 p -96.24 162.74 13.39 Favored 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 174.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 631' ' ' GLY . . . . . . . . . . . . . . . -97.26 -136.11 8.95 Favored Glycine 0 N--CA 1.407 -3.266 0 N-CA-C 110.616 -0.994 . . . . 0.0 110.616 176.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 632' ' ' PRO . . . . . 0.841 ' HG3' ' HG2' ' A' ' 647' ' ' GLU . 33.6 Cg_exo -58.63 147.03 89.37 Favored 'Trans proline' 0 CA--C 1.542 0.924 0 C-N-CA 123.485 2.79 . . . . 0.0 112.607 -179.716 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 633' ' ' PRO . . . . . 0.657 ' HD2' HG22 ' A' ' 645' ' ' THR . 23.6 Cg_endo -62.07 158.8 37.25 Favored 'Trans proline' 0 C--O 1.244 0.79 0 C-N-CA 123.408 2.738 . . . . 0.0 112.512 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 634' ' ' PRO . . . . . 0.587 ' HG2' HD21 ' A' ' 681' ' ' LEU . 22.0 Cg_endo -67.0 -156.46 0.03 OUTLIER 'Trans proline' 0 CA--C 1.545 1.068 0 C-N-CA 123.608 2.872 . . . . 0.0 111.462 174.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 635' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -122.58 166.0 15.54 Favored 'General case' 0 C--N 1.297 -1.679 0 C-N-CA 119.602 -0.839 . . . . 0.0 109.221 176.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 636' ' ' LEU . . . . . 0.69 HD13 ' HG2' ' A' ' 682' ' ' PRO . 33.9 tp -103.57 141.74 35.49 Favored 'General case' 0 N--CA 1.412 -2.367 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 176.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 637' ' ' LEU . . . . . 0.45 HD12 ' HB2' ' A' ' 638' ' ' ASN . 2.2 tm? -40.83 -67.26 0.26 Allowed 'General case' 0 C--N 1.324 -0.537 0 O-C-N 125.013 1.446 . . . . 0.0 110.991 178.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 638' ' ' ASN . . . . . 0.501 HD22 ' HB2' ' A' ' 660' ' ' ASN . 1.3 t30 -129.13 52.5 1.96 Allowed 'General case' 0 N--CA 1.426 -1.628 0 C-N-CA 118.829 -1.148 . . . . 0.0 110.16 -175.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 639' ' ' GLY . . . . . 0.623 ' HA3' ' HA ' ' A' ' 659' ' ' CYS . . . -176.16 -158.1 18.93 Favored Glycine 1 C--N 1.249 -4.256 0 N-CA-C 108.805 -1.718 . . . . 0.0 108.805 -179.668 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 640' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -167.86 -168.99 1.07 Allowed 'General case' 0 N--CA 1.451 -0.4 0 CA-C-N 118.742 1.271 . . . . 0.0 112.027 -177.615 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 641' ' ' VAL . . . . . 0.414 HG12 ' H ' ' A' ' 643' ' ' GLU . 68.0 t -92.61 132.77 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.056 0 C-N-CA 125.299 1.44 . . . . 0.0 110.022 -175.232 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 642' ' ' LYS . . . . . 0.469 ' HE2' ' HB3' ' A' ' 658' ' ' TYR . 13.9 ptpt -104.05 -1.88 26.79 Favored 'General case' 0 C--N 1.319 -0.719 0 CA-C-O 122.282 1.039 . . . . 0.0 109.222 178.792 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 643' ' ' GLU . . . . . 0.414 ' H ' HG12 ' A' ' 641' ' ' VAL . 10.7 mm-40 -90.61 173.9 7.8 Favored 'General case' 0 C--N 1.309 -1.181 0 CA-C-N 114.247 -1.342 . . . . 0.0 109.247 -179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 644' ' ' LYS . . . . . . . . . . . . . 31.6 mmmt -104.03 147.12 27.76 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-O 120.869 0.366 . . . . 0.0 110.151 176.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 645' ' ' THR . . . . . 0.657 HG22 ' HD2' ' A' ' 633' ' ' PRO . 40.1 p -80.83 117.06 21.16 Favored 'General case' 0 C--N 1.299 -1.59 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.634 -178.755 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 646' ' ' LYS . . . . . . . . . . . . . 49.0 mtmt -83.27 -25.97 31.11 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.637 177.982 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 647' ' ' GLU . . . . . 0.841 ' HG2' ' HG3' ' A' ' 632' ' ' PRO . 44.3 mt-10 73.01 -7.18 1.54 Allowed 'General case' 0 N--CA 1.481 1.105 0 C-N-CA 124.843 1.257 . . . . 0.0 113.579 176.629 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 648' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -145.73 100.73 3.46 Favored 'General case' 0 C--N 1.297 -1.717 0 N-CA-C 106.328 -1.73 . . . . 0.0 106.328 168.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 649' ' ' TYR . . . . . 0.764 ' HB3' ' HG3' ' A' ' 653' ' ' GLU . 13.6 m-85 -94.74 -70.0 0.73 Allowed 'General case' 0 C--N 1.292 -1.926 0 CA-C-N 115.433 -0.803 . . . . 0.0 111.763 -178.837 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 650' ' ' GLY . . . . . 0.567 ' HA2' ' HA ' ' A' ' 629' ' ' SER . . . 121.7 -111.13 1.78 Allowed Glycine 0 C--N 1.312 -0.789 0 C-N-CA 119.686 -1.245 . . . . 0.0 112.878 178.02 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 651' ' ' HIS . . . . . 0.68 ' CD2' HG22 ' A' ' 627' ' ' VAL . 84.8 t60 -142.57 135.11 27.91 Favored 'General case' 0 C--N 1.316 -0.859 0 N-CA-C 109.545 -0.539 . . . . 0.0 109.545 -178.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 652' ' ' SER . . . . . . . . . . . . . 50.8 m 76.33 15.53 2.25 Favored 'General case' 0 CA--C 1.538 0.491 0 C-N-CA 124.66 1.184 . . . . 0.0 111.88 178.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 653' ' ' GLU . . . . . 0.764 ' HG3' ' HB3' ' A' ' 649' ' ' TYR . 54.9 mm-40 -80.7 135.13 35.96 Favored 'General case' 0 C--N 1.31 -1.127 0 CA-C-N 114.881 -1.054 . . . . 0.0 108.819 178.377 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 654' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 671' ' ' ILE . 16.2 m -114.66 151.16 16.45 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.132 0 N-CA-C 112.618 0.599 . . . . 0.0 112.618 -179.088 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 655' ' ' VAL . . . . . 0.571 HG21 ' HB3' ' A' ' 633' ' ' PRO . 48.0 t -131.92 135.37 58.71 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.067 0 CA-C-N 115.402 -0.817 . . . . 0.0 109.177 178.58 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 656' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -103.13 130.15 50.22 Favored 'General case' 0 N--CA 1.424 -1.74 0 CA-C-O 121.519 0.676 . . . . 0.0 110.785 -178.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 657' ' ' TYR . . . . . 0.592 ' HB3' HD22 ' A' ' 636' ' ' LEU . 71.0 m-85 -106.77 161.4 14.7 Favored 'General case' 0 C--N 1.294 -1.811 0 CA-C-N 114.994 -1.003 . . . . 0.0 110.844 178.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 658' ' ' TYR . . . . . 0.469 ' HB3' ' HE2' ' A' ' 642' ' ' LYS . 53.8 p90 -136.63 152.17 50.13 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 106.0 -1.852 . . . . 0.0 106.0 174.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 659' ' ' CYS . . . . . 0.623 ' HA ' ' HA3' ' A' ' 639' ' ' GLY . 94.2 m -97.95 169.13 9.85 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 176.143 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 660' ' ' ASN . . . . . 0.501 ' HB2' HD22 ' A' ' 638' ' ' ASN . 0.2 OUTLIER -58.41 157.58 17.48 Favored Pre-proline 0 N--CA 1.484 1.241 0 N-CA-C 108.589 -0.893 . . . . 0.0 108.589 176.618 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 661' ' ' PRO . . . . . 0.421 ' HD2' ' CG ' ' A' ' 660' ' ' ASN . 66.0 Cg_endo -72.04 7.6 1.66 Allowed 'Trans proline' 0 CA--C 1.555 1.545 0 C-N-CA 123.778 2.985 . . . . 0.0 113.84 -178.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 662' ' ' ARG . . . . . 0.535 ' HA ' ' HB2' ' A' ' 710' ' ' TYR . 15.7 ptt180 -120.0 -9.58 9.61 Favored 'General case' 0 C--N 1.317 -0.805 0 CA-C-O 121.766 0.793 . . . . 0.0 110.049 178.287 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 663' ' ' PHE . . . . . 0.506 ' CD1' ' HG3' ' A' ' 662' ' ' ARG . 41.9 m-85 -119.93 161.34 21.05 Favored 'General case' 0 CA--C 1.479 -1.779 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 178.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 664' ' ' LEU . . . . . 0.738 ' HG ' ' CD1' ' A' ' 711' ' ' TYR 0.318 0.0 OUTLIER -130.26 141.35 50.63 Favored 'General case' 0 C--N 1.256 -3.493 0 C-N-CA 120.061 -0.656 . . . . 0.0 112.732 179.895 . . . . . . . . 4 4 . 1 . 020 nuclear nobuild full ' A' A ' 665' ' ' MET . . . . . 0.561 ' HG2' ' HB3' ' A' ' 669' ' ' ASN . 56.7 tpp -61.65 124.54 20.99 Favored 'General case' 0 C--N 1.306 -1.302 0 CA-C-N 113.841 -1.527 . . . . 0.0 111.171 -177.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 666' ' ' LYS . . . . . 0.468 ' HB3' HG13 ' A' ' 683' ' ' VAL . 63.5 tttm -106.35 -49.77 3.28 Favored 'General case' 0 C--N 1.308 -1.197 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.507 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 667' ' ' GLY . . . . . . . . . . . . . . . -87.18 -163.52 39.02 Favored Glycine 0 C--O 1.243 0.712 0 C-N-CA 120.889 -0.672 . . . . 0.0 113.951 -173.926 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 668' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -75.87 105.27 2.05 Favored 'Trans proline' 0 N--CA 1.45 -1.036 0 C-N-CA 122.601 2.2 . . . . 0.0 110.575 178.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 669' ' ' ASN . . . . . 0.561 ' HB3' ' HG2' ' A' ' 665' ' ' MET . 3.7 p-10 -72.49 4.99 3.28 Favored 'General case' 0 C--N 1.295 -1.785 0 CA-C-N 115.004 -0.998 . . . . 0.0 113.199 -173.051 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 670' ' ' LYS . . . . . 0.487 ' HA ' ' O ' ' A' ' 655' ' ' VAL . 41.2 mtmt -132.27 128.98 38.97 Favored 'General case' 0 C--N 1.298 -1.673 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 177.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 671' ' ' ILE . . . . . 0.583 HG21 ' HG ' ' A' ' 681' ' ' LEU . 43.6 pt -118.72 166.59 12.95 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.806 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -177.503 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 672' ' ' GLN . . . . . 0.521 ' HA ' ' O ' ' A' ' 653' ' ' GLU . 33.1 tt0 -134.52 137.61 44.0 Favored 'General case' 0 C--N 1.288 -2.073 0 O-C-N 123.657 0.598 . . . . 0.0 110.606 -175.532 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 673' ' ' CYS . . . . . . . . . . . . . 51.7 t -83.47 110.18 17.97 Favored 'General case' 0 C--N 1.289 -2.049 0 CA-C-N 115.054 -0.975 . . . . 0.0 108.955 177.303 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 674' ' ' VAL . . . . . . . . . . . . . 29.2 m -95.96 -168.74 0.17 Allowed 'Isoleucine or valine' 0 C--N 1.28 -2.45 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 177.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 675' ' ' ASP . . . . . 0.535 ' HA ' ' CG ' ' A' ' 628' ' ' GLN . 9.8 p-10 -82.78 78.87 9.32 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-O 122.849 1.309 . . . . 0.0 111.66 -178.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 676' ' ' GLY . . . . . 0.548 ' N ' ' HG2' ' A' ' 628' ' ' GLN . . . 146.45 -45.3 0.8 Allowed Glycine 0 N--CA 1.401 -3.668 0 CA-C-N 113.177 -1.829 . . . . 0.0 111.708 170.535 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 677' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -144.66 -168.78 3.0 Favored 'General case' 0 C--N 1.299 -1.587 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 -176.145 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 678' ' ' TRP . . . . . . . . . . . . . 83.4 m95 -102.0 168.4 9.42 Favored 'General case' 0 C--N 1.3 -1.565 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 176.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 679' ' ' THR . . . . . . . . . . . . . 29.7 p -78.67 -170.21 2.03 Favored 'General case' 0 C--N 1.3 -1.56 0 CA-C-O 120.723 0.297 . . . . 0.0 111.194 -179.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 680' ' ' THR . . . . . . . . . . . . . 33.1 m -71.14 112.56 7.38 Favored 'General case' 0 N--CA 1.42 -1.93 0 CA-C-O 121.267 0.556 . . . . 0.0 110.215 -178.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 681' ' ' LEU . . . . . 0.587 HD21 ' HG2' ' A' ' 634' ' ' PRO . 5.5 mp -68.98 153.48 96.06 Favored Pre-proline 0 N--CA 1.437 -1.089 0 CA-C-N 115.183 -0.917 . . . . 0.0 111.884 178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 682' ' ' PRO . . . . . 0.69 ' HG2' HD13 ' A' ' 636' ' ' LEU . 75.7 Cg_endo -73.19 -176.35 2.4 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 123.031 2.487 . . . . 0.0 112.442 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 683' ' ' VAL . . . . . 0.468 HG13 ' HB3' ' A' ' 666' ' ' LYS . 11.2 p -145.27 146.65 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.419 -2.002 0 N-CA-C 107.163 -1.421 . . . . 0.0 107.163 -178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 684' ' ' CYS . . . . . 0.441 ' SG ' HD21 ' A' ' 636' ' ' LEU . 63.7 m -114.29 138.54 50.38 Favored 'General case' 0 C--N 1.296 -1.755 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -177.427 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 685' ' ' ILE . . . . . 0.44 HD13 ' HD2' ' A' ' 666' ' ' LYS . 21.9 pt -130.17 146.36 34.2 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.751 0 N-CA-C 109.377 -0.601 . . . . 0.0 109.377 179.788 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 686' ' ' VAL . . . . . 0.521 HG23 ' O ' ' A' ' 662' ' ' ARG . 9.1 p -98.06 118.22 44.21 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 177.891 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 687' ' ' GLU . . . . . 0.466 ' HG2' HD11 ' A' ' 664' ' ' LEU . 5.3 pt-20 -85.6 -13.69 47.99 Favored 'General case' 0 C--N 1.303 -1.452 0 C-N-CA 118.899 -1.12 . . . . 0.0 109.043 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 688' ' ' GLU . . . . . . . . . . . . 0.27 12.3 pt-20 45.3 63.23 1.84 Allowed 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.281 1.833 . . . . 0.0 113.922 -179.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 689' ' ' SER . . . . . . . . . . . . . 8.8 t -147.38 156.84 43.26 Favored 'General case' 0 N--CA 1.419 -1.99 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 177.532 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 690' ' ' THR . . . . . . . . . . . . . 17.0 p -115.64 155.84 26.94 Favored 'General case' 0 C--N 1.29 -1.99 0 N-CA-C 113.027 0.751 . . . . 0.0 113.027 -173.17 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 691' ' ' CYS . . . . . . . . . . . . . 26.2 m -93.21 -4.5 51.88 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.912 173.017 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 692' ' ' GLY . . . . . . . . . . . . . . . 104.07 -90.21 0.72 Allowed Glycine 0 N--CA 1.421 -2.346 0 N-CA-C 110.48 -1.048 . . . . 0.0 110.48 176.196 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 693' ' ' ASP . . . . . 0.476 ' HA ' ' CE1' ' A' ' 709' ' ' TYR . 6.5 p-10 -168.65 -172.89 1.75 Allowed 'General case' 0 C--N 1.307 -1.276 0 C-N-CA 124.476 1.11 . . . . 0.0 108.107 -179.31 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 694' ' ' ILE . . . . . 0.627 HG23 ' CZ ' ' A' ' 717' ' ' PHE . 1.1 mp -64.87 126.73 91.67 Favored Pre-proline 0 N--CA 1.434 -1.258 0 CA-C-O 121.555 0.693 . . . . 0.0 112.559 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 695' ' ' PRO . . . . . 0.546 ' HD3' ' CD1' ' A' ' 738' ' ' TRP . 50.6 Cg_endo -71.28 -174.5 1.22 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.511 2.807 . . . . 0.0 112.065 178.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 696' ' ' GLU . . . . . . . . . . . . . 26.4 tt0 -108.44 113.87 27.26 Favored 'General case' 0 N--CA 1.41 -2.425 0 CA-C-N 115.705 -0.679 . . . . 0.0 110.297 -179.257 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 697' ' ' LEU . . . . . 0.915 HD23 ' HA3' ' A' ' 700' ' ' GLY . 20.3 tp -92.04 135.83 33.65 Favored 'General case' 0 C--N 1.291 -1.968 0 N-CA-C 104.61 -2.367 . . . . 0.0 104.61 171.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 698' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -58.0 -34.37 69.94 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.735 1.013 . . . . 0.0 113.735 -171.763 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 699' ' ' HIS . . . . . . . . . . . . . 85.9 m-70 -137.0 18.41 3.0 Favored 'General case' 0 C--N 1.315 -0.9 0 CA-C-O 121.856 0.836 . . . . 0.0 110.376 178.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 700' ' ' GLY . . . . . 0.915 ' HA3' HD23 ' A' ' 697' ' ' LEU . . . -127.32 176.33 17.88 Favored Glycine 0 N--CA 1.43 -1.733 0 CA-C-N 114.349 -1.296 . . . . 0.0 110.746 178.5 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 701' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -158.33 -154.41 0.43 Allowed 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 106.589 -1.634 . . . . 0.0 106.589 -177.586 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 702' ' ' ALA . . . . . 0.51 ' HA ' ' HA ' ' A' ' 717' ' ' PHE . . . -138.79 156.09 47.64 Favored 'General case' 0 C--N 1.284 -2.282 0 CA-C-N 118.819 0.736 . . . . 0.0 112.611 -169.092 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 703' ' ' GLN . . . . . 0.526 ' CD ' ' HB2' ' A' ' 718' ' ' ASN . 0.0 OUTLIER -96.37 -59.3 1.86 Allowed 'General case' 0 CA--C 1.496 -1.131 0 CA-C-N 115.598 -0.728 . . . . 0.0 110.494 -178.057 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 704' ' ' LEU . . . . . 0.484 ' O ' HD12 ' A' ' 704' ' ' LEU . 4.3 pp -114.6 127.71 55.93 Favored 'General case' 0 N--CA 1.417 -2.124 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.113 -177.905 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 705' ' ' SER . . . . . 0.455 ' HB3' HD13 ' A' ' 694' ' ' ILE . 1.8 p -106.38 124.06 49.02 Favored 'General case' 0 C--N 1.274 -2.686 0 CA-C-N 114.516 -1.22 . . . . 0.0 108.569 172.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 706' ' ' SER . . . . . . . . . . . . . 2.4 p -125.67 90.78 49.86 Favored Pre-proline 0 C--N 1.301 -1.533 0 N-CA-C 113.995 1.109 . . . . 0.0 113.995 -178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 707' ' ' PRO . . . . . 0.46 ' HA ' ' C ' ' A' ' 708' ' ' PRO . 5.9 Cg_endo -90.74 150.35 4.11 Favored 'Trans proline' 0 N--CA 1.437 -1.849 0 C-N-CA 122.644 2.229 . . . . 0.0 111.657 174.912 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 708' ' ' PRO . . . . . 0.46 ' C ' ' HA ' ' A' ' 707' ' ' PRO . 73.1 Cg_endo -74.31 134.05 33.91 Favored 'Cis proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.639 -1.817 . . . . 0.0 110.995 -1.222 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 709' ' ' TYR . . . . . 0.476 ' CE1' ' HA ' ' A' ' 693' ' ' ASP . 21.2 m-85 -77.7 82.51 4.1 Favored 'General case' 0 C--N 1.305 -1.331 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 710' ' ' TYR . . . . . 0.535 ' HB2' ' HA ' ' A' ' 662' ' ' ARG . 5.9 m-30 -87.46 166.53 14.73 Favored 'General case' 0 CA--C 1.487 -1.472 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.257 178.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 711' ' ' TYR . . . . . 0.738 ' CD1' ' HG ' ' A' ' 664' ' ' LEU . 3.3 t80 -61.13 135.99 57.93 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 108.147 -1.057 . . . . 0.0 108.147 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 712' ' ' GLY . . . . . . . . . . . . . . . 98.06 -22.28 41.66 Favored Glycine 0 C--N 1.296 -1.667 0 CA-C-N 115.562 -0.744 . . . . 0.0 113.504 -175.747 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 713' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -74.69 163.62 27.5 Favored 'General case' 0 C--O 1.255 1.376 0 CA-C-N 117.817 0.808 . . . . 0.0 109.095 177.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 714' ' ' SER . . . . . . . . . . . . . 1.3 m -136.41 147.91 47.51 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.122 0.487 . . . . 0.0 110.144 -173.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 715' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 730' ' ' SER . 33.6 t -130.59 140.46 48.71 Favored 'Isoleucine or valine' 0 C--N 1.285 -2.23 0 CA-C-N 115.271 -0.877 . . . . 0.0 109.911 178.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 716' ' ' GLU . . . . . 0.631 ' HG2' ' HB3' ' A' ' 730' ' ' SER . 46.2 mt-10 -102.33 128.27 48.96 Favored 'General case' 0 C--N 1.308 -1.217 0 CA-C-O 121.164 0.506 . . . . 0.0 111.029 174.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 717' ' ' PHE . . . . . 0.627 ' CZ ' HG23 ' A' ' 694' ' ' ILE . 3.1 m-85 -98.45 158.46 15.57 Favored 'General case' 0 C--N 1.292 -1.913 0 C-N-CA 124.717 1.207 . . . . 0.0 109.707 176.84 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 718' ' ' ASN . . . . . 0.526 ' HB2' ' CD ' ' A' ' 703' ' ' GLN . 4.0 t-20 -144.61 145.16 31.64 Favored 'General case' 0 C--N 1.288 -2.108 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 719' ' ' CYS . . . . . 0.512 ' HA ' ' HA2' ' A' ' 700' ' ' GLY . 96.9 m -96.25 158.06 15.61 Favored 'General case' 0 C--N 1.274 -2.675 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.777 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 720' ' ' SER . . . . . . . . . . . . . 21.1 t -57.28 150.9 16.99 Favored 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 108.894 -0.78 . . . . 0.0 108.894 177.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 721' ' ' GLU . . . . . . . . . . . . . 6.8 tp10 -52.47 -39.46 61.18 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.289 0.848 . . . . 0.0 113.289 -172.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 722' ' ' SER . . . . . . . . . . . . . 24.8 t -78.39 1.83 20.74 Favored 'General case' 0 CA--C 1.554 1.116 0 CA-C-O 121.668 0.747 . . . . 0.0 111.149 -179.012 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 723' ' ' PHE . . . . . 0.495 ' HB3' ' HB3' ' A' ' 744' ' ' CYS . 80.3 m-85 -123.59 147.96 46.83 Favored 'General case' 0 N--CA 1.433 -1.319 0 N-CA-C 109.322 -0.622 . . . . 0.0 109.322 -179.896 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 724' ' ' THR . . . . . . . . . . . . . 9.7 t -114.43 143.0 45.64 Favored 'General case' 0 C--N 1.272 -2.789 0 N-CA-C 107.783 -1.192 . . . . 0.0 107.783 176.037 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 725' ' ' MET . . . . . 0.522 ' HE2' ' HG3' ' A' ' 742' ' ' PRO . 8.2 ptm -92.74 141.89 27.95 Favored 'General case' 0 N--CA 1.424 -1.738 0 CA-C-O 121.483 0.659 . . . . 0.0 110.489 -176.367 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 726' ' ' ILE . . . . . . . . . . . . . 44.3 mt -114.81 114.42 46.51 Favored 'Isoleucine or valine' 0 C--N 1.28 -2.436 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 177.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 727' ' ' GLY . . . . . . . . . . . . . . . 123.53 -155.77 17.66 Favored Glycine 0 N--CA 1.427 -1.912 0 C-N-CA 120.712 -0.756 . . . . 0.0 112.031 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 728' ' ' HIS . . . . . . . . . . . . . 2.1 t-80 -95.34 136.66 35.42 Favored 'General case' 0 CA--C 1.444 -3.134 0 CA-C-O 122.283 1.039 . . . . 0.0 108.407 -175.795 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 729' ' ' ARG . . . . . . . . . . . . . 47.8 mtp180 -70.32 -37.1 74.65 Favored 'General case' 1 N--CA 1.375 -4.221 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.291 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 730' ' ' SER . . . . . 0.631 ' HB3' ' HG2' ' A' ' 716' ' ' GLU . 2.5 p -102.33 138.36 39.36 Favored 'General case' 0 N--CA 1.407 -2.586 0 CA-C-O 122.168 0.985 . . . . 0.0 113.368 -174.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 731' ' ' ILE . . . . . 0.781 HG21 HD23 ' A' ' 741' ' ' LEU . 10.9 pt -115.97 167.03 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.41 -2.44 0 CA-C-N 113.736 -1.575 . . . . 0.0 108.3 179.737 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 732' ' ' THR . . . . . . . . . . . . . 44.0 m -134.02 137.33 44.65 Favored 'General case' 0 C--N 1.274 -2.709 0 N-CA-C 109.557 -0.535 . . . . 0.0 109.557 -178.332 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 733' ' ' CYS . . . . . . . . . . . . . 42.4 t -67.32 103.94 1.38 Allowed 'General case' 0 C--N 1.308 -1.232 0 O-C-N 123.882 0.739 . . . . 0.0 109.778 177.231 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 734' ' ' ILE . . . . . . . . . . . . . 48.9 mm -128.49 110.59 21.66 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 CA-C-N 115.99 -0.55 . . . . 0.0 111.084 -176.207 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 735' ' ' HIS . . . . . . . . . . . . . 31.8 m-70 68.63 21.4 7.95 Favored 'General case' 0 N--CA 1.487 1.382 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 175.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 736' ' ' GLY . . . . . . . . . . . . . . . 92.73 18.93 39.05 Favored Glycine 0 N--CA 1.434 -1.433 0 C-N-CA 120.373 -0.918 . . . . 0.0 112.365 178.839 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 737' ' ' VAL . . . . . . . . . . . . . 11.7 p -153.15 154.88 7.01 Favored 'Isoleucine or valine' 0 N--CA 1.426 -1.67 0 N-CA-C 106.32 -1.733 . . . . 0.0 106.32 176.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 738' ' ' TRP . . . . . 0.546 ' CD1' ' HD3' ' A' ' 695' ' ' PRO . 92.6 m95 -76.21 169.72 17.67 Favored 'General case' 0 C--N 1.288 -2.107 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 177.744 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 739' ' ' THR . . . . . 0.598 ' HB ' ' HG3' ' A' ' 740' ' ' GLN . 9.2 p -49.98 -74.82 0.03 OUTLIER 'General case' 0 C--N 1.306 -1.311 0 N-CA-C 114.892 1.441 . . . . 0.0 114.892 -177.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 740' ' ' GLN . . . . . 0.598 ' HG3' ' HB ' ' A' ' 739' ' ' THR . 0.0 OUTLIER -161.54 -30.67 0.05 OUTLIER 'General case' 0 CA--C 1.496 -1.121 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -169.066 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 741' ' ' LEU . . . . . 0.781 HD23 HG21 ' A' ' 731' ' ' ILE . 22.2 mt 70.79 153.58 0.15 Allowed Pre-proline 0 N--CA 1.473 0.714 0 O-C-N 124.685 1.24 . . . . 0.0 111.596 -179.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 742' ' ' PRO . . . . . 0.522 ' HG3' ' HE2' ' A' ' 725' ' ' MET . 73.4 Cg_endo -81.8 -166.41 0.4 Allowed 'Trans proline' 0 N--CA 1.44 -1.622 0 C-N-CA 121.927 1.751 . . . . 0.0 110.034 174.13 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 743' ' ' GLN . . . . . . . . . . . . . 11.8 pt20 -140.71 147.25 38.92 Favored 'General case' 0 C--N 1.288 -2.069 0 N-CA-C 106.958 -1.497 . . . . 0.0 106.958 176.197 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 744' ' ' CYS . . . . . 0.495 ' HB3' ' HB3' ' A' ' 723' ' ' PHE . 8.8 m -104.21 143.83 32.42 Favored 'General case' 0 C--N 1.282 -2.352 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 -179.487 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 745' ' ' VAL . . . . . . . . . . . . . 13.4 m -131.89 137.16 55.53 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 N-CA-C 108.014 -1.106 . . . . 0.0 108.014 174.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 746' ' ' ALA . . . . . . . . . . . . . . . -63.35 117.09 6.16 Favored 'General case' 0 C--N 1.31 -1.139 0 O-C-N 123.555 0.534 . . . . 0.0 110.387 -178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 747' ' ' ILE . . . . . . . . . . . . . 63.0 mt . . . . . 0 C--N 1.311 -1.091 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 178.523 . . . . . . . . 0 0 . 1 stop_ save_